{"meta":{"query_hash":"88f7942411f9","filters":{"venue":"Blood Advances"},"cohort_total":598,"direct_labels_cover":1,"predictions_cover":598,"exported":598,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/88f7942411f9","api":"https://metacan.xera.ac/api/v1/cohort?venue=Blood+Advances"},"results":[{"id":"W2557980811","doi":"10.1182/bloodadvances.2016000836","title":"Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination","year":2016,"lang":"en","type":"article","venue":"Blood Advances","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; Government of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Varicella zoster virus; Postherpetic neuralgia; Cumulative incidence; Vaccination; Incidence (geometry); Hematopoietic stem cell transplantation; Transplantation; Aciclovir; Disease; Valaciclovir; Pediatrics; Internal medicine; Immunology; Viral disease; Virus; Herpesviridae; Pharmacology","score_opus":0.007065541815262595,"score_gpt":0.2551546026745968,"score_spread":0.2480890608593342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557980811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289906,0.0022714175,0.0026535792,0.00013497057,0.00015653243,0.00048592128,0.000059729733,0.000074669915,0.0012641163],"genre_scores_gemma":[0.99614424,0.00084184867,0.0015831557,0.000100465746,0.0000720541,0.00009609693,0.000026623376,0.00003203386,0.00110346],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891686,0.00004579603,0.00025578885,0.0003217228,0.00021352732,0.0002462723],"domain_scores_gemma":[0.9994868,0.0000517362,0.00009064343,0.00021097246,0.00005947247,0.000100349054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006693575,0.00019633069,0.00021923745,0.000099635356,0.00008819526,0.000018140952,0.000045268862,0.00009233837,0.00030110704],"category_scores_gemma":[0.000013500643,0.0001264222,0.000106009,0.00015604508,0.000026872674,0.0003703553,0.000010299497,0.000060733695,0.000073646006],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067696575,0.0021107292,0.5327238,0.00059797574,0.0002676756,0.0002895217,0.00041059504,0.0000095829455,0.30545026,0.000016507847,0.0001360082,0.15731043],"study_design_scores_gemma":[0.013757269,0.0012919367,0.083632804,0.00051822275,0.0014706826,0.0003818522,0.00006327429,0.000010648716,0.850842,0.00032910827,0.04701855,0.0006836383],"about_ca_topic_score_codex":0.000020736099,"about_ca_topic_score_gemma":0.000021327105,"teacher_disagreement_score":0.54539174,"about_ca_system_score_codex":0.000059104954,"about_ca_system_score_gemma":0.000038917577,"threshold_uncertainty_score":0.51553476},"labels":[],"label_agreement":null},{"id":"W2558514376","doi":"10.1182/bloodadvances.2016000877","title":"Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia","year":2016,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Platelet factor 4; Heparin; Heparin-induced thrombocytopenia; Platelet; Platelet activation; Polyphosphate; Chemistry; Thrombin; Monoclonal antibody; Biochemistry; Antibody; Immunology; Biology","score_opus":0.030147835277931034,"score_gpt":0.2909204260492202,"score_spread":0.26077259077128917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558514376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178046,0.00033134763,0.000053985605,0.0024370959,0.00063576305,0.0014353285,0.00009066309,0.00031084506,0.002924533],"genre_scores_gemma":[0.99674654,0.00094728154,0.00058024866,0.0005236545,0.0003424123,0.00015752765,0.0000788626,0.00012657889,0.0004968794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951598,0.00016980244,0.0011521499,0.0012733713,0.00091620215,0.0013286499],"domain_scores_gemma":[0.9974236,0.00039250313,0.00045245732,0.00094081624,0.00018581415,0.00060481543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003411695,0.0008063006,0.0017021007,0.000457556,0.00024825055,0.00009578414,0.0005393009,0.00041819306,0.0008457225],"category_scores_gemma":[0.0002876808,0.0005873011,0.00025353263,0.00068755593,0.00019925855,0.0010768326,0.00025973917,0.00058212597,0.00028607863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048255225,0.00087348843,0.14003785,0.00013758006,0.0003787099,0.0002109066,0.00060215546,0.000003489798,0.8101545,0.0010982985,0.00006477785,0.045955706],"study_design_scores_gemma":[0.0071471413,0.0005440014,0.33093283,0.00045747744,0.000091263275,0.00009491714,0.00014156995,0.000007854194,0.6546744,0.0006666578,0.004581864,0.00066001125],"about_ca_topic_score_codex":0.0012871134,"about_ca_topic_score_gemma":0.0031216869,"teacher_disagreement_score":0.19089499,"about_ca_system_score_codex":0.00042439558,"about_ca_system_score_gemma":0.00042557463,"threshold_uncertainty_score":0.99965787},"labels":[],"label_agreement":null},{"id":"W2558885337","doi":"10.1182/bloodadvances.2016000067","title":"Platelets as immune-sensing cells","year":2016,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Platelet; Join (topology); Immune system; Point (geometry); Data science; Biology; Immunology; Computer science; Mathematics","score_opus":0.007197545241836836,"score_gpt":0.25089779410628454,"score_spread":0.24370024886444772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558885337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132676,0.005279996,0.00005007156,0.0005929329,0.00018641526,0.00015761684,0.0000062394934,0.00007657976,0.012323396],"genre_scores_gemma":[0.9932981,0.001604648,0.0014362818,0.00020081112,0.00006179003,0.0000026759978,0.0000041699864,0.00001792488,0.0033735775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927455,0.000009333574,0.00014560572,0.00020074146,0.0001386115,0.00023116556],"domain_scores_gemma":[0.99959713,0.00005670657,0.000054129257,0.00018096685,0.00002908658,0.00008196004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032105156,0.00012441272,0.00023734385,0.00004270835,0.000057490084,0.000007965707,0.00004059735,0.000043651275,0.00012893522],"category_scores_gemma":[0.000029938372,0.000072220464,0.00006817076,0.00006646554,0.000047009988,0.00013146573,0.000017854143,0.000042141055,0.00048625638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002426801,0.00055402087,0.004294051,0.000053872616,0.00031369287,0.0041789715,0.000108049084,0.0000012361226,0.55500823,0.0002144423,0.00021541669,0.43481535],"study_design_scores_gemma":[0.006129591,0.00048385732,0.0027266173,0.00031981495,0.00019073974,0.0008301096,0.00006532627,0.000002956929,0.9105062,0.002017801,0.076511234,0.0002157509],"about_ca_topic_score_codex":0.000016302389,"about_ca_topic_score_gemma":0.0000047238136,"teacher_disagreement_score":0.4345996,"about_ca_system_score_codex":0.000012118909,"about_ca_system_score_gemma":0.000028928065,"threshold_uncertainty_score":0.6250004},"labels":[],"label_agreement":null},{"id":"W2613723809","doi":"10.1182/bloodadvances.2016001883","title":"Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"McMaster University; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Ibrutinib; Meta-analysis; Medicine; Confidence interval; Internal medicine; Relative risk; Clinical trial; Leukemia","score_opus":0.38906250886974897,"score_gpt":0.4683237556215452,"score_spread":0.07926124675179624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613723809","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.6528124e-7,0.9958555,0.000121051075,0.000028125114,0.00002362123,0.0036385295,0.00007070294,0.00002515543,0.00023692165],"genre_scores_gemma":[0.00003910869,0.9985875,0.00037315665,0.000015837933,0.000032899134,0.0003734243,0.00004134721,0.000049990966,0.00048676433],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965634,0.00023841069,0.0012799734,0.00066164025,0.0008695846,0.00038699672],"domain_scores_gemma":[0.99555624,0.0009020177,0.0018641377,0.0013024996,0.0001708071,0.0002043159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010510996,0.00055590924,0.013380335,0.00046140148,0.00014017332,0.00009204709,0.00036013345,0.00011685789,0.00006536118],"category_scores_gemma":[0.0008584389,0.00029018408,0.0017920719,0.0007525784,0.0002886058,0.00026571448,0.00016044232,0.0003676973,0.000004929152],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003819742,0.000043895223,0.0000018433649,0.84244615,0.15613763,0.000046171714,0.0000137420875,2.4130532e-7,1.1007905e-8,0.00015868492,0.000010642571,0.001137143],"study_design_scores_gemma":[0.00071723835,0.00007585189,5.502812e-8,0.26857364,0.692263,0.00032581016,0.000017400887,0.00000459552,3.5800983e-7,0.000008160554,0.037818093,0.000195773],"about_ca_topic_score_codex":0.000028100883,"about_ca_topic_score_gemma":0.00002441163,"teacher_disagreement_score":0.5738725,"about_ca_system_score_codex":0.0014930258,"about_ca_system_score_gemma":0.002648932,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W2620145341","doi":"10.1182/bloodadvances.2017004697","title":"Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Cladribine; Rituximab; Medicine; Hairy cell leukemia; Leukemia; Internal medicine; Oncology; Immunology; Lymphoma","score_opus":0.010231672994868497,"score_gpt":0.26559551846557355,"score_spread":0.25536384547070506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620145341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397916,0.0020373666,0.000032089185,0.0004975462,0.000021889473,0.00089245284,0.0000113456235,0.000048978985,0.002479166],"genre_scores_gemma":[0.9963103,0.00030133754,0.0023380362,0.0002087324,0.00006011493,0.00012084792,0.000023876413,0.000040253002,0.00059650594],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99798244,0.000044260996,0.00028973212,0.0005867613,0.0005667126,0.0005300691],"domain_scores_gemma":[0.99863786,0.0001168346,0.00018101805,0.00070000073,0.00011695359,0.0002473272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016074309,0.00028423595,0.00048469703,0.00013402311,0.00020534771,0.0000921206,0.00020206942,0.00008715431,0.00002471294],"category_scores_gemma":[0.000091910944,0.00018504378,0.000031448744,0.00013709895,0.0004707889,0.00036662695,0.0001438322,0.00027344323,0.000008647464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017382013,0.0070421407,0.8182969,0.0035933557,0.0006202376,0.0271569,0.0038736525,0.00072304864,0.010942938,0.00018384191,0.0005972377,0.10958775],"study_design_scores_gemma":[0.5827412,0.021806236,0.11729612,0.0052466365,0.00072262064,0.0030360532,0.003877281,0.019691136,0.22179008,0.00012151503,0.021623356,0.0020477506],"about_ca_topic_score_codex":0.0030952217,"about_ca_topic_score_gemma":0.0063578156,"teacher_disagreement_score":0.70100075,"about_ca_system_score_codex":0.001902629,"about_ca_system_score_gemma":0.0021618227,"threshold_uncertainty_score":0.7545867},"labels":[],"label_agreement":null},{"id":"W2623395015","doi":"10.1182/bloodadvances.2017005173","title":"In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Biotechnology and Biological Sciences Research Council; University of Bristol; British Heart Foundation","keywords":"GPVI; Platelet; Regulator; Platelet activation; Cell biology; Function (biology); Glycoprotein; Platelet membrane glycoprotein; Thrombus; Chemistry; Biology; Biochemistry; Immunology; Medicine; Internal medicine; Gene","score_opus":0.013012311169204238,"score_gpt":0.2922856410582335,"score_spread":0.27927332988902925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623395015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283296,0.0015761327,0.0000385059,0.0002556697,0.00013814292,0.00032018364,0.000029340035,0.000026880343,0.004782188],"genre_scores_gemma":[0.9973012,0.00050808216,0.00036700958,0.000066201115,0.000059717233,0.000033029668,0.000039939518,0.000016260356,0.0016085141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870616,0.00002838059,0.00034042075,0.00037268264,0.00031008196,0.00024226012],"domain_scores_gemma":[0.9988485,0.000064676206,0.0003963372,0.00050019997,0.000098719116,0.00009156377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008260504,0.0002022428,0.0006900807,0.00030717114,0.00016626224,0.000039568815,0.00015889773,0.00008573796,0.00015998867],"category_scores_gemma":[0.00013245645,0.00016672486,0.00020574992,0.0003006954,0.00017401224,0.0006579847,0.00005352555,0.000111475376,0.00003798014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026559203,0.0033757023,0.9285767,0.0004103443,0.011801575,0.0024829474,0.0016731076,0.000712081,0.027075876,0.0011749039,0.00030208917,0.019758737],"study_design_scores_gemma":[0.013323676,0.0017696806,0.853314,0.00040461405,0.005939021,0.000091357884,0.0010017422,0.0003885852,0.10393781,0.01677079,0.0025043148,0.00055442104],"about_ca_topic_score_codex":0.0004486572,"about_ca_topic_score_gemma":0.0011934346,"teacher_disagreement_score":0.07686194,"about_ca_system_score_codex":0.000023447657,"about_ca_system_score_gemma":0.00005125351,"threshold_uncertainty_score":0.6798842},"labels":[],"label_agreement":null},{"id":"W2635609779","doi":"10.1182/bloodadvances.2017005629","title":"Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institutes of Health; National Human Genome Research Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University of Michigan; Howard Hughes Medical Institute","keywords":"ADAMTS13; Genetic variants; Genetics; Biology; Gene; Immunology; Genotype","score_opus":0.022732326780712825,"score_gpt":0.29480251529035395,"score_spread":0.27207018850964115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2635609779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988139,0.0069740587,0.0000036259435,0.00004079938,0.0008554291,0.0004022549,0.00013797783,0.000033675777,0.0034131885],"genre_scores_gemma":[0.99782723,0.00013638301,0.00015182428,0.00003718941,0.000047660982,0.000054733657,0.000007880255,0.000024110772,0.0017129909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824,0.00015460644,0.00058298773,0.00046137796,0.0000895883,0.00047145237],"domain_scores_gemma":[0.99816614,0.00017903704,0.00075922994,0.00079321716,0.00006433825,0.000038010778],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016802698,0.00025819635,0.0005337464,0.00013398267,0.0003114032,0.00003487612,0.00082285743,0.00014206176,0.001725534],"category_scores_gemma":[0.00035646555,0.00024537244,0.00009826721,0.000060172264,0.00022877824,0.0002831865,0.0002844148,0.00014375415,0.0005648941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015633192,0.00036275457,0.96536624,0.00019283281,0.00013952875,0.0001783534,0.00012928978,0.000016433994,0.02604862,0.00009150792,0.000184585,0.0071335393],"study_design_scores_gemma":[0.003363241,0.00021291351,0.8797656,0.00068697584,0.00012517013,0.00015019719,0.00039398746,0.000005132434,0.10427897,0.00074700144,0.009961416,0.0003093468],"about_ca_topic_score_codex":0.00048429598,"about_ca_topic_score_gemma":0.0015831048,"teacher_disagreement_score":0.08560057,"about_ca_system_score_codex":0.00002016504,"about_ca_system_score_gemma":0.00009287766,"threshold_uncertainty_score":0.9999999},"labels":[],"label_agreement":null},{"id":"W2668200717","doi":"10.1182/bloodadvances.2017004820","title":"Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood groups and transfusion","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; RTI International; National Institutes of Health; Blood Systems Research Institute; University of California, San Francisco; Institute For Transfusion Medicine; University of Pittsburgh","keywords":"Hemolysis; Ethnic group; Red blood cell; Omics; Medicine; Genetic predisposition; Gerontology; Biology; Immunology; Demography; Internal medicine; Bioinformatics; Political science","score_opus":0.01610343930907197,"score_gpt":0.27554764196415543,"score_spread":0.25944420265508344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2668200717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954394,0.0030534866,0.0000017879735,0.00011711185,0.00009497934,0.00063686963,0.00015864494,0.00001315671,0.00048454708],"genre_scores_gemma":[0.9980129,0.0013743831,0.0002208616,0.00001725606,0.000055818557,0.0000085911715,0.0000036541112,0.000018655826,0.00028786564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998575,0.00007072436,0.00046591586,0.00038126475,0.0003063512,0.00020079035],"domain_scores_gemma":[0.9982898,0.00008264471,0.00061984087,0.00083650736,0.00007842877,0.00009274174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003272456,0.00019338637,0.0006246866,0.000051055882,0.0002489191,0.000024776757,0.00024317525,0.00009069072,0.0000015137026],"category_scores_gemma":[0.0001150209,0.00013006305,0.00007350164,0.00007366628,0.00029485062,0.00014945152,0.0002039834,0.00018838397,8.912109e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064751157,0.0028346991,0.9482997,0.0007532133,0.00018912091,0.00024510824,0.0025514856,0.0000043108444,0.038467806,0.0000039977413,0.00000792524,0.0059950952],"study_design_scores_gemma":[0.014541515,0.0010708963,0.6767619,0.0006256146,0.0015038879,0.000037223475,0.002518297,0.000020527454,0.30262166,0.00007686565,0.000059820413,0.00016175903],"about_ca_topic_score_codex":0.00024879363,"about_ca_topic_score_gemma":0.0014634179,"teacher_disagreement_score":0.2715378,"about_ca_system_score_codex":0.0000030268025,"about_ca_system_score_gemma":0.00002537452,"threshold_uncertainty_score":0.53038174},"labels":[],"label_agreement":null},{"id":"W2735763423","doi":"10.1182/bloodadvances.2017007955","title":"Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Genome British Columbia; University of Victoria","funders":"","keywords":"Proteomics; Fibrinogen; Fibrinolysis; Coagulation; Bioinformatics; Oncology; Computational biology; Medicine; Internal medicine; Biology; Biochemistry","score_opus":0.07336845511313186,"score_gpt":0.3612675516637885,"score_spread":0.2878990965506566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735763423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469477,0.0004817787,0.00058889325,0.0017466134,0.00040867913,0.0013630206,0.000101832906,0.00015111743,0.00046327108],"genre_scores_gemma":[0.99434394,0.00017439321,0.0044448436,0.00037548275,0.00010266095,0.00018910722,0.000053936892,0.00002880027,0.0002868295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986574,0.00006966101,0.00028920942,0.0003843478,0.0003076147,0.00029175857],"domain_scores_gemma":[0.9988313,0.000063503656,0.00030063698,0.00038876882,0.00022418473,0.00019165152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015703554,0.00021079945,0.0004084265,0.0000697328,0.00061618973,0.00014826453,0.00013480608,0.0001235177,0.00016747446],"category_scores_gemma":[0.00049373426,0.0001894421,0.000061053484,0.00009589382,0.000083930936,0.00046646915,0.000058140944,0.00014069767,0.000012883293],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028916993,0.00027493594,0.30330434,0.00003523865,0.0001827165,0.0000023063703,0.00027740485,0.000035512367,0.6918392,0.00062859943,0.000039644652,0.0033511326],"study_design_scores_gemma":[0.00241039,0.00015085793,0.7807474,0.00016518518,0.00020259446,0.0000021286696,0.00006488018,0.00053531333,0.21461122,0.00019158251,0.00072791486,0.00019055186],"about_ca_topic_score_codex":0.00010763185,"about_ca_topic_score_gemma":0.00035211744,"teacher_disagreement_score":0.47744304,"about_ca_system_score_codex":0.000048297512,"about_ca_system_score_gemma":0.000104981984,"threshold_uncertainty_score":0.77252245},"labels":[],"label_agreement":null},{"id":"W2750408220","doi":"10.1182/bloodadvances.2017007559","title":"Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Erythropoiesis; Anemia; Etiology; Internal medicine; Intensive care medicine","score_opus":0.01693601692040384,"score_gpt":0.2891432423573993,"score_spread":0.27220722543699544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750408220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953178,0.002630601,0.0000055982864,0.00070574816,0.00007257659,0.0004020658,0.000008739627,0.0000356452,0.0008212203],"genre_scores_gemma":[0.9957551,0.0003213403,0.0033766623,0.00007671021,0.000033165794,0.000022555525,0.00000895736,0.000023724228,0.00038183492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987541,0.000052719664,0.00020427807,0.00037432258,0.00034881948,0.00026578477],"domain_scores_gemma":[0.9989951,0.00009997073,0.000106249674,0.000630524,0.000058759677,0.00010938771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019405282,0.0002112334,0.00048766413,0.00006902811,0.00029092963,0.000050514165,0.000091249996,0.00006619112,0.000021519398],"category_scores_gemma":[0.0002813119,0.00014488843,0.0000957208,0.000046626486,0.00020076634,0.00024059185,0.00006116754,0.00013295856,0.0000053788567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044866875,0.00032001463,0.9843362,0.00009013454,0.00019811171,0.00027097267,0.0002061609,0.000025630012,0.000026446474,0.0000049064824,0.000015256205,0.014057506],"study_design_scores_gemma":[0.010202685,0.00094580377,0.9857229,0.00030337737,0.00030226074,0.000021939317,0.00023482935,0.0000056064655,0.0003084486,0.000021798862,0.0017567488,0.00017358089],"about_ca_topic_score_codex":0.00009749952,"about_ca_topic_score_gemma":0.000055628734,"teacher_disagreement_score":0.013883925,"about_ca_system_score_codex":0.000026365815,"about_ca_system_score_gemma":0.00003580575,"threshold_uncertainty_score":0.59083784},"labels":[],"label_agreement":null},{"id":"W2760163521","doi":"10.1182/bloodadvances.2017007112","title":"Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"LEO Pharma; Servier; Daiichi-Sankyo; Pfizer; McMaster University; CSL Behring; Celgene; Bristol-Myers Squibb","keywords":"Apixaban; Pharmacokinetics; Medicine; Pharmacology; Rivaroxaban; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.034213854272402734,"score_gpt":0.3384299350468502,"score_spread":0.30421608077444745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760163521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883027,0.001560113,0.00035350377,0.002130309,0.00013539701,0.00035625417,0.000007225138,0.000029692817,0.007124791],"genre_scores_gemma":[0.9952215,0.0011151386,0.0024499844,0.000036092748,0.00024997964,3.602941e-7,0.000011464484,0.0000073650335,0.00090809696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999509,0.00000852482,0.00013743302,0.00012284874,0.00014122897,0.000081000886],"domain_scores_gemma":[0.9995436,0.000029839217,0.00017221946,0.00017370292,0.000041001378,0.00003960954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007288755,0.000074685224,0.00018890495,0.00003851226,0.000099799516,0.000018433815,0.000044848726,0.000019396655,0.00003657491],"category_scores_gemma":[0.000046188707,0.000055177905,0.00002287085,0.000026842326,0.00010554873,0.00021081162,0.00003296021,0.00003051633,0.000001341572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003264543,0.00001027691,0.977334,0.000121669385,0.00008859166,0.000007724934,0.00004248071,0.000029325223,0.0035141117,0.0004758589,0.000036768164,0.018012738],"study_design_scores_gemma":[0.0047288155,0.00027519956,0.94861037,0.000098439836,0.00046172694,0.00001274617,0.000046643785,0.00020616341,0.010705894,0.00016443043,0.03458219,0.00010736836],"about_ca_topic_score_codex":0.000010987746,"about_ca_topic_score_gemma":0.00000855416,"teacher_disagreement_score":0.034545425,"about_ca_system_score_codex":0.0000025369204,"about_ca_system_score_gemma":0.000008810469,"threshold_uncertainty_score":0.22500896},"labels":[],"label_agreement":null},{"id":"W2760217744","doi":"10.1182/bloodadvances.2017009530","title":"Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Myelofibrosis; Ruxolitinib; Hazard ratio; Internal medicine; Medicine; Mutation; International Prognostic Scoring System; Oncology; Myeloid; Proportional hazards model; Univariate analysis; EZH2; Multivariate analysis; Gastroenterology; Bone marrow; Gene; Myelodysplastic syndromes; Confidence interval; Biology; Genetics","score_opus":0.021548198773284902,"score_gpt":0.33064449314742783,"score_spread":0.30909629437414293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760217744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741936,0.0004687179,0.0000018941217,0.000306065,0.00010983455,0.00051944936,0.000050217517,0.000012527268,0.0011119308],"genre_scores_gemma":[0.99795765,0.0011944924,0.00050167483,0.00007584783,0.00006106903,0.00007867804,0.000023456616,0.00001666837,0.00009044538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990898,0.000025998834,0.00027869391,0.00023923906,0.00018207847,0.000184183],"domain_scores_gemma":[0.9991111,0.00016176989,0.0002187738,0.00036905776,0.00006744181,0.00007183741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046123885,0.00018292961,0.00039317913,0.00010517822,0.00016789605,0.000038862127,0.00008839283,0.000041139134,0.000060110673],"category_scores_gemma":[0.00012180392,0.00012083731,0.00014940479,0.000035990455,0.000052522904,0.00021034066,0.000025018411,0.00007294397,0.000016084357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015844073,0.0020216557,0.9884581,0.000018512983,0.00019450646,0.000006039397,0.00017768652,0.00005609305,0.0014713656,0.00010582149,0.00002179248,0.0073099663],"study_design_scores_gemma":[0.0064315037,0.002675141,0.9734593,0.00016865905,0.000038277947,0.0000010078171,0.000015978902,0.0000063801217,0.016890492,0.000098534125,0.00011244736,0.000102251775],"about_ca_topic_score_codex":0.000080112004,"about_ca_topic_score_gemma":0.00019692436,"teacher_disagreement_score":0.0154191265,"about_ca_system_score_codex":0.00007259667,"about_ca_system_score_gemma":0.00009058733,"threshold_uncertainty_score":0.49276024},"labels":[],"label_agreement":null},{"id":"W2765241801","doi":"10.1182/bloodadvances.2017007021","title":"Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Canadian Blood Services; University of Toronto; Centre hospitalier universitaire de Québec; St. Michael's Hospital","funders":"Health Canada; Hospital for Sick Children; China Scholarship Council; University of Toronto; Canadian Blood Services; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institutes of Health; National Science Foundation","keywords":"Antigen; Antigen processing; CD8; Cell biology; MHC class I; Major histocompatibility complex; Platelet; MHC restriction; MHC class II; In vitro; Biology; Chemistry; Immunology; Molecular biology; Biochemistry","score_opus":0.0133673952817504,"score_gpt":0.26851489473052226,"score_spread":0.25514749944877185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765241801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869202,0.003582356,0.000049705843,0.0032146887,0.00012413989,0.0006423617,0.000066106215,0.000049216473,0.005351271],"genre_scores_gemma":[0.9935729,0.0022383884,0.0022081765,0.0005635325,0.00009921312,0.0000406581,0.000012906736,0.00002833751,0.0012359079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890316,0.000011028992,0.00015709974,0.00039203637,0.00021385282,0.00032279818],"domain_scores_gemma":[0.99920166,0.000028951836,0.00003241415,0.00041954385,0.000040704075,0.00027673406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039584047,0.00022999808,0.00038066704,0.00005449724,0.00022181186,0.00007782629,0.00016165792,0.00007159319,0.000045061188],"category_scores_gemma":[0.000023324175,0.00016969042,0.000060351533,0.000051816176,0.000054279255,0.00017307365,0.00006740615,0.00009992986,0.00006014883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048280647,0.006523692,0.14436069,0.0014753848,0.0031248378,0.01823386,0.005315908,0.00039700945,0.55302924,0.0018469621,0.008098028,0.25276634],"study_design_scores_gemma":[0.0056141526,0.000995049,0.06414433,0.00035897404,0.00028090557,0.000362895,0.00018632469,0.000031334006,0.7231217,0.00053044874,0.20388317,0.0004906896],"about_ca_topic_score_codex":0.00004456559,"about_ca_topic_score_gemma":0.00005804243,"teacher_disagreement_score":0.25227565,"about_ca_system_score_codex":0.000007942292,"about_ca_system_score_gemma":0.00002053701,"threshold_uncertainty_score":0.69197744},"labels":[],"label_agreement":null},{"id":"W2767286122","doi":"10.1182/bloodadvances.2017010355","title":"A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Strain (injury); Phenotype; Knockout mouse; Biology; Genetics; Anatomy; Gene","score_opus":0.006531248503340475,"score_gpt":0.3028832994302317,"score_spread":0.2963520509268912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767286122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897469,0.009039118,0.0008319132,0.000031845975,0.000035124987,0.00007408385,0.000043726384,0.0000038136745,0.00019344826],"genre_scores_gemma":[0.9968376,0.0014745111,0.0014460746,0.000005322357,0.0000163682,0.000007130324,0.000008999542,0.000006157676,0.00019781287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954504,0.000007314274,0.000115041286,0.00016665613,0.000047525013,0.0001184342],"domain_scores_gemma":[0.9997004,0.0000070082933,0.000048119444,0.00020318017,0.000014039618,0.00002722521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006940256,0.000079411904,0.00009962085,0.000020457994,0.00004105542,0.000014749584,0.000106217696,0.000035755347,0.0000020252144],"category_scores_gemma":[0.000053689437,0.00007619817,0.00002471428,0.00001046392,0.00005298349,0.000005678472,0.000050021947,0.000031659274,2.486407e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001259732,0.00003915337,0.011296186,0.000057373276,0.00001792178,0.0000020905775,0.00008768298,0.0004493693,0.9650883,0.000019737246,0.0000013440738,0.022928212],"study_design_scores_gemma":[0.0008189722,0.0001880279,0.0461826,0.000033522356,0.000014344674,0.000006867624,0.00025698968,0.00018409069,0.94890517,0.0001555274,0.0030849539,0.00016893573],"about_ca_topic_score_codex":0.000012128316,"about_ca_topic_score_gemma":0.00016001308,"teacher_disagreement_score":0.034886416,"about_ca_system_score_codex":0.0000018168938,"about_ca_system_score_gemma":0.000007860116,"threshold_uncertainty_score":0.31072715},"labels":[],"label_agreement":null},{"id":"W2770115049","doi":"10.1182/bloodadvances.2017012112","title":"Maintenance of telomere length in AML","year":2017,"lang":"en","type":"review","venue":"Blood Advances","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Telomere; Telomerase; Chronic lymphocytic leukemia; Myeloid leukemia; Leukemia; Cancer research; Biology; Cancer; Stem cell; Immunology; Genetics; DNA; Gene","score_opus":0.08855138058254122,"score_gpt":0.4001026266057539,"score_spread":0.3115512460232127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770115049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121510195,0.9913703,0.0000032437097,0.000043166456,0.0003748312,0.0008518782,0.00007725223,0.00004850674,0.007109279],"genre_scores_gemma":[0.00045686917,0.99556184,0.0008645485,0.00003546989,0.00028615273,0.000081977414,0.000047225007,0.00006658202,0.0025993132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733865,0.00008206727,0.0010149617,0.00065561896,0.00038497781,0.0005237274],"domain_scores_gemma":[0.9974763,0.0001920283,0.00094601285,0.0011194462,0.00010712746,0.00015908708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027496397,0.0005355357,0.0032682612,0.00037358407,0.000070982765,0.000019377865,0.00057151885,0.00029588465,0.00006314956],"category_scores_gemma":[0.0005293574,0.00039368932,0.0005003582,0.00032525757,0.00031781805,0.00021088161,0.00009981434,0.0005912574,0.000054200747],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020801348,0.0002563907,0.0007285424,0.028878711,0.00011395103,0.00028557848,0.00004833473,1.4134294e-7,0.0000033869567,0.00020669457,0.000117718526,0.9693397],"study_design_scores_gemma":[0.00084294984,0.00016144679,0.0003782782,0.045137085,0.0006870383,0.00023546071,0.00004666827,4.5595743e-7,0.000041097053,0.00007003279,0.95203185,0.00036761578],"about_ca_topic_score_codex":0.000051878356,"about_ca_topic_score_gemma":0.000107192966,"teacher_disagreement_score":0.96897215,"about_ca_system_score_codex":0.000051116956,"about_ca_system_score_gemma":0.00048425418,"threshold_uncertainty_score":0.9998515},"labels":[],"label_agreement":null},{"id":"W2770790219","doi":"10.1182/bloodadvances.2017011601","title":"CD86 regulates myeloma cell survival","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Multiple myeloma; Cancer research; Downregulation and upregulation; Gene silencing; CD86; Signal transduction; CD28; Biology; Medicine; Cell biology; T cell; Immunology; Genetics; Gene; Immune system","score_opus":0.025556134169272066,"score_gpt":0.3246470050546573,"score_spread":0.2990908708853853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770790219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238079,0.0036394529,0.000008827077,0.0006386514,0.00021678004,0.0002990354,0.00001799494,0.000069432,0.07130193],"genre_scores_gemma":[0.9851949,0.00067508925,0.0020995187,0.00003116823,0.0002543273,0.000023943308,0.000021033058,0.000019446099,0.011680573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988836,0.000022205586,0.00013607994,0.00027715514,0.000328121,0.00035280836],"domain_scores_gemma":[0.99886125,0.000060359784,0.00009748642,0.0006811639,0.000073099414,0.00022664842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095148316,0.00014406817,0.00024933528,0.00004640779,0.0003731724,0.00007287117,0.0002053495,0.00004755503,0.00016013357],"category_scores_gemma":[0.00019063069,0.00010698723,0.00008522527,0.0000338204,0.0001487711,0.00025622934,0.00008681882,0.00010559754,0.00019326548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043226063,0.00093387556,0.8745295,0.00023207159,0.00022581368,0.0009983684,0.00007709006,0.0000018850402,0.020386763,0.00028446424,0.0003205788,0.10157738],"study_design_scores_gemma":[0.005868289,0.00045408538,0.76849115,0.00008968037,0.00011502577,0.000044116634,0.00006610434,0.000034478115,0.19034207,0.00047328844,0.033852093,0.00016962572],"about_ca_topic_score_codex":0.00005541191,"about_ca_topic_score_gemma":0.00005639229,"teacher_disagreement_score":0.1699553,"about_ca_system_score_codex":0.00001366882,"about_ca_system_score_gemma":0.00005379618,"threshold_uncertainty_score":0.43628126},"labels":[],"label_agreement":null},{"id":"W2772326091","doi":"10.1182/bloodadvances.2017010942","title":"Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Amgen Canada","keywords":"Medicine; Interquartile range; Immune thrombocytopenia; Confidence interval; Hematology; Severe bleeding; Pediatrics; Internal medicine; Surgery; Platelet","score_opus":0.02847892635415331,"score_gpt":0.2967831409619002,"score_spread":0.2683042146077469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772326091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96080124,0.029069128,0.0000023591354,0.0017833269,0.00006198483,0.00018654446,0.00008571904,0.0000074590043,0.008002221],"genre_scores_gemma":[0.99339753,0.0049513397,0.0012859661,0.00007137785,0.00003826681,0.000011569568,0.000017042315,0.000010071564,0.0002168213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993287,0.000011521294,0.00021167159,0.00018121931,0.00014496536,0.00012197873],"domain_scores_gemma":[0.99904424,0.00012400166,0.00031240965,0.00043779003,0.000043720025,0.000037826212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059861202,0.000114887545,0.00047863496,0.000014505717,0.00013608612,0.000017345585,0.00018749436,0.00004968095,0.000056285575],"category_scores_gemma":[0.00009324385,0.00007178183,0.000064362735,0.000026381555,0.00027493233,0.00018568036,0.00007296261,0.0000774985,0.0000017016072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011641989,0.00067170063,0.89214313,0.00019363208,0.00061793457,0.00009928337,0.00044161425,3.2377685e-7,0.07541447,0.0002699512,0.00014388871,0.029887632],"study_design_scores_gemma":[0.002967813,0.000182794,0.9344174,0.00046081687,0.00054572884,0.00002820879,0.00024669015,0.0000010893167,0.058567815,0.0015494803,0.00094366114,0.000088455585],"about_ca_topic_score_codex":0.0006848003,"about_ca_topic_score_gemma":0.00009548605,"teacher_disagreement_score":0.042274296,"about_ca_system_score_codex":0.0000058014925,"about_ca_system_score_gemma":0.000034214838,"threshold_uncertainty_score":0.2927178},"labels":[],"label_agreement":null},{"id":"W2774352722","doi":"10.1182/bloodadvances.2017gs102562","title":"DFCI/BCH-HITO quality improvement project for hematologic malignancies: implementation and validation of MRD by flow cytometry in pediatric acute leukemia treatment protocols","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Hematologic Neoplasms; Oncology; Flow cytometry; Medicine; Leukemia; Internal medicine; Quality (philosophy); Cancer; Immunology","score_opus":0.04328637857977705,"score_gpt":0.4280707599888696,"score_spread":0.38478438140909255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774352722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755125,0.00029547932,0.0011944043,0.00017172948,0.00004383752,0.022338722,0.0003170307,0.000030365809,0.00009590897],"genre_scores_gemma":[0.96197814,0.0008239911,0.011991222,0.00003685054,0.00013740416,0.024586681,0.00020848493,0.000028938204,0.00020831269],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802184,0.000055440603,0.0006388603,0.00047423187,0.00041856943,0.0003910681],"domain_scores_gemma":[0.9985264,0.00022052115,0.00055702607,0.00044856162,0.00016195724,0.00008551774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004841326,0.00023285772,0.000549868,0.00020234511,0.0001648217,0.000055958648,0.00017645974,0.00009691091,0.000010829875],"category_scores_gemma":[0.0003069606,0.00017690187,0.000079683414,0.00016874941,0.000105612125,0.00036940127,0.000087945504,0.00007065344,0.0000012362558],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025205559,0.0015859971,0.7234767,0.0054366835,0.0004535379,0.000056512992,0.001061731,0.0000152281855,0.19333462,0.00015836894,0.0009127116,0.07098734],"study_design_scores_gemma":[0.030861897,0.006691835,0.037801504,0.00020301703,0.0005448564,0.000038738144,0.001075528,0.0003169067,0.92042595,0.00037471182,0.0012965158,0.00036852257],"about_ca_topic_score_codex":0.000326141,"about_ca_topic_score_gemma":0.00007438443,"teacher_disagreement_score":0.7270913,"about_ca_system_score_codex":0.0006221617,"about_ca_system_score_gemma":0.0007364242,"threshold_uncertainty_score":0.7213849},"labels":[],"label_agreement":null},{"id":"W2774408258","doi":"10.1182/bloodadvances.2017009472","title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nodular sclerosis; CD30; Medicine; Vincristine; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Pathology; Cyclophosphamide; Chemotherapy; Hodgkin lymphoma","score_opus":0.02281939306840379,"score_gpt":0.31848659060466666,"score_spread":0.29566719753626286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774408258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957072,0.0024305088,0.0000013937344,0.00040448003,0.00009226823,0.0005000135,0.000025981066,0.000032712094,0.0008054241],"genre_scores_gemma":[0.9985885,0.00039431246,0.0005998668,0.000053084084,0.00014497127,0.000047425227,0.0000063456782,0.000014216623,0.00015130412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887395,0.00005109426,0.00027782132,0.00036657567,0.000226278,0.00020430672],"domain_scores_gemma":[0.99873316,0.00024374117,0.0003193974,0.0004969224,0.00006781826,0.00013898434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012230781,0.00020140271,0.0006166259,0.000051035982,0.00017484734,0.000035018285,0.00012231214,0.00006750612,0.0000037509335],"category_scores_gemma":[0.00014530975,0.00011847548,0.000053692824,0.000036591424,0.00045148324,0.00006984257,0.00009349452,0.00006633382,0.0000034039872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031892434,0.0032925971,0.9336883,0.00004763573,0.00024001814,0.00073262793,0.0002378968,2.0489338e-7,0.000039535957,0.000034082263,0.000040653296,0.06132752],"study_design_scores_gemma":[0.018743662,0.006361556,0.97029185,0.0001738305,0.00088766956,0.000160566,0.00060370244,7.3230683e-7,0.0021390873,0.00006039396,0.00045072366,0.00012623511],"about_ca_topic_score_codex":0.00007382941,"about_ca_topic_score_gemma":0.00023814554,"teacher_disagreement_score":0.061201286,"about_ca_system_score_codex":0.000014957129,"about_ca_system_score_gemma":0.000050600705,"threshold_uncertainty_score":0.483129},"labels":[],"label_agreement":null},{"id":"W2774435803","doi":"10.1182/bloodadvances.2017012310","title":"Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Gastroenterology; Internal medicine; Confidence interval; Macrophage activation syndrome; Area under the curve; Sepsis; Receiver operating characteristic; Immunology; Malignancy; Ferritin; Disease","score_opus":0.013478112865195757,"score_gpt":0.30485264285988134,"score_spread":0.2913745299946856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774435803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701631,0.0022683304,0.000013291574,0.00419027,0.0002523382,0.00057476835,0.000017894356,0.000059168226,0.022460805],"genre_scores_gemma":[0.9899664,0.003818308,0.0003431689,0.00055875967,0.00012995549,0.00006285023,0.000012444672,0.000024640383,0.005083451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987722,0.000025438452,0.00028052722,0.00030243897,0.00025420045,0.00036518974],"domain_scores_gemma":[0.9986606,0.00040718567,0.000138868,0.0005300578,0.0001707477,0.00009249398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015090598,0.0001549004,0.00034553828,0.00009782362,0.00021756,0.000061620594,0.00020912982,0.00007432655,0.00023006875],"category_scores_gemma":[0.0051113223,0.0001331002,0.000073867974,0.00007731272,0.00022772877,0.00043404519,0.00012804521,0.00028089332,0.00036751755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029917582,0.0013358777,0.8691363,0.00043813259,0.0001300398,0.000635026,0.0024877102,0.0000026915359,0.017324302,0.0002642979,0.006893918,0.10105258],"study_design_scores_gemma":[0.014132611,0.002166565,0.4299087,0.0033632934,0.00016471985,0.00011399203,0.0045173466,0.0003344004,0.24049075,0.000530612,0.30338675,0.00089027954],"about_ca_topic_score_codex":0.00015728686,"about_ca_topic_score_gemma":0.00022611572,"teacher_disagreement_score":0.43922755,"about_ca_system_score_codex":0.000028871076,"about_ca_system_score_gemma":0.00012126912,"threshold_uncertainty_score":0.61191},"labels":[],"label_agreement":null},{"id":"W2782034044","doi":"10.1182/bloodadvances.2017gs99978","title":"SickKids-Caribbean Initiative: collaborating to improve the diagnosis and care of children with cancer and serious blood disorders in the Caribbean","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Health Sciences Research and Education","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Caribbean region; Blood cancer; Medicine; Political science; Childhood cancer; Pediatric cancer; Blood Disorder; Cancer; Family medicine; Internal medicine; Latin Americans","score_opus":0.03563355976408267,"score_gpt":0.4177501415107179,"score_spread":0.3821165817466352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782034044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801534,0.004212769,0.0000015642908,0.01260986,0.00013568319,0.0019450098,0.00014757576,0.0000075489725,0.0007866207],"genre_scores_gemma":[0.9947395,0.0032815821,0.0001777689,0.0004931837,0.00015056404,0.0011260968,0.0000049483406,0.000008753949,0.000017654333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854654,0.00025360717,0.00023565993,0.00027048533,0.00026635075,0.00042737028],"domain_scores_gemma":[0.99860615,0.00052683876,0.00023929786,0.00033593876,0.00016368432,0.00012812261],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006204433,0.00011608582,0.00017923162,0.000052091185,0.0019525727,0.00006205541,0.00036017236,0.000045448596,0.000007301937],"category_scores_gemma":[0.000610762,0.000060965027,0.000010231599,0.00025455854,0.00033169633,0.0003359863,0.000119178076,0.00031026945,6.831498e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018430488,0.0000405987,0.9359023,0.00013899678,0.000015145611,3.875448e-7,0.041113723,0.0000065781355,0.000026619582,0.00006870453,0.00009227295,0.022576254],"study_design_scores_gemma":[0.00084944296,0.00039400504,0.9231952,0.0002040902,0.000033491448,6.617494e-7,0.073159695,0.000005787406,0.00018508,0.000096850476,0.0017795714,0.000096129064],"about_ca_topic_score_codex":0.009911399,"about_ca_topic_score_gemma":0.13020033,"teacher_disagreement_score":0.12028892,"about_ca_system_score_codex":0.00002015176,"about_ca_system_score_gemma":0.00059000036,"threshold_uncertainty_score":0.99934673},"labels":[],"label_agreement":null},{"id":"W2784875453","doi":"10.1182/bloodadvances.2017011510","title":"Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research; Compute Canada; McGill University","keywords":"Dormancy; Biology; Mutation; Term (time); Dynamics (music); Evolutionary dynamics; Evolutionary biology; Resistance (ecology); Genetics; Medicine; Ecology; Psychology; Gene; Population","score_opus":0.00882148161357588,"score_gpt":0.2782397888592992,"score_spread":0.2694183072457233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784875453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633324,0.002140966,0.00021844862,0.0003002624,0.00009355271,0.00025101236,0.000028609693,0.000026390062,0.0006075036],"genre_scores_gemma":[0.9955135,0.0010889574,0.0026793315,0.00011406418,0.0001702412,0.000009292634,0.0000569434,0.000019653833,0.00034800617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886125,0.000026849222,0.00024120053,0.00027024702,0.0003745774,0.00022589263],"domain_scores_gemma":[0.9993263,0.0001346385,0.00009841963,0.0001526161,0.00014500151,0.00014300807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000122050405,0.00013418848,0.000233882,0.000115660325,0.000071927025,0.000014512091,0.000067796034,0.00007543384,0.00007597721],"category_scores_gemma":[0.000085465304,0.000108381064,0.000030335817,0.0001322106,0.0003991827,0.00022528182,0.00007807853,0.00012825304,0.000007462465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019800833,0.0011358041,0.80941206,0.00088741,0.000697682,0.00041387396,0.0030438884,0.0000071189816,0.018072529,0.0011353354,0.00011553931,0.16309868],"study_design_scores_gemma":[0.0064973678,0.0016979383,0.98566127,0.00024964538,0.00014980051,0.0004085735,0.000045659275,0.00068300957,0.0037925297,0.0005534691,0.00011840025,0.00014232463],"about_ca_topic_score_codex":0.000011490906,"about_ca_topic_score_gemma":0.000027082055,"teacher_disagreement_score":0.17624922,"about_ca_system_score_codex":0.000034677163,"about_ca_system_score_gemma":0.00016683097,"threshold_uncertainty_score":0.44196516},"labels":[],"label_agreement":null},{"id":"W2789400319","doi":"10.1182/bloodadvances.2017007880","title":"Dock8 regulates BCR signaling and activation of memory B cells via WASP and CD19","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"CD19; breakpoint cluster region; Cell biology; Memory B cell; Biology; Chemistry; B cell; Immunology; Receptor; Antigen; Antibody; Genetics","score_opus":0.004446589406252071,"score_gpt":0.20647877009225432,"score_spread":0.20203218068600226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789400319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532681,0.045682177,0.00014827454,0.00004112543,0.00025113084,0.0000988915,0.0000044771064,0.000026234944,0.00047955784],"genre_scores_gemma":[0.9990024,0.00046202977,0.00012983187,0.000040856434,0.000007459845,0.000003836528,0.000011713203,0.000007254155,0.0003346461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936867,0.000052135234,0.00019137193,0.00019252406,0.000022688413,0.00017263884],"domain_scores_gemma":[0.9996064,0.00009475539,0.00012497282,0.000121410965,0.000048525053,0.0000039772463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012592389,0.000111361136,0.0001794807,0.00005629734,0.00019392633,0.0000073816277,0.00007885139,0.00008842736,0.00007122997],"category_scores_gemma":[0.00002397777,0.00009605156,0.000024500623,0.00008124749,0.00050021394,0.0002006948,0.00004481806,0.00008172258,0.000009746555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053162967,0.000064531196,0.00020698804,0.000035692494,0.00004456864,2.1808592e-7,0.0008159008,0.0000072476705,0.9719254,0.00010388774,0.0000059146064,0.02673651],"study_design_scores_gemma":[0.00076899235,0.0002004331,0.0015387257,0.000059366575,0.000037692036,0.000009103064,0.00082266453,0.0000060597276,0.9911284,0.0008250104,0.0044834176,0.000120158395],"about_ca_topic_score_codex":0.000043046257,"about_ca_topic_score_gemma":0.0000018787432,"teacher_disagreement_score":0.04573424,"about_ca_system_score_codex":0.0000021843812,"about_ca_system_score_gemma":0.000011326705,"threshold_uncertainty_score":0.3916869},"labels":[],"label_agreement":null},{"id":"W2789589674","doi":"10.1182/bloodadvances.2017014704","title":"Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hamilton Health Sciences; McMaster Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Fusion gene; Oncology; Medicine; Internal medicine; Acute lymphocytic leukemia; ABL; Tyrosine kinase; Cancer research; Hazard ratio; Immunology; Leukemia; Biology; Gene; Lymphoblastic Leukemia; Genetics; Receptor","score_opus":0.009447931865033935,"score_gpt":0.2952524425280913,"score_spread":0.28580451066305734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789589674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966363,0.0012039708,0.0008292398,0.00004806695,0.0000930323,0.000619726,0.000102968275,0.00007061365,0.00039612292],"genre_scores_gemma":[0.9907094,0.002162833,0.006380284,0.000026313455,0.0004967446,0.00006260415,0.000029966843,0.000045975503,0.00008587642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997787,0.000099436664,0.0005589651,0.0004931599,0.00046305737,0.0005984014],"domain_scores_gemma":[0.99771464,0.0010622788,0.00028384998,0.00037007275,0.0002857531,0.0002834324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002652996,0.00029240013,0.0005395389,0.00047630203,0.00018154155,0.000023345501,0.00017233907,0.00013785572,0.000087344364],"category_scores_gemma":[0.001999545,0.00022803528,0.00011366046,0.0011188263,0.00037443262,0.0002716105,0.00017515247,0.00031390035,0.000022292215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005637245,0.0006123036,0.969555,0.00032890876,0.00028990113,0.0002516261,0.00051448814,0.00028247992,0.01864136,0.000093408606,0.0001565668,0.008710216],"study_design_scores_gemma":[0.0092929,0.0035064484,0.9689458,0.0003881266,0.00090966874,0.00029400625,0.00016536712,0.006575686,0.009245644,0.00022887696,0.00008981466,0.00035766314],"about_ca_topic_score_codex":0.0007154001,"about_ca_topic_score_gemma":0.00013790066,"teacher_disagreement_score":0.009395717,"about_ca_system_score_codex":0.0004643938,"about_ca_system_score_gemma":0.0013407097,"threshold_uncertainty_score":0.9299009},"labels":[],"label_agreement":null},{"id":"W2798072661","doi":"10.1182/bloodadvances.2018017160","title":"Risk of recurrent venous thromboembolism according to baseline risk factor profiles","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Aspirin; Placebo; Hazard ratio; Rivaroxaban; Risk factor; Venous thromboembolism; Internal medicine; Confidence interval; Proportional hazards model; Surgery; Thrombosis; Warfarin; Atrial fibrillation","score_opus":0.014098676050533323,"score_gpt":0.2938281998884391,"score_spread":0.2797295238379058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798072661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055994,0.0034783157,0.0012082044,0.0002531637,0.0008667868,0.0011119075,0.00028460432,0.00012378932,0.0021133123],"genre_scores_gemma":[0.9854354,0.0055102888,0.007548822,0.0002685657,0.0010214573,0.00007980706,0.000015737904,0.000042874144,0.000077031444],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980163,0.00010258001,0.00051273225,0.0005027515,0.00042082524,0.00044482935],"domain_scores_gemma":[0.9984457,0.00014752254,0.0003795948,0.00053672795,0.0002655775,0.00022491072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003906584,0.00027504802,0.000891937,0.00019935973,0.00019626941,0.000021110123,0.00021342294,0.00006882717,0.00028868736],"category_scores_gemma":[0.00067730655,0.00022069721,0.00016724161,0.00036450918,0.00012868978,0.00016458539,0.00015123787,0.00019235251,0.0001272665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038826844,0.007211949,0.1850016,0.0007923592,0.0015315606,0.000036099846,0.0038840373,0.00010351342,0.009531739,0.00078588695,0.0035017347,0.78723127],"study_design_scores_gemma":[0.0035111199,0.009689053,0.7063363,0.0012789329,0.0032877615,0.00001974538,0.0025081073,0.00018153829,0.17320085,0.001154624,0.097973675,0.0008582478],"about_ca_topic_score_codex":0.00016949457,"about_ca_topic_score_gemma":0.000099865814,"teacher_disagreement_score":0.786373,"about_ca_system_score_codex":0.000030909072,"about_ca_system_score_gemma":0.000060961367,"threshold_uncertainty_score":0.8999771},"labels":[],"label_agreement":null},{"id":"W2800166901","doi":"10.1182/bloodadvances.2017015479","title":"Analysis of the thrombotic and fibrinolytic activities of tumor cell–derived extracellular vesicles","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Microvesicles; Cell culture; Plasmin; Fibrin; Extracellular; Cancer research; Chemistry; A549 cell; Cell; Cell biology; Immunology; Medicine; Biology; Biochemistry; microRNA","score_opus":0.005763486582701513,"score_gpt":0.22891691527174649,"score_spread":0.22315342868904497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800166901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829055,0.016354926,0.00020408409,0.00001351682,0.000050810744,0.0001114274,0.000032113352,0.0000054196203,0.0003221975],"genre_scores_gemma":[0.9986989,0.0002588223,0.00077147037,0.000020633208,0.000060010574,0.0000046939267,0.000007407201,0.000012853018,0.00016521962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999164,0.00006297919,0.00022517194,0.00025426035,0.00014020411,0.00015339757],"domain_scores_gemma":[0.9991955,0.000031304055,0.0002256738,0.00044808918,0.0000559492,0.000043444626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008356989,0.00012649207,0.00023056824,0.000052231066,0.00006523337,0.000008489169,0.00022760859,0.000043002954,0.000019010935],"category_scores_gemma":[0.000052259667,0.000098606106,0.00014680126,0.00022022503,0.0006626741,0.000009738255,0.00014395139,0.000038452163,5.007218e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029038485,0.00011835481,0.03877312,0.00007584659,0.00029235263,0.0000012395412,0.00009430055,0.000079025325,0.96000385,0.000050683924,0.000006305465,0.00047585767],"study_design_scores_gemma":[0.00026441508,0.00015844018,0.040179707,0.000018919303,0.0008320902,0.000002607446,0.00025659782,0.000105786945,0.95770943,0.000086387,0.00027627932,0.00010933001],"about_ca_topic_score_codex":0.000006621643,"about_ca_topic_score_gemma":0.000030536376,"teacher_disagreement_score":0.016096104,"about_ca_system_score_codex":0.0000023462665,"about_ca_system_score_gemma":0.00003868268,"threshold_uncertainty_score":0.40210402},"labels":[],"label_agreement":null},{"id":"W2801615503","doi":"10.1182/bloodadvances.2017014944","title":"Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Cancer Institute","keywords":"Medicine; Young adult; Lymphoblastic Leukemia; Pediatric cancer; Pediatrics; Quarter (Canadian coin); Cancer; Oncology; Leukemia; Internal medicine","score_opus":0.009176209606571959,"score_gpt":0.29517683253800125,"score_spread":0.2860006229314293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801615503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982818,0.0006167453,0.00010155466,0.00006551799,0.00008345273,0.00072008907,0.000041786123,0.000027729444,0.0000613409],"genre_scores_gemma":[0.99893165,0.00011493639,0.0006357157,0.00011748179,0.000067570094,0.000039922754,0.000016126372,0.000023343731,0.000053275424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985204,0.000052636682,0.00035481906,0.00037829293,0.00041435478,0.00027954968],"domain_scores_gemma":[0.99914855,0.00014940504,0.00010339148,0.000252505,0.00021731971,0.00012880363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081867016,0.00019594416,0.000472996,0.00020416031,0.00006072666,0.000015956759,0.00008676995,0.000068991554,0.0000099841345],"category_scores_gemma":[0.00022125631,0.00015277136,0.000035703248,0.00017400064,0.00008514728,0.00011362705,0.00008153582,0.00011603722,0.0000018979669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032666183,0.00031566515,0.99461037,0.00044061546,0.00008624362,0.00009171906,0.0010209786,0.000006780607,0.0002394675,0.0000109641705,0.0000030941046,0.0028474487],"study_design_scores_gemma":[0.010742913,0.0019303629,0.98228276,0.00047233189,0.0002640528,0.000033176697,0.002415014,0.0005383354,0.0011586447,0.0000114817,0.000008756294,0.00014218022],"about_ca_topic_score_codex":0.00093909027,"about_ca_topic_score_gemma":0.002774066,"teacher_disagreement_score":0.012327611,"about_ca_system_score_codex":0.00027409673,"about_ca_system_score_gemma":0.00025367716,"threshold_uncertainty_score":0.6229835},"labels":[],"label_agreement":null},{"id":"W2802073123","doi":"10.1182/bloodadvances.2017013052","title":"Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Office of Naval Research; Kite Pharma; Health Resources and Services Administration; Swedish Orphan Biovitrum; Otsuka Pharmaceutical; Juno Therapeutics; Astellas Pharma; Janssen Scientific Affairs; National Institutes of Health; Telomere Diagnostics; bluebird bio; Sunesis; Chimerix; Medical College of Wisconsin; Takeda Oncology; University of Minnesota; Karyopharm Therapeutics; U.S. Navy; Celgene; U.S. Department of Defense; Sanofi; U.S. Department of Health and Human Services; Astellas Pharma US; National Institute of Allergy and Infectious Diseases; Angiocrine Bioscience; National Center for Advancing Translational Sciences; HistoGenetics; Sanofi Genzyme; Patient-Centered Outcomes Research Institute; Pharmacyclics; Cerus Corporation; Bristol-Myers Squibb; Medac; Jazz Pharmaceuticals; Be The Match Foundation; Spectrum Pharmaceuticals; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Amgen; Atara Biotherapeutics; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences","keywords":"Sibling; Graft-versus-host disease; Medicine; Disease; Host (biology); Internal medicine; Immunology; Biology; Psychology; Genetics","score_opus":0.023367659088868512,"score_gpt":0.28358137306203085,"score_spread":0.26021371397316234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802073123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560416,0.0008972999,0.0003629585,0.00006824688,0.00023977965,0.000609186,0.00008053835,0.000057169786,0.0020806629],"genre_scores_gemma":[0.996436,0.00047081924,0.002638686,0.0000359425,0.00007218031,0.000034886583,0.000097768,0.000029234016,0.0001844635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984027,0.000053080203,0.0004631482,0.000381804,0.00036066992,0.00033857004],"domain_scores_gemma":[0.99906534,0.00016431203,0.0001541306,0.00028337078,0.000119398326,0.00021347703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013683102,0.00021638501,0.00043470418,0.00020614215,0.000060036396,0.0000102403155,0.000120732235,0.00006766847,0.0001322147],"category_scores_gemma":[0.000030307689,0.00017775258,0.00005761578,0.0005199735,0.00019664576,0.0002046772,0.000008387014,0.00013042182,0.000030210796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00968912,0.0008173841,0.98019236,0.0008386945,0.00015139252,0.00037897422,0.0016962196,0.00015621287,0.00555907,0.000037086356,0.000005756035,0.00047770873],"study_design_scores_gemma":[0.05256826,0.0030913935,0.80921364,0.008297562,0.0020965766,0.00023841804,0.0014037291,0.001008813,0.11993064,0.0000609067,0.0011655681,0.0009244896],"about_ca_topic_score_codex":0.0000771838,"about_ca_topic_score_gemma":0.00044792713,"teacher_disagreement_score":0.17097874,"about_ca_system_score_codex":0.000024697003,"about_ca_system_score_gemma":0.000094407435,"threshold_uncertainty_score":0.72485393},"labels":[],"label_agreement":null},{"id":"W2804666281","doi":"10.1182/bloodadvances.2018016667","title":"Quinoline-3-carboxamides such as tasquinimod are not specific inhibitors of S100A9","year":2018,"lang":"en","type":"letter","venue":"Blood Advances","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Quinoline; Pharmacology; Medicine; Chemistry","score_opus":0.011489880478414793,"score_gpt":0.2432732299778485,"score_spread":0.23178334949943372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804666281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8596245,0.07791696,0.000077108714,0.048504908,0.003098435,0.0013002458,0.0010425773,0.00012040099,0.008314879],"genre_scores_gemma":[0.65678173,0.023268953,0.003298944,0.2128883,0.08582162,0.00031972304,0.0033206514,0.00056978274,0.013730295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756634,0.00008193265,0.0005502147,0.0008846511,0.0003994399,0.00051741936],"domain_scores_gemma":[0.99820167,0.000027358654,0.00059904595,0.0008426006,0.0002558724,0.00007343234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012574381,0.00051990413,0.0005870857,0.00012639833,0.00008874055,0.000040269464,0.000584031,0.000864632,0.00009557512],"category_scores_gemma":[0.00009130221,0.0004688701,0.0003274513,0.00014562317,0.00040002426,0.000010892431,0.00021566823,0.0004957179,0.0000540232],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016047193,0.00027864455,0.0012642011,0.00057288015,0.00038060127,0.00020410697,0.00005144199,0.0000072049534,0.35018152,0.00003499827,0.64344025,0.0034236745],"study_design_scores_gemma":[0.00033825194,0.00047632385,0.00008758772,0.0001589808,0.00004455615,0.000020072937,0.000037396472,1.894545e-7,0.4238628,0.000093781804,0.57454145,0.0003386169],"about_ca_topic_score_codex":0.00002215833,"about_ca_topic_score_gemma":0.000028477692,"teacher_disagreement_score":0.20284277,"about_ca_system_score_codex":0.000010080216,"about_ca_system_score_gemma":0.000105599305,"threshold_uncertainty_score":0.9997763},"labels":[],"label_agreement":null},{"id":"W2806632051","doi":"10.1182/bloodadvances.2017gs101973","title":"Development of research capacity in sickle cell anemia in Uganda: impact of collaborations","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Anemia; Sickle cell anemia; Medicine; Intensive care medicine; Immunology; Internal medicine; Disease","score_opus":0.056748969258174596,"score_gpt":0.36570605877801954,"score_spread":0.30895708951984496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806632051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010766,0.0016286767,0.0000024972226,0.00009788764,0.000028890307,0.00024806446,0.000009989447,0.0000042057613,0.00787214],"genre_scores_gemma":[0.9967561,0.00050786044,0.0025933606,0.0000027980593,0.000009461295,0.000009702259,0.0000041971825,0.0000055979935,0.00011094589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991362,0.000030619383,0.00029526252,0.00012619385,0.00021716613,0.0001945361],"domain_scores_gemma":[0.9993824,0.000047570724,0.0001160149,0.00023767621,0.00016457448,0.000051771924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040252323,0.00006780775,0.0002328173,0.00016931219,0.00009190814,0.000006625939,0.00010876975,0.00007425945,0.000025196305],"category_scores_gemma":[0.00025349643,0.000052091178,0.000029249888,0.00029136997,0.00019498018,0.000109843764,0.000036008594,0.00019716343,0.0000026504204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018825232,0.0013812822,0.8952754,0.0005231114,0.00003007363,0.000034178836,0.005320148,0.00031748123,0.09271901,0.000087980065,0.000069920876,0.004053148],"study_design_scores_gemma":[0.0051731654,0.0004351189,0.77773505,0.00068519363,0.000022571512,0.0000049120445,0.0040598875,0.0000447666,0.21010591,0.0002574572,0.001341531,0.00013444008],"about_ca_topic_score_codex":0.00042419345,"about_ca_topic_score_gemma":0.0016083473,"teacher_disagreement_score":0.11754037,"about_ca_system_score_codex":0.000050179864,"about_ca_system_score_gemma":0.00058170594,"threshold_uncertainty_score":0.21242166},"labels":[],"label_agreement":null},{"id":"W2810973315","doi":"10.1182/bloodadvances.2018019034","title":"Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Amgen","keywords":"Blinatumomab; Medicine; Adverse effect; Internal medicine; Incidence (geometry); Cytokine release syndrome; Lymphoblastic Leukemia; Leukemia; Disease","score_opus":0.012164309201738936,"score_gpt":0.279230710711235,"score_spread":0.26706640150949607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810973315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931741,0.0006482211,0.0008674672,0.00019855045,0.00020564423,0.00089205353,0.0000086523,0.00019634132,0.0038090125],"genre_scores_gemma":[0.9879446,0.00034679027,0.009668534,0.00039343588,0.00030214948,0.000110930756,0.00002965415,0.000095267205,0.0011086252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677217,0.00007041603,0.0005520598,0.00080031523,0.0008672772,0.0009377651],"domain_scores_gemma":[0.9983238,0.00017991793,0.00020989704,0.0006546558,0.00030587055,0.00032588514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021504458,0.00045393058,0.00078093173,0.00038790246,0.00014355265,0.000013520322,0.00037668983,0.00015575188,0.00011121755],"category_scores_gemma":[0.00013902738,0.00035929593,0.00009661589,0.0010885779,0.0003885148,0.0005097884,0.00011576708,0.0003587575,0.00013202618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02893234,0.0026359693,0.869612,0.000849183,0.0015855381,0.0034140698,0.0022894556,0.0016233458,0.050259605,0.0003659415,0.00032262263,0.03810992],"study_design_scores_gemma":[0.15903096,0.0123297945,0.6692501,0.0037572251,0.0010199687,0.0027720854,0.0017210424,0.014437538,0.12494489,0.00038942345,0.0084454315,0.0019015508],"about_ca_topic_score_codex":0.000054827196,"about_ca_topic_score_gemma":0.00024372952,"teacher_disagreement_score":0.20036191,"about_ca_system_score_codex":0.00097352837,"about_ca_system_score_gemma":0.0010385972,"threshold_uncertainty_score":0.9998859},"labels":[],"label_agreement":null},{"id":"W2811286257","doi":"10.1182/bloodadvances.2018016584","title":"Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"National Cancer Institute; National Institutes of Health; Enzon Pharmaceuticals","keywords":"Medicine; Lymphoblastic Leukemia; Protocol (science); Oncology; Internal medicine; Leukemia; Pediatrics; Pathology","score_opus":0.02030835921070442,"score_gpt":0.3242821859915467,"score_spread":0.3039738267808423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811286257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9252143,0.0002701053,0.00047786397,0.00078219146,0.00037893053,0.042565804,0.00038557997,0.00035249777,0.029572757],"genre_scores_gemma":[0.9759888,0.00015089073,0.0069422773,0.00023203414,0.0004953583,0.014914865,0.00010611416,0.00007317094,0.0010964791],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965354,0.0001719152,0.0011006644,0.00074595213,0.00077102636,0.00067503395],"domain_scores_gemma":[0.99739695,0.00054294575,0.000662576,0.00075972185,0.00040334594,0.00023446728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069208816,0.00032120352,0.0006236138,0.00036369739,0.00010603738,0.000024079876,0.00033831073,0.00023468275,0.0000601867],"category_scores_gemma":[0.0019331144,0.00026533028,0.00009271996,0.0007308907,0.0005830006,0.00030898198,0.00014016294,0.00041831925,0.00011425457],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059009377,0.017443487,0.2963807,0.0038588662,0.004619782,0.002412884,0.008996296,0.000566454,0.27847138,0.0025685371,0.024718026,0.30095422],"study_design_scores_gemma":[0.18129244,0.01367415,0.448524,0.0033969781,0.00184969,0.0013328488,0.0010056286,0.009908799,0.18718149,0.0010234436,0.14919116,0.0016193673],"about_ca_topic_score_codex":0.00026882772,"about_ca_topic_score_gemma":0.00019938526,"teacher_disagreement_score":0.29933485,"about_ca_system_score_codex":0.00058481,"about_ca_system_score_gemma":0.0014525405,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W2855531598","doi":"10.1182/bloodadvances.2017011643","title":"The common VWF single nucleotide variants c.2365A&gt;G and c.2385T&gt;C modify VWF biosynthesis and clearance","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Umm Al-Qura University","keywords":"Von Willebrand factor; In vivo; Von Willebrand disease; Population; Linkage disequilibrium; Internal medicine; Endocrinology; Biology; Messenger RNA; Recombinant DNA; Genotype; Single-nucleotide polymorphism; Chemistry; Molecular biology; Genetics; Platelet; Gene; Medicine","score_opus":0.011271840676844388,"score_gpt":0.24896415034546002,"score_spread":0.23769230966861563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2855531598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737321,0.0145299705,0.0000109150815,0.0012268043,0.00015453632,0.00029369775,0.000021371325,0.000063358675,0.009967245],"genre_scores_gemma":[0.99370605,0.0047792024,0.00072772236,0.0003502628,0.00013855456,0.000013388118,0.0000040014643,0.000026855465,0.0002539538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890167,0.000037936126,0.00020455534,0.00034259967,0.00018198327,0.00033124624],"domain_scores_gemma":[0.9992686,0.0001702489,0.00009515071,0.00028473054,0.000049291244,0.000132015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010904616,0.00019762534,0.00033920418,0.000041942436,0.00045388198,0.00006577867,0.00009340699,0.00006692907,0.000014471842],"category_scores_gemma":[0.00007430325,0.00013513763,0.000040620824,0.00012275772,0.00043269226,0.00019840397,0.00005896633,0.000092226124,0.000028888546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025744122,0.0037154788,0.10712584,0.000416884,0.0016493567,0.0011457733,0.001481049,0.000004664002,0.08589134,0.007905965,0.0011019112,0.7869873],"study_design_scores_gemma":[0.016607532,0.005547987,0.40801385,0.0012539536,0.0018361318,0.0015243351,0.001003342,0.0008733501,0.08577671,0.014557151,0.46160278,0.0014028726],"about_ca_topic_score_codex":0.000042762007,"about_ca_topic_score_gemma":0.00031981253,"teacher_disagreement_score":0.78558445,"about_ca_system_score_codex":0.000008590787,"about_ca_system_score_gemma":0.000025541129,"threshold_uncertainty_score":0.5510753},"labels":[],"label_agreement":null},{"id":"W2862188711","doi":"10.1182/bloodadvances.2018018903","title":"Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Gut flora; Lung; Immunology; Biology; Antibody; Specific-pathogen-free; Feces; Medicine; Microbiology; Internal medicine; Pulmonary edema","score_opus":0.0069592753328273785,"score_gpt":0.2885156245738843,"score_spread":0.28155634924105694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2862188711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922797,0.00050567085,0.003003394,0.0014952609,0.0003810021,0.0007151449,0.000024955361,0.00007431366,0.0015205598],"genre_scores_gemma":[0.950713,0.000085749496,0.04809426,0.00033003732,0.0001964175,0.000052553765,0.00001513027,0.000021821726,0.0004910762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989962,0.0000272844,0.00041005702,0.0002079813,0.00012963671,0.00022881292],"domain_scores_gemma":[0.9992629,0.000084267864,0.00008931803,0.00024250399,0.00025096233,0.00007003316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019389042,0.00014158229,0.00024862506,0.00010547902,0.00019229673,0.000009251657,0.00013898959,0.000029047056,0.00014106477],"category_scores_gemma":[0.0001291078,0.000095436226,0.00006228789,0.00041430243,0.00019027248,0.000058527672,0.000060630395,0.00014906954,0.000049675567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003210809,0.00036369252,0.026902007,0.000050749055,0.0002857048,0.000008894159,0.00043630868,0.000004393639,0.9616534,0.00018036834,0.0024605652,0.0073328065],"study_design_scores_gemma":[0.0014906421,0.00068441255,0.01858666,0.00057294517,0.00030630405,0.0003240205,0.00008296555,0.0000050373774,0.92717236,0.00008443693,0.050562464,0.00012774255],"about_ca_topic_score_codex":0.000009001577,"about_ca_topic_score_gemma":0.00009347266,"teacher_disagreement_score":0.0481019,"about_ca_system_score_codex":0.000038023143,"about_ca_system_score_gemma":0.00012146195,"threshold_uncertainty_score":0.38917765},"labels":[],"label_agreement":null},{"id":"W2883071434","doi":"10.1182/bloodadvances.2017015396","title":"Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health; American College of Radiology Imaging Network","keywords":"Chemoimmunotherapy; Lenalidomide; Medicine; Consolidation (business); Internal medicine; Oncology; Chronic lymphocytic leukemia; Multiple myeloma; Leukemia","score_opus":0.01737723329979448,"score_gpt":0.2944825228539592,"score_spread":0.27710528955416475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883071434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902234,0.0022875746,0.00044198675,0.00048366436,0.00024009368,0.0016269919,0.00012001848,0.00011503484,0.00446122],"genre_scores_gemma":[0.98539835,0.0011039188,0.0105464915,0.00036300177,0.0006471417,0.00015164388,0.00020188706,0.00006326895,0.0015243147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809813,0.000030015512,0.00038629808,0.00049678196,0.0004884624,0.00050031336],"domain_scores_gemma":[0.9983438,0.00030731905,0.00019970459,0.00046680385,0.0005509635,0.00013135739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003019381,0.00021499551,0.00033767652,0.000067935536,0.00018557103,0.00003764634,0.0001706656,0.00009353475,0.000041547784],"category_scores_gemma":[0.0004918896,0.00016385218,0.00006730314,0.00025540995,0.00025966507,0.00029698035,0.00003657409,0.000120928846,0.00003916196],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10772961,0.0055161705,0.08228474,0.0030636373,0.0025827822,0.0000597276,0.005265979,0.0004490857,0.016743522,0.002251938,0.011221418,0.7628314],"study_design_scores_gemma":[0.3130124,0.009258328,0.048610598,0.003097859,0.000522727,0.00008388723,0.00024105854,0.0019056506,0.29607397,0.00073443825,0.32525653,0.0012025769],"about_ca_topic_score_codex":0.00007503196,"about_ca_topic_score_gemma":0.00020611109,"teacher_disagreement_score":0.7616288,"about_ca_system_score_codex":0.0010197394,"about_ca_system_score_gemma":0.0011467711,"threshold_uncertainty_score":0.6681698},"labels":[],"label_agreement":null},{"id":"W2883847557","doi":"10.1182/bloodadvances.2018017418","title":"Significant gynecological bleeding in women with low von Willebrand factor levels","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Science Foundation Ireland","keywords":"Von Willebrand factor; Medicine; Pregnancy; Plasma levels; Von Willebrand disease; Obstetrics; Gynecology; Internal medicine; Endocrinology; Platelet; Biology","score_opus":0.013899423504590454,"score_gpt":0.2620923926778076,"score_spread":0.24819296917321715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883847557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609965,0.00042841793,0.000017023032,0.00015212772,0.00005937914,0.00027880888,0.000013124053,0.000041145777,0.0029102948],"genre_scores_gemma":[0.9985936,0.00013348981,0.0006857024,0.0002090643,0.00007069667,0.00004281916,0.0000031449608,0.000012216348,0.00024925644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990738,0.000013230578,0.00014773537,0.00026437614,0.00015691612,0.00034391484],"domain_scores_gemma":[0.9996329,0.00006461059,0.000051223855,0.00010661075,0.000035221074,0.00010941547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050648505,0.00014493002,0.00031722756,0.000064538974,0.00005824465,0.000013639952,0.00005397641,0.000054316166,0.0002842834],"category_scores_gemma":[0.000044423814,0.00008969822,0.000019426914,0.00016463485,0.00011606399,0.00014528398,0.000015523043,0.0000889328,0.000029263403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025095877,0.0030934317,0.8658554,0.000179143,0.00044393787,0.0028291014,0.002350405,0.000011745437,0.024308195,0.00009803274,0.00005998042,0.09826106],"study_design_scores_gemma":[0.01707137,0.008109623,0.9256356,0.00040462965,0.00011637211,0.00014900393,0.0013117163,0.000033437966,0.03669212,0.0007259415,0.009275166,0.00047505205],"about_ca_topic_score_codex":0.000007016124,"about_ca_topic_score_gemma":0.000042015432,"teacher_disagreement_score":0.09778601,"about_ca_system_score_codex":0.000039610342,"about_ca_system_score_gemma":0.00004251224,"threshold_uncertainty_score":0.36577868},"labels":[],"label_agreement":null},{"id":"W2888717942","doi":"10.1182/bloodadvances.2016003616","title":"Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Centre for Blood Research, University of British Columbia; Michael Smith Health Research BC","keywords":"Antidote; Heparin; Mechanism of action; Anticoagulant; Pharmacology; Medicine; Anticoagulant therapy; Chemistry; Internal medicine; Biochemistry; Toxicity; In vitro","score_opus":0.029432619847877955,"score_gpt":0.34427431307725226,"score_spread":0.3148416932293743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888717942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802256,0.0009209728,0.000044362056,0.00009132687,0.00009018901,0.00023843354,0.000006323707,0.000008766786,0.0005770624],"genre_scores_gemma":[0.9978848,0.0013731277,0.0006285563,0.000023029452,0.000052871044,0.0000039937026,0.0000016561638,0.00000682198,0.000025141788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935144,0.000026384767,0.00019109299,0.00018051355,0.00015480025,0.00009575294],"domain_scores_gemma":[0.9995516,0.00005108001,0.00018749223,0.000110487475,0.000049022467,0.000050334886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012864117,0.00009805034,0.00047206573,0.00007584929,0.000037237667,0.000003813089,0.00002344137,0.00004507472,0.000010315183],"category_scores_gemma":[0.00003219439,0.0000822068,0.000021526208,0.0000637844,0.00019667624,0.00010794028,0.00004884032,0.00005688635,1.661856e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008578341,0.0037762735,0.417574,0.002699154,0.00046429748,0.000004844971,0.0026968077,0.000006984364,0.42380473,0.006393567,0.00043174427,0.14128979],"study_design_scores_gemma":[0.0019848254,0.00436633,0.27194294,0.00036778775,0.00040201386,0.00000664027,0.0010770002,0.0001398946,0.7182488,0.0004204047,0.000931889,0.00011151665],"about_ca_topic_score_codex":0.00020973968,"about_ca_topic_score_gemma":0.0002153828,"teacher_disagreement_score":0.29444402,"about_ca_system_score_codex":0.0000053861254,"about_ca_system_score_gemma":0.000011042156,"threshold_uncertainty_score":0.3352296},"labels":[],"label_agreement":null},{"id":"W2889540205","doi":"10.1182/bloodadvances.2018020644","title":"Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Hemolysis; Dosing; Medicine; Internal medicine; Gastroenterology","score_opus":0.014049926594325253,"score_gpt":0.29706908988143665,"score_spread":0.2830191632871114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889540205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876821,0.010421404,0.000007183973,0.000049208054,0.0005344014,0.00038697055,0.0002801664,0.000034227953,0.00060433603],"genre_scores_gemma":[0.9993163,0.00005887217,0.00019592473,0.000028824148,0.0000642187,0.000027365128,0.00008665066,0.000011399221,0.00021047283],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99856955,0.0001482986,0.00054105296,0.0003338691,0.000081842576,0.00032537658],"domain_scores_gemma":[0.99895793,0.00015195366,0.00033374,0.00029804572,0.00023641899,0.000021907212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014722711,0.00020004537,0.0004279611,0.000110220186,0.00010300306,0.000005722795,0.00022924146,0.000057300906,0.00010512084],"category_scores_gemma":[0.00017248986,0.00014567572,0.000048501613,0.0001871814,0.00046522843,0.00017913732,0.00008957311,0.00009776595,0.00004541157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033497095,0.01775431,0.8850367,0.00065497006,0.0029057234,0.000052155974,0.004675774,0.000027779564,0.017653678,0.00046724945,0.009221713,0.028052837],"study_design_scores_gemma":[0.29578105,0.020343363,0.2941404,0.0018785256,0.0008220765,0.00005370117,0.0044169705,0.000002632346,0.27369598,0.00083467417,0.10662125,0.0014093759],"about_ca_topic_score_codex":0.000022647846,"about_ca_topic_score_gemma":0.00016068581,"teacher_disagreement_score":0.5908963,"about_ca_system_score_codex":0.000025626752,"about_ca_system_score_gemma":0.000048768547,"threshold_uncertainty_score":0.5940483},"labels":[],"label_agreement":null},{"id":"W2889602315","doi":"10.1182/bloodadvances.2018022608","title":"Single-cell heterogeneity in Sézary syndrome","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Kom op tegen Kanker; Rigshospitalet; Danmarks Frie Forskningsfond; H. Lundbeck A/S; Lundbeckfonden; Novo Nordisk; Gentofte Hospital; Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Romidepsin; Cancer research; Population; Biology; Cell; Flow cytometry; Lymphoma; Antigen; Immunology; Histone deacetylase; Medicine; Histone; Genetics; Gene","score_opus":0.024980896253172104,"score_gpt":0.3120613421799412,"score_spread":0.28708044592676907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889602315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97989166,0.0043811826,0.000024930423,0.00024097988,0.000081276594,0.00036099224,0.0000064614624,0.00005368765,0.01495884],"genre_scores_gemma":[0.99736804,0.00018201736,0.0009914965,0.0003004111,0.000100815465,0.00002609135,0.000009561876,0.000023732478,0.0009978121],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987053,0.0000526631,0.0002097668,0.00034182228,0.0003134889,0.0003769067],"domain_scores_gemma":[0.99939185,0.000062415005,0.00003972062,0.00027623627,0.00010800963,0.000121742516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117079086,0.00014323925,0.00026604574,0.00015169277,0.00006496406,0.00001703546,0.000116358926,0.000060645827,0.00022215415],"category_scores_gemma":[0.00011926986,0.00012642334,0.000058213504,0.00031985078,0.00022875083,0.00012644309,0.00006128657,0.0001292273,0.00019718824],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043821783,0.002777229,0.84631467,0.00026104157,0.000061979925,0.002008668,0.0003754197,0.0000051005004,0.13663226,0.000032796073,0.00015318693,0.010939451],"study_design_scores_gemma":[0.010106455,0.008385832,0.09078041,0.0004103335,0.00011591009,0.010780897,0.0006139051,0.00024377732,0.835993,0.00092957856,0.040890243,0.0007496692],"about_ca_topic_score_codex":0.000026706351,"about_ca_topic_score_gemma":0.00033477668,"teacher_disagreement_score":0.75553423,"about_ca_system_score_codex":0.000050429855,"about_ca_system_score_gemma":0.000086928296,"threshold_uncertainty_score":0.5155394},"labels":[],"label_agreement":null},{"id":"W2889905232","doi":"10.1182/bloodadvances.2018015677","title":"A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Juravinski Hospital; London Health Sciences Centre; Population Health Research Institute; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Cytarabine; Medicine; Tolerability; Myeloid leukemia; Internal medicine; Acute leukemia; Refractory (planetary science); Pharmacology; Oncology; Leukemia; Adverse effect; Gastroenterology; Biology","score_opus":0.018134387283612014,"score_gpt":0.33993825940579453,"score_spread":0.32180387212218253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889905232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585366,0.00013626376,0.000080593716,0.00026669045,0.00008674276,0.0022414655,0.000011542357,0.000055217137,0.0012678034],"genre_scores_gemma":[0.99267185,0.00005367108,0.0062559294,0.00013886638,0.0002478254,0.00019996628,0.00012075391,0.000045046458,0.00026608483],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974915,0.00012235924,0.00044783286,0.0005133119,0.00091128214,0.00051373965],"domain_scores_gemma":[0.99880344,0.00012570097,0.00018530607,0.0003562185,0.0003978234,0.00013152561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005953459,0.0002602538,0.00049847626,0.00039856235,0.00008062414,0.000026204158,0.00017054725,0.00009006916,0.000059708473],"category_scores_gemma":[0.00027362411,0.00018096704,0.000030838837,0.001061787,0.00022379885,0.0004944483,0.00005601627,0.0004524845,0.000024903096],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6651329,0.011067523,0.21517025,0.00023684176,0.00049841095,0.00063058466,0.0017705086,0.000079235455,0.010780153,0.00015224067,0.00012780548,0.09435355],"study_design_scores_gemma":[0.8329955,0.079887696,0.07351988,0.0006703792,0.0003282962,0.000037756126,0.00017010572,0.0016477744,0.009534881,0.00014034669,0.0006436755,0.0004237293],"about_ca_topic_score_codex":0.000067781475,"about_ca_topic_score_gemma":0.00033127074,"teacher_disagreement_score":0.16786258,"about_ca_system_score_codex":0.0004638173,"about_ca_system_score_gemma":0.00082462316,"threshold_uncertainty_score":0.7379622},"labels":[],"label_agreement":null},{"id":"W2890359662","doi":"10.1182/bloodadvances.2018021931","title":"Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"Health Canada; Canadian Blood Services; National Institutes of Health; University of Alberta; Saudi Arabian Cultural Bureau; National Heart, Lung, and Blood Institute; Australian Government","keywords":"Affect (linguistics); Blood product; Red blood cell; Blood cell; Medicine; Immunology; Pharmacology; Psychology; Pathology; Communication","score_opus":0.014809874072437786,"score_gpt":0.2750614353960939,"score_spread":0.2602515613236561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890359662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98283464,0.0018192942,0.00028219353,0.0005260366,0.0008601344,0.00041833718,0.0000061867886,0.0002745039,0.01297867],"genre_scores_gemma":[0.98960084,0.0004509687,0.0073243068,0.00045052537,0.0016754357,0.000032076223,0.000011759777,0.000049776325,0.00040428774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982182,0.00008235889,0.00033480386,0.0006783498,0.00029069046,0.0003956101],"domain_scores_gemma":[0.99872094,0.00017556571,0.0004797484,0.00042529855,0.00016259556,0.000035844663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080703327,0.00035172974,0.00038266453,0.00024263808,0.0005193546,0.00040193496,0.0002718236,0.000087159846,0.00025748037],"category_scores_gemma":[0.00019521687,0.00032162317,0.00008718313,0.00027589788,0.00017762322,0.0030452248,0.00018066367,0.00028216527,0.000057429792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047155927,0.0039918935,0.0687867,0.0021118394,0.00082351477,0.00010363344,0.0002844906,0.000004381075,0.4851564,0.0018890572,0.00017760905,0.43619892],"study_design_scores_gemma":[0.0030364266,0.00012943395,0.15782091,0.000092903174,0.001607806,0.000043819535,0.00008556709,0.00009272898,0.683273,0.00086922396,0.15217134,0.0007767904],"about_ca_topic_score_codex":0.00006422138,"about_ca_topic_score_gemma":0.000035780347,"teacher_disagreement_score":0.43542212,"about_ca_system_score_codex":0.0000044058215,"about_ca_system_score_gemma":0.00002322163,"threshold_uncertainty_score":0.9999236},"labels":[],"label_agreement":null},{"id":"W2890395064","doi":"10.1182/bloodadvances.2017015560","title":"CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"Medical Research Council; Blood Cancer UK; Cancer Research UK","keywords":"Ataxia-telangiectasia; DNA damage; CD40; Biology; Gene; DNA repair; Chronic lymphocytic leukemia; Phosphorylation; Cancer research; Molecular biology; DNA; In vitro; Cell biology; Immunology; Genetics; Leukemia","score_opus":0.027885966507372555,"score_gpt":0.3332748335227997,"score_spread":0.3053888670154271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890395064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968694,0.00090550474,0.0006785277,0.0003425586,0.00007704218,0.00039974702,0.000015646678,0.00004613011,0.00066544785],"genre_scores_gemma":[0.9934413,0.000082586295,0.006009009,0.000025705582,0.0002008951,0.000013573176,0.000038177845,0.000020044095,0.00016874573],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830025,0.00017415461,0.00048094706,0.00030399274,0.00047538913,0.00026528563],"domain_scores_gemma":[0.9987248,0.000554512,0.0001456281,0.00024595816,0.00025325734,0.00007582946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076090934,0.00014153484,0.0002737066,0.00027935763,0.000083355095,0.000013062469,0.000103583414,0.00011669411,0.00013825692],"category_scores_gemma":[0.00045030483,0.00013118966,0.000053251104,0.0006274736,0.00022071424,0.00033648626,0.000031624983,0.00010913265,0.000014138356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004778073,0.00032629466,0.022248026,0.00019980011,0.00008830494,0.000037186037,0.0011897794,0.0024224813,0.9630625,0.0005870047,0.00001578619,0.005044725],"study_design_scores_gemma":[0.019942729,0.0007802253,0.51600266,0.00047902064,0.00013170774,0.00008555002,0.00012576926,0.09860548,0.36007997,0.002494816,0.0010287551,0.00024335214],"about_ca_topic_score_codex":0.00009587914,"about_ca_topic_score_gemma":0.00013629824,"teacher_disagreement_score":0.6029826,"about_ca_system_score_codex":0.0005759479,"about_ca_system_score_gemma":0.0016573318,"threshold_uncertainty_score":0.53497595},"labels":[],"label_agreement":null},{"id":"W2891060378","doi":"10.1182/bloodadvances.2018019919","title":"B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell–dominant T-cell responses via IL-33","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Japan Society for the Promotion of Science; Universität Ulm","keywords":"Treg cell; Cell biology; Signal transduction; Cell; T cell; Immunology; Biology; IL-2 receptor; Immune system; Genetics","score_opus":0.007486035408711377,"score_gpt":0.2091745635819196,"score_spread":0.20168852817320823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891060378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500555,0.0016390381,0.000856292,0.000026968362,0.00024865236,0.0003105502,0.000394399,0.00003739441,0.001481168],"genre_scores_gemma":[0.99624515,0.0003457776,0.0014024242,0.00004178939,0.00007471273,0.000015054998,0.000024719693,0.000022087637,0.0018282903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880296,0.00014062498,0.0002911291,0.00036693047,0.00005825085,0.00034012806],"domain_scores_gemma":[0.999137,0.0001836207,0.00028596516,0.00023091529,0.00013609554,0.000026402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020468459,0.00022851738,0.0003445316,0.00009972967,0.00024416394,0.000011129984,0.0001421878,0.00015047613,0.000037961217],"category_scores_gemma":[0.000030328474,0.00016805007,0.000038943428,0.00015243211,0.00042683913,0.00022487962,0.000042532134,0.00015507964,0.00004009859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010784997,0.0003086266,0.0003260291,0.000119872435,0.000051987376,0.000005097153,0.0016469334,0.0000046362084,0.9934761,0.000020419939,0.000059245227,0.0029025655],"study_design_scores_gemma":[0.0021755663,0.0018709033,0.00027248252,0.00012705603,0.00009930911,0.000025481728,0.00042374458,0.000003807956,0.9568972,0.00010531754,0.037768576,0.00023055269],"about_ca_topic_score_codex":0.00004799733,"about_ca_topic_score_gemma":0.00003919008,"teacher_disagreement_score":0.037709333,"about_ca_system_score_codex":0.000008660716,"about_ca_system_score_gemma":0.000086862485,"threshold_uncertainty_score":0.68528825},"labels":[],"label_agreement":null},{"id":"W2896678815","doi":"10.1182/bloodadvances.2018021469","title":"The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"European Hematology Association","keywords":"Medicine; Mutation; Myeloproliferative Disorders; Internal medicine; Genetics; Biology; Gene","score_opus":0.013784527794097277,"score_gpt":0.31572397991956763,"score_spread":0.30193945212547035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896678815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922325,0.0038179501,0.00001478441,0.0015951155,0.00014476794,0.0005680634,0.000068167355,0.000028422373,0.0015302425],"genre_scores_gemma":[0.9971366,0.0009956828,0.0010513414,0.00042349155,0.000107200816,0.000110670146,0.000031742056,0.000015770063,0.00012753584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987226,0.000050288916,0.00036509233,0.00027768314,0.00032674396,0.00025758886],"domain_scores_gemma":[0.998639,0.00045888277,0.00019797219,0.00018305024,0.00036676103,0.00015432986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009720269,0.00022329214,0.0003678208,0.00006494691,0.000294879,0.00004433572,0.000058205896,0.00004891673,0.00009393467],"category_scores_gemma":[0.00023656317,0.00012097011,0.00006737454,0.00015938157,0.00028558515,0.00016949969,0.0000398079,0.00009270387,0.00001455812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014336475,0.0024839868,0.92437387,0.00009300831,0.001235189,0.00009987947,0.0038253993,0.000015511132,0.0019911777,0.00436351,0.0009956565,0.059089165],"study_design_scores_gemma":[0.019801501,0.014600304,0.5670278,0.00032297752,0.0006740938,0.00036255945,0.002487634,0.00048512968,0.37324595,0.0014417367,0.019031454,0.0005188429],"about_ca_topic_score_codex":0.000008663855,"about_ca_topic_score_gemma":0.000115963485,"teacher_disagreement_score":0.37125477,"about_ca_system_score_codex":0.0000141496475,"about_ca_system_score_gemma":0.00012782423,"threshold_uncertainty_score":0.49330178},"labels":[],"label_agreement":null},{"id":"W2896704395","doi":"10.1182/bloodadvances.2018023572","title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre","keywords":"BCL6; Breakpoint; Biology; Gene rearrangement; Lymphoma; Fluorescence in situ hybridization; Gene duplication; Chromosomal translocation; Locus (genetics); Cancer research; Gene; Diffuse large B-cell lymphoma; Comparative genomic hybridization; Genetics; Molecular biology; B cell; Antibody; Chromosome; Immunology; Germinal center","score_opus":0.00887678908744598,"score_gpt":0.25382857226473066,"score_spread":0.24495178317728467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896704395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261165,0.006110012,0.00002269599,0.00033940302,0.000051203482,0.00022313582,0.000009544501,0.000015124844,0.0006172372],"genre_scores_gemma":[0.9941363,0.000763099,0.0047248392,0.00012675722,0.00009385394,0.000044469987,0.000013308076,0.0000093065,0.000088086286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993244,0.000023795665,0.00014641124,0.00021713848,0.0001235578,0.00016468694],"domain_scores_gemma":[0.9996548,0.000029536175,0.000069766495,0.0001526529,0.000042058786,0.000051141025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004552912,0.00011136621,0.00024052853,0.00007864539,0.00003099492,0.0000037610862,0.000032346405,0.000041332318,0.000024237115],"category_scores_gemma":[0.0000118161015,0.00007194135,0.000019386405,0.000112277514,0.00018916324,0.000049153765,0.000021891656,0.000019547051,0.00000432094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006148758,0.0014284153,0.8872322,0.000086021406,0.00015863853,0.0001571843,0.0002743702,0.000015416159,0.0053475774,0.0003609683,0.00006548336,0.10425889],"study_design_scores_gemma":[0.0113588385,0.0020008506,0.9165694,0.00018961592,0.00019577653,0.0001900003,0.0000731055,0.000007686991,0.06262846,0.00027441795,0.0064049964,0.00010686139],"about_ca_topic_score_codex":0.00021043883,"about_ca_topic_score_gemma":0.00033049184,"teacher_disagreement_score":0.104152024,"about_ca_system_score_codex":0.000017729886,"about_ca_system_score_gemma":0.000028301129,"threshold_uncertainty_score":0.2933683},"labels":[],"label_agreement":null},{"id":"W2897082958","doi":"10.1182/bloodadvances.2018023713","title":"A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Hemostasis and Thrombosis Research Society","keywords":"Desmopressin; Medicine; Internal medicine; Endocrinology","score_opus":0.0188025705446245,"score_gpt":0.32252019319385333,"score_spread":0.30371762264922886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897082958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911227,0.0031908827,0.00002741506,0.0042603235,0.000051234216,0.00061970757,0.000006867617,0.00004559092,0.00067523995],"genre_scores_gemma":[0.99726975,0.00012213319,0.0009722848,0.0002802087,0.000111715,0.00006489793,0.0000050760054,0.000017606442,0.0011563401],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987055,0.000093026974,0.00020264293,0.00033488288,0.00021569566,0.00044821732],"domain_scores_gemma":[0.99900585,0.00030767848,0.00003039677,0.00019014023,0.00015636775,0.00030955632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049917906,0.00015785846,0.00032206738,0.00031831503,0.0001331592,0.000035255674,0.00008060723,0.000076360586,0.000023679422],"category_scores_gemma":[0.0011283848,0.00012158098,0.000035792644,0.00048650245,0.00025291112,0.00012458705,0.00006366079,0.000117588825,0.000010150478],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023430737,0.0005359625,0.7820085,0.00023045721,0.00020568221,0.0011435448,0.00165781,0.0000023399634,0.17629528,0.00039421543,0.00031331382,0.013782155],"study_design_scores_gemma":[0.031480365,0.004789712,0.35787126,0.001895251,0.00042740288,0.000216535,0.009442187,0.00033425298,0.56509644,0.0021061501,0.025604613,0.0007357931],"about_ca_topic_score_codex":0.000051392977,"about_ca_topic_score_gemma":0.00009701008,"teacher_disagreement_score":0.42413723,"about_ca_system_score_codex":0.000068309455,"about_ca_system_score_gemma":0.00019785171,"threshold_uncertainty_score":0.49579284},"labels":[],"label_agreement":null},{"id":"W2897599786","doi":"10.1182/bloodadvances.2018020693","title":"Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Midostaurin; Receptor tyrosine kinase; Autophosphorylation; Cancer research; Kinome; Tyrosine kinase; Signal transduction; Biology; Kinase; Cell biology; Pharmacology; Chemistry; Myeloid leukemia; Protein kinase A","score_opus":0.015596002285941473,"score_gpt":0.29850386602446094,"score_spread":0.28290786373851945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897599786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960105,0.0015126417,0.000014692818,0.00048813043,0.000036871683,0.00040924334,0.000012022118,0.00003855371,0.0014773558],"genre_scores_gemma":[0.99839175,0.00066447514,0.00033052877,0.0002910221,0.00009737888,0.000022707794,0.00003655989,0.000021143873,0.00014440638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989059,0.000054319014,0.000261172,0.00025973102,0.00026493004,0.0002539701],"domain_scores_gemma":[0.9993843,0.00012855876,0.0000955525,0.00017220681,0.00013138918,0.00008798942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113716014,0.00014422629,0.00029514194,0.00014845743,0.000033659828,0.000012140019,0.000056306686,0.00007783082,0.00012785732],"category_scores_gemma":[0.00012382769,0.000115510986,0.00002739774,0.00033314392,0.00029408638,0.00018583359,0.000039644616,0.00012838542,0.000016939272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014196568,0.0013735883,0.010104166,0.00017205325,0.00014828693,0.00004444284,0.00049808586,0.0000027206283,0.97111166,0.0004840473,0.000100395024,0.014540918],"study_design_scores_gemma":[0.010497933,0.0047261706,0.051400963,0.0004663416,0.00009698156,0.00006717357,0.00037295942,0.0000614557,0.9300459,0.0010961088,0.0010064751,0.00016150836],"about_ca_topic_score_codex":0.00010869354,"about_ca_topic_score_gemma":0.000032717875,"teacher_disagreement_score":0.0412968,"about_ca_system_score_codex":0.000057699806,"about_ca_system_score_gemma":0.00021230298,"threshold_uncertainty_score":0.47104013},"labels":[],"label_agreement":null},{"id":"W2898485821","doi":"10.1182/bloodadvances.2018019950","title":"Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Children’s Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Leukemia; Gene; Transcription factor; Cancer research; Mutation; B cell; Cell growth; Kinase; Genetics; Antibody","score_opus":0.01577984397359641,"score_gpt":0.2827782203627125,"score_spread":0.2669983763891161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898485821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981169,0.00039676225,0.00030768444,0.000052147374,0.000012572261,0.00028522592,0.000033634326,0.000009567389,0.0007855244],"genre_scores_gemma":[0.99586797,0.00023045446,0.003578796,0.000042977674,0.000020689164,0.000022677466,0.000014793684,0.000012972575,0.00020867285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989957,0.00003186566,0.00031449064,0.00020946312,0.0002543606,0.00019407895],"domain_scores_gemma":[0.9994293,0.000118514086,0.00010468622,0.00015657287,0.00012649797,0.000064446926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001198044,0.00010248832,0.00026710154,0.00022830453,0.00001771627,0.0000035705932,0.00007617756,0.00007785225,0.000009294356],"category_scores_gemma":[0.00018786981,0.000092444716,0.000023018836,0.00027813858,0.00023021107,0.0001680531,0.0000456011,0.000115558505,0.0000022741945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022471411,0.0004700831,0.013933988,0.0002142385,0.000015104439,0.00001042041,0.00078201765,0.0003298071,0.9818466,0.00006761999,0.00003671985,0.002068734],"study_design_scores_gemma":[0.007627683,0.0006905356,0.0038722362,0.0001858744,0.000044953296,0.000008297248,0.00041929906,0.024858095,0.9617812,0.00035316517,0.000043805434,0.00011483593],"about_ca_topic_score_codex":0.0003870725,"about_ca_topic_score_gemma":0.00035710813,"teacher_disagreement_score":0.024528287,"about_ca_system_score_codex":0.00014034631,"about_ca_system_score_gemma":0.00036061477,"threshold_uncertainty_score":0.3769786},"labels":[],"label_agreement":null},{"id":"W2899051998","doi":"10.1182/bloodadvances.2018020123","title":"CD16+ monocytes give rise to CD103+RALDH2+TCF4+ dendritic cells with unique transcriptional and immunological features","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Caprion (Canada); Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CD16; Biology; Cell biology; Dendritic cell; Monocyte; Immunology; CD3; Antigen","score_opus":0.007028036523521517,"score_gpt":0.23186672641171102,"score_spread":0.2248386898881895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899051998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8938585,0.10333285,0.0004026672,0.00061103754,0.0004573253,0.00040779536,0.00005829438,0.00013766944,0.00073386193],"genre_scores_gemma":[0.98837256,0.0038129357,0.0021367315,0.0006157788,0.00007301289,0.00007975378,0.000022708287,0.000029477744,0.004857029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984467,0.00028696543,0.00025843107,0.00045329527,0.000056074925,0.0004985143],"domain_scores_gemma":[0.9992548,0.00024088129,0.00008016979,0.00026651248,0.00011949773,0.00003813237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015017916,0.0003162722,0.0003746247,0.00013939742,0.00044796127,0.00004461298,0.0002848278,0.00022568711,0.00040440416],"category_scores_gemma":[0.000045899033,0.00023026831,0.000075058466,0.00018676551,0.00096102746,0.00027636296,0.000055518358,0.00032513487,0.00017114088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031093177,0.00026172248,0.0006037243,0.000018779647,0.00032545906,0.000017110042,0.0009858072,0.0000043888704,0.9805757,0.002377103,0.0002803016,0.011440603],"study_design_scores_gemma":[0.0023171527,0.0027112975,0.022607647,0.000109750865,0.00008865511,0.00041202805,0.00054384785,3.2510297e-7,0.79172206,0.00040692367,0.17869174,0.0003885756],"about_ca_topic_score_codex":0.00005404658,"about_ca_topic_score_gemma":0.000048334074,"teacher_disagreement_score":0.18885364,"about_ca_system_score_codex":0.000016352287,"about_ca_system_score_gemma":0.000060516017,"threshold_uncertainty_score":0.9390069},"labels":[],"label_agreement":null},{"id":"W2899318740","doi":"10.1182/bloodadvances.2018026732","title":"Differential attenuation of β2 integrin–dependent and –independent neutrophil migration by Ly6G ligation","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Research Foundation; Rheumatology Research Foundation; National Institute of General Medical Sciences; American Heart Association; Canadian Institutes of Health Research; Arthritis National Research Foundation","keywords":"Integrin; Ligation; Integrin alpha M; Immunology; Peritonitis; Chemotaxis; Inflammation; Cell biology; Biology; Chemistry; Molecular biology; Cell; Receptor; Flow cytometry; Biochemistry; Genetics","score_opus":0.004585666691573893,"score_gpt":0.20525652887215637,"score_spread":0.20067086218058247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899318740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549335,0.0024785434,0.00070651015,0.0001991018,0.0005248466,0.00034968843,0.000053619748,0.000032983306,0.00016134026],"genre_scores_gemma":[0.99765843,0.0007235645,0.000075394455,0.000056277186,0.00003424657,0.000023164795,0.00023786182,0.000013445623,0.0011775867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998976,0.000109266424,0.000304113,0.0003408526,0.000078350764,0.00019141474],"domain_scores_gemma":[0.99943256,0.000056826902,0.00022406112,0.00018139704,0.00008487576,0.000020275054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008438786,0.00017902216,0.00026957208,0.000085235675,0.00007272189,0.000015670883,0.00012025508,0.00013765524,0.00030719343],"category_scores_gemma":[0.000015063855,0.00014961217,0.00005100216,0.00007411379,0.00007311225,0.00029241107,0.000060451795,0.00016866182,0.00010035291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096998316,0.00015606004,0.0069508315,0.000035594574,0.000075924596,8.120316e-7,0.00018110579,0.000006914301,0.9858737,0.0014877118,0.000052419702,0.005081921],"study_design_scores_gemma":[0.0016679119,0.0004592909,0.006986633,0.00004937063,0.00007637204,0.000015322932,0.00024590472,0.0000060649536,0.98753774,0.0006834783,0.0021055087,0.00016640987],"about_ca_topic_score_codex":0.00005456973,"about_ca_topic_score_gemma":0.00004703087,"teacher_disagreement_score":0.0049155112,"about_ca_system_score_codex":0.000014442897,"about_ca_system_score_gemma":0.000017033026,"threshold_uncertainty_score":0.61010075},"labels":[],"label_agreement":null},{"id":"W2901030743","doi":"10.1182/bloodadvances.2018023077","title":"Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Receiver operating characteristic; Medicine; Internal medicine; Confidence interval; Heparin-induced thrombocytopenia; Prospective cohort study; Heparin","score_opus":0.06555340450332754,"score_gpt":0.3511234097928374,"score_spread":0.2855700052895099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901030743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926272,0.0021507523,0.00003108906,0.0008164956,0.00040612614,0.0023250326,0.00003887754,0.000032483036,0.0015719294],"genre_scores_gemma":[0.9981102,0.0003927479,0.0007080235,0.00013203871,0.00025881172,0.00027175044,0.000003813194,0.00003728278,0.00008535179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815387,0.000063444655,0.00058691815,0.00045931857,0.00037344184,0.00036301443],"domain_scores_gemma":[0.9977797,0.0005418378,0.0004416767,0.0007214506,0.00040949916,0.0001058379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002736881,0.00028916445,0.0009993603,0.000064853186,0.00036542083,0.000024086497,0.00039696676,0.00012488113,0.0000464399],"category_scores_gemma":[0.00041258647,0.00016127122,0.00020738083,0.00043259675,0.00082361413,0.00020488107,0.00022726477,0.00023172794,0.0000040973596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021581951,0.00056663173,0.94300526,0.00027247414,0.00041700935,7.4163245e-7,0.0014785611,0.0000014604145,0.043900922,0.0027725708,0.000104866514,0.0072637023],"study_design_scores_gemma":[0.0016728622,0.0011004797,0.5174952,0.00033586915,0.0006266279,0.000011727548,0.0004330185,0.00003941061,0.4763172,0.0006901555,0.0011479636,0.00012945822],"about_ca_topic_score_codex":0.0001829063,"about_ca_topic_score_gemma":0.0007665076,"teacher_disagreement_score":0.4324163,"about_ca_system_score_codex":0.00003137941,"about_ca_system_score_gemma":0.00016130917,"threshold_uncertainty_score":0.657645},"labels":[],"label_agreement":null},{"id":"W2902174064","doi":"10.1182/bloodadvances.2018022954","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":812,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University; Impact","funders":"","keywords":"Venous thromboembolism; Medicine; Hematology; Intensive care medicine; Internal medicine; Disease; Emergency medicine; Thrombosis","score_opus":0.02535771443580039,"score_gpt":0.34342861896023796,"score_spread":0.3180709045244376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902174064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98667455,0.003082205,0.004373074,0.0015223996,0.00040186435,0.0034201816,0.00009765791,0.000048897673,0.00037918173],"genre_scores_gemma":[0.84227073,0.0067296796,0.14874758,0.0010766201,0.000273158,0.0006611121,0.00009186947,0.000056928286,0.00009231778],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980587,0.000022130962,0.00072380115,0.00042466936,0.00042105475,0.00034966925],"domain_scores_gemma":[0.99817973,0.00010562383,0.00047125673,0.00031298905,0.0008026273,0.00012778924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033750184,0.00022843113,0.0012560821,0.0000661422,0.00010695916,0.000006366118,0.00017594486,0.00008576416,0.000027502034],"category_scores_gemma":[0.00020470498,0.00018176969,0.00024474863,0.00018343356,0.00075189304,0.00008216233,0.00012573203,0.00005098753,9.79313e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030343845,0.03494144,0.11269696,0.040075295,0.014192368,0.00002068361,0.0048173317,0.000006114279,0.0020979852,0.033625778,0.08815244,0.6663392],"study_design_scores_gemma":[0.077558696,0.113044515,0.42891815,0.005972836,0.009764494,0.000037768445,0.0075517306,0.0009711586,0.04858311,0.012950135,0.29243118,0.0022162362],"about_ca_topic_score_codex":0.000048536294,"about_ca_topic_score_gemma":0.00000910346,"teacher_disagreement_score":0.664123,"about_ca_system_score_codex":0.000013847864,"about_ca_system_score_gemma":0.000048315167,"threshold_uncertainty_score":0.74123526},"labels":[],"label_agreement":null},{"id":"W2902233584","doi":"10.1182/bloodadvances.2018024893","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":507,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Impact","funders":"","keywords":"Venous thromboembolism; Hematology; Medicine; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.05807273748209407,"score_gpt":0.37080153789704645,"score_spread":0.3127288004149524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902233584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97487974,0.007252252,0.011699883,0.0011716239,0.00034461112,0.0022732555,0.000032629072,0.00005636322,0.002289641],"genre_scores_gemma":[0.7709092,0.01934105,0.2090201,0.00031812704,0.00013823899,0.00010071266,0.000024422437,0.00003243806,0.00011570289],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998229,0.000020157657,0.00077108166,0.000343464,0.0003424305,0.00029381103],"domain_scores_gemma":[0.99833405,0.000039145765,0.00064132607,0.00044469576,0.0004906959,0.000050089235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002647174,0.00020986852,0.0010756676,0.000090318834,0.000062872045,0.000004198864,0.00019238723,0.000046228553,0.00003767631],"category_scores_gemma":[0.000006700834,0.0001776801,0.00026199417,0.0002994535,0.00048914604,0.00009204698,0.00009942219,0.000035962195,0.000002028371],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018827096,0.024729108,0.01694942,0.023216918,0.023508037,0.0000363218,0.0035067191,0.0013227586,0.027134057,0.104173236,0.03483677,0.73870397],"study_design_scores_gemma":[0.020293945,0.021484515,0.32339656,0.004968546,0.0076132887,0.000039337614,0.017108444,0.0019287389,0.48476553,0.004395383,0.112787925,0.0012177881],"about_ca_topic_score_codex":0.0000472953,"about_ca_topic_score_gemma":0.000004188277,"teacher_disagreement_score":0.7374862,"about_ca_system_score_codex":0.0000141033415,"about_ca_system_score_gemma":0.00001959475,"threshold_uncertainty_score":0.72455835},"labels":[],"label_agreement":null},{"id":"W2902418274","doi":"10.1182/bloodadvances.2018024786","title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":445,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Hospital for Sick Children; SickKids Foundation; University of Toronto; Impact","funders":"","keywords":"Medicine; Guideline; Asymptomatic; Intensive care medicine; Psychological intervention; Venous thrombosis; Deep vein; Thrombosis; Appropriate Use Criteria; Antithrombotic; Multidisciplinary approach; Internal medicine; Nursing; Pathology","score_opus":0.07240966129061698,"score_gpt":0.3675710435781027,"score_spread":0.29516138228748573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902418274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838711,0.0096133845,0.0029621937,0.0005755926,0.00052884134,0.0014280439,0.00011039958,0.00007667463,0.00083374314],"genre_scores_gemma":[0.9005695,0.007042343,0.09139627,0.00020859495,0.00052895147,0.000078839665,0.000030773022,0.000043171523,0.00010158216],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980868,0.000029753202,0.0008552334,0.00037484022,0.0003267192,0.00032663494],"domain_scores_gemma":[0.9978909,0.000079981706,0.0007828445,0.0004864048,0.0006689443,0.000090935435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014326932,0.00026584824,0.001546971,0.00011945133,0.000076434095,0.0000037235611,0.00015947573,0.00008974365,0.0000450805],"category_scores_gemma":[0.000021371196,0.00021882319,0.00036501276,0.00041573556,0.00040946496,0.00007562302,0.000047374604,0.00003808733,0.0000044979156],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00246796,0.09530463,0.041745435,0.022529798,0.027414763,0.000055398243,0.015717693,0.00021919134,0.1966338,0.15368734,0.013815503,0.43040848],"study_design_scores_gemma":[0.017441627,0.045017533,0.056612045,0.0006749026,0.01288089,0.0001104461,0.006042782,0.0004170983,0.8282754,0.00942775,0.022166746,0.0009328145],"about_ca_topic_score_codex":0.00005991988,"about_ca_topic_score_gemma":0.000010435437,"teacher_disagreement_score":0.63164157,"about_ca_system_score_codex":0.000023371986,"about_ca_system_score_gemma":0.00009100256,"threshold_uncertainty_score":0.89233506},"labels":[],"label_agreement":null},{"id":"W2902914300","doi":"10.1182/bloodadvances.2018024489","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":719,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Venous thromboembolism; Medicine; Hematology; Heparin-induced thrombocytopenia; Heparin; MEDLINE; Intensive care medicine; Internal medicine; Political science; Thrombosis; Law","score_opus":0.09715893215794777,"score_gpt":0.39122127171707305,"score_spread":0.2940623395591253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902914300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892647,0.00117578,0.00083446316,0.0013894911,0.0005049793,0.0014497297,0.000055929795,0.00010782187,0.0052170935],"genre_scores_gemma":[0.90860796,0.0015558006,0.08847484,0.0006155684,0.00035473297,0.000108117616,0.00002806981,0.00006724911,0.00018767737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706894,0.00004710701,0.0011471856,0.0006822192,0.00041569228,0.0006388748],"domain_scores_gemma":[0.9971215,0.00012749272,0.00072381605,0.000859282,0.0009821916,0.00018570943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036113165,0.0004127707,0.0021688472,0.0001194758,0.00016705584,0.000011999533,0.00041386555,0.00015203308,0.00008850478],"category_scores_gemma":[0.00007975552,0.00035644727,0.00047306446,0.0005908362,0.0008572716,0.00021136481,0.00021244206,0.0001470827,0.000024779949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012127471,0.0069645215,0.028505886,0.006938125,0.009647369,0.000038875944,0.0023695724,0.0000093155795,0.79059553,0.028509822,0.012028036,0.113180175],"study_design_scores_gemma":[0.006080926,0.0068891025,0.055252787,0.0010018821,0.002511095,0.00014253457,0.0025473647,0.00012647698,0.89092964,0.0022932861,0.031532027,0.0006929086],"about_ca_topic_score_codex":0.00021031495,"about_ca_topic_score_gemma":0.000074084484,"teacher_disagreement_score":0.112487264,"about_ca_system_score_codex":0.000043880802,"about_ca_system_score_gemma":0.00016831813,"threshold_uncertainty_score":0.9998888},"labels":[],"label_agreement":null},{"id":"W2903022860","doi":"10.1182/bloodadvances.2018024802","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":596,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Thrombosis and Atherosclerosis Research Institute; University of Ottawa; McMaster University; Impact; Ottawa Hospital","funders":"","keywords":"Venous thromboembolism; Hematology; Medicine; Context (archaeology); Pregnancy; Intensive care medicine; Internal medicine; Venous thrombosis; Cardiology; Thrombosis; Biology","score_opus":0.06259893554747141,"score_gpt":0.35852611053002087,"score_spread":0.29592717498254945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903022860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966951,0.019326923,0.0037984634,0.0031190356,0.00068308273,0.0032463411,0.000118414035,0.000068880014,0.002687866],"genre_scores_gemma":[0.97007513,0.002112085,0.026757631,0.000780815,0.00011107771,0.000085429034,0.000014995585,0.000025728767,0.000037087986],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981808,0.000056606303,0.00083430845,0.00029860548,0.00033997782,0.0002896771],"domain_scores_gemma":[0.998164,0.0001235345,0.0006530372,0.00050148455,0.00051617547,0.000041754713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030104816,0.00020207303,0.0012089164,0.000080131686,0.00006056501,0.0000036654278,0.0002862745,0.00007715604,0.0000242859],"category_scores_gemma":[0.000046256027,0.00014706852,0.00023479047,0.0003938325,0.0006330024,0.000084980486,0.00006061293,0.00008083481,0.0000021514045],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009721632,0.028980222,0.010950179,0.015700337,0.0068573253,0.00003658823,0.03587014,0.00005112824,0.11122874,0.3367119,0.008149695,0.4444916],"study_design_scores_gemma":[0.01833789,0.019834517,0.08038458,0.008412833,0.004322818,0.00017666191,0.061952166,0.0005391058,0.7544628,0.03187197,0.0187232,0.0009814488],"about_ca_topic_score_codex":0.00008651668,"about_ca_topic_score_gemma":0.00005725707,"teacher_disagreement_score":0.6432341,"about_ca_system_score_codex":0.00001015241,"about_ca_system_score_gemma":0.00006254873,"threshold_uncertainty_score":0.59972805},"labels":[],"label_agreement":null},{"id":"W2903137725","doi":"10.1182/bloodadvances.2018024828","title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Calgary; University of Ottawa; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital; Rockyview General Hospital; McMaster University","funders":"","keywords":"Venous thromboembolism; Medicine; Hematology; Internal medicine; Intensive care medicine; Thrombosis","score_opus":0.0496841269740711,"score_gpt":0.35857032478063855,"score_spread":0.30888619780656745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903137725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676941,0.018067632,0.00203807,0.0027118928,0.0009049153,0.0032406324,0.00026819936,0.00013885049,0.004935697],"genre_scores_gemma":[0.89487845,0.024642566,0.078206,0.0010891912,0.0004988736,0.00043257617,0.00004581093,0.00009088299,0.00011562471],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99675906,0.000046671877,0.0013706931,0.00063016254,0.00056875707,0.0006246816],"domain_scores_gemma":[0.99657315,0.00019831015,0.0011733329,0.0008568268,0.0010571147,0.00014124945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004215623,0.0004147863,0.002744824,0.00017850749,0.0001303721,0.000008065626,0.00043727894,0.00012248766,0.00009981197],"category_scores_gemma":[0.00009399883,0.00036608873,0.00057998096,0.0005707227,0.0012621338,0.00015407991,0.00023730527,0.000104392704,0.000008194845],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012755977,0.07021322,0.04590912,0.04385531,0.029278597,0.00009024656,0.009710061,0.0003232186,0.021681145,0.10291301,0.21943398,0.45531648],"study_design_scores_gemma":[0.012849421,0.029716862,0.18343313,0.0060605947,0.014417609,0.0001052908,0.016590228,0.0002671897,0.5068511,0.009718661,0.21822773,0.0017621954],"about_ca_topic_score_codex":0.0003037371,"about_ca_topic_score_gemma":0.00005023308,"teacher_disagreement_score":0.48516995,"about_ca_system_score_codex":0.00003428216,"about_ca_system_score_gemma":0.000092982096,"threshold_uncertainty_score":0.9998791},"labels":[],"label_agreement":null},{"id":"W2904522373","doi":"10.1182/bloodadvances.2017014639","title":"CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Calgary Laboratory Services; University of Calgary; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Ontario Ministry of Research and Innovation; Canada Research Chairs; Princess Margaret Cancer Foundation","keywords":"T-cell receptor; Biology; Sanger sequencing; Polymerase chain reaction; Molecular biology; Locus (genetics); Gene; DNA sequencing; genomic DNA; Population; Gene rearrangement; Genetics; T cell","score_opus":0.019576549644762124,"score_gpt":0.3100120321077201,"score_spread":0.290435482462958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904522373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404412,0.014852545,0.0005802906,0.0020363054,0.001070233,0.0027686378,0.00011008915,0.00031624496,0.037824485],"genre_scores_gemma":[0.81299025,0.0013161957,0.039006267,0.0011630488,0.0048129493,0.00043234424,0.00019386473,0.00017743348,0.13990764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832016,0.000033895627,0.00026373184,0.00050120783,0.00037151523,0.0005095075],"domain_scores_gemma":[0.9987728,0.00013285324,0.000087069435,0.00047010134,0.00034705567,0.00019010855],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027238327,0.00020567779,0.00033633734,0.000091650334,0.0001872613,0.00002896397,0.00017611752,0.00008069843,0.0013058909],"category_scores_gemma":[0.00023100717,0.00016659821,0.00014591552,0.00018193736,0.0002113005,0.00014743968,0.00004482109,0.00022335084,0.00009714461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087588764,0.00039005306,0.0040644165,0.0003931677,0.000089500834,0.000034148543,0.0003087285,0.0000015061406,0.957289,0.000084125575,0.005115105,0.0313544],"study_design_scores_gemma":[0.0021435097,0.0007032222,0.000028575687,0.00007312107,0.000060533624,0.000057377758,0.00027004041,0.000059656915,0.6498666,0.00017180941,0.34641176,0.00015379566],"about_ca_topic_score_codex":0.000020878708,"about_ca_topic_score_gemma":0.000022040289,"teacher_disagreement_score":0.34129664,"about_ca_system_score_codex":0.00004834454,"about_ca_system_score_gemma":0.00016573537,"threshold_uncertainty_score":0.999607},"labels":[],"label_agreement":null},{"id":"W2904880706","doi":"10.1182/bloodadvances.2018018168","title":"The SMAC mimetic LCL-161 displays antitumor activity in preclinical models of rituximab-resistant B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; University at Buffalo; National Institutes of Health","keywords":"Rituximab; In vivo; Cancer research; Lymphoma; Pharmacology; Cytotoxic T cell; Ex vivo; Medicine; In vitro; Chemistry; Immunology; Biology; Biochemistry","score_opus":0.012824870771506569,"score_gpt":0.27364519125284353,"score_spread":0.26082032048133696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904880706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907775,0.0057613794,0.0018061147,0.000045349378,0.00018457496,0.00018238701,0.0000149242005,0.000006178586,0.0012216198],"genre_scores_gemma":[0.99657536,0.0018510723,0.00096483703,0.000017386878,0.00014837662,0.000013602625,0.000009893257,0.0000127895455,0.0004066947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906003,0.00006671999,0.000241731,0.0002939188,0.00013093093,0.00020666406],"domain_scores_gemma":[0.99939805,0.0000440628,0.00014047649,0.00031673125,0.000058882342,0.000041791973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023568052,0.00012241726,0.00016840031,0.000023342582,0.00010633743,0.000014903516,0.00018108073,0.00009326951,0.000003848951],"category_scores_gemma":[0.000036473353,0.00008543879,0.00008184601,0.000078227284,0.00020178052,0.000011019486,0.00008417192,0.000039856517,0.0000027425901],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045951913,0.000968063,0.0005920263,0.000047926987,0.000025387799,0.00000316262,0.000028181483,0.00015207632,0.9786064,0.0007301968,0.00002517568,0.018361887],"study_design_scores_gemma":[0.0024901342,0.000643941,0.005473565,0.000033740205,0.000038616232,0.0000044257145,0.000033172397,0.0019007205,0.97890407,0.002125297,0.008185527,0.00016677391],"about_ca_topic_score_codex":0.000024781297,"about_ca_topic_score_gemma":0.00026338032,"teacher_disagreement_score":0.018195111,"about_ca_system_score_codex":0.0000053042004,"about_ca_system_score_gemma":0.000044883207,"threshold_uncertainty_score":0.3484093},"labels":[],"label_agreement":null},{"id":"W2908861200","doi":"10.1182/bloodadvances.2019000923","title":"Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Mobilization; Yield (engineering); Stem cell; Internal medicine; Medicine; Cell biology; Biology; Political science","score_opus":0.032144367777409005,"score_gpt":0.2782178132010064,"score_spread":0.2460734454235974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908861200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7500101,0.0024534795,0.2354106,0.0018512416,0.00033873846,0.0031666125,0.00006132793,0.00045184878,0.0062560407],"genre_scores_gemma":[0.8831362,0.0002488727,0.11398738,0.0013325526,0.00044272025,0.00021795246,0.00005021771,0.00005301701,0.0005310596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987327,0.000020486996,0.00033864475,0.0004062182,0.00022920988,0.00027273313],"domain_scores_gemma":[0.9990378,0.0003644361,0.000104871695,0.00013607222,0.00013313539,0.00022369684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106013584,0.00017878332,0.0003134895,0.000052860814,0.00009942409,0.000031961292,0.0000981912,0.00007244428,0.000059744678],"category_scores_gemma":[0.00008800286,0.00016090547,0.00007967938,0.0003001446,0.000016601278,0.00021277096,0.000013978725,0.00009343442,0.000027466423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003728785,0.0016177922,0.04000617,0.017102603,0.0004790735,0.00012948434,0.021120204,0.06839254,0.8174406,0.00069172535,0.0015717353,0.027719276],"study_design_scores_gemma":[0.0030091412,0.0012337888,0.00021025127,0.00040629256,0.00041747812,0.000031477895,0.0013689472,0.0044057523,0.9731879,0.000013057919,0.0154063525,0.00030951953],"about_ca_topic_score_codex":0.00000430603,"about_ca_topic_score_gemma":0.0000043893715,"teacher_disagreement_score":0.15574732,"about_ca_system_score_codex":0.000015951626,"about_ca_system_score_gemma":0.00006068232,"threshold_uncertainty_score":0.65615344},"labels":[],"label_agreement":null},{"id":"W2908990133","doi":"10.1182/bloodadvances.2018024133","title":"Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis","year":2019,"lang":"en","type":"review","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Prothrombin complex concentrate; MEDLINE; Confidence interval; Thrombosis; Surgery; Gastroenterology; Warfarin; Atrial fibrillation","score_opus":0.2077379151200556,"score_gpt":0.4014478521935785,"score_spread":0.19370993707352288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908990133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050426584,0.98777044,0.00003535166,0.0000739422,0.0001481224,0.004570033,0.00010683747,0.00010609992,0.0071387677],"genre_scores_gemma":[0.0014380813,0.9861626,0.0021143167,0.000013886821,0.00012771745,0.00007685772,0.0003868283,0.000072456955,0.00960725],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968274,0.00013505365,0.0012422669,0.0007220988,0.0007088906,0.00036423904],"domain_scores_gemma":[0.99766976,0.00018151062,0.0013365826,0.0005866462,0.000117053016,0.00010847111],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002316686,0.0006510942,0.006448044,0.0004773267,0.000066444816,0.000043467688,0.00021993316,0.0001602747,0.0011440918],"category_scores_gemma":[0.000014931707,0.00039274138,0.002752258,0.0017118836,0.00010647245,0.00019652714,0.000110973044,0.00019612143,0.00004698327],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009317596,0.00010915484,0.0017734948,0.06912147,0.85675985,0.00007174217,0.000065580076,0.000046118534,0.000006879441,0.0009619953,0.00006900725,0.0709215],"study_design_scores_gemma":[0.00095527666,0.00015651708,0.000078261204,0.0012844383,0.53054446,0.0000037343364,0.00004318143,0.000004763047,0.000026751994,0.0000057451584,0.46660516,0.0002917435],"about_ca_topic_score_codex":0.0000075219273,"about_ca_topic_score_gemma":0.0000031348086,"teacher_disagreement_score":0.46653613,"about_ca_system_score_codex":0.000049505168,"about_ca_system_score_gemma":0.000068362606,"threshold_uncertainty_score":0.9998524},"labels":[],"label_agreement":null},{"id":"W2912655525","doi":"10.1182/bloodadvances.2018020602","title":"PD-L1 and tumor-associated macrophages in de novo DLBCL","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Medicine; Cancer research; Myeloid; Immunology; Biology; Oncology; Internal medicine","score_opus":0.003343574571653689,"score_gpt":0.21101526798638415,"score_spread":0.20767169341473046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912655525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345244,0.01012721,0.000004646821,0.00007599079,0.0012439657,0.000100816505,0.0000023882365,0.000042881053,0.0049496572],"genre_scores_gemma":[0.9820741,0.00040733672,0.000026395697,0.00028464568,0.000011125962,0.000007790238,0.000021508897,0.0000080399,0.017159047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993863,0.00007643176,0.00014619522,0.00016745304,0.000015212199,0.00020837017],"domain_scores_gemma":[0.99973536,0.00007386377,0.00006931347,0.0000888115,0.000023804472,0.000008850753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101810605,0.00009184437,0.0001488967,0.00006887079,0.00005057383,0.000011966427,0.000060639468,0.00007649936,0.0007562298],"category_scores_gemma":[0.00006443154,0.00008380788,0.000027901442,0.00007968046,0.000043090215,0.00018656535,0.000026972422,0.00018319573,0.000450908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019271072,0.00036324284,0.23493816,0.000025656334,0.00007331349,0.000013749279,0.000294144,0.000010044892,0.76083237,0.00020079683,0.00059425243,0.0024615603],"study_design_scores_gemma":[0.0073486012,0.00052368996,0.30328488,0.00013662648,0.000049372105,0.0003229467,0.0010849884,0.00001137612,0.41889128,0.00023761166,0.26775375,0.00035485387],"about_ca_topic_score_codex":0.000047924335,"about_ca_topic_score_gemma":0.00004854813,"teacher_disagreement_score":0.3419411,"about_ca_system_score_codex":0.000020203956,"about_ca_system_score_gemma":0.000016260712,"threshold_uncertainty_score":0.8280186},"labels":[],"label_agreement":null},{"id":"W2913165883","doi":"10.1182/bloodadvances.2018026286","title":"Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Eye Institute; National Heart, Lung, and Blood Institute","keywords":"Lung; Platelet; Immunology; Apoptosis; In vivo; Biology; Medicine; Internal medicine","score_opus":0.0063975760261207725,"score_gpt":0.24869364680422865,"score_spread":0.24229607077810789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913165883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304193,0.0020601586,0.00001003349,0.00007381092,0.00021331866,0.0012611671,0.000018651828,0.000098023076,0.0032229035],"genre_scores_gemma":[0.9977125,0.0009448748,0.00041624933,0.00018532801,0.0000877133,0.000059859547,0.000028972043,0.000033778837,0.0005307566],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998798,0.000029256307,0.00023286344,0.0004098319,0.0001999993,0.00033006357],"domain_scores_gemma":[0.9994583,0.0000485657,0.00011775379,0.00019777809,0.000046476966,0.00013110206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007616005,0.00025452362,0.0004010132,0.00011829923,0.00011025071,0.000030071613,0.000047741396,0.000112644484,0.00003295642],"category_scores_gemma":[0.0000296346,0.00020861662,0.00007358586,0.00015760011,0.000025470901,0.00027344073,0.000040837236,0.00021786001,0.00006471315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007901941,0.0016270624,0.48550534,0.0015378711,0.0005238639,0.00056002266,0.0004288986,0.00006326656,0.4846082,0.00005009323,0.000057517525,0.024247684],"study_design_scores_gemma":[0.017544331,0.0024426032,0.076186106,0.0009518621,0.0009004886,0.00041914408,0.00011595902,0.0011562512,0.89516836,0.00025934607,0.0038869379,0.0009685844],"about_ca_topic_score_codex":0.00006592432,"about_ca_topic_score_gemma":0.000015166916,"teacher_disagreement_score":0.4105602,"about_ca_system_score_codex":0.000036111684,"about_ca_system_score_gemma":0.000062568375,"threshold_uncertainty_score":0.8507139},"labels":[],"label_agreement":null},{"id":"W2913853823","doi":"10.1182/bloodadvances.2018023176","title":"Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"In utero; Transplantation; Immunodeficiency; Sibling; Stem cell; Severe combined immunodeficiency; Medicine; Immunology; Immune system; Hematopoietic stem cell transplantation; Fetus; Pregnancy; Biology; Internal medicine; Psychology; Developmental psychology; Genetics","score_opus":0.004223471529893692,"score_gpt":0.2048873355451139,"score_spread":0.2006638640152202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913853823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9368059,0.056249592,0.000018124218,0.000047681344,0.00071349926,0.00042641454,0.000017951132,0.000057184312,0.0056636636],"genre_scores_gemma":[0.99643964,0.0017794627,0.000014777434,0.00007117226,0.0000012024137,0.000035055575,0.00010764168,0.000016848038,0.0015341796],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983521,0.00016900526,0.0005173614,0.00040580868,0.000050422772,0.00050530455],"domain_scores_gemma":[0.9994045,0.00012215508,0.0001449473,0.00029759662,0.000026278443,0.0000045408256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002447514,0.0002353633,0.0003714846,0.00023372866,0.00008645857,0.000018009783,0.00039356132,0.00019094942,0.00024133394],"category_scores_gemma":[0.0000049169475,0.0002248413,0.00007745775,0.0004142972,0.00009527708,0.00046047563,0.000033966608,0.00037030582,0.0004020247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013989841,0.0032419274,0.2735502,0.00067435816,0.00006309854,0.0000812031,0.009439665,0.0036757106,0.6533248,0.0016282625,0.000007239993,0.052914575],"study_design_scores_gemma":[0.058356415,0.00195568,0.6165251,0.0011062752,0.00015930855,0.00030234284,0.025842788,0.00014195581,0.27061558,0.001320517,0.020918598,0.0027554182],"about_ca_topic_score_codex":0.00018980597,"about_ca_topic_score_gemma":0.000055480905,"teacher_disagreement_score":0.38270918,"about_ca_system_score_codex":0.000023633445,"about_ca_system_score_gemma":0.000053599553,"threshold_uncertainty_score":0.9168762},"labels":[],"label_agreement":null},{"id":"W2914149209","doi":"10.1182/bloodadvances.2018026518","title":"Extended therapy for unprovoked venous thromboembolism: when is it indicated?","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation; Bayer HealthCare; Sanofi; Daiichi Sankyo Europe; Bristol-Myers Squibb; Pfizer","keywords":"Venous thromboembolism; Medicine; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.020175807610861962,"score_gpt":0.3006885087672398,"score_spread":0.28051270115637783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914149209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9565674,0.011683559,0.00018543859,0.007181578,0.00085203006,0.004714551,0.000039286027,0.00022449715,0.018551663],"genre_scores_gemma":[0.9723828,0.0070968745,0.0037653057,0.012174664,0.00042244556,0.0005275316,0.00007332237,0.000086439504,0.0034706192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815947,0.000023935312,0.00035570434,0.0005801853,0.00036237534,0.00051832583],"domain_scores_gemma":[0.9988983,0.00008449283,0.00018735211,0.0005702745,0.00011326671,0.00014627608],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019073524,0.00028865552,0.00087219744,0.00013405344,0.00012272934,0.000042251453,0.00024350027,0.0001106112,0.0011443362],"category_scores_gemma":[0.000029985174,0.00023401555,0.00021021657,0.00015955091,0.00006969642,0.0002282022,0.00005745742,0.00013927567,0.00027268435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001927578,0.037217453,0.034188747,0.003951832,0.007847433,0.00015607968,0.02767939,0.00006175965,0.0525932,0.018706007,0.18790486,0.62776566],"study_design_scores_gemma":[0.010759521,0.005132669,0.05685608,0.00031526908,0.0007773431,0.000027457241,0.0013647447,0.00005997788,0.04876119,0.012516685,0.8627688,0.0006602456],"about_ca_topic_score_codex":0.000037104754,"about_ca_topic_score_gemma":0.000008075962,"teacher_disagreement_score":0.67486393,"about_ca_system_score_codex":0.000030289462,"about_ca_system_score_gemma":0.00008938091,"threshold_uncertainty_score":0.99976873},"labels":[],"label_agreement":null},{"id":"W2917438066","doi":"10.1182/bloodadvances.2018028480","title":"Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"PLK1; Myeloid leukemia; Myelodysplastic syndromes; Cancer research; KRAS; NPM1; Leukemia; Biology; Medicine; Oncology; Internal medicine; Karyotype; Cancer; Cell cycle; Gene; Bone marrow; Genetics; Chromosome","score_opus":0.013014442551224687,"score_gpt":0.28194717570945704,"score_spread":0.26893273315823235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917438066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864433,0.0009178049,0.0000578477,0.0022997966,0.00008830778,0.00064995076,0.000037695936,0.00007010822,0.009435224],"genre_scores_gemma":[0.99398106,0.00017874672,0.0028351194,0.0014072219,0.00020637002,0.000012055155,0.00006631506,0.000024388317,0.0012887235],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99880606,0.000045824327,0.00013956385,0.00038121841,0.00031425062,0.00031308475],"domain_scores_gemma":[0.999257,0.00013055626,0.000039634862,0.00025645283,0.0001012946,0.00021503156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014809283,0.00015894402,0.00030164013,0.000110292305,0.00007129858,0.000022047176,0.00004997681,0.00009220053,0.00010540287],"category_scores_gemma":[0.00011276903,0.0001309358,0.00004279884,0.00024717505,0.00007801592,0.00020434834,0.000100512036,0.000308633,0.00023839306],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007238919,0.0002726333,0.056938164,0.00042130845,0.00009660725,0.00032851697,0.0004381315,0.00004163679,0.91989315,0.00082952465,0.002863214,0.017153215],"study_design_scores_gemma":[0.013087446,0.0036250998,0.6219302,0.00088644295,0.00036509466,0.0016731268,0.001617245,0.0012035632,0.1612541,0.00079677784,0.19243386,0.001127057],"about_ca_topic_score_codex":0.000020284278,"about_ca_topic_score_gemma":0.00003445046,"teacher_disagreement_score":0.75863904,"about_ca_system_score_codex":0.000051434756,"about_ca_system_score_gemma":0.000065431625,"threshold_uncertainty_score":0.53394073},"labels":[],"label_agreement":null},{"id":"W2921068994","doi":"10.1182/bloodadvances.2018025593","title":"Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services; Calgary Laboratory Services; Oncolytics Biotech (Canada); University of Calgary","funders":"National Cancer Institute; Oncolytics Biotech; Alberta Innovates; Cancer Research Society","keywords":"Oncolytic virus; Bortezomib; Cancer research; Medicine; Multiple myeloma; Tumor microenvironment; Immune system; Immunotherapy; Immunosuppression; Immunology; Pharmacology","score_opus":0.017466040954155118,"score_gpt":0.3217153832903964,"score_spread":0.3042493423362413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921068994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873403,0.011875504,0.00004196851,0.000032267082,0.00006641947,0.00027460273,0.00001715084,0.0000073944534,0.00034442774],"genre_scores_gemma":[0.9941176,0.00461343,0.0005830727,0.0000639833,0.00005523745,0.000029522484,0.000016254033,0.000027057094,0.0004938248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998803,0.00009490192,0.00030257012,0.00038445005,0.00016590074,0.00024917178],"domain_scores_gemma":[0.9993078,0.00008810041,0.00010551499,0.00038833646,0.000054604006,0.000055647597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003196204,0.00014665558,0.000269347,0.000055557695,0.000021442935,0.000009368947,0.00020792971,0.00012824513,0.000010178734],"category_scores_gemma":[0.0000863825,0.00013367906,0.00006723231,0.00007804503,0.00011748277,0.000012653552,0.000079459256,0.00012276239,0.0000022264107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025840595,0.00026569524,0.016682101,0.000038762602,0.00006240144,0.000001417122,0.00003946217,0.00050581753,0.95942193,0.000013104591,0.0000037975465,0.020381445],"study_design_scores_gemma":[0.0065717855,0.0066585927,0.014154248,0.000057090027,0.000014726888,0.000003842268,0.00012588687,0.004146884,0.96406263,0.00026556486,0.003565137,0.000373609],"about_ca_topic_score_codex":0.000017395272,"about_ca_topic_score_gemma":0.00039459436,"teacher_disagreement_score":0.020007836,"about_ca_system_score_codex":0.0000081635,"about_ca_system_score_gemma":0.00014014887,"threshold_uncertainty_score":0.5451274},"labels":[],"label_agreement":null},{"id":"W2921760415","doi":"10.1182/bloodadvances.2018025163","title":"Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Vitamin K antagonist; Confidence interval; Relative risk; Meta-analysis; Randomized controlled trial; MEDLINE; Cochrane Library; Internal medicine; Vitamin k; Quality of evidence; Warfarin","score_opus":0.14254403084974993,"score_gpt":0.41611358008005733,"score_spread":0.2735695492303074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921760415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.089999e-7,0.9919695,0.00037284303,0.0002513443,0.000066176544,0.0070165633,0.00018235605,0.000023872788,0.00011681753],"genre_scores_gemma":[0.000023784669,0.99261636,0.0018754462,0.0001008583,0.00010848521,0.00013643772,0.00032473882,0.00003447112,0.004779431],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99727726,0.00018376551,0.0015252162,0.00049009116,0.00034097902,0.00018266766],"domain_scores_gemma":[0.9964259,0.00081211503,0.0019237719,0.00059173955,0.00017952881,0.00006692543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056914886,0.00044253474,0.011567681,0.0003547857,0.00005656136,0.00002741294,0.00014548347,0.00012841939,0.00008108654],"category_scores_gemma":[0.00040980658,0.00027463387,0.003316694,0.0007807452,0.000063448155,0.00017582689,0.00006212054,0.00008554039,0.000009811172],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004893913,0.000010355712,0.000034690427,0.8865321,0.11178678,0.000002740619,0.00000766609,7.7612543e-7,2.0308207e-7,0.00020110812,0.000041345098,0.00137732],"study_design_scores_gemma":[0.00035146368,0.000083476916,0.000005481457,0.032658152,0.8430403,0.000012039445,0.000016422437,0.000003456872,0.0000014676763,0.000010288175,0.12359845,0.00021901786],"about_ca_topic_score_codex":0.0000021571532,"about_ca_topic_score_gemma":0.0000024120236,"teacher_disagreement_score":0.85387397,"about_ca_system_score_codex":0.000018193641,"about_ca_system_score_gemma":0.00006830314,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W2926583732","doi":"10.1182/bloodadvances.2018030635","title":"Germline deletion of ETV6 in familial acute lymphoblastic leukemia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; American Lebanese Syrian Associated Charities; National Cancer Institute; National Institutes of Health; Children's Hospital Foundation; St. Jude Children's Research Hospital; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center","keywords":"Lymphoblastic Leukemia; Germline; Medicine; Leukemia; Cancer research; Genetics; Biology; Internal medicine; Gene","score_opus":0.007118531863083495,"score_gpt":0.27266534921437763,"score_spread":0.26554681735129415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926583732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942899,0.0010910066,0.00030058724,0.00012724029,0.00021299876,0.0005223547,0.000021822134,0.000046881665,0.0033872223],"genre_scores_gemma":[0.99522996,0.0007297115,0.0022531003,0.0001535943,0.00015419532,0.000026663707,0.00003665936,0.000032118187,0.0013840179],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980828,0.000045894376,0.00047838263,0.00038496614,0.0005841421,0.00042382302],"domain_scores_gemma":[0.9989658,0.0002489507,0.0001337839,0.0003829471,0.00014261028,0.00012590337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020265755,0.00019571483,0.00051399437,0.0002629931,0.000021315036,0.0000074043164,0.00018327309,0.00013310525,0.00017336612],"category_scores_gemma":[0.00019585047,0.00016484076,0.00009893551,0.00048337673,0.00012624824,0.00020848584,0.000087638095,0.00020375475,0.00017256902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048839753,0.0014240269,0.4161708,0.0018630819,0.0005969076,0.00092902,0.00065394654,0.0026528644,0.53659916,0.0013895369,0.00047279344,0.03236388],"study_design_scores_gemma":[0.10498829,0.008823239,0.5175659,0.003364378,0.0014483273,0.0017359714,0.0010373525,0.03294379,0.30592847,0.0017805002,0.018682105,0.0017016794],"about_ca_topic_score_codex":0.00009431685,"about_ca_topic_score_gemma":0.00003321706,"teacher_disagreement_score":0.23067069,"about_ca_system_score_codex":0.00045990676,"about_ca_system_score_gemma":0.0008336981,"threshold_uncertainty_score":0.6722011},"labels":[],"label_agreement":null},{"id":"W2936913202","doi":"10.1182/bloodadvances.2018030577","title":"Targeting CD47 in Sézary syndrome with SIRPαFc","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"National Cancer Institute","keywords":"CD47; Phagocytosis; Lymphoma; Decoy; Medicine; Cutaneous T-cell lymphoma; Cancer research; Immunology; Receptor; Internal medicine; Mycosis fungoides","score_opus":0.009672638446286328,"score_gpt":0.2801466938646356,"score_spread":0.27047405541834924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936913202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97946966,0.004311919,0.000006870401,0.0002746273,0.00007405648,0.0005062772,0.0000021551089,0.000051731,0.015302721],"genre_scores_gemma":[0.9867179,0.00041718574,0.0013865505,0.00015057872,0.00007747352,0.000026535457,0.000011656305,0.00003207212,0.011180069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988027,0.000032614433,0.00016797875,0.00029042942,0.00036062367,0.00034562504],"domain_scores_gemma":[0.99947023,0.000098152515,0.000042812608,0.00025910634,0.000042529737,0.00008717263],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020822725,0.00012499733,0.00028836066,0.00012570171,0.000024743416,0.0000134426145,0.00010609021,0.000044927358,0.00180013],"category_scores_gemma":[0.000036614558,0.00009355202,0.000036483576,0.00030521705,0.000052391893,0.0001772902,0.00003641786,0.00025715958,0.00015791487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079639076,0.0005137779,0.78475875,0.0004666513,0.0001256777,0.0024893223,0.00033039873,0.000275651,0.19705325,0.00008257122,0.00007007222,0.013037514],"study_design_scores_gemma":[0.04285132,0.0129272835,0.41775775,0.0036339585,0.0002955827,0.007354936,0.0043182,0.0008918782,0.11599791,0.0010437898,0.39086,0.0020673804],"about_ca_topic_score_codex":0.00002800582,"about_ca_topic_score_gemma":0.000022962562,"teacher_disagreement_score":0.39078993,"about_ca_system_score_codex":0.00002942664,"about_ca_system_score_gemma":0.00007496431,"threshold_uncertainty_score":0.99911237},"labels":[],"label_agreement":null},{"id":"W2939663996","doi":"10.1182/bloodadvances.2018027482","title":"Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Bispebjerg Hospital; University of Alberta; Kræftens Bekæmpelse; Canadian Dermatology Foundation","keywords":"Mycosis fungoides; Exome sequencing; Lymphoma; Exome; Cutaneous T-cell lymphoma; Biology; Medicine; Computational biology; Immunology; Genetics; Gene; Mutation","score_opus":0.014171525630292814,"score_gpt":0.27947525125223543,"score_spread":0.2653037256219426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939663996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97836196,0.016663939,0.000017829585,0.00028633274,0.00013152909,0.0014077518,0.00007962978,0.0001065651,0.0029444862],"genre_scores_gemma":[0.9939066,0.0015510111,0.000648849,0.0008166657,0.00006694683,0.000083371444,0.000106649546,0.00007246567,0.0027474482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692893,0.00017838192,0.00056271604,0.0008546835,0.000656242,0.0008190276],"domain_scores_gemma":[0.99836016,0.00032414703,0.00016573552,0.0006387088,0.00024701402,0.00026425548],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001398061,0.000411328,0.0008195809,0.00026669164,0.0001069118,0.00005013204,0.00028078453,0.00017236233,0.00016687662],"category_scores_gemma":[0.00011799276,0.00039023007,0.00017610846,0.00056617137,0.00014473473,0.00022995581,0.00012916648,0.0002689559,0.0004889131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079063245,0.0009555441,0.48774388,0.0006916738,0.000119669974,0.0009594809,0.00035583234,0.00021058544,0.50101864,0.000013964251,0.0002783624,0.006861697],"study_design_scores_gemma":[0.050834067,0.0066894623,0.052006233,0.001860411,0.00054312777,0.018187419,0.006037909,0.0038018625,0.7534666,0.0006844761,0.10258173,0.0033067223],"about_ca_topic_score_codex":0.00019809531,"about_ca_topic_score_gemma":0.00022070827,"teacher_disagreement_score":0.43573767,"about_ca_system_score_codex":0.00041120464,"about_ca_system_score_gemma":0.00031783854,"threshold_uncertainty_score":0.999855},"labels":[],"label_agreement":null},{"id":"W2942563145","doi":"10.1182/bloodadvances.2018030247","title":"Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Health Services; University of Calgary","funders":"","keywords":"Globulin; Rabbit (cipher); Chemistry; Internal medicine; Medicine; Immunology; Computer science","score_opus":0.004068806364805607,"score_gpt":0.24740190694939748,"score_spread":0.24333310058459187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942563145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907293,0.0021810601,0.00031196582,0.000085355925,0.0003029948,0.0010722105,0.00003727378,0.000068694826,0.0052111503],"genre_scores_gemma":[0.9966808,0.00045231121,0.0021078298,0.00007491433,0.000055297554,0.000019446532,0.000029152632,0.000024342517,0.00055592315],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986777,0.00005822677,0.00034457527,0.0003105717,0.00036722678,0.00024171405],"domain_scores_gemma":[0.9992103,0.00019766927,0.00008373542,0.00032434348,0.000052986557,0.00013098893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023155927,0.00018767278,0.0005179052,0.0001028267,0.000021844171,0.0000066847165,0.00010653076,0.00008688201,0.0001676719],"category_scores_gemma":[0.00003342398,0.00014459642,0.00010768067,0.0002499172,0.000031374504,0.000112070535,0.000009638489,0.00010845471,0.00022558222],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013069835,0.0001754962,0.61169684,0.0043811533,0.00013775703,0.00013340055,0.0005845046,0.00012961139,0.3783799,0.00012332447,0.000027116657,0.0029238868],"study_design_scores_gemma":[0.0049745063,0.0039299782,0.04384048,0.0015785324,0.00040623453,0.00023160901,0.000041634834,0.000016622906,0.94299495,0.000009823324,0.0017867963,0.00018885646],"about_ca_topic_score_codex":0.000009123269,"about_ca_topic_score_gemma":0.0000044262874,"teacher_disagreement_score":0.5678564,"about_ca_system_score_codex":0.000009277543,"about_ca_system_score_gemma":0.000036269128,"threshold_uncertainty_score":0.58964705},"labels":[],"label_agreement":null},{"id":"W2942682252","doi":"10.1182/bloodadvances.2018030171","title":"GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Kite Pharma; Health Resources and Services Administration; National Institutes of Health; Swedish Orphan Biovitrum; Janssen Scientific Affairs; Mundipharma EDO; Astellas Pharma; Adaptive Biotechnologies; bluebird bio; Chimerix; Medical College of Wisconsin; Takeda Oncology; University of Minnesota; Karyopharm Therapeutics; U.S. Navy; Celgene; U.S. Department of Defense; Sanofi; U.S. Department of Health and Human Services; Astellas Pharma US; National Center for Advancing Translational Sciences; HistoGenetics; Sanofi Genzyme; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; Medac; Jazz Pharmaceuticals; Be The Match Foundation; Spectrum Pharmaceuticals; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Amgen; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Hazard ratio; Internal medicine; Gastroenterology; Total body irradiation; Busulfan; Proportional hazards model; Umbilical cord; Confidence interval; Univariate analysis; Transplantation; Methotrexate; Hematopoietic stem cell transplantation; Cyclophosphamide; Multivariate analysis; Immunology; Chemotherapy","score_opus":0.004829612228905772,"score_gpt":0.23070961643729834,"score_spread":0.22588000420839258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942682252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581325,0.00048288237,0.0011913344,0.000035778638,0.000101839265,0.0014545246,0.00006367707,0.000028822653,0.0008278893],"genre_scores_gemma":[0.99337786,0.0010434509,0.0050250306,0.000065550434,0.000048440754,0.00009978209,0.00013446395,0.000027682276,0.00017772554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998927,0.00001979005,0.0002657472,0.0003346216,0.00022916975,0.00022369786],"domain_scores_gemma":[0.99944085,0.0001726187,0.00011364392,0.00012268785,0.00007283059,0.00007734097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007516917,0.00017370353,0.0002943448,0.00013761302,0.000030010442,0.000013247494,0.00005422499,0.00005904331,0.000017996868],"category_scores_gemma":[0.0000050908384,0.00013828902,0.000034157012,0.00015873383,0.000025590027,0.00024074929,0.0000043394502,0.000091928436,0.000012287932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009343253,0.00023360369,0.9922088,0.0029362945,0.00004777995,0.000045838362,0.0018551835,0.00008470922,0.0009958544,0.000114577226,0.000004245544,0.00053879526],"study_design_scores_gemma":[0.04337262,0.0027096628,0.88190925,0.00074892363,0.001968971,0.00014689317,0.0005046569,0.0002280793,0.066914804,0.00059653947,0.00022390686,0.0006757042],"about_ca_topic_score_codex":0.000011036777,"about_ca_topic_score_gemma":0.00002017743,"teacher_disagreement_score":0.11029955,"about_ca_system_score_codex":0.00003215104,"about_ca_system_score_gemma":0.00006938677,"threshold_uncertainty_score":0.5639263},"labels":[],"label_agreement":null},{"id":"W2944066308","doi":"10.1182/bloodadvances.2019031039","title":"Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Massachusetts General Hospital","keywords":"Rituximab; Thrombotic thrombocytopenic purpura; Medicine; Immune system; Immunology; Thrombocytopenic purpura; Purpura (gastropod); Internal medicine; Antibody; Platelet; Biology","score_opus":0.0075072055385702495,"score_gpt":0.2436602776491439,"score_spread":0.23615307211057365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944066308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95818543,0.040278506,0.0000014783519,0.000021747524,0.0003915405,0.00050610333,0.000038096423,0.000020120304,0.00055695575],"genre_scores_gemma":[0.99928963,0.00044892862,0.00005386977,0.0000048501324,0.000007276841,0.000012253717,0.000025355985,0.0000101098,0.0001477528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888664,0.0001186369,0.00050915167,0.00023913819,0.000046914738,0.00019952595],"domain_scores_gemma":[0.99909157,0.00028138197,0.00025394524,0.00032671483,0.000034385645,0.000012021841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014869336,0.0001339057,0.0005621119,0.00010422977,0.00002372051,0.0000030459785,0.00021546544,0.00006907945,0.00037403905],"category_scores_gemma":[0.000083982515,0.00011645949,0.00006710215,0.00013911926,0.00020089024,0.00015515361,0.00012264945,0.00009610187,0.000036849735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016231948,0.0011676622,0.70264554,0.00033202057,0.0002338058,0.0000018598867,0.00032801632,0.000020025334,0.2937093,0.0008213119,0.000028768278,0.00054938707],"study_design_scores_gemma":[0.01161799,0.0005565827,0.8854749,0.00045963182,0.00014809838,0.000019602161,0.0005452615,0.0000012955123,0.099622056,0.00021536057,0.0011641608,0.00017505253],"about_ca_topic_score_codex":0.000057154466,"about_ca_topic_score_gemma":0.0000270762,"teacher_disagreement_score":0.19408724,"about_ca_system_score_codex":0.000008700302,"about_ca_system_score_gemma":0.000035133882,"threshold_uncertainty_score":0.474908},"labels":[],"label_agreement":null},{"id":"W2946865182","doi":"10.1182/bloodadvances.2019000067","title":"A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation","year":2019,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Boehringer Ingelheim (Canada)","funders":"American Society of Hematology","keywords":"Meta-analysis; Medicine; MEDLINE; Internal medicine; Intensive care medicine; Biology; Biochemistry","score_opus":0.04035227045431714,"score_gpt":0.36018137315583687,"score_spread":0.3198291027015197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946865182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020826528,0.99370176,0.0000010218263,0.000018028346,0.000012115841,0.0058703823,0.00008618025,0.00000743932,0.00009481484],"genre_scores_gemma":[0.0004805148,0.99736047,0.00019365542,0.000095452044,0.000003868383,0.00049237156,0.0011830871,0.000019969975,0.00017063755],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9982449,0.00014574589,0.0008952482,0.00032576948,0.0002640462,0.00012430601],"domain_scores_gemma":[0.9986265,0.000055799323,0.00083065993,0.00035583967,0.00009187037,0.00003938482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020362434,0.00028186268,0.007975104,0.00045860998,0.000014094533,0.00001009677,0.00006923336,0.000048801612,0.000120035955],"category_scores_gemma":[0.000030039515,0.00016023066,0.0005591038,0.00075148494,0.000022052993,0.00010529027,0.000027284423,0.000062719526,0.0000031486509],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021342012,0.0010157304,0.0015476211,0.8881683,0.10458546,8.483695e-7,0.000012358096,6.469051e-7,8.865923e-9,0.00003728031,0.000024258796,0.0046053748],"study_design_scores_gemma":[0.00031435536,0.00025391264,0.0011765045,0.06762108,0.9255682,0.0000017615081,0.000014934209,6.789773e-7,2.9331136e-7,7.4061956e-7,0.004910425,0.00013709668],"about_ca_topic_score_codex":0.00006135272,"about_ca_topic_score_gemma":0.00006750006,"teacher_disagreement_score":0.82098275,"about_ca_system_score_codex":0.000034905803,"about_ca_system_score_gemma":0.00009320176,"threshold_uncertainty_score":0.6534017},"labels":[],"label_agreement":null},{"id":"W2947505750","doi":"10.1182/bloodadvances.2018030585","title":"Primed PMNs in healthy mouse and human circulation are first responders during acute inflammation","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Inflammation; Medicine; Immunology; Circulation (fluid dynamics); Internal medicine","score_opus":0.007682172373507514,"score_gpt":0.23666461186363544,"score_spread":0.22898243949012792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947505750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978342,0.0011163569,0.00001125905,0.000353978,0.00012420311,0.0003933793,0.000009855297,0.000052018382,0.00010472298],"genre_scores_gemma":[0.99910426,0.00023878363,0.000054666216,0.000056625915,0.000022522883,0.000025425496,0.000050102295,0.000013476387,0.00043411853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910176,0.00009651183,0.00023253454,0.00030097342,0.000033464166,0.00023478564],"domain_scores_gemma":[0.9995922,0.000044447967,0.00015283424,0.00016956171,0.000023058827,0.000017936116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001075429,0.00013654993,0.00021342716,0.00016452064,0.00017572235,0.000013101816,0.00008151035,0.00010828731,0.00006529334],"category_scores_gemma":[0.000014250577,0.00012942633,0.000025727051,0.00011602732,0.00004896438,0.0003403563,0.00004446101,0.00015920559,0.00007753932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026151875,0.000045602963,0.039398547,0.00006528304,0.00004617381,0.000007473121,0.00032372028,0.000043922235,0.9582507,0.0013765689,0.0000019084694,0.00017859806],"study_design_scores_gemma":[0.0035409748,0.0002528174,0.19148363,0.000083370825,0.00002674592,0.000020828513,0.0003105341,0.0000014064138,0.80210274,0.0004943611,0.0014826768,0.00019990606],"about_ca_topic_score_codex":0.000020637803,"about_ca_topic_score_gemma":0.000237346,"teacher_disagreement_score":0.15614794,"about_ca_system_score_codex":0.000028787275,"about_ca_system_score_gemma":0.000014433858,"threshold_uncertainty_score":0.5277853},"labels":[],"label_agreement":null},{"id":"W2948352962","doi":"10.1182/bloodadvances.2018030387","title":"Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update","year":2019,"lang":"en","type":"review","venue":"Blood Advances","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Cilag; National Cancer Institute; Italfarmaco; Ipsen; Servier; Kyowa Hakko Kirin; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Daiichi Sankyo Europe; Sanofi; Biogen; Celgene; American Society of Clinical Oncology; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Biosimilar; Anemia; Randomized controlled trial; Internal medicine; Cancer; Intensive care medicine; Epoetin alfa; Guideline; Cochrane Library; Oncology; Myelodysplastic syndromes; Clinical trial; Pathology","score_opus":0.05770829144142951,"score_gpt":0.4484844334443418,"score_spread":0.3907761420029123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948352962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010508917,0.9895404,0.000028116385,0.0006188178,0.0005302766,0.0020796037,0.00016274386,0.000121050376,0.006813929],"genre_scores_gemma":[0.0000331592,0.950579,0.04528057,0.00039228023,0.00033519915,0.00013426153,0.00076684385,0.0001347357,0.0023439366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948485,0.00027685464,0.0024284183,0.0010099785,0.0008772422,0.00055901776],"domain_scores_gemma":[0.9951929,0.0005806845,0.002662492,0.0008899123,0.00046456011,0.00020945082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074946776,0.0007984659,0.0035450007,0.00013775653,0.000109089306,0.000028402881,0.0003091636,0.00037808984,0.00034650008],"category_scores_gemma":[0.00027201985,0.0005384833,0.00067468936,0.0005824608,0.00023483972,0.00022353463,0.00018912145,0.0006440967,0.00008772591],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013311155,0.0022474586,0.0011243708,0.03973118,0.006181315,0.0009768184,0.000030237054,0.00004191543,1.9237788e-7,0.000079418285,0.0033184842,0.9461355],"study_design_scores_gemma":[0.0039245873,0.0010957301,0.000049845028,0.057802975,0.029919099,0.00011051692,0.00025982468,0.0000074760615,0.0000044468634,0.0000052811533,0.9063381,0.00048214462],"about_ca_topic_score_codex":0.0000844205,"about_ca_topic_score_gemma":0.000028160895,"teacher_disagreement_score":0.9456534,"about_ca_system_score_codex":0.00020835026,"about_ca_system_score_gemma":0.00048536653,"threshold_uncertainty_score":0.9997067},"labels":[],"label_agreement":null},{"id":"W2948657609","doi":"10.1182/bloodadvances.2019032094","title":"Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children’s Oncology Group","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Medicine; Term (time); Pediatric oncology; Oncology; Internal medicine; Pediatrics; Cancer; Physics","score_opus":0.007721760638578987,"score_gpt":0.2716214274506278,"score_spread":0.2638996668120488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948657609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195844,0.0056030895,0.00016846506,0.00035810567,0.0001203255,0.0011372974,0.00020156827,0.00004317215,0.00040955597],"genre_scores_gemma":[0.99606013,0.002243802,0.001066858,0.000084756866,0.00013833205,0.000031639014,0.00016036016,0.000037535996,0.00017656205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777013,0.0001282253,0.00040712013,0.000556359,0.0007591203,0.0003790246],"domain_scores_gemma":[0.9982177,0.00049654976,0.00033826145,0.0006791985,0.00010241947,0.00016587667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040213123,0.0002400448,0.00066559843,0.00005945956,0.0000713097,0.000021050857,0.00023778743,0.00011034244,0.00015964343],"category_scores_gemma":[0.00011936079,0.00013645,0.00007420173,0.00014359332,0.00036936827,0.00014164078,0.00017933204,0.00034173933,0.000013774919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082762766,0.00026636556,0.9918231,0.00003744342,0.0011528376,0.0005654228,0.00019172902,0.0000058152336,0.00030753543,0.000017467133,0.0000660398,0.004738643],"study_design_scores_gemma":[0.008508468,0.0027883803,0.98210806,0.00018394443,0.0007580718,0.0041204784,0.00009373014,0.0000050652184,0.0006452344,0.000047269634,0.00057076715,0.00017055402],"about_ca_topic_score_codex":0.00092124025,"about_ca_topic_score_gemma":0.0005197868,"teacher_disagreement_score":0.0097150365,"about_ca_system_score_codex":0.00011823326,"about_ca_system_score_gemma":0.00037491435,"threshold_uncertainty_score":0.55642694},"labels":[],"label_agreement":null},{"id":"W2949446975","doi":"10.1182/bloodadvances.2019000358","title":"B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Mutation; Lymphoblastic Leukemia; Leukemia; Complete remission; Acute leukemia; Pediatrics; Oncology; Internal medicine; Genetics; Chemotherapy; Biology; Gene","score_opus":0.003997724510921166,"score_gpt":0.21921476631359127,"score_spread":0.2152170418026701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949446975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863496,0.0012717427,0.00019597837,0.0000935002,0.00014114106,0.0006896786,0.000009295086,0.00009454731,0.011154533],"genre_scores_gemma":[0.99125695,0.00004397185,0.007979648,0.000059166865,0.00007987646,0.000062961735,0.000023570683,0.000018435288,0.00047541986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985788,0.000022942462,0.00023082242,0.00042400244,0.0004442934,0.00029917725],"domain_scores_gemma":[0.9993794,0.00009482064,0.00012745384,0.00022285737,0.00010216441,0.00007328516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007590767,0.0001894542,0.0002682406,0.00010519538,0.00006405861,0.000016015982,0.00008910656,0.00005958187,0.00007873265],"category_scores_gemma":[0.000033984463,0.00013702037,0.000037967824,0.0003310451,0.00024579774,0.00015989984,0.000023108485,0.00015862763,0.000028020815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026531385,0.00082261494,0.87581944,0.001463297,0.00035882366,0.0017484484,0.0020421804,0.09324962,0.019242428,0.001523162,0.00009360291,0.0009832261],"study_design_scores_gemma":[0.098868944,0.0164263,0.5366488,0.008144493,0.0038010099,0.02074231,0.0067662494,0.010961233,0.28549048,0.0009992053,0.0073807184,0.0037702124],"about_ca_topic_score_codex":0.00008292831,"about_ca_topic_score_gemma":0.000049430662,"teacher_disagreement_score":0.33917063,"about_ca_system_score_codex":0.00014837849,"about_ca_system_score_gemma":0.0005106322,"threshold_uncertainty_score":0.5587529},"labels":[],"label_agreement":null},{"id":"W2952209878","doi":"10.1182/bloodadvances.2019000050","title":"Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Navy; Astellas Pharma; Incyte; bluebird bio; Gilead Sciences; Actinium Pharmaceuticals; Atara Biotherapeutics; Bristol-Myers Squibb; Cerus Corporation; Angiocrine Bioscience; HistoGenetics; National Institute of Allergy and Infectious Diseases; Celgene; National Institutes of Health; U.S. Department of Health and Human Services; Health Resources and Services Administration; Astellas Pharma US; Amgen; U.S. Department of Defense","keywords":"Medicine; Calcineurin; Internal medicine; Hazard ratio; Myeloid leukemia; Cyclophosphamide; Transplantation; Gastroenterology; Oncology; Incidence (geometry); Confidence interval; Hematopoietic stem cell transplantation; Surgery; Chemotherapy","score_opus":0.017451374586883315,"score_gpt":0.29982374931913086,"score_spread":0.2823723747322475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952209878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937257,0.00020960072,0.004021268,0.00034717424,0.00016377249,0.00091704266,0.000049977167,0.00004245536,0.000522967],"genre_scores_gemma":[0.9855521,0.00082463847,0.013029569,0.00008585727,0.000027547245,0.00004016421,0.00013525035,0.00002493922,0.0002799342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986791,0.000020548607,0.0005192418,0.00027089208,0.00028659563,0.00022359367],"domain_scores_gemma":[0.99915725,0.00040214922,0.0001283638,0.00017586608,0.00006604659,0.00007031367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018400913,0.00015346735,0.00053088646,0.00016296851,0.000031666183,0.000008557946,0.000085451975,0.000091181406,0.00005062684],"category_scores_gemma":[0.000034930705,0.00013080832,0.00010756155,0.00018134223,0.000034247187,0.00018608125,0.000006046204,0.00009901251,0.000016560514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016727328,0.00017995572,0.7270798,0.0050507137,0.00018888836,0.00005202442,0.0016890172,0.00039900042,0.26246917,0.00051886775,0.000009326938,0.0006905111],"study_design_scores_gemma":[0.019094085,0.0007850659,0.5884347,0.0027918862,0.0013768942,0.00019782808,0.0006420159,0.0025968403,0.38193545,0.0008161037,0.00090610154,0.00042302065],"about_ca_topic_score_codex":0.000024919185,"about_ca_topic_score_gemma":0.000047882884,"teacher_disagreement_score":0.1386451,"about_ca_system_score_codex":0.00004955141,"about_ca_system_score_gemma":0.000073516865,"threshold_uncertainty_score":0.53342086},"labels":[],"label_agreement":null},{"id":"W2961112061","doi":"10.1182/bloodadvances.2019000251","title":"COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Aalborg Universitetshospital; Aalborg Universitet","keywords":"Oncology; Stage (stratigraphy); Internal medicine; Retrospective cohort study; Multicenter study; Outcome (game theory); Medicine; Overall survival; Biology","score_opus":0.005943054272169658,"score_gpt":0.24933367953388658,"score_spread":0.24339062526171693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961112061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583244,0.0005167105,0.0000010356579,0.000041977106,0.0001539769,0.0022791459,0.00016530204,0.000064019936,0.000945361],"genre_scores_gemma":[0.998532,0.00009101081,0.00025927302,0.00011555809,0.00004640352,0.00009065305,0.00003173066,0.000030098794,0.0008032591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832356,0.000033298336,0.00027818445,0.00052693207,0.00048238802,0.00035560774],"domain_scores_gemma":[0.99908715,0.000066712746,0.00016514696,0.00035118122,0.00013300328,0.00019679216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006929517,0.00026463345,0.000486192,0.00007027779,0.00010545883,0.000037198257,0.00005753204,0.00004191427,0.00006887268],"category_scores_gemma":[0.000038857226,0.00016750484,0.00005038906,0.00011130219,0.00008067527,0.0002933855,0.000086146996,0.0001024614,0.000020355033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005832913,0.0071813343,0.98951393,0.00006360106,0.00042785468,0.00007023953,0.0011968357,0.0000033410092,0.0000084346175,0.000013994158,0.000014697407,0.0009224294],"study_design_scores_gemma":[0.033336096,0.0061130263,0.95736164,0.00012062441,0.00045887745,0.0000014011079,0.0010916357,0.000009561374,0.00026457274,0.0000024480487,0.001058522,0.00018156784],"about_ca_topic_score_codex":0.00014228931,"about_ca_topic_score_gemma":0.000113449925,"teacher_disagreement_score":0.032752804,"about_ca_system_score_codex":0.00010025793,"about_ca_system_score_gemma":0.000030082945,"threshold_uncertainty_score":0.68306494},"labels":[],"label_agreement":null},{"id":"W2963496214","doi":"10.1182/bloodadvances.2019000151","title":"Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Lymphoma; Medicine; Internal medicine; Oncology; Cancer research; Biology","score_opus":0.010419713182177843,"score_gpt":0.26191942435312415,"score_spread":0.2514997111709463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963496214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98148304,0.0046127476,0.0000013411786,0.00007034311,0.00026226122,0.001047014,0.000033911714,0.00007587537,0.012413441],"genre_scores_gemma":[0.9663828,0.0014248362,0.00009459586,0.00026432844,0.00008062253,0.00005678615,0.00007700148,0.00006728844,0.031551737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974018,0.00011907813,0.00034889166,0.0005505963,0.0009524025,0.00062725827],"domain_scores_gemma":[0.99858797,0.00010725559,0.00012202379,0.00065730384,0.00013664877,0.00038877735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002799177,0.00026415216,0.00041819434,0.00020401725,0.000095254225,0.000021172702,0.00019366037,0.00011244738,0.0015542823],"category_scores_gemma":[0.0001389987,0.00022649828,0.0001225701,0.0003156468,0.000058689235,0.000293358,0.00017104216,0.00023377639,0.0006162856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020656055,0.0096359905,0.91780216,0.00028008205,0.000027645878,0.00008039252,0.00021768411,0.0000057441043,0.060085107,0.000008965783,0.00013074532,0.009659859],"study_design_scores_gemma":[0.09296575,0.0011422981,0.6436487,0.00047898683,0.000119381686,0.000008534332,0.00010925106,0.00021717833,0.027614526,0.00008162692,0.23304617,0.00056758715],"about_ca_topic_score_codex":0.00004978221,"about_ca_topic_score_gemma":0.000115320145,"teacher_disagreement_score":0.27415347,"about_ca_system_score_codex":0.0002422916,"about_ca_system_score_gemma":0.00016363856,"threshold_uncertainty_score":0.9993584},"labels":[],"label_agreement":null},{"id":"W2963687945","doi":"10.1182/bloodadvances.2018026591","title":"IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Chronic lymphocytic leukemia; Immunology; Leukemia; Medicine; Internal medicine; Oncology","score_opus":0.017972039684874104,"score_gpt":0.3057286261187398,"score_spread":0.2877565864338657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963687945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894736,0.005826447,0.000012578577,0.0001116999,0.00013765959,0.0021861002,0.00008590075,0.000087951754,0.0020780617],"genre_scores_gemma":[0.9806787,0.0020557404,0.00032102538,0.00010058987,0.00029556802,0.001078611,0.000047063295,0.000058424113,0.015364326],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823016,0.000046612626,0.00031319432,0.0005763083,0.0002602356,0.00057348126],"domain_scores_gemma":[0.99846226,0.0007607201,0.00006220393,0.00040257777,0.00006345386,0.00024878528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021632043,0.00025454056,0.0005256879,0.0002173177,0.0000838439,0.000026255386,0.000103636485,0.000110303576,0.00047844072],"category_scores_gemma":[0.00023768425,0.00021333681,0.00009461924,0.0003307878,0.00007978748,0.00019356301,0.00011147692,0.0000750431,0.0005057802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005055532,0.0018052463,0.6744683,0.0065175095,0.00223312,0.00051253155,0.0018767723,0.021885041,0.0637314,0.0005442434,0.003566645,0.21780366],"study_design_scores_gemma":[0.24893157,0.021178277,0.054435678,0.002156751,0.00097140507,0.0009268224,0.00019846036,0.0396419,0.11927189,0.00036095927,0.510343,0.0015832647],"about_ca_topic_score_codex":0.00061909837,"about_ca_topic_score_gemma":0.00077323185,"teacher_disagreement_score":0.6200326,"about_ca_system_score_codex":0.069359966,"about_ca_system_score_gemma":0.0094799725,"threshold_uncertainty_score":0.99613535},"labels":[],"label_agreement":null},{"id":"W2964166353","doi":"10.1182/bloodadvances.2018028423","title":"Distinct clinical and biological implications of CUX1 in myeloid neoplasms","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Edward P. Evans Foundation","keywords":"Frameshift mutation; Myeloid; Cancer research; Biology; Myeloid leukemia; Somatic cell; Gene knockdown; Progenitor cell; Locus (genetics); Germline; Bone marrow; Myelodysplastic syndromes; Genetics; Germline mutation; Gene; Molecular biology; Mutation; Immunology; Stem cell","score_opus":0.034966826256635074,"score_gpt":0.3643098961475505,"score_spread":0.32934306989091544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964166353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247473,0.0014237378,0.000020854917,0.0009996904,0.000045652163,0.00037248197,0.0000149747975,0.000021869684,0.004626016],"genre_scores_gemma":[0.99557954,0.001503684,0.0023906485,0.00012167816,0.00006687165,0.00002062332,0.000015446794,0.000008104939,0.00029338672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897903,0.000058946367,0.00036178698,0.00028812853,0.00011225238,0.00019986533],"domain_scores_gemma":[0.9990209,0.00048805392,0.00007142894,0.00026191204,0.00005414426,0.000103588376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031167537,0.000088910776,0.0003473269,0.000072150244,0.0000181592,0.0000044127837,0.00010553759,0.00009207649,0.000088205474],"category_scores_gemma":[0.00043714582,0.000063026055,0.00005111425,0.00020855888,0.00027039569,0.000069809175,0.00009095013,0.00024696707,0.00003565879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011158192,0.00020161604,0.97742736,0.000049492297,0.000018582541,0.0000070011843,0.000023388679,6.5143337e-7,0.0039223605,0.00078531995,0.000044369495,0.017408267],"study_design_scores_gemma":[0.0022673674,0.0005500134,0.98719627,0.000050686696,0.000019171917,0.00004850325,0.0000810649,0.000029969493,0.001020633,0.00078451127,0.00787998,0.000071824936],"about_ca_topic_score_codex":0.000016844955,"about_ca_topic_score_gemma":0.000026829399,"teacher_disagreement_score":0.017336441,"about_ca_system_score_codex":0.000013737495,"about_ca_system_score_gemma":0.00010069054,"threshold_uncertainty_score":0.25701278},"labels":[],"label_agreement":null},{"id":"W2964322184","doi":"10.1182/bloodadvances.2019000445","title":"Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"Hematopoietic cell; Human leukocyte antigen; Hematopoietic stem cell transplantation; Transplantation; Haematopoiesis; Immunology; Oncology; Medicine; Internal medicine; Cancer research; Biology; Stem cell; Genetics; Antigen","score_opus":0.004261237840010862,"score_gpt":0.21006691419420417,"score_spread":0.2058056763541933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964322184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777463,0.017171182,0.0000904306,0.00006478293,0.0030700671,0.00032965964,0.000004722022,0.0000609476,0.0014619197],"genre_scores_gemma":[0.99031055,0.002634819,0.00009800765,0.0001162323,0.000013814945,0.0000544301,0.00012848986,0.000019184914,0.006624449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882746,0.00014916445,0.00037858888,0.0003262384,0.000040594452,0.0002779682],"domain_scores_gemma":[0.99955475,0.000067045774,0.00012412443,0.00020267264,0.000035933634,0.000015492877],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000082491635,0.00018494455,0.0002374126,0.00013284043,0.00004267096,0.000010911143,0.000108867025,0.0001942121,0.0020527127],"category_scores_gemma":[0.0000071646296,0.00017015763,0.00008159319,0.00015385372,0.00004757712,0.00018605679,0.000014740057,0.0002921762,0.0022560558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020023258,0.00084909686,0.13381203,0.00035807455,0.00011709556,0.000061386214,0.001963867,0.00035177072,0.85689014,0.00005971295,0.000242792,0.0032916872],"study_design_scores_gemma":[0.009616348,0.0009181808,0.19676258,0.00039706464,0.00023755466,0.00042694,0.00071855827,0.000014465178,0.73411244,0.00024322639,0.05580935,0.00074327184],"about_ca_topic_score_codex":0.000018616542,"about_ca_topic_score_gemma":0.000033987602,"teacher_disagreement_score":0.12277769,"about_ca_system_score_codex":0.000025988076,"about_ca_system_score_gemma":0.000022583394,"threshold_uncertainty_score":0.9988595},"labels":[],"label_agreement":null},{"id":"W2964681165","doi":"10.1182/bloodadvances.2019000306","title":"Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Persistence (discontinuity); Mutation; Chemotherapy; Allele; Induction chemotherapy; Medicine; Leukemia; Immunology; Oncology; Biology; Genetics; Internal medicine; Gene","score_opus":0.01736502105976898,"score_gpt":0.30250963145663357,"score_spread":0.28514461039686456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964681165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704576,0.0014157367,0.000100057005,0.00027550067,0.000044205513,0.00073707884,0.000030581683,0.000022184482,0.00032888903],"genre_scores_gemma":[0.99707127,0.00061103,0.0015868052,0.00009114018,0.000047101945,0.000084933024,0.000013962121,0.000015572301,0.00047818842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993372,0.000018210909,0.0001441045,0.0002271813,0.00010039213,0.0001729345],"domain_scores_gemma":[0.9994205,0.00016563316,0.00008095621,0.00019004285,0.00009027147,0.000052597257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088795845,0.00011587961,0.00024950402,0.00010047385,0.000028127482,0.000007444509,0.00005446041,0.00006684952,0.000059692582],"category_scores_gemma":[0.00008750563,0.00007541498,0.00011407739,0.00012418699,0.000082247345,0.00016210692,0.000012227791,0.00011492969,0.000007019146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0172571,0.001665008,0.3971263,0.0024704887,0.0016176831,0.000020791682,0.00391968,0.0008520914,0.45870435,0.00027282274,0.0006298116,0.1154639],"study_design_scores_gemma":[0.02304707,0.029536575,0.60391796,0.0013598676,0.00033806925,0.00084354496,0.004051282,0.0023430765,0.32458588,0.006274418,0.002871483,0.0008307484],"about_ca_topic_score_codex":0.000009225243,"about_ca_topic_score_gemma":0.0000020887703,"teacher_disagreement_score":0.2067917,"about_ca_system_score_codex":0.00010114165,"about_ca_system_score_gemma":0.00014480218,"threshold_uncertainty_score":0.30753335},"labels":[],"label_agreement":null},{"id":"W2969918675","doi":"10.1182/bloodadvances.2018024729","title":"Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Baycrest Hospital; University of Toronto; Health Sciences Centre; Queen's University","funders":"Ontario Institute for Cancer Research; Southeastern Ontario Academic Medical Organization; Canadian Cancer Society Research Institute; European Hematology Association","keywords":"Haematopoiesis; Inflammation; Immunology; Interleukin 6; Medicine; Biology; Bioinformatics; Stem cell; Genetics","score_opus":0.007020401147990897,"score_gpt":0.254749389596823,"score_spread":0.24772898844883207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969918675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953555,0.003241602,0.000010036535,0.00007089034,0.00004551389,0.00022638698,0.000020867881,0.000011897019,0.0010173105],"genre_scores_gemma":[0.9957915,0.0011901013,0.0025874048,0.00003402472,0.000051933705,0.0000052308487,0.0000072456696,0.000013595271,0.0003189535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991525,0.000021267291,0.0002872267,0.00014702327,0.0002476709,0.0001443111],"domain_scores_gemma":[0.99932516,0.00012087602,0.00014375226,0.00022038283,0.0001226389,0.00006718658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010242171,0.00009077562,0.0003585017,0.000081982726,0.000013509558,0.0000030629162,0.00008019058,0.000049430128,0.000111454545],"category_scores_gemma":[0.0000833091,0.00007589943,0.00003986304,0.000091197995,0.00017117946,0.000061320105,0.00006228135,0.00010021814,0.000013131118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015896354,0.000092587645,0.9126272,0.0013765985,0.00008411456,0.000024033525,0.00012269849,0.000001091208,0.081643395,0.00041965712,0.000026452048,0.0034231732],"study_design_scores_gemma":[0.0015178736,0.0003619702,0.8915738,0.00021413523,0.00009636635,0.00009441493,0.00013337198,0.000046873134,0.102980375,0.00012679193,0.0027598906,0.000094137344],"about_ca_topic_score_codex":0.000008360044,"about_ca_topic_score_gemma":0.0000021951682,"teacher_disagreement_score":0.02133698,"about_ca_system_score_codex":0.000010807203,"about_ca_system_score_gemma":0.00011779966,"threshold_uncertainty_score":0.30950886},"labels":[],"label_agreement":null},{"id":"W2972847538","doi":"10.1182/bloodadvances.2019000338","title":"Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oak Ridge Institute for Science and Education; McGill University; U.S. Department of Energy","keywords":"Immunogenicity; Peripheral blood mononuclear cell; Pharmacology; Recombinant DNA; Thrombin; Medicine; Antibody; Cell; Immunology; Chemistry; Biochemistry; In vitro; Gene; Platelet","score_opus":0.007554641355725461,"score_gpt":0.25567666598150735,"score_spread":0.2481220246257819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972847538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923166,0.005676445,0.000054695138,0.000072697934,0.0000664708,0.0002794318,0.000032231674,0.000025171803,0.0014762287],"genre_scores_gemma":[0.9968452,0.0006450791,0.00056033843,0.000010302295,0.000031335105,0.000006764991,0.000057899022,0.000010677729,0.0018324294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992628,0.000013561439,0.00015821407,0.0001517485,0.00025023439,0.00016342595],"domain_scores_gemma":[0.9996206,0.00004293587,0.00004657894,0.00017449085,0.000051800773,0.00006355554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054939657,0.00008990383,0.00019069444,0.00005513729,0.000020358226,0.0000046033883,0.00006287908,0.00004718746,0.00012943265],"category_scores_gemma":[0.000018476838,0.00006890525,0.000062879444,0.00010280121,0.000022833894,0.00009649387,0.000020550544,0.000090789355,0.000039703664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042006614,0.0002151283,0.13932575,0.00018647706,0.00006879127,0.000006849362,0.00005073692,0.000017460072,0.8584359,0.000008774461,0.000018349794,0.0016237732],"study_design_scores_gemma":[0.0017396385,0.00034646678,0.01847489,0.000067567344,0.00005045229,0.0000067760516,0.000062204854,0.000075489785,0.9780145,0.000015750747,0.0010690562,0.000077191085],"about_ca_topic_score_codex":0.000019421825,"about_ca_topic_score_gemma":0.00000395138,"teacher_disagreement_score":0.12085086,"about_ca_system_score_codex":0.0000198941,"about_ca_system_score_gemma":0.00003124595,"threshold_uncertainty_score":0.28098744},"labels":[],"label_agreement":null},{"id":"W2979178674","doi":"10.1182/bloodadvances.2019000458","title":"Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Alliance; Stage (stratigraphy); Lymphoma; Randomized controlled trial; Follicular phase; Medicine; Oncology; Radiation therapy; Internal medicine; Biology; Political science","score_opus":0.0177656881242941,"score_gpt":0.3046307155433004,"score_spread":0.2868650274190063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979178674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481076,0.0011286106,4.7455376e-7,0.0020206643,0.0002657584,0.00094938895,0.00009122822,0.000019760062,0.0007133601],"genre_scores_gemma":[0.99812406,0.00027178598,0.0002767771,0.0005418287,0.00008999542,0.00012511273,0.000040494415,0.000013968859,0.0005159809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983365,0.0001056293,0.00034400937,0.00035041108,0.00065667153,0.00020678055],"domain_scores_gemma":[0.99886686,0.00019868593,0.00016098266,0.00065213663,0.00007173038,0.00004963018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025901425,0.0002047051,0.00037222714,0.00003303669,0.00007336284,0.00003317391,0.00045577728,0.00003038014,0.00012281431],"category_scores_gemma":[0.000056363842,0.00010278975,0.00012049123,0.00014717798,0.000057156114,0.0002680508,0.00006723654,0.00004444609,0.000024272113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008911673,0.0056936853,0.983657,0.000009561919,0.00039291105,0.00021538787,0.001441895,0.000022322745,0.00010238129,0.00034912012,0.000044834193,0.007981758],"study_design_scores_gemma":[0.009327468,0.0007340196,0.96989346,0.00006970181,0.00018115104,0.000018318693,0.004434654,0.000014962409,0.0009278428,0.00008201902,0.014205617,0.00011077076],"about_ca_topic_score_codex":0.0012853319,"about_ca_topic_score_gemma":0.0008564624,"teacher_disagreement_score":0.014160783,"about_ca_system_score_codex":0.000075685595,"about_ca_system_score_gemma":0.00007951645,"threshold_uncertainty_score":0.41916445},"labels":[],"label_agreement":null},{"id":"W2980371692","doi":"10.1182/bloodadvances.2019000350","title":"Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Chronic lymphocytic leukemia; Drug; Drug resistance; Thrombospondin 1; Thrombospondin; Leukemia; Cancer research; Chemistry; Medicine; Pharmacology; Immunology; Biology; Biochemistry; Microbiology; Metalloproteinase; Enzyme; Angiogenesis","score_opus":0.005637323439451374,"score_gpt":0.25207909436016657,"score_spread":0.2464417709207152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980371692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96152246,0.02735947,0.000061981926,0.00013346436,0.00021456528,0.0011969811,0.000009230119,0.0003588916,0.009142978],"genre_scores_gemma":[0.9687442,0.0023222321,0.005021562,0.0001781149,0.00028370947,0.000074561336,0.00006092289,0.00012241877,0.023192232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961586,0.00011196947,0.00055874046,0.00096718664,0.0011051041,0.0010984181],"domain_scores_gemma":[0.9977443,0.00050996104,0.0002689562,0.0009165044,0.00025254168,0.00030771663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042614414,0.0005032054,0.0009010096,0.00022236514,0.00020155481,0.00008006688,0.00041030222,0.00014477364,0.0005269331],"category_scores_gemma":[0.00022405083,0.00038402303,0.0001566643,0.00082153594,0.0003614116,0.0005969678,0.00015524271,0.00043418296,0.00044729232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008889472,0.0006041756,0.031332884,0.013180262,0.0035430058,0.0038412497,0.0041800854,0.019975968,0.90044993,0.0031538631,0.005374973,0.005474144],"study_design_scores_gemma":[0.18440259,0.0030643945,0.009120148,0.0083833,0.0015798984,0.0013296795,0.0030897204,0.02785754,0.6315266,0.0012468849,0.12470012,0.0036991367],"about_ca_topic_score_codex":0.00030330042,"about_ca_topic_score_gemma":0.00020891333,"teacher_disagreement_score":0.2689233,"about_ca_system_score_codex":0.031070298,"about_ca_system_score_gemma":0.020339556,"threshold_uncertainty_score":0.9998612},"labels":[],"label_agreement":null},{"id":"W2981261950","doi":"10.1182/bloodadvances.2018026575","title":"Generation and function of progenitor T cells from StemRegenin-1–expanded CD34+ human hematopoietic progenitor cells","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; Canadian Institutes of Health Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Canada First Research Excellence Fund; National Cancer Institute; National Institutes of Health; Children's Cancer Research Fund; Ontario Institute for Regenerative Medicine; Krembil Foundation; University of Toronto","keywords":"Progenitor cell; CD34; Haematopoiesis; Progenitor; Cell biology; Function (biology); Interleukin 3; Stem cell; Biology; Immunology; T cell; Antigen-presenting cell","score_opus":0.02414054077781971,"score_gpt":0.2921499308567681,"score_spread":0.2680093900789484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981261950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923287,0.004958855,0.000038951075,0.00004196897,0.0005167989,0.0015293956,0.000026833133,0.000060107333,0.0004983966],"genre_scores_gemma":[0.9924983,0.0002456993,0.001169311,0.000032854485,0.00083306077,0.00008452524,0.00006942443,0.000046862107,0.0050199754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824536,0.00008165435,0.00039294336,0.0004677157,0.00052931474,0.0002829946],"domain_scores_gemma":[0.9990376,0.00006856248,0.00016994294,0.00041159312,0.00016687161,0.00014540036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017207,0.00021587797,0.00043634456,0.00011622349,0.00008009763,0.000035411755,0.00010022431,0.00012175544,0.0009819384],"category_scores_gemma":[0.000009554458,0.00018609478,0.00010689547,0.00017288233,0.00009892149,0.00019457338,0.00004788615,0.00017314966,0.0000626866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026426368,0.00031041936,0.015217415,0.0002858559,0.0001653629,0.000006988171,0.00025241624,0.0000065190734,0.9765545,0.00003333039,0.00008064351,0.00682226],"study_design_scores_gemma":[0.0030737927,0.0011153723,0.0012408696,0.00009160301,0.00021670737,0.000012703329,0.00025819984,0.00008016168,0.9876751,0.0000931124,0.005962226,0.00018017938],"about_ca_topic_score_codex":0.00003454328,"about_ca_topic_score_gemma":0.000024552874,"teacher_disagreement_score":0.013976545,"about_ca_system_score_codex":0.00002888369,"about_ca_system_score_gemma":0.000086599575,"threshold_uncertainty_score":0.9999313},"labels":[],"label_agreement":null},{"id":"W2981477253","doi":"10.1182/bloodadvances.2019000722","title":"Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Agency for Healthcare Research and Quality","keywords":"Medicine; Total body irradiation; Fludarabine; Cyclophosphamide; Busulfan; Aplastic anemia; Internal medicine; Transplantation; Gastroenterology; Hazard ratio; Immunology; Bone marrow; Chemotherapy; Confidence interval","score_opus":0.011367319710883738,"score_gpt":0.2726663269988797,"score_spread":0.261299007287996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981477253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946738,0.00057307014,0.0013012737,0.00010164106,0.00012557273,0.0007658433,0.000075233715,0.000028154265,0.0023554033],"genre_scores_gemma":[0.9941778,0.0002007363,0.0048415917,0.00005006974,0.000037447517,0.00004687324,0.00022871378,0.00001578495,0.00040095169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991631,0.000018368035,0.0003025424,0.00019445234,0.00016405448,0.00015749507],"domain_scores_gemma":[0.99923366,0.00044777547,0.00011351888,0.00011007189,0.00005488316,0.000040079707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010025523,0.000100249315,0.00026495993,0.00010374783,0.000018859771,0.000003932697,0.000035413053,0.0000609832,0.00008528205],"category_scores_gemma":[0.00003832334,0.00009752444,0.000045827113,0.00013252655,0.000026090696,0.00015337043,0.0000017011454,0.0000692782,0.000011862581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013268606,0.00046635495,0.477788,0.01807895,0.000090614994,0.00009089963,0.0022740997,0.0017744437,0.49439383,0.0021227372,0.000060928367,0.0015322779],"study_design_scores_gemma":[0.041298978,0.0021003168,0.25558692,0.0071427715,0.0013811208,0.001187645,0.0014614705,0.00091799616,0.6844461,0.0013851789,0.0023391463,0.0007523328],"about_ca_topic_score_codex":0.000013929987,"about_ca_topic_score_gemma":0.00005361569,"teacher_disagreement_score":0.22220108,"about_ca_system_score_codex":0.000014668454,"about_ca_system_score_gemma":0.000044008935,"threshold_uncertainty_score":0.39769313},"labels":[],"label_agreement":null},{"id":"W2981626013","doi":"10.1182/bloodadvances.2019000593","title":"Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Hematopoietic cell; CAR T-cell therapy; CD19; Medicine; Cell therapy; Hematopoietic stem cell transplantation; Genetic enhancement; Haematopoiesis; Oncology; Toxicity; Chimeric antigen receptor; Internal medicine; Immunology; Transplantation; Stem cell; T cell; Peripheral blood; Biology; Gene; Immune system","score_opus":0.006991509777375879,"score_gpt":0.24902891076368824,"score_spread":0.24203740098631238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981626013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96430296,0.029585121,0.0000071114227,0.0001009704,0.00011530085,0.0010409979,0.00003885231,0.000030664498,0.004778053],"genre_scores_gemma":[0.98411524,0.012151736,0.00038550675,0.00014187444,0.000058671274,0.000059017042,0.00003070898,0.00004565395,0.003011606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981361,0.0000884238,0.00044681484,0.0004208044,0.00046671982,0.00044116282],"domain_scores_gemma":[0.9991042,0.00011970159,0.00009068576,0.00048117945,0.00007857881,0.0001256715],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022314177,0.0002351719,0.00054638745,0.00016480859,0.00001743574,0.000005862162,0.00018788934,0.00011733048,0.0031764433],"category_scores_gemma":[0.000005558919,0.00018854052,0.0001682532,0.0002796386,0.00008264815,0.00009520979,0.000020471261,0.0002610808,0.000088788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066325823,0.0011461711,0.2328794,0.001069709,0.000064136715,0.00014514693,0.0022410476,0.00004186276,0.7519373,0.000006822416,0.000008697965,0.0038270794],"study_design_scores_gemma":[0.016511569,0.0014685125,0.035886705,0.0005802855,0.000051708514,0.00004119122,0.00044771857,0.000025653513,0.9333782,0.00005555509,0.011233755,0.00031913762],"about_ca_topic_score_codex":0.00004814005,"about_ca_topic_score_gemma":0.00005651113,"teacher_disagreement_score":0.19699271,"about_ca_system_score_codex":0.000029380906,"about_ca_system_score_gemma":0.00010521058,"threshold_uncertainty_score":0.9977348},"labels":[],"label_agreement":null},{"id":"W2982514984","doi":"10.1182/bloodadvances.2019000641","title":"Replication timing alterations in leukemia affect clinically relevant chromosome domains","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Institutes of Health Research","keywords":"Biology; Replication timing; Lineage (genetic); Epigenetics; Leukemia; DNA replication; Cellular differentiation; DNA methylation; CD34; Genetics; DNA; Immunology; Gene; Stem cell; Gene expression","score_opus":0.020014518474105587,"score_gpt":0.34170447513679003,"score_spread":0.32168995666268446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982514984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988064,0.0006075758,0.000447808,0.000858078,0.00014753749,0.0009547472,0.000008655783,0.000096639094,0.008814985],"genre_scores_gemma":[0.98815936,0.0005173838,0.008308143,0.00043170337,0.00025024987,0.000102187405,0.000062203275,0.000032586526,0.0021361595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979813,0.00008128431,0.00052890414,0.0006122641,0.00041924682,0.00037696818],"domain_scores_gemma":[0.9980489,0.0006657609,0.00013740556,0.00091292366,0.0000948347,0.00014019247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005876094,0.0001595484,0.00036076063,0.00015937723,0.0000607681,0.000026902308,0.00018427325,0.00011381164,0.00013351625],"category_scores_gemma":[0.001045028,0.00013436774,0.00008450482,0.00038610454,0.00008085823,0.00028878098,0.000077606295,0.000320893,0.0003870657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020210666,0.0016837841,0.47803226,0.0013152491,0.00033885034,0.0007319253,0.0015013707,0.0021897652,0.4506888,0.0046955887,0.0017393378,0.055061996],"study_design_scores_gemma":[0.08499934,0.01252652,0.50699043,0.0065111257,0.0010131096,0.0026263613,0.001579201,0.06620014,0.18408242,0.0060104625,0.12450338,0.002957482],"about_ca_topic_score_codex":0.000032940487,"about_ca_topic_score_gemma":0.00003342469,"teacher_disagreement_score":0.26660636,"about_ca_system_score_codex":0.00050554366,"about_ca_system_score_gemma":0.0006730419,"threshold_uncertainty_score":0.5479358},"labels":[],"label_agreement":null},{"id":"W2984017198","doi":"10.1182/bloodadvances.2019030981","title":"Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"CHU Sainte-Justine Foundation; Leukemia and Lymphoma Society of Canada; Fondation Charles-Bruneau; Terry Fox Research Institute; Canadian Cancer Society Research Institute; Leukemia and Lymphoma Society","keywords":"Leukemia; Cancer research; Biomarker; Medicine; Immunology; Biology; Bioinformatics; Genetics","score_opus":0.008602249814117193,"score_gpt":0.24541951443200882,"score_spread":0.23681726461789163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984017198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919054,0.0066883243,0.0002291699,0.000063889325,0.0000715298,0.0002927485,0.000010308448,0.000007632211,0.00073101965],"genre_scores_gemma":[0.9983667,0.00016775298,0.00055105175,0.00016320057,0.000042954256,0.000012240862,0.000012054716,0.000010865634,0.00067315256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925786,0.00003424472,0.00020776871,0.0002510216,0.000089800626,0.00015929308],"domain_scores_gemma":[0.9996627,0.000015634576,0.00006569036,0.00016550471,0.000030687443,0.000059791168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001161684,0.00011560492,0.00016524973,0.000054048123,0.00002597469,0.000012896442,0.00010750476,0.00006147247,0.000007557916],"category_scores_gemma":[0.000029095861,0.000108047614,0.000034959885,0.000084835396,0.00004054415,0.000016333623,0.000058054917,0.000046343248,0.0000016091432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007431209,0.000022742588,0.0052740253,0.00006527515,0.000049482594,6.3203834e-7,0.0001027435,0.00388843,0.9878719,0.0005471672,0.00005757456,0.002045717],"study_design_scores_gemma":[0.0018136634,0.000433931,0.0013013037,0.00008587859,0.000018029154,0.000004282167,0.00024309251,0.00027801524,0.98705083,0.002501521,0.0060379608,0.0002314881],"about_ca_topic_score_codex":0.00020065275,"about_ca_topic_score_gemma":0.00017950652,"teacher_disagreement_score":0.006520571,"about_ca_system_score_codex":0.000024491641,"about_ca_system_score_gemma":0.000091715425,"threshold_uncertainty_score":0.4406054},"labels":[],"label_agreement":null},{"id":"W2988383085","doi":"10.1182/bloodadvances.2019031112","title":"Thrombus stability explains the factor V Leiden paradox: a mouse model","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Thrombus; Medicine; Factor V Leiden; Pulmonary embolism; Embolization; Thrombosis; Femoral vein; Asymptomatic; Embolism; Deep vein; Venous thrombosis; Cardiology; Internal medicine; Radiology; Pathology","score_opus":0.03907083807189455,"score_gpt":0.2863774643388191,"score_spread":0.24730662626692457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988383085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992776,0.0008094479,0.0012409067,0.00093383016,0.00019235826,0.0007623653,0.000033461656,0.00015931095,0.0030923563],"genre_scores_gemma":[0.99562776,0.00018554876,0.001862895,0.0007508433,0.00007377088,0.000030116411,0.000011321906,0.00002660279,0.001431116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986483,0.00005105221,0.0002686962,0.00035985588,0.0003887722,0.00028332556],"domain_scores_gemma":[0.99893653,0.00009823424,0.00010556826,0.0006599386,0.00008444431,0.00011526172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015358638,0.00019309549,0.00035157867,0.0000387955,0.00011138869,0.000029633222,0.00018165045,0.00007628208,0.0005091128],"category_scores_gemma":[0.000059220587,0.00012260559,0.00012965976,0.00014080184,0.00006768014,0.0003521644,0.00005842204,0.0001947347,0.00017446905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043472796,0.003144722,0.17689686,0.00057216856,0.0007240939,0.000013811219,0.0052816346,0.0019828249,0.75414604,0.046163626,0.00023193886,0.010407567],"study_design_scores_gemma":[0.007920699,0.0011176196,0.0402078,0.00016564781,0.0005755888,0.000047125315,0.0026925753,0.015976164,0.90791744,0.014949298,0.007559016,0.0008710469],"about_ca_topic_score_codex":0.000010997317,"about_ca_topic_score_gemma":0.000034388857,"teacher_disagreement_score":0.15377139,"about_ca_system_score_codex":0.000021075513,"about_ca_system_score_gemma":0.00008259691,"threshold_uncertainty_score":0.55744284},"labels":[],"label_agreement":null},{"id":"W2988451298","doi":"10.1182/bloodadvances.2020003060","title":"Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Hazard ratio; Cohort; Internal medicine; Confidence interval; Genetic genealogy; Cohort study; Incidence (geometry); Relative risk; Oncology; Demography; Pediatrics; Population","score_opus":0.006624429034261539,"score_gpt":0.249123947827727,"score_spread":0.24249951879346549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988451298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301165,0.003063382,0.000027291531,0.00013101348,0.00016591008,0.0005771574,0.000042562984,0.000047372283,0.002933665],"genre_scores_gemma":[0.99489284,0.0026554463,0.0009123095,0.0006457959,0.0002522558,0.000117405274,0.000086824504,0.00003948822,0.00039764846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743146,0.00011323057,0.00042974486,0.0005965875,0.00080974156,0.0006192174],"domain_scores_gemma":[0.9987271,0.00037221148,0.00011156399,0.00046461687,0.00014332472,0.00018120113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016319475,0.0003076073,0.000468974,0.000119988654,0.00015719933,0.00008049591,0.00025641627,0.00013535898,0.000065339314],"category_scores_gemma":[0.0003164705,0.00022193455,0.00007199311,0.00049689476,0.00043937485,0.00024799403,0.0001687505,0.00034414924,0.000019333169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008794496,0.000834333,0.9831124,0.00021598907,0.00032596677,0.0015570526,0.0007988323,0.00007128427,0.00056210556,0.00008818367,0.0004933606,0.011852539],"study_design_scores_gemma":[0.007045673,0.00038418316,0.98758495,0.00020861473,0.00034988104,0.0006460715,0.00065081124,0.00017417381,0.0016571895,0.00021122047,0.0008305197,0.00025668877],"about_ca_topic_score_codex":0.000077886616,"about_ca_topic_score_gemma":0.00012778593,"teacher_disagreement_score":0.01159585,"about_ca_system_score_codex":0.000261293,"about_ca_system_score_gemma":0.00076994457,"threshold_uncertainty_score":0.9050228},"labels":[],"label_agreement":null},{"id":"W2989047686","doi":"10.1182/bloodadvances.2019000449","title":"More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Health and Medical Research Council; National Institutes of Health","keywords":"Medicine; Oncology; Negativity effect; Internal medicine; Peri; Psychology; Developmental psychology","score_opus":0.008444506848344384,"score_gpt":0.2535488958911792,"score_spread":0.2451043890428348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989047686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97231424,0.026012676,0.00001606246,0.00012576995,0.0001936625,0.0006990025,0.000105662766,0.00006540583,0.00046750501],"genre_scores_gemma":[0.975781,0.021733882,0.0020292997,0.00008767237,0.0001821025,0.000075264536,0.000041209198,0.000033327015,0.000036197216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822754,0.00010552076,0.00034271082,0.00055283384,0.00036964237,0.0004017678],"domain_scores_gemma":[0.9990977,0.00019887181,0.00017271141,0.00028082466,0.000084350664,0.00016551654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003188767,0.00027352356,0.0004794407,0.00014229522,0.00009007965,0.000052521198,0.00008457568,0.00010909373,0.000014857386],"category_scores_gemma":[0.00020118014,0.00021991682,0.0000999076,0.00015136431,0.000026738362,0.0003211104,0.000083668354,0.00019143065,0.000022839113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006634068,0.0005838828,0.98420006,0.00009653307,0.00013898658,0.000059716156,0.00072024163,0.0024469926,0.000109424,0.00002409532,0.0000060036564,0.010950628],"study_design_scores_gemma":[0.008420687,0.0011180635,0.9846732,0.00013147913,0.001154088,0.00007427793,0.00018198794,0.0028757309,0.0007007951,0.00013537043,0.00023665925,0.00029765777],"about_ca_topic_score_codex":0.0011803936,"about_ca_topic_score_gemma":0.00047299682,"teacher_disagreement_score":0.01065297,"about_ca_system_score_codex":0.00006364529,"about_ca_system_score_gemma":0.00011350932,"threshold_uncertainty_score":0.8967948},"labels":[],"label_agreement":null},{"id":"W2990080997","doi":"10.1182/bloodadvances.2019000374","title":"TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; Atlantic Cancer Research Institute; University of New Brunswick","funders":"Canadian Institutes of Health Research; Fondation de la recherche en santé du Nouveau-Brunswick; Beatrice Hunter Cancer Research Institute; Cancer Research Institute","keywords":"Suppressor; Multiple myeloma; Cancer research; Apoptosis; Hippo signaling pathway; Biology; Medicine; Internal medicine; Cancer; Genetics","score_opus":0.004771189800993283,"score_gpt":0.2176592461174785,"score_spread":0.21288805631648522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990080997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937301,0.0033394322,0.00008875527,0.00005182115,0.00018111705,0.00020305751,0.000067813555,0.000028329136,0.0023095603],"genre_scores_gemma":[0.9960562,0.00003379987,0.0006483585,0.00014472628,0.00014300982,0.000045172597,0.00016274487,0.000023177896,0.0027428195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892,0.00004819678,0.00021054187,0.00040551904,0.00012133023,0.00029438763],"domain_scores_gemma":[0.9994947,0.000036383506,0.00008224626,0.00027933242,0.000038344813,0.00006899394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109699264,0.0001608688,0.00016456383,0.000040106446,0.00007797977,0.000023674414,0.00015008738,0.00008310874,0.00007966333],"category_scores_gemma":[0.00012185553,0.0001519835,0.000070984934,0.00010706653,0.000043273998,0.000011638391,0.000057719782,0.00010152807,0.000101957645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049334798,0.00010989496,0.016889272,0.000023731842,0.000021203754,0.000005178807,0.000048134316,0.00048075352,0.9811081,0.000012756351,0.00010187232,0.0011497175],"study_design_scores_gemma":[0.0014094907,0.0003488499,0.0016726129,0.000049792867,0.000016982622,0.000025834286,0.00028637928,0.00015571894,0.9010973,0.000060022834,0.09459368,0.00028331287],"about_ca_topic_score_codex":0.000041575804,"about_ca_topic_score_gemma":0.00007646841,"teacher_disagreement_score":0.09449181,"about_ca_system_score_codex":0.0000056528183,"about_ca_system_score_gemma":0.00004306803,"threshold_uncertainty_score":0.61977077},"labels":[],"label_agreement":null},{"id":"W2990184116","doi":"10.1182/bloodadvances.2019000717","title":"Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"CD19; Immunology; Antibody; Chimeric antigen receptor; Immunotherapy; Medicine; Antigen; Receptor; Immunity; Virology; Virus; Immune system; Internal medicine","score_opus":0.009515221250823522,"score_gpt":0.2747866744039755,"score_spread":0.2652714531531519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990184116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743503,0.012669095,0.000011119956,0.00015161591,0.000226974,0.00086211174,0.000021475767,0.00011400637,0.0115933055],"genre_scores_gemma":[0.9586898,0.011433215,0.0030489794,0.00008937973,0.00013702051,0.00004141781,0.00005190796,0.0000543788,0.02645389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983757,0.00008573851,0.00035081556,0.00035306803,0.00046824006,0.00036640605],"domain_scores_gemma":[0.9989928,0.0000963719,0.00016449639,0.00048634887,0.00020525887,0.00005473691],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021001608,0.00020529747,0.00048359454,0.00017122885,0.000044061402,0.000020822885,0.0001680156,0.00008301722,0.0035770577],"category_scores_gemma":[0.00003600733,0.0001717596,0.00014166781,0.00046175954,0.00011522904,0.00046385123,0.000043445412,0.00018239378,0.0001226671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009875654,0.00034035614,0.28284237,0.00021105372,0.000111007765,0.000004249283,0.00023627536,0.0000026941414,0.70914656,0.0000050115077,0.00011099552,0.00600188],"study_design_scores_gemma":[0.0032494552,0.00078532664,0.1744527,0.0001805241,0.000033962675,0.0000058267656,0.00012611086,0.0000645181,0.7693141,0.000047691312,0.051530905,0.00020883649],"about_ca_topic_score_codex":0.00007085573,"about_ca_topic_score_gemma":0.00000798228,"teacher_disagreement_score":0.10838966,"about_ca_system_score_codex":0.000019722158,"about_ca_system_score_gemma":0.00008415605,"threshold_uncertainty_score":0.9973338},"labels":[],"label_agreement":null},{"id":"W2990623561","doi":"10.1182/bloodadvances.2019000176","title":"Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; ZonMw; Amsterdam University Medical Centers","keywords":"Innate lymphoid cell; Immunology; Innate immune system; Disease; Graft-versus-host disease; Host (biology); Biology; Medicine; Immune system; Genetics; Pathology","score_opus":0.01323746299447102,"score_gpt":0.2386078850368114,"score_spread":0.2253704220423404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990623561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802881,0.013664473,0.000005259526,0.000041906318,0.0018863378,0.00045176182,0.0010726645,0.00014488728,0.002444636],"genre_scores_gemma":[0.99767154,0.00039850417,0.000053137344,0.0001305646,0.00006476954,0.000048121976,0.00020925413,0.000043786316,0.0013803096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979318,0.00024098867,0.00037379857,0.0006415115,0.00008721077,0.0007247354],"domain_scores_gemma":[0.9988152,0.00014794685,0.00032866726,0.000571371,0.00007649418,0.000060363807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012175461,0.00038645952,0.0005031624,0.00019375668,0.000309976,0.000047116882,0.00046858573,0.00022056547,0.00026620057],"category_scores_gemma":[0.0000740997,0.0003512232,0.00013772244,0.00023103332,0.0002375433,0.00057775906,0.00019084755,0.0004678191,0.00050790375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006153107,0.0004415897,0.040199608,0.0001593637,0.00016898906,0.00010189555,0.0007026027,0.00007201836,0.95649004,0.00022231374,0.00054771104,0.00027858096],"study_design_scores_gemma":[0.010670987,0.0003682574,0.06845303,0.00061717554,0.00016804307,0.000014121875,0.0015262199,0.000004970264,0.8324743,0.0002943834,0.08449487,0.0009136538],"about_ca_topic_score_codex":0.00005708,"about_ca_topic_score_gemma":0.0001262733,"teacher_disagreement_score":0.124015726,"about_ca_system_score_codex":0.000035010908,"about_ca_system_score_gemma":0.000076370576,"threshold_uncertainty_score":0.99989396},"labels":[],"label_agreement":null},{"id":"W2991013013","doi":"10.1182/bloodadvances.2019001062","title":"Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Primary central nervous system lymphoma; Outcome (game theory); Lymphoma; Human immunodeficiency virus (HIV); Medicine; Pediatrics; Central nervous system; Immunodeficiency; Oncology; Internal medicine; Immunology; Immune system","score_opus":0.0029996100863289806,"score_gpt":0.22571558229874444,"score_spread":0.22271597221241546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991013013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791233,0.01914288,6.800374e-7,0.00005632741,0.00021778495,0.00090526853,0.000019726707,0.00005294569,0.00048106472],"genre_scores_gemma":[0.99867517,0.000650831,0.00018004281,0.00023159332,0.00009836982,0.000029293114,0.000041719122,0.000022083079,0.00007091465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988731,0.000038500915,0.00022125492,0.00036478712,0.00018101731,0.0003213149],"domain_scores_gemma":[0.9995264,0.000055821867,0.000074170915,0.00017802222,0.000013909031,0.00015172208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053672942,0.00021651783,0.00046860494,0.000084991494,0.000040424744,0.000028953198,0.000045956753,0.000079459154,0.0000019846543],"category_scores_gemma":[0.000014423217,0.00016640806,0.000049878563,0.00008862938,0.00004149393,0.00012606166,0.00006157964,0.0000686613,0.000008649412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014964677,0.00047325177,0.8959733,0.00082212716,0.00007037343,0.00027695313,0.00005422163,0.0000024324538,0.00010470558,0.000051029638,0.000010635639,0.102011286],"study_design_scores_gemma":[0.011786518,0.00029536212,0.9852171,0.0011111544,0.00019963775,0.0004558278,0.000022500413,0.0000054248376,0.0006407973,0.000007132035,0.00010059337,0.00015795502],"about_ca_topic_score_codex":0.000116284864,"about_ca_topic_score_gemma":0.000035933615,"teacher_disagreement_score":0.101853326,"about_ca_system_score_codex":0.000085776905,"about_ca_system_score_gemma":0.000030926924,"threshold_uncertainty_score":0.6785924},"labels":[],"label_agreement":null},{"id":"W2991882427","doi":"10.1182/bloodadvances.2019000916","title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; American Heart Association; Mayo Clinic","keywords":"Hematology; Medicine; Disease; Internal medicine; Intensive care medicine; Kidney disease; Kidney; Cardiology; Immunology","score_opus":0.010542620731997977,"score_gpt":0.2810765644987329,"score_spread":0.27053394376673495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991882427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8331246,0.1506287,0.0002526904,0.013045498,0.0003510937,0.0013022815,0.00041985058,0.00008537974,0.00078993844],"genre_scores_gemma":[0.9468794,0.03059736,0.011626963,0.0052525843,0.00025825333,0.00007712295,0.00026947443,0.000066464076,0.004972386],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906087,0.0000151805325,0.00026761147,0.00028919973,0.0001432027,0.00022392637],"domain_scores_gemma":[0.99903184,0.000057547815,0.00013047937,0.0002478384,0.00015806816,0.0003742219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067871064,0.00014925939,0.0004249636,0.000029436338,0.000044492514,0.000003908935,0.000061435254,0.000041261712,0.000020038773],"category_scores_gemma":[0.00009838939,0.000113955684,0.00021586576,0.00010580762,0.00020035799,0.00007081805,0.000039116676,0.00006962918,0.000005253936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017208784,0.0011733356,0.8663882,0.007863676,0.0005212377,0.000054595508,0.00022415246,0.0003082925,0.009629329,0.00049018726,0.09430935,0.017316742],"study_design_scores_gemma":[0.010138164,0.0012423217,0.03902936,0.00095575536,0.0022269005,0.000053178035,0.002603686,0.0027529788,0.004696762,0.0009583004,0.93456525,0.0007773493],"about_ca_topic_score_codex":0.000021404448,"about_ca_topic_score_gemma":3.9950197e-7,"teacher_disagreement_score":0.8402559,"about_ca_system_score_codex":0.0000052048326,"about_ca_system_score_gemma":0.00015881896,"threshold_uncertainty_score":0.4646978},"labels":[],"label_agreement":null},{"id":"W2991907358","doi":"10.1182/bloodadvances.2019000975","title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":594,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University; Impact; Dalhousie University","funders":"","keywords":"Medicine; Guideline; Perioperative; Venous thromboembolism; Prostatectomy; Vascular surgery; Low molecular weight heparin; Orthopedic surgery; Surgery; Cardiac surgery; Intensive care medicine; Heparin; Internal medicine; Thrombosis; Prostate","score_opus":0.021403377672802287,"score_gpt":0.33502501719400124,"score_spread":0.3136216395211989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991907358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136937,0.003968502,0.000111296504,0.00026458217,0.00033844943,0.0026968548,0.00006792913,0.000029903562,0.001153099],"genre_scores_gemma":[0.9760672,0.008346518,0.014925255,0.00012858017,0.000059451675,0.0001483829,0.00012032473,0.000048202382,0.00015611993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972241,0.000057933805,0.0012801066,0.0004972251,0.00050211453,0.0004385055],"domain_scores_gemma":[0.9978194,0.00010079727,0.0009836778,0.00052021525,0.000502386,0.00007347529],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036546215,0.00029792718,0.0023984418,0.00016526645,0.000031991487,0.0000047210533,0.00025745103,0.000105454,0.000051360075],"category_scores_gemma":[0.000033374254,0.0002655886,0.00047241864,0.00041830476,0.00024019678,0.00015208588,0.00014940386,0.00009807908,0.0000046615346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027003272,0.12847692,0.42458326,0.04783708,0.012944436,0.000078846264,0.0060135443,0.0019571714,0.0054929177,0.051074844,0.012967099,0.30587357],"study_design_scores_gemma":[0.024276683,0.014475934,0.91043013,0.004017815,0.0028091632,0.000017614131,0.0032463537,0.0001907526,0.017731437,0.0041985256,0.017787393,0.0008182226],"about_ca_topic_score_codex":0.00018634467,"about_ca_topic_score_gemma":0.000014520006,"teacher_disagreement_score":0.48584685,"about_ca_system_score_codex":0.000036027082,"about_ca_system_score_gemma":0.00006439053,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W2992108607","doi":"10.1182/bloodadvances.2019000791","title":"The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"MAGIC (telescope); Biomarker; Algorithm; Medicine; Disease; Internal medicine; Computer science; Biology; Physics","score_opus":0.02049118854891974,"score_gpt":0.30055705164423807,"score_spread":0.28006586309531833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992108607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957271,0.0016949264,0.00010207348,0.00054840517,0.00016770908,0.0011155463,0.00028339776,0.000027520464,0.0003332798],"genre_scores_gemma":[0.9931705,0.0014840227,0.0041304994,0.00002416586,0.000017092532,0.00004937538,0.000050962397,0.00001971008,0.0010536928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881995,0.00013067812,0.00035589433,0.000250424,0.00026874142,0.00017432567],"domain_scores_gemma":[0.9986371,0.0004938366,0.00015900668,0.00048565405,0.000121733305,0.00010267887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002236537,0.00014848934,0.00030461702,0.00004920399,0.000033070904,0.00000581927,0.000082317725,0.00003754525,0.00009145167],"category_scores_gemma":[0.00003850492,0.000090065405,0.00013794501,0.00021111473,0.00014979676,0.000076298355,0.000009960123,0.000030453019,0.00002352556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12582684,0.0067829704,0.30200812,0.0032303187,0.005380119,0.00029580915,0.00524407,0.000014003423,0.50387335,0.00039123173,0.00010612289,0.04684707],"study_design_scores_gemma":[0.025616921,0.006252725,0.27126765,0.0006324275,0.0047681085,0.00005954353,0.0005899118,0.0005806654,0.67708796,0.00061139645,0.012142285,0.00039038772],"about_ca_topic_score_codex":0.000016165131,"about_ca_topic_score_gemma":0.0000025997472,"teacher_disagreement_score":0.17321464,"about_ca_system_score_codex":0.000038611797,"about_ca_system_score_gemma":0.00016324544,"threshold_uncertainty_score":0.36727607},"labels":[],"label_agreement":null},{"id":"W2992191998","doi":"10.1182/bloodadvances.2019gs121537","title":"Improving access to hemophilia care in sub-Saharan Africa by capacity building","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Medicine; Business","score_opus":0.02168585716477894,"score_gpt":0.3068095277495268,"score_spread":0.28512367058474786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992191998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780342,0.016635682,0.000012722518,0.0006841194,0.00014225452,0.0009696916,0.000027468199,0.000056976543,0.0034368748],"genre_scores_gemma":[0.9970585,0.00066006766,0.0011523869,0.0001127424,0.000109089306,0.00006477951,0.000018620876,0.000025275163,0.0007985196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846977,0.00003254771,0.000210528,0.00043729515,0.00035934008,0.00049053616],"domain_scores_gemma":[0.99930054,0.00007059486,0.00004160826,0.00029802264,0.000079296085,0.0002099656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012656528,0.00018037557,0.00033206822,0.00018669506,0.00006416314,0.000049070877,0.00021800709,0.000077869205,0.000065650405],"category_scores_gemma":[0.00009544986,0.0001422128,0.00006734617,0.0004329987,0.000036064455,0.00034632484,0.00010955194,0.00022505221,0.00009121325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003251615,0.00040828303,0.3005517,0.0009630467,0.000067822715,0.00013602797,0.00071461475,0.00003464768,0.60898805,0.00001997842,0.0012687366,0.08652189],"study_design_scores_gemma":[0.005886004,0.001280705,0.02717017,0.00070275494,0.00009957754,0.000028268583,0.0003225387,0.000066936926,0.85073173,0.00014402688,0.113040164,0.0005271132],"about_ca_topic_score_codex":0.00009247064,"about_ca_topic_score_gemma":0.00007468406,"teacher_disagreement_score":0.27338156,"about_ca_system_score_codex":0.00009759825,"about_ca_system_score_gemma":0.00007130592,"threshold_uncertainty_score":0.57992697},"labels":[],"label_agreement":null},{"id":"W2992332113","doi":"10.1182/bloodadvances.2019gs121524","title":"Building a network for hemophilia care in China: 15 years of achievement for the Hemophilia Treatment Center Collaborative Network of China","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; University of Calgary","funders":"","keywords":"China; Center (category theory); Medicine; Pediatrics; Political science; Chemistry","score_opus":0.011226751977722485,"score_gpt":0.3044062852492758,"score_spread":0.2931795332715533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992332113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728486,0.019950608,0.00007728243,0.00096138194,0.00032560993,0.0053173145,0.00020311383,0.000016533519,0.00029953566],"genre_scores_gemma":[0.98601395,0.0017387635,0.010500702,0.00003600023,0.00044199848,0.00048459417,0.000087781365,0.000037075195,0.00065915973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983581,0.000049884555,0.00043292798,0.000358781,0.00028819084,0.0005121499],"domain_scores_gemma":[0.99881667,0.00036942796,0.00019748721,0.00037262196,0.0001666596,0.000077155535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002573048,0.00023512026,0.0006557745,0.00006310619,0.00009472348,0.000009499637,0.0001654186,0.00008214814,0.000018043358],"category_scores_gemma":[0.00005282608,0.00015068526,0.00022907865,0.00045750153,0.000102101345,0.00008091583,0.000051895742,0.00009639515,0.0000015185748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008102073,0.0030257371,0.8423527,0.0021694517,0.0019401382,0.000029486038,0.0050791753,0.01647281,0.0032067124,0.004168557,0.0006484719,0.11280467],"study_design_scores_gemma":[0.081080034,0.036065526,0.6274178,0.004260919,0.0020644004,0.000025278026,0.0042202324,0.0022658648,0.05437545,0.006974614,0.18008946,0.0011604169],"about_ca_topic_score_codex":0.000034144803,"about_ca_topic_score_gemma":0.00013132497,"teacher_disagreement_score":0.2149349,"about_ca_system_score_codex":0.00011357139,"about_ca_system_score_gemma":0.00017653662,"threshold_uncertainty_score":0.6144767},"labels":[],"label_agreement":null},{"id":"W2992870481","doi":"10.1182/bloodadvances.2019000883","title":"End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Feinberg School of Medicine; Northwestern University; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Doris Duke Charitable Foundation","keywords":"Medicine; Intensive care medicine; Clinical trial; Food and drug administration; Disease; MEDLINE; Resource (disambiguation); Drug trial; Physical therapy; Internal medicine; Medical emergency","score_opus":0.017256968994655515,"score_gpt":0.3187295266241372,"score_spread":0.3014725576294817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992870481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9465921,0.047145545,0.000030134745,0.0022747996,0.00023298732,0.0011290743,0.000076493976,0.000050893883,0.0024679592],"genre_scores_gemma":[0.9857024,0.008293797,0.0012098497,0.0013810385,0.000586589,0.00003337452,0.000075489435,0.000048451377,0.0026690145],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849916,0.00014352164,0.0005012261,0.00042656032,0.000171183,0.0002583762],"domain_scores_gemma":[0.99859643,0.0006432384,0.00017480407,0.00020540993,0.000040064337,0.00034003812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011225293,0.00017418951,0.0006277936,0.0000445451,0.00007530535,0.00002121479,0.000053178275,0.000119710436,0.000026513311],"category_scores_gemma":[0.0005647093,0.00012666601,0.00019103086,0.00006355002,0.00014312411,0.000098676755,0.000048435388,0.00019853543,0.000010326755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012058644,0.0030976734,0.587379,0.0064027687,0.0011642318,0.0004836695,0.0009783792,0.00010402556,0.008615479,0.00067486655,0.019206572,0.3598347],"study_design_scores_gemma":[0.021194985,0.0014568343,0.014527875,0.00084099075,0.0017401896,0.00008135136,0.0011287373,0.0007018129,0.0019717042,0.00094124966,0.9548969,0.00051731744],"about_ca_topic_score_codex":0.000003253765,"about_ca_topic_score_gemma":7.1663334e-7,"teacher_disagreement_score":0.9356904,"about_ca_system_score_codex":0.000004462458,"about_ca_system_score_gemma":0.000060943396,"threshold_uncertainty_score":0.516529},"labels":[],"label_agreement":null},{"id":"W2992929603","doi":"10.1182/bloodadvances.2019000989","title":"Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"BCL6; Tissue microarray; Primary central nervous system lymphoma; Lymphoma; Immunohistochemistry; Diffuse large B-cell lymphoma; Germinal center; Pathology; Population; Biology; Cancer research; Medicine; Oncology; B cell; Immunology; Antibody","score_opus":0.004682424687550408,"score_gpt":0.24079021047376006,"score_spread":0.23610778578620967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992929603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97164917,0.023911638,0.000024886003,0.000024765415,0.00018106643,0.00063612405,0.000056642995,0.000028888226,0.0034868103],"genre_scores_gemma":[0.9970935,0.00018586549,0.0024422125,0.00006935235,0.000044707354,0.000013650804,0.000035047113,0.000021089654,0.00009455664],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988339,0.000032249663,0.00030386075,0.0002577029,0.00028981504,0.00028246417],"domain_scores_gemma":[0.999264,0.000034781424,0.00020816522,0.0003238119,0.0000830845,0.000086177984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006892121,0.00017052265,0.0005970961,0.000066100925,0.00002380341,0.0000057202487,0.00008271057,0.000068810325,0.000016063183],"category_scores_gemma":[0.000010748848,0.00013230224,0.00012821371,0.00012961481,0.000040903975,0.00007392637,0.000036512738,0.00002792731,0.0000048886423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020538404,0.001562719,0.69221646,0.0020802424,0.00060609373,0.0002976331,0.00015893442,0.000085012485,0.2912922,0.00085322757,0.000031779375,0.010610321],"study_design_scores_gemma":[0.0030932236,0.00027160064,0.4568749,0.00055601686,0.0004969842,0.0002097544,0.0001305309,0.000009702294,0.537128,0.0000037000966,0.0011316154,0.000093991235],"about_ca_topic_score_codex":0.00014472379,"about_ca_topic_score_gemma":0.0000050306494,"teacher_disagreement_score":0.24583578,"about_ca_system_score_codex":0.00010846356,"about_ca_system_score_gemma":0.00013559974,"threshold_uncertainty_score":0.5395129},"labels":[],"label_agreement":null},{"id":"W2993666578","doi":"10.1182/bloodadvances.2019000966","title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; University of Oklahoma Health Sciences Center; National Institutes of Health; University of Oklahoma","keywords":"Medicine; Guideline; Rituximab; Immune thrombocytopenia; Intensive care medicine; Clinical trial; MEDLINE; Randomized controlled trial; Dosing; Hematology; Family medicine; Pediatrics; Internal medicine; Immunology; Antibody; Pathology","score_opus":0.02765874513328463,"score_gpt":0.34830664063336286,"score_spread":0.3206478955000782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993666578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828431,0.013649614,0.00012603265,0.0018599512,0.000111435314,0.0005654613,0.000035923782,0.000028093398,0.00078039564],"genre_scores_gemma":[0.94197184,0.0033818383,0.051120646,0.0008897127,0.00005212348,0.00004073414,0.000087909066,0.000025583135,0.0024295887],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928343,0.00000578262,0.00026075004,0.00018259263,0.00009413717,0.00017332433],"domain_scores_gemma":[0.99938774,0.000062034225,0.0001620464,0.00019632082,0.0001592588,0.000032604825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005166215,0.00011016658,0.00063096406,0.000020350377,0.000024327788,0.0000025845957,0.00006539548,0.000032385742,0.000042810043],"category_scores_gemma":[0.000029612187,0.00008075754,0.00017258927,0.000090471505,0.00008020759,0.00007032889,0.000020973204,0.000036246805,0.000023574219],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016192205,0.004589567,0.5560668,0.002563733,0.004486002,0.00007715941,0.0007204132,0.00009181353,0.23295002,0.0042589973,0.0420905,0.15048574],"study_design_scores_gemma":[0.040046364,0.008788349,0.06855801,0.0008160697,0.0018313099,0.00074629125,0.0035307836,0.0006449666,0.43246314,0.00429938,0.43726572,0.0010096037],"about_ca_topic_score_codex":0.000054179203,"about_ca_topic_score_gemma":0.000007731504,"teacher_disagreement_score":0.48750883,"about_ca_system_score_codex":0.0000055236715,"about_ca_system_score_gemma":0.000041465333,"threshold_uncertainty_score":0.32931972},"labels":[],"label_agreement":null},{"id":"W2994185600","doi":"10.1182/bloodadvances.2019000931","title":"2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Guideline; Multidisciplinary approach; Medicine; Family medicine; Intensive care medicine; MEDLINE; Disease; Medical education; Internal medicine; Pathology; Political science","score_opus":0.042248007520699654,"score_gpt":0.3286298951923438,"score_spread":0.2863818876716442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994185600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6538666,0.31218928,0.00013418535,0.03203445,0.00009976709,0.00041206996,0.000030111476,0.000037653565,0.0011958671],"genre_scores_gemma":[0.6526272,0.3021733,0.033382356,0.0077610565,0.00012196238,0.000049065682,0.00008288068,0.00005064817,0.003751523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992438,0.000055880588,0.0002473202,0.00019708902,0.000103428254,0.00015247446],"domain_scores_gemma":[0.9991997,0.00020596382,0.00018084269,0.0002310968,0.00012391894,0.000058493424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022704806,0.00010672966,0.00031219522,0.000024364332,0.000046745175,0.000002481787,0.00007277462,0.00004404658,0.000015223601],"category_scores_gemma":[0.00009316745,0.00006466537,0.00006821059,0.0001678927,0.00033368915,0.000049802544,0.00004216191,0.00012951174,0.0000065825097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009595363,0.0032961413,0.17817953,0.0047675776,0.0016694915,0.000026409924,0.0051323506,0.00018846849,0.10235634,0.024492906,0.21639125,0.46254],"study_design_scores_gemma":[0.0077391127,0.0015275241,0.03240139,0.00042874826,0.0012677318,0.00014721768,0.031379856,0.0005338918,0.018001042,0.005940956,0.8999137,0.0007187894],"about_ca_topic_score_codex":0.000033134667,"about_ca_topic_score_gemma":0.000003384882,"teacher_disagreement_score":0.68352246,"about_ca_system_score_codex":0.0000029996086,"about_ca_system_score_gemma":0.00005051252,"threshold_uncertainty_score":0.2636977},"labels":[],"label_agreement":null},{"id":"W2996025285","doi":"10.1182/bloodadvances.2019000647","title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Agence Nationale de la Recherche","keywords":"Internal medicine; Medicine; Vincristine; Immunophenotyping; Cyclophosphamide; Myeloid leukemia; Oncology; Transplantation; Leukemia; Myeloid; Lymphoma; Gastroenterology; Immunology; Chemotherapy; Antigen","score_opus":0.011121265610002649,"score_gpt":0.2575552602353257,"score_spread":0.24643399462532306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996025285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831317,0.010355318,0.000013149553,0.0010293352,0.00013580821,0.0009249699,0.00003500348,0.000063827785,0.004310876],"genre_scores_gemma":[0.98500085,0.0036920686,0.00030640527,0.00018830401,0.0000776039,0.000066529734,0.000039322455,0.000045789646,0.010583143],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828476,0.0000522637,0.00018513334,0.0005039319,0.0004996262,0.00047428507],"domain_scores_gemma":[0.9987471,0.0005079612,0.00006130222,0.00029181564,0.00014828902,0.0002435147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047916736,0.0002706002,0.00041489606,0.00015030657,0.00009573327,0.00008822302,0.0001094614,0.00008974682,0.00012468187],"category_scores_gemma":[0.00029008026,0.00021843995,0.000075867094,0.00019101384,0.00014620111,0.00026247674,0.00007648581,0.00021339531,0.000110161855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038649293,0.0013661637,0.96937543,0.0010203609,0.00007652222,0.0002759379,0.0005038102,0.000019653427,0.008191655,0.00007412335,0.00041941195,0.018290417],"study_design_scores_gemma":[0.09880669,0.022378288,0.12312563,0.00250847,0.0020695548,0.0038287106,0.01016144,0.0028037683,0.46346742,0.0021339494,0.26473868,0.003977434],"about_ca_topic_score_codex":0.0000093710705,"about_ca_topic_score_gemma":0.000058149188,"teacher_disagreement_score":0.8462498,"about_ca_system_score_codex":0.00004193664,"about_ca_system_score_gemma":0.0000872874,"threshold_uncertainty_score":0.8907723},"labels":[],"label_agreement":null},{"id":"W2997476486","doi":"10.1182/bloodadvances.2019000488","title":"Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Institute of General Medical Sciences; Cancer Research UK; European Hematology Association","keywords":"Myeloid; Langerhans cell histiocytosis; Biology; Dendritic cell; Lesion; Immunology; Bone marrow; Langerin; Antigen; Pathology; Medicine","score_opus":0.01671060837169836,"score_gpt":0.2591382869210894,"score_spread":0.24242767854939107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997476486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901361,0.0029504346,0.0009795323,0.0013095186,0.00045354295,0.0007618467,0.000043578253,0.00015288066,0.0032125742],"genre_scores_gemma":[0.99299157,0.00017924221,0.0047756815,0.0009927037,0.00027456818,0.00003183619,0.000024809213,0.000041657273,0.00068794837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998397,0.00003288975,0.00030784155,0.0005056329,0.00037900085,0.00037765448],"domain_scores_gemma":[0.99917144,0.000038683764,0.00011425229,0.0002144611,0.000075391625,0.00038576158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045828187,0.00024466467,0.0003976823,0.000063782485,0.00015832804,0.000033914253,0.00011820908,0.00007290287,0.00015810541],"category_scores_gemma":[0.00007609279,0.00022071454,0.00012816652,0.0002671484,0.000043191456,0.00013699092,0.000054750828,0.0001392245,0.00032642006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012486796,0.00553638,0.045519494,0.00362948,0.0012355547,0.008999861,0.007897321,0.012533444,0.7510633,0.00028668958,0.005949025,0.15610078],"study_design_scores_gemma":[0.029279836,0.006343718,0.021354705,0.003441332,0.0045524836,0.0004760609,0.009610709,0.0037505827,0.7868186,0.000807942,0.13066404,0.0028999767],"about_ca_topic_score_codex":0.000021459948,"about_ca_topic_score_gemma":0.000012687837,"teacher_disagreement_score":0.1532008,"about_ca_system_score_codex":0.00003551767,"about_ca_system_score_gemma":0.00006273055,"threshold_uncertainty_score":0.9000478},"labels":[],"label_agreement":null},{"id":"W3005282054","doi":"10.1182/bloodadvances.2019001223","title":"Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Meta-analysis; Venous thromboembolism; Medicine; Intensive care medicine; MEDLINE; Internal medicine; Thrombosis; Biology","score_opus":0.030362133901359514,"score_gpt":0.32007356842080303,"score_spread":0.28971143451944353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005282054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007936918,0.9909905,0.000009475782,0.0002347755,0.00007410441,0.0079930425,0.00045135163,0.000070408634,0.00016836221],"genre_scores_gemma":[0.000073042356,0.99675137,0.00037595746,0.00022066676,0.0000844246,0.002097969,0.00015308779,0.00008344645,0.00016002782],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99597913,0.0003461213,0.0018038128,0.0009496016,0.00053124444,0.00039009936],"domain_scores_gemma":[0.9962346,0.00026992595,0.0019912692,0.0011118241,0.00011948362,0.000272907],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0002731766,0.0009584348,0.03149151,0.00033258522,0.00008871616,0.000036486897,0.0002766669,0.00016402011,0.00018258086],"category_scores_gemma":[0.0001422001,0.0005629847,0.0050544394,0.0010853257,0.00011745522,0.00011260358,0.000112791466,0.00018350633,0.000044235083],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001463957,0.0017174295,0.0000026839186,0.6553143,0.33565205,0.00009116498,0.00011591738,4.412943e-7,1.0704638e-8,0.00005367509,0.00004300442,0.007007817],"study_design_scores_gemma":[0.0003139953,0.0019313546,0.000012145689,0.042414647,0.8420348,0.00003227679,0.000033878376,4.6332886e-7,8.3494206e-7,0.000018097016,0.11280984,0.00039764796],"about_ca_topic_score_codex":0.000047090536,"about_ca_topic_score_gemma":0.000013435305,"teacher_disagreement_score":0.61289966,"about_ca_system_score_codex":0.000075039185,"about_ca_system_score_gemma":0.00013309995,"threshold_uncertainty_score":0.9996822},"labels":[],"label_agreement":null},{"id":"W3006053835","doi":"10.1182/bloodadvances.2018027870","title":"WASP and Mst1 coregulate B-cell development and B-cell receptor signaling","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; The Scarborough Hospital; Institute of Infection and Immunity","funders":"","keywords":"Cell biology; Receptor; Signal transduction; Cell; Biology; Genetics","score_opus":0.009261869320203503,"score_gpt":0.20017631976139597,"score_spread":0.19091445044119246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006053835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98203963,0.016707066,0.000357296,0.0001146084,0.00005115036,0.0001003498,0.000010457302,0.000023168537,0.0005962496],"genre_scores_gemma":[0.98777556,0.0006910365,0.010499199,0.0003640071,0.00018514556,0.000009780162,0.000044287834,0.000021089558,0.00040989602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910676,0.000029151797,0.00017462354,0.00039418373,0.00009369209,0.00020155944],"domain_scores_gemma":[0.9996243,0.000013827973,0.000070308975,0.00009543089,0.000032072476,0.00016406525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008946565,0.00016375288,0.00014788068,0.00001570724,0.0001142637,0.000029678202,0.000086837914,0.00008076336,0.000011281737],"category_scores_gemma":[0.000021900942,0.00015128581,0.000027284921,0.000051069874,0.00006225286,0.000006338398,0.00008073304,0.00007049681,0.0000096694475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003701273,0.00004707782,0.0010757418,0.000090017966,0.000017803368,0.0000044273547,0.0003214321,0.000036895868,0.9930359,0.0000071737327,0.000040496638,0.0052859806],"study_design_scores_gemma":[0.00075226655,0.0002144089,0.00003237359,0.000017993723,0.000019466132,0.000004335529,0.00015771782,0.000019465588,0.87532383,0.000014367805,0.123242006,0.00020176847],"about_ca_topic_score_codex":0.0000013130588,"about_ca_topic_score_gemma":0.0000018762631,"teacher_disagreement_score":0.123201504,"about_ca_system_score_codex":0.0000019686565,"about_ca_system_score_gemma":0.000044250643,"threshold_uncertainty_score":0.61692566},"labels":[],"label_agreement":null},{"id":"W3006233208","doi":"10.1182/bloodadvances.2019000525","title":"Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"Legend Biotech; Novartis Pharmaceuticals Corporation","keywords":"Cytokine release syndrome; Immunogenicity; Immunology; Medicine; CD19; Hazard ratio; Internal medicine; Tocilizumab; Oncology; Biology; Immunotherapy; Flow cytometry; Cancer; Antibody; Confidence interval; Chimeric antigen receptor","score_opus":0.0500624111526647,"score_gpt":0.3459240145316899,"score_spread":0.29586160337902523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006233208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245834,0.004899353,0.000027512184,0.0009616996,0.0001271362,0.0005852105,0.000006401986,0.000037337468,0.0008969781],"genre_scores_gemma":[0.99695563,0.0013526274,0.00068516855,0.00037639827,0.00017878217,0.0000123871605,0.000017473705,0.000030283425,0.00039121724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981771,0.0001591547,0.0005738501,0.00046160197,0.00032285185,0.00030542456],"domain_scores_gemma":[0.99907565,0.00028963588,0.00007724372,0.00024152231,0.0000469105,0.00026901055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037465343,0.00016728441,0.0004161303,0.00014532737,0.000026683594,0.00001767875,0.00012193908,0.00014814672,0.00025184776],"category_scores_gemma":[0.00072390144,0.0001555582,0.00007587279,0.00045305467,0.000093092145,0.00011965743,0.000092826594,0.00058076484,0.000029090128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006987373,0.0005586881,0.6938382,0.000060642466,0.000029329847,0.000100579455,0.0009171981,0.000030439922,0.28854275,0.000010557067,0.000025874378,0.015187001],"study_design_scores_gemma":[0.0062471125,0.0015831625,0.9286353,0.00009639604,0.0000346689,0.0000044588046,0.00029130458,0.000106573294,0.037960067,0.00007460302,0.02476414,0.00020219559],"about_ca_topic_score_codex":0.00007939509,"about_ca_topic_score_gemma":0.00014115204,"teacher_disagreement_score":0.2505827,"about_ca_system_score_codex":0.000052161467,"about_ca_system_score_gemma":0.00006034854,"threshold_uncertainty_score":0.6343479},"labels":[],"label_agreement":null},{"id":"W3007507981","doi":"10.1182/bloodadvances.2019001026","title":"Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Kite Pharma; MorphoSys; BeiGene; Novartis Pharmaceuticals Corporation; Celgene; Gilead Sciences; Chugai Pharmaceutical; Servier; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Lymphoma; Quality of life (healthcare); Term (time); Oncology; Internal medicine; Biology","score_opus":0.03035533187023569,"score_gpt":0.3139951859388295,"score_spread":0.2836398540685938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007507981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98729223,0.010032785,0.000018746534,0.00026299927,0.00010245727,0.00059999415,0.00003818817,0.00006450007,0.0015881142],"genre_scores_gemma":[0.997027,0.00085544377,0.00016364748,0.000936464,0.00013270631,0.0000624147,0.00003089541,0.000048514386,0.00074296247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730927,0.00018246705,0.000846354,0.0004993895,0.0007061872,0.00045634026],"domain_scores_gemma":[0.99850994,0.00017968174,0.00030037353,0.00050481415,0.0001237574,0.0003814403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002741308,0.00023363212,0.0006314895,0.00012249565,0.000031095908,0.000013020346,0.00014995069,0.00012570323,0.0011081677],"category_scores_gemma":[0.00043881836,0.00021074654,0.00017742992,0.00041721683,0.00011416155,0.00015402242,0.00011952174,0.00025228408,0.000036724447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036313215,0.009475846,0.81320673,0.0008378301,0.00013415405,0.00063793,0.0016337953,0.0000013848756,0.14959267,0.000004844291,0.00005720383,0.020786293],"study_design_scores_gemma":[0.043544043,0.0014854237,0.8658167,0.00019521097,0.00011146003,0.000016100857,0.00039532362,0.000022916596,0.08057899,0.00002260192,0.0074219247,0.0003892942],"about_ca_topic_score_codex":0.00004556755,"about_ca_topic_score_gemma":0.000112299895,"teacher_disagreement_score":0.069013685,"about_ca_system_score_codex":0.00004969201,"about_ca_system_score_gemma":0.0002163136,"threshold_uncertainty_score":0.999805},"labels":[],"label_agreement":null},{"id":"W3007678852","doi":"10.1182/bloodadvances.2019000084","title":"Impact of gender and caregiving responsibilities on academic success in hematology","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Hematology; Internal medicine; Medicine; Psychology; Gerontology","score_opus":0.04864717954081438,"score_gpt":0.36173524413412705,"score_spread":0.3130880645933127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007678852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98680663,0.0044288635,0.0000036685315,0.0007418357,0.000053841755,0.00007579616,0.0000065935915,0.000016252847,0.00786653],"genre_scores_gemma":[0.9987662,0.00087919354,0.000033721633,0.000211682,0.00006163277,0.0000013372365,6.13208e-7,0.0000021944072,0.000043435677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992312,0.00011423526,0.00010897912,0.00014446527,0.0002467382,0.00015439239],"domain_scores_gemma":[0.9995135,0.00028015912,0.000049902377,0.000048996753,0.000029555833,0.00007790706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003375088,0.00005565514,0.00016621103,0.000051255938,0.000068463756,0.000007413418,0.00018235124,0.000061493534,0.00005143889],"category_scores_gemma":[0.0005910085,0.000048106973,0.000027866306,0.0001776341,0.00033091893,0.00018161602,0.000042848562,0.00013865287,0.0000011348675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096560216,0.00002338179,0.9356079,0.00005411639,0.000016004098,0.000018574508,0.05229438,0.00003973734,0.00012937,0.010180099,0.00012072176,0.0014191541],"study_design_scores_gemma":[0.0029558712,0.0013965875,0.55813664,0.00038871946,0.00010252251,0.000008417123,0.41515225,0.000022256987,0.0022103388,0.010915909,0.0082254475,0.00048507148],"about_ca_topic_score_codex":0.00035141516,"about_ca_topic_score_gemma":0.00023265577,"teacher_disagreement_score":0.3774713,"about_ca_system_score_codex":0.00001452109,"about_ca_system_score_gemma":0.00008397755,"threshold_uncertainty_score":0.19617455},"labels":[],"label_agreement":null},{"id":"W3007752132","doi":"10.1182/bloodadvances.2019000885","title":"A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Edoxaban; Medicine; Anticoagulant; Bolus (digestion); Apixaban; Placebo; Pharmacology; Anesthesia; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.07116701488639715,"score_gpt":0.38447714479680206,"score_spread":0.3133101299104049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007752132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963545,0.0008956225,0.00022758417,0.0012572686,0.000053771237,0.0011236952,0.000011581707,0.000014720917,0.00006124502],"genre_scores_gemma":[0.99842274,0.000115130664,0.001174042,0.00009052439,0.00014178437,0.0000032233224,0.000018316901,0.000008030886,0.000026181751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920577,0.000026246527,0.00035319102,0.00017055275,0.00014628533,0.000097961754],"domain_scores_gemma":[0.9995771,0.00009198021,0.00015266589,0.00008153913,0.000042018753,0.000054702938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011878258,0.0000825776,0.00035676884,0.00008961978,0.000020702897,0.000003398912,0.000032432497,0.000023949315,0.000008282141],"category_scores_gemma":[0.00015282827,0.00007365191,0.000038525417,0.0001925645,0.000030828254,0.00012733538,0.000020025795,0.000034567318,2.3922024e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036804408,0.00038966752,0.9817364,0.0007342788,0.00010969639,0.00000416733,0.0023692881,0.00015983352,0.004350791,0.00018084401,0.000051453637,0.0062331166],"study_design_scores_gemma":[0.17231019,0.049513552,0.7237369,0.00036748484,0.0017563095,0.0000066900857,0.017417489,0.010938214,0.008375129,0.0004597002,0.014524097,0.00059428415],"about_ca_topic_score_codex":0.000036982587,"about_ca_topic_score_gemma":0.00004701369,"teacher_disagreement_score":0.25799957,"about_ca_system_score_codex":0.000004673509,"about_ca_system_score_gemma":0.00001735215,"threshold_uncertainty_score":0.30034375},"labels":[],"label_agreement":null},{"id":"W3008653672","doi":"10.1182/bloodadvances.2019001414","title":"A practical approach to evaluating postoperative thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Medicine; Perioperative; Thrombopoietin; Platelet; Heparin; Heparin-induced thrombocytopenia; Disseminated intravascular coagulation; Thrombosis; Surgery; Anesthesia; Intensive care medicine; Internal medicine","score_opus":0.14447404203108044,"score_gpt":0.4097067193195269,"score_spread":0.26523267728844646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008653672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89202404,0.00037907323,0.002644726,0.021379814,0.00014739243,0.0016967383,0.000015298554,0.00026432975,0.08144858],"genre_scores_gemma":[0.86023206,0.00004674183,0.13124026,0.007844863,0.00030603187,0.00010213786,0.00002033859,0.000044157576,0.0001634122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775875,0.00012675064,0.00040433984,0.00074161764,0.0005015368,0.00046702367],"domain_scores_gemma":[0.9985724,0.00013087764,0.000095941235,0.00033164138,0.00019872529,0.0006703925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002411946,0.0003014872,0.0007864358,0.000060536673,0.00018606264,0.00006897448,0.00017143747,0.00010321726,0.00020979877],"category_scores_gemma":[0.0011279328,0.00024729184,0.00012444113,0.00055349886,0.00007870734,0.00046394585,0.00016810905,0.00040004446,0.0004922165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013136372,0.003270746,0.021978924,0.000550583,0.0011227889,0.0002703898,0.01145459,0.00019145792,0.9151102,0.020427935,0.0035787865,0.020730015],"study_design_scores_gemma":[0.023028819,0.023053614,0.10155291,0.0007660683,0.004326451,0.0020058425,0.012301631,0.00634872,0.6287398,0.0008826454,0.19337401,0.0036195074],"about_ca_topic_score_codex":0.000020649106,"about_ca_topic_score_gemma":0.0000068703393,"teacher_disagreement_score":0.28637037,"about_ca_system_score_codex":0.00004111067,"about_ca_system_score_gemma":0.00030068282,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W3009821158","doi":"10.1182/bloodadvances.2019001114","title":"Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"BCL6; Angioimmunoblastic T-cell lymphoma; Cancer research; Lymphoma; Tumor microenvironment; Biology; B cell; B-cell activating factor; T cell; Germinal center; Immunology; Antibody; Immune system; Tumor cells","score_opus":0.007275264933565479,"score_gpt":0.27688971610077845,"score_spread":0.26961445116721294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009821158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643664,0.032954726,0.000002383724,0.0017614164,0.000021531063,0.00060683966,0.000050297418,0.000023349268,0.00021307175],"genre_scores_gemma":[0.9970202,0.00055550697,0.001650539,0.0005588367,0.00003936619,0.000083431136,0.000020838872,0.0000115936655,0.000059685324],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991995,0.000015498514,0.00018794027,0.000264277,0.0001865917,0.00014620947],"domain_scores_gemma":[0.99965096,0.000027767275,0.00009620455,0.00008426022,0.000033761266,0.000107042884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027718119,0.00012730545,0.0002681395,0.000024550918,0.000029215327,0.000010322455,0.000051302857,0.000058020323,0.00002443271],"category_scores_gemma":[0.000032457017,0.00009033759,0.000039153507,0.0001379304,0.00007563431,0.000111215544,0.000037806465,0.00007700486,0.0000024434519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002717149,0.0014102071,0.88346356,0.0005674855,0.00007904992,0.00029526497,0.0011562246,0.0000043009636,0.07767348,0.000023852735,0.0005807469,0.03447409],"study_design_scores_gemma":[0.007872217,0.0019212968,0.16083114,0.0009155868,0.00012260472,0.000038251506,0.00021012168,0.00005266643,0.8081727,0.00006086544,0.019601943,0.00020057702],"about_ca_topic_score_codex":0.000021246951,"about_ca_topic_score_gemma":0.000011153396,"teacher_disagreement_score":0.73049927,"about_ca_system_score_codex":0.000012867406,"about_ca_system_score_gemma":0.000035977413,"threshold_uncertainty_score":0.368386},"labels":[],"label_agreement":null},{"id":"W3010494064","doi":"10.1182/bloodadvances.2019000462","title":"Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; SickKids Foundation; McMaster University Medical Centre; Hospital for Sick Children; McMaster University; Impact","funders":"","keywords":"Medicine; MEDLINE; PsycINFO; Guideline; Population; Thematic analysis; Family medicine; Meta-analysis; Grading (engineering); Venous thrombosis; Qualitative research; Internal medicine; Thrombosis; Pathology; Environmental health","score_opus":0.05055115150209153,"score_gpt":0.3721931242874885,"score_spread":0.32164197278539697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010494064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012181414,0.99384123,0.000020525855,0.0011547875,0.00007695004,0.004590818,0.00005017384,0.000054986776,0.0001983632],"genre_scores_gemma":[0.000012411843,0.9932012,0.0033855678,0.0021760203,0.00007123836,0.0010199518,0.00004352248,0.000033896922,0.000056194636],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971498,0.00010045528,0.0015709773,0.00048533874,0.00043308313,0.00026033306],"domain_scores_gemma":[0.99763525,0.00018110231,0.0012257064,0.00046095386,0.00020922824,0.0002877439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024928202,0.00044465932,0.0060721003,0.000088175795,0.00006793752,0.000018999623,0.0001917827,0.0000506423,0.000011678323],"category_scores_gemma":[0.00074454077,0.00028228963,0.00060103886,0.00050864025,0.000118291035,0.00008741294,0.0002558847,0.00013250657,0.000010329907],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025375768,0.0000796534,0.000009314581,0.7565871,0.0007156379,0.000009500871,0.00008926132,2.3640666e-7,3.8791363e-8,0.00010491709,0.003493281,0.23890851],"study_design_scores_gemma":[0.00007812378,0.0002830018,0.0000034586078,0.50299317,0.010066913,0.000017983653,0.00016711254,0.0000013121452,8.1966147e-7,0.000021632322,0.48619783,0.00016862842],"about_ca_topic_score_codex":0.000008739395,"about_ca_topic_score_gemma":0.0000023804105,"teacher_disagreement_score":0.48270455,"about_ca_system_score_codex":0.000028132143,"about_ca_system_score_gemma":0.00015720143,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W3013483274","doi":"10.1182/bloodadvances.2019000960","title":"Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Impact; University of Calgary; Western University; McMaster University; University of Ottawa; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Deep vein; Pulmonary embolism; Thrombosis; MEDLINE; Internal medicine; Diagnostic accuracy; Publication bias; Venous thrombosis; Grading (engineering); Surgery","score_opus":0.06191163969537646,"score_gpt":0.35215767317897967,"score_spread":0.2902460334836032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013483274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008629545,0.9945638,0.000005405215,0.0004185801,0.0000394265,0.004416087,0.0002882235,0.00001390319,0.0002459406],"genre_scores_gemma":[0.00056646205,0.99760324,0.0002395961,0.00036121026,0.000017086692,0.0011102948,0.000023412274,0.000040468134,0.00003822297],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960585,0.000328926,0.0022424008,0.00052809477,0.0006327194,0.00020934176],"domain_scores_gemma":[0.99272716,0.0023948334,0.003314614,0.0012450462,0.00021769633,0.00010066966],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005562132,0.0005341488,0.018378245,0.0002514105,0.000040285297,0.00001060946,0.0005204425,0.0001195306,0.00032850847],"category_scores_gemma":[0.0031787707,0.00027590914,0.0043100147,0.0019344834,0.00019123622,0.00010059991,0.00030435165,0.00019960896,0.0000025865406],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.288517e-7,0.00110799,0.000084232335,0.81393766,0.17700581,0.0000039326974,0.00005072881,6.736026e-7,3.3942052e-7,0.00006569905,0.000090385554,0.0076519065],"study_design_scores_gemma":[0.00011282193,0.00014020977,0.00006801752,0.101090856,0.85127354,0.0000043369446,0.000031527245,0.0000010890515,0.000014016579,0.000009509923,0.047076352,0.00017771103],"about_ca_topic_score_codex":0.000031532414,"about_ca_topic_score_gemma":0.000038555845,"teacher_disagreement_score":0.7128468,"about_ca_system_score_codex":0.000021245556,"about_ca_system_score_gemma":0.00008746355,"threshold_uncertainty_score":0.9999693},"labels":[],"label_agreement":null},{"id":"W3015573582","doi":"10.1182/bloodadvances.2020001513","title":"Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"American Society of Hematology","keywords":"Meta-analysis; Medicine; Internal medicine; Cardiology","score_opus":0.0783563222120394,"score_gpt":0.3700606859692734,"score_spread":0.29170436375723396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015573582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.1760066e-7,0.98134595,0.00049105607,0.00039355768,0.00009137322,0.016728446,0.00028598364,0.00017205633,0.0004914314],"genre_scores_gemma":[0.0000036500762,0.9856011,0.002479919,0.0018781148,0.00019296964,0.008890914,0.00048273036,0.0001926025,0.00027799647],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949196,0.00027903687,0.0019965165,0.0012454602,0.00089533866,0.0006640296],"domain_scores_gemma":[0.9955454,0.00039363417,0.0018571562,0.0015681029,0.0002986781,0.00033701613],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0006070996,0.0012230399,0.029913563,0.0003780236,0.00016791053,0.000058956706,0.00061992556,0.00020932169,0.00016937919],"category_scores_gemma":[0.0003791997,0.00069809746,0.007533594,0.0019385446,0.00008056998,0.00018214763,0.00013594034,0.00037380762,0.00009735447],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024498368,0.0008248316,3.2537739e-7,0.65933704,0.33609018,0.000053777483,0.000026722839,0.0000016841554,1.3753288e-8,0.0002750907,0.00027103836,0.0031168454],"study_design_scores_gemma":[0.00021444322,0.00058268727,6.849511e-7,0.12447981,0.52561754,0.000058069636,0.000017101602,0.0000010874367,2.5078396e-7,0.00002465852,0.34862813,0.00037553813],"about_ca_topic_score_codex":0.000008887494,"about_ca_topic_score_gemma":0.000023539613,"teacher_disagreement_score":0.5348572,"about_ca_system_score_codex":0.00009969498,"about_ca_system_score_gemma":0.0003696634,"threshold_uncertainty_score":0.999547},"labels":[],"label_agreement":null},{"id":"W3015817862","doi":"10.1182/bloodadvances.2019000840","title":"DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McMaster University; McGill University; Impact","funders":"Canadian Institutes of Health Research; American Society of Hematology","keywords":"Medicine; Pulmonary embolism; Intensive care medicine; Randomized controlled trial; MEDLINE; Meta-analysis; Internal medicine; Venous thrombosis; Systematic review; Major bleeding; Thrombosis; Myocardial infarction","score_opus":0.08889026318751231,"score_gpt":0.3950200033962771,"score_spread":0.30612974020876477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015817862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013436646,0.9905825,0.000012685123,0.0020151322,0.000092493916,0.0067145624,0.00008458632,0.00006446611,0.0004322063],"genre_scores_gemma":[0.000004291752,0.9901536,0.0006596978,0.006090769,0.00006565606,0.002395511,0.0003343958,0.00005508674,0.00024097286],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944273,0.00031847545,0.0027618804,0.0007948237,0.0012774133,0.00042011013],"domain_scores_gemma":[0.996851,0.00035052025,0.001407481,0.0008006857,0.00020968265,0.0003805904],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009211418,0.0008124308,0.018921923,0.00044552755,0.000055917295,0.00005742289,0.00045654786,0.0002531538,0.0005507083],"category_scores_gemma":[0.0031572839,0.00046966973,0.0024757255,0.0013167018,0.000094394585,0.00028456157,0.0003102501,0.00034428638,0.000054217824],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002451155,0.0003647035,0.000032601485,0.87086034,0.11662789,0.000075856275,0.000033633773,1.3020804e-7,4.0528264e-10,0.000043816588,0.0030349207,0.008923663],"study_design_scores_gemma":[0.0003980775,0.00012597586,0.000009361646,0.07568505,0.5259793,0.0000098849005,0.000013900815,7.8660935e-7,3.142772e-8,0.000006878304,0.39751804,0.00025272171],"about_ca_topic_score_codex":0.000042406755,"about_ca_topic_score_gemma":0.0001146115,"teacher_disagreement_score":0.7951753,"about_ca_system_score_codex":0.00006920262,"about_ca_system_score_gemma":0.0002756033,"threshold_uncertainty_score":0.9997755},"labels":[],"label_agreement":null},{"id":"W3016129507","doi":"10.1182/bloodadvances.2019001343","title":"IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Université de Montréal; Izaak Walton Killam Health Centre; Kingston General Hospital; Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Placebo; Regimen; Adverse effect; Randomized controlled trial; Methylprednisolone; Headaches; Internal medicine; Platelet; Pediatrics; Anesthesia; Surgery","score_opus":0.019224380595475526,"score_gpt":0.27675865088055707,"score_spread":0.2575342702850815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016129507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98090404,0.004615306,0.000009826674,0.000988973,0.0001902612,0.0013922281,0.000119468285,0.000042980988,0.011736893],"genre_scores_gemma":[0.9977387,0.0011393869,0.00028499498,0.00030859496,0.0001564778,0.00005008132,0.00008168255,0.00001864484,0.00022141816],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99863255,0.00006485186,0.0005132116,0.00029247225,0.0002799425,0.00021694522],"domain_scores_gemma":[0.9993146,0.000196657,0.0001937477,0.0001582563,0.00003776731,0.00009898582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016795177,0.00018512942,0.00097175885,0.000080453974,0.000024096747,0.000010702637,0.00008714801,0.00007922672,0.00006781219],"category_scores_gemma":[0.0004410265,0.00013530167,0.00017158837,0.0002057661,0.0000790442,0.00011413778,0.0000260616,0.00013508703,0.000054110922],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96311176,0.0032716582,0.0026468737,0.00018040229,0.0010049214,0.0009767242,0.0019930894,0.000027240547,0.00028353278,0.00006717491,0.0010994816,0.025337173],"study_design_scores_gemma":[0.98674,0.000745479,0.00096260477,0.00017443429,0.00026945866,0.000033199398,0.00011120746,0.000030361127,0.003294528,0.00024245723,0.0072352057,0.00016104372],"about_ca_topic_score_codex":0.000028414124,"about_ca_topic_score_gemma":0.00004186532,"teacher_disagreement_score":0.025176128,"about_ca_system_score_codex":0.0000069579078,"about_ca_system_score_gemma":0.00007111493,"threshold_uncertainty_score":0.55174416},"labels":[],"label_agreement":null},{"id":"W3016882075","doi":"10.1182/bloodadvances.2019001261","title":"Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Obinutuzumab; Rituximab; Lymphoma; CHOP; Diffuse large B-cell lymphoma; Chemotherapy; Follicular lymphoma; Aggressive lymphoma; Internal medicine; Bone marrow; Oncology; Biopsy","score_opus":0.009754244757057669,"score_gpt":0.2923774273024534,"score_spread":0.28262318254539576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016882075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677455,0.0019433522,4.1399753e-7,0.00053675903,0.000018331151,0.00041981367,0.000033758268,0.000016472986,0.00025654578],"genre_scores_gemma":[0.9983579,0.0009968592,0.00038222354,0.00015358778,0.00001290832,0.00004036349,0.00002435668,0.000016181875,0.000015650034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989356,0.0000828502,0.00031905738,0.0002777307,0.00018995444,0.00019483449],"domain_scores_gemma":[0.9994621,0.00012697176,0.00011344646,0.00015994438,0.000035839093,0.000101642654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000998221,0.00018354405,0.00042194643,0.00013072765,0.000015458383,0.000008644355,0.00004008687,0.00005230915,0.000027996139],"category_scores_gemma":[0.000065617736,0.00013394846,0.00007682694,0.0002813853,0.000043201333,0.000079140365,0.00002055975,0.00004779213,0.0000029292669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045970944,0.0035343424,0.97018814,0.000044862933,0.00009657603,0.000179656,0.00026121337,0.000012165249,0.009601686,0.0000078106,0.0000141359615,0.011462307],"study_design_scores_gemma":[0.017091181,0.0038813143,0.9665757,0.0002449239,0.00004077589,0.000009694432,0.00005816604,0.00003366422,0.011846654,0.000011520307,0.0000976097,0.00010882596],"about_ca_topic_score_codex":0.00033062196,"about_ca_topic_score_gemma":0.000021661648,"teacher_disagreement_score":0.012494085,"about_ca_system_score_codex":0.00016190401,"about_ca_system_score_gemma":0.000106124666,"threshold_uncertainty_score":0.54622597},"labels":[],"label_agreement":null},{"id":"W3018868482","doi":"10.1182/bloodadvances.2020001726","title":"Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Bendamustine; Autoimmune hemolytic anemia; Medicine; Immunosuppression; Hemolytic anemia; Fludarabine; Anemia; Immunology; Internal medicine; Chemotherapy; Rituximab; Antibody; Cyclophosphamide","score_opus":0.023774130815769654,"score_gpt":0.3495339668743425,"score_spread":0.32575983605857284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018868482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040870003,0.9937954,5.5695637e-7,0.00017864179,0.00015718509,0.005429347,0.000049583825,0.00003972602,0.00030870704],"genre_scores_gemma":[0.000094950396,0.9981901,0.00013724,0.00013125731,0.000197591,0.00032092322,0.000062166306,0.00007176992,0.0007940124],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959662,0.0003392951,0.001932846,0.0006614576,0.0007492864,0.00035092796],"domain_scores_gemma":[0.9959632,0.00056633604,0.0014423073,0.0015483747,0.00026605872,0.00021370478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007338254,0.00055929984,0.004934384,0.00010890567,0.000087086984,0.00003301279,0.00036422143,0.00029143278,0.000018569515],"category_scores_gemma":[0.0047964193,0.00029157454,0.00075202907,0.0011963281,0.00014117488,0.00009157051,0.00033789745,0.000933614,0.0000080629625],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004287116,0.0000452354,1.6364152e-7,0.86327446,0.000301918,0.121215284,0.000055798984,1.0076929e-8,0.0000021557423,0.000011007761,0.000035146128,0.015054549],"study_design_scores_gemma":[0.0008391313,0.000069438844,3.389711e-8,0.5428089,0.007393613,0.41390973,0.000019792082,0.000001877248,0.000016024405,0.0000026418138,0.03480404,0.00013481012],"about_ca_topic_score_codex":0.000023679162,"about_ca_topic_score_gemma":0.0000033343035,"teacher_disagreement_score":0.3204656,"about_ca_system_score_codex":0.0010236733,"about_ca_system_score_gemma":0.006181772,"threshold_uncertainty_score":0.9999536},"labels":[],"label_agreement":null},{"id":"W3019053883","doi":"10.1182/bloodadvances.2019000425","title":"Coagulation factor XII contributes to hemostasis when activated by soil in wounds","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Aquarium; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Hemostasis; Factor XII; Chemistry; Coagulation; Tissue factor; Clotting time; Internal medicine; Medicine","score_opus":0.019581872734456784,"score_gpt":0.2692981128224354,"score_spread":0.2497162400879786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019053883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770606,0.009556038,0.00047884753,0.011693703,0.00012164764,0.0004987466,0.00008379003,0.00015356504,0.0003530745],"genre_scores_gemma":[0.9957848,0.0001323492,0.00043407845,0.0028242008,0.00012817777,0.000028253155,0.00015375213,0.00002654474,0.00048779853],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987063,0.0000305668,0.0003521597,0.00036270873,0.00024777043,0.00030053357],"domain_scores_gemma":[0.99934804,0.00012709119,0.00010052619,0.00015392342,0.000091956674,0.00017848056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006138565,0.00019908826,0.00040614873,0.000089413814,0.00007385844,0.00003554933,0.00009363715,0.00007799148,0.00015674322],"category_scores_gemma":[0.0003021196,0.0001846013,0.000070275026,0.0004322652,0.00004031165,0.00029542486,0.000033419958,0.00011634818,0.000030923722],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000998495,0.00058295013,0.650406,0.0002143765,0.00023328057,0.00003152802,0.0033479335,0.0002568187,0.2534885,0.0002715386,0.008373845,0.081794746],"study_design_scores_gemma":[0.005587556,0.0004934086,0.15937185,0.00022681378,0.00013814816,0.000007619619,0.00047185694,0.00033119938,0.66999197,0.0005927763,0.16237038,0.0004164341],"about_ca_topic_score_codex":0.00010404712,"about_ca_topic_score_gemma":0.00006974669,"teacher_disagreement_score":0.49103412,"about_ca_system_score_codex":0.000042501593,"about_ca_system_score_gemma":0.000060561008,"threshold_uncertainty_score":0.7527823},"labels":[],"label_agreement":null},{"id":"W3022476818","doi":"10.1182/bloodadvances.2020001646","title":"The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Kingston General Hospital; Queen's University; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Population; Autologous stem-cell transplantation; Diffuse large B-cell lymphoma; Oncology; Confidence interval; Lymphoma; Surgery","score_opus":0.011723917783342514,"score_gpt":0.25202227729299287,"score_spread":0.24029835950965037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022476818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238914,0.0057605635,0.00006651598,0.0007930968,0.000026520895,0.00013077323,0.0005903668,0.000014573606,0.00022845736],"genre_scores_gemma":[0.9981656,0.0011375173,0.00019806529,0.00014633678,0.000020492324,0.0000309596,0.00027345007,0.000005583367,0.000021992006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896145,0.000052040778,0.00033904018,0.00023339427,0.00027536412,0.00013869218],"domain_scores_gemma":[0.99916446,0.0003543334,0.00016170702,0.00015762493,0.000063712214,0.000098133154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008480533,0.00012674843,0.0006895468,0.0001509756,0.000053440996,0.00000784521,0.000058947608,0.000043157062,0.00008296843],"category_scores_gemma":[0.000034068362,0.00007922884,0.00033565305,0.0008499854,0.00019116791,0.000055939345,0.0000137417865,0.0000422343,9.651453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005328669,0.0004914365,0.9794335,0.000049387465,0.016729416,0.00008621597,0.0004655227,0.00012542066,0.00023968237,0.00074282754,0.000009777518,0.0010939733],"study_design_scores_gemma":[0.002397909,0.00037388183,0.95233387,0.000018126724,0.041888703,0.0000047105664,0.00013906948,0.0009759154,0.0013104965,0.000035963294,0.00044625674,0.00007508185],"about_ca_topic_score_codex":0.00006990176,"about_ca_topic_score_gemma":0.00055327755,"teacher_disagreement_score":0.027099585,"about_ca_system_score_codex":0.000009724311,"about_ca_system_score_gemma":0.000032930806,"threshold_uncertainty_score":0.32308584},"labels":[],"label_agreement":null},{"id":"W3022959153","doi":"10.1182/bloodadvances.2019001084","title":"Survival following allogeneic transplant in patients with myelofibrosis","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Astellas Pharma US; University of Texas MD Anderson Cancer Center; Adaptive Biotechnologies; Janssen Scientific Affairs; Health Resources and Services Administration; Biomedical Advanced Research and Development Authority; Astellas Pharma; Swedish Orphan Biovitrum; Karyopharm Therapeutics; Omeros Corporation; bluebird bio; Atara Biotherapeutics; Medac; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; Actinium Pharmaceuticals; University of Pittsburgh; U.S. Department of Defense; Medical College of Wisconsin; Daiichi Sankyo Europe; University of Wisconsin-Madison; Takeda Oncology; University of Minnesota; Memorial Sloan-Kettering Cancer Center; Mundipharma EDO; U.S. Navy; Celgene; Sanofi; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; National Center for Advancing Translational Sciences; Janssen Biotech; HistoGenetics; Janssen Pharmaceuticals; Sanofi Genzyme; Incyte; Patient-Centered Outcomes Research Institute; CSL Behring; Bristol-Myers Squibb; Spectrum Pharmaceuticals; Amgen; National Heart, Lung, and Blood Institute; Pfizer; Be The Match Foundation; National Cancer Institute; Gilead Sciences","keywords":"Myelofibrosis; Medicine; Oncology; Internal medicine; Immunology; Bone marrow","score_opus":0.010111506304074607,"score_gpt":0.2263255340203082,"score_spread":0.21621402771623358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022959153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672,0.0009973113,0.000029311199,0.0009321831,0.000079109384,0.0004590325,0.000026565118,0.00004037178,0.00071611453],"genre_scores_gemma":[0.9975253,0.00019808969,0.001544716,0.0005008395,0.000059989914,0.00006670489,0.000067088724,0.00002020443,0.000017078712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893516,0.000029487588,0.00019484578,0.0003226603,0.00029087128,0.00022695397],"domain_scores_gemma":[0.99961513,0.000057419067,0.000043341137,0.000103367056,0.000028513914,0.00015224132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003537581,0.00018064432,0.0003679384,0.000037523158,0.000044512915,0.000011416207,0.000051699895,0.000035696474,0.000038509825],"category_scores_gemma":[0.000019340461,0.00012295417,0.000077788514,0.0001935464,0.000021168049,0.00011876389,0.000010206961,0.00008453666,0.000014082071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041868977,0.0005940708,0.9948313,0.000053961543,0.00015966101,0.00012455051,0.0003515469,0.00002603199,0.0002490777,0.000044807945,0.000007021922,0.003139268],"study_design_scores_gemma":[0.008704268,0.0018312784,0.9767909,0.00022707444,0.00027975507,0.0000015695051,0.0000632524,0.0000053469357,0.010166905,0.0000088692705,0.0017419778,0.00017881017],"about_ca_topic_score_codex":0.000009368247,"about_ca_topic_score_gemma":0.000060906088,"teacher_disagreement_score":0.018040419,"about_ca_system_score_codex":0.000016117898,"about_ca_system_score_gemma":0.000035024867,"threshold_uncertainty_score":0.50139254},"labels":[],"label_agreement":null},{"id":"W3023631491","doi":"10.1182/bloodadvances.2020001518","title":"Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Helsingin Yliopisto; Amgen","keywords":"Medicine; Internal medicine; Oncology; Intensive care medicine","score_opus":0.004630928837424983,"score_gpt":0.19207855713733066,"score_spread":0.1874476282999057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023631491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381727,0.0042269584,0.000015288784,0.00032061577,0.00006724525,0.0011495412,0.00018460087,0.00015098791,0.00006751576],"genre_scores_gemma":[0.99656373,0.00063269195,0.0019795783,0.00029504418,0.00011819036,0.00015522004,0.00014231056,0.00006872849,0.00004448101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843544,0.000029576608,0.00027869752,0.0005260218,0.00044878322,0.00028148195],"domain_scores_gemma":[0.998912,0.000087193504,0.00023606373,0.00039760664,0.00015247687,0.00021468516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002451446,0.0003352735,0.0005721361,0.000043107175,0.000112879716,0.000044077173,0.000119662436,0.00006735653,0.000053909014],"category_scores_gemma":[0.000017632889,0.0002044572,0.000077863944,0.00024829677,0.00007642286,0.00015861294,0.000025003268,0.00012860166,0.000053301817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004080306,0.002027499,0.9677986,0.00008324193,0.00090543524,0.00012220022,0.000688947,0.000019153722,0.0003978339,0.000029552313,0.000017686645,0.02382953],"study_design_scores_gemma":[0.03379854,0.0159129,0.9387167,0.0005199162,0.00070177345,0.000012167497,0.00014820519,0.0000054276566,0.009415844,0.000046688077,0.0004125102,0.00030931152],"about_ca_topic_score_codex":0.00071498915,"about_ca_topic_score_gemma":0.00007231558,"teacher_disagreement_score":0.029718235,"about_ca_system_score_codex":0.000053631404,"about_ca_system_score_gemma":0.00006183357,"threshold_uncertainty_score":0.8337523},"labels":[],"label_agreement":null},{"id":"W3024102980","doi":"10.1182/bloodadvances.2019001265","title":"Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Confidence interval; Stage (stratigraphy); Subgroup analysis; Lymphoma; Oncology; Cohort; Proportional hazards model; Retrospective cohort study; B symptoms; Chemotherapy; Disease; Gastroenterology","score_opus":0.010232299588997757,"score_gpt":0.2585615000814247,"score_spread":0.24832920049242693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024102980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96550065,0.03086815,0.000010867151,0.002353068,0.000030931864,0.0008289142,0.00016187501,0.00003327985,0.00021227963],"genre_scores_gemma":[0.9974895,0.0014042832,0.00033381057,0.00036078552,0.000056353252,0.00019289224,0.00004319338,0.000016419652,0.00010272719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879754,0.000041622712,0.00029010104,0.00038553696,0.00025258758,0.00023263863],"domain_scores_gemma":[0.99901223,0.00033967246,0.00013651395,0.0002421354,0.000036201276,0.00023323121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007488123,0.00019171729,0.00033904205,0.000026050695,0.00005610376,0.000016003223,0.000096015116,0.000021904345,0.00001534142],"category_scores_gemma":[0.00046364273,0.000121960045,0.00006015372,0.0002337065,0.00013644034,0.00015628249,0.00007893212,0.000044399345,0.000004206508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042030087,0.0007874653,0.9783101,0.00033162185,0.00004123861,0.00024266036,0.00031439814,0.000024297127,0.0011651284,0.00019357572,0.00011531592,0.018053887],"study_design_scores_gemma":[0.008799673,0.0006428363,0.9797968,0.00042647836,0.0003114059,0.000018339231,0.0002640493,0.0002400035,0.00400756,0.00014363343,0.0051642978,0.000184887],"about_ca_topic_score_codex":0.00005393236,"about_ca_topic_score_gemma":0.00006873062,"teacher_disagreement_score":0.0319889,"about_ca_system_score_codex":0.000022071996,"about_ca_system_score_gemma":0.00006135501,"threshold_uncertainty_score":0.49733865},"labels":[],"label_agreement":null},{"id":"W3024374829","doi":"10.1182/bloodadvances.2019000839","title":"Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Daiichi Sankyo Europe; National Cancer Institute; Office of Naval Research; Legend Biotech; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Agency for Healthcare Research and Quality; Health Resources and Services Administration; bluebird bio; Kiadis Pharma; Daiichi-Sankyo; Swedish Orphan Biovitrum; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Chimerix; Medac; Jazz Pharmaceuticals; Atara Biotherapeutics; Actinium Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; National Center for Advancing Translational Sciences; Janssen Biotech; HistoGenetics; U.S. Department of Defense; Sanofi; GlaxoSmithKline; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; U.S. Navy; Celgene; CSL Behring; Bristol-Myers Squibb; Terumo BCT; AstraZeneca; Biomedical Advanced Research and Development Authority; Amgen; Astellas Pharma US","keywords":"Medicine; Internal medicine; Transplantation; Population; Interquartile range; Incidence (geometry); Cumulative incidence; Aplastic anemia; Pediatrics; Gastroenterology; Surgery; Bone marrow","score_opus":0.017734838766937603,"score_gpt":0.271110409099197,"score_spread":0.2533755703322594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024374829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381745,0.0023116644,0.002390595,0.0003773968,0.000032696786,0.0008166432,0.00012140896,0.00005074724,0.00008138871],"genre_scores_gemma":[0.99419934,0.0034372814,0.0017036248,0.00029013093,0.000057021454,0.00006450917,0.00022279206,0.000017261595,0.000008067917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908054,0.000026110876,0.0002636415,0.00029832634,0.00014721796,0.00018414421],"domain_scores_gemma":[0.99958146,0.00012221972,0.00006026822,0.00007709095,0.000019497558,0.00013946873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006409545,0.0001323583,0.00024373342,0.000040263858,0.00004043905,0.000012819918,0.00003928241,0.00004239727,0.000008515411],"category_scores_gemma":[0.00002746765,0.000117878604,0.000048894075,0.0001033725,0.00003579044,0.00013677435,0.0000042620413,0.00005022234,0.0000021298072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019967886,0.00009172275,0.9867607,0.001215144,0.000080735415,0.000049219067,0.00062852894,0.00024411143,0.009714773,0.00017062611,9.723134e-7,0.0008437929],"study_design_scores_gemma":[0.0048048655,0.00029654911,0.958577,0.0003098842,0.00068942766,0.0000972566,0.00010038294,0.0003271648,0.03426564,0.00032189427,0.000029925304,0.00018001904],"about_ca_topic_score_codex":0.000017929546,"about_ca_topic_score_gemma":0.000108492546,"teacher_disagreement_score":0.028183706,"about_ca_system_score_codex":0.000009769557,"about_ca_system_score_gemma":0.000056413694,"threshold_uncertainty_score":0.48069498},"labels":[],"label_agreement":null},{"id":"W3024882174","doi":"10.1182/bloodadvances.2020001755","title":"A user guide to the American Society of Hematology clinical practice guidelines","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Cochrane; St. Michael's Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; University of Toronto; McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Terminology; Presentation (obstetrics); Medicine; Hematology; Clinical Practice; MEDLINE; Intensive care medicine; Internal medicine; Medical education; Family medicine; Political science; Surgery","score_opus":0.2600502902970013,"score_gpt":0.5752629601102752,"score_spread":0.31521266981327395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024882174","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08188214,0.0019175352,0.018589996,0.89554286,0.00029820148,0.0008720212,0.000024069344,0.00009786767,0.00077531795],"genre_scores_gemma":[0.040411085,0.0025125218,0.6027181,0.35255688,0.0015623424,0.00003429623,0.000016438637,0.0000311777,0.00015715002],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966085,0.00020974758,0.0021208415,0.00039927504,0.0004384533,0.00022317057],"domain_scores_gemma":[0.99325466,0.0037768714,0.0010411121,0.00040430875,0.0012932963,0.0002297544],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016858202,0.0001501406,0.0005977661,0.00001794042,0.000058172012,0.000011439759,0.00022441601,0.000045063007,0.000055135002],"category_scores_gemma":[0.05871581,0.000100197176,0.00026547376,0.00048857456,0.00020603507,0.00025431905,0.00015812617,0.0002842296,0.000074774776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013237365,0.0006248025,0.04703101,0.00012431352,0.0005510744,0.000034696805,0.00037740773,0.0001312453,0.001643223,0.00048285438,0.77350324,0.17417242],"study_design_scores_gemma":[0.0014659759,0.0013211061,0.004003393,0.00003425721,0.0005831371,0.00009687345,0.0042466926,0.00027254628,0.0009565281,0.000028943165,0.9868839,0.000106686784],"about_ca_topic_score_codex":0.00012659613,"about_ca_topic_score_gemma":0.000048980877,"teacher_disagreement_score":0.5841281,"about_ca_system_score_codex":0.000009112351,"about_ca_system_score_gemma":0.00022378295,"threshold_uncertainty_score":0.949213},"labels":[],"label_agreement":null},{"id":"W3030429552","doi":"10.1182/bloodadvances.2020001768","title":"Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McMaster University; Impact; Cochrane","funders":"","keywords":"Hematology; Current (fluid); Medicine; Internal medicine; Intensive care medicine; Engineering ethics; Engineering","score_opus":0.16725409189366103,"score_gpt":0.45000391457550887,"score_spread":0.28274982268184784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030429552","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51429474,0.1707337,0.07597784,0.23534155,0.0006416472,0.0024725203,0.000026267147,0.000093636365,0.00041806075],"genre_scores_gemma":[0.3929563,0.07501487,0.5016887,0.028503839,0.0007138692,0.0010373441,0.000018198474,0.0000309246,0.000035950223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991599,0.00004418515,0.00033332763,0.00021130101,0.00011467735,0.0001366475],"domain_scores_gemma":[0.9984555,0.0007941179,0.000324376,0.00012406059,0.00026083257,0.000041086798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029285392,0.00009478723,0.00042691774,0.000021385906,0.00008655605,0.0000071785453,0.00008776966,0.000016730328,0.000009176655],"category_scores_gemma":[0.0011408096,0.000060768823,0.00005986374,0.00025457528,0.00029382124,0.000094737916,0.00006125242,0.00006675167,9.3151704e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043707798,0.0024864248,0.009671456,0.0021751383,0.0016363816,0.000007250561,0.028163226,0.000069534006,0.003448853,0.051116038,0.0785041,0.8222845],"study_design_scores_gemma":[0.0010291644,0.0015678408,0.0008422521,0.00007867934,0.00076419505,0.000024089904,0.09011392,0.00029165845,0.004970945,0.0002966578,0.89989376,0.00012685527],"about_ca_topic_score_codex":0.000026247812,"about_ca_topic_score_gemma":0.0000040931636,"teacher_disagreement_score":0.8221577,"about_ca_system_score_codex":0.0000030628364,"about_ca_system_score_gemma":0.0000415989,"threshold_uncertainty_score":0.24780807},"labels":[],"label_agreement":null},{"id":"W3032329880","doi":"10.1182/bloodadvances.2019001075","title":"Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Occupational Cancer Research Centre","funders":"","keywords":"RHOA; Sanger sequencing; Exon; Molecular biology; Mutation; Biology; Cancer research; Genetics; Medicine; Gene","score_opus":0.0074789650766743905,"score_gpt":0.2056046915260458,"score_spread":0.1981257264493714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032329880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822026,0.0008061077,0.0000051059747,0.000088836816,0.000031222055,0.0003548862,0.00013203756,0.000031214608,0.0003303522],"genre_scores_gemma":[0.9967099,0.000058865666,0.0028354202,0.00007066434,0.000026966321,0.000060191396,0.00020309688,0.000015317335,0.000019617992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992026,0.000018737022,0.00020572222,0.0002396471,0.00019201523,0.00014129914],"domain_scores_gemma":[0.99952054,0.00010547008,0.00009863308,0.00011687415,0.000055553977,0.00010295422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000008272433,0.0001327731,0.0002649542,0.00003149953,0.00003364721,0.000005123525,0.000046251305,0.000035440233,0.00005926161],"category_scores_gemma":[0.000044492095,0.00009790005,0.00003939075,0.00017319259,0.00004216875,0.00009018938,0.000023672623,0.000024008761,0.000010483948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057783717,0.0019926112,0.9871645,0.000040680363,0.000064417865,0.000052530817,0.00081895,0.00010470658,0.0020023622,0.0000012518132,0.0000070600386,0.0071730907],"study_design_scores_gemma":[0.026716052,0.0009401522,0.8406213,0.00007918652,0.00014110601,0.0000012775927,0.00026952822,0.00028547752,0.13028102,0.0000046320233,0.00055611465,0.00010415194],"about_ca_topic_score_codex":0.00019714405,"about_ca_topic_score_gemma":0.00070068863,"teacher_disagreement_score":0.1465432,"about_ca_system_score_codex":0.000063042,"about_ca_system_score_gemma":0.000049768485,"threshold_uncertainty_score":0.39922482},"labels":[],"label_agreement":null},{"id":"W3032758825","doi":"10.1182/bloodadvances.2019000770","title":"High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Indeterminate; Sensitivity (control systems); Biology; Cell biology; Immunology; Stem cell","score_opus":0.011402129020833344,"score_gpt":0.25343473749715356,"score_spread":0.24203260847632022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032758825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995447,0.00017158547,0.00024493787,0.0029508544,0.000018562047,0.00061473495,0.00010119222,0.00006846551,0.00038269113],"genre_scores_gemma":[0.9967015,0.000012695301,0.0024602704,0.0004027125,0.00011981489,0.000031605763,0.00002853887,0.000030254248,0.00021261018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831975,0.00010737131,0.00024524183,0.00036703778,0.00064240536,0.00031819596],"domain_scores_gemma":[0.99899095,0.000115044255,0.00021889617,0.000185006,0.00029807744,0.00019199695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017930493,0.00019333113,0.000544828,0.00006889911,0.00006239888,0.000011482943,0.00009364153,0.00010036084,0.000075740536],"category_scores_gemma":[0.00042337342,0.00014915978,0.000089106645,0.00038061963,0.00023223991,0.00022549435,0.000083435494,0.00035685947,0.000013378331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003552756,0.0010375862,0.0148799615,0.00060970325,0.0013305396,0.0036272337,0.0013452481,0.000040018356,0.9683105,0.00021897025,0.00031055426,0.0047369767],"study_design_scores_gemma":[0.0046293507,0.0013981118,0.016966613,0.00030281916,0.00028591134,0.00013092121,0.00030149202,0.00032027977,0.9750936,0.00013051796,0.00022612922,0.0002142371],"about_ca_topic_score_codex":0.00006539743,"about_ca_topic_score_gemma":0.000016219457,"teacher_disagreement_score":0.0067831646,"about_ca_system_score_codex":0.00006179667,"about_ca_system_score_gemma":0.00027223132,"threshold_uncertainty_score":0.6082559},"labels":[],"label_agreement":null},{"id":"W3033237799","doi":"10.1182/bloodadvances.2020001923","title":"Gene expression profiling of gray zone lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; Biology; Gene expression profiling; Phenotype; Gene; Cancer research; Tumor microenvironment; Gene expression; Immunology; Genetics; Tumor cells","score_opus":0.0165713444203845,"score_gpt":0.2615862098945795,"score_spread":0.245014865474195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033237799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545784,0.0121501,0.00014220459,0.0005151398,0.00006203174,0.0002625795,0.0000148719,0.00005582896,0.0013393885],"genre_scores_gemma":[0.97608566,0.00077040633,0.02259427,0.0002955438,0.00014815279,0.00003624249,0.000021768352,0.000011755857,0.000036213023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992588,0.000013191903,0.00019476656,0.00021155748,0.00019024996,0.00013144116],"domain_scores_gemma":[0.99956733,0.00003603581,0.000089432964,0.00014024551,0.000043736192,0.0001232037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002669976,0.00010895683,0.00026141707,0.000023009026,0.00003263354,0.0000044327994,0.00005086966,0.000032646,0.00003908466],"category_scores_gemma":[0.000043982298,0.00007616044,0.00007643896,0.00011288582,0.000032594187,0.0000799161,0.000030712014,0.00001956462,0.00001894969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002624582,0.0014685044,0.41313303,0.000321028,0.0001317321,0.00020261666,0.00032200618,0.00002200374,0.5301228,0.00017568943,0.0001518821,0.053686243],"study_design_scores_gemma":[0.0036769053,0.00048140239,0.018679583,0.0001233144,0.00014586338,0.000023099432,0.00009399794,0.000015290576,0.9731248,0.000025702677,0.0035364886,0.000073570634],"about_ca_topic_score_codex":0.000007433512,"about_ca_topic_score_gemma":7.427374e-7,"teacher_disagreement_score":0.44300196,"about_ca_system_score_codex":0.000012123433,"about_ca_system_score_gemma":0.00004586244,"threshold_uncertainty_score":0.31057325},"labels":[],"label_agreement":null},{"id":"W3033331335","doi":"10.1182/bloodadvances.2020001441","title":"Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Bispebjerg Hospital; University of Alberta; Canadian Dermatology Foundation","keywords":"Pathogenesis; Lymphoma; Biology; Cancer research; Pathology; Medicine; Genetics; Computational biology; Immunology","score_opus":0.015232671423235906,"score_gpt":0.26453092603462797,"score_spread":0.24929825461139207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033331335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839089,0.014356484,0.00008321147,0.00072133966,0.000017304443,0.0005429004,0.000023191042,0.000018215113,0.0003284593],"genre_scores_gemma":[0.99839157,0.00076605333,0.00032122355,0.00039286146,0.00006233183,0.000027599144,0.00000831207,0.000016003052,0.000014062227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988079,0.00012320223,0.00025770915,0.00030344632,0.00027847127,0.00022924757],"domain_scores_gemma":[0.99946594,0.00011698534,0.00007440128,0.00018527311,0.00006543307,0.00009195316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011406454,0.00014103782,0.00029604818,0.000059564016,0.000052989453,0.000013844605,0.00013587774,0.00004801148,0.000012959316],"category_scores_gemma":[0.00016053522,0.00010396751,0.000058914025,0.00028950564,0.00014956832,0.0000588077,0.00004621836,0.00007727871,0.000005962146],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010250687,0.00092467794,0.22454622,0.00054031773,0.00005420843,0.0005174622,0.0021062305,0.00013956732,0.75576437,0.00006823757,0.000021938846,0.01429168],"study_design_scores_gemma":[0.028248487,0.0066571613,0.585655,0.0002997376,0.0007003154,0.014764748,0.010143452,0.0073009674,0.34101906,0.0013235903,0.002649151,0.0012383246],"about_ca_topic_score_codex":0.000033785185,"about_ca_topic_score_gemma":0.00008629347,"teacher_disagreement_score":0.4147453,"about_ca_system_score_codex":0.000032842658,"about_ca_system_score_gemma":0.00012928784,"threshold_uncertainty_score":0.4239672},"labels":[],"label_agreement":null},{"id":"W3034025622","doi":"10.1182/bloodadvances.2019001373","title":"Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Dosing; Odds ratio; Low molecular weight heparin; Confidence interval; Confounding; Internal medicine; Heparin; Retrospective cohort study; Venous thromboembolism; Logistic regression; Surgery; Gastroenterology; Thrombosis","score_opus":0.014024371313934275,"score_gpt":0.2456880940388677,"score_spread":0.23166372272493344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034025622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952155,0.0016758078,0.0003344442,0.0002839163,0.000074336036,0.00138437,0.000014485028,0.000044011907,0.00097312714],"genre_scores_gemma":[0.9962051,0.00034345384,0.002941355,0.00024557393,0.00007909033,0.00009020796,0.00005347066,0.000031316034,0.000010419766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867684,0.00002169256,0.00033629694,0.00039823144,0.00025244773,0.00031449998],"domain_scores_gemma":[0.99928886,0.00003461494,0.00019482212,0.00026942277,0.00007934275,0.00013296129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004327377,0.00022887514,0.000976572,0.0000606705,0.000061069535,0.000014920575,0.00010535644,0.00004616567,0.000008344514],"category_scores_gemma":[0.000027394084,0.00018283685,0.00010576418,0.0001969833,0.00006706544,0.00011276459,0.0000381397,0.000048086946,0.0000022560353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009467538,0.014046717,0.96774346,0.0013702848,0.000715137,0.0000860743,0.0018400247,0.0006397961,0.0016762208,0.0011855598,0.000093547016,0.009656412],"study_design_scores_gemma":[0.015119177,0.006432455,0.93066007,0.00061634294,0.0009898274,0.0000019471215,0.00014399948,0.00017971393,0.040566307,0.00013720934,0.004794628,0.0003583458],"about_ca_topic_score_codex":0.00008166722,"about_ca_topic_score_gemma":0.000050775518,"teacher_disagreement_score":0.038890086,"about_ca_system_score_codex":0.000058006706,"about_ca_system_score_gemma":0.000050687435,"threshold_uncertainty_score":0.74558705},"labels":[],"label_agreement":null},{"id":"W3035235169","doi":"10.1182/bloodadvances.2020001937","title":"Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Impact; St. Joseph’s Healthcare Hamilton; Cochrane","funders":"Centers for Disease Control and Prevention","keywords":"Medicine; Intensive care medicine; Malignancy; Disease; Delphi method; Risk assessment; Venous thromboembolism; Internal medicine; Thrombosis","score_opus":0.03590044271924325,"score_gpt":0.3751211396205208,"score_spread":0.33922069690127754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035235169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007173087,0.9938029,0.0014793194,0.00018481066,0.00018448482,0.004060316,0.000024598654,0.000032124004,0.00015973393],"genre_scores_gemma":[0.0007924917,0.9952534,0.0014142371,0.000108282875,0.00013931854,0.002175555,0.00005840688,0.000037235568,0.000021087602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978495,0.00010820226,0.00090153917,0.00051937933,0.00041699066,0.00020433654],"domain_scores_gemma":[0.99876726,0.0003135284,0.0005086979,0.000199751,0.00004349494,0.00016728899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059964176,0.00028761258,0.0022035663,0.00017488877,0.00007377656,0.000054488726,0.00011320725,0.00014011878,0.0000054683605],"category_scores_gemma":[0.00030653665,0.00021289849,0.00012151599,0.00015814327,0.00004569671,0.00019779512,0.000108854765,0.00020163751,0.0000013533454],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004335696,0.00038938745,0.00004905312,0.41524273,0.00046818543,0.000024016155,0.0003352766,0.0000022188062,3.2463936e-7,0.0017009226,0.00008597982,0.5816976],"study_design_scores_gemma":[0.0032256742,0.00071389036,0.00014324118,0.43296263,0.011399796,0.000083333805,0.0009522465,0.004341981,0.0000027841224,0.0012847994,0.54415494,0.0007346827],"about_ca_topic_score_codex":0.000017340366,"about_ca_topic_score_gemma":0.000013981671,"teacher_disagreement_score":0.5809629,"about_ca_system_score_codex":0.000059207767,"about_ca_system_score_gemma":0.000095492556,"threshold_uncertainty_score":0.86817485},"labels":[],"label_agreement":null},{"id":"W3035839621","doi":"10.1182/bloodadvances.2019001144","title":"Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Queen's University","keywords":"Immune system; Dysbiosis; Immunology; Butyrate; Gut flora; Spleen; Antibody; Biology; Mesenteric lymph nodes; Medicine","score_opus":0.011252301587281143,"score_gpt":0.23656014676577936,"score_spread":0.22530784517849822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035839621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791446,0.008044243,0.000040447256,0.010653609,0.001276215,0.00028229578,0.000008951586,0.000082239145,0.0004673997],"genre_scores_gemma":[0.99348134,0.00019633547,0.000044495784,0.0015392753,0.000040617873,0.000033966757,0.000015955413,0.000013233141,0.004634753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898297,0.00020404393,0.00028603987,0.00025896038,0.0000317626,0.00023623923],"domain_scores_gemma":[0.9994666,0.00018758468,0.00007567872,0.00020979582,0.00003802135,0.000022327327],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011726891,0.00015186895,0.00020639913,0.00007253624,0.00013006387,0.000016938688,0.0002163534,0.00008010029,0.0010438187],"category_scores_gemma":[0.00032817083,0.00010771508,0.00007665047,0.00024795957,0.00005850554,0.00017260884,0.00008628651,0.00025476405,0.000958939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020370453,0.00010043638,0.0008352486,0.000009090486,0.00005326914,0.000003960222,0.0009902116,0.000060769384,0.9917753,0.000040130035,0.00065237965,0.0034421962],"study_design_scores_gemma":[0.001211599,0.00048445913,0.039072134,0.000030368967,0.000018265813,0.000020452433,0.0005539031,0.000009916241,0.51758355,0.000020176874,0.44083068,0.00016448589],"about_ca_topic_score_codex":0.00003211711,"about_ca_topic_score_gemma":0.000011670391,"teacher_disagreement_score":0.47419173,"about_ca_system_score_codex":0.000017438073,"about_ca_system_score_gemma":0.000017869737,"threshold_uncertainty_score":0.99986935},"labels":[],"label_agreement":null},{"id":"W3036230532","doi":"10.1182/bloodadvances.2020001435","title":"Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; Cancer Council Victoria; Mayo Clinic; Medical Research Council; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; University of Utah; Utah State University; Huntsman Cancer Institute; Utah Department of Health; National Health and Medical Research Council","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Monoclonal gammopathy; Medicine; Monoclonal; Paraproteinemias; Genetics; Internal medicine; Biology; Immunology; Monoclonal antibody; Antibody","score_opus":0.037700322618257225,"score_gpt":0.29661162675624286,"score_spread":0.25891130413798563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036230532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827625,0.015967892,0.00006100049,0.0002202576,0.000021540805,0.00055293774,0.0001294671,0.000025246056,0.0002591674],"genre_scores_gemma":[0.9925371,0.0016456958,0.005575514,0.000046601883,0.000050806124,0.000026698468,0.000022349735,0.000017488454,0.00007778993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889,0.00003868053,0.0002973261,0.00026620174,0.00029753652,0.00021028738],"domain_scores_gemma":[0.99917865,0.00015274328,0.00014310073,0.00013930236,0.00014436357,0.0002418499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044820405,0.0001447474,0.0003793543,0.0000474903,0.000026480004,0.0000045329084,0.00008604199,0.00004659451,0.000027404554],"category_scores_gemma":[0.00028869716,0.00012229112,0.00005962634,0.0001828922,0.00011662875,0.0000748406,0.000048753198,0.00008150424,0.0000038136584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016997478,0.0006296817,0.459355,0.0011992848,0.0002696649,0.00013911161,0.00046553148,0.000027155298,0.49780473,0.000037096725,0.000019595856,0.038353406],"study_design_scores_gemma":[0.0071070357,0.0023740397,0.17538363,0.00015947591,0.00015772278,0.00002775949,0.00012242494,0.005605988,0.8076812,0.000038730104,0.001192913,0.00014910648],"about_ca_topic_score_codex":0.000008263574,"about_ca_topic_score_gemma":0.000012241743,"teacher_disagreement_score":0.30987644,"about_ca_system_score_codex":0.0000066887783,"about_ca_system_score_gemma":0.000075734344,"threshold_uncertainty_score":0.49868876},"labels":[],"label_agreement":null},{"id":"W3036240123","doi":"10.1182/bloodadvances.2020001736","title":"Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Organoid; Immune system; Phenotype; CD34; Immunology; Peripheral blood; Medicine; Cellular differentiation; Biology; Bioinformatics; Stem cell; Neuroscience; Cell biology; Genetics; Gene","score_opus":0.035082393593689684,"score_gpt":0.3026999698242738,"score_spread":0.2676175762305841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036240123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72862214,0.20730025,0.03388995,0.012124458,0.0063812914,0.0034086036,0.0004725049,0.0007434681,0.0070573655],"genre_scores_gemma":[0.9960842,0.0005131644,0.0006931446,0.0015991091,0.0000209833,0.0001685291,0.0001675746,0.000031983185,0.00072129164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975232,0.00024738748,0.00088251155,0.00065049046,0.000069218004,0.0006272336],"domain_scores_gemma":[0.99510366,0.0040839207,0.0002202162,0.00041313,0.00013694352,0.0000421353],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058295066,0.00030483172,0.00061500666,0.00007138291,0.00059508614,0.00003766667,0.00069794175,0.00023803375,0.00018666424],"category_scores_gemma":[0.0086819045,0.00026489358,0.00033653775,0.00041639744,0.00027009632,0.00018252853,0.00018759794,0.0003668344,0.00068060035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004317758,0.008105918,0.037157174,0.00026446546,0.001076241,0.00004230593,0.0031400123,0.00141,0.23765075,0.02890018,0.01001374,0.6679214],"study_design_scores_gemma":[0.015672842,0.0049038623,0.08708588,0.000281287,0.00059674634,0.000049004502,0.0027752633,0.0000587149,0.02400107,0.0028210618,0.8601768,0.0015774673],"about_ca_topic_score_codex":0.000008599195,"about_ca_topic_score_gemma":0.000004942462,"teacher_disagreement_score":0.85016304,"about_ca_system_score_codex":0.000012167339,"about_ca_system_score_gemma":0.0001287402,"threshold_uncertainty_score":0.99998033},"labels":[],"label_agreement":null},{"id":"W3036739471","doi":"10.1182/bloodadvances.2020001851","title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Psychological intervention; Chronic pain; Intensive care medicine; Clinical trial; Guideline; Multidisciplinary approach; MEDLINE; Disease; Intervention (counseling); Health care; Randomized controlled trial; Physical therapy; Nursing; Internal medicine; Pathology","score_opus":0.013901907210588779,"score_gpt":0.2912497343093321,"score_spread":0.27734782709874334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036739471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63186806,0.2691732,0.012742833,0.08233172,0.00016374465,0.0024374926,0.00026439858,0.00013483848,0.00088369934],"genre_scores_gemma":[0.86017597,0.084167644,0.051155813,0.0038018133,0.00016132917,0.00006650048,0.00006466616,0.000036960297,0.00036929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930745,0.000013959588,0.00026301204,0.00018275456,0.00009509341,0.00013770215],"domain_scores_gemma":[0.99953663,0.000036783524,0.00014369685,0.00009891676,0.0000785584,0.00010542861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072693365,0.00009571141,0.00031613326,0.000009579595,0.000023550152,0.0000015140357,0.00005285871,0.000024928728,0.000010429833],"category_scores_gemma":[0.000019683317,0.000074165626,0.00011398706,0.00013356535,0.00017194236,0.000027094322,0.000037735248,0.000042848234,5.232171e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035518997,0.0034436958,0.06691236,0.09610045,0.009909194,0.00034207644,0.0027994574,0.0018091049,0.109974146,0.004110437,0.16867457,0.5323726],"study_design_scores_gemma":[0.028966727,0.011512026,0.0035391354,0.0024168293,0.011304147,0.000041954685,0.019446326,0.03327238,0.14600077,0.001370819,0.7409113,0.0012175904],"about_ca_topic_score_codex":0.000002563235,"about_ca_topic_score_gemma":5.526085e-7,"teacher_disagreement_score":0.5722367,"about_ca_system_score_codex":0.000004064654,"about_ca_system_score_gemma":0.000037327307,"threshold_uncertainty_score":0.30243865},"labels":[],"label_agreement":null},{"id":"W3036766167","doi":"10.1182/bloodadvances.2020001558","title":"Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Impact; University of Calgary; Western University; McMaster University; University of Ottawa; Thrombosis and Atherosclerosis Research Institute","funders":"McMaster University; American Society of Hematology","keywords":"Medicine; Pulmonary embolism; Deep vein; Meta-analysis; Confidence interval; Thrombosis; MEDLINE; Incidence (geometry); Hazard ratio; Surgery; Internal medicine","score_opus":0.032250030036446733,"score_gpt":0.32585490295707437,"score_spread":0.29360487292062765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036766167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017733111,0.99449074,0.0000035479143,0.00013275136,0.0000139544845,0.005064371,0.000086293185,0.00002620321,0.00016438572],"genre_scores_gemma":[0.000093123024,0.99826056,0.0003433484,0.00035389155,0.000005116977,0.00071034476,0.00014566665,0.00004099828,0.000046959605],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99708873,0.0002283042,0.0014186575,0.0005548548,0.0004867767,0.00022265068],"domain_scores_gemma":[0.99779916,0.0002429599,0.0011248662,0.0006074799,0.00011811268,0.00010739662],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00023270697,0.00053045235,0.020460082,0.00044393152,0.000025051304,0.000015659034,0.00019789244,0.00008128401,0.00016286878],"category_scores_gemma":[0.00023847536,0.000281105,0.0014275064,0.0015622653,0.000056431443,0.000095294265,0.00009339824,0.00017263799,0.0000053611643],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012025669,0.00063247175,0.00061887474,0.70368457,0.29414636,0.000008627829,0.000028917799,4.4032853e-7,2.1000774e-9,0.000055135675,0.000008425999,0.00081499],"study_design_scores_gemma":[0.00036337267,0.00027344804,0.0019418667,0.052409574,0.9370406,8.009005e-7,0.000016520336,3.3274318e-7,8.844832e-8,0.0000025517734,0.00770909,0.00024173043],"about_ca_topic_score_codex":0.000020624913,"about_ca_topic_score_gemma":0.00010948559,"teacher_disagreement_score":0.651275,"about_ca_system_score_codex":0.00003439249,"about_ca_system_score_gemma":0.00004414548,"threshold_uncertainty_score":0.9999641},"labels":[],"label_agreement":null},{"id":"W3036940367","doi":"10.1182/bloodadvances.2019001367","title":"KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Leukemia and Lymphoma Society","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Internal medicine; Oncology; Hodgkin lymphoma; Lymphoma; Cancer research; Cancer; Immunotherapy","score_opus":0.010373646224218222,"score_gpt":0.24068443535989895,"score_spread":0.23031078913568073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036940367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883843,0.00454029,0.00001119134,0.00464539,0.00013475012,0.0004067369,0.000041689742,0.000058804584,0.0013227122],"genre_scores_gemma":[0.99695593,0.00037156642,0.0014747083,0.0006928997,0.00019467196,0.00012254399,0.000026871505,0.00003112686,0.0001297091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983214,0.00005075775,0.00043046786,0.00046234223,0.00038501256,0.00035002682],"domain_scores_gemma":[0.99922884,0.00009437644,0.00012114721,0.00026836872,0.00005989415,0.0002273928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049024595,0.0002633323,0.00062698295,0.000086266235,0.000026869737,0.000017193597,0.00012527018,0.00011107157,0.00019521113],"category_scores_gemma":[0.00011193624,0.00020942016,0.00021560585,0.00031917894,0.000096508724,0.00016022482,0.00007442995,0.00008956242,0.00008528898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053491197,0.004789825,0.92125946,0.00057104597,0.0004016244,0.0013224523,0.0013242114,0.000017829738,0.0024526073,0.0008260727,0.0020630162,0.05962272],"study_design_scores_gemma":[0.09462693,0.0032737541,0.7582609,0.00072206353,0.00076944794,0.000117520656,0.0007378117,0.00014004088,0.054134384,0.00026548718,0.08635786,0.0005937626],"about_ca_topic_score_codex":0.000034027686,"about_ca_topic_score_gemma":0.00011004697,"teacher_disagreement_score":0.16299854,"about_ca_system_score_codex":0.00006777549,"about_ca_system_score_gemma":0.0001449704,"threshold_uncertainty_score":0.8539906},"labels":[],"label_agreement":null},{"id":"W3036970379","doi":"10.1182/bloodadvances.2020002195","title":"Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; Canadian Agency for Drugs and Technologies in Health; Dalhousie University; McMaster University; Impact","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Relative risk; Asymptomatic; Confidence interval; Randomized controlled trial; Deep vein; Pulmonary embolism; Internal medicine; Thrombosis; Surgery","score_opus":0.034133972128794474,"score_gpt":0.3205800138911587,"score_spread":0.2864460417623642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036970379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257857,0.001578492,0.00031967097,0.0015962392,0.00043741614,0.0019946306,0.000025315092,0.00013966292,0.0013299976],"genre_scores_gemma":[0.9937056,0.0015541511,0.0019017017,0.0021458627,0.00026675148,0.00029491397,0.0000465949,0.000040368916,0.000044102973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981116,0.000058979374,0.0005754417,0.00053857244,0.0002597518,0.00045564023],"domain_scores_gemma":[0.9991897,0.00015531867,0.00020168966,0.00015811711,0.00012272877,0.00017244254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012460844,0.00023769574,0.0007739963,0.000102897764,0.00014105794,0.000037201567,0.0001741128,0.000066567474,0.000101921316],"category_scores_gemma":[0.00042392858,0.00021518057,0.00033584307,0.00032053722,0.000058895588,0.00024622618,0.00013010604,0.00020188255,0.000021252989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014393103,0.0816071,0.61231774,0.036349405,0.0029630065,0.000698581,0.0075148134,0.0026240814,0.010910746,0.012326219,0.0063715866,0.22487739],"study_design_scores_gemma":[0.035223972,0.019061994,0.90568584,0.0034930336,0.0027825735,0.000019634648,0.0013895615,0.0012715175,0.009632749,0.0028257691,0.017240582,0.001372774],"about_ca_topic_score_codex":0.000009890298,"about_ca_topic_score_gemma":0.000034626522,"teacher_disagreement_score":0.2933681,"about_ca_system_score_codex":0.000036184836,"about_ca_system_score_gemma":0.000044080076,"threshold_uncertainty_score":0.87748086},"labels":[],"label_agreement":null},{"id":"W3037474453","doi":"10.1182/bloodadvances.2020001696","title":"Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Genome British Columbia; Spinal Cord Injury BC; Queen's University; McGill University; Princess Margaret Cancer Centre; Simon Fraser University","funders":"Fondation de l'Hôpital général juif; Jewish General Hospital; Terry Fox Research Institute; Cancer Research UK; Genome British Columbia; Michael Smith Health Research BC; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"CHOP; Rituximab; Missense mutation; Vincristine; Lymphoma; Cancer research; Nonsense mutation; Biology; CD20; Mutation; Oncology; Immunology; Internal medicine; Medicine; Cyclophosphamide; Genetics; Chemotherapy; Gene","score_opus":0.010694570391632404,"score_gpt":0.23190720499040354,"score_spread":0.22121263459877114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037474453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528104,0.04502978,0.000003279312,0.0006622961,0.000020617445,0.00025444053,0.00003038552,0.000016473357,0.0011723391],"genre_scores_gemma":[0.99160963,0.005336776,0.0026285225,0.00015837864,0.000041455267,0.00005369358,0.000008235371,0.000009488689,0.00015382949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993063,0.000019631769,0.00020484079,0.00023933209,0.00010318334,0.00012670166],"domain_scores_gemma":[0.99964315,0.000053263266,0.00006659053,0.00012171911,0.000019065266,0.00009621638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000012491282,0.000119070326,0.0002565231,0.000034111134,0.000020483394,0.0000030369856,0.000030119834,0.000030772986,0.000015491023],"category_scores_gemma":[0.000013285445,0.00009217647,0.00004594915,0.00009101182,0.000030988722,0.0000336536,0.000015264599,0.000014316224,0.0000042858683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020335907,0.0015159046,0.98889816,0.00019437798,0.00004928264,0.0002340645,0.0004023684,0.000012741947,0.00070381095,0.00006975409,0.00003292255,0.007683263],"study_design_scores_gemma":[0.013516383,0.0012807229,0.96680677,0.00015050983,0.0001653982,0.000016223188,0.00013715465,0.000022038945,0.010603158,0.000098252574,0.0071079335,0.00009548516],"about_ca_topic_score_codex":0.000069505324,"about_ca_topic_score_gemma":0.000088663815,"teacher_disagreement_score":0.039693005,"about_ca_system_score_codex":0.00007182779,"about_ca_system_score_gemma":0.000069741414,"threshold_uncertainty_score":0.37588477},"labels":[],"label_agreement":null},{"id":"W3038688534","doi":"10.1182/bloodadvances.2018027813","title":"Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; National Institutes of Health; Queen's University","keywords":"Exon; Von Willebrand disease; Von Willebrand factor; Multiplex ligation-dependent probe amplification; Copy-number variation; Pathogenesis; Biology; Recombinant DNA; Molecular biology; Gene; Genetics; Immunology; Platelet","score_opus":0.009356801172691295,"score_gpt":0.23704738545942106,"score_spread":0.22769058428672975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038688534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969151,0.0005433054,0.0013907824,0.00061189884,0.00005608363,0.00026955313,0.00010729179,0.00003730926,0.00006866821],"genre_scores_gemma":[0.99826443,0.00082052103,0.0004868325,0.00020686579,0.000028733868,0.000017858494,0.00012945328,0.000013849606,0.00003143448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993149,0.000013759081,0.0001973224,0.0001853411,0.00012924235,0.00015942522],"domain_scores_gemma":[0.99971825,0.000014623174,0.0000796883,0.000087041764,0.0000239816,0.000076399905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015590087,0.0001131681,0.0002899184,0.000051101826,0.000034243873,0.0000054623256,0.00004197921,0.0000485645,0.00005951868],"category_scores_gemma":[0.00002239113,0.000091526425,0.000054277498,0.00015805085,0.000011539789,0.00013813887,0.000017956787,0.00006145934,0.000008220739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007930185,0.0004630442,0.017555369,0.00011469139,0.00006383661,0.00011278004,0.0004173241,0.0000017722455,0.9792435,0.00066476996,6.333135e-7,0.0012829626],"study_design_scores_gemma":[0.011357518,0.0011442868,0.25927973,0.0003368029,0.00031359028,0.0000462583,0.00016744177,0.00034060355,0.72063774,0.00095989683,0.0050360044,0.00038016806],"about_ca_topic_score_codex":0.000002226078,"about_ca_topic_score_gemma":0.000012973691,"teacher_disagreement_score":0.2586058,"about_ca_system_score_codex":0.0000077917475,"about_ca_system_score_gemma":0.00001572458,"threshold_uncertainty_score":0.37323394},"labels":[],"label_agreement":null},{"id":"W3039230543","doi":"10.1182/bloodadvances.2019001212","title":"Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Oncology; Internal medicine; Phases of clinical research; Phase (matter); Clinical trial; Bone marrow; Chemistry","score_opus":0.025519984638298777,"score_gpt":0.3188262696074818,"score_spread":0.293306284969183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039230543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540585,0.0023101182,0.000004017464,0.0010983454,0.00002105845,0.00088679144,0.000016650121,0.0000081503085,0.00024902166],"genre_scores_gemma":[0.9990657,0.00058541505,0.00020449105,0.00007667541,0.000019373507,0.000029047169,0.0000036169542,0.0000071446593,0.000008519049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991636,0.00006475594,0.00030520186,0.00020005928,0.00016652793,0.00009981268],"domain_scores_gemma":[0.9994412,0.00021240328,0.00014786464,0.00009856033,0.000040791492,0.000059149814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010918881,0.000107930275,0.00034870952,0.000040678402,0.00004685833,0.0000063610387,0.000038396985,0.000023317578,0.0000067022124],"category_scores_gemma":[0.00018259592,0.00007034398,0.00003172752,0.00018297804,0.00007768812,0.000076830445,0.000043459764,0.00006918998,2.4117392e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075223215,0.005900609,0.96703523,0.00022523718,0.0001300095,0.00001119908,0.0051068817,0.0000066150997,0.0025622172,0.0010708118,0.0000033941503,0.017195567],"study_design_scores_gemma":[0.036723733,0.003380069,0.9278944,0.0003315975,0.0002640973,0.0000070057185,0.0021150003,0.00006698481,0.028823722,0.00007749299,0.00023720144,0.00007868392],"about_ca_topic_score_codex":0.000018150176,"about_ca_topic_score_gemma":0.000026304304,"teacher_disagreement_score":0.039140813,"about_ca_system_score_codex":0.000008665382,"about_ca_system_score_gemma":0.000030216424,"threshold_uncertainty_score":0.28685442},"labels":[],"label_agreement":null},{"id":"W3040264829","doi":"10.1182/bloodadvances.2020001758","title":"Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research; Advanced Medical Research Foundation; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Brigham and Women's Hospital; Boston Children's Hospital; Breast Cancer Research Foundation","keywords":"Bone marrow; Inflammation; Haematopoiesis; Flow cytometry; Platelet; Myeloid; Megakaryocyte; Cell biology; Immunology; In vivo; Immunophenotyping; Chemistry; Biology; Pathology; Stem cell; Medicine","score_opus":0.008159017298855882,"score_gpt":0.21469219399648823,"score_spread":0.20653317669763235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040264829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651156,0.033403326,0.0003336484,0.00070879195,0.000038000573,0.00022045366,0.000012825246,0.000033579905,0.00013376295],"genre_scores_gemma":[0.9969945,0.0015130942,0.00081567204,0.00013693824,0.00037022453,0.000025192883,0.000036727863,0.000025282648,0.0000823762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990308,0.00006391133,0.00022304036,0.00033805618,0.00013078036,0.000213377],"domain_scores_gemma":[0.99946386,0.000015906468,0.00011837714,0.00024235624,0.000032864937,0.00012662928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088129396,0.00016909177,0.00012403827,0.000014699734,0.00016038009,0.0000537644,0.0001751222,0.00007720159,0.000012060044],"category_scores_gemma":[0.00010869438,0.00013919409,0.000053929416,0.00007337734,0.00014439042,0.000023060107,0.000116238145,0.00010444768,0.000008429717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009485649,0.000020687303,0.0011677301,0.00007587484,0.00003674198,0.00003297038,0.0001344823,0.0003597059,0.9941702,0.00008596011,0.000021026304,0.0037997968],"study_design_scores_gemma":[0.0007968265,0.000086414504,0.002686433,0.000013160299,0.00003654518,0.00003103983,0.00016833498,0.00019932323,0.98659074,0.00019546304,0.008999079,0.0001966448],"about_ca_topic_score_codex":0.0000015185948,"about_ca_topic_score_gemma":0.0000056645167,"teacher_disagreement_score":0.03189023,"about_ca_system_score_codex":0.000002772235,"about_ca_system_score_gemma":0.000023245326,"threshold_uncertainty_score":0.567617},"labels":[],"label_agreement":null},{"id":"W3040414213","doi":"10.1182/bloodadvances.2020001846","title":"Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Autoantibody; Bone marrow; Medicine; Platelet; Immunology; Immune thrombocytopenia; Immune system; Antibody; Pathology","score_opus":0.009485742333120216,"score_gpt":0.23737720525258232,"score_spread":0.2278914629194621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040414213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928075,0.0041755573,0.0000028168843,0.0010420858,0.00001828203,0.0003828325,0.000025330608,0.000016615426,0.0015289772],"genre_scores_gemma":[0.9986626,0.00034386996,0.00054550846,0.00033456113,0.00001267745,0.000012097565,0.000054680044,0.000010007708,0.000024015546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999269,0.000019206645,0.0001925608,0.00015522951,0.00021405073,0.00014993796],"domain_scores_gemma":[0.9996729,0.000037362977,0.0000901047,0.00013438128,0.0000321064,0.000033161767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000374794,0.00011835172,0.00039898712,0.000027305285,0.000032736378,0.0000065783915,0.00008367343,0.000025079456,0.00003381542],"category_scores_gemma":[0.000027836644,0.00006363376,0.000038616283,0.00018103722,0.000068486355,0.00012025596,0.000019449146,0.00008774327,0.000008113614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011533704,0.0018716569,0.98281467,0.00027109863,0.0002755215,0.00078370405,0.0022809417,0.000022935648,0.001264829,0.00015822491,0.00011052045,0.008992522],"study_design_scores_gemma":[0.013150278,0.0020666223,0.96847445,0.0001796108,0.00022038903,0.000032797496,0.00072736695,0.000015992639,0.008840003,0.0001623875,0.005954528,0.00017558146],"about_ca_topic_score_codex":0.00001904285,"about_ca_topic_score_gemma":0.000025186791,"teacher_disagreement_score":0.014340232,"about_ca_system_score_codex":0.0000039876586,"about_ca_system_score_gemma":0.000022244549,"threshold_uncertainty_score":0.25949094},"labels":[],"label_agreement":null},{"id":"W3043099150","doi":"10.1182/bloodadvances.2019001266","title":"Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Moonshot Research and Development Program; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Takeda Oncology; Genentech; Health Resources and Services Administration; National Institutes of Health; MacroGenics; Omeros Corporation; Janssen Scientific Affairs; Mundipharma EDO; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; CTI Biopharma; bluebird bio; Cancer Moonshot; Chimerix; Medac; Jazz Pharmaceuticals; Janssen Biotech; HistoGenetics; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Celgene; Karyopharm Therapeutics; Atara Biotherapeutics; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Biomedical Advanced Research and Development Authority; Amgen; CSL Behring; Bristol-Myers Squibb; Janssen Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; GlaxoSmithKline; Agios Pharmaceuticals; Sierra Oncology; Astellas Pharma US","keywords":"Medicine; Busulfan; Fludarabine; Melphalan; Internal medicine; Total body irradiation; Alemtuzumab; Hazard ratio; Transplantation; Myeloid leukemia; Gastroenterology; Surgery; Leukemia; Oncology; Hematopoietic stem cell transplantation; Chemotherapy; Cyclophosphamide; Confidence interval","score_opus":0.0338867392681122,"score_gpt":0.3146726970560506,"score_spread":0.2807859577879384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043099150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642501,0.00052685133,0.029776035,0.0028365646,0.000309924,0.0011629619,0.00006843081,0.00027571898,0.00079341326],"genre_scores_gemma":[0.94838893,0.00006104119,0.048812706,0.0017847636,0.00033581507,0.00006804544,0.00038743293,0.000048308724,0.00011293899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982805,0.000027212287,0.0005204846,0.0005201429,0.00031243637,0.00033919138],"domain_scores_gemma":[0.9987673,0.00016446644,0.00029433,0.00026708262,0.00028013022,0.00022666794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020647969,0.0002249477,0.0005462637,0.00007122318,0.00015182086,0.000025597208,0.0000851903,0.000100656165,0.000035628775],"category_scores_gemma":[0.00031533095,0.00021562785,0.00014621377,0.00024040336,0.00008507892,0.0001859069,0.000012025518,0.00016181446,0.000009278781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024340956,0.00017706072,0.0078865085,0.0017260122,0.00072767376,0.0029580628,0.0012581223,0.000866674,0.9804021,0.0001879094,0.0005716886,0.00080409046],"study_design_scores_gemma":[0.0059630275,0.00066896185,0.0026990727,0.00092553697,0.0023506589,0.0024766424,0.00048183702,0.005593616,0.97472376,0.00016143244,0.0035498932,0.00040555088],"about_ca_topic_score_codex":0.000014971882,"about_ca_topic_score_gemma":0.0000027189542,"teacher_disagreement_score":0.019036671,"about_ca_system_score_codex":0.000088180015,"about_ca_system_score_gemma":0.00040891126,"threshold_uncertainty_score":0.8793048},"labels":[],"label_agreement":null},{"id":"W3044843104","doi":"10.1182/bloodadvances.2020002137","title":"Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children; Université de Montréal; McMaster University; Centre Hospitalier Universitaire Sainte-Justine; Canadian Blood Services; St. Michael's Hospital; SickKids Foundation; University of Toronto; University Health Network; Ottawa Hospital; University of Ottawa","funders":"Canadian Blood Services","keywords":"Medicine; Neonatal alloimmune thrombocytopenia; Odds ratio; Prospective cohort study; Retrospective cohort study; Fetus; Confidence interval; Pregnancy; Pediatrics; Human leukocyte antigen; Meta-analysis; Population; Obstetrics; Immunology; Internal medicine; Antigen","score_opus":0.033383915331041694,"score_gpt":0.3642677797100728,"score_spread":0.3308838643790311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044843104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012876873,0.9924664,0.0000134777465,0.000052811,0.00018666907,0.005493737,0.00087342423,0.000069892165,0.0007148483],"genre_scores_gemma":[0.00083302124,0.99702877,0.0003552877,0.00009764787,0.00006003253,0.0002845535,0.0008407633,0.0001336779,0.0003662583],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99447066,0.0002494697,0.002890562,0.0008147755,0.0010456099,0.00052893173],"domain_scores_gemma":[0.99555594,0.0003972093,0.0024781595,0.0011548247,0.00015082094,0.00026305768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003667833,0.0011768395,0.013779452,0.00024887876,0.00006309285,0.00001763783,0.0006198871,0.00032664672,0.00023019395],"category_scores_gemma":[0.0006264739,0.0007239231,0.003160126,0.00072931,0.00017655987,0.00033016896,0.00018518392,0.0006382801,0.00016463533],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006138108,0.0005759629,0.00004613675,0.87031686,0.004879415,0.0012878123,0.000030917246,3.4145393e-7,0.0000017845553,0.000040663326,0.000027298835,0.12273145],"study_design_scores_gemma":[0.0027969908,0.0020972972,0.000027305181,0.8845976,0.025870305,0.0020441764,0.000033179178,0.0000018114927,0.000020969375,0.00002167194,0.08185328,0.0006354235],"about_ca_topic_score_codex":0.00005192981,"about_ca_topic_score_gemma":0.000010464957,"teacher_disagreement_score":0.12209602,"about_ca_system_score_codex":0.00016390005,"about_ca_system_score_gemma":0.00053815584,"threshold_uncertainty_score":0.9995212},"labels":[],"label_agreement":null},{"id":"W3045583280","doi":"10.1182/bloodadvances.2020002253","title":"Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Kawasaki Disease and Coronary Complications","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hemolysis; Medicine; Immunology; Antibody; Haptoglobin; Antibody titer; Titer; Proinflammatory cytokine; Inflammation","score_opus":0.0113107950392572,"score_gpt":0.26343781187618304,"score_spread":0.25212701683692584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045583280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98663026,0.0038113587,0.000008554231,0.007874639,0.000026718719,0.0006932706,0.00005743996,0.00010901707,0.00078872504],"genre_scores_gemma":[0.997464,0.0006917196,0.0002459809,0.0005151288,0.00010508873,0.00015195404,0.00051036454,0.000026020669,0.00028974458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852717,0.00006977947,0.00028084713,0.0004958168,0.00030376966,0.00032263907],"domain_scores_gemma":[0.9992389,0.000068645175,0.00015968815,0.00024369445,0.000072076116,0.00021698402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056851328,0.00020829687,0.0003705685,0.00011564548,0.000055548942,0.000021839094,0.00009274574,0.00004820874,0.000029889625],"category_scores_gemma":[0.00018965857,0.00017510907,0.00006916051,0.0010083425,0.0000283733,0.00027003113,0.000019941319,0.000116324154,0.000021526279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000287098,0.0026016175,0.98993874,0.00008256987,0.00021233018,0.00028505325,0.00022799871,0.00006821834,0.004927706,0.000062958265,0.000029584606,0.001276132],"study_design_scores_gemma":[0.0059199086,0.0007348157,0.987335,0.00018103319,0.0008563501,0.000005547412,0.00016211827,0.00022275491,0.0010692826,0.0000539677,0.0032156347,0.00024358723],"about_ca_topic_score_codex":0.00006051256,"about_ca_topic_score_gemma":0.00018568251,"teacher_disagreement_score":0.010833722,"about_ca_system_score_codex":0.00015388819,"about_ca_system_score_gemma":0.00016344173,"threshold_uncertainty_score":0.71407413},"labels":[],"label_agreement":null},{"id":"W3046714011","doi":"10.1182/bloodadvances.2020002068","title":"Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Rituximab; Medicine; Mantle cell lymphoma; Internal medicine; Vincristine; CHOP; Bendamustine; International Prognostic Index; Hazard ratio; Gastroenterology; Autologous stem-cell transplantation; Cyclophosphamide; Chemotherapy; Oncology; Surgery; Lymphoma; Confidence interval","score_opus":0.00821392251384283,"score_gpt":0.220686257138358,"score_spread":0.21247233462451515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046714011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885978,0.00936064,0.000003175642,0.00069206307,0.00002583482,0.00038435284,0.00001883839,0.000033181313,0.00088412815],"genre_scores_gemma":[0.98904085,0.009697959,0.0006275916,0.0004647719,0.000049011825,0.000036645764,0.000036466572,0.000015755038,0.000030974188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920374,0.000013232817,0.00014755562,0.00030689992,0.00015748225,0.00017108466],"domain_scores_gemma":[0.9996899,0.00002715562,0.000050538518,0.00008015424,0.000024573055,0.00012772316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023613193,0.00016285939,0.0002654761,0.00005745106,0.00004972515,0.000019653662,0.000027562057,0.000041324387,0.000014875315],"category_scores_gemma":[0.000004787338,0.000110997134,0.000018482917,0.00015749744,0.000041816766,0.00016754126,0.00001034488,0.000038576887,0.0000054001657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079487433,0.0028706817,0.9559083,0.00013413728,0.00005175324,0.000097320866,0.0006274551,0.0000034775992,0.000507713,0.000031216176,0.00003827829,0.0389348],"study_design_scores_gemma":[0.065264784,0.0035318334,0.88869685,0.00018781623,0.00017588695,0.00006204363,0.0002053626,0.000020087646,0.034495823,0.00007316466,0.007043599,0.00024274173],"about_ca_topic_score_codex":0.00012446118,"about_ca_topic_score_gemma":0.000024498144,"teacher_disagreement_score":0.067211434,"about_ca_system_score_codex":0.0000142504805,"about_ca_system_score_gemma":0.000035074616,"threshold_uncertainty_score":0.45263317},"labels":[],"label_agreement":null},{"id":"W3046998131","doi":"10.1182/bloodadvances.2020002335","title":"Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Apixaban; Medicine; Dabigatran; Rivaroxaban; Dosing; Perioperative; Renal function; Bleed; Urology; Atrial fibrillation; Anticoagulant; Creatinine; Internal medicine; Anesthesia; Surgery; Warfarin","score_opus":0.07623660977707361,"score_gpt":0.3292678125012159,"score_spread":0.25303120272414226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046998131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984607,0.0002598012,0.0000104301325,0.0002952209,0.00010590234,0.0005508188,0.000011364411,0.00007270425,0.00023303626],"genre_scores_gemma":[0.99909776,0.00004131947,0.0003360637,0.00013063019,0.0002315777,0.0000040621853,0.000026208681,0.000016749727,0.000115610565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884886,0.00004001764,0.00036803106,0.00029147667,0.000261564,0.00019006668],"domain_scores_gemma":[0.99942595,0.00012907559,0.00016914018,0.00010315416,0.00008067112,0.00009202763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011273677,0.00013781224,0.00048000133,0.000100276855,0.000030292931,0.00000975393,0.000059022714,0.000041456482,0.00003305561],"category_scores_gemma":[0.0010891204,0.00010117314,0.00007720385,0.00040246436,0.000034287335,0.0003926925,0.00003331154,0.000066180175,0.0000019931308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006632474,0.00006787325,0.99635094,0.00035687652,0.00007227238,0.000011061944,0.00048379396,0.000057783258,0.0004942804,0.000007869865,0.00005080348,0.0013831896],"study_design_scores_gemma":[0.0015092553,0.0005079261,0.9903194,0.00015161166,0.00012857688,0.0000011629908,0.00018519137,0.00010471647,0.0066200416,0.000011901748,0.0003379058,0.00012232592],"about_ca_topic_score_codex":0.000008458489,"about_ca_topic_score_gemma":0.00003513769,"teacher_disagreement_score":0.006125761,"about_ca_system_score_codex":0.00001369594,"about_ca_system_score_gemma":0.00010824812,"threshold_uncertainty_score":0.41257206},"labels":[],"label_agreement":null},{"id":"W3047569349","doi":"10.1182/bloodadvances.2020001920","title":"American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Grand River Hospital; McMaster University; Health Sciences Centre; Impact","funders":"","keywords":"Medicine; Guideline; Intensive care medicine; Hematology; Myeloid leukemia; Supportive psychotherapy; Internal medicine; Disease; Family medicine; Pathology","score_opus":0.02674448791496178,"score_gpt":0.3442270041501308,"score_spread":0.31748251623516904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047569349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751028,0.004240569,0.0011674215,0.017811693,0.000047352187,0.0012693376,0.000074618336,0.00009529955,0.00019093738],"genre_scores_gemma":[0.7765596,0.0075957803,0.2053659,0.008621874,0.0008524862,0.00046386378,0.00015260364,0.00010515646,0.00028274168],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978636,0.000045610464,0.00072418025,0.0005499383,0.00031088642,0.00050582166],"domain_scores_gemma":[0.9983014,0.0005133973,0.00029754805,0.00025594924,0.00041106308,0.00022068319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017267151,0.00025595358,0.00089510763,0.000063081985,0.000052384028,0.000008871842,0.00023985504,0.000098718454,0.00003122725],"category_scores_gemma":[0.0010885405,0.00021549298,0.00025022725,0.0006947147,0.00025016797,0.00015431488,0.00010289829,0.00027694725,0.0000066267103],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007287008,0.0009807284,0.2717573,0.006485329,0.0019984357,0.0009359974,0.013581129,0.00131122,0.10801996,0.00026808286,0.11850852,0.4688663],"study_design_scores_gemma":[0.14100036,0.012037528,0.05269722,0.0045400416,0.0020912383,0.0006968114,0.0479677,0.13470826,0.51167357,0.0003567358,0.089608006,0.002622508],"about_ca_topic_score_codex":0.00026998267,"about_ca_topic_score_gemma":0.000073674164,"teacher_disagreement_score":0.46624377,"about_ca_system_score_codex":0.00014173759,"about_ca_system_score_gemma":0.0005606069,"threshold_uncertainty_score":0.87875485},"labels":[],"label_agreement":null},{"id":"W3048225164","doi":"10.1182/bloodadvances.2020001880","title":"Iron deficiency following bariatric surgery: a retrospective cohort study","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Hazard ratio; Anemia; Retrospective cohort study; Ferritin; Iron deficiency; Iron-deficiency anemia; Surgery; Confidence interval; Internal medicine; Incidence (geometry); Proportional hazards model; Cohort study; Gastroenterology","score_opus":0.01557874063958754,"score_gpt":0.26267809617873356,"score_spread":0.24709935553914603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048225164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893111,0.0047476212,0.00006535817,0.0008650403,0.00067582075,0.0007669568,0.000003981982,0.00022748321,0.0033366296],"genre_scores_gemma":[0.9982552,0.00019118591,0.0003129878,0.00059540966,0.00043382013,0.00004186958,0.000007574226,0.000026933782,0.00013499617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980528,0.00008581723,0.0004082603,0.0005557932,0.0005408315,0.00035652216],"domain_scores_gemma":[0.99895734,0.00037413804,0.0001332087,0.00025977063,0.000057303885,0.00021823624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000494877,0.00022330787,0.00076658407,0.00012115183,0.00015671455,0.00002609922,0.00010369032,0.00006153121,0.0001102668],"category_scores_gemma":[0.0010994965,0.00018324029,0.00032100332,0.0010463317,0.000026021407,0.00025744372,0.000054245575,0.00022516664,0.000051323954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007641428,0.00047082396,0.9970064,0.000050736347,0.000098853576,0.00031987095,0.00037809316,0.0000044785884,0.00007977886,0.00005436596,0.00024526136,0.0012148838],"study_design_scores_gemma":[0.0011064272,0.0003864196,0.99538976,0.000016166927,0.00097362464,0.000019647625,0.0006326213,0.000008693055,0.00019845666,0.00005118183,0.0009979379,0.00021904644],"about_ca_topic_score_codex":0.000031209984,"about_ca_topic_score_gemma":0.0000058442206,"teacher_disagreement_score":0.008944115,"about_ca_system_score_codex":0.000037980426,"about_ca_system_score_gemma":0.000121650075,"threshold_uncertainty_score":0.74723226},"labels":[],"label_agreement":null},{"id":"W3048886060","doi":"10.1182/bloodadvances.2020002142","title":"Gene therapy for hemophilia: anticipating the unexpected","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Genetic enhancement; Medicine; Gene; Bioinformatics; Internal medicine; Biology; Genetics","score_opus":0.06063301568724029,"score_gpt":0.35008542375024126,"score_spread":0.289452408063001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048886060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96102613,0.010730992,0.000087176006,0.025999254,0.00006187143,0.0009996272,0.000011408326,0.00009231563,0.0009912144],"genre_scores_gemma":[0.9931364,0.0014489598,0.00275937,0.001322773,0.00069267873,0.0001258481,0.000023844728,0.000021662343,0.00046842766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991643,0.000024072153,0.00014600213,0.00021481942,0.00020138986,0.00024943176],"domain_scores_gemma":[0.9994517,0.00016743466,0.000038944105,0.00015178259,0.00008034081,0.000109822264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007960727,0.000110260306,0.00019483056,0.000020305251,0.00016882863,0.000016490047,0.000101333695,0.000034816323,0.00005689196],"category_scores_gemma":[0.00017705375,0.00005788116,0.00009477864,0.00021078142,0.00006990623,0.000058445497,0.000020761012,0.000101678845,0.000018282071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020943289,0.0013911714,0.13844971,0.00045476778,0.0010807778,0.00022561273,0.004194088,0.00004559496,0.593202,0.000592065,0.0018478847,0.25642198],"study_design_scores_gemma":[0.010041606,0.003026255,0.011322968,0.00007091096,0.00021600736,0.000038215963,0.00072083704,0.00078599126,0.89102155,0.0005043115,0.08200005,0.00025132345],"about_ca_topic_score_codex":0.0000026657856,"about_ca_topic_score_gemma":0.000001185656,"teacher_disagreement_score":0.29781953,"about_ca_system_score_codex":0.000006151519,"about_ca_system_score_gemma":0.000052593638,"threshold_uncertainty_score":0.23603253},"labels":[],"label_agreement":null},{"id":"W3082945900","doi":"10.1182/bloodadvances.2020001879","title":"Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NEOMED Institute; McGill University","funders":"","keywords":"Bromodomain; Cancer research; Acetylation; Biology; In vivo; Prostate cancer; In vitro; Pharmacology; Chemistry; Cancer; Biochemistry; Gene","score_opus":0.007588730780189812,"score_gpt":0.2201553180888164,"score_spread":0.21256658730862657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082945900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962567,0.0019345938,0.00006963078,0.001002847,0.00010434254,0.00013004284,0.00002644989,0.000007671331,0.00046772722],"genre_scores_gemma":[0.9987821,0.00020743173,0.00031241667,0.00031221283,0.0002616732,0.0000056183344,0.0000057757297,0.0000067391147,0.00010606049],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950665,0.0000328573,0.000098752615,0.00018138568,0.00009107457,0.00008925761],"domain_scores_gemma":[0.99970937,0.0000061190794,0.00008112712,0.00012823669,0.000026626181,0.00004849744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038525082,0.00008039338,0.00009313969,0.0000072354824,0.000052588464,0.000009562609,0.0000851646,0.000041930485,0.000006664672],"category_scores_gemma":[0.00010272059,0.000057447327,0.00004292627,0.00006734494,0.000104706225,0.000009237258,0.000108059176,0.00005400532,0.0000011843225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003647015,0.000039800303,0.0054545314,0.000032647855,0.000015477452,7.547125e-7,0.000025078689,0.0000037647378,0.990851,0.00006933023,0.0005543498,0.0029168],"study_design_scores_gemma":[0.00037035142,0.00015936197,0.0032744596,0.0000105138715,0.0000124173575,0.0000042469433,0.000026251946,0.000007269024,0.9445068,0.000019887104,0.051534675,0.00007372974],"about_ca_topic_score_codex":0.0000036616855,"about_ca_topic_score_gemma":0.000007663285,"teacher_disagreement_score":0.050980326,"about_ca_system_score_codex":0.0000010128317,"about_ca_system_score_gemma":0.000028355855,"threshold_uncertainty_score":0.2342634},"labels":[],"label_agreement":null},{"id":"W3083933015","doi":"10.1182/bloodadvances.2019000977","title":"Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"T-cell receptor; Biology; Repertoire; Immunology; clone (Java method); Transplantation; Major histocompatibility complex; T cell; Minor histocompatibility antigen; Antigen; Immune system; Genetics; Gene; Medicine; Internal medicine","score_opus":0.02028387443195072,"score_gpt":0.24558801278704742,"score_spread":0.22530413835509672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083933015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962333,0.009263351,0.0013230867,0.0029593923,0.00034490696,0.00093858567,0.000016560103,0.000121902,0.022699172],"genre_scores_gemma":[0.99468637,0.0023833863,0.0017425432,0.00076737057,0.00015708522,0.000061449144,0.00006365758,0.00002521331,0.000112912174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807745,0.00010348561,0.0005501235,0.00048673459,0.00044370536,0.0003384771],"domain_scores_gemma":[0.9992193,0.00019194285,0.00010533432,0.00031878043,0.000027068772,0.000137547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028371045,0.0002414734,0.0003975564,0.00007968152,0.00012484606,0.000028768916,0.00019857907,0.000093784125,0.00008444753],"category_scores_gemma":[0.000022574099,0.00017727066,0.0001785308,0.00042481764,0.000072553084,0.00020081717,0.000009262779,0.00029474983,0.00009216676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015562554,0.0036992414,0.20064731,0.007910993,0.0001769549,0.010007681,0.06940816,0.00055202364,0.6937287,0.002038876,0.0011514346,0.009122364],"study_design_scores_gemma":[0.02836934,0.0019715477,0.011460673,0.004258442,0.0016395041,0.0025246677,0.01446446,0.0004260055,0.83380085,0.00060811656,0.09874058,0.0017358327],"about_ca_topic_score_codex":0.000007956187,"about_ca_topic_score_gemma":0.0000129740665,"teacher_disagreement_score":0.18918665,"about_ca_system_score_codex":0.00002428711,"about_ca_system_score_gemma":0.00007694789,"threshold_uncertainty_score":0.72288877},"labels":[],"label_agreement":null},{"id":"W3084593436","doi":"10.1182/bloodadvances.2019001052","title":"Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University of Ottawa; Western University; McMaster University; Ottawa Hospital; University of Calgary; Impact","funders":"McMaster University; American Society of Hematology","keywords":"Medicine; Confidence interval; Pulmonary embolism; Pulmonary angiography; Meta-analysis; Pre- and post-test probability; Diagnostic accuracy; D-dimer; Radiology; Internal medicine; Nuclear medicine","score_opus":0.06649080756101727,"score_gpt":0.36537840906824876,"score_spread":0.2988876015072315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084593436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.2399507e-7,0.9890263,0.000015408546,0.0009320311,0.000032347616,0.009214197,0.0006302787,0.000024567616,0.00012453522],"genre_scores_gemma":[0.00004840972,0.9931193,0.00024901802,0.00042460914,0.00004554207,0.005855579,0.00011966332,0.000047058293,0.0000908097],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968572,0.00016536115,0.0018565642,0.00051174074,0.00038660812,0.00022247969],"domain_scores_gemma":[0.98977846,0.006874066,0.0021457567,0.0008707382,0.00023210184,0.000098877725],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005162363,0.00050372886,0.016247913,0.00025136748,0.00006722345,0.000016034855,0.00040333645,0.00009542517,0.00014375696],"category_scores_gemma":[0.0034252256,0.0002528982,0.0036448678,0.0013456417,0.00011383185,0.00008403502,0.00015054487,0.00015290926,0.0000023468394],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014763098,0.00041905025,0.0000032573412,0.74969745,0.23835425,0.000008642396,0.00002208602,4.396971e-7,7.792472e-8,0.00023842698,0.00015851443,0.011096307],"study_design_scores_gemma":[0.000092977534,0.00014747206,0.00001118531,0.047839783,0.73175776,0.000010860579,0.0000324408,0.0000029556566,0.0000024452297,0.000012836878,0.21993734,0.00015195268],"about_ca_topic_score_codex":0.000021264636,"about_ca_topic_score_gemma":0.000012643937,"teacher_disagreement_score":0.7018577,"about_ca_system_score_codex":0.000015031213,"about_ca_system_score_gemma":0.00008298839,"threshold_uncertainty_score":0.9999923},"labels":[],"label_agreement":null},{"id":"W3085980128","doi":"10.1182/bloodadvances.2020002662","title":"ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sierra Wireless (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Hepcidin; Anemia; Myelofibrosis; Medicine; Erythropoiesis; Internal medicine; Neutropenia; Gastroenterology; Ruxolitinib; Ineffective erythropoiesis; Bone marrow; Immunology; Chemotherapy","score_opus":0.025583402700213535,"score_gpt":0.3067703012933573,"score_spread":0.2811868985931438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085980128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867166,0.0071495613,0.000019780271,0.003784227,0.00019378979,0.001446551,0.00008219732,0.00007750531,0.00052975887],"genre_scores_gemma":[0.9862211,0.010657067,0.001791824,0.00046880805,0.00046766704,0.0002480156,0.00004928407,0.00003017764,0.00006610962],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817973,0.00008586994,0.00047063694,0.00060674653,0.0003433063,0.00031373368],"domain_scores_gemma":[0.99915373,0.00023547777,0.00010110309,0.00016495895,0.000057960122,0.0002867688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100132704,0.00030656144,0.00063925044,0.000100116624,0.00010511959,0.00003911714,0.000076050695,0.00010487213,0.00026165816],"category_scores_gemma":[0.00027706922,0.00024209126,0.00010826042,0.00028860397,0.00007644391,0.00035477625,0.000041714342,0.00019089243,0.00001533566],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12369395,0.017515186,0.45148894,0.0022491692,0.00077000656,0.0019987242,0.008979547,0.000042989646,0.24220227,0.00060018955,0.0021084717,0.14835055],"study_design_scores_gemma":[0.24520493,0.012059277,0.010308466,0.00065789925,0.0006607542,0.00007504999,0.0010233577,0.000058270623,0.70110494,0.00018254727,0.028071655,0.0005928402],"about_ca_topic_score_codex":0.00004655989,"about_ca_topic_score_gemma":0.00013674513,"teacher_disagreement_score":0.4589027,"about_ca_system_score_codex":0.000022098202,"about_ca_system_score_gemma":0.00008814046,"threshold_uncertainty_score":0.9872195},"labels":[],"label_agreement":null},{"id":"W3088398423","doi":"10.1182/bloodadvances.2020002947","title":"Systems-based hematology: highlighting successes and next steps","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Hematology; Internal medicine; MEDLINE; Medicine; Computational biology; Computer science; Biology; Biochemistry","score_opus":0.09012642471052464,"score_gpt":0.41528515258679505,"score_spread":0.3251587278762704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088398423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012546421,0.9959546,0.000026350242,0.00195602,0.00039321624,0.0010348348,0.00007359074,0.0001384293,0.0004104542],"genre_scores_gemma":[0.00013161688,0.9976728,0.00053531217,0.000662486,0.00067275896,0.00011178407,0.00006165857,0.000055387056,0.00009618808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723387,0.00037254574,0.0011398244,0.0006808262,0.00027682594,0.00029611334],"domain_scores_gemma":[0.9947377,0.0034121373,0.0010346597,0.00038628795,0.00012750067,0.00030174587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042262234,0.00044908572,0.0034050366,0.00008707004,0.00010706961,0.00013242889,0.00016758806,0.0003196795,0.00003518547],"category_scores_gemma":[0.001752536,0.0003136293,0.00028185855,0.0003345406,0.000109221946,0.00027427857,0.00006462074,0.000594215,0.000052581418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086823944,0.00031802652,0.000203071,0.17228007,0.0008102953,0.00081708044,0.0000230116,6.9747693e-7,0.0000015077836,0.0046665845,0.0001245708,0.8206683],"study_design_scores_gemma":[0.0010716213,0.00028194807,0.0000016144137,0.018155396,0.0050110877,0.0001729193,0.000055045006,0.000019520472,0.0000023974749,0.0000053794342,0.9749201,0.00030297198],"about_ca_topic_score_codex":0.00001445032,"about_ca_topic_score_gemma":0.000007983214,"teacher_disagreement_score":0.9747955,"about_ca_system_score_codex":0.000017736475,"about_ca_system_score_gemma":0.00047437192,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W3089665196","doi":"10.1182/bloodadvances.2020002621","title":"Comparison of outcomes of HCT in blast phase of <i>BCR-ABL1</i>− MPN with de novo AML and with AML following MDS","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Daiichi Sankyo Europe; National Cancer Institute; Office of Naval Research; Legend Biotech; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Health Resources and Services Administration; bluebird bio; Kiadis Pharma; Swedish Orphan Biovitrum; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Atara Biotherapeutics; Actinium Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; Medical College of Wisconsin; Janssen Biotech; HistoGenetics; U.S. Department of Defense; Sanofi; GlaxoSmithKline; U.S. Navy; Celgene; CSL Behring; Bristol-Myers Squibb; Terumo BCT; AstraZeneca; Astellas Pharma US; Biomedical Advanced Research and Development Authority; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Medac; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Hazard ratio; Internal medicine; Medicine; Myeloid leukemia; Oncology; Myelodysplastic syndromes; Proportional hazards model; Transplantation; Confidence interval; Myeloid; Leukemia; International Prognostic Scoring System; Gastroenterology; Bone marrow","score_opus":0.029240018982305417,"score_gpt":0.36560192174549944,"score_spread":0.336361902763194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089665196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961506,0.001962605,0.00034073234,0.0005552863,0.000010538182,0.00036470842,0.0000212078,0.000016946668,0.0005773412],"genre_scores_gemma":[0.99003935,0.00011274141,0.009634375,0.0001108658,0.000022580867,0.000011871742,0.000007404228,0.000023807394,0.000036977213],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985763,0.000043609925,0.00041886666,0.0002521021,0.00044038333,0.0002687757],"domain_scores_gemma":[0.99914974,0.00020367192,0.0002093769,0.00020019463,0.0000884669,0.00014852064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016239738,0.00016951218,0.00089766923,0.00012250648,0.000020369936,0.0000045438815,0.00013358249,0.000049515693,0.000011743515],"category_scores_gemma":[0.0001650355,0.000116081195,0.000056849345,0.00046088302,0.0002418143,0.00015156987,0.000056746336,0.00023170628,4.7471337e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015764494,0.0006800801,0.93948233,0.0006386514,0.0002728332,0.00012171023,0.0016834134,0.0001461327,0.05300819,0.000027185248,0.000022165244,0.0023408432],"study_design_scores_gemma":[0.05188804,0.013258269,0.14526427,0.0014812698,0.0008840517,0.00008673488,0.008051909,0.001320205,0.7759442,0.000029469735,0.0013761972,0.0004153916],"about_ca_topic_score_codex":0.00009656817,"about_ca_topic_score_gemma":0.00015835112,"teacher_disagreement_score":0.79421806,"about_ca_system_score_codex":0.000025311767,"about_ca_system_score_gemma":0.00024299102,"threshold_uncertainty_score":0.4733654},"labels":[],"label_agreement":null},{"id":"W3089930892","doi":"10.1182/bloodadvances.2020002637","title":"Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Rivaroxaban; Asymptomatic; Anticoagulant; Cohort; Thrombosis; Odds ratio; Confidence interval; Venous thrombosis; Surgery; Internal medicine; Pediatrics; Warfarin","score_opus":0.034056106020031285,"score_gpt":0.3268725296792808,"score_spread":0.29281642365924954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089930892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883056,0.009058603,0.000028017685,0.0009517686,0.0001639293,0.000682205,0.000033015018,0.000059026785,0.0007178236],"genre_scores_gemma":[0.96546364,0.033725966,0.00021021048,0.00034978814,0.00016296565,0.000013771507,0.000016389142,0.000027186807,0.000030105242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802357,0.0002204864,0.0007179819,0.00037588165,0.00020008332,0.00046201338],"domain_scores_gemma":[0.99890083,0.0003608172,0.00031526297,0.00021399246,0.0000511164,0.00015796619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022901327,0.00020239314,0.0006581047,0.00010402316,0.00023476456,0.00000628548,0.0001772502,0.00014238272,0.0001106913],"category_scores_gemma":[0.0000830964,0.000164882,0.00012036272,0.00046162275,0.00006810401,0.00012500458,0.00007321796,0.00034645532,0.00002651584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067764777,0.0034466037,0.90495497,0.00084097177,0.00026200808,0.000034296903,0.047496676,0.00026023027,0.0059011043,0.0005403283,0.000059878726,0.035525285],"study_design_scores_gemma":[0.017924093,0.003675269,0.9601885,0.0003672033,0.00062935747,0.0000047995354,0.0023372143,0.00038806314,0.0022580728,0.00047745474,0.010868952,0.0008810134],"about_ca_topic_score_codex":0.00014600933,"about_ca_topic_score_gemma":0.00007301689,"teacher_disagreement_score":0.05523354,"about_ca_system_score_codex":0.000023711978,"about_ca_system_score_gemma":0.00010075667,"threshold_uncertainty_score":0.6723693},"labels":[],"label_agreement":null},{"id":"W3090209681","doi":"10.1182/bloodadvances.2020001830","title":"American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1428,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Pulmonary embolism; Guideline; Deep vein; Thrombosis; Warfarin; Venous thromboembolism; Venous thrombosis; Intensive care medicine; Hematology; Vitamin K antagonist; Internal medicine; Atrial fibrillation","score_opus":0.056630311612821255,"score_gpt":0.3469072988106524,"score_spread":0.2902769871978311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090209681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553055,0.029755786,0.0016382801,0.009755877,0.00013559585,0.0022806486,0.00012963903,0.00006730846,0.0009313659],"genre_scores_gemma":[0.8900697,0.05855081,0.050151333,0.0008085887,0.00014752145,0.00017336763,0.000038777514,0.00004185791,0.000018002514],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981991,0.000025373478,0.00077840005,0.00044118945,0.0002638833,0.0002920321],"domain_scores_gemma":[0.9986795,0.00009029742,0.0005377381,0.0003037146,0.0002551601,0.00013354848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008752998,0.00027793273,0.0018001511,0.00005100163,0.00005085573,0.000005005049,0.00014070378,0.00005776008,0.000024282443],"category_scores_gemma":[0.00002221397,0.00023074573,0.00032115265,0.00029426106,0.00035406175,0.000082260296,0.000099963814,0.000039428534,8.684972e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016524568,0.03746694,0.053324446,0.043713506,0.02436109,0.00013015323,0.014144497,0.0012472256,0.057743922,0.037620652,0.008812299,0.7197828],"study_design_scores_gemma":[0.02913166,0.0642807,0.38394204,0.0031841411,0.029190032,0.00013180781,0.056916274,0.008227758,0.252862,0.004123469,0.16554637,0.0024637259],"about_ca_topic_score_codex":0.00007615179,"about_ca_topic_score_gemma":0.000005826524,"teacher_disagreement_score":0.7173191,"about_ca_system_score_codex":0.000016209733,"about_ca_system_score_gemma":0.000029935953,"threshold_uncertainty_score":0.9409538},"labels":[],"label_agreement":null},{"id":"W3091867553","doi":"10.1182/bloodadvances.2020001721","title":"Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; National Institute of Mental Health; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Proband; Telomere; Penetrance; Hematology; Internal medicine; Diamond–Blackfan anemia; Biology; Medicine; Dyskeratosis congenita; Immunology; Phenotype; Genetics; Mutation; Gene","score_opus":0.012854447468424074,"score_gpt":0.2666836753495976,"score_spread":0.2538292278811735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091867553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97531545,0.02212311,0.000050075687,0.0015495905,0.00002853411,0.00045938397,0.000022723852,0.00006379349,0.00038731936],"genre_scores_gemma":[0.988916,0.008694178,0.0017938511,0.00036539894,0.000065158936,0.00004982551,0.000013459871,0.000012261794,0.00008988204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990116,0.000040290935,0.00020210867,0.0004211706,0.00010234443,0.000222536],"domain_scores_gemma":[0.99951506,0.00013965543,0.00006235629,0.00011473357,0.000034704004,0.00013349776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031928244,0.00016391171,0.0003046477,0.000058147336,0.00006549809,0.0000089574705,0.000071806906,0.000058390917,0.00003351241],"category_scores_gemma":[0.00015080023,0.000107420004,0.000016240814,0.00025513998,0.00027193068,0.00018277645,0.00004694222,0.00013669714,0.0000033102833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010208855,0.00019991247,0.98043644,0.0010794997,0.000021621843,0.00014696096,0.0010308052,0.0000040113364,0.0009365571,0.00025135133,0.000008815962,0.014863155],"study_design_scores_gemma":[0.00529557,0.0021480683,0.9810526,0.0006946719,0.00017714789,0.00053536554,0.0039212015,0.00047948334,0.001682725,0.0004876966,0.0030542205,0.00047129535],"about_ca_topic_score_codex":0.000054320033,"about_ca_topic_score_gemma":0.00018230535,"teacher_disagreement_score":0.01439186,"about_ca_system_score_codex":0.0000029792307,"about_ca_system_score_gemma":0.00004401336,"threshold_uncertainty_score":0.43804607},"labels":[],"label_agreement":null},{"id":"W3091879967","doi":"10.1182/bloodadvances.2020002474","title":"Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Ottawa Hospital","funders":"","keywords":"Medicine; Chemotherapy; Lymphoma; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Radiation therapy; Palliative care; Oncology; Surgery","score_opus":0.01951592783642985,"score_gpt":0.29658823361944225,"score_spread":0.2770723057830124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091879967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939345,0.0001063417,0.000019386245,0.00030236854,0.00015806255,0.00039383685,0.00069075124,0.000040753926,0.0043539796],"genre_scores_gemma":[0.99786353,0.00018971648,0.00048775203,0.0004693538,0.00010267887,0.0000136556755,0.00058524974,0.000028111308,0.00025997468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980234,0.0001249236,0.00040288107,0.00044061537,0.00074883236,0.00025934706],"domain_scores_gemma":[0.99831325,0.00044135746,0.00013118408,0.00021956353,0.0006488964,0.0002457269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009982961,0.00017979355,0.00030646686,0.00010626395,0.0000502264,0.000020412288,0.00024129762,0.000055452925,0.000104228],"category_scores_gemma":[0.003086854,0.00015993541,0.00006209868,0.00023933909,0.00011021887,0.0001738551,0.00005739407,0.00018020952,0.0000720084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022040024,0.0065693003,0.9475163,0.00050840207,0.0002726121,0.00034309438,0.0020173388,0.0011445576,0.007904828,0.00006734346,0.00096606737,0.010650094],"study_design_scores_gemma":[0.07082805,0.029847099,0.5348133,0.0007631725,0.00028110822,0.00014869384,0.0015645598,0.01090732,0.34203932,0.00016418708,0.0074615115,0.001181679],"about_ca_topic_score_codex":0.000091828246,"about_ca_topic_score_gemma":0.0002832531,"teacher_disagreement_score":0.41270304,"about_ca_system_score_codex":0.00003266013,"about_ca_system_score_gemma":0.00012903237,"threshold_uncertainty_score":0.6521977},"labels":[],"label_agreement":null},{"id":"W3092073603","doi":"10.1182/bloodadvances.2020002904","title":"Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Instituto de Salud Carlos III; Associazione Italiana per la Ricerca sul Cancro; Deutsche Forschungsgemeinschaft; Agios Pharmaceuticals","keywords":"Midostaurin; Medicine; Internal medicine; Myeloid leukemia; Oncology; NPM1; Context (archaeology); Biology","score_opus":0.01202841802879141,"score_gpt":0.2649148928057713,"score_spread":0.2528864747769799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092073603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926261,0.0017567702,0.00006251741,0.0041671842,0.00003099774,0.0010736448,0.000082221166,0.000038734946,0.00016183511],"genre_scores_gemma":[0.9950206,0.0005365556,0.002617832,0.0010757996,0.00027522258,0.00011849546,0.00023683284,0.000029648681,0.000088989524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833304,0.00011788226,0.0003270604,0.00044057638,0.0004992865,0.00028214368],"domain_scores_gemma":[0.99895173,0.00037429723,0.00011439249,0.00028139626,0.000103187485,0.00017500426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012975982,0.00019499545,0.00041358074,0.00007964672,0.000107683016,0.000051587496,0.00018342066,0.00006712433,0.00006837814],"category_scores_gemma":[0.00036117242,0.00011920517,0.00005995381,0.00066140556,0.0001738805,0.0002565419,0.000080297206,0.00038521906,0.000017632754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07745413,0.0005716994,0.8757247,0.000111980255,0.0020582487,0.00047857288,0.0054180017,0.00019739837,0.0014463754,0.00007713714,0.00076653785,0.035695232],"study_design_scores_gemma":[0.35872886,0.0055771326,0.6058498,0.00030602972,0.0033767598,0.000018341132,0.0035822475,0.0020282774,0.006422236,0.00047673483,0.012786961,0.0008465914],"about_ca_topic_score_codex":0.00023191326,"about_ca_topic_score_gemma":0.00026709496,"teacher_disagreement_score":0.28127474,"about_ca_system_score_codex":0.00010525378,"about_ca_system_score_gemma":0.000357807,"threshold_uncertainty_score":0.48610458},"labels":[],"label_agreement":null},{"id":"W3092608642","doi":"10.1182/bloodadvances.2020002482","title":"Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Jewish General Hospital; McMaster University; McGill University; Impact; Cochrane","funders":"","keywords":"Systematic review; Medicine; MEDLINE; Risk assessment; Venous thromboembolism; Meta-analysis; Medical literature; Intensive care medicine; Family medicine; Internal medicine; Pathology","score_opus":0.08485540348015408,"score_gpt":0.3735121347667285,"score_spread":0.28865673128657443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092608642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83384585,0.1506286,0.0025720792,0.0018473096,0.00019396546,0.010065323,0.00004056546,0.00005952978,0.0007467979],"genre_scores_gemma":[0.8524332,0.13900834,0.006790746,0.0010286291,0.0000673992,0.0006292158,0.000018642866,0.000019690806,0.0000041423878],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9984695,0.00009798474,0.0006772631,0.000263382,0.00033015295,0.00016176637],"domain_scores_gemma":[0.99916506,0.000107023145,0.0003331901,0.00015869027,0.00006779064,0.0001682253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061731343,0.00013900749,0.0011114745,0.000046696954,0.00003115889,0.000011393697,0.00010020691,0.0000408697,0.000017375505],"category_scores_gemma":[0.0005708677,0.00010010754,0.00008416239,0.00012664846,0.000028638298,0.0002553479,0.000054541197,0.00007494781,6.786198e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020701674,0.009177408,0.18681353,0.71874565,0.0009778421,0.00003585643,0.006002331,0.00031715413,0.00012003914,0.034667138,0.0009165921,0.042019464],"study_design_scores_gemma":[0.09020563,0.031924523,0.3246523,0.31842628,0.019361177,0.000020344009,0.0068752742,0.15047991,0.00096523674,0.023641793,0.030282078,0.003165453],"about_ca_topic_score_codex":0.00002134414,"about_ca_topic_score_gemma":0.000016573093,"teacher_disagreement_score":0.40031934,"about_ca_system_score_codex":0.000014749834,"about_ca_system_score_gemma":0.000027206837,"threshold_uncertainty_score":0.4082267},"labels":[],"label_agreement":null},{"id":"W3092660013","doi":"10.1182/bloodadvances.2020002650","title":"Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Alberta","funders":"","keywords":"Cytokine storm; Immunology; Proinflammatory cytokine; Cytolysis; Natural killer cell; Cytokine; Interleukin; Interleukin 21; Interleukin 12; Medicine; IL-2 receptor; Biology; T cell; Disease; Inflammation; Coronavirus disease 2019 (COVID-19); Internal medicine; Immune system; Cytotoxicity; Cytotoxic T cell; Infectious disease (medical specialty)","score_opus":0.006811501531896344,"score_gpt":0.2133110984926539,"score_spread":0.20649959696075754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092660013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946409,0.00197782,0.000017994347,0.000309784,0.0009647533,0.00014465136,0.000003681904,0.000041177685,0.0018992495],"genre_scores_gemma":[0.99657905,0.00005887962,0.00001466308,0.00073496543,0.00001059989,0.0000036599856,0.000027969798,0.0000051837064,0.0025650214],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996347,0.000037152087,0.000067165915,0.00014113911,0.000019166006,0.00010069672],"domain_scores_gemma":[0.9998366,0.000034464065,0.000046082685,0.00005035705,0.000013925256,0.000018550863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000018433784,0.00007577072,0.000098968456,0.000023871575,0.00005137767,0.0000061752894,0.000035968453,0.000045867655,0.00036597697],"category_scores_gemma":[0.000029166811,0.000058555506,0.000013824967,0.000057745503,0.00003896519,0.00015569232,0.00001694579,0.00014297497,0.00012072071],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008037117,0.0015531293,0.83904845,0.0004445955,0.00032085786,0.00002346883,0.0026717857,0.00009903253,0.08353405,0.00011947363,0.04412181,0.020026231],"study_design_scores_gemma":[0.012521226,0.0011614668,0.19023731,0.000039109316,0.0000737406,0.000025942698,0.000368545,0.0000274964,0.024878826,0.000022132823,0.7701593,0.00048490183],"about_ca_topic_score_codex":0.000011994477,"about_ca_topic_score_gemma":0.000008049648,"teacher_disagreement_score":0.7260375,"about_ca_system_score_codex":0.000015468393,"about_ca_system_score_gemma":0.000024567931,"threshold_uncertainty_score":0.40071914},"labels":[],"label_agreement":null},{"id":"W3093284859","doi":"10.1182/bloodadvances.2020002623","title":"The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood groups and transfusion","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia, Okanagan Campus; International Collaboration On Repair Discoveries; University of British Columbia","funders":"National Institutes of Health; Michael Smith Health Research BC; Weston Brain Institute; Vancouver Coastal Health Research Institute; Heart and Stroke Foundation of Canada","keywords":"Medicine; ABO blood group system; Mechanical ventilation; Intensive care unit; Internal medicine; Comorbidity; Renal replacement therapy; Prospective cohort study; Cohort study","score_opus":0.0068508655913227445,"score_gpt":0.2349400243198143,"score_spread":0.22808915872849156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093284859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330187,0.003672183,0.0000957439,0.0024829488,0.000028642347,0.0003157826,0.000023657383,0.00002027939,0.00005889352],"genre_scores_gemma":[0.99703044,0.002321105,0.00027043413,0.00028768563,0.0000463145,0.000011602977,0.000014213331,0.000007870808,0.0000103643515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991937,0.00004758549,0.00021508134,0.00017671836,0.00025729073,0.00010960664],"domain_scores_gemma":[0.9993601,0.00016168779,0.00018690036,0.0000899646,0.000048196507,0.00015315821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017504883,0.00008867115,0.00020913793,0.000034172408,0.000067714805,0.000008137738,0.000043493405,0.000041618347,0.000006392571],"category_scores_gemma":[0.00022099612,0.000057410838,0.000029306872,0.00024108542,0.00007454536,0.00016532486,0.0000143593525,0.00010922585,2.4770046e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010380816,0.00041859775,0.98925185,0.00055510865,0.00009430743,0.000011205359,0.00072075904,0.000015552343,0.0044159596,0.00012135945,0.0000042240354,0.0033530174],"study_design_scores_gemma":[0.008708403,0.0009062765,0.9813612,0.0001594429,0.00069014414,0.0000044058183,0.0006991465,0.00006715621,0.0054642125,0.00014544127,0.0016957136,0.000098434204],"about_ca_topic_score_codex":0.00010679231,"about_ca_topic_score_gemma":0.0006101584,"teacher_disagreement_score":0.007890604,"about_ca_system_score_codex":0.000010897289,"about_ca_system_score_gemma":0.00006291771,"threshold_uncertainty_score":0.2341146},"labels":[],"label_agreement":null},{"id":"W3093553460","doi":"10.1182/bloodadvances.2020001742","title":"Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"Universität Wien; Medizinische Universität Wien; Austrian Science Fund; Celgene","keywords":"CD38; CD34; Stem cell; Myeloid leukemia; Bone marrow; Molecular biology; Antigen; Biology; Leukemia; CD33; Myeloid; Cancer research; Immunology; Cell biology","score_opus":0.016458255240048153,"score_gpt":0.2756455365045918,"score_spread":0.2591872812645436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093553460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875804,0.0103652105,0.0000710361,0.00096103776,0.00002560691,0.00087230036,0.000028353992,0.000023361172,0.000072681],"genre_scores_gemma":[0.9874683,0.0022802108,0.009805973,0.00012120409,0.00012931853,0.00006322184,0.000018673996,0.00002197543,0.00009110164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866325,0.00008267343,0.00036406596,0.00039107486,0.00026152996,0.0002374177],"domain_scores_gemma":[0.99942416,0.0001190488,0.000102866456,0.00011976036,0.000072173956,0.0001620202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020095697,0.00016234655,0.00038071786,0.00013949987,0.000032333257,0.000016492075,0.0000662118,0.00009582445,0.000009830261],"category_scores_gemma":[0.00012935659,0.00013180249,0.000018887173,0.00025991595,0.00013143914,0.0002583003,0.00011494683,0.00023156265,0.000001382613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006436544,0.00018206885,0.36541295,0.0014245037,0.00002278159,0.00009080381,0.0018128447,0.000024220231,0.60900354,0.000021330077,0.00018461207,0.021176701],"study_design_scores_gemma":[0.0065691993,0.000817328,0.027168738,0.0006438061,0.000048190577,0.000033766057,0.0022973828,0.003109349,0.9547107,0.000088258486,0.0042763506,0.00023690572],"about_ca_topic_score_codex":0.000028601646,"about_ca_topic_score_gemma":0.000018737192,"teacher_disagreement_score":0.34570718,"about_ca_system_score_codex":0.000024759816,"about_ca_system_score_gemma":0.00009135661,"threshold_uncertainty_score":0.53747493},"labels":[],"label_agreement":null},{"id":"W3093975417","doi":"10.1182/bloodadvances.2020002119","title":"Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Genentech; National Institutes of Health; Astellas Pharma; MacroGenics; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Memorial Sloan-Kettering Cancer Center; Gilead Sciences; Cardinal Health; Amgen; Pfizer; PTC Therapeutics; Celgene; Eli Lilly and Company; AstraZeneca; Agios Pharmaceuticals","keywords":"Ruxolitinib; Decitabine; Medicine; Myeloproliferative neoplasm; Internal medicine; Phases of clinical research; Confidence interval; Population; Clinical endpoint; Oncology; Gastroenterology; Clinical trial; Myelofibrosis; Surgery; Bone marrow","score_opus":0.019484069314681895,"score_gpt":0.3019457263841157,"score_spread":0.2824616570694338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093975417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704975,0.0007063018,0.0000035661137,0.0003029663,0.000013397221,0.0017117116,0.000052744326,0.000016168435,0.00014338738],"genre_scores_gemma":[0.99895513,0.00020648379,0.00040651477,0.00018291552,0.000026594249,0.00015896592,0.000038893006,0.000018373414,0.000006129419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859023,0.00006842171,0.0004224383,0.0004555101,0.00024008645,0.00022330771],"domain_scores_gemma":[0.99932486,0.00012341498,0.00013183712,0.000109786706,0.00012239446,0.000187736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062596955,0.00025322684,0.0006397184,0.00013066902,0.000041149327,0.000018445855,0.000039416576,0.000040515846,0.000021278267],"category_scores_gemma":[0.00009133528,0.00018107762,0.000015204746,0.00038893567,0.00008318498,0.00022900604,0.00003873626,0.0001497126,8.883671e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003572174,0.019160178,0.9592923,0.00009324877,0.00013438535,0.00013986624,0.0052215834,0.000010461697,0.00018582192,0.000025189232,0.0000037122886,0.012161088],"study_design_scores_gemma":[0.18705201,0.034474373,0.7664463,0.00026642892,0.00020123596,0.000008891214,0.0028996011,0.00017435908,0.008070604,0.000018062468,0.00013962231,0.00024854572],"about_ca_topic_score_codex":0.000029056602,"about_ca_topic_score_gemma":0.00028143983,"teacher_disagreement_score":0.19284603,"about_ca_system_score_codex":0.000016034082,"about_ca_system_score_gemma":0.000053868698,"threshold_uncertainty_score":0.7384131},"labels":[],"label_agreement":null},{"id":"W3094097256","doi":"10.1182/bloodadvances.2020002963","title":"Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; McMaster University; Impact","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine; Meta-analysis; Systematic review; Adverse effect; Heparin; Grading (engineering); Population; Thrombosis; Quality of evidence; Internal medicine","score_opus":0.3716175426913189,"score_gpt":0.46621626076382994,"score_spread":0.09459871807251102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094097256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036533893,0.98639804,0.000014869097,0.00007889265,0.00015289841,0.008281209,0.00004280223,0.00008729316,0.0049074558],"genre_scores_gemma":[0.0004621859,0.9938288,0.0032881377,0.00007971974,0.000101618134,0.001455634,0.0000530449,0.0001221585,0.0006087095],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99378407,0.0007500639,0.0030888242,0.0012258241,0.00064378395,0.000507416],"domain_scores_gemma":[0.99564695,0.00041010356,0.0020604657,0.0013647081,0.00011612644,0.0004016719],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00080240564,0.0012574812,0.0225088,0.00028859157,0.00011719276,0.000062702755,0.00055988843,0.0003387886,0.00019937736],"category_scores_gemma":[0.00025490986,0.0007499617,0.0026751007,0.0009692449,0.00013286101,0.00026595627,0.00043714934,0.0005726998,0.0001870807],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007701255,0.00026136133,0.0000035028963,0.85096055,0.047926772,0.00027206598,0.000053589138,5.2383037e-8,0.000045932466,0.00080255436,0.000029004264,0.09963693],"study_design_scores_gemma":[0.0004949192,0.00026932135,0.000007866291,0.055426087,0.42994055,0.0002723708,0.000052730313,5.4140213e-7,0.00017578379,0.000041639083,0.512802,0.0005161939],"about_ca_topic_score_codex":0.000020640597,"about_ca_topic_score_gemma":0.000008786487,"teacher_disagreement_score":0.79553443,"about_ca_system_score_codex":0.00007200897,"about_ca_system_score_gemma":0.00016884242,"threshold_uncertainty_score":0.99949515},"labels":[],"label_agreement":null},{"id":"W3095207098","doi":"10.1182/bloodadvances.2020003083","title":"Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Mechanical ventilation; Emergency department; Retrospective cohort study; Cohort; Emergency medicine; Venous thromboembolism; Venous thrombosis; Cohort study; Prospective cohort study; Pulmonary embolism; Thrombosis; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.01433636997892015,"score_gpt":0.273504135066946,"score_spread":0.25916776508802586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095207098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942378,0.0009005321,0.00004163997,0.00083879265,0.00006838667,0.0017994908,0.000024401212,0.00006416262,0.002024834],"genre_scores_gemma":[0.9973432,0.00016015636,0.0006955496,0.0015816197,0.000073377094,0.0000969991,0.000014183205,0.000026946034,0.000007999457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998408,0.000050880706,0.00035855456,0.00044983756,0.0004644369,0.00026824404],"domain_scores_gemma":[0.9991491,0.000034963396,0.00018886075,0.0002688104,0.00010882876,0.00024943476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010807422,0.00020161424,0.00087611785,0.000105261024,0.000057170797,0.000009862166,0.00014717673,0.000038851696,0.00010891544],"category_scores_gemma":[0.00027321014,0.00015765493,0.000054695793,0.0004944368,0.000088738896,0.00016669235,0.00006575158,0.00015868575,0.000008514144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009447843,0.009722085,0.9811075,0.0002731688,0.00027711567,0.0001284134,0.0067836726,0.00006616537,0.00008860734,0.00067415496,0.00009882361,0.0006858554],"study_design_scores_gemma":[0.006524699,0.0057000476,0.9838011,0.00008746134,0.000404317,0.0000014639344,0.0021634372,0.000003209354,0.00016817747,0.0004820324,0.00048722586,0.00017678914],"about_ca_topic_score_codex":0.00034353766,"about_ca_topic_score_gemma":0.0003376793,"teacher_disagreement_score":0.0064302203,"about_ca_system_score_codex":0.00007097278,"about_ca_system_score_gemma":0.00013080977,"threshold_uncertainty_score":0.6428981},"labels":[],"label_agreement":null},{"id":"W3097104656","doi":"10.1182/bloodadvances.2020002758","title":"Abortive γδTCR rearrangements suggest ILC2s are derived from T-cell precursors","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Mitacs; Emory University","keywords":"T-cell receptor; Innate lymphoid cell; Biology; Effector; Gene; T cell; Lineage (genetic); Receptor; Cell biology; Immune system; Gene rearrangement; Genetics; Immunology; Acquired immune system","score_opus":0.013167154898525945,"score_gpt":0.2116711150032622,"score_spread":0.19850396010473625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097104656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96942526,0.016905656,0.0000981338,0.00031176416,0.0008235883,0.00033508067,0.0038038571,0.00020018555,0.0080964705],"genre_scores_gemma":[0.99565643,0.001660196,0.00041215552,0.00076411065,0.00018073864,0.000038483857,0.00041558652,0.000029760722,0.00084256503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985635,0.00013487098,0.00028518678,0.00053197786,0.000059318598,0.00042514686],"domain_scores_gemma":[0.9992817,0.00010185586,0.00022910589,0.00023971783,0.000085362626,0.000062269595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000050287315,0.00026836622,0.00038054583,0.000036316167,0.00020543301,0.000018242763,0.00032044091,0.00018140532,0.00040794973],"category_scores_gemma":[0.00012844321,0.00024356856,0.00009266398,0.0001685156,0.00016974311,0.00023262716,0.00009400777,0.00027590856,0.0011723958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036692244,0.0005080215,0.034495063,0.00009568268,0.0004104642,0.00007161949,0.005049629,0.000013744166,0.95168084,0.00006603482,0.0041676187,0.0030743647],"study_design_scores_gemma":[0.0026859983,0.000351904,0.01201107,0.00006301915,0.00015908638,0.000004716738,0.002221957,9.582762e-7,0.6361475,0.00016251931,0.34583068,0.00036060976],"about_ca_topic_score_codex":0.00006570628,"about_ca_topic_score_gemma":0.00009826355,"teacher_disagreement_score":0.34166306,"about_ca_system_score_codex":0.000011218161,"about_ca_system_score_gemma":0.000052799143,"threshold_uncertainty_score":0.9996053},"labels":[],"label_agreement":null},{"id":"W3097417633","doi":"10.1182/bloodadvances.2020001802","title":"CD200 expression marks leukemia stem cells in human AML","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; McGill University; University Health Network; Western University","funders":"","keywords":"Myeloid leukemia; CD34; Leukemia; NPM1; Stem cell; Population; Biology; Haematopoiesis; Phenotype; Progenitor cell; Cancer research; Molecular biology; Immunology; Gene; Medicine; Genetics; Karyotype","score_opus":0.021576943423611123,"score_gpt":0.29392016912771074,"score_spread":0.27234322570409963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097417633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861916,0.002557075,0.00007427913,0.0010049,0.000072034614,0.00053452584,0.0000131103,0.00012434176,0.009428189],"genre_scores_gemma":[0.99421126,0.0005181533,0.0018193399,0.0009077639,0.0003998979,0.000043208875,0.000017640246,0.000042818872,0.002039906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998269,0.000077955796,0.000331264,0.0004628233,0.0004264744,0.00043244252],"domain_scores_gemma":[0.99918765,0.00008629798,0.00007724337,0.00029884165,0.00005093344,0.00029901275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001538112,0.00019394822,0.00037646756,0.0001052587,0.00007540818,0.000021632326,0.00024133066,0.00011499764,0.00039872862],"category_scores_gemma":[0.000042853288,0.00016182194,0.00007288491,0.0003556444,0.000084764775,0.00020927443,0.0001465928,0.0005378331,0.00014043614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003122042,0.00014432856,0.019694336,0.00040965562,0.000026247273,0.00073266594,0.0006937583,0.00012963449,0.9618464,0.00007096037,0.0063341726,0.009605617],"study_design_scores_gemma":[0.0050840094,0.00054183096,0.0026386823,0.00033100403,0.00004396716,0.000026039439,0.00086067355,0.00032846673,0.91622066,0.00006832577,0.07359038,0.00026592446],"about_ca_topic_score_codex":0.000026692238,"about_ca_topic_score_gemma":0.0000124468115,"teacher_disagreement_score":0.06725621,"about_ca_system_score_codex":0.00018048777,"about_ca_system_score_gemma":0.00021745356,"threshold_uncertainty_score":0.6598907},"labels":[],"label_agreement":null},{"id":"W3098767142","doi":"10.1182/bloodadvances.2020001658","title":"Processing methods and storage duration impact extracellular vesicle counts in red blood cell units","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Platelet; Red blood cell; Extracellular vesicle; Extracellular vesicles; Whole blood; Flow cytometry; Blood cell; Andrology; Chemistry; Immunology; Medicine; Biology; Biochemistry; Microvesicles","score_opus":0.029182467626455297,"score_gpt":0.32509560602777576,"score_spread":0.29591313840132044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098767142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769573,0.018394852,0.0012452091,0.000329893,0.00008314871,0.00017743591,0.0000039793226,0.00005633308,0.0027517995],"genre_scores_gemma":[0.989931,0.0005120601,0.00883247,0.00025891938,0.00013651769,0.000005176626,0.000016387938,0.000011717009,0.00029575313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945986,0.00006314424,0.00014105283,0.0001670703,0.00006440537,0.000104493854],"domain_scores_gemma":[0.9997249,0.000033163356,0.000063963394,0.00006163309,0.00004083207,0.000075508935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000947387,0.00008121268,0.0001594403,0.000034297005,0.00003355325,0.000008739293,0.000023058186,0.000047596004,0.00008463111],"category_scores_gemma":[0.00009128104,0.0000675754,0.000016297616,0.0002285209,0.000027217202,0.000118930635,0.000009692123,0.00011254346,0.000008441574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017747981,0.00014950319,0.0074064275,0.0002948987,0.000017104487,0.00007993135,0.00063499936,0.00005875294,0.9706856,0.000022196109,0.00012057462,0.020352526],"study_design_scores_gemma":[0.017928105,0.005137818,0.06619898,0.00052990584,0.0008767248,0.00042542812,0.0025241033,0.013731245,0.746302,0.00066066225,0.14461002,0.001075018],"about_ca_topic_score_codex":0.000002438659,"about_ca_topic_score_gemma":0.000001301435,"teacher_disagreement_score":0.22438361,"about_ca_system_score_codex":0.0000069102534,"about_ca_system_score_gemma":0.000056717134,"threshold_uncertainty_score":0.27556446},"labels":[],"label_agreement":null},{"id":"W3099852263","doi":"10.1182/bloodadvances.2020002814","title":"A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Dalhousie University; University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; International Prognostic Index; Confidence interval; Retrospective cohort study; Oncology; Framingham Risk Score; Proportional hazards model; Refractory (planetary science); Transplantation; Cohort; Gastroenterology; Lymphoma; Diffuse large B-cell lymphoma; Disease","score_opus":0.0380345259632921,"score_gpt":0.3125265435253339,"score_spread":0.2744920175620418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099852263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98390794,0.012653018,0.0016445831,0.0002091563,0.0001094343,0.0007275606,0.0004894104,0.000077057135,0.0001818485],"genre_scores_gemma":[0.97322106,0.017040845,0.0091206655,0.00022911253,0.00017968523,0.0000979835,0.00006033529,0.000027007762,0.000023296929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861896,0.00005908583,0.0004183098,0.00048792578,0.00017390907,0.00024182857],"domain_scores_gemma":[0.9983273,0.00071687053,0.00042423804,0.0001656352,0.000068340414,0.00029760532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001232343,0.00024709574,0.00050737464,0.000030505624,0.00016905334,0.000021425927,0.000070481496,0.00011563154,0.0000075305807],"category_scores_gemma":[0.0009929764,0.00015713209,0.00020150833,0.000069220696,0.000101573336,0.00015261595,0.00002673996,0.00023280423,0.0000030895765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040602736,0.00054396695,0.9705836,0.00013021906,0.0003474443,0.000052896794,0.0013637899,0.00009132688,0.000051878156,0.000077201024,0.00013730279,0.026214352],"study_design_scores_gemma":[0.04674272,0.015226846,0.7788328,0.0025390254,0.009702876,0.00009995388,0.0028631487,0.11916307,0.011774668,0.0017724797,0.009899917,0.001382495],"about_ca_topic_score_codex":0.000060579318,"about_ca_topic_score_gemma":0.00006979064,"teacher_disagreement_score":0.1917508,"about_ca_system_score_codex":0.000020452526,"about_ca_system_score_gemma":0.00009040079,"threshold_uncertainty_score":0.6407661},"labels":[],"label_agreement":null},{"id":"W3102785656","doi":"10.1182/bloodadvances.2020002727","title":"Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in <i>BCR-ABL</i>–negative MPN in blast phase","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Hazard ratio; Cumulative incidence; Internal medicine; Medicine; Oncology; Transplantation; Incidence (geometry); Proportional hazards model; Gastroenterology; Confidence interval","score_opus":0.025070125697652934,"score_gpt":0.29864880761343404,"score_spread":0.2735786819157811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102785656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965552,0.0015033197,0.000016415188,0.0007865566,0.000092021495,0.0007535577,0.000047479807,0.00002562608,0.00021978923],"genre_scores_gemma":[0.9974723,0.00073604233,0.0013280205,0.00014874882,0.00008681948,0.000115846924,0.000020014188,0.000027963966,0.00006428379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844605,0.00008259802,0.0005135588,0.00044025574,0.0002467779,0.00027075774],"domain_scores_gemma":[0.9992856,0.00014705854,0.00019083411,0.00017631821,0.000058175996,0.00014201281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057520225,0.00029136724,0.0006856729,0.00014237297,0.000030369858,0.000009460838,0.00008369134,0.00006902245,0.00012188142],"category_scores_gemma":[0.00016586599,0.0002151758,0.00011458335,0.000331301,0.00010123487,0.00014245156,0.00003197259,0.00014727195,0.000011545477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030345086,0.001988131,0.96676683,0.00008672596,0.00016653603,0.00011824448,0.0022882947,0.00021147306,0.023432085,0.000010808744,0.000014209175,0.0046132314],"study_design_scores_gemma":[0.0105414335,0.0023299651,0.60866237,0.00018962336,0.00019493308,0.000021004196,0.0011139895,0.00008788568,0.37607545,0.000063604384,0.00048065273,0.00023910993],"about_ca_topic_score_codex":0.00007737165,"about_ca_topic_score_gemma":0.00049557834,"teacher_disagreement_score":0.35810447,"about_ca_system_score_codex":0.00004258262,"about_ca_system_score_gemma":0.00007077394,"threshold_uncertainty_score":0.87746143},"labels":[],"label_agreement":null},{"id":"W3107792394","doi":"10.1182/bloodadvances.2020003314","title":"Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Astex Pharmaceuticals; Jazz Pharmaceuticals; Medical Research Council; Celgene; Gilead Sciences; Alexion Pharmaceuticals; Astellas Pharma; TG Therapeutics; Pfizer; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Adverse effect; Anemia; Pharmacokinetics; Internal medicine; Randomized controlled trial; Pharmacodynamics; Gastroenterology; Bone marrow","score_opus":0.05893450828529068,"score_gpt":0.3189789532074175,"score_spread":0.2600444449221268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107792394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801775,0.0014893454,0.0000041290214,0.015240115,0.00021313004,0.0013104916,0.00020557603,0.000039841412,0.0013198435],"genre_scores_gemma":[0.994329,0.0011767166,0.0022850197,0.0014735663,0.00039918904,0.00021243238,0.0000784174,0.000025275194,0.000020383693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979958,0.0001981663,0.0007072455,0.00046244136,0.0003338506,0.00030251005],"domain_scores_gemma":[0.99679625,0.0023447953,0.00031852943,0.0003564349,0.00007291125,0.000111097375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027585577,0.00025491766,0.00055984734,0.000036223,0.00015469868,0.000031711286,0.0002041258,0.00006746389,0.00004212636],"category_scores_gemma":[0.0014956251,0.00013783504,0.00015388403,0.0003287671,0.000084217005,0.00017066264,0.00007710478,0.0002604698,0.000008033016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12209039,0.0031525637,0.48968896,0.00017917245,0.0008501784,0.00018132557,0.019375974,0.00014600367,0.007875241,0.00051067595,0.0012739644,0.35467556],"study_design_scores_gemma":[0.40207574,0.0098751495,0.40721557,0.0016933893,0.0009865235,0.0000118605785,0.007905834,0.00019097488,0.12891997,0.0006759202,0.0397156,0.00073349226],"about_ca_topic_score_codex":0.000039898165,"about_ca_topic_score_gemma":0.00015755492,"teacher_disagreement_score":0.35394207,"about_ca_system_score_codex":0.000027236187,"about_ca_system_score_gemma":0.00007629508,"threshold_uncertainty_score":0.562075},"labels":[],"label_agreement":null},{"id":"W3110039915","doi":"10.1182/bloodadvances.2020002646","title":"Mesenchymal stromal cells in hematopoietic cell transplantation","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Mesenchymal stem cell; Transplantation; Immunology; Stromal cell; Paracrine signalling; Hematopoietic stem cell transplantation; Cell therapy; Biology; Haematopoiesis; Graft-versus-host disease; Cancer research; Immune system; Stem cell; Bone marrow; Context (archaeology); Medicine; Cell biology; Internal medicine; Receptor","score_opus":0.03707227384673804,"score_gpt":0.3488574601570446,"score_spread":0.31178518631030655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110039915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014148884,0.9856968,0.000025382016,0.00004793664,0.00017740225,0.0017595618,0.00007370035,0.00006606182,0.012011663],"genre_scores_gemma":[0.00027265903,0.9965779,0.0011091063,0.000023643735,0.00028594612,0.00016974003,0.00016634895,0.00008653265,0.0013081166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660057,0.00024566083,0.0009252514,0.0007954751,0.0008161761,0.0006168518],"domain_scores_gemma":[0.998581,0.00036383912,0.00026388894,0.00038016096,0.000049872757,0.0003612534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026634062,0.00054089125,0.0022603564,0.00032555423,0.000048042202,0.000035527984,0.00032951956,0.00031962272,0.0003375288],"category_scores_gemma":[0.00005005922,0.00043234398,0.00045510035,0.00078151945,0.000084853964,0.00014273552,0.000058288588,0.0009565836,0.00046497173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008622818,0.00059778744,0.00016326184,0.24060582,0.00013068199,0.0063713053,0.0002863453,0.0000033635185,0.00026694214,0.00007609365,0.00011323658,0.7512989],"study_design_scores_gemma":[0.0011669323,0.0004275189,0.00001563818,0.013443926,0.0012026313,0.0004671289,0.00006227365,0.0000040791138,0.0011896734,0.000018519231,0.9815999,0.00040172902],"about_ca_topic_score_codex":0.000014879382,"about_ca_topic_score_gemma":0.000016700727,"teacher_disagreement_score":0.98148674,"about_ca_system_score_codex":0.000082586244,"about_ca_system_score_gemma":0.00057887833,"threshold_uncertainty_score":0.99981284},"labels":[],"label_agreement":null},{"id":"W3111140326","doi":"10.1182/bloodadvances.2020003170","title":"Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Hydroxychloroquine; Internal medicine; Multiple myeloma; Hematologic disease; Hematology; Disease; Cancer; Incidence (geometry); Intensive care medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.19364041496145148,"score_gpt":0.4618986584622338,"score_spread":0.2682582435007823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111140326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218724,0.0057176286,0.0000723175,0.070320085,0.000033026943,0.0009425704,0.00084767776,0.00004106658,0.00015325255],"genre_scores_gemma":[0.98951185,0.0005085653,0.0012374568,0.0083761765,0.000057327004,0.00002039221,0.00024068108,0.000011488191,0.000036042016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982798,0.00013726823,0.00031234114,0.00042567152,0.00060604286,0.0002388741],"domain_scores_gemma":[0.9970031,0.0014244543,0.0002007143,0.00062517484,0.00040194372,0.00034462867],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00043138833,0.00012773775,0.00043537983,0.000037355618,0.00016847806,0.000021030302,0.00023831465,0.000048085418,0.000031586966],"category_scores_gemma":[0.009054977,0.00006718324,0.000016961309,0.0004688755,0.0003620643,0.00019257535,0.00024699137,0.00019362125,0.0000021075775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004113524,0.00012970853,0.9935181,0.00030181982,0.00009653283,0.0002259847,0.001968445,0.0000016271538,0.000054089738,0.000071664275,0.002874866,0.0003457692],"study_design_scores_gemma":[0.0027993135,0.0009716197,0.917089,0.00013360543,0.00013912201,0.000023236966,0.003674913,0.000007674902,0.00056477723,0.00041574074,0.07406405,0.00011697346],"about_ca_topic_score_codex":0.00046972526,"about_ca_topic_score_gemma":0.0007596499,"teacher_disagreement_score":0.07642917,"about_ca_system_score_codex":0.00002150009,"about_ca_system_score_gemma":0.0011374566,"threshold_uncertainty_score":0.9992922},"labels":[],"label_agreement":null},{"id":"W3111394247","doi":"10.1182/bloodadvances.2020002827","title":"A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Cilag; National Cancer Institute; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Multiple myeloma; Term (time); Negativity effect; Meta-analysis; Oncology; Internal medicine; Survival analysis; Medicine; Psychology; Developmental psychology","score_opus":0.04332111366551855,"score_gpt":0.34186931996023096,"score_spread":0.2985482062947124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111394247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019626502,0.9770841,0.0000066099683,0.000043909968,0.0000225401,0.002373925,0.00068482757,0.000020857087,0.00013674085],"genre_scores_gemma":[0.18259609,0.8155765,0.0003386547,0.000016056147,0.00002799223,0.0006100949,0.00067594514,0.00006046132,0.00009821387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635726,0.0005841624,0.0008715783,0.00068896456,0.00095167157,0.0005463684],"domain_scores_gemma":[0.99727726,0.0011590053,0.0005451494,0.0007140194,0.00012330404,0.00018129084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036723915,0.00059081713,0.005840371,0.00052362215,0.000054235334,0.000034946002,0.00038492144,0.00013281257,0.00009627027],"category_scores_gemma":[0.0006266502,0.00028100508,0.0014588928,0.001898579,0.00011931533,0.00024780125,0.00017520486,0.0005067838,0.00000857539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001345859,0.0016689237,0.8151978,0.0020902655,0.05345762,0.0001237919,0.00007954464,0.0000018484861,5.3578493e-8,0.000005526409,2.6953123e-7,0.12723972],"study_design_scores_gemma":[0.00521406,0.00043675647,0.8160087,0.000681098,0.15462582,0.000002206287,0.00007253313,0.000009396179,0.000009869166,0.0000106409125,0.022593472,0.0003354893],"about_ca_topic_score_codex":0.00026027055,"about_ca_topic_score_gemma":0.008955328,"teacher_disagreement_score":0.16296959,"about_ca_system_score_codex":0.00006723835,"about_ca_system_score_gemma":0.00021887277,"threshold_uncertainty_score":0.99996424},"labels":[],"label_agreement":null},{"id":"W3111429272","doi":"10.1182/bloodadvances.2020002456","title":"The evolution of factor XI and the kallikrein-kinin system","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; British Heart Foundation","keywords":"Prekallikrein; Factor XII; Zymogen; Kallikrein; Hemostasis; Biology; High-molecular-weight kininogen; Coagulation; Kininogen; Thrombin; Internal medicine; Endocrinology; Immunology; Biochemistry; Platelet; Medicine; Enzyme","score_opus":0.010214525132050449,"score_gpt":0.23046449895781923,"score_spread":0.22024997382576877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111429272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8214066,0.16393965,0.0006644773,0.0089384755,0.00035441018,0.000835229,0.000025358844,0.0001447594,0.0036910535],"genre_scores_gemma":[0.9986164,0.00061508093,0.00011788896,0.0001346933,0.0002569504,0.000012335959,0.0000024369456,0.000009278603,0.00023491691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924207,0.00004665804,0.0002395908,0.00014631372,0.00019719606,0.00012820306],"domain_scores_gemma":[0.9993149,0.00027489444,0.00013716488,0.00014773067,0.00005906994,0.00006624954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001224129,0.00009512242,0.00022205302,0.000013689434,0.00015270346,0.000016180726,0.000085989894,0.000030917297,0.000007976485],"category_scores_gemma":[0.00015187195,0.00004772168,0.000070995295,0.00012634884,0.00020976456,0.00008124434,0.000029197809,0.00006541544,0.0000049112427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029315269,0.00023607718,0.5656473,0.0021169058,0.000922429,0.000031667434,0.011067926,0.00012569051,0.009386513,0.32754898,0.00095473754,0.07903023],"study_design_scores_gemma":[0.027373707,0.0017602363,0.71525127,0.0013476909,0.0018320607,0.00023143485,0.024592146,0.008890715,0.03546836,0.0037951602,0.17865995,0.00079730013],"about_ca_topic_score_codex":0.00004648866,"about_ca_topic_score_gemma":0.000024246992,"teacher_disagreement_score":0.3237538,"about_ca_system_score_codex":0.000013033334,"about_ca_system_score_gemma":0.00004768253,"threshold_uncertainty_score":0.19460337},"labels":[],"label_agreement":null},{"id":"W3111589245","doi":"10.1182/bloodadvances.2020003269","title":"A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital; University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"Thrombosis; Medicine; Pooling; Data collection; Antithrombotic; Venous thrombosis; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Clinical research; Hematology; Myocardial infarction; Incidence (geometry); Internal medicine; Disease; Computer science; Infectious disease (medical specialty)","score_opus":0.3751994338490369,"score_gpt":0.5802635733872529,"score_spread":0.20506413953821595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111589245","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.335691,0.105037734,0.004940635,0.53724176,0.0015365187,0.0139518455,0.00078280334,0.00036505406,0.00045260653],"genre_scores_gemma":[0.9149414,0.07307336,0.0023531448,0.008876946,0.00028736456,0.00023747537,0.000045807097,0.000021435593,0.00016312393],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768025,0.0001524379,0.0009938198,0.0005096597,0.0004051746,0.00025864568],"domain_scores_gemma":[0.9767161,0.022070913,0.0002715939,0.00054279447,0.00020474134,0.00019387314],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020016266,0.00013338872,0.000669919,0.00005060842,0.0001427312,0.000008438478,0.00039740215,0.000060856968,0.000032775402],"category_scores_gemma":[0.18151881,0.000083492734,0.000121814424,0.00060060155,0.0004453381,0.00016899085,0.0005318306,0.00028205712,0.0000047125395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002935476,0.0018661809,0.9359367,0.00382707,0.0039837616,0.000028690512,0.0021110785,0.00035038136,0.00040591237,0.0002819341,0.017777687,0.030495146],"study_design_scores_gemma":[0.044228144,0.01035881,0.20975985,0.001022732,0.0029415803,0.0000023733942,0.008022542,0.0138062965,0.0005633925,0.004260402,0.7044647,0.00056919025],"about_ca_topic_score_codex":0.000039028295,"about_ca_topic_score_gemma":0.00019902336,"teacher_disagreement_score":0.72617686,"about_ca_system_score_codex":0.000048236878,"about_ca_system_score_gemma":0.00046541367,"threshold_uncertainty_score":0.8253756},"labels":[],"label_agreement":null},{"id":"W3111623305","doi":"10.1182/bloodadvances.2020002977","title":"Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Bleed; Single Center; Dosing; Titer; Recombinant factor VIIa; Cohort; Internal medicine; Concomitant; Hemostatics; Recombinant DNA; Thrombosis; Hemostasis; Gastroenterology; Surgery; Immunology; Antibody","score_opus":0.04825481812712677,"score_gpt":0.30217234928884096,"score_spread":0.25391753116171417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111623305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877069,0.002536177,0.000010726103,0.0056499746,0.00021955311,0.002548114,0.00009342237,0.00008610625,0.0011490305],"genre_scores_gemma":[0.994456,0.0008348855,0.002300675,0.00042501182,0.00019968458,0.00044700602,0.00041689226,0.000044554523,0.00087527075],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798137,0.000032548094,0.0004581886,0.0006376617,0.0003299658,0.0005602736],"domain_scores_gemma":[0.9990988,0.0001544574,0.00008680065,0.0002533513,0.00007051054,0.000336131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007692269,0.00030907025,0.00068193435,0.000118876844,0.00009443504,0.000024704008,0.00011212627,0.000098028686,0.00016446048],"category_scores_gemma":[0.0001294427,0.00022438672,0.00017192567,0.0003078533,0.000072661926,0.0001300337,0.00005127606,0.00008265866,0.00003358925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036362445,0.0075220936,0.88416284,0.00022265567,0.00063183525,0.0005867538,0.0017489252,0.000008586298,0.06461739,0.000037866103,0.00080102443,0.036023766],"study_design_scores_gemma":[0.10691184,0.037507985,0.09962256,0.001313859,0.0016711025,0.00010355952,0.0016238246,0.000872584,0.5991683,0.0009626734,0.14883849,0.001403225],"about_ca_topic_score_codex":0.00006216561,"about_ca_topic_score_gemma":0.000046638914,"teacher_disagreement_score":0.7845403,"about_ca_system_score_codex":0.00020393501,"about_ca_system_score_gemma":0.0001159113,"threshold_uncertainty_score":0.9150225},"labels":[],"label_agreement":null},{"id":"W3111703281","doi":"10.1182/bloodadvances.2020002712","title":"Acute erythroid leukemia is enriched in <i>NUP98</i> fusions: a report from the Children’s Oncology Group","year":2020,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Hematopathology; Myeloid leukemia; Leukemia; Myeloid; Myelodysplastic syndromes; Oncology; Internal medicine; Cancer research; Medicine; Karyotype; Biology; Cytogenetics; Bone marrow; Genetics; Gene; Chromosome","score_opus":0.0176872080017864,"score_gpt":0.3056332826538567,"score_spread":0.2879460746520703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111703281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357666,0.013017444,0.00020057747,0.04543171,0.00017891178,0.0012384421,0.000105869134,0.00017037874,0.0038900864],"genre_scores_gemma":[0.9499902,0.010185228,0.006239095,0.030834662,0.0015385081,0.00024199678,0.0003723584,0.00007895183,0.00051897153],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972681,0.00015656208,0.0006327579,0.0007933703,0.0005813578,0.0005678859],"domain_scores_gemma":[0.9981514,0.0005527008,0.0002244779,0.0006779719,0.00008774264,0.00030567384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032937794,0.00029379316,0.00066226453,0.0000733758,0.00014191541,0.000031687865,0.0004819446,0.00020790963,0.00034047183],"category_scores_gemma":[0.00073244283,0.00019997302,0.00016231943,0.0007180792,0.0002475035,0.0002463139,0.00034708684,0.0010203226,0.00015435634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003315473,0.0013525023,0.5314562,0.00012690829,0.0021392887,0.021695953,0.010521396,0.000035918176,0.19885597,0.00027502823,0.11990942,0.11031596],"study_design_scores_gemma":[0.023322051,0.002607258,0.25345674,0.00026509713,0.0013338239,0.0042554303,0.0026285497,0.00058586366,0.021567987,0.0016424579,0.6873463,0.0009884891],"about_ca_topic_score_codex":0.00081081316,"about_ca_topic_score_gemma":0.00033948396,"teacher_disagreement_score":0.5674368,"about_ca_system_score_codex":0.00037396763,"about_ca_system_score_gemma":0.00087956566,"threshold_uncertainty_score":0.8154663},"labels":[],"label_agreement":null},{"id":"W3119244553","doi":"10.1182/bloodadvances.2020002995","title":"Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC","funders":"Broad Institute","keywords":"Notch signaling pathway; Biology; Cancer research; Lymphoma; Diffuse large B-cell lymphoma; Chronic lymphocytic leukemia; B cell; Splenic marginal zone lymphoma; Signal transduction; Cell biology; Leukemia; Immunology; Antibody","score_opus":0.02571232708116198,"score_gpt":0.33115807238932454,"score_spread":0.30544574530816254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119244553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396306,0.0022760378,0.000082890074,0.0024500631,0.00001998879,0.0006028059,0.000012600651,0.000013277963,0.0005793003],"genre_scores_gemma":[0.99655217,0.00050244026,0.0021309927,0.00030985416,0.000057887828,0.00020638289,0.000042261025,0.000020187534,0.00017781535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987649,0.000040195187,0.00033016122,0.00038423543,0.00016433129,0.00031622176],"domain_scores_gemma":[0.99897265,0.00055840117,0.00006530591,0.0002207036,0.00011320674,0.00006972356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022155755,0.00012275697,0.00028722055,0.00019829144,0.000038062135,0.00001953416,0.00007846796,0.00007453446,0.000015007416],"category_scores_gemma":[0.00036630462,0.00012243964,0.000037074435,0.0006812493,0.000044953482,0.00020000982,0.000054524317,0.00019535133,0.0000020645587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054927234,0.002540065,0.40623093,0.0019722714,0.00004224651,0.0002314004,0.0055973334,0.0009282566,0.5504006,0.00057780044,0.00011249504,0.03081733],"study_design_scores_gemma":[0.04901135,0.00027550192,0.08725755,0.0012294123,0.000045028053,0.000099611796,0.0037648517,0.0034788314,0.8493652,0.0027486486,0.0023738206,0.00035020246],"about_ca_topic_score_codex":0.0004390748,"about_ca_topic_score_gemma":0.0014577421,"teacher_disagreement_score":0.31897336,"about_ca_system_score_codex":0.0013504142,"about_ca_system_score_gemma":0.0018217267,"threshold_uncertainty_score":0.49929437},"labels":[],"label_agreement":null},{"id":"W3120545968","doi":"10.1182/bloodadvances.2020003264","title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":367,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Impact","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Guideline; Desmopressin; Intensive care medicine; Von Willebrand disease; Multidisciplinary approach; Context (archaeology); Family medicine; Von Willebrand factor; Internal medicine; Pathology","score_opus":0.019049406160299463,"score_gpt":0.2969092868152321,"score_spread":0.2778598806549326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120545968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94007045,0.032557216,0.000021607,0.008103133,0.00018088621,0.0003337854,0.000043917138,0.000018493154,0.018670486],"genre_scores_gemma":[0.9669977,0.017509608,0.0024249554,0.0014930908,0.00011693342,0.00005072443,0.000091880414,0.000021126258,0.01129397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992222,0.000016637001,0.00018681167,0.00020624959,0.00023373781,0.00013433352],"domain_scores_gemma":[0.9994575,0.0000317113,0.000060174523,0.00029337112,0.00008710903,0.000070138136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050486986,0.000113904156,0.0002015237,0.000020786407,0.000057924102,0.000009132615,0.000058800484,0.000016436808,0.0002660357],"category_scores_gemma":[0.000037616224,0.00006826301,0.00008647158,0.00013538745,0.00003642914,0.00004650343,0.000033910754,0.00004311281,0.00002490683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026904691,0.014422948,0.18042699,0.003301661,0.008369205,0.031198084,0.00047252144,0.00060885656,0.0030401659,0.0298912,0.030789731,0.69478816],"study_design_scores_gemma":[0.017995706,0.000935964,0.089126706,0.003748529,0.0042999047,0.00013234331,0.0025313229,0.00014933968,0.043119658,0.012864038,0.8243974,0.0006991153],"about_ca_topic_score_codex":0.0000031044565,"about_ca_topic_score_gemma":0.0000068929708,"teacher_disagreement_score":0.79360765,"about_ca_system_score_codex":0.000005859277,"about_ca_system_score_gemma":0.000030135308,"threshold_uncertainty_score":0.29129043},"labels":[],"label_agreement":null},{"id":"W3121114429","doi":"10.1182/bloodadvances.2020003265","title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":542,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Guideline; Von Willebrand disease; Grading (engineering); Multidisciplinary approach; MEDLINE; Family medicine; Intensive care medicine; Disease; Von Willebrand factor; Pathology; Internal medicine","score_opus":0.02462713352040196,"score_gpt":0.3049519138868048,"score_spread":0.28032478036640285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121114429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948293,0.03816948,0.0000044152416,0.009900169,0.00013935557,0.00019994423,0.00007069068,0.000013772245,0.0032092044],"genre_scores_gemma":[0.9786755,0.01687161,0.00050898275,0.0015491248,0.00013856859,0.000073606876,0.00006894884,0.000016566924,0.0020970758],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999174,0.000026570058,0.00020760624,0.00021694381,0.00023010482,0.00014474729],"domain_scores_gemma":[0.9992702,0.00013833129,0.00007284773,0.00028922685,0.00013804523,0.0000913483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005190269,0.00012597341,0.0002585328,0.000024984758,0.000067165536,0.0000103803595,0.000059896138,0.000024879695,0.0004187363],"category_scores_gemma":[0.00042158822,0.000074784206,0.000112017435,0.00015593923,0.000051576,0.00006155661,0.00002577947,0.000057409045,0.000023274228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059793243,0.0051110024,0.8373317,0.0003510713,0.0010076213,0.003801652,0.00020277407,0.00011565659,0.0010800416,0.0017694756,0.019858716,0.12877233],"study_design_scores_gemma":[0.012946714,0.0011671975,0.13346504,0.0022870714,0.0025648684,0.00012270606,0.0011236182,0.00009270463,0.14195588,0.007904586,0.6957208,0.00064879627],"about_ca_topic_score_codex":0.000010003103,"about_ca_topic_score_gemma":0.000028947072,"teacher_disagreement_score":0.70386666,"about_ca_system_score_codex":0.0000058211835,"about_ca_system_score_gemma":0.00007104069,"threshold_uncertainty_score":0.4584869},"labels":[],"label_agreement":null},{"id":"W3123702139","doi":"10.1182/bloodadvances.2020002833","title":"Rapid removal of phagosomal ferroportin in macrophages contributes to nutritional immunity","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Phagosome; Phagocytosis; Cell biology; Transferrin receptor; Ferroportin; Biology; Transport protein; Innate immune system; Endocytosis; Macrophage; Transferrin; Receptor; Biochemistry; Immunology; Inflammation; Hepcidin","score_opus":0.011307054936487173,"score_gpt":0.2803678707847892,"score_spread":0.26906081584830205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123702139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90962857,0.08506138,0.000065997396,0.0010457655,0.0001367406,0.00018090243,0.000048101083,0.000018792432,0.0038137625],"genre_scores_gemma":[0.9888604,0.0028493067,0.007073899,0.0005789842,0.000082569175,0.000016890463,0.0000807898,0.000010972645,0.0004461445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990066,0.00005939173,0.00033661275,0.00018929684,0.00020054399,0.00020754083],"domain_scores_gemma":[0.9994439,0.00007211605,0.000069980844,0.00019200493,0.00015139056,0.00007060605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013918879,0.00010743923,0.0003565473,0.000118856035,0.000036300484,0.000006601541,0.000070009024,0.00004594017,0.00029040643],"category_scores_gemma":[0.0004144162,0.00010081743,0.00007707685,0.00040314544,0.00007657002,0.00008918643,0.000043766424,0.00011482388,0.000009841072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002409268,0.008541536,0.27591422,0.0017682641,0.00018732098,0.0046691285,0.000785316,0.00010175686,0.5809454,0.012965428,0.0010227837,0.11068961],"study_design_scores_gemma":[0.010890468,0.0002339122,0.36023703,0.0002771636,0.00017131564,0.00037445524,0.0020232599,0.0000037285733,0.54629964,0.0019481011,0.07732016,0.00022074381],"about_ca_topic_score_codex":0.000030025427,"about_ca_topic_score_gemma":0.00005239387,"teacher_disagreement_score":0.11046887,"about_ca_system_score_codex":0.000008094047,"about_ca_system_score_gemma":0.00012879723,"threshold_uncertainty_score":0.41112155},"labels":[],"label_agreement":null},{"id":"W3123961624","doi":"10.1182/bloodadvances.2020003712","title":"Specifications of the variant curation guidelines for <i>ITGA2B</i>/<i>ITGB3</i>: ClinGen Platelet Disorder Variant Curation Panel","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Human Genome Research Institute; University of North Carolina at Chapel Hill; National Institutes of Health; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research","keywords":"Medical genetics; Context (archaeology); Concordance; Genetics; Computational biology; Genomics; Bioinformatics; Biology; Medicine; Gene; Genome","score_opus":0.05521978043006399,"score_gpt":0.2995825097296057,"score_spread":0.24436272929954173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123961624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7787232,0.06599703,0.13608873,0.010674294,0.0025610756,0.0020504184,0.0020759914,0.000050769657,0.0017785067],"genre_scores_gemma":[0.9745307,0.006551229,0.015072686,0.0006902295,0.00083716295,0.00013185068,0.0011822537,0.000035032954,0.00096885243],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903053,0.000040643146,0.00037116805,0.0003065444,0.000106041545,0.00014508692],"domain_scores_gemma":[0.9988077,0.000024089275,0.00020765908,0.00038144444,0.00054047874,0.000038587048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010247425,0.00012606903,0.0001319753,0.000015562022,0.00016616452,0.000028484561,0.00017408992,0.0000748398,0.0000115376415],"category_scores_gemma":[0.00033901478,0.00009465736,0.00014024675,0.00010401425,0.000047314676,0.000018048153,0.0000622369,0.000036941692,0.0000014475509],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014970628,0.00081982487,0.0010342053,0.00015067394,0.00029226192,0.000013049662,0.00013390208,0.005826528,0.96227676,0.009692829,0.0038153145,0.015794946],"study_design_scores_gemma":[0.001314714,0.00016734171,0.0013788022,0.00004566986,0.00021214821,0.00008401083,0.00044114853,0.0006727864,0.3790189,0.0036022866,0.6127364,0.00032578447],"about_ca_topic_score_codex":0.000007665154,"about_ca_topic_score_gemma":0.000104488696,"teacher_disagreement_score":0.6089211,"about_ca_system_score_codex":0.000003445501,"about_ca_system_score_gemma":0.00016181052,"threshold_uncertainty_score":0.3860015},"labels":[],"label_agreement":null},{"id":"W3126964460","doi":"10.1182/bloodadvances.2020002910","title":"Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Refractory (planetary science); Gastroenterology; Nausea; Phases of clinical research; Diarrhea; Surgery; Chemotherapy","score_opus":0.006723838885264753,"score_gpt":0.2380142866764259,"score_spread":0.23129044779116115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126964460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936907,0.0050498075,0.0000025673723,0.000120861136,0.000040602765,0.00025842153,0.000021110294,0.0000128669335,0.0008030449],"genre_scores_gemma":[0.99626434,0.0013565822,0.0019493066,0.00008531438,0.0000214156,0.000016920028,0.000051089795,0.00001198994,0.00024302906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991369,0.00002921833,0.00022483687,0.0002449488,0.00021460369,0.00014948605],"domain_scores_gemma":[0.99941003,0.00014282482,0.00009270334,0.0001922028,0.000084606014,0.000077626464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004009293,0.00012536353,0.00033347897,0.000048895286,0.000028635131,0.000005766566,0.000028859096,0.00003864602,0.000057216123],"category_scores_gemma":[0.00006844448,0.000080338985,0.00002421742,0.00018452219,0.00006660523,0.000102436854,0.00002582483,0.00003343662,0.0000024406386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047797086,0.0048255264,0.9162278,0.00011693496,0.00012109729,0.00038363668,0.0001100029,0.0000030604256,0.000080043734,0.00006372255,0.000022406484,0.07326603],"study_design_scores_gemma":[0.041988403,0.0018178943,0.9446153,0.00048288034,0.000173316,0.000033986318,0.00008168542,0.0000010461063,0.0037270302,0.0000050804633,0.006981182,0.00009220148],"about_ca_topic_score_codex":0.000022302067,"about_ca_topic_score_gemma":0.00007085851,"teacher_disagreement_score":0.07317383,"about_ca_system_score_codex":0.000044964723,"about_ca_system_score_gemma":0.00014956956,"threshold_uncertainty_score":0.32761285},"labels":[],"label_agreement":null},{"id":"W3127208318","doi":"10.1182/bloodadvances.2020003654","title":"Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"National Cancer Institute","keywords":"Myelodysplastic syndromes; Transplantation; Medicine; Oncology; Internal medicine","score_opus":0.017304896780636594,"score_gpt":0.2849124697079314,"score_spread":0.2676075729272948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127208318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.918077,0.0021051732,0.0772066,0.00047490123,0.00026411808,0.0006939505,0.000086849686,0.00009079773,0.0010005981],"genre_scores_gemma":[0.97684324,0.003563484,0.018327769,0.000103058424,0.000070997434,0.00010688035,0.00025532694,0.000035820805,0.0006934545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986944,0.00005597815,0.0003667363,0.00041398703,0.0002280162,0.00024087487],"domain_scores_gemma":[0.9987047,0.0007661538,0.0000960629,0.00012516456,0.00016833429,0.0001396251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011899735,0.00019137842,0.00037266806,0.00008610043,0.00009395466,0.000028393626,0.000042612257,0.000105117964,0.000057112695],"category_scores_gemma":[0.00014424248,0.00017453442,0.000079795114,0.00019189756,0.00009813411,0.00031500868,0.0000074360523,0.00014361754,0.000016788315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010819304,0.004998439,0.28765517,0.038290836,0.009659627,0.014383732,0.05605716,0.0015667002,0.41529915,0.13536254,0.00012855206,0.0257788],"study_design_scores_gemma":[0.045353714,0.0026952983,0.1452682,0.0066431765,0.011881083,0.015236425,0.0048889616,0.0047257347,0.71927756,0.04051635,0.0018082416,0.0017052433],"about_ca_topic_score_codex":0.0000100577345,"about_ca_topic_score_gemma":0.00003061885,"teacher_disagreement_score":0.30397844,"about_ca_system_score_codex":0.000023479242,"about_ca_system_score_gemma":0.00008184248,"threshold_uncertainty_score":0.7117307},"labels":[],"label_agreement":null},{"id":"W3127460195","doi":"10.1182/bloodadvances.2020003442","title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":849,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Provincial Health Services Authority; University of Toronto; St. Michael's Hospital; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"Marie Curie","keywords":"Medicine; Guideline; Intensive care medicine; Cancer; Venous thromboembolism; Fondaparinux; Ambulatory; Low molecular weight heparin; Hematology; Internal medicine; Heparin; Thrombosis; Pathology","score_opus":0.025944293416009255,"score_gpt":0.3358472331441514,"score_spread":0.30990293972814215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127460195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904004,0.0075578596,0.00015945858,0.00070471107,0.0000539398,0.00092149747,0.000030127812,0.000006423514,0.00016562708],"genre_scores_gemma":[0.9124394,0.036028378,0.0504231,0.00024413367,0.000052026244,0.00046748534,0.000079905745,0.000026268066,0.00023929325],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991009,0.000015831974,0.00032373407,0.00025406334,0.0001440468,0.00016142754],"domain_scores_gemma":[0.9993176,0.000024393645,0.00021148611,0.000167176,0.00024586378,0.000033505294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054150114,0.00012584175,0.00070766633,0.000037571488,0.000024023702,0.0000030287742,0.000033413056,0.00002231137,0.000021170626],"category_scores_gemma":[0.000006701235,0.000096277035,0.00008154803,0.00017619898,0.000089365465,0.00005229968,0.000034056684,0.000021474141,1.3493636e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030546813,0.014473564,0.44568348,0.002932574,0.0032798257,0.000020967833,0.0008846547,0.00027322816,0.0003281188,0.0021836895,0.0007072634,0.52892715],"study_design_scores_gemma":[0.010852383,0.0048752967,0.9531228,0.0015772221,0.0020589505,0.00000370988,0.003072143,0.000040695646,0.013474997,0.0003747049,0.010336259,0.00021085785],"about_ca_topic_score_codex":0.00013674327,"about_ca_topic_score_gemma":0.00026696056,"teacher_disagreement_score":0.5287163,"about_ca_system_score_codex":0.000026838581,"about_ca_system_score_gemma":0.000052433028,"threshold_uncertainty_score":0.39260638},"labels":[],"label_agreement":null},{"id":"W3128604271","doi":"10.1182/bloodadvances.2020003763","title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":416,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; University of Ottawa; McGill University; Impact; McMaster University; University of Toronto; Cochrane; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Guideline; Intensive care medicine; MEDLINE; Grading (engineering); Evidence-based medicine; Randomized controlled trial; Clinical trial; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Alternative medicine; Infectious disease (medical specialty); Pathology","score_opus":0.07209585009790037,"score_gpt":0.338944024403058,"score_spread":0.2668481743051576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128604271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384123,0.0003706077,0.00080363295,0.004283611,0.000039156927,0.00060571573,0.000024641698,0.000005894106,0.000025521003],"genre_scores_gemma":[0.9778153,0.00064872217,0.01899206,0.0023938802,0.000026180409,0.000045889712,0.000039624345,0.000011511559,0.000026850339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991781,0.00002852218,0.00029806365,0.00018676027,0.00018918309,0.00011937708],"domain_scores_gemma":[0.998984,0.00024468577,0.00022507846,0.00023278863,0.00028112577,0.000032359334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090159614,0.000089180125,0.00043896193,0.00003385184,0.00003356503,0.000004271533,0.000045775443,0.000021087,0.000026004347],"category_scores_gemma":[0.00038162194,0.000055119555,0.00007737095,0.0002581217,0.00013505717,0.000057432117,0.000026150641,0.000037013368,3.2762674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003392118,0.0046677883,0.95772994,0.0012092077,0.0005398486,0.000006163066,0.000691719,0.0029243764,0.0011981258,0.0070963427,0.0049392064,0.018658103],"study_design_scores_gemma":[0.0060642995,0.0038400153,0.9171105,0.0005641927,0.00046101268,0.0000027293827,0.0017489184,0.0003923536,0.026798515,0.00063523115,0.042147987,0.00023424016],"about_ca_topic_score_codex":0.00009715834,"about_ca_topic_score_gemma":0.00009640554,"teacher_disagreement_score":0.0406194,"about_ca_system_score_codex":0.000014034284,"about_ca_system_score_gemma":0.000080043064,"threshold_uncertainty_score":0.22477102},"labels":[],"label_agreement":null},{"id":"W3129105568","doi":"10.1182/bloodadvances.2020002971","title":"Molecular coevolution of coagulation factor VIII and von Willebrand factor","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Coevolution; Von Willebrand factor; Biology; In silico; Coagulation; Computational biology; Recombinant DNA; Sequence (biology); Gene; Molecular evolution; Genetics; Evolutionary biology; Phylogenetics; Immunology; Medicine","score_opus":0.008765449688569122,"score_gpt":0.25881209110249354,"score_spread":0.2500466414139244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129105568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798732,0.019162962,0.00018310604,0.00010527526,0.000045442444,0.00012582136,0.00003862559,0.000015883961,0.00044968133],"genre_scores_gemma":[0.9983237,0.0009563284,0.00051496516,0.000038070062,0.000009408414,0.0000036164424,0.00005173621,0.0000072455123,0.00009496073],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994992,0.00001357174,0.000120654164,0.00014869454,0.00012656637,0.000091300426],"domain_scores_gemma":[0.9997316,0.000021390431,0.000056291574,0.00009035243,0.00006136655,0.00003897667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000010238505,0.000081410115,0.00020573183,0.000029613142,0.000029215538,0.0000052358714,0.000013190544,0.000039701485,0.000041678875],"category_scores_gemma":[0.000036298883,0.00006846619,0.000036208698,0.00007865529,0.000033305823,0.000104231454,0.0000108605755,0.000034301407,0.0000017448838],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019297766,0.0009244683,0.47565266,0.00036008726,0.00042393667,0.00049658515,0.00036316027,0.00003464018,0.4618141,0.00038160995,0.000015468078,0.059340294],"study_design_scores_gemma":[0.0061905268,0.00041095287,0.45931283,0.00016938655,0.00029369246,0.00016477265,0.00015132515,0.00012822602,0.5280538,0.00076605496,0.0041836775,0.00017474637],"about_ca_topic_score_codex":0.000007461203,"about_ca_topic_score_gemma":0.000010063464,"teacher_disagreement_score":0.06623971,"about_ca_system_score_codex":0.000006972807,"about_ca_system_score_gemma":0.000027432512,"threshold_uncertainty_score":0.27919704},"labels":[],"label_agreement":null},{"id":"W3131641547","doi":"10.1182/bloodadvances.2020003560","title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Hazard ratio; Major bleeding; Internal medicine; Confidence interval; Cardiology; Lower risk; Vitamin k; Proportional hazards model; Prospective cohort study","score_opus":0.03450271442617218,"score_gpt":0.30359457262663525,"score_spread":0.26909185820046305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131641547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803502,0.009605543,0.0000132768555,0.0066612707,0.00017600221,0.0002647525,0.000015726899,0.00003669185,0.0028765579],"genre_scores_gemma":[0.99415106,0.0031952085,0.00078766304,0.00010320641,0.0010134819,6.458834e-7,0.000060012855,0.000009218505,0.00067953323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990225,0.000050280163,0.000305627,0.0003030019,0.00019357738,0.00012503334],"domain_scores_gemma":[0.9987093,0.00084213,0.00013800121,0.00021575703,0.000043416683,0.00005136437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018535781,0.000115609306,0.00024474098,0.000025902324,0.00009042234,0.000051065013,0.000032858276,0.00006596196,0.000026560703],"category_scores_gemma":[0.00080720976,0.000077666795,0.00004484473,0.00023245902,0.000071018054,0.00018456414,0.00005047176,0.00010868192,0.0000011669074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043961377,0.000003069033,0.993876,0.000026149188,0.00014804272,0.00013608669,0.00042152707,0.0002959227,0.00013282626,0.0003277559,0.000074182724,0.0041188425],"study_design_scores_gemma":[0.009976317,0.000109501394,0.96588755,0.00023851209,0.00050182675,0.00003430774,0.0012391233,0.0002200259,0.00038676045,0.0007486239,0.02048688,0.00017058452],"about_ca_topic_score_codex":0.00011410721,"about_ca_topic_score_gemma":0.00034358155,"teacher_disagreement_score":0.027988445,"about_ca_system_score_codex":0.00000727589,"about_ca_system_score_gemma":0.00004071497,"threshold_uncertainty_score":0.316716},"labels":[],"label_agreement":null},{"id":"W3133685805","doi":"10.1182/bloodadvances.2020002982","title":"Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Contraindication; Medicine; Internal medicine; Vincristine; International Prognostic Index; Rituximab; Population; Gastroenterology; Diffuse large B-cell lymphoma; Surgery; Oncology; Cyclophosphamide; Lymphoma; Chemotherapy; Pathology","score_opus":0.007586780525837057,"score_gpt":0.280367191135127,"score_spread":0.2727804106092899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133685805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971894,0.0013895468,0.000027571135,0.0008976728,0.00003808079,0.0003484794,0.00002538283,0.000007770209,0.00007609443],"genre_scores_gemma":[0.9985155,0.0002143078,0.0009609771,0.00017111558,0.000015158617,0.00003777806,0.00004159504,0.000006288829,0.000037283364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935305,0.000017234475,0.00017119486,0.00019446012,0.00015831219,0.000105773055],"domain_scores_gemma":[0.9995897,0.000052113803,0.00008010407,0.00011025591,0.00010495044,0.000062885054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021674621,0.00009816855,0.00027946767,0.000052613927,0.00002212331,0.000008324787,0.000022087837,0.000022844728,0.00001184049],"category_scores_gemma":[0.000061858394,0.000064962485,0.000026083544,0.00011149196,0.00004450034,0.00011209605,0.00001751104,0.000023773819,0.0000011578558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014383816,0.0022210109,0.9811201,0.000038044553,0.00011818332,0.00007413714,0.00022593956,0.0000024642852,0.0001154708,0.00004906365,0.0000024030878,0.015889315],"study_design_scores_gemma":[0.00923376,0.00049509434,0.9816644,0.00016801195,0.00015132823,0.0000063548296,0.00009579192,0.0000013007858,0.008073718,0.000016482458,0.000024813146,0.00006889979],"about_ca_topic_score_codex":0.000014515172,"about_ca_topic_score_gemma":0.00017247391,"teacher_disagreement_score":0.015820416,"about_ca_system_score_codex":0.000013804092,"about_ca_system_score_gemma":0.00004289786,"threshold_uncertainty_score":0.26490933},"labels":[],"label_agreement":null},{"id":"W3133912993","doi":"10.1182/bloodadvances.2020003359","title":"Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Agence Nationale de la Recherche","keywords":"Carcinogenesis; Transcriptome; Ontogeny; Biology; Cancer research; Cell biology; Computational biology; Genetics; Gene; Gene expression","score_opus":0.012863400850084113,"score_gpt":0.2805265148911837,"score_spread":0.26766311404109955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133912993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757342,0.022539308,0.00014342072,0.0003452093,0.000115070274,0.0005068051,0.000120731595,0.000039426235,0.00045585306],"genre_scores_gemma":[0.99408585,0.0021259086,0.0027118917,0.0005414095,0.00008736712,0.00007593872,0.00004364545,0.000046488105,0.00028149507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979552,0.00011826055,0.00036335742,0.00072184415,0.0003334593,0.00050787843],"domain_scores_gemma":[0.99892384,0.00027112573,0.00003775303,0.00032327604,0.00010656519,0.00033746482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000849259,0.0002668926,0.00052689423,0.00017526107,0.00008937962,0.00004970056,0.00012886447,0.00009054055,0.00015951964],"category_scores_gemma":[0.00017286825,0.00027376358,0.00009574606,0.00032432636,0.000090406706,0.00010457128,0.00008078422,0.00017646026,0.00007066162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046363185,0.00056961615,0.30237994,0.0001729469,0.00009070617,0.0013317192,0.0007462992,0.00017780153,0.69060314,0.0000059235135,0.000015880398,0.003442403],"study_design_scores_gemma":[0.0068083154,0.0005845383,0.0816093,0.00021742511,0.00025286735,0.0011574029,0.0013061385,0.00036710605,0.90379566,0.00016755794,0.0032559934,0.0004777224],"about_ca_topic_score_codex":0.00024925848,"about_ca_topic_score_gemma":0.012865936,"teacher_disagreement_score":0.22077064,"about_ca_system_score_codex":0.00012704948,"about_ca_system_score_gemma":0.00037171334,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W3135339074","doi":"10.1182/bloodadvances.2020002690","title":"End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Rituximab; Vincristine; Internal medicine; International Prognostic Index; Confidence interval; Diffuse large B-cell lymphoma; Oncology; Progression-free survival; CHOP; Obinutuzumab; Prednisone; Nuclear medicine; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.013699833991832009,"score_gpt":0.2620760841848614,"score_spread":0.2483762501930294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135339074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95433444,0.04174164,0.0000010209894,0.00089903723,0.00011425541,0.00044692238,0.0007781798,0.00003273067,0.001651786],"genre_scores_gemma":[0.9735459,0.023594668,0.00137235,0.00007806959,0.00013008933,0.00025860817,0.00037302473,0.000020148813,0.0006271304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985455,0.000039163544,0.00042079593,0.0005509672,0.00017739624,0.00026617336],"domain_scores_gemma":[0.9989485,0.00033162915,0.00011259188,0.0004016912,0.000048381433,0.00015721121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003694857,0.00028836072,0.00056796893,0.00007067563,0.000042369167,0.000017026878,0.00003692603,0.00002048547,0.00010371602],"category_scores_gemma":[0.000069104695,0.00020153324,0.00012033325,0.00014987834,0.00007273873,0.00011738901,0.000036777798,0.000036370606,0.000013693582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010305608,0.008184568,0.9148365,0.00007386514,0.00059303996,0.014998426,0.00066755654,0.000035693458,0.00014458025,0.000033872697,0.000029903349,0.059371404],"study_design_scores_gemma":[0.07187686,0.0052733677,0.72174424,0.0011174934,0.001727133,0.0007908741,0.00031017076,0.0000772859,0.11932161,0.00036034823,0.0770221,0.00037850323],"about_ca_topic_score_codex":0.0010199422,"about_ca_topic_score_gemma":0.004395557,"teacher_disagreement_score":0.19309227,"about_ca_system_score_codex":0.00020498685,"about_ca_system_score_gemma":0.00017262112,"threshold_uncertainty_score":0.8218287},"labels":[],"label_agreement":null},{"id":"W3138496492","doi":"10.1182/bloodadvances.2020003510","title":"Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Pharmacyclics; Genentech; Astellas Pharma; Incyte; Agios Pharmaceuticals; Jazz Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Kaiser Permanente; University of Rochester; Teva Pharmaceutical Industries; Kite Pharma; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Transplantation; Cytarabine; Clinical endpoint; Neutropenia; Post-hoc analysis; Gastroenterology; Myeloid leukemia; Surgery; Oncology; Chemotherapy; Randomized controlled trial","score_opus":0.011201238644042485,"score_gpt":0.31226726340611655,"score_spread":0.30106602476207406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138496492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823601,0.012994425,0.00037607635,0.00191045,0.00006861049,0.00072779955,0.00015409186,0.00016841476,0.0012400055],"genre_scores_gemma":[0.9685051,0.0047273533,0.020579536,0.0009870996,0.00047459645,0.000111946385,0.00066764257,0.00012480232,0.0038219406],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967704,0.00019324264,0.00042949148,0.0009817486,0.000913174,0.0007119574],"domain_scores_gemma":[0.997161,0.00039499786,0.0002717118,0.0009078231,0.0007070662,0.00055743684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018915365,0.00046320714,0.0008281479,0.00021093329,0.00028319962,0.00007897012,0.00026301364,0.000151051,0.00068405876],"category_scores_gemma":[0.00045675063,0.00030130454,0.00012493435,0.0009721856,0.00027903513,0.0005549585,0.00012174264,0.0008572422,0.00003643903],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050304182,0.009653039,0.092811994,0.0025782855,0.004067625,0.03705309,0.005133644,0.00028891678,0.10478489,0.00010543618,0.00794232,0.68527657],"study_design_scores_gemma":[0.20787328,0.019807803,0.13375743,0.0077464697,0.0037958315,0.002260477,0.014029302,0.0005379919,0.5729794,0.000053987085,0.03502383,0.0021342258],"about_ca_topic_score_codex":0.0003155764,"about_ca_topic_score_gemma":0.0006120769,"teacher_disagreement_score":0.68314236,"about_ca_system_score_codex":0.00010904488,"about_ca_system_score_gemma":0.0012782671,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W3138501536","doi":"10.1182/bloodadvances.2020002998","title":"Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Jewish General Hospital; McGill University and Génome Québec Innovation Centre; McGill University; McGill University Health Centre","funders":"McGill University Health Centre; McGill University","keywords":"Podoplanin; Microvesicles; Cancer research; Tissue factor; Biology; Cell biology; Glioma; Platelet activation; Chemistry; microRNA; Platelet; Immunology; Coagulation; Medicine; Internal medicine; Gene; Biochemistry","score_opus":0.009020714708177042,"score_gpt":0.24313524846206028,"score_spread":0.23411453375388325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138501536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96442485,0.032832097,0.001007423,0.00007175425,0.00008843796,0.00040703313,0.000042570817,0.000073147305,0.0010527178],"genre_scores_gemma":[0.98649156,0.00021373498,0.00953227,0.00006237553,0.0002560211,0.00010730675,0.00055778224,0.00006848916,0.0027104295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981083,0.00010528628,0.0003232218,0.00072268094,0.00030315047,0.00043733936],"domain_scores_gemma":[0.9987246,0.00001455558,0.00018355371,0.0006572656,0.00015843633,0.000261638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009133441,0.00031081002,0.00022168063,0.000035991452,0.00019282401,0.00007565762,0.00026247793,0.00012079114,0.00004447906],"category_scores_gemma":[0.00009232705,0.00028247578,0.00013680334,0.00024395662,0.00015474804,0.000021697386,0.00012411697,0.00013765325,0.00004176218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000318255,0.0014683696,0.029256357,0.00015226756,0.00009154381,0.0009679362,0.000048015503,0.00022989327,0.9578471,0.00036504108,0.0001056397,0.009149561],"study_design_scores_gemma":[0.0013473392,0.0008033406,0.0021319753,0.00007731758,0.00022919242,0.0004382381,0.00025607747,0.000038800896,0.9533328,0.00042699496,0.040393893,0.0005240344],"about_ca_topic_score_codex":0.000008633987,"about_ca_topic_score_gemma":0.00021223465,"teacher_disagreement_score":0.040288255,"about_ca_system_score_codex":0.000012776998,"about_ca_system_score_gemma":0.0002605859,"threshold_uncertainty_score":0.99996275},"labels":[],"label_agreement":null},{"id":"W3155302493","doi":"10.1182/bloodadvances.2020001834","title":"Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Placebo; Hazard ratio; Exacerbation; Clinical trial; Refractory (planetary science); Gastroenterology; Thrombotic thrombocytopenic purpura; Tolerability; Incidence (geometry); Platelet; Surgery; Adverse effect; Confidence interval","score_opus":0.019467730108799743,"score_gpt":0.2993234846913363,"score_spread":0.27985575458253653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155302493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740715,0.02479575,0.000039811912,0.000040105097,0.0003630127,0.00025667524,0.00010549799,0.00005423168,0.00027339402],"genre_scores_gemma":[0.99832124,0.00054395676,0.00007690096,0.000026025951,0.000016201997,0.00005661602,0.00041139097,0.000011050641,0.0005366312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982335,0.00037867704,0.00046510666,0.00052956596,0.00006585669,0.0003273056],"domain_scores_gemma":[0.99913085,0.00014731863,0.00016419598,0.0004435709,0.000082896084,0.000031185937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001618847,0.00021801714,0.0006556954,0.00014334531,0.00010264615,0.00003157303,0.0002037995,0.00009589637,0.00094542257],"category_scores_gemma":[0.00013680717,0.00019421687,0.00011505797,0.0007942138,0.00012536152,0.0002942247,0.00016017961,0.000105379026,0.000028690527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045840043,0.0005489782,0.939657,0.00010108955,0.0020449918,0.00007284291,0.00018710991,0.000041184012,0.05594527,0.00020142822,0.0000429109,0.0011113713],"study_design_scores_gemma":[0.0020737965,0.000060935152,0.951633,0.000109725814,0.0014461899,0.000038757924,0.000893744,0.0000070393776,0.040661,0.0003883198,0.002397839,0.00028968372],"about_ca_topic_score_codex":0.00024281236,"about_ca_topic_score_gemma":0.0027897295,"teacher_disagreement_score":0.024251794,"about_ca_system_score_codex":0.000043454347,"about_ca_system_score_gemma":0.00009584888,"threshold_uncertainty_score":0.9999679},"labels":[],"label_agreement":null},{"id":"W3157363204","doi":"10.1182/bloodadvances.2020002398","title":"Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Impact; University of Calgary; Western University; McMaster University; University of Ottawa; Thrombosis and Atherosclerosis Research Institute","funders":"McMaster University; American Society of Hematology","keywords":"Medicine; Pulmonary embolism; Incidence (geometry); Confidence interval; Meta-analysis; Internal medicine; Mortality rate; Pediatrics; Surgery","score_opus":0.02680877845822041,"score_gpt":0.32032679942089237,"score_spread":0.293518020962672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157363204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000236759,0.9954621,9.682514e-7,0.00006438754,0.000019496374,0.0040696464,0.00010352697,0.000017693952,0.00023849097],"genre_scores_gemma":[0.00005960759,0.99818325,0.00018362771,0.00022923047,0.000005799359,0.0007427637,0.00030298877,0.000037571317,0.0002551457],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99707866,0.00025981906,0.0014033983,0.0005517605,0.0004767307,0.00022962342],"domain_scores_gemma":[0.9977533,0.00023239898,0.0010050229,0.00075103407,0.00017214632,0.00008606588],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0002754068,0.0005016282,0.020765174,0.0005447875,0.0000247766,0.00001459989,0.00016073497,0.000089690955,0.00016054833],"category_scores_gemma":[0.00017727286,0.00026986346,0.0015467894,0.0014523355,0.000050901104,0.00009106026,0.000102227445,0.00016559788,0.0000021815533],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011679884,0.0010054066,0.0003648357,0.7416505,0.2555389,0.00004508458,0.000011492843,3.9191767e-7,1.4812893e-9,0.000098531025,0.0000064258174,0.0012772048],"study_design_scores_gemma":[0.0002337981,0.0001093152,0.0014482903,0.0989754,0.89123815,0.000004583077,0.000015953416,1.1326943e-7,4.989249e-8,0.0000020558577,0.0077483775,0.00022390095],"about_ca_topic_score_codex":0.000020296535,"about_ca_topic_score_gemma":0.000041019874,"teacher_disagreement_score":0.64267516,"about_ca_system_score_codex":0.000026537435,"about_ca_system_score_gemma":0.000063393396,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W3158563222","doi":"10.1182/bloodadvances.2020002773","title":"Treating lymphoma is now a bit EZ-er","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Simon Fraser University","funders":"","keywords":"EZH2; Medicine; Epigenetics; Germinal center; Cancer research; Lymphoma; Follicular lymphoma; Pharmacology; Oncology; Bioinformatics; Computational biology; Internal medicine; Immunology; Biology; B cell; Genetics","score_opus":0.033772514931445126,"score_gpt":0.3482347193749741,"score_spread":0.31446220444352896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158563222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007127041,0.98813236,0.0000010866404,0.00012454484,0.00025285225,0.0007046427,0.00010616818,0.00008874536,0.010518321],"genre_scores_gemma":[0.000015318437,0.9919455,0.0015133207,0.00029064986,0.000573233,0.0005001625,0.0002913953,0.00008070753,0.004789726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776393,0.00006973221,0.00062416086,0.0007617467,0.00036767166,0.00041272774],"domain_scores_gemma":[0.99845654,0.0002693487,0.000354861,0.0006278511,0.00008764043,0.00020378196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000070976435,0.0006156999,0.0025959052,0.00014683738,0.00011037771,0.00005889714,0.00013773296,0.00023873807,0.00042668753],"category_scores_gemma":[0.0000756332,0.00041460898,0.000998346,0.00043383654,0.000052463623,0.00010277278,0.00008531955,0.00009773533,0.00034752136],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031897848,0.00102527,0.0007756254,0.008444196,0.001066967,0.001056965,0.00003936732,3.923032e-8,1.7378547e-7,0.000058676153,0.0013057988,0.98622376],"study_design_scores_gemma":[0.0019090743,0.00020347378,0.000072844654,0.03363595,0.007772722,0.0009222938,0.000029970675,3.8983978e-7,0.0000772889,0.0000093813105,0.95501167,0.00035492875],"about_ca_topic_score_codex":0.00002417727,"about_ca_topic_score_gemma":0.000014424622,"teacher_disagreement_score":0.9858688,"about_ca_system_score_codex":0.00018104428,"about_ca_system_score_gemma":0.0005832135,"threshold_uncertainty_score":0.9998306},"labels":[],"label_agreement":null},{"id":"W3165665563","doi":"10.1182/bloodadvances.2021004259","title":"Mitochondrial localization and moderated activity are key to murine erythroid enucleation","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Centre National de la Recherche Scientifique; American Heart Association; New York State Stem Cell Science; Institut National de la Santé et de la Recherche Médicale; York University; Icahn School of Medicine at Mount Sinai","keywords":"Mitochondrion; Cell biology; Enucleation; Erythroblast; Organelle; Biology; Glycolysis; Biochemistry; Metabolism; Haematopoiesis; Genetics; Stem cell","score_opus":0.012620609791072922,"score_gpt":0.2606265589030079,"score_spread":0.24800594911193496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165665563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856234,0.0009510743,0.010607929,0.0012092084,0.00049846806,0.00021904736,0.000010924292,0.000087338616,0.0007925704],"genre_scores_gemma":[0.99282855,0.00065640185,0.0032328693,0.0014585351,0.00053070224,0.000019189152,0.000071011316,0.000017356711,0.0011853692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993265,0.000047049987,0.0001143643,0.0002810146,0.00010864456,0.00012242816],"domain_scores_gemma":[0.9995187,0.000029433995,0.00005529932,0.00013890093,0.00015970545,0.00009798632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022176959,0.000101140824,0.00020614319,0.00004714425,0.00009125033,0.000015352702,0.000016904723,0.00006522197,0.000107367865],"category_scores_gemma":[0.00015467506,0.000094136565,0.000028427734,0.00020308193,0.000029950148,0.00014005882,0.000026236534,0.000080644895,0.000021754107],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013368875,0.00070040225,0.0122509515,0.00026784194,0.0000940815,0.000103636994,0.0005107089,0.0021451314,0.9608233,0.00024116485,0.001412778,0.02011313],"study_design_scores_gemma":[0.0098642735,0.0018083521,0.11287218,0.00043321904,0.00039349587,0.0005058728,0.00077063584,0.006132633,0.6683643,0.00081766135,0.1973904,0.0006469955],"about_ca_topic_score_codex":0.000006503087,"about_ca_topic_score_gemma":0.00006822319,"teacher_disagreement_score":0.292459,"about_ca_system_score_codex":0.000013382034,"about_ca_system_score_gemma":0.000040944706,"threshold_uncertainty_score":0.38387778},"labels":[],"label_agreement":null},{"id":"W3176618462","doi":"10.1182/bloodadvances.2021004629","title":"Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Seroconversion; Confidence interval; Influenza vaccine; CD20; Immunogenicity; Immunology; Gastroenterology; Vaccination; Antigen; Antibody; Lymphoma","score_opus":0.03856182996323942,"score_gpt":0.3287690543417925,"score_spread":0.29020722437855306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176618462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023441891,0.9972008,0.0000026296896,0.00003066243,0.00016297695,0.0020646793,0.00025745385,0.000034371853,0.000012003908],"genre_scores_gemma":[0.00010137365,0.99717474,0.000035389854,0.000208466,0.000003567949,0.00041523727,0.00037868088,0.000052946165,0.0016296116],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99211156,0.0048246616,0.0019417253,0.00064512185,0.00010711628,0.0003698048],"domain_scores_gemma":[0.9950108,0.0020938283,0.0016371754,0.0010708348,0.00016531246,0.000022035058],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014903191,0.00073757657,0.014939682,0.0005764965,0.00016468545,0.000026046466,0.00050495565,0.0003551906,0.00049325434],"category_scores_gemma":[0.00082312967,0.00045696367,0.005087095,0.0013483252,0.000081125494,0.00017576669,0.00012558274,0.00034184539,0.00002114538],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009860257,0.00039143933,0.000008611027,0.3150775,0.6765889,0.000011889979,0.000078927296,1.5057726e-7,0.00008899565,0.000009450456,0.000037004065,0.007608518],"study_design_scores_gemma":[0.00054511084,0.00017949846,0.0000097846005,0.029718177,0.69308275,0.000026776708,0.000018235465,7.3699895e-9,0.00011744329,8.300607e-7,0.27595836,0.00034304746],"about_ca_topic_score_codex":0.000008489834,"about_ca_topic_score_gemma":0.0000022677596,"teacher_disagreement_score":0.28535935,"about_ca_system_score_codex":0.000017273615,"about_ca_system_score_gemma":0.0001479414,"threshold_uncertainty_score":0.9997882},"labels":[],"label_agreement":null},{"id":"W3181302422","doi":"10.1182/bloodadvances.2021004698","title":"Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Deep vein; Pulmonary embolism; Thrombosis; Surgery; Central venous catheter; Catheter; Venous thrombosis; Retrospective cohort study; Malignancy; Internal medicine","score_opus":0.007740525575613717,"score_gpt":0.24279555023692262,"score_spread":0.2350550246613089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181302422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153155,0.004891598,0.00005474833,0.00010577249,0.000091775255,0.00027836298,0.00006394173,0.000035031582,0.0029472234],"genre_scores_gemma":[0.994573,0.001722487,0.0032167232,0.00015408252,0.0000755448,0.000033288834,0.000055902456,0.000030911127,0.00013805236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984066,0.00011745371,0.00035516275,0.00037344807,0.0003938384,0.00035353517],"domain_scores_gemma":[0.99890786,0.00006559478,0.00026002625,0.00043842685,0.00019698258,0.00013108795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001536351,0.00020011129,0.0007058661,0.00006685529,0.000047599224,0.000009812371,0.00010049651,0.000078327575,0.00025608263],"category_scores_gemma":[0.00011138967,0.00015552333,0.00017009,0.000254512,0.00013241559,0.00021238126,0.000065635235,0.0001373602,0.000002025442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037361798,0.022727305,0.94533616,0.0005242283,0.002189571,0.0016452511,0.002194478,0.0001555576,0.0068492615,0.00018633346,0.000045753946,0.017772505],"study_design_scores_gemma":[0.0014310218,0.000663522,0.96735424,0.00044133372,0.0018447216,0.00009391121,0.00071052526,0.000116389085,0.025970032,0.00021100484,0.0009540668,0.00020925631],"about_ca_topic_score_codex":0.000090248795,"about_ca_topic_score_gemma":0.00031984298,"teacher_disagreement_score":0.022063782,"about_ca_system_score_codex":0.000028545555,"about_ca_system_score_gemma":0.00007464423,"threshold_uncertainty_score":0.63420576},"labels":[],"label_agreement":null},{"id":"W3183393077","doi":"10.1182/bloodadvances.2021004421","title":"Self-reported positive impact of mentored clinical research training is associated with academic success in hematology","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Social connectedness; Medical education; Likert scale; Psychology; Mentorship; Medicine; Family medicine; Internal medicine; Social psychology","score_opus":0.2919969644591093,"score_gpt":0.58090504666685,"score_spread":0.28890808220774067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183393077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874694,0.0039792866,0.0000070290735,0.004201286,0.000044138673,0.00049879745,0.000023991186,0.00003193052,0.0024666083],"genre_scores_gemma":[0.9954411,0.0030914252,0.00042180213,0.00067579135,0.000093057904,0.000025868194,0.00005057776,0.000018923456,0.00018149466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555516,0.00077718316,0.00083459925,0.00041620314,0.0011706165,0.0012462432],"domain_scores_gemma":[0.99393034,0.0026030387,0.00022293885,0.0002586186,0.0008317784,0.0021532876],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0048525766,0.00014181634,0.00082432054,0.0002378446,0.00006192923,0.0000073475794,0.00012477742,0.00029102465,0.000110589994],"category_scores_gemma":[0.05663533,0.00009933995,0.00010695916,0.00122922,0.000349816,0.00015876518,0.00005716407,0.0015868066,0.000003834928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011845795,0.0018105052,0.9709276,0.00033119912,0.0010311542,0.0047289333,0.0029541962,0.0000014968775,0.0013472465,0.0000798363,0.00071249966,0.014890736],"study_design_scores_gemma":[0.02139611,0.008970144,0.93332565,0.0045067607,0.00034462762,0.0011111945,0.0026700452,0.00025830255,0.02383374,0.00058751035,0.0026661723,0.00032976363],"about_ca_topic_score_codex":0.00014619944,"about_ca_topic_score_gemma":0.00015405491,"teacher_disagreement_score":0.051782753,"about_ca_system_score_codex":0.0001968879,"about_ca_system_score_gemma":0.011513722,"threshold_uncertainty_score":0.9940901},"labels":[],"label_agreement":null},{"id":"W3186090849","doi":"10.1182/bloodadvances.2020003985","title":"Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Imperial Experimental Cancer Medicine Centre; Blood Cancer UK; University of Southampton; Cancer Research UK; F. Hoffmann-La Roche","keywords":"Obinutuzumab; Single-nucleotide polymorphism; Internal medicine; Rituximab; Hazard ratio; Medicine; Oncology; Univariate analysis; Lymphoma; Follicular lymphoma; Genotype; Confidence interval; Immunology; Multivariate analysis; Biology; Genetics","score_opus":0.018987636017080093,"score_gpt":0.29280627918824487,"score_spread":0.2738186431711648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186090849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922539,0.0031787928,0.0000034917928,0.0008284543,0.00020981078,0.00031754232,0.00012349815,0.000049379636,0.0030351456],"genre_scores_gemma":[0.99372894,0.00024395878,0.0024301512,0.00055532216,0.0002397971,0.000019428713,0.00015878705,0.000045931105,0.002577659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975105,0.00007472243,0.00045377022,0.00052431395,0.0007913254,0.00064539723],"domain_scores_gemma":[0.9988383,0.00014070237,0.00011351068,0.00037364254,0.00023246474,0.00030139476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011799378,0.00031468036,0.0006327068,0.00016517546,0.00010422097,0.000056883215,0.0001671915,0.00008555555,0.0008893866],"category_scores_gemma":[0.00013741718,0.00021813005,0.00017486572,0.00050625025,0.0001623665,0.00029119648,0.00011359688,0.0002217728,0.00015825873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021952027,0.002148132,0.9462764,0.00012569907,0.00014675208,0.00043732658,0.000108738896,0.000009179105,0.0039000222,0.00009706139,0.00014134955,0.04441411],"study_design_scores_gemma":[0.018600784,0.0024118163,0.8976718,0.00047959585,0.0001107407,0.00011722036,0.00014024471,0.000014970697,0.028651217,0.00009957393,0.051160097,0.0005419484],"about_ca_topic_score_codex":0.00018763304,"about_ca_topic_score_gemma":0.000081057726,"teacher_disagreement_score":0.05101875,"about_ca_system_score_codex":0.00024115446,"about_ca_system_score_gemma":0.00034484843,"threshold_uncertainty_score":0.9738159},"labels":[],"label_agreement":null},{"id":"W3186414440","doi":"10.1182/bloodadvances.2021004634","title":"A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Cancer Institute","keywords":"Fetal hemoglobin; Single-nucleotide polymorphism; Medicine; Vaso-occlusive crisis; Thalassemia; Genome-wide association study; Cohort; Acute chest syndrome; Sickle cell anemia; Disease; Bioinformatics; Genetics; Oncology; Internal medicine; Genotype; Gene; Biology; Pregnancy; Fetus","score_opus":0.00577165618541612,"score_gpt":0.2511603282568519,"score_spread":0.2453886720714358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186414440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.908013,0.08776658,0.00023537526,0.00170254,0.00024671425,0.00067028415,0.00006613835,0.00006434549,0.0012350254],"genre_scores_gemma":[0.9737134,0.019280382,0.0023162963,0.0014115406,0.0003592125,0.00012341072,0.00015212983,0.00004677325,0.0025968521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883753,0.000045648296,0.00024283813,0.00035007726,0.00016726532,0.00035661625],"domain_scores_gemma":[0.9992783,0.00012123147,0.00006961494,0.00022710004,0.00008402784,0.00021970912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013152217,0.00016310955,0.00027678307,0.00009189419,0.000076126795,0.000012911033,0.00007430044,0.000080492864,0.000046887508],"category_scores_gemma":[0.00021789197,0.00013902337,0.00016252091,0.00042776135,0.000033217504,0.0000976145,0.00004352877,0.00015891403,0.000014409409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016762716,0.0066357157,0.9106757,0.004260327,0.00053260283,0.0067366236,0.0016546345,0.0005415495,0.0084492965,0.000619617,0.005071962,0.05314568],"study_design_scores_gemma":[0.13043173,0.0097217085,0.36598188,0.002896586,0.029511172,0.00062811567,0.016878964,0.005425154,0.052450385,0.020896383,0.35878226,0.006395656],"about_ca_topic_score_codex":0.000005610298,"about_ca_topic_score_gemma":0.000028347824,"teacher_disagreement_score":0.5446938,"about_ca_system_score_codex":0.00002072596,"about_ca_system_score_gemma":0.00035278735,"threshold_uncertainty_score":0.5669209},"labels":[],"label_agreement":null},{"id":"W3186485642","doi":"10.1182/bloodadvances.2021004770","title":"Prognostic significance of <i>FCGR2B</i> expression for the response of DLBCL patients to rituximab or obinutuzumab treatment","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC","funders":"Imperial Experimental Cancer Medicine Centre; Blood Cancer UK; University of Southampton; F. Hoffmann-La Roche; Kay Kendall Leukaemia Fund; Michael Smith Health Research BC; National Cancer Institute; National Institutes of Health; Cancer Research UK; U.S. Department of Health and Human Services","keywords":"Obinutuzumab; CHOP; Rituximab; Vincristine; Hazard ratio; Internal medicine; Lymphoma; CD20; Medicine; Chemoimmunotherapy; Cyclophosphamide; Oncology; Cancer research; Chemistry; Immunology; Confidence interval; Chemotherapy","score_opus":0.032235789902937996,"score_gpt":0.3410705343796894,"score_spread":0.3088347444767514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186485642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992337,0.0047516134,0.00011915933,0.0009467507,0.000101226644,0.0013072309,0.0002582758,0.000011123099,0.00016766122],"genre_scores_gemma":[0.987639,0.0008455642,0.006348832,0.00014656936,0.00008367911,0.0003239889,0.00003291325,0.000016500484,0.004562958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877375,0.00008508353,0.00030580207,0.00024540903,0.00036041057,0.00022953734],"domain_scores_gemma":[0.9975507,0.001604449,0.00010263785,0.00027250694,0.0003684837,0.0001011803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001382596,0.00013293808,0.00035633164,0.000043771837,0.00008383348,0.000006094356,0.00011585946,0.00003289655,0.000058299913],"category_scores_gemma":[0.0008389161,0.000068484136,0.00012569879,0.00022292217,0.000100104575,0.00004921856,0.000055483997,0.000052308125,0.000004762633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087826006,0.010477401,0.122565985,0.0019495648,0.0005239905,0.00014566374,0.0015416022,0.00013218769,0.69138384,0.00019145243,0.0016114494,0.08165087],"study_design_scores_gemma":[0.005922462,0.00503477,0.026084851,0.0004361633,0.00016585672,0.000012898666,0.0002648903,0.00002679632,0.8882802,0.000056203593,0.07361258,0.00010234416],"about_ca_topic_score_codex":0.000026828837,"about_ca_topic_score_gemma":0.000023876559,"teacher_disagreement_score":0.19689636,"about_ca_system_score_codex":0.00003682504,"about_ca_system_score_gemma":0.0004059833,"threshold_uncertainty_score":0.2792702},"labels":[],"label_agreement":null},{"id":"W3190191917","doi":"10.1182/bloodadvances.2021004268","title":"Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Guideline; Latin Americans; Context (archaeology); Medicine; Venous thromboembolism; Medical education; Family medicine; Political science; Surgery; Geography; Pathology","score_opus":0.15822921823250416,"score_gpt":0.3991420747143183,"score_spread":0.24091285648181412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190191917","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3205586,0.0530276,0.5632338,0.041235782,0.00288958,0.017076058,0.00060560834,0.00008867069,0.0012843165],"genre_scores_gemma":[0.57085276,0.0049771876,0.41811317,0.0027845048,0.00036468412,0.0019801052,0.0000538602,0.000049402992,0.00082433893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988479,0.00005375814,0.0004806281,0.00024046568,0.00016938333,0.00020787145],"domain_scores_gemma":[0.99746007,0.0010360172,0.00042628206,0.00036431456,0.00068826764,0.000025044723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005063921,0.00013008826,0.0006729127,0.000031521886,0.00012519058,0.0000063426337,0.00017518339,0.00002929912,0.0000083920795],"category_scores_gemma":[0.0005588208,0.00007858676,0.00027892765,0.00017152872,0.00015298113,0.000036705518,0.00006677552,0.000035897938,2.305474e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003257598,0.0016478795,0.00046013016,0.002912963,0.0028188862,0.0000018693694,0.0021729667,0.0025595033,0.0043175686,0.09290487,0.0051122736,0.8847653],"study_design_scores_gemma":[0.01081093,0.003915479,0.05214665,0.0010534365,0.011004768,0.000010388249,0.07345517,0.002697957,0.13787115,0.022441013,0.68414927,0.00044376732],"about_ca_topic_score_codex":0.00007009439,"about_ca_topic_score_gemma":0.00025072228,"teacher_disagreement_score":0.8843216,"about_ca_system_score_codex":0.000010700042,"about_ca_system_score_gemma":0.000058491623,"threshold_uncertainty_score":0.32046753},"labels":[],"label_agreement":null},{"id":"W3191156599","doi":"10.1182/bloodadvances.2021004267","title":"ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Guideline; Latin Americans; Context (archaeology); Venous thromboembolism; Pulmonary embolism; Family medicine; Grading (engineering); Deep vein; Intensive care medicine; Thrombosis; Surgery; Political science; Geography; Pathology","score_opus":0.03556740932165674,"score_gpt":0.350101530976782,"score_spread":0.31453412165512523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191156599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90668875,0.07096051,0.0027052257,0.008683338,0.000692762,0.0028151039,0.0001579643,0.00014687402,0.0071495],"genre_scores_gemma":[0.6890769,0.10036021,0.20111763,0.0055545424,0.0007658634,0.0010087079,0.00025962072,0.00021004376,0.001646468],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965026,0.00010516575,0.0010865298,0.00091352017,0.0005084768,0.00088374974],"domain_scores_gemma":[0.9980775,0.00025450255,0.000420042,0.00066314946,0.00035596214,0.00022884486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004942523,0.00048576217,0.0018067522,0.00021601774,0.00018620738,0.000049883085,0.0002720087,0.00018558868,0.0001613161],"category_scores_gemma":[0.00026844844,0.00046411878,0.0003047725,0.00059561327,0.00027122433,0.00022129921,0.0003081815,0.0002681025,0.000010449699],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037568063,0.017847778,0.051821884,0.017739015,0.0070641204,0.0026640443,0.007134618,0.0014274464,0.01877887,0.03579414,0.031962194,0.8073902],"study_design_scores_gemma":[0.03377941,0.0044346997,0.3840585,0.00858663,0.011293813,0.0005885446,0.04367623,0.001529457,0.08776753,0.054225586,0.36587113,0.0041884566],"about_ca_topic_score_codex":0.00020019345,"about_ca_topic_score_gemma":0.00027916202,"teacher_disagreement_score":0.80320174,"about_ca_system_score_codex":0.00008827959,"about_ca_system_score_gemma":0.00018314901,"threshold_uncertainty_score":0.9997811},"labels":[],"label_agreement":null},{"id":"W3192460245","doi":"10.1182/bloodadvances.2021005328","title":"Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies","year":2021,"lang":"en","type":"letter","venue":"Blood Advances","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Messenger RNA; Medicine; Immunology; Biology; Internal medicine; Gene; Genetics; Infectious disease (medical specialty)","score_opus":0.02400499539641135,"score_gpt":0.30997213690828374,"score_spread":0.2859671415118724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192460245","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95585835,0.006099638,0.00002146391,0.036048483,0.00021909969,0.00091164385,0.00012555617,0.00013220901,0.0005835603],"genre_scores_gemma":[0.082436375,0.00014909006,0.00035035927,0.91551435,0.0009375251,0.00016304212,0.00008781002,0.00015738083,0.00020408127],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972255,0.0001288987,0.0003826874,0.0006825655,0.0010303931,0.0005499163],"domain_scores_gemma":[0.9983364,0.00036977572,0.00029032765,0.00063445035,0.00031284295,0.000056253528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016305591,0.00040629206,0.0009936246,0.00039822934,0.000056254514,0.000025377862,0.00029046336,0.00037480073,0.000017333557],"category_scores_gemma":[0.0005134542,0.00030766235,0.00015145483,0.0006498741,0.00015671499,0.00020990954,0.00012378943,0.00076778705,0.0000086434065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080107857,0.0007968876,0.97327346,0.0036981762,0.00023948376,0.0014735295,0.00012635613,0.0000015962463,0.0017825284,0.0000029365422,0.01552558,0.0022784106],"study_design_scores_gemma":[0.0079015,0.0008205173,0.04051013,0.00087958784,0.0002292147,0.00005606284,0.000053239473,0.0000016912492,0.054018162,0.0000591039,0.89503187,0.00043891964],"about_ca_topic_score_codex":0.0003490536,"about_ca_topic_score_gemma":0.0002264039,"teacher_disagreement_score":0.9327633,"about_ca_system_score_codex":0.00016507362,"about_ca_system_score_gemma":0.0014091363,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W3194367680","doi":"10.1182/bloodadvances.2020003844","title":"Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Cytokine release syndrome; Immunogenicity; Antibody; Immunology; Medicine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; B cell; Immunotherapy; Immune system; Oncology; Chimeric antigen receptor","score_opus":0.010106057027941427,"score_gpt":0.2702827667122035,"score_spread":0.2601767096842621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194367680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96110934,0.03364602,0.00002535039,0.00010251954,0.00015902612,0.00028314593,0.000034960638,0.00006607326,0.0045735533],"genre_scores_gemma":[0.9714235,0.013597463,0.00058434723,0.00037928263,0.00013758265,0.00004054303,0.00003919113,0.000059827136,0.013738252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785024,0.00012524496,0.0003727296,0.00058271864,0.0004490577,0.00062003575],"domain_scores_gemma":[0.99878573,0.00026107923,0.00008627723,0.000536494,0.00010433504,0.00022608155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002351789,0.0002649404,0.0004944768,0.00015207574,0.000110754016,0.000043444958,0.00015068185,0.00015337528,0.00057865767],"category_scores_gemma":[0.00014446254,0.00025204188,0.00012075951,0.00045538877,0.00013076274,0.00017625358,0.00018900045,0.00025983754,0.000055582375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001018589,0.0057943324,0.02520882,0.00029869418,0.00027879846,0.0033500744,0.0006162485,0.0000044068584,0.9236744,0.00006371919,0.00012612353,0.039565768],"study_design_scores_gemma":[0.12177127,0.0013064954,0.097186215,0.00048932055,0.00063394767,0.0016932577,0.0010283766,0.00050032634,0.6543931,0.0004602208,0.11960413,0.00093338167],"about_ca_topic_score_codex":0.00004896283,"about_ca_topic_score_gemma":0.00016382105,"teacher_disagreement_score":0.2692814,"about_ca_system_score_codex":0.00028441413,"about_ca_system_score_gemma":0.0005805511,"threshold_uncertainty_score":0.9999932},"labels":[],"label_agreement":null},{"id":"W3194397741","doi":"10.1182/bloodadvances.2021004375","title":"Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Vinblastine; Medicine; Bleomycin; Stage (stratigraphy); Nuclear medicine; Positron emission tomography; Chemotherapy; Radiation therapy; Lymphoma; Oncology; Vincristine; Hodgkin's lymphoma; Internal medicine; Radiology; Cyclophosphamide","score_opus":0.01675286529882216,"score_gpt":0.2905401237329178,"score_spread":0.2737872584340957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194397741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625051,0.034068912,0.000033307202,0.00013275429,0.000042593812,0.0004229492,0.00008155858,0.000020059619,0.0026927744],"genre_scores_gemma":[0.9932727,0.0033208628,0.0028603517,0.000060027207,0.000037359216,0.000053927954,0.00003225768,0.000020025896,0.0003424636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985516,0.000098599194,0.00048773986,0.00032551182,0.00030145896,0.0002350961],"domain_scores_gemma":[0.9986933,0.00026571506,0.00026158747,0.0005119517,0.00015889005,0.00010856923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019209975,0.00023598436,0.0008330276,0.00007033845,0.00005776094,0.000014084808,0.000100247154,0.000048238962,0.000048528484],"category_scores_gemma":[0.00021283058,0.00012752737,0.00034930668,0.00028081064,0.0002788523,0.00008758991,0.00008765799,0.00003710682,0.0000019874208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021236613,0.005887541,0.94831395,0.0006881076,0.0020362781,0.0007953761,0.00079313497,0.0002186974,0.0044340827,0.0032650395,0.000049894796,0.03139426],"study_design_scores_gemma":[0.07577863,0.001358982,0.7964138,0.00041507737,0.0020423776,0.0018128422,0.0016735591,0.0020125632,0.11572694,0.00021142386,0.0021614933,0.00039230136],"about_ca_topic_score_codex":0.0004093678,"about_ca_topic_score_gemma":0.000016804406,"teacher_disagreement_score":0.15190013,"about_ca_system_score_codex":0.000072057264,"about_ca_system_score_gemma":0.00022845564,"threshold_uncertainty_score":0.5200415},"labels":[],"label_agreement":null},{"id":"W3194857218","doi":"10.1182/bloodadvances.2020003669","title":"Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Immunology; Immune tolerance; Immunosuppression; Myeloid; Myeloid-derived Suppressor Cell; Haematopoiesis; T cell; Transplantation; Microchimerism; Medicine; Immune system; Cancer research; Biology; Stem cell; Internal medicine; Suppressor; Cancer","score_opus":0.0069794823961097565,"score_gpt":0.2327630657271686,"score_spread":0.22578358333105883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194857218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96467656,0.033521853,0.00005097519,0.00004533141,0.000838908,0.00019624339,0.000023095916,0.000015772288,0.0006312495],"genre_scores_gemma":[0.9938191,0.0012283424,0.0038914024,0.00010179585,0.000010151648,0.00004003924,0.000024838126,0.00001870286,0.000865629],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986345,0.0000830991,0.00048660336,0.00038898733,0.00005540533,0.0003513641],"domain_scores_gemma":[0.9994162,0.000086956294,0.00013410427,0.00026029788,0.00007805094,0.00002442985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011407866,0.00019623895,0.00039868228,0.000082309445,0.00008682071,0.000008328395,0.00021744666,0.00013599674,0.00016890075],"category_scores_gemma":[0.000016397047,0.00019368976,0.000033598182,0.00022396739,0.00010086923,0.00010242196,0.000111670284,0.00021776669,0.00005576775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082900195,0.00027691794,0.0022926896,0.000118555974,0.00004494737,0.00002424875,0.0087819155,0.000050532744,0.9844845,0.000011901729,0.00003222236,0.0037987023],"study_design_scores_gemma":[0.0014847161,0.00005246104,0.004318241,0.00040479822,0.00002520613,0.00004221078,0.0008116473,1.846568e-7,0.98075426,0.000026525886,0.011856058,0.0002237103],"about_ca_topic_score_codex":0.0000075503376,"about_ca_topic_score_gemma":0.000058027872,"teacher_disagreement_score":0.03229351,"about_ca_system_score_codex":0.00002477797,"about_ca_system_score_gemma":0.00015434415,"threshold_uncertainty_score":0.7898439},"labels":[],"label_agreement":null},{"id":"W3195402262","doi":"10.1182/bloodadvances.2020002539","title":"Arhgef2 regulates mitotic spindle orientation in hematopoietic stem cells and is essential for productive hematopoiesis","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Manitoba; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Stem cell; Cell biology; Mitosis; Biology; Orientation (vector space); Hematopoietic stem cell","score_opus":0.011001105593713296,"score_gpt":0.2654156663118171,"score_spread":0.2544145607181038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195402262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918852,0.004483296,0.0012106003,0.0007963735,0.00030709422,0.0009999088,0.000030837582,0.000049500315,0.00023720082],"genre_scores_gemma":[0.987158,0.00059200363,0.010796674,0.00012802343,0.00014384613,0.00015133282,0.000041975367,0.00003810177,0.00095003156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837416,0.000044634722,0.00043826542,0.0005881834,0.0002670655,0.00028766456],"domain_scores_gemma":[0.9991581,0.00017907558,0.00012757885,0.0002603932,0.00017841301,0.00009644062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015216683,0.00020505667,0.00043711934,0.000112556125,0.00007508189,0.000033657427,0.00004935189,0.0000896468,0.000044045322],"category_scores_gemma":[0.000035990433,0.00019898749,0.00007812482,0.00032834144,0.0000861391,0.00023693296,0.000017926826,0.00009207764,0.000008938533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090334145,0.0024195442,0.0477444,0.020314997,0.000535311,0.0005912579,0.027183361,0.00012225384,0.8867182,0.004597389,0.0003163131,0.008553623],"study_design_scores_gemma":[0.002918944,0.00014990062,0.0024325054,0.00065836136,0.00034106657,0.00034010914,0.0036214723,0.00007932223,0.9872984,0.0014504835,0.0004994111,0.0002099672],"about_ca_topic_score_codex":0.0000060663774,"about_ca_topic_score_gemma":0.000021806147,"teacher_disagreement_score":0.10058025,"about_ca_system_score_codex":0.000026806345,"about_ca_system_score_gemma":0.00010687997,"threshold_uncertainty_score":0.81144744},"labels":[],"label_agreement":null},{"id":"W3196160512","doi":"10.1182/bloodadvances.2021004475","title":"An irradiated marrow niche reveals a small non-collagenous protein mediator of homing, dermatopontin","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Heart, Lung, and Blood Institute","keywords":"Homing (biology); Mediator; Niche; Bone marrow; Biology; Cell biology; Immunology; Ecology","score_opus":0.006752065893865956,"score_gpt":0.23155085610530332,"score_spread":0.22479879021143737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196160512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895601,0.00925295,0.00019568022,0.000048471742,0.00010021739,0.00024230634,0.000056824785,0.000022855034,0.00052054244],"genre_scores_gemma":[0.99211353,0.00025387903,0.006329182,0.00012217648,0.0002157233,0.000056186836,0.0001530085,0.000032109103,0.00072423264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986836,0.00013543112,0.00032065096,0.00042020253,0.00014064004,0.00029951296],"domain_scores_gemma":[0.9990416,0.000014689111,0.00017793478,0.0004578003,0.00016991996,0.00013803659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020945397,0.00018682583,0.00027685723,0.000036604604,0.000078646786,0.000021952923,0.0002378435,0.00016113657,0.000027600036],"category_scores_gemma":[0.0001638586,0.0001825663,0.00009962827,0.0001598714,0.000063926,0.0000074171235,0.000050881652,0.00008347174,0.000006527293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003662179,0.00025832432,0.003911474,0.00010560197,0.000059742975,0.000060520884,0.00014178883,0.000033955384,0.99425644,0.0000108373315,0.00003094481,0.0010937568],"study_design_scores_gemma":[0.0007525916,0.00030568472,0.00070355885,0.00006544112,0.000046251087,0.00004466444,0.00018629973,0.000017720624,0.9893566,0.00007498571,0.008213744,0.00023250545],"about_ca_topic_score_codex":0.0000115788935,"about_ca_topic_score_gemma":0.000116936324,"teacher_disagreement_score":0.008999071,"about_ca_system_score_codex":0.0000044599064,"about_ca_system_score_gemma":0.00021814737,"threshold_uncertainty_score":0.74448377},"labels":[],"label_agreement":null},{"id":"W3196325957","doi":"10.1182/bloodadvances.2021004287","title":"IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Hemophagocytic lymphohistiocytosis; Sepsis; Proteome; Immunology; Signature (topology); Medicine; Severe sepsis; Systemic inflammatory response syndrome; Intensive care medicine; Biology; Septic shock; Pathology; Bioinformatics","score_opus":0.011330786001757905,"score_gpt":0.2661727459402887,"score_spread":0.2548419599385308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196325957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94652015,0.04975621,0.0000070098686,0.0009802091,0.0000640866,0.00037347202,0.000020628779,0.000035905618,0.0022423514],"genre_scores_gemma":[0.9949482,0.0032340568,0.0006013451,0.00031663038,0.00023287338,0.00009499055,0.000043773267,0.000019202173,0.00050891406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855936,0.00010494589,0.00028854993,0.00035871033,0.00039641932,0.0002920037],"domain_scores_gemma":[0.99913615,0.0003266996,0.00008080155,0.00029969905,0.00008938159,0.00006726249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018202166,0.00017052639,0.0003336977,0.00009042784,0.00014333057,0.00005625867,0.00014662844,0.000097989316,0.00009882788],"category_scores_gemma":[0.000842787,0.0001199648,0.00006713569,0.000542321,0.00009751324,0.00015513813,0.000075726384,0.00030472435,0.000014231911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045665787,0.0015247134,0.921161,0.0016394057,0.00027001553,0.0034877183,0.005181496,0.00008981173,0.015348274,0.00027043023,0.0013517232,0.049218733],"study_design_scores_gemma":[0.015367224,0.0007673695,0.8487182,0.00062635844,0.0010305621,0.0004038339,0.01213429,0.00072340143,0.051271114,0.0029573673,0.06490542,0.0010948472],"about_ca_topic_score_codex":0.000052827923,"about_ca_topic_score_gemma":0.00006638915,"teacher_disagreement_score":0.072442815,"about_ca_system_score_codex":0.000028093948,"about_ca_system_score_gemma":0.00024045723,"threshold_uncertainty_score":0.48920226},"labels":[],"label_agreement":null},{"id":"W3196660659","doi":"10.1182/bloodadvances.2021004727","title":"Characteristics of Upper and Lower Extremity Deep Vein Thrombosis and Predictors of Post-Thrombotic Syndrome in Children","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Physicians' Services Incorporated Foundation","keywords":"Medicine; Thrombosis; Deep vein; Percentile; Post-thrombotic syndrome; Internal medicine; Venous thrombosis; Pulmonary embolism; Surgery; Pediatrics","score_opus":0.006801865264090222,"score_gpt":0.23883390060363044,"score_spread":0.23203203533954023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196660659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937404,0.0052885143,0.000008285549,0.00022931719,0.000102587655,0.00029501927,0.000040080173,0.000013333867,0.0002824728],"genre_scores_gemma":[0.9887879,0.010304826,0.0006811289,0.00011593329,0.000028335691,0.000010353811,0.000030383742,0.00001593489,0.000025234871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893534,0.00003181572,0.0003672001,0.00028658798,0.00019332313,0.00018573915],"domain_scores_gemma":[0.99940264,0.0000597499,0.00014129154,0.00022551371,0.00008979847,0.000081003665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107568194,0.00014877033,0.0006923313,0.0000966269,0.000025685738,0.000008824328,0.000053676722,0.000061423496,0.00007497117],"category_scores_gemma":[0.00010469138,0.00013370988,0.000051285097,0.00016263704,0.00015678849,0.00013209555,0.00013701417,0.000092262824,7.8257165e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012725238,0.0012474452,0.9925504,0.00042266425,0.00023429081,0.000025783866,0.0002641731,0.0000016534782,0.0023931046,0.00018941784,0.000008166946,0.002650209],"study_design_scores_gemma":[0.0010467374,0.00036937193,0.99527186,0.00038394664,0.00048237454,0.00007259141,0.00016555446,0.0000067184646,0.0019060703,0.00009250497,0.00008794977,0.0001143454],"about_ca_topic_score_codex":0.000045713783,"about_ca_topic_score_gemma":0.000030842508,"teacher_disagreement_score":0.0050163125,"about_ca_system_score_codex":0.000009283236,"about_ca_system_score_gemma":0.000034135803,"threshold_uncertainty_score":0.54525304},"labels":[],"label_agreement":null},{"id":"W3197049258","doi":"10.1182/bloodadvances.2020003534","title":"Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"University of Oxford; University of Bristol; National Institute for Health and Care Research","keywords":"CD19; Minimal residual disease; CD34; Medicine; Leukemia; Immunology; Cancer research; Transplantation; Stem cell; Antigen; Oncology; Internal medicine; Biology","score_opus":0.01476344073809838,"score_gpt":0.3032942440092108,"score_spread":0.2885308032711124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197049258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709721,0.023102691,0.00014420912,0.00019937758,0.00016805268,0.00041272596,0.000006971878,0.00013097582,0.0048628678],"genre_scores_gemma":[0.9462808,0.034351893,0.011122001,0.00041496876,0.0017714058,0.00003331635,0.00008452959,0.00011532765,0.005825752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978205,0.00009730504,0.00031358065,0.0005434518,0.0006530341,0.00057211553],"domain_scores_gemma":[0.99881524,0.00019126492,0.00012891326,0.00039501177,0.0002981493,0.00017142594],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029839895,0.00024851895,0.0004371494,0.00011589176,0.00018174529,0.00006474006,0.0001467864,0.000076913544,0.0012367402],"category_scores_gemma":[0.000096477306,0.00018884102,0.0000988659,0.00078876794,0.00008428046,0.00021775738,0.000058066078,0.00040944596,0.000041184056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013541033,0.0002441418,0.10660603,0.00018714527,0.000093974486,0.0005673089,0.0001609635,0.00025637695,0.8794266,0.00001017627,0.000085662105,0.012226185],"study_design_scores_gemma":[0.0048760367,0.0006708011,0.004967663,0.00012166257,0.00011759485,0.00023461551,0.00067384844,0.00017976118,0.9642752,0.000032729433,0.0234774,0.00037272822],"about_ca_topic_score_codex":0.000018918274,"about_ca_topic_score_gemma":0.000004404858,"teacher_disagreement_score":0.10163837,"about_ca_system_score_codex":0.000051168812,"about_ca_system_score_gemma":0.0005304905,"threshold_uncertainty_score":0.9996763},"labels":[],"label_agreement":null},{"id":"W3197168928","doi":"10.1182/bloodadvances.2021004338","title":"Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Genital Health and Disease","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Sickle cell trait; Priapism; Stuttering; Exchange transfusion; Medicine; Hemoglobinopathy; Cell; Red Cell; Internal medicine; Anesthesia; Surgery; Biology; Audiology; Hemolytic anemia; Genetics; Disease","score_opus":0.006719472356754344,"score_gpt":0.23112952392708594,"score_spread":0.2244100515703316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197168928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888198,0.004525655,0.000013009983,0.00020475656,0.000028152368,0.0006311516,0.000022851716,0.00020346227,0.005551197],"genre_scores_gemma":[0.9976815,0.0001491551,0.0012607038,0.0002752596,0.000028757815,0.000087563705,0.000078313926,0.000028335822,0.00041039308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987854,0.00004373063,0.00022719,0.0003489739,0.0002455774,0.00034915397],"domain_scores_gemma":[0.9993681,0.00002205264,0.000063439315,0.00019346866,0.0000749415,0.00027805023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035995956,0.00018639122,0.00028090551,0.00008225309,0.00005671752,0.0000112158405,0.00003692742,0.00004841491,0.000088786845],"category_scores_gemma":[0.0000061845217,0.00013380681,0.000034962784,0.0003848014,0.000028387256,0.00011551915,0.000010713578,0.000113242575,0.0000053851595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033593882,0.03354539,0.31910095,0.028056845,0.00017734859,0.059137873,0.022810493,0.0016704508,0.4160428,0.000014818506,0.0004654661,0.085383676],"study_design_scores_gemma":[0.06069156,0.016545532,0.19493781,0.0017707554,0.0009850119,0.00085574907,0.005977146,0.001065838,0.7076007,0.00003378276,0.008274738,0.0012613758],"about_ca_topic_score_codex":0.0000859941,"about_ca_topic_score_gemma":0.0003301096,"teacher_disagreement_score":0.29155788,"about_ca_system_score_codex":0.000027170177,"about_ca_system_score_gemma":0.00018149352,"threshold_uncertainty_score":0.54564834},"labels":[],"label_agreement":null},{"id":"W3197580570","doi":"10.1182/bloodadvances.2020004101","title":"Abnormal B-cell development in TIMP-deficient bone marrow","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Lymphopoiesis; Haematopoiesis; Stem cell; Stromal cell; Cell biology; Biology; Bone marrow; Stem cell factor; Progenitor cell; Hematopoietic stem cell; Stromal cell-derived factor 1; Immunology; Cancer research; Chemokine; Inflammation","score_opus":0.012644632326499,"score_gpt":0.2730177191693473,"score_spread":0.2603730868428483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197580570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613695,0.0133431535,0.00005044043,0.00082653883,0.000104511084,0.00023381031,0.0000035621001,0.00004818889,0.024020307],"genre_scores_gemma":[0.9668673,0.0007415204,0.019821009,0.0005550432,0.000116556854,0.000058905396,0.00005298746,0.00002931566,0.011757317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983181,0.000043364922,0.00032540623,0.00036582703,0.0004643573,0.00048293974],"domain_scores_gemma":[0.99931675,0.00006673433,0.000049857652,0.00027926522,0.00012603121,0.00016135385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025435636,0.00015179813,0.00029080798,0.00013912519,0.000063274296,0.000019851528,0.00010120304,0.000067726505,0.0003192461],"category_scores_gemma":[0.00012008489,0.00013582868,0.00005103315,0.00046747958,0.000054696677,0.000121436125,0.00013825313,0.00030785138,0.00020733364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008364389,0.007977755,0.35064808,0.002219155,0.00023207757,0.02475253,0.003459345,0.0004366496,0.38735482,0.00068305794,0.0050115995,0.21638848],"study_design_scores_gemma":[0.005389575,0.00014948023,0.02204736,0.0001774154,0.000037607406,0.0004914277,0.00061728386,0.00006390514,0.6747554,0.00003901018,0.29596722,0.00026432564],"about_ca_topic_score_codex":0.000010277099,"about_ca_topic_score_gemma":0.000077637385,"teacher_disagreement_score":0.32860073,"about_ca_system_score_codex":0.00016485856,"about_ca_system_score_gemma":0.0008503783,"threshold_uncertainty_score":0.55389327},"labels":[],"label_agreement":null},{"id":"W3197874686","doi":"10.1182/bloodadvances.2021005096","title":"Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Swedish Orphan Biovitrum; Radboud Universitair Medisch Centrum; Maastricht Universitair Medisch Centrum; Amsterdam University Medical Centers; Great Ormond Street Hospital for Children; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Universiteit Maastricht; Radboud Universiteit; Imperial College Healthcare NHS Trust; Imperial College London; Cardiff University; Universitair Medisch Centrum Groningen; CSL Behring; Leids Universitair Medisch Centrum; Universiteit Leiden; Institute of Infection and Immunity; Royal Free London NHS Foundation Trust","keywords":"Medicine; Documentation; Population; Dosing; Covariate; Data collection; Best practice; Medical physics; Statistics; Computer science; Internal medicine; Mathematics","score_opus":0.24274431957649095,"score_gpt":0.513110085561485,"score_spread":0.270365765984994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197874686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025582377,0.97300315,0.0000011400776,0.000029407058,0.00005038818,0.0011501737,0.00003305305,0.000005480907,0.0001448486],"genre_scores_gemma":[0.021819035,0.9772205,0.0005063736,0.000004260281,0.00007251284,0.00004875778,0.0002893176,0.000020370537,0.000018918152],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99783105,0.00043104668,0.0006344989,0.00031557627,0.00063006545,0.00015776002],"domain_scores_gemma":[0.9987585,0.00023151148,0.00032306561,0.00019319124,0.00041727372,0.0000764551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005112523,0.00020922547,0.0012646466,0.00015962798,0.000019869114,0.000008703155,0.000059178677,0.00012253993,0.000059315313],"category_scores_gemma":[0.00039980808,0.0001563178,0.00011130777,0.00033881696,0.000040488958,0.00028759823,0.00002851195,0.00019131602,0.0000010657842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019876114,0.00083319936,0.0007449463,0.023544254,0.0002048197,0.000019285775,0.000080216574,0.00020664236,0.000029735427,0.000036856403,3.3918727e-7,0.9742798],"study_design_scores_gemma":[0.032331273,0.005041968,0.00090156886,0.48919842,0.09917273,0.0011422569,0.00271412,0.108324766,0.0020346346,0.0009024137,0.25539988,0.0028359538],"about_ca_topic_score_codex":0.00006217992,"about_ca_topic_score_gemma":0.000014273889,"teacher_disagreement_score":0.9714439,"about_ca_system_score_codex":0.000054250922,"about_ca_system_score_gemma":0.0003359975,"threshold_uncertainty_score":0.63744545},"labels":[],"label_agreement":null},{"id":"W3197892791","doi":"10.1182/bloodadvances.2021005493","title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; University of Ottawa; McGill University; Impact; McMaster University; University of Toronto; Cochrane; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Hematology; 2019-20 coronavirus outbreak; Critically ill; Intensive care medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); MEDLINE; Internal medicine; Virology; Biology","score_opus":0.06481556353240148,"score_gpt":0.3224186269089308,"score_spread":0.25760306337652933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197892791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944709,0.000038013015,0.00061301596,0.0037979402,0.000076018914,0.000945449,0.000048784583,0.0000058549363,0.0000040307486],"genre_scores_gemma":[0.98964864,0.00028393537,0.004304211,0.0056403214,0.000016065653,0.000031486732,0.000055406414,0.000016072678,0.000003840633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839175,0.0001229875,0.00065333035,0.0002886862,0.0003454005,0.00019785669],"domain_scores_gemma":[0.99654305,0.0011205086,0.00041295093,0.00035500925,0.0015251565,0.000043342294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022762784,0.00015853185,0.000668751,0.00009015717,0.000047274156,0.000011758954,0.000087485416,0.000043206444,0.000020514939],"category_scores_gemma":[0.0052471505,0.000094894,0.00010420022,0.00035083923,0.0002884718,0.0001549329,0.00007571847,0.00009600371,3.9429153e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000335785,0.0032689427,0.98769486,0.00040536525,0.00014539491,0.0000022986776,0.0005327949,0.002180383,0.00025303286,0.0015737931,0.0005027086,0.0031046583],"study_design_scores_gemma":[0.00133722,0.001315791,0.9899524,0.0008836402,0.00012925496,3.429947e-7,0.0005897744,0.0013841109,0.0036706051,0.00011692304,0.00051601126,0.0001039379],"about_ca_topic_score_codex":0.00021538408,"about_ca_topic_score_gemma":0.00023046855,"teacher_disagreement_score":0.0050195227,"about_ca_system_score_codex":0.000035791567,"about_ca_system_score_gemma":0.00006762232,"threshold_uncertainty_score":0.62817085},"labels":[],"label_agreement":null},{"id":"W3197946407","doi":"10.1182/bloodadvances.2021004658","title":"A new murine <i>Rpl5</i> ( <i>uL18</i> ) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Haploinsufficiency; Penetrance; Biology; Diamond–Blackfan anemia; Germline; Germline mutation; Mutation; Genetics; Mutant; Exome sequencing; Phenotype; Germline mosaicism; Erythropoiesis; Cancer research; Gene; Anemia; Ribosome; Medicine; Internal medicine","score_opus":0.008000115345912667,"score_gpt":0.2391799691360729,"score_spread":0.23117985379016023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197946407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88721555,0.019243404,0.08758977,0.00044338126,0.00013007027,0.000349889,0.00012070934,0.00003291642,0.0048743063],"genre_scores_gemma":[0.9610816,0.0028761805,0.03271144,0.00023632166,0.00014664966,0.000048436083,0.00018311209,0.000023580178,0.0026926822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904525,0.000036304704,0.00025456928,0.00035576688,0.00013090708,0.00017720756],"domain_scores_gemma":[0.99925435,0.000011883268,0.00013078898,0.00035874345,0.00016424582,0.00008001206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075947835,0.00014200673,0.00016087235,0.000025391302,0.000051993793,0.000019671541,0.00014861657,0.00008716188,0.00002123858],"category_scores_gemma":[0.000048165566,0.00013710622,0.00007736271,0.00014698271,0.00004752185,0.000016702159,0.000047043282,0.00006422039,0.0000015111918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046982866,0.00013051451,0.0005329272,0.00007862499,0.000037389877,0.0000058071078,0.00006455508,0.007245526,0.98265916,0.0008741215,0.00050878373,0.007815607],"study_design_scores_gemma":[0.0008114609,0.00014435349,0.00022408627,0.00003441687,0.00006852457,0.000026690172,0.000077101125,0.0006055659,0.98154414,0.0015016964,0.014765523,0.00019641411],"about_ca_topic_score_codex":0.0000419742,"about_ca_topic_score_gemma":0.00013881584,"teacher_disagreement_score":0.07386605,"about_ca_system_score_codex":0.0000067380884,"about_ca_system_score_gemma":0.00042673948,"threshold_uncertainty_score":0.55910295},"labels":[],"label_agreement":null},{"id":"W3197991753","doi":"10.1182/bloodadvances.2020003958","title":"Engraftment characterization of risk-stratified AML in NSGS mice","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Interreg; Instituto de Salud Carlos III; Generalitat de Catalunya; Ministerio de Economía y Competitividad; Health Canada; Centres de Recerca de Catalunya","keywords":"Myeloid leukemia; Bone marrow; Medicine; Leukemia; Haematopoiesis; CD34; Transplantation; Mesenchymal stem cell; Internal medicine; Oncology; Cancer research; Stem cell; Biology; Pathology","score_opus":0.011552938393422744,"score_gpt":0.2844216532935622,"score_spread":0.2728687149001395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197991753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648416,0.001189784,0.00010005432,0.00043506824,0.00006110018,0.000215932,0.00003461387,0.000019865116,0.0014594069],"genre_scores_gemma":[0.99388784,0.0026741326,0.002475471,0.000097225304,0.000093311624,0.000025551837,0.00015474268,0.000012717791,0.00057902146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990224,0.00007431113,0.000261144,0.00022001048,0.00024150242,0.0001805897],"domain_scores_gemma":[0.99941206,0.00009234301,0.000104569015,0.00020212197,0.00012772939,0.00006120247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014344504,0.000089953006,0.00023702398,0.00008586386,0.00002389923,0.00000811744,0.00006334424,0.000050957235,0.00010233376],"category_scores_gemma":[0.00026792433,0.000080929036,0.00004299105,0.0003463237,0.000044794175,0.00012586657,0.000033373977,0.00018335233,0.000012675688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012499001,0.00046173958,0.046071604,0.00016684756,0.00005178564,0.00016234636,0.00047799878,0.0000068174368,0.9338143,0.00023773537,0.000011948827,0.018411884],"study_design_scores_gemma":[0.0022529592,0.000116249146,0.18218324,0.00012690658,0.000060581933,0.00003121838,0.0003274183,0.00006899491,0.81073135,0.00012517291,0.0038935856,0.0000823208],"about_ca_topic_score_codex":0.000029670808,"about_ca_topic_score_gemma":0.0000813731,"teacher_disagreement_score":0.13611163,"about_ca_system_score_codex":0.0000458155,"about_ca_system_score_gemma":0.00022007349,"threshold_uncertainty_score":0.33001903},"labels":[],"label_agreement":null},{"id":"W3198124923","doi":"10.1182/bloodadvances.2020003848","title":"Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Fludarabine; Chemotherapy; Survival rate; Surgery; Cyclophosphamide","score_opus":0.015949554239113296,"score_gpt":0.32829919814359676,"score_spread":0.31234964390448344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198124923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98405224,0.007704128,0.000020719976,0.00028639153,0.000096132426,0.0003631575,0.000023165774,0.00004299131,0.007411092],"genre_scores_gemma":[0.9887173,0.0015866528,0.0017752947,0.0003116673,0.00007707355,0.000020291072,0.00002719008,0.000059207512,0.00742531],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802077,0.00009770619,0.00041360114,0.00041362483,0.0006042869,0.0004500217],"domain_scores_gemma":[0.9988019,0.00019946869,0.0001511775,0.0005585694,0.00015885831,0.00013001997],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021893629,0.00023128308,0.00082164246,0.00014631602,0.00004018285,0.00001579341,0.00016466186,0.00010387871,0.0010087239],"category_scores_gemma":[0.000034435885,0.00018555784,0.00012791077,0.00043863585,0.00011211308,0.00012630889,0.000048499867,0.00023430212,0.000022389278],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010225822,0.006045181,0.60500985,0.0003888153,0.00015187942,0.00025301948,0.0011052536,0.0000122719575,0.37864444,0.000033976485,0.00018394107,0.0071487757],"study_design_scores_gemma":[0.021467749,0.00094398274,0.0646338,0.00016783449,0.00006602813,0.00001351743,0.0018382049,0.00002628141,0.82068217,0.00001640688,0.08991213,0.00023189248],"about_ca_topic_score_codex":0.00003579727,"about_ca_topic_score_gemma":0.00020087723,"teacher_disagreement_score":0.54037607,"about_ca_system_score_codex":0.00007033727,"about_ca_system_score_gemma":0.00025348653,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W3198126629","doi":"10.1182/bloodadvances.2021004675","title":"Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; University of Toronto; Children's Hospital of Eastern Ontario; University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Anemia; Pediatrics; Prospective cohort study; Physical therapy; Internal medicine","score_opus":0.017342505388039362,"score_gpt":0.2818008683293568,"score_spread":0.2644583629413174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198126629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734205,0.025623607,0.000013863549,0.00055704854,0.000027379188,0.00015463223,0.000012355123,0.000015511818,0.00017508729],"genre_scores_gemma":[0.99593616,0.0029123,0.00070935517,0.00034851767,0.000013913199,0.0000044601466,0.00003348059,0.000005493701,0.00003630658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992061,0.00007990468,0.00028140467,0.00022825725,0.00008289818,0.000121412726],"domain_scores_gemma":[0.99956805,0.000054298256,0.00012440214,0.00011105323,0.000050725746,0.000091484006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010685822,0.00008109398,0.00034106607,0.000043117765,0.000031962372,0.0000024163567,0.000016028256,0.000038533773,0.000015545153],"category_scores_gemma":[0.00012259725,0.0000619521,0.00001474736,0.00018693398,0.00010814185,0.000056434325,0.000017488483,0.00009796514,5.089996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051491155,0.00033076876,0.98539776,0.00037697147,0.000028398952,0.000012638939,0.00051981944,0.000019386345,0.0032920542,0.00036332553,0.000007835497,0.009136148],"study_design_scores_gemma":[0.0044928347,0.0006314275,0.9927346,0.00019796196,0.000015104547,0.000054496715,0.00040148725,0.000008730531,0.0012455399,0.00011046522,0.000033096352,0.000074226904],"about_ca_topic_score_codex":0.00021704653,"about_ca_topic_score_gemma":0.00035132185,"teacher_disagreement_score":0.022711305,"about_ca_system_score_codex":0.000003883315,"about_ca_system_score_gemma":0.000099271085,"threshold_uncertainty_score":0.25263333},"labels":[],"label_agreement":null},{"id":"W3198223284","doi":"10.1182/bloodadvances.2021004352","title":"Suboptimal iron deficiency screening in pregnancy and the impact of socioeconomic status in a high-resource setting","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Ferritin; Pregnancy; Odds ratio; Anemia; Prenatal care; Confidence interval; Obstetrics; Cohort; Pediatrics; Internal medicine; Population; Environmental health; Biology","score_opus":0.006453389798163983,"score_gpt":0.2632380352763514,"score_spread":0.25678464547818747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198223284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9145708,0.08393576,0.000025816636,0.00016466735,0.000014930724,0.0001718631,0.00000821825,0.0000075137696,0.0011004134],"genre_scores_gemma":[0.99557424,0.002131038,0.0021618241,0.000043424312,0.000019091105,0.00001045917,0.00000942834,0.000009733675,0.000040758292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911547,0.000074983654,0.00025867007,0.00019724942,0.00008368002,0.00026993876],"domain_scores_gemma":[0.9995621,0.00014661801,0.00009834112,0.00013599882,0.000015842428,0.000041092324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001849934,0.00010427436,0.00029666393,0.00007272445,0.000034609424,0.00001022572,0.00004689179,0.000035029338,0.00003105656],"category_scores_gemma":[0.00013511018,0.0000721486,0.00005938103,0.00012780385,0.0001398999,0.00012520781,0.000042334537,0.00013361956,8.4476653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002370863,0.00018874886,0.9600563,0.00019707666,0.00000773718,0.000028356233,0.0020138093,0.0029452783,0.00076842535,0.0005176123,0.000004895761,0.03303464],"study_design_scores_gemma":[0.012929016,0.00011096501,0.9800717,0.00035175335,0.000071221795,0.00002034961,0.004754094,0.00026267007,0.0008106136,0.00043702294,0.000051252006,0.00012932722],"about_ca_topic_score_codex":0.00044003106,"about_ca_topic_score_gemma":0.00013662328,"teacher_disagreement_score":0.08180472,"about_ca_system_score_codex":0.000010326417,"about_ca_system_score_gemma":0.000101493475,"threshold_uncertainty_score":0.29421344},"labels":[],"label_agreement":null},{"id":"W3198291825","doi":"10.1182/bloodadvances.2021004567","title":"Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Factor XII; Prekallikrein; Chemistry; Thrombin; Internal medicine; Fibrin; Molecular biology; Plasminogen activator; Antithrombin; Endocrinology; Thromboplastin; Biochemistry; Coagulation; Kallikrein; Platelet; Biology; Immunology; Heparin; Medicine; Enzyme","score_opus":0.019201634308536625,"score_gpt":0.28008631032410325,"score_spread":0.26088467601556664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198291825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94565713,0.05025727,0.000018711775,0.002914733,0.00020994015,0.00039047227,0.00011045404,0.00008294794,0.00035836594],"genre_scores_gemma":[0.9919908,0.0026975998,0.0007919046,0.0015900418,0.00011694694,0.000037854246,0.00007147539,0.000044237117,0.002659149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791414,0.000045388184,0.0004905845,0.0006857296,0.00041063986,0.00045352717],"domain_scores_gemma":[0.9990609,0.00009935928,0.0001654482,0.00030996097,0.00015041888,0.00021390954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000092153634,0.0003278682,0.00057884934,0.00010108988,0.00012380346,0.000046765326,0.00010932141,0.00015899651,0.0006159327],"category_scores_gemma":[0.00012087062,0.00030965146,0.000093199604,0.00047393006,0.000062439554,0.0003052721,0.00007667118,0.00019745665,0.000031863572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015128995,0.00083270844,0.45831323,0.00028753837,0.00026586978,0.00017336891,0.0022372445,0.0000012895265,0.5139766,0.000081099104,0.0014508272,0.022229],"study_design_scores_gemma":[0.0038497145,0.0002333716,0.1106227,0.00028416901,0.00019291934,0.000070587215,0.000521184,0.00006379884,0.87296104,0.00017004035,0.010616339,0.00041416445],"about_ca_topic_score_codex":0.0006489951,"about_ca_topic_score_gemma":0.00025655728,"teacher_disagreement_score":0.35898447,"about_ca_system_score_codex":0.000058811238,"about_ca_system_score_gemma":0.0001414856,"threshold_uncertainty_score":0.99993557},"labels":[],"label_agreement":null},{"id":"W3198626816","doi":"10.1182/bloodadvances.2021004865","title":"Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Office of Naval Research; Legend Biotech; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Health Resources and Services Administration; National Institutes of Health; Astellas Pharma; bluebird bio; Kiadis Pharma; Daiichi-Sankyo; Omeros Corporation; Pfizer; Incyte; National Institute of Allergy and Infectious Diseases; Angiocrine Bioscience; Cancer Moonshot; Medical College of Wisconsin; StemCyte; Bristol-Myers Squibb; CSL Behring; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; U.S. Navy; Celgene; U.S. Department of Defense; Moonshot Research and Development Program; Sanofi; Astellas Pharma US; Biomedical Advanced Research and Development Authority; Amgen; Jazz Pharmaceuticals; Be The Match Foundation; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences","keywords":"Hematopoietic cell; Lymphoma; Diffuse large B-cell lymphoma; Hematopoietic stem cell transplantation; Transplantation; Medicine; Haematopoiesis; Cancer research; Pathology; Oncology; Internal medicine; Biology; Stem cell; Genetics","score_opus":0.010620727828908683,"score_gpt":0.27504908834132746,"score_spread":0.2644283605124188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198626816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729237,0.024633562,0.0007185656,0.00016539413,0.00015738208,0.0004790472,0.000042248175,0.00006926555,0.0008108449],"genre_scores_gemma":[0.987888,0.0045888117,0.004385505,0.0002813388,0.00006466942,0.00006462302,0.000121232806,0.00003965688,0.0025661932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984865,0.000045244502,0.0002605375,0.0004538412,0.00028098552,0.0004728901],"domain_scores_gemma":[0.99908257,0.00025344733,0.000064911634,0.00029423274,0.00013011252,0.00017472451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013489695,0.00018990577,0.000368908,0.00007216863,0.000107484775,0.000028875602,0.00008882686,0.00011571087,0.000048233556],"category_scores_gemma":[0.00005919074,0.0001657044,0.00008426691,0.00020762152,0.00007515832,0.000117673415,0.000039731643,0.000074859534,0.00002831778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007870738,0.07115572,0.059219483,0.07959589,0.0022922955,0.0756958,0.014567187,0.00017076763,0.62141776,0.0035520217,0.003179046,0.061283275],"study_design_scores_gemma":[0.26929513,0.0022818935,0.010283721,0.0005634551,0.0020296727,0.027410313,0.00097284035,0.0012377704,0.6407077,0.001129427,0.043093797,0.000994329],"about_ca_topic_score_codex":0.000009603056,"about_ca_topic_score_gemma":0.00002564109,"teacher_disagreement_score":0.2614244,"about_ca_system_score_codex":0.00034556448,"about_ca_system_score_gemma":0.0013354128,"threshold_uncertainty_score":0.67572296},"labels":[],"label_agreement":null},{"id":"W3198965035","doi":"10.1182/bloodadvances.2021004916","title":"Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Cancer Moonshot; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Biomedical Advanced Research and Development Authority; National Institutes of Health; National Center for Advancing Translational Sciences; Health Resources and Services Administration; bluebird bio; Astellas Pharma; Angiocrine Bioscience; National Institute of Allergy and Infectious Diseases; Celgene; Actinium Pharmaceuticals; Moonshot Research and Development Program; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Hazard ratio; Internal medicine; Umbilical cord; Cyclophosphamide; Transplantation; Gastroenterology; Hematopoietic stem cell transplantation; Human leukocyte antigen; Graft-versus-host disease; Hematopoietic cell; Lymphoblastic Leukemia; Cord blood; Oncology; Retrospective cohort study; Leukemia; Haematopoiesis; Immunology; Chemotherapy; Confidence interval; Antigen; Stem cell; Biology","score_opus":0.01435071129726823,"score_gpt":0.29011770793372843,"score_spread":0.2757669966364602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198965035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94399697,0.003446367,0.04623389,0.00041388223,0.00072482537,0.0013115287,0.00016764016,0.00033158684,0.0033733263],"genre_scores_gemma":[0.95813197,0.0069821263,0.028322525,0.00049316237,0.00024868915,0.00021478233,0.00056342327,0.000114909155,0.0049284366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750954,0.0000609823,0.00071987946,0.0006596157,0.00051473884,0.00053521583],"domain_scores_gemma":[0.998241,0.0007000634,0.0001688661,0.00034908552,0.00027029953,0.00027070122],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016055335,0.00035382874,0.0006414068,0.00015705245,0.00016564493,0.00006432936,0.00013706942,0.00022539291,0.00028253676],"category_scores_gemma":[0.00011227309,0.0003076859,0.00022939725,0.0005003264,0.00009915084,0.00026620537,0.000014604791,0.00020080256,0.00008529496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025340559,0.007963534,0.044215202,0.04763605,0.0054724216,0.03132231,0.007349915,0.0009767894,0.81249917,0.008176828,0.0010741912,0.007973049],"study_design_scores_gemma":[0.02110304,0.0019407575,0.0022979341,0.0017866693,0.013939228,0.01089115,0.00063138123,0.000515499,0.94327,0.000909851,0.0020291673,0.00068531785],"about_ca_topic_score_codex":0.0000058380842,"about_ca_topic_score_gemma":0.00004251661,"teacher_disagreement_score":0.13077086,"about_ca_system_score_codex":0.00005827952,"about_ca_system_score_gemma":0.0005961313,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W3199052835","doi":"10.1182/bloodadvances.2021004580","title":"Outcomes of acute lymphoblastic leukemia with <i>KMT2A</i> (<i>MLL</i>) rearrangement: the MD Anderson experience","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Minimal residual disease; Medicine; Confidence interval; Internal medicine; Leukemia; Oncology; Gene rearrangement; Hematopoietic stem cell transplantation; Gastroenterology; Transplantation; Pediatrics; Biology; Genetics; Gene","score_opus":0.011557432780519334,"score_gpt":0.27880323980497407,"score_spread":0.2672458070244547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199052835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98466235,0.00505759,0.0012799745,0.0011593793,0.00017568022,0.0005120711,0.00003688521,0.00008838707,0.0070277015],"genre_scores_gemma":[0.9910231,0.0021865212,0.0031907791,0.001069371,0.00011539849,0.00010506795,0.000022201772,0.000046226804,0.0022412906],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755085,0.00007321553,0.00037393958,0.00049770495,0.0009902667,0.00051402574],"domain_scores_gemma":[0.9981786,0.00041213425,0.0001702895,0.0007510202,0.0003108111,0.00017714463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014723817,0.00027929855,0.00054805976,0.00007286307,0.00015998594,0.00003683304,0.0003129661,0.0000760059,0.00014663996],"category_scores_gemma":[0.00020805125,0.00015921266,0.00012585436,0.0006269393,0.0005223185,0.00026031514,0.00014765836,0.00019762239,0.000021153714],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040933476,0.0022046727,0.5779053,0.0015805438,0.0065583577,0.008934505,0.011988052,0.00039848857,0.3560542,0.0020350139,0.0075342148,0.020713327],"study_design_scores_gemma":[0.03300386,0.0027451024,0.09991285,0.0012786472,0.0037837317,0.0039852583,0.012541628,0.00062851957,0.79831684,0.00039749857,0.042259347,0.0011467318],"about_ca_topic_score_codex":0.000056079094,"about_ca_topic_score_gemma":0.000055789053,"teacher_disagreement_score":0.47799242,"about_ca_system_score_codex":0.0002140575,"about_ca_system_score_gemma":0.0010548341,"threshold_uncertainty_score":0.64925045},"labels":[],"label_agreement":null},{"id":"W3199392341","doi":"10.1182/bloodadvances.2021005205","title":"A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Antibody; Glycoprotein; Association (psychology); Medicine; Immunology; Computational biology; Biology; Psychology; Molecular biology","score_opus":0.029380492892118845,"score_gpt":0.3607999481885565,"score_spread":0.3314194552964376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199392341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008848435,0.99368054,0.0000040400864,0.00010655496,0.00010246056,0.005316596,0.00012570326,0.000026724445,0.0005488817],"genre_scores_gemma":[0.000021186337,0.9975103,0.00018257492,0.000027224069,0.0001242397,0.00039964647,0.00008507902,0.00004290356,0.0016068071],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961467,0.00084465224,0.0014362597,0.00037466304,0.00093064224,0.0002671163],"domain_scores_gemma":[0.9959213,0.0012389028,0.0016825756,0.00071097584,0.00036975628,0.00007645827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012622075,0.0003276964,0.004323193,0.00013191391,0.00010217639,0.000028378823,0.00025935195,0.00018680377,0.000014704804],"category_scores_gemma":[0.004437025,0.00018516876,0.00055118307,0.00065454567,0.00007640333,0.00009019254,0.00015723419,0.0003522799,0.000013032021],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[1.8370702e-7,0.000037015416,0.0035567128,0.9904323,0.0011629985,0.000021010253,0.000045181307,5.408152e-9,9.563742e-7,0.000055265205,0.000072673516,0.0046156477],"study_design_scores_gemma":[0.00021681609,0.000028907514,0.00003414073,0.94336194,0.012515209,0.0020221116,0.000098378696,8.729082e-8,0.000011600131,0.000010702397,0.041554306,0.00014578571],"about_ca_topic_score_codex":0.000007036424,"about_ca_topic_score_gemma":0.000003252836,"teacher_disagreement_score":0.047070395,"about_ca_system_score_codex":0.00012061781,"about_ca_system_score_gemma":0.00046932837,"threshold_uncertainty_score":0.75509626},"labels":[],"label_agreement":null},{"id":"W3199490133","doi":"10.1182/bloodadvances.2021004965","title":"CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Myeloid leukemia; Biology; Fusion gene; Computational biology; Myeloid; Genetics; Bioinformatics; Cancer research; Gene","score_opus":0.008445822330512004,"score_gpt":0.2703552193312903,"score_spread":0.2619093970007783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199490133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98249775,0.008344562,0.00048798774,0.0021265508,0.00009509542,0.00036211842,0.0000543796,0.00014827991,0.005883289],"genre_scores_gemma":[0.9885857,0.0014350453,0.0067586508,0.0005482311,0.00014248135,0.000048924245,0.00013925754,0.00006399252,0.0022776818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783283,0.000073837444,0.00030299663,0.00065675477,0.0006036173,0.0005299794],"domain_scores_gemma":[0.99875575,0.00015940522,0.00008802908,0.0004465392,0.00023754318,0.00031273847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014589285,0.00033774652,0.00061374484,0.00009594045,0.00018758132,0.00007276152,0.0001504552,0.000104329,0.00007903011],"category_scores_gemma":[0.00030180227,0.0002389341,0.00011141692,0.00037993843,0.0001744257,0.00019269572,0.00011065314,0.0003960827,0.000011390019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011596221,0.00078272825,0.7070402,0.00108408,0.0016230609,0.019364143,0.0010588303,0.000022892507,0.2166319,0.000813504,0.0005236363,0.049895413],"study_design_scores_gemma":[0.02727617,0.002224982,0.48879158,0.0012444108,0.0033961372,0.0061004898,0.0018190596,0.00033921524,0.3607059,0.0007285329,0.1056791,0.0016944158],"about_ca_topic_score_codex":0.000041259384,"about_ca_topic_score_gemma":0.00017238915,"teacher_disagreement_score":0.21824859,"about_ca_system_score_codex":0.00006814912,"about_ca_system_score_gemma":0.00034889032,"threshold_uncertainty_score":0.97434497},"labels":[],"label_agreement":null},{"id":"W3199862571","doi":"10.1182/bloodadvances.2020003577","title":"How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McMaster University; Impact; Cochrane","funders":"","keywords":"Guideline; Grading (engineering); Computer science; Process (computing); Process management; Key (lock); Trustworthiness; Medicine; Engineering; Pathology","score_opus":0.15016961516497715,"score_gpt":0.45595428119330816,"score_spread":0.305784666028331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199862571","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19317336,0.0074850875,0.09480731,0.6950629,0.0016285744,0.0062429663,0.00037130938,0.00020742053,0.0010210986],"genre_scores_gemma":[0.32807776,0.001088731,0.645016,0.015457056,0.0019410244,0.0005619035,0.00085730274,0.00009403079,0.0069061806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973449,0.00008697027,0.0013174656,0.00044479105,0.00051083433,0.00029502023],"domain_scores_gemma":[0.9962667,0.00065799727,0.00056053477,0.00051222194,0.0018679353,0.00013459878],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012198635,0.00020556303,0.0004463697,0.000082690676,0.00011226279,0.00006656061,0.0001338129,0.000070436574,0.000091026006],"category_scores_gemma":[0.009568311,0.00014228163,0.00020949754,0.00033972866,0.00006490048,0.00043443832,0.000082183964,0.0001232544,0.000004226011],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030974937,0.0016122091,0.06716634,0.0012323055,0.0009933823,0.00027661727,0.000947269,0.00045461312,0.08525444,0.003509699,0.21571042,0.6197452],"study_design_scores_gemma":[0.004016792,0.0008678784,0.0030533778,0.0002459202,0.0011314689,0.00031877836,0.0036812536,0.00051275676,0.0554232,0.0029527252,0.92753977,0.00025607646],"about_ca_topic_score_codex":0.000050428036,"about_ca_topic_score_gemma":0.0005253892,"teacher_disagreement_score":0.71182936,"about_ca_system_score_codex":0.000021169866,"about_ca_system_score_gemma":0.0005084148,"threshold_uncertainty_score":0.9987745},"labels":[],"label_agreement":null},{"id":"W3200510877","doi":"10.1182/bloodadvances.2020004162","title":"Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Interquartile range; Immune thrombocytopenia; Platelet; Internal medicine; Gastroenterology","score_opus":0.0065936553162622485,"score_gpt":0.2350430216238385,"score_spread":0.22844936630757626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200510877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961935,0.0013294788,0.000053861288,0.000109692635,0.00005795185,0.0004955358,0.00007550698,0.000022347744,0.0016620747],"genre_scores_gemma":[0.9982797,0.0001321339,0.0012176337,0.000054087235,0.000010706319,0.0000309227,0.00020645364,0.000016933951,0.000051442792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986404,0.000051298837,0.00036370533,0.0003242987,0.00038860488,0.00023165294],"domain_scores_gemma":[0.99910647,0.00008160615,0.00013445476,0.00034232714,0.0002701746,0.00006498494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013104045,0.0001814643,0.0006307665,0.000067353125,0.00005182803,0.000010288384,0.00007122297,0.0000806328,0.00013281533],"category_scores_gemma":[0.00014109329,0.00013855669,0.000056552475,0.00039922417,0.0000799518,0.00021008062,0.000031823056,0.00015661403,0.0000059081976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062431383,0.0036109427,0.9869167,0.00013604852,0.00036484704,0.00031892952,0.00024191254,0.000088882494,0.0008364707,0.00013725796,0.000008258593,0.006715406],"study_design_scores_gemma":[0.014208755,0.00047736394,0.9705677,0.0002460129,0.00014887702,0.000040179886,0.00011487435,0.000020141022,0.012650241,0.0006225293,0.0007301123,0.0001732086],"about_ca_topic_score_codex":0.000056563083,"about_ca_topic_score_gemma":0.00021111302,"teacher_disagreement_score":0.016349027,"about_ca_system_score_codex":0.000043780357,"about_ca_system_score_gemma":0.0002274513,"threshold_uncertainty_score":0.56501776},"labels":[],"label_agreement":null},{"id":"W3200752197","doi":"10.1182/bloodadvances.2021005327","title":"Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Multiple myeloma; Tumor necrosis factor alpha; Bone marrow; Cancer research; Medicine; Intravasation; Interleukin 6; Inflammation; Immunology; Biology; Metastasis; Internal medicine; Cancer","score_opus":0.009523889715419667,"score_gpt":0.3072454667300081,"score_spread":0.2977215770145884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200752197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987521,0.011192478,0.00012254892,0.00024342454,0.00004618689,0.0003787622,0.000046775738,0.000030248948,0.00041860895],"genre_scores_gemma":[0.99249345,0.0010516287,0.00403775,0.000009981988,0.00005959536,0.000035840134,0.000045801735,0.000016820466,0.0022491054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888587,0.000041147625,0.00021086965,0.00028596527,0.00034612668,0.00023000564],"domain_scores_gemma":[0.9992236,0.00014988403,0.00007791457,0.00021659695,0.0001743657,0.00015765516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070071364,0.00013280351,0.00026305008,0.00006864114,0.00006723539,0.000020466754,0.000049576443,0.000045437562,0.000094522715],"category_scores_gemma":[0.00038399294,0.000108728505,0.000043306496,0.00016387927,0.00008722218,0.00017044407,0.00005980803,0.000081827566,0.0000127020885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017189706,0.00051194587,0.17447253,0.0003917227,0.00017313525,0.00084042316,0.00049908395,8.2902017e-7,0.5974786,0.00003358573,0.000025396084,0.22540085],"study_design_scores_gemma":[0.0013432634,0.00036716388,0.36451206,0.00017889458,0.00007403,0.00008843143,0.00009957449,0.000030987325,0.63237685,0.00010830775,0.00075174065,0.00006867462],"about_ca_topic_score_codex":0.000058756006,"about_ca_topic_score_gemma":0.00007626359,"teacher_disagreement_score":0.22533217,"about_ca_system_score_codex":0.000014261962,"about_ca_system_score_gemma":0.000042067346,"threshold_uncertainty_score":0.443382},"labels":[],"label_agreement":null},{"id":"W3200845029","doi":"10.1182/bloodadvances.2021004765","title":"Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Center for Advancing Translational Sciences; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Winship Cancer Institute; Seagen; Incyte; Astellas Pharma; Adaptive Biotechnologies; TG Therapeutics; H. Lundbeck A/S; BeiGene; Purdue Pharma; Regeneron Pharmaceuticals; National Institutes of Health; Ohio State University; Omeros Corporation; Verastem Oncology; Spectrum Pharmaceuticals; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; Purdue University; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Emory University","keywords":"Medicine; Intensive care; Oncology; Internal medicine; Intensive care medicine","score_opus":0.015180867002017012,"score_gpt":0.2590935902796956,"score_spread":0.24391272327767857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200845029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889858,0.008861774,0.000013236117,0.0008578556,0.000500544,0.00044496622,0.00006559765,0.00005639726,0.0002138383],"genre_scores_gemma":[0.9936671,0.001914861,0.0006407742,0.0018718429,0.00014114293,0.00017456143,0.00010254484,0.000039291233,0.0014478682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985332,0.00005179215,0.00029130097,0.00045931552,0.0003709031,0.00029348637],"domain_scores_gemma":[0.99709284,0.0001591964,0.00012219157,0.00037646794,0.0021106696,0.00013865392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003784648,0.00028258492,0.0005392372,0.00006297015,0.000075100885,0.000059149475,0.00006785575,0.000068043526,0.00017675698],"category_scores_gemma":[0.00031377355,0.00016639385,0.00011132319,0.00019198749,0.00012912614,0.0002945499,0.00006325483,0.000109947156,0.00004198012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002756012,0.0011577378,0.98155123,0.00004517669,0.00068016193,0.0014580076,0.0010272734,0.0000012024094,0.00012959327,0.0000233586,0.00016543339,0.011004798],"study_design_scores_gemma":[0.012363407,0.0014607548,0.9609484,0.0004494512,0.00036859966,0.000051820145,0.0028675925,6.1821754e-7,0.016463172,0.00004702174,0.004733864,0.00024526674],"about_ca_topic_score_codex":0.00010204234,"about_ca_topic_score_gemma":0.00044920904,"teacher_disagreement_score":0.020602811,"about_ca_system_score_codex":0.000047160265,"about_ca_system_score_gemma":0.00014697853,"threshold_uncertainty_score":0.6785344},"labels":[],"label_agreement":null},{"id":"W3200920093","doi":"10.1182/bloodadvances.2021005286","title":"Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Prednisone; Medicine; Internal medicine; Observational study; Cohort; Corticosteroid; Survival analysis; Calcineurin; Pharmacotherapy; Gastroenterology; Transplantation","score_opus":0.018405964890309184,"score_gpt":0.3251381030668568,"score_spread":0.30673213817654765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200920093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90472764,0.039646063,0.04305595,0.0071557383,0.000867574,0.0016731871,0.00072664325,0.00012047513,0.0020267216],"genre_scores_gemma":[0.98461777,0.0042572506,0.010379429,0.00009065155,0.0001956397,0.000054512413,0.00033274954,0.000017006705,0.00005502035],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990378,0.0000712694,0.00024314618,0.00024544756,0.00027476525,0.00012754987],"domain_scores_gemma":[0.99834967,0.00092027953,0.00014199023,0.00025397562,0.00025286677,0.000081222584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019238719,0.000103007274,0.00030197477,0.00009647639,0.00004716429,0.000014769148,0.00004920927,0.000042166866,0.00006311068],"category_scores_gemma":[0.0005077917,0.000094571056,0.00010236934,0.000422739,0.000042112795,0.00023071829,0.000010533593,0.000049937844,6.7414317e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051158555,0.011285806,0.20618817,0.013880773,0.06695128,0.0012691786,0.02054755,0.0021458962,0.49802473,0.06187014,0.0003217564,0.06635615],"study_design_scores_gemma":[0.07006701,0.0030096474,0.66235334,0.0006245614,0.05923922,0.00008066501,0.0032482292,0.0023932322,0.15522246,0.0013163207,0.04148489,0.00096045237],"about_ca_topic_score_codex":0.000014796801,"about_ca_topic_score_gemma":0.00016103726,"teacher_disagreement_score":0.45616513,"about_ca_system_score_codex":0.000016031441,"about_ca_system_score_gemma":0.00019098214,"threshold_uncertainty_score":0.3856496},"labels":[],"label_agreement":null},{"id":"W3201017497","doi":"10.1182/bloodadvances.2021004451","title":"Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University","keywords":"Immunology; Immunotherapy; Epitope; Antigen; Immune tolerance; Antibody; Human leukocyte antigen; Immune system; T cell; Medicine; Virology","score_opus":0.028047529218406718,"score_gpt":0.2964604726467773,"score_spread":0.2684129434283706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201017497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90027773,0.09752626,0.000060378487,0.000789062,0.00015851104,0.00021441672,0.000027788992,0.00001858888,0.0009272471],"genre_scores_gemma":[0.89087784,0.10305749,0.0046216766,0.000095406846,0.00042009205,0.000016718657,0.00008298409,0.000022356415,0.0008054051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985542,0.00006920096,0.0003467836,0.00033325225,0.00040742545,0.0002891291],"domain_scores_gemma":[0.9993153,0.000094441486,0.00007630252,0.00021746951,0.00023303785,0.00006343872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101183934,0.00018154642,0.0004133226,0.00012356114,0.00007760714,0.000024126388,0.00010021435,0.00005924218,0.00019408886],"category_scores_gemma":[0.000018260407,0.00013381182,0.0000878802,0.0003536645,0.00018428676,0.00021086463,0.00002677379,0.00017118372,0.0000073249707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056186726,0.0005294129,0.109854,0.00021171817,0.0001245528,0.00011985062,0.0003976516,0.000040852457,0.8803564,0.0003942263,0.00013778334,0.0072717257],"study_design_scores_gemma":[0.0018831671,0.00038088925,0.050256636,0.00027357118,0.000013843593,0.00009528326,0.000260539,0.000015465392,0.88324445,0.00006657462,0.063345,0.00016454881],"about_ca_topic_score_codex":0.00006639489,"about_ca_topic_score_gemma":0.00034225965,"teacher_disagreement_score":0.06320722,"about_ca_system_score_codex":0.000010227351,"about_ca_system_score_gemma":0.00013765576,"threshold_uncertainty_score":0.5456687},"labels":[],"label_agreement":null},{"id":"W3201071899","doi":"10.1182/bloodadvances.2021004881","title":"Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and <i>KMT2A</i>-rearranged AML","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"Office of Naval Research; Pharmacyclics; Sanofi Genzyme; Takeda Oncology; Genentech; Health Resources and Services Administration; National Institutes of Health; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; National Institute of Allergy and Infectious Diseases; Angiocrine Bioscience; Karyopharm Therapeutics; Actinium Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; Cancer Moonshot; Medical College of Wisconsin; StemCyte; Memorial Sloan-Kettering Cancer Center; Weill Cornell Medical College; CSL Behring; Bristol-Myers Squibb; Legend Biotech; American Society of Clinical Oncology; GlaxoSmithKline; Be The Match Foundation; Seagen; Astellas Pharma US; Clinical and Translational Science Center, Weill Cornell Medical College; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Medac; Jazz Pharmaceuticals","keywords":"Internal medicine; Medicine; Adverse effect; Myeloid leukemia; Oncology; Disease; Transplantation; Leukemia; Risk stratification; Hematopoietic stem cell transplantation","score_opus":0.014142526233996474,"score_gpt":0.28569069142534126,"score_spread":0.2715481651913448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201071899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889662,0.0067952885,0.000014915412,0.001721033,0.00018494052,0.0005711164,0.00022132583,0.000091890666,0.0014332803],"genre_scores_gemma":[0.9695822,0.027208658,0.0010314444,0.0005515862,0.00014422693,0.0002382421,0.00016318056,0.000041683612,0.001038795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773455,0.00027125716,0.00043262934,0.0006256854,0.00047557088,0.0004603013],"domain_scores_gemma":[0.9980594,0.00078691635,0.00019656566,0.0004871887,0.00020809344,0.00026186643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039222307,0.00025310568,0.00052195706,0.00020941507,0.00014505385,0.000024304654,0.00014601811,0.00015097819,0.00012538901],"category_scores_gemma":[0.0025264476,0.00021217226,0.000111790156,0.00039855583,0.00022029867,0.00031924873,0.00019669114,0.00058412965,0.00006941971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023642337,0.0003581087,0.9699002,0.00012500698,0.00012817532,0.00028098596,0.00052971987,0.000005744642,0.0040919203,0.000011941418,0.00041679907,0.023914961],"study_design_scores_gemma":[0.0054566856,0.0003462545,0.96586037,0.00016744171,0.0002742845,0.000054923763,0.0012622495,0.00014643371,0.014025051,0.00007045435,0.012124628,0.00021123826],"about_ca_topic_score_codex":0.00017319222,"about_ca_topic_score_gemma":0.001507518,"teacher_disagreement_score":0.023703722,"about_ca_system_score_codex":0.00020620308,"about_ca_system_score_gemma":0.00020193408,"threshold_uncertainty_score":0.8652134},"labels":[],"label_agreement":null},{"id":"W3201447830","doi":"10.1182/bloodadvances.2020004098","title":"The brain-derived neurotrophic factor prompts platelet aggregation and secretion","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; KU Leuven; Canadian Vascular Network","keywords":"Tropomyosin receptor kinase B; Autocrine signalling; Brain-derived neurotrophic factor; Neurotrophic factors; Internal medicine; Endocrinology; Platelet; Cell biology; Neurotrophin; Paracrine signalling; Biology; Chemistry; Receptor; Medicine","score_opus":0.019525157133856347,"score_gpt":0.2608021692978145,"score_spread":0.24127701216395817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201447830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949076,0.0014983325,0.00012820149,0.0026540128,0.00036611085,0.00016950109,0.000009367144,0.00005058499,0.00021626469],"genre_scores_gemma":[0.997242,0.0012687192,0.00010546318,0.0006833186,0.00015387514,0.000020926063,0.000005713961,0.000008903291,0.00051110366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991169,0.00016243117,0.00013170141,0.00028665256,0.0001595833,0.00014276031],"domain_scores_gemma":[0.999473,0.00023065362,0.00008341858,0.0001385776,0.00003656235,0.000037839447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005031199,0.00009049463,0.0000733139,0.000016920934,0.00046486474,0.00012348263,0.00007416909,0.000033181597,0.000012002482],"category_scores_gemma":[0.00044239743,0.00006171166,0.000024934763,0.00013719949,0.00010203949,0.0003400411,0.000032544263,0.000092301896,0.0000066412326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014782742,0.000023991559,0.00012672985,0.000012067132,0.0000020850607,0.000023534052,0.00006249793,0.000032777185,0.9690834,0.0018044878,0.000015983023,0.028797612],"study_design_scores_gemma":[0.00027554898,0.000073602445,0.001271596,0.000015196244,0.000004974072,0.00007728766,0.000015242548,0.00022023935,0.9830146,0.0014594016,0.013488141,0.00008418686],"about_ca_topic_score_codex":8.958693e-7,"about_ca_topic_score_gemma":0.000014499153,"teacher_disagreement_score":0.028713426,"about_ca_system_score_codex":0.0000042982265,"about_ca_system_score_gemma":0.000027545202,"threshold_uncertainty_score":0.35754105},"labels":[],"label_agreement":null},{"id":"W3201593720","doi":"10.1182/bloodadvances.2021005317","title":"Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University Health Network; Western University; St. Michael's Hospital; Lawson Health Research Institute","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Gastroenterology; Internal medicine; Platelet; Confidence interval; Prospective cohort study","score_opus":0.02134178332231589,"score_gpt":0.27948263764231507,"score_spread":0.25814085431999917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201593720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97187597,0.0257024,0.0000031941836,0.00012487725,0.0005761597,0.0010272877,0.00017288176,0.00007433347,0.0004429175],"genre_scores_gemma":[0.9991017,0.00014018254,0.000038812355,0.00004406934,0.00001923155,0.00014387691,0.00014313574,0.000025316222,0.0003436758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964064,0.0012278144,0.0010459647,0.0006809762,0.00012701465,0.00051184045],"domain_scores_gemma":[0.99768764,0.0009715534,0.00029850553,0.00083367695,0.00016789573,0.000040751667],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006753146,0.0003144544,0.0009338108,0.00013070543,0.000131592,0.0000174631,0.0004714661,0.00007560512,0.0022732143],"category_scores_gemma":[0.001131391,0.0002920278,0.00014213884,0.00052528037,0.0003012154,0.00024549148,0.00031117626,0.00025180326,0.00008714278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012611927,0.00675248,0.59626424,0.00015141419,0.0004944396,0.000054147335,0.0007173134,0.000019333442,0.39514315,0.00011165,0.000036130627,0.00012957775],"study_design_scores_gemma":[0.008048097,0.0024845528,0.881376,0.00018125326,0.0003968775,0.000054929536,0.008095041,0.0000015734927,0.097653694,0.00034721472,0.0008950892,0.00046567278],"about_ca_topic_score_codex":0.0006085079,"about_ca_topic_score_gemma":0.006056687,"teacher_disagreement_score":0.29748946,"about_ca_system_score_codex":0.000031147672,"about_ca_system_score_gemma":0.00022720077,"threshold_uncertainty_score":0.9999532},"labels":[],"label_agreement":null},{"id":"W3201852707","doi":"10.1182/bloodadvances.2021005308","title":"Bilineal evolution of a <i>U2AF1</i>-mutated clone associated with acquisition of distinct secondary mutations","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute","keywords":"Myeloid; RUNX1; Somatic evolution in cancer; Biology; Mutation; Cancer research; ETV6; Myeloid leukemia; Neuroblastoma RAS viral oncogene homolog; clone (Java method); Genetics; Gene; KRAS; Transcription factor","score_opus":0.008940469371699832,"score_gpt":0.2725094340022355,"score_spread":0.26356896463053564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201852707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400526,0.0026619455,0.00068152876,0.00036114253,0.00003765982,0.00027178624,0.00022587001,0.000051145264,0.0017036885],"genre_scores_gemma":[0.9960153,0.00007553377,0.0026934228,0.000035513647,0.00005063898,0.000020986374,0.00073744083,0.000019734769,0.0003514253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986282,0.000104464736,0.0003797181,0.00024643878,0.0004241562,0.00021700212],"domain_scores_gemma":[0.9983366,0.00024798425,0.00024343381,0.00023102626,0.00085525675,0.00008568393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018543619,0.00012446001,0.00038045505,0.00012575167,0.00005972538,0.000005518205,0.000066883804,0.00007532212,0.00014645336],"category_scores_gemma":[0.00050258695,0.000102707585,0.00007408771,0.00090159,0.00023674988,0.00018419152,0.000037132024,0.00020968766,0.0000035064706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015539161,0.003370587,0.279705,0.0011931948,0.0013548888,0.00070145505,0.0007739029,0.00050944224,0.70226073,0.00080782117,0.0002911874,0.007477902],"study_design_scores_gemma":[0.011208167,0.0016685296,0.47308174,0.0008442543,0.0008384,0.00030617125,0.0014554939,0.00096582004,0.508245,0.0007688938,0.00036095933,0.0002565751],"about_ca_topic_score_codex":0.000064095526,"about_ca_topic_score_gemma":0.000151252,"teacher_disagreement_score":0.19401571,"about_ca_system_score_codex":0.00014194002,"about_ca_system_score_gemma":0.0010127673,"threshold_uncertainty_score":0.41882938},"labels":[],"label_agreement":null},{"id":"W3204023367","doi":"10.1182/bloodadvances.2021004368","title":"Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Impact","funders":"","keywords":"Meta-analysis; Medicine; Systematic review; Test (biology); MEDLINE; Pediatrics; Internal medicine; Biology","score_opus":0.06975570821057389,"score_gpt":0.39367858097121494,"score_spread":0.323922872760641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204023367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009672099,0.9956454,2.4522976e-7,0.000088738896,0.000004088511,0.0030159196,0.00021455268,0.0000026795453,0.00006117584],"genre_scores_gemma":[0.0032031157,0.9952477,0.0001801481,0.0000732917,0.0000033601411,0.0011334908,0.00014091788,0.000011325733,0.000006635002],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99780244,0.00024554905,0.0011970049,0.0003499052,0.00026614606,0.00013897892],"domain_scores_gemma":[0.99613714,0.002538236,0.0008841553,0.00035485628,0.00005204304,0.00003356949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005438695,0.00030827094,0.008571333,0.00028183206,0.000017122115,0.00001731479,0.00012166931,0.00007028325,0.000022956912],"category_scores_gemma":[0.0010870403,0.00015583402,0.0007273768,0.0011793195,0.00004107867,0.000119590026,0.000050160612,0.00016276164,1.6762884e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011485154,0.0008297344,0.00671712,0.9033629,0.06985165,0.000110140696,0.00007657017,2.87093e-7,2.2402418e-8,0.000019503495,0.0000026733492,0.019028276],"study_design_scores_gemma":[0.00045696873,0.000104584855,0.0008356916,0.20646936,0.7914469,0.000083583065,0.00008886771,7.6136786e-7,4.9104574e-7,0.000003812457,0.0003938207,0.000115159986],"about_ca_topic_score_codex":0.000049814098,"about_ca_topic_score_gemma":0.00011455066,"teacher_disagreement_score":0.7215952,"about_ca_system_score_codex":0.000014345048,"about_ca_system_score_gemma":0.000063028056,"threshold_uncertainty_score":0.63547266},"labels":[],"label_agreement":null},{"id":"W3204045414","doi":"10.1182/bloodadvances.2021005682","title":"Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute","keywords":"BCL6; Cancer research; Lymphoma; Biology; Ubiquitin ligase; Molecular biology; B cell; Gene; Genetics; Ubiquitin; Immunology; Antibody","score_opus":0.009868486249774931,"score_gpt":0.2757344045850493,"score_spread":0.26586591833527434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204045414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94238627,0.04700195,0.00001565496,0.001995813,0.00015005734,0.00025800648,0.000021351978,0.000032999873,0.008137882],"genre_scores_gemma":[0.994261,0.002024194,0.0025815037,0.00043938486,0.000052938954,0.000104382125,0.000058087895,0.00001435112,0.00046411454],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897915,0.000039800492,0.00029462462,0.00026047303,0.00022823703,0.0001977204],"domain_scores_gemma":[0.9993752,0.00011460903,0.0000873753,0.0002475814,0.000095606774,0.00007958407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047764683,0.00014079566,0.000330602,0.00008341869,0.000036233323,0.000009957141,0.000054761746,0.000048524267,0.0002496888],"category_scores_gemma":[0.000051010113,0.00011124615,0.000105319705,0.00030243298,0.000056017092,0.000098843055,0.000020945747,0.000030990886,0.00003513731],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017114045,0.013829537,0.8426923,0.00035018518,0.000959896,0.0034768635,0.0015749519,0.00012813695,0.026550207,0.027237102,0.00012892019,0.08290075],"study_design_scores_gemma":[0.009758318,0.0005684122,0.32312056,0.00035715158,0.00044238166,0.0002975827,0.000680991,0.000021531761,0.6010541,0.0056680324,0.05781308,0.00021790786],"about_ca_topic_score_codex":0.00012624305,"about_ca_topic_score_gemma":0.00008335896,"teacher_disagreement_score":0.57450384,"about_ca_system_score_codex":0.00006658391,"about_ca_system_score_gemma":0.00026668466,"threshold_uncertainty_score":0.45364863},"labels":[],"label_agreement":null},{"id":"W3204135709","doi":"10.1182/bloodadvances.2021005430","title":"von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University","funders":"National Hemophilia Foundation","keywords":"Medicine; Von Willebrand disease; Von Willebrand factor; Meta-analysis; Internal medicine; Confidence interval; Gastroenterology; Coagulopathy; Platelet; Immunology","score_opus":0.07997562773607883,"score_gpt":0.3646543332560374,"score_spread":0.28467870551995855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204135709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008443362,0.9948563,0.000001916137,0.00023990092,0.00001657389,0.0038191401,0.000917202,0.000010392052,0.000054161366],"genre_scores_gemma":[0.0006022579,0.9967862,0.000051026673,0.00024643907,0.000011343626,0.001796662,0.00024599987,0.000030118956,0.0002299701],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968884,0.0005931838,0.001214282,0.0005729042,0.0004858996,0.00024535053],"domain_scores_gemma":[0.9974317,0.00083423307,0.00077723205,0.00075464847,0.00007498446,0.00012722464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034654947,0.0005772042,0.011517917,0.00025057708,0.00005448528,0.000033131535,0.00021085418,0.0001093826,0.0002537139],"category_scores_gemma":[0.00044025123,0.0002724488,0.0024771045,0.0011620335,0.000073969015,0.00013126759,0.000046884423,0.00020046819,0.0000036786178],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029527919,0.0004372993,0.0004496802,0.86720455,0.12628701,0.0003981723,0.00005096359,2.1184059e-7,1.0092473e-8,0.0000118543585,0.000025410045,0.0051318896],"study_design_scores_gemma":[0.00045926514,0.000054791704,0.000065382315,0.095427506,0.86564684,0.0000652754,0.000026308364,1.9465828e-7,4.8127015e-7,0.000013691753,0.03802256,0.00021769968],"about_ca_topic_score_codex":0.000009973271,"about_ca_topic_score_gemma":0.00004781037,"teacher_disagreement_score":0.77177703,"about_ca_system_score_codex":0.000018033745,"about_ca_system_score_gemma":0.000109852735,"threshold_uncertainty_score":0.99997276},"labels":[],"label_agreement":null},{"id":"W3204209359","doi":"10.1182/bloodadvances.2020003576","title":"Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Guideline; Pulmonary embolism; Cost effectiveness; MEDLINE; Appropriate Use Criteria; Intensive care medicine; Radiology; Surgery; Internal medicine; Pathology; Risk analysis (engineering)","score_opus":0.07179990306651876,"score_gpt":0.4011092335468281,"score_spread":0.3293093304803093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204209359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002409684,0.9738436,0.00030689698,0.000016175161,0.00042246043,0.024567926,0.00017765237,0.00007267097,0.0005902628],"genre_scores_gemma":[0.000021771455,0.983698,0.0004154393,0.00013491824,0.00015887007,0.014944451,0.00046385886,0.000118551696,0.000044105473],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961726,0.0005862999,0.001548543,0.00073756895,0.00046734523,0.00048761544],"domain_scores_gemma":[0.99209315,0.005228425,0.0011664951,0.0009863932,0.0003811801,0.00014433754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010532873,0.00072350266,0.013419644,0.00018225932,0.00009028563,0.000049528408,0.0003641551,0.00021465946,0.000036354828],"category_scores_gemma":[0.0026402506,0.0005286835,0.0014886972,0.00052433356,0.000111466405,0.00018165639,0.00012249815,0.0002455767,0.000016564765],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033465965,0.0016401783,6.045032e-7,0.94765186,0.0026678597,0.00008378788,0.00003505757,0.0000022173945,4.1018785e-7,0.0036986158,0.00020648785,0.0440096],"study_design_scores_gemma":[0.00044265323,0.00050993124,0.0000042036777,0.7013715,0.05716936,0.00011336579,0.00010690937,2.1551607e-7,0.0000067298215,0.00013995683,0.23980384,0.0003313402],"about_ca_topic_score_codex":0.000012191469,"about_ca_topic_score_gemma":0.000006765058,"teacher_disagreement_score":0.24628033,"about_ca_system_score_codex":0.00008873138,"about_ca_system_score_gemma":0.0008041144,"threshold_uncertainty_score":0.99971646},"labels":[],"label_agreement":null},{"id":"W3204312506","doi":"10.1182/bloodadvances.2021005709","title":"Impact of a grant program to spur advances in sickle cell disease research","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute for Advanced Research; Doris Duke Charitable Foundation","keywords":"Investment (military); Disease; Medicine; Grant funding; Clinical trial; Clinical research; Family medicine; Business; Political science; Internal medicine; Public administration","score_opus":0.018236698237144022,"score_gpt":0.37584066516930364,"score_spread":0.3576039669321596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204312506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90819806,0.08325107,0.000007673355,0.00070212514,0.00007274492,0.0007427219,0.000021373673,0.000042463253,0.006961741],"genre_scores_gemma":[0.98766947,0.010090839,0.0012598156,0.00004860602,0.000047228354,0.0000901243,0.000019975465,0.000020719603,0.00075322663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983565,0.00008610071,0.00029460868,0.00035168367,0.00043635262,0.00047471572],"domain_scores_gemma":[0.9989549,0.000084367195,0.00004781082,0.00031756744,0.0002432163,0.00035215673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021367648,0.00014245986,0.00032892535,0.00018778088,0.000055509718,0.000013870688,0.000102980666,0.000057900925,0.00008868085],"category_scores_gemma":[0.00030162573,0.000105407045,0.00015188087,0.0011282004,0.00011938924,0.00016322931,0.00006781364,0.0002821586,0.000022799637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022727563,0.016219204,0.55973434,0.002636575,0.00015172613,0.0031157676,0.0020423478,0.0023909213,0.024235014,0.00027123353,0.00061806117,0.38631207],"study_design_scores_gemma":[0.02896865,0.018336136,0.5004919,0.006445346,0.00075846043,0.00021260245,0.015337351,0.0007230004,0.08754471,0.0055934046,0.33370855,0.0018798836],"about_ca_topic_score_codex":0.00006848446,"about_ca_topic_score_gemma":0.000076952514,"teacher_disagreement_score":0.3844322,"about_ca_system_score_codex":0.00003459364,"about_ca_system_score_gemma":0.00040528594,"threshold_uncertainty_score":0.42983744},"labels":[],"label_agreement":null},{"id":"W3205072810","doi":"10.1182/bloodadvances.2021004970","title":"Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Brentuximab vedotin; Internal medicine; Quality of life (healthcare); Oncology; Confidence interval; Classical Hodgkin lymphoma; Hazard ratio; Lymphoma; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.029216302996506044,"score_gpt":0.3286447617787381,"score_spread":0.299428458782232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205072810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193073,0.015039403,0.00018740297,0.0007121557,0.00017130686,0.0002887699,0.00022125235,0.000034435983,0.0014145413],"genre_scores_gemma":[0.9943419,0.0011894658,0.003395497,0.0002633854,0.00010143347,0.000090378555,0.00023811906,0.000021597325,0.00035819295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793774,0.00010954776,0.00078678643,0.0004473527,0.00044376947,0.000274796],"domain_scores_gemma":[0.9977748,0.000804697,0.00042866496,0.0005067993,0.0003065113,0.00017854305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018116478,0.00021781726,0.0012551423,0.00020414057,0.000056552275,0.00001049356,0.00010487128,0.00010884884,0.00011189351],"category_scores_gemma":[0.0006345772,0.00017938916,0.00071874226,0.0006778063,0.00012398441,0.00010827188,0.000048418256,0.00004735678,0.000004305967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041732076,0.022511324,0.835633,0.0013059883,0.013356517,0.00013205667,0.00041902054,0.00012173409,0.009627427,0.008435084,0.0009230346,0.10336162],"study_design_scores_gemma":[0.031072458,0.0015286738,0.85357726,0.00019882424,0.008406954,0.000018201654,0.00039929987,0.00018545239,0.06537295,0.00026882437,0.038661,0.00031011045],"about_ca_topic_score_codex":0.00004687491,"about_ca_topic_score_gemma":0.00010443832,"teacher_disagreement_score":0.10305151,"about_ca_system_score_codex":0.000072674404,"about_ca_system_score_gemma":0.0004519381,"threshold_uncertainty_score":0.73152775},"labels":[],"label_agreement":null},{"id":"W3205218854","doi":"10.1182/bloodadvances.2021005666","title":"Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature","year":2021,"lang":"en","type":"review","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Impact","funders":"","keywords":"Medicine; Tranexamic acid; Von Willebrand disease; Von Willebrand factor; Meta-analysis; Desmopressin; Randomized controlled trial; Observational study; MEDLINE; Perioperative; Clinical trial; Surgery; Internal medicine; Blood loss; Platelet","score_opus":0.01570524279407971,"score_gpt":0.29049529718814393,"score_spread":0.27479005439406423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205218854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076626835,0.99499756,3.2310356e-7,0.000005032353,0.00006614428,0.0034855427,0.0002480554,0.0000037422635,0.00042735622],"genre_scores_gemma":[0.00025316235,0.9985387,0.00013108095,0.000004072552,0.00001118551,0.00016436278,0.00039171067,0.000020219217,0.00048552893],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980895,0.00021027034,0.00090847217,0.00025132272,0.00041807932,0.00012235019],"domain_scores_gemma":[0.9980799,0.000101974314,0.0010602014,0.0005859425,0.00011172789,0.000060241608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001122675,0.00029962018,0.0033858223,0.00005921042,0.000019915735,0.000004716715,0.00015826533,0.000068907386,0.00001710639],"category_scores_gemma":[0.000036543264,0.00012756814,0.0006070687,0.00044961864,0.000068459936,0.000052243373,0.000061374696,0.00010770328,6.5210475e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044686683,0.0009623915,0.0022427165,0.9431841,0.001386027,0.00024852756,0.000018869827,2.0138629e-7,8.473826e-9,0.000054230233,0.000032298918,0.05182599],"study_design_scores_gemma":[0.0013834412,0.00011395134,0.00022206843,0.72155446,0.011395748,0.000018200597,0.00001066243,4.5901373e-8,0.0000011683226,0.0000069915545,0.26518872,0.000104526254],"about_ca_topic_score_codex":4.4013717e-7,"about_ca_topic_score_gemma":6.0983166e-7,"teacher_disagreement_score":0.26515642,"about_ca_system_score_codex":0.000011205191,"about_ca_system_score_gemma":0.000057649377,"threshold_uncertainty_score":0.5202078},"labels":[],"label_agreement":null},{"id":"W3205560383","doi":"10.1182/bloodadvances.2021005291","title":"High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Disease; Hemophagocytic lymphohistiocytosis; Lymphoma; Hematopoietic stem cell transplantation; Immunology; Internal medicine; Virus; Mortality rate","score_opus":0.003215570053717854,"score_gpt":0.21515599501597657,"score_spread":0.2119404249622587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205560383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859369,0.012536582,0.000009542591,0.00010900666,0.00009028103,0.00038338528,0.0004187587,0.00001889153,0.00049666624],"genre_scores_gemma":[0.9977146,0.001677277,0.00015556363,0.00005495475,0.00003269047,0.00003040556,0.00013285126,0.000026691889,0.0001749828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985902,0.000079279365,0.0003293812,0.0003384462,0.00040514785,0.00025758735],"domain_scores_gemma":[0.99883306,0.000057389396,0.00036401098,0.00033327163,0.00018105589,0.0002312405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049274,0.00018670774,0.0004474678,0.0000805297,0.000037415233,0.000004478773,0.000080135134,0.00004774062,0.00007767831],"category_scores_gemma":[0.00020229867,0.0001540782,0.00011765233,0.00034725462,0.00011193139,0.00015797517,0.000030629697,0.00016739528,0.0000031349682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004244203,0.00265391,0.98530096,0.0005614995,0.00020705977,0.00008340042,0.00018276054,0.0016557251,0.00076687784,0.000046954927,0.000044154247,0.0042524915],"study_design_scores_gemma":[0.022783406,0.0010852483,0.9470012,0.0006176276,0.0010948336,1.3504838e-7,0.00038412164,0.000024619672,0.025996152,0.0005044743,0.0002701066,0.00023802917],"about_ca_topic_score_codex":0.00026241803,"about_ca_topic_score_gemma":0.00043614037,"teacher_disagreement_score":0.038299717,"about_ca_system_score_codex":0.00010212287,"about_ca_system_score_gemma":0.0006540703,"threshold_uncertainty_score":0.62831265},"labels":[],"label_agreement":null},{"id":"W3205877886","doi":"10.1182/bloodadvances.2021005808","title":"Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Warfarin; Medicine; Apixaban; Antiphospholipid syndrome; Thrombosis; Randomized controlled trial; Internal medicine; Cardiology; Rivaroxaban; Atrial fibrillation","score_opus":0.024464400607814296,"score_gpt":0.320748659133729,"score_spread":0.2962842585259147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205877886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845065,0.0043221987,0.00013104739,0.0008644927,0.0003350711,0.0040510283,0.00000813304,0.00008492447,0.0017524437],"genre_scores_gemma":[0.99324864,0.00057531946,0.0041116974,0.00015474483,0.00011200352,0.0006214422,0.000022847453,0.00005086067,0.0011024636],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967817,0.00039374258,0.0007273134,0.00066050346,0.00085801043,0.0005787318],"domain_scores_gemma":[0.9981988,0.0005540073,0.00014239833,0.0006468826,0.00018757801,0.0002703116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008231519,0.00029565167,0.0018845313,0.00020875136,0.00006513284,0.00004886588,0.000204492,0.00008614727,0.000234421],"category_scores_gemma":[0.00071177754,0.00021080747,0.00019700376,0.000962257,0.00015444699,0.00015355364,0.00012063184,0.0002714748,0.00007196577],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8597479,0.010208021,0.10068302,0.0035147364,0.0024393247,0.004139658,0.006466375,0.0004188722,0.010276641,0.0005982844,0.0005760208,0.0009311771],"study_design_scores_gemma":[0.96888375,0.0010121112,0.0019861988,0.0031399222,0.0004229823,0.00684661,0.001623889,0.00008421778,0.014816006,0.00015985286,0.00065177126,0.0003727132],"about_ca_topic_score_codex":0.000084359555,"about_ca_topic_score_gemma":0.00022149929,"teacher_disagreement_score":0.10913585,"about_ca_system_score_codex":0.00010306268,"about_ca_system_score_gemma":0.00042550015,"threshold_uncertainty_score":0.8596479},"labels":[],"label_agreement":null},{"id":"W3206027994","doi":"10.1182/bloodadvances.2021005498","title":"Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Hematopoietic stem cell transplantation; Immunology; Transplantation; Leukemia; Bone marrow; Haematopoiesis; Inflammation; Stem cell; Graft-versus-host disease; Disease; Endothelial stem cell; Cancer research; Internal medicine; Biology","score_opus":0.008025384924289156,"score_gpt":0.2406562403486364,"score_spread":0.23263085542434725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206027994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939939,0.0010499726,0.002339629,0.00032208953,0.00014129374,0.00043755653,0.000060721275,0.000046878067,0.0016079906],"genre_scores_gemma":[0.96385264,0.0005032618,0.034489878,0.0004428732,0.000102770544,0.000102568556,0.00006148492,0.000033750886,0.00041079332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985808,0.00005711069,0.0003470124,0.00040615685,0.00031634382,0.0002925621],"domain_scores_gemma":[0.9994578,0.00011530396,0.00006153654,0.00016868043,0.00007204705,0.00012468008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009964089,0.00018468431,0.00031105368,0.00010396737,0.00003324375,0.000019887588,0.00004934856,0.0000660124,0.00009074305],"category_scores_gemma":[0.000016197904,0.00016628481,0.0000495077,0.00029722575,0.000027362628,0.00014768948,0.0000068459276,0.000115931754,0.000027728765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008221313,0.00027562783,0.036853317,0.001006299,0.00004685404,0.003103133,0.0025700002,0.0009837919,0.95099527,0.00002607536,0.000004351855,0.0033131377],"study_design_scores_gemma":[0.0037928235,0.0002499892,0.027904809,0.0010357812,0.00028737524,0.0010147459,0.00042937606,0.000047210644,0.96432537,0.00004457587,0.00060160994,0.0002663505],"about_ca_topic_score_codex":0.000019745248,"about_ca_topic_score_gemma":0.00057810295,"teacher_disagreement_score":0.03215025,"about_ca_system_score_codex":0.000021747079,"about_ca_system_score_gemma":0.00007065055,"threshold_uncertainty_score":0.67808974},"labels":[],"label_agreement":null},{"id":"W3206120741","doi":"10.1182/bloodadvances.2021005589","title":"Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Impact","funders":"","keywords":"Medicine; Desmopressin; Tranexamic acid; Observational study; Randomized controlled trial; Obstetrics; Von Willebrand disease; Gynecology; Von Willebrand factor; Surgery; Blood loss; Internal medicine","score_opus":0.009065419903063567,"score_gpt":0.23847594308169917,"score_spread":0.2294105231786356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206120741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7043865,0.29444355,8.687299e-7,0.000038419115,0.000023558781,0.0006306349,0.000013742734,0.0000024992532,0.00046024667],"genre_scores_gemma":[0.9521938,0.046763904,0.00037337543,0.000029889647,0.000003052643,0.000067658475,0.000007707702,0.000004901909,0.00055571384],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9992902,0.000061056024,0.00027030538,0.00012666758,0.00015287125,0.0000988539],"domain_scores_gemma":[0.9993263,0.00009645689,0.00023243832,0.00024273018,0.00005699796,0.000045115015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000862471,0.000093248505,0.00058110827,0.000032824148,0.000018370587,0.0000034356526,0.000049043356,0.000018430394,0.000011479382],"category_scores_gemma":[0.000104112936,0.000044132183,0.0000494789,0.00036589726,0.000050816077,0.000050828963,0.00003161098,0.000033654313,1.9159418e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005672171,0.0027626762,0.3397538,0.63951814,0.0022500379,0.0014382872,0.0014467294,0.000016144748,0.00075810624,0.00051001715,0.0000594432,0.010919383],"study_design_scores_gemma":[0.02280017,0.0028788003,0.693037,0.245749,0.010020376,0.0003419408,0.006140164,0.000016267777,0.010065588,0.0022135528,0.006128017,0.0006091668],"about_ca_topic_score_codex":3.801135e-7,"about_ca_topic_score_gemma":0.0000014015761,"teacher_disagreement_score":0.39376915,"about_ca_system_score_codex":0.0000107218975,"about_ca_system_score_gemma":0.000020400686,"threshold_uncertainty_score":0.17996582},"labels":[],"label_agreement":null},{"id":"W3206547192","doi":"10.1182/bloodadvances.2021005966","title":"Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cumulative incidence; Hazard ratio; Incidence (geometry); Thrombosis; Internal medicine; Prospective cohort study; Retrospective cohort study; Malignancy; Confidence interval; Population; Cumulative dose; Deep vein; Surgery; Cohort","score_opus":0.012745447675061266,"score_gpt":0.2997105762483987,"score_spread":0.28696512857333745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206547192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128985,0.0018094141,0.00001414761,0.00039321624,0.00018710466,0.0025049676,0.00000838715,0.00009248769,0.0037003977],"genre_scores_gemma":[0.997208,0.0011554434,0.00045018084,0.0003012115,0.000084780244,0.00049609516,0.000029416773,0.000038882372,0.00023597592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804586,0.00008738993,0.0003598924,0.0006319931,0.0004868843,0.00038796413],"domain_scores_gemma":[0.999123,0.000045554993,0.00014937972,0.00034876572,0.00024462427,0.00008869978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019391107,0.00025058645,0.000988455,0.00010735393,0.00010951353,0.00005031386,0.00008956067,0.00005962424,0.00019544692],"category_scores_gemma":[0.00007732791,0.00020252135,0.000062019266,0.000588574,0.00006012619,0.00031881378,0.00007965422,0.00019708891,0.000010879295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006427735,0.010383252,0.9855681,0.0000827703,0.0007078089,0.0003902034,0.0009313695,0.00016660258,0.0008326645,0.0001443071,0.00004376935,0.00068487175],"study_design_scores_gemma":[0.0073070684,0.0006704679,0.9846354,0.000372769,0.0010483725,0.000010167318,0.001387636,0.00006231015,0.0038583959,0.000085612744,0.00031869332,0.00024310236],"about_ca_topic_score_codex":0.0005295523,"about_ca_topic_score_gemma":0.007379664,"teacher_disagreement_score":0.009712784,"about_ca_system_score_codex":0.00014072526,"about_ca_system_score_gemma":0.00013765076,"threshold_uncertainty_score":0.8258581},"labels":[],"label_agreement":null},{"id":"W3209106125","doi":"10.1182/bloodadvances.2021005050","title":"SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Spike Protein; Platelet; Medicine; Betacoronavirus; Immunology; Biology; Internal medicine; Outbreak","score_opus":0.05778734086525779,"score_gpt":0.35687170411824637,"score_spread":0.2990843632529886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209106125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879755,0.0006905858,0.00011975498,0.0037701428,0.00037225004,0.0007129816,0.000010253442,0.00019352634,0.005332939],"genre_scores_gemma":[0.99405324,0.00070204725,0.001253359,0.0033886058,0.0001951561,0.00008359978,0.00009055448,0.00006534036,0.00016811315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703896,0.0001587492,0.0007090591,0.0009188753,0.0005213091,0.00065302313],"domain_scores_gemma":[0.99839586,0.00020508161,0.00021806665,0.00072222063,0.00016188416,0.00029688564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033140546,0.00042434916,0.001073971,0.00025756034,0.00017934915,0.000092839146,0.00024503592,0.0002670562,0.00032061478],"category_scores_gemma":[0.00074140984,0.00040444024,0.00016665869,0.0008498653,0.000038849357,0.0008463568,0.0001684668,0.0005501348,0.00016802977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019308209,0.00086381665,0.018463312,0.00022086676,0.00016807517,0.0006835473,0.00043109298,0.000014963818,0.9729134,0.000650336,0.0001490432,0.005248502],"study_design_scores_gemma":[0.007557301,0.00030045598,0.027094333,0.00027771824,0.0001515196,0.0003358891,0.00053037365,0.000017192482,0.95085263,0.0011431925,0.011289821,0.0004495754],"about_ca_topic_score_codex":0.000395106,"about_ca_topic_score_gemma":0.0017392738,"teacher_disagreement_score":0.022060733,"about_ca_system_score_codex":0.0003032426,"about_ca_system_score_gemma":0.0008798271,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W3209149195","doi":"10.1182/bloodadvances.2021006047","title":"Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Cancer Society Research Institute; Genome Canada; Canadian Institutes of Health Research; Government of Canada; National Institutes of Health; Deutsche Krebshilfe","keywords":"Myeloid leukemia; Prenylation; Rab; Geranylgeranylation; Statin; Leukemia; Cancer research; Vesicular transport protein; Pharmacology; Biology; Medicine; Immunology; Cell biology; Internal medicine; Vesicle; Biochemistry; GTPase; Enzyme","score_opus":0.005565687706735674,"score_gpt":0.24193579460382925,"score_spread":0.23637010689709356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209149195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590486,0.0034436549,0.00009995297,0.00024648584,0.00008410248,0.00009629359,0.000018096245,0.0000038995845,0.00010265357],"genre_scores_gemma":[0.9970211,0.00050626707,0.0016511134,0.0002723793,0.000033573397,0.0000141769915,0.000010496587,0.000009084623,0.00048180606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992369,0.00012394568,0.00019101957,0.000207012,0.00011183294,0.00012928342],"domain_scores_gemma":[0.9995623,0.000016410797,0.00009212991,0.0002575637,0.000047564194,0.000023985813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013674179,0.000086587126,0.000105586434,0.000020564665,0.0000394445,0.000009769875,0.0001352781,0.000056072877,0.000009104698],"category_scores_gemma":[0.00015742447,0.00006602444,0.00007067676,0.00013964801,0.00005472677,0.000006655867,0.00007296,0.000061398954,0.0000010253406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014336847,0.00004250531,0.0016403411,0.0000144678215,0.000021165473,0.000018583085,0.00016040719,0.00007158148,0.99293023,0.000015173214,0.00008486934,0.0048573087],"study_design_scores_gemma":[0.0005076886,0.000099343364,0.006063452,0.00004944538,0.00001541375,0.00001863202,0.00013620267,0.000025831318,0.9650245,0.00003074008,0.027941214,0.000087538014],"about_ca_topic_score_codex":0.0000042729907,"about_ca_topic_score_gemma":0.00003532535,"teacher_disagreement_score":0.02790573,"about_ca_system_score_codex":0.000009887752,"about_ca_system_score_gemma":0.00019056795,"threshold_uncertainty_score":0.26923984},"labels":[],"label_agreement":null},{"id":"W3211260362","doi":"10.1182/bloodadvances.2021005945","title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Health Sciences Centre; Ottawa Hospital; University of Ottawa; McGill University; Impact; McMaster University; University of Toronto; Cochrane; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Guideline; Intensive care medicine; MEDLINE; Appropriate Use Criteria; Multidisciplinary approach; Randomized controlled trial; Grading (engineering); Venous thromboembolism; Coronavirus disease 2019 (COVID-19); Evidence-based medicine; Risk assessment; Family medicine; Emergency medicine; Thrombosis; Internal medicine; Alternative medicine; Disease; Infectious disease (medical specialty); Pathology","score_opus":0.053524257441926376,"score_gpt":0.32212554226325885,"score_spread":0.2686012848213325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211260362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993836,0.00038838398,0.00050886924,0.0039569293,0.000090436,0.0010674564,0.000088246656,0.000015407217,0.000048283764],"genre_scores_gemma":[0.98395836,0.0009269224,0.011202212,0.0036665122,0.00004947735,0.00007094731,0.000065665605,0.000030164932,0.000029712635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830264,0.00007484833,0.00055051513,0.00041541594,0.00039301373,0.00026355326],"domain_scores_gemma":[0.9980654,0.00051068503,0.00044656702,0.00046780723,0.00043465907,0.00007484107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002023821,0.00021274686,0.00079819316,0.00008874126,0.00009381713,0.000014355103,0.000106865074,0.000047481437,0.00006398798],"category_scores_gemma":[0.0008423124,0.0001365201,0.00015951741,0.0004684641,0.00021429775,0.00013210159,0.000065142194,0.00010562799,0.000002603641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014080756,0.020984206,0.8876712,0.0041945037,0.0022401004,0.0000304829,0.0027311866,0.006344646,0.0066306,0.022193424,0.010428393,0.035143234],"study_design_scores_gemma":[0.0049721217,0.0093761645,0.9265917,0.0018389154,0.0005526864,0.0000047623325,0.0013940689,0.00044157376,0.030799007,0.00058936956,0.022922363,0.00051729515],"about_ca_topic_score_codex":0.00010198656,"about_ca_topic_score_gemma":0.00008105374,"teacher_disagreement_score":0.03892052,"about_ca_system_score_codex":0.000034880206,"about_ca_system_score_gemma":0.00013059183,"threshold_uncertainty_score":0.55671287},"labels":[],"label_agreement":null},{"id":"W3212430506","doi":"10.1182/bloodadvances.2021005418","title":"<i>TET2</i> mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; Edward P. Evans Foundation; National Heart, Lung, and Blood Institute; American-Italian Cancer Foundation; Vera and Joseph Dresner Foundation; Leukemia and Lymphoma Society","keywords":"Myelodysplastic syndromes; Dioxygenase; Mutation; DNA; Cancer research; Genetics; Biology; Gene; Immunology; Bone marrow","score_opus":0.01639163811844425,"score_gpt":0.29893026594684563,"score_spread":0.2825386278284014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212430506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804165,0.009118593,0.00005850236,0.000616559,0.00010013213,0.0002466749,0.000024042329,0.00003632917,0.009382716],"genre_scores_gemma":[0.99442345,0.0010370238,0.0019362405,0.00013244088,0.000055640296,0.00005744352,0.000047068494,0.00002100501,0.0022897173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984658,0.000066096385,0.0003706153,0.0003327346,0.00041425353,0.00035053186],"domain_scores_gemma":[0.9989462,0.00034681216,0.00007903133,0.00031495042,0.00017625533,0.00013678493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014304597,0.00013858895,0.0003547576,0.00016811762,0.000052323,0.000011428411,0.00011712012,0.000058643476,0.00021800867],"category_scores_gemma":[0.0010303198,0.00012412595,0.00007980818,0.0008622052,0.00016241994,0.00016640752,0.00006802834,0.00021766225,0.00006908375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007920525,0.008788361,0.21063998,0.0042095906,0.00057989475,0.02499852,0.0038168568,0.0017674551,0.69424856,0.010058927,0.0012051639,0.038894664],"study_design_scores_gemma":[0.013270928,0.001832496,0.058904354,0.0017009573,0.0005544181,0.0049409843,0.0055955364,0.0003222505,0.850377,0.0042604376,0.057456605,0.00078399084],"about_ca_topic_score_codex":0.0000207797,"about_ca_topic_score_gemma":0.00008416867,"teacher_disagreement_score":0.15612851,"about_ca_system_score_codex":0.00005545841,"about_ca_system_score_gemma":0.00076442567,"threshold_uncertainty_score":0.5061709},"labels":[],"label_agreement":null},{"id":"W3213050308","doi":"10.1182/bloodadvances.2021005794","title":"Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Bendamustine; Hazard ratio; Internal medicine; Cohort; Confidence interval; Rituximab; Clinical endpoint; Randomized controlled trial; Oncology; Surgery; Lymphoma","score_opus":0.03337199370905094,"score_gpt":0.2962263346243567,"score_spread":0.2628543409153058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213050308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8902329,0.10749107,0.000010528857,0.0012938462,0.00021822419,0.00023482727,0.000059040285,0.000038409053,0.00042111138],"genre_scores_gemma":[0.96814907,0.026368072,0.0042007715,0.00034945746,0.00019883804,0.000009677098,0.0004391072,0.000025052432,0.00025997745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985003,0.000049158203,0.00028168855,0.00068027305,0.00023796869,0.0002506375],"domain_scores_gemma":[0.9989121,0.00015487103,0.00008082962,0.00058506377,0.00005139393,0.00021576906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013732248,0.00020735544,0.000500733,0.00006748074,0.000069254966,0.000033792883,0.00007915832,0.000075602344,0.000038167866],"category_scores_gemma":[0.00023833792,0.00017284117,0.000026887807,0.00016164077,0.00006908099,0.0002378883,0.00025400618,0.0001334055,0.000010162309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042414002,0.004278649,0.8411232,0.00020227405,0.0002680381,0.0031102896,0.00018533728,0.000004749207,0.0012245663,0.0004935824,0.00084047334,0.14784466],"study_design_scores_gemma":[0.042405237,0.00035156644,0.8882309,0.0004726199,0.00066421117,0.00056385825,0.00034664397,0.00020971532,0.0023671573,0.0002995642,0.06377602,0.00031250645],"about_ca_topic_score_codex":0.00030847962,"about_ca_topic_score_gemma":0.0006714252,"teacher_disagreement_score":0.14753215,"about_ca_system_score_codex":0.000053121847,"about_ca_system_score_gemma":0.00028843613,"threshold_uncertainty_score":0.7048258},"labels":[],"label_agreement":null},{"id":"W3213869674","doi":"10.1182/bloodadvances.2021005916","title":"Consensus statement for the perinatal management of patients with α thalassemia major","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto; University of British Columbia","funders":"","keywords":"Thalassemia; Statement (logic); Medicine; Beta thalassemia; Intensive care medicine; MEDLINE; Business; Pediatrics; Internal medicine; Political science","score_opus":0.005432047806301406,"score_gpt":0.24440526019914408,"score_spread":0.23897321239284267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213869674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98529434,0.010082002,0.00018764274,0.0010968898,0.00013868407,0.00073396275,0.000064820546,0.000017743825,0.0023838906],"genre_scores_gemma":[0.99224216,0.0011649912,0.005127483,0.000110795365,0.000014683338,0.00005760807,0.000040491494,0.000013684821,0.0012281043],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934644,0.000008766837,0.00016687435,0.00014697359,0.00018392593,0.00014700579],"domain_scores_gemma":[0.999539,0.000054991044,0.00007172325,0.00016967453,0.00012919174,0.000035430196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048436774,0.00008524858,0.00013895294,0.000013572877,0.00006669516,0.0000055451724,0.00004329965,0.000022303879,0.000042340303],"category_scores_gemma":[0.000009788592,0.000046642144,0.000046979614,0.000095378025,0.00007039471,0.00002360781,0.000028284458,0.00005144978,0.000001430887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060058204,0.008149233,0.6435517,0.01327157,0.0113550555,0.001296164,0.0017859726,0.001141093,0.0014206462,0.016141552,0.0052148895,0.29066628],"study_design_scores_gemma":[0.044620313,0.0032111784,0.404856,0.0016405834,0.004253793,0.00008135226,0.026919,0.00015595797,0.035127748,0.0004503398,0.4780588,0.0006249461],"about_ca_topic_score_codex":0.0000025919799,"about_ca_topic_score_gemma":0.000005247551,"teacher_disagreement_score":0.4728439,"about_ca_system_score_codex":0.000009535589,"about_ca_system_score_gemma":0.00003901723,"threshold_uncertainty_score":0.19020115},"labels":[],"label_agreement":null},{"id":"W3214409149","doi":"10.1182/bloodadvances.2021005627","title":"Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; University of Calgary; University of Alberta; Université de Montréal; Western University; University of Toronto; University of Ottawa; McGill University; Canadian Blood Services; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Waterloo; McMaster University; Ottawa Hospital; Health Sciences Centre","funders":"Canadian Institutes of Health Research; Health Canada; Government of Canada; Australian Government; Canadian Blood Services; McMaster University","keywords":"Eltrombopag; Medicine; Antibody; Perioperative; Immune thrombocytopenia; Immunology; Intensive care medicine; Anesthesia","score_opus":0.023341345339602908,"score_gpt":0.31716532370491446,"score_spread":0.29382397836531154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214409149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93861943,0.05596557,0.0008905282,0.00021346737,0.00016738399,0.0022158842,0.00009019919,0.000014871512,0.0018226386],"genre_scores_gemma":[0.989933,0.0064163827,0.003013592,0.000029874724,0.000013237713,0.00026077247,0.00006216807,0.000015026265,0.0002559594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991501,0.00005183035,0.0002734501,0.00020307339,0.00015231004,0.00016921025],"domain_scores_gemma":[0.9991759,0.00021869461,0.000119586286,0.000282541,0.0001781254,0.000025127461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015919234,0.0001393354,0.0005913387,0.000021317288,0.00008636216,0.00000813562,0.000100477875,0.000032828208,0.000044439283],"category_scores_gemma":[0.00002877658,0.000091007314,0.00014441389,0.00015706953,0.00010891442,0.00007358444,0.000049693495,0.00005918349,0.000002382288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014231208,0.018999182,0.021160461,0.013610879,0.025804617,0.0025150557,0.003992397,0.0010695271,0.53314966,0.028251162,0.000046036213,0.33716983],"study_design_scores_gemma":[0.013687501,0.0018842542,0.1535078,0.00091248145,0.0018160843,0.00016307867,0.0025283317,0.000026443497,0.8184689,0.0005940603,0.006220015,0.00019103341],"about_ca_topic_score_codex":0.000022960965,"about_ca_topic_score_gemma":0.000009098349,"teacher_disagreement_score":0.3369788,"about_ca_system_score_codex":0.000020759924,"about_ca_system_score_gemma":0.00006230273,"threshold_uncertainty_score":0.37111706},"labels":[],"label_agreement":null},{"id":"W3215063928","doi":"10.1182/bloodadvances.2021004938","title":"Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences","keywords":"Deferiprone; Medicine; Deferoxamine; Thalassemia; Internal medicine; Gastroenterology; Deferasirox; Adverse effect; Chelation therapy; Randomized controlled trial; Clinical endpoint; Neutropenia; Anemia; Beta thalassemia; Chemotherapy","score_opus":0.020403443249380367,"score_gpt":0.3119759037942403,"score_spread":0.2915724605448599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215063928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97386616,0.020868663,0.00011210387,0.0005896682,0.00012540385,0.0027413673,0.00003478824,0.000028976752,0.0016328768],"genre_scores_gemma":[0.9892637,0.0038274033,0.004644926,0.00084179116,0.00007570662,0.00042784962,0.000027785636,0.0000391846,0.00085165846],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985013,0.00011598262,0.00041578434,0.00047093822,0.00020289885,0.00029310927],"domain_scores_gemma":[0.9992903,0.00023851029,0.000071674134,0.00020563755,0.000078017714,0.000115889045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047594248,0.00021695532,0.0008444602,0.00006556067,0.00011184766,0.00004336561,0.00009456865,0.000117201314,0.00008709272],"category_scores_gemma":[0.00025150678,0.00016673427,0.000066582346,0.00024586314,0.00012546967,0.00016346459,0.00007165971,0.00020670844,0.000002655522],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36435583,0.052745957,0.3921239,0.0031508573,0.001676646,0.0016307628,0.012695616,0.00013170026,0.03555009,0.0035591566,0.00025042266,0.13212904],"study_design_scores_gemma":[0.9661879,0.0024278432,0.006727977,0.00057944906,0.001046169,0.00027119074,0.005494588,0.0003026777,0.0021774732,0.00075858325,0.0134881055,0.000538037],"about_ca_topic_score_codex":0.000150634,"about_ca_topic_score_gemma":0.0007480097,"teacher_disagreement_score":0.6018321,"about_ca_system_score_codex":0.000018708994,"about_ca_system_score_gemma":0.00014369837,"threshold_uncertainty_score":0.67992264},"labels":[],"label_agreement":null},{"id":"W3216230580","doi":"10.1182/bloodadvances.2021005895","title":"Multifaceted pathomolecular mechanism of a <i>VWF</i> large deletion involved in the pathogenesis of severe VWD","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Cell biology; Angiogenesis; Biology; Endothelial stem cell; Transcriptome; Downregulation and upregulation; Immunology; Gene; Gene expression; Cancer research; Platelet; Genetics","score_opus":0.009001995773476632,"score_gpt":0.24404772971762723,"score_spread":0.2350457339441506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216230580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910742,0.007692092,0.0002936439,0.00013608838,0.000030487543,0.0002614601,0.00009749894,0.000010075885,0.0004044209],"genre_scores_gemma":[0.99636126,0.0012482248,0.0019896713,0.00023254321,0.0000078030325,0.000027408205,0.000098605415,0.000010347767,0.000024122031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991026,0.00009861823,0.00023725965,0.00018378826,0.00022292849,0.00015482062],"domain_scores_gemma":[0.9994871,0.000054279586,0.00010726149,0.00022827722,0.00009583074,0.000027273363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014750133,0.000105648774,0.00031229595,0.000045294044,0.000026375232,0.0000029585115,0.00006186216,0.00005608586,0.000020071633],"category_scores_gemma":[0.00009203042,0.000076475466,0.000092185495,0.00028118736,0.000022028204,0.0000531457,0.00002329497,0.000061249986,0.000001368277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025834612,0.0064764395,0.060244743,0.0006874803,0.0003588895,0.0040530097,0.0018201061,0.000046711735,0.90864027,0.0043046772,0.000016851476,0.013092478],"study_design_scores_gemma":[0.021425372,0.0009519185,0.048842486,0.0007873923,0.0010621281,0.00047294472,0.007894234,0.00028814274,0.90830624,0.005778748,0.0037733293,0.00041703918],"about_ca_topic_score_codex":0.000019875051,"about_ca_topic_score_gemma":0.00019770644,"teacher_disagreement_score":0.021167025,"about_ca_system_score_codex":0.000005772976,"about_ca_system_score_gemma":0.000068680005,"threshold_uncertainty_score":0.3118579},"labels":[],"label_agreement":null},{"id":"W4200019298","doi":"10.1182/bloodadvances.2021005741","title":"A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Terry Fox Foundation; Ontario Genomics Institute; Ontario Institute for Cancer Research; Government of Canada; Canadian Institutes of Health Research; China Scholarship Council; Ontario Genomics; Genome Canada; Mayo Clinic","keywords":"Myeloid leukemia; Medicine; Oncology; Internal medicine; Cohort; Risk stratification","score_opus":0.023593416256952573,"score_gpt":0.3544770853825217,"score_spread":0.33088366912556916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200019298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904396,0.0013835552,0.0039175623,0.0002614713,0.0003072397,0.0015321069,0.00083577016,0.000076851466,0.0012458244],"genre_scores_gemma":[0.8396268,0.0035690172,0.15314801,0.00070728833,0.000462989,0.00043503498,0.00077402365,0.00014142648,0.0011354304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965517,0.000376998,0.0008733038,0.0007585212,0.0009096056,0.0005298744],"domain_scores_gemma":[0.99526143,0.00084774895,0.0005319813,0.0007441755,0.0023068136,0.00030786684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011921423,0.00032635205,0.0010093289,0.00012675849,0.00015980977,0.000036119065,0.00028322657,0.0001939484,0.00009088473],"category_scores_gemma":[0.001041889,0.00024275691,0.00018692865,0.00075360277,0.00027721198,0.00034283864,0.00016192798,0.00060290005,0.0000065846484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012815219,0.0010780996,0.96322215,0.0005846683,0.0015734492,0.00019525694,0.00006976782,0.000021400721,0.0009302288,0.0001635796,0.00083458726,0.030045278],"study_design_scores_gemma":[0.027382681,0.0030208018,0.89592737,0.0005880575,0.00170845,0.000024663159,0.00036602994,0.0002746658,0.018946411,0.000102703576,0.051098797,0.0005593451],"about_ca_topic_score_codex":0.000008262623,"about_ca_topic_score_gemma":0.000037193753,"teacher_disagreement_score":0.15081283,"about_ca_system_score_codex":0.00026033152,"about_ca_system_score_gemma":0.0052821073,"threshold_uncertainty_score":0.98993397},"labels":[],"label_agreement":null},{"id":"W4200101750","doi":"10.1182/bloodadvances.2021005240","title":"Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Oncology; Risk analysis (engineering); Risk assessment; Myelodysplastic syndromes; Internal medicine; Intensive care medicine; Computer science; Cancer; Computer security; Immunotherapy","score_opus":0.015406730698258484,"score_gpt":0.2841526436120235,"score_spread":0.26874591291376504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200101750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467534,0.0019766667,0.000059244754,0.0008477909,0.00010297567,0.00069060654,0.000046279732,0.00006847775,0.0015326097],"genre_scores_gemma":[0.9902943,0.0019623076,0.0038735217,0.00011665473,0.000037493766,0.00018670433,0.00009661955,0.00003972325,0.003392718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758875,0.00014612013,0.00055112626,0.0005773591,0.0005141499,0.000622497],"domain_scores_gemma":[0.9987497,0.00042111718,0.00014952724,0.0003536155,0.00016523035,0.0001608311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039321103,0.00023924439,0.00060342846,0.00034053586,0.0000831936,0.00004135297,0.00016216961,0.00013862734,0.0002971388],"category_scores_gemma":[0.0009978905,0.00020480434,0.00005899384,0.0013388754,0.00010437439,0.00039979874,0.00010695098,0.0006378967,0.0001333449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049207094,0.0066718487,0.8145897,0.0024352304,0.00034038525,0.042818118,0.0010796774,0.0015734985,0.04812396,0.0014280695,0.0002820171,0.07573679],"study_design_scores_gemma":[0.034237206,0.002198597,0.8354131,0.0019743326,0.00024949113,0.0038291144,0.0014900818,0.006209093,0.10942697,0.0020008602,0.0021642877,0.0008068673],"about_ca_topic_score_codex":0.0002653745,"about_ca_topic_score_gemma":0.0016528679,"teacher_disagreement_score":0.07492992,"about_ca_system_score_codex":0.00029769266,"about_ca_system_score_gemma":0.0007664477,"threshold_uncertainty_score":0.8351679},"labels":[],"label_agreement":null},{"id":"W4200321533","doi":"10.1182/bloodadvances.2021006189","title":"Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Orionin Tutkimussäätiö; Academy of Finland; Biocenter Finland; Helsingin Yliopisto","keywords":"Classical Hodgkin lymphoma; Tumor microenvironment; Lymphoma; Protein expression; Outcome (game theory); Cancer research; Hodgkin lymphoma; Oncology; Expression (computer science); Medicine; Internal medicine; Biology; Tumor cells; Computer science; Genetics; Gene","score_opus":0.012840922598093335,"score_gpt":0.25250506780368964,"score_spread":0.2396641452055963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200321533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226797,0.004138582,0.000002939498,0.0024162962,0.000053672702,0.00060250185,0.000013193356,0.000007947869,0.00049688364],"genre_scores_gemma":[0.9977705,0.00018206962,0.0010694274,0.0005050517,0.00004478003,0.0002804172,0.000018411658,0.000010201357,0.00011916086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876153,0.00010719145,0.0003610284,0.00023840168,0.00034640986,0.00018544527],"domain_scores_gemma":[0.9993154,0.000116471645,0.00013511998,0.0003653104,0.000028352255,0.000039373444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011483271,0.00014825712,0.00026808772,0.000023672548,0.000060097158,0.000012471601,0.00011853226,0.000029456598,0.000031323736],"category_scores_gemma":[0.000113477996,0.000068201356,0.00011774861,0.00012121849,0.00009296354,0.000054729295,0.000073969735,0.000053792137,0.000010780941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008771261,0.005565651,0.9672636,0.0000923327,0.000037753507,0.00017143073,0.00028421538,0.000003803667,0.014380064,0.00015175885,0.00008286778,0.011878809],"study_design_scores_gemma":[0.0034480162,0.00023318155,0.69668,0.00019757028,0.00007531175,0.000028691173,0.00029963767,0.0000017362654,0.2893174,0.00009522879,0.009559566,0.00006368003],"about_ca_topic_score_codex":0.0000186939,"about_ca_topic_score_gemma":0.000034879173,"teacher_disagreement_score":0.27493733,"about_ca_system_score_codex":0.00004805199,"about_ca_system_score_gemma":0.000038578222,"threshold_uncertainty_score":0.27811706},"labels":[],"label_agreement":null},{"id":"W4200386633","doi":"10.1182/bloodadvances.2021005862","title":"Precancer and cancer-associated depression and anxiety among older adults with blood cancers in the United States","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cancer survivorship and care","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Anxiety; Medicine; Depression (economics); Internal medicine; Cancer; Comorbidity; Multiple myeloma; Cohort; Odds ratio; Epidemiology; Psychiatry; Oncology","score_opus":0.004961947611912656,"score_gpt":0.2418275584170422,"score_spread":0.23686561080512955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200386633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942976,0.05573009,0.0000028159002,0.00048173184,0.0000919424,0.00035195064,0.000053795367,0.000035535166,0.0002761281],"genre_scores_gemma":[0.95385545,0.044925347,0.00004407163,0.0006607499,0.000068099114,0.0001837926,0.00008912992,0.000021088295,0.00015229007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987467,0.00009218127,0.00017427251,0.00042146016,0.0002801285,0.00028527895],"domain_scores_gemma":[0.99934566,0.00010446487,0.00009870716,0.00019887909,0.00015058894,0.000101694306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011727674,0.0001952937,0.00028143232,0.000064262415,0.00010601706,0.000040880495,0.000065605,0.0000753448,0.00003522128],"category_scores_gemma":[0.00003704983,0.0001258236,0.000027166174,0.0006081734,0.00014625404,0.00016888828,0.00003671619,0.00023930063,1.15130334e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021942776,0.00015056113,0.9767818,0.0002543494,0.00012107464,0.000087239714,0.008283281,0.000102620346,0.00011864167,0.0000045271063,0.000057610272,0.01381887],"study_design_scores_gemma":[0.008657557,0.00029047916,0.95303184,0.003213009,0.0006512293,0.00009460377,0.017484095,0.0002186469,0.008856668,0.00003727789,0.0071133506,0.0003512259],"about_ca_topic_score_codex":0.010612096,"about_ca_topic_score_gemma":0.14709619,"teacher_disagreement_score":0.13648409,"about_ca_system_score_codex":0.000044317305,"about_ca_system_score_gemma":0.00015822602,"threshold_uncertainty_score":0.9959763},"labels":[],"label_agreement":null},{"id":"W4200536979","doi":"10.1182/bloodadvances.2021006043","title":"The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Hematocrit; Nausea; Internal medicine; Gastroenterology; Vomiting; Ruxolitinib; Adverse effect; Polycythemia vera; Phlebotomy; Clinical endpoint; Regimen; Anemia; Surgery; Myelofibrosis; Clinical trial","score_opus":0.012022650763287865,"score_gpt":0.27513504460580723,"score_spread":0.2631123938425194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200536979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445117,0.0025342838,0.0000027552571,0.0008575064,0.0001356944,0.0008048966,0.00018124342,0.000030247931,0.0010022045],"genre_scores_gemma":[0.9982797,0.00025377647,0.0006186708,0.00017165241,0.00011762643,0.00011713008,0.0002362336,0.000021587095,0.00018364827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983447,0.00009235315,0.00038509566,0.0005006314,0.000399217,0.00027798093],"domain_scores_gemma":[0.9988124,0.00038875375,0.00013601486,0.00042047998,0.00013672742,0.000105620136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009636404,0.00022892063,0.00036906765,0.000036674082,0.00020057938,0.00006799517,0.000081830316,0.000036005466,0.000028153685],"category_scores_gemma":[0.00019421376,0.00013233071,0.000048676127,0.00024995554,0.000072375595,0.00011134906,0.000043475935,0.00016103417,0.000011353897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005317831,0.04109919,0.92524964,0.000010686097,0.00040895626,0.0007705717,0.0011943664,0.0000067922997,0.0002511779,0.000024556724,0.00009297741,0.025573272],"study_design_scores_gemma":[0.1439122,0.018021297,0.7306985,0.0005149235,0.00074525736,0.00001752228,0.003560129,0.000017659378,0.08194978,0.00014361048,0.019938366,0.00048070593],"about_ca_topic_score_codex":0.00008256426,"about_ca_topic_score_gemma":0.001064004,"teacher_disagreement_score":0.19455107,"about_ca_system_score_codex":0.00006142629,"about_ca_system_score_gemma":0.00011633181,"threshold_uncertainty_score":0.539629},"labels":[],"label_agreement":null},{"id":"W4200538316","doi":"10.1182/bloodadvances.2021005634","title":"Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Transcriptome; Gene; Fusion gene; Cancer research; Genetics; Gene expression profiling; ETV6; Molecular biology; Bioinformatics; Gene expression; Oncology; Chromosomal translocation; Medicine","score_opus":0.0157163094770454,"score_gpt":0.31541668072477097,"score_spread":0.2997003712477256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200538316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8982355,0.0042325635,0.0046850345,0.010058815,0.0006052412,0.06801195,0.0006396816,0.0005477302,0.01298348],"genre_scores_gemma":[0.9221472,0.00033177095,0.0039624088,0.0035947056,0.0007248745,0.056243006,0.0013471012,0.00013769371,0.011511252],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957178,0.00023245093,0.0010187868,0.0010467559,0.0011556068,0.0008285473],"domain_scores_gemma":[0.9969265,0.0008355875,0.00028027451,0.0012747706,0.0003682817,0.0003145881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004638405,0.00041059067,0.0009868655,0.00026127897,0.00012650511,0.00010109625,0.00042728343,0.00021981115,0.0006758533],"category_scores_gemma":[0.00086709234,0.0002861148,0.0003583427,0.0021756613,0.0003391263,0.00030123763,0.0001826357,0.000557133,0.00010842365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049029724,0.005449658,0.56075054,0.00097093446,0.027857663,0.13856234,0.0021481705,0.0017029939,0.22636686,0.00032642495,0.020194963,0.0107665],"study_design_scores_gemma":[0.05961767,0.0008996135,0.19381763,0.00093711895,0.019957103,0.0072475085,0.0019948431,0.004633788,0.061243296,0.0018470018,0.64609337,0.0017110459],"about_ca_topic_score_codex":0.000778055,"about_ca_topic_score_gemma":0.0015768108,"teacher_disagreement_score":0.6258984,"about_ca_system_score_codex":0.0009834159,"about_ca_system_score_gemma":0.0025249156,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W4205235414","doi":"10.1182/bloodadvances.2021005949","title":"Inflammasome activation in neutrophils of patients with severe COVID-19","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Neutrophil extracellular traps; Inflammasome; Inflammation; AIM2; Immunology; Pathogenesis; NLRC4; Biology; Cell biology; Caspase 1","score_opus":0.003920356252455646,"score_gpt":0.2146122455091818,"score_spread":0.21069188925672613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205235414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987657,0.00041983704,0.000031733503,0.000083474224,0.000034870965,0.00018761563,0.000020683154,0.000004983452,0.0004511049],"genre_scores_gemma":[0.9991771,0.00006285372,0.00009220768,0.00023989829,0.000017246872,0.00005272603,0.00025313103,0.000009946807,0.00009487008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993795,0.00004376231,0.00014658086,0.00017257793,0.00012889004,0.00012867522],"domain_scores_gemma":[0.9996662,0.000008595179,0.00011017789,0.00015672966,0.00003215892,0.000026125805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005950023,0.00008392022,0.00009585746,0.000054908127,0.000071769726,0.0000034319378,0.00012249983,0.000025902185,0.00004714354],"category_scores_gemma":[0.00004322634,0.0000785978,0.000027514325,0.0001402064,0.000036170626,0.000011623255,0.000079474295,0.000065060114,4.886745e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012971248,0.00062013103,0.8144834,0.00010015286,0.00008026481,0.0000033512208,0.00037132917,0.017405959,0.16168886,0.00017995469,0.00012749832,0.003641938],"study_design_scores_gemma":[0.01479073,0.0037740562,0.35728914,0.000027010188,0.000053971038,0.0000073190245,0.0020912096,0.000009420017,0.31767768,0.0006821883,0.30274424,0.0008530579],"about_ca_topic_score_codex":0.000012863464,"about_ca_topic_score_gemma":0.000025464777,"teacher_disagreement_score":0.4571943,"about_ca_system_score_codex":0.000011746489,"about_ca_system_score_gemma":0.000082590894,"threshold_uncertainty_score":0.3205125},"labels":[],"label_agreement":null},{"id":"W4205286061","doi":"10.1182/bloodadvances.2021006208","title":"Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institute of Nursing Research; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Eye Institute; National Institute on Aging; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; Canadian Institutes of Health Research; National Institutes of Health; Government of Alberta; Agency for Healthcare Research and Quality; National Center for Advancing Translational Sciences; Health Resources and Services Administration; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institute on Minority Health and Health Disparities; National Center for Research Resources; Centers for Disease Control and Prevention","keywords":"Lymphoma; Medicine; Internal medicine; Confidence interval; Cohort; Oncology; Anaplastic large-cell lymphoma; Human immunodeficiency virus (HIV); Pediatrics; Immunology","score_opus":0.009679304087547386,"score_gpt":0.26335519745897956,"score_spread":0.25367589337143215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205286061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800854,0.016655756,0.00000987065,0.0005661956,0.00004260309,0.0009217727,0.00009321247,0.000032003558,0.0015932315],"genre_scores_gemma":[0.9888914,0.00042024438,0.008935868,0.00050921657,0.000018026054,0.0005821182,0.00003562153,0.000024869714,0.00058262114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987972,0.00003562629,0.00020300996,0.00048435174,0.00020241749,0.00027739463],"domain_scores_gemma":[0.99933475,0.00021489116,0.00009360886,0.0001593908,0.000030822823,0.00016652622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009888971,0.00026003187,0.0006273279,0.00012795362,0.0002096808,0.000039273655,0.000050371033,0.000035026063,0.000012697918],"category_scores_gemma":[0.000013661985,0.00019010039,0.000032747117,0.0001833315,0.000059236147,0.000120166886,0.00010742038,0.00006232816,0.0000014156917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005203571,0.0007523077,0.9932923,0.00019279456,0.00007915535,0.000034400728,0.0030073149,0.000041755586,0.00031777407,0.0003501975,0.00009971689,0.0013119419],"study_design_scores_gemma":[0.04188813,0.0034904962,0.91989535,0.0001937642,0.00061053486,0.0003782671,0.010278542,0.000121547404,0.00836272,0.0002124413,0.014026594,0.0005416002],"about_ca_topic_score_codex":0.00007782361,"about_ca_topic_score_gemma":0.00023083323,"teacher_disagreement_score":0.07339692,"about_ca_system_score_codex":0.00006703698,"about_ca_system_score_gemma":0.000084774685,"threshold_uncertainty_score":0.7752069},"labels":[],"label_agreement":null},{"id":"W4206186218","doi":"10.1182/bloodadvances.2020003910","title":"Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Total body irradiation; Medicine; Busulfan; Cumulative incidence; Incidence (geometry); Cohort; Internal medicine; Fludarabine; Confidence interval; Population; Surgery; Chemotherapy; Oncology; Cyclophosphamide","score_opus":0.010919298990420748,"score_gpt":0.27383485020709075,"score_spread":0.26291555121667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206186218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707586,0.0006959331,0.0005629699,0.000102546284,0.000097126605,0.0008189779,0.00009394282,0.000050120812,0.0005025304],"genre_scores_gemma":[0.9964883,0.00007325361,0.0022848663,0.00012700968,0.000042176758,0.00035494418,0.00012576464,0.000025250725,0.00047846785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849176,0.0000863662,0.00036177953,0.00029371172,0.0005729912,0.00019337484],"domain_scores_gemma":[0.9992643,0.00011129326,0.00022906181,0.00020424751,0.000107728054,0.000083394116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014619001,0.00016343148,0.0003339228,0.000103500905,0.000088473185,0.000007538135,0.000065784756,0.0000307876,0.00068309664],"category_scores_gemma":[0.000026507008,0.00012653232,0.000049788025,0.00027382292,0.00008804316,0.00025638938,0.000019135425,0.0001228287,0.00000808018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012636914,0.0022466362,0.84521335,0.002591812,0.0005843041,0.0018698534,0.0118827075,0.003951173,0.11686208,0.0011061183,0.000030161718,0.0010248545],"study_design_scores_gemma":[0.016999431,0.0061196494,0.7991127,0.0018512133,0.0013699838,0.0026660901,0.0037363276,0.0014017578,0.16502573,0.00046016625,0.00046140875,0.0007955968],"about_ca_topic_score_codex":0.000032036896,"about_ca_topic_score_gemma":0.00003792221,"teacher_disagreement_score":0.04816364,"about_ca_system_score_codex":0.000055656976,"about_ca_system_score_gemma":0.00017902875,"threshold_uncertainty_score":0.7479429},"labels":[],"label_agreement":null},{"id":"W4206366768","doi":"10.1182/bloodadvances.2021005928","title":"Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto; Queen's University","funders":"","keywords":"Von Willebrand factor; Cysteine; Hemostasis; Chemistry; Phenotype; Desmopressin; Von Willebrand disease; Secretion; Internal medicine; Endocrinology; Expressivity; Molecular biology; Biochemistry; Genetics; Medicine; Biology; Gene; Platelet; Enzyme","score_opus":0.0403180791953961,"score_gpt":0.3418105232383684,"score_spread":0.3014924440429723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206366768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793745,0.009166497,0.00064188964,0.00007008972,0.00011208416,0.00032594532,0.00022213087,0.000029288467,0.0014946018],"genre_scores_gemma":[0.9925514,0.00019508127,0.0068738167,0.000053902877,0.00001901492,0.000080435486,0.00006300165,0.000010505287,0.00015287897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990852,0.00008623726,0.00019247136,0.00024051705,0.00023521009,0.00016038073],"domain_scores_gemma":[0.9993254,0.00025853622,0.00016301005,0.0001240891,0.00007121992,0.000057740923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017841428,0.00012674142,0.00035411058,0.00007673702,0.00018491682,0.0000056145304,0.000042888907,0.000023585308,0.00002948736],"category_scores_gemma":[0.00016983018,0.00011128401,0.00003998098,0.00022149482,0.00013098287,0.00019534717,0.000056908924,0.00009662872,0.0000013304228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030424758,0.01083172,0.04235393,0.0015725488,0.0019977782,0.0007577788,0.02296673,0.0019000582,0.75508374,0.15810516,0.00022591082,0.0011621558],"study_design_scores_gemma":[0.11155268,0.040281978,0.06958539,0.0022866598,0.0073986365,0.0037563427,0.121455595,0.00087663595,0.49612564,0.053943474,0.08934622,0.003390747],"about_ca_topic_score_codex":0.00016185692,"about_ca_topic_score_gemma":0.000037738875,"teacher_disagreement_score":0.2589581,"about_ca_system_score_codex":0.00001857066,"about_ca_system_score_gemma":0.000084325045,"threshold_uncertainty_score":0.45380303},"labels":[],"label_agreement":null},{"id":"W4210520468","doi":"10.1182/bloodadvances.2021006415","title":"Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche; Leukemia and Lymphoma Society","keywords":"Medicine; Internal medicine; Hazard ratio; International Prognostic Index; Oncology; Diffuse large B-cell lymphoma; Rituximab; Biomarker; Refractory (planetary science); Lymphoma; Bendamustine; Gastroenterology; Confidence interval; Biology","score_opus":0.0036537555200150556,"score_gpt":0.18651651546493545,"score_spread":0.18286275994492038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210520468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278617,0.0057163388,0.00018272836,0.0000033144047,0.00012532446,0.00020677115,0.00066201406,0.000010393525,0.00030692125],"genre_scores_gemma":[0.99839985,0.00025741183,0.00083891273,0.00006954702,0.000063398154,0.00005018081,0.0002532676,0.00003415208,0.000033279022],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892503,0.000050394057,0.00022579846,0.00033062568,0.00022446258,0.00024370331],"domain_scores_gemma":[0.9992617,0.000033473403,0.0003145097,0.00026128782,0.00007069535,0.000058385802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012588115,0.00014711103,0.00015958345,0.000029217124,0.0002136237,0.000011317728,0.00016963869,0.000028284217,0.000007783102],"category_scores_gemma":[0.00008654981,0.00014442822,0.000059503265,0.00008333922,0.00003394482,0.0000074873756,0.00017697208,0.00008077627,5.2148766e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043552578,0.0069349147,0.63706845,0.0001477515,0.0001475748,0.000012373014,0.00019506368,0.0013037163,0.3498218,0.0000408294,0.0001691702,0.0037228288],"study_design_scores_gemma":[0.023600264,0.00206172,0.018296216,0.00003756634,0.00022513137,0.000007785769,0.00075291155,0.00010932099,0.898809,0.00008488787,0.055230148,0.0007850437],"about_ca_topic_score_codex":0.00001531653,"about_ca_topic_score_gemma":0.000014033489,"teacher_disagreement_score":0.6187722,"about_ca_system_score_codex":0.000023397462,"about_ca_system_score_gemma":0.00008343692,"threshold_uncertainty_score":0.5889612},"labels":[],"label_agreement":null},{"id":"W4211106014","doi":"10.1182/bloodadvances.2019000812","title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","year":2019,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1090,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Amgen","keywords":"Immune thrombocytopenia; Consensus conference; Medicine; Intensive care medicine; MEDLINE; Pregnancy; Expectant management; Immunology; Political science; Internal medicine; Antibody","score_opus":0.013914612293685557,"score_gpt":0.25907320180372223,"score_spread":0.24515858951003666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211106014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711279,0.0008134769,7.6964784e-7,0.0017074248,0.00009692189,0.0003429905,0.000005155084,0.000011622406,0.025893705],"genre_scores_gemma":[0.9967604,0.0006484156,0.00085411035,0.0002012852,0.000007387008,0.000008745829,0.000092980656,0.000005023278,0.0014216097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951786,0.000009262986,0.00015019959,0.0001248109,0.00014125262,0.000056586447],"domain_scores_gemma":[0.9996799,0.000026178574,0.000103466904,0.00014416748,0.000028842782,0.000017416744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006887885,0.00006166017,0.00016259587,0.000023244349,0.000020423224,0.000005175127,0.000036946705,0.000015699661,0.00004880274],"category_scores_gemma":[0.0000071634527,0.00003819344,0.000019724963,0.000047667945,0.000052966938,0.000036262045,0.000025531146,0.00003617092,0.000010822174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012889918,0.0018574162,0.862457,0.0008803125,0.0044870554,0.0046713785,0.00043987783,0.00006150825,0.061099254,0.024017187,0.0016897882,0.03705027],"study_design_scores_gemma":[0.006310723,0.00048690144,0.9344418,0.0005224382,0.00037483536,0.0007351429,0.00035315994,0.000041983505,0.037536874,0.0025691618,0.016473183,0.00015378311],"about_ca_topic_score_codex":0.000008152096,"about_ca_topic_score_gemma":0.0000013749494,"teacher_disagreement_score":0.07198485,"about_ca_system_score_codex":0.000008882479,"about_ca_system_score_gemma":0.000013015054,"threshold_uncertainty_score":0.15574832},"labels":[],"label_agreement":null},{"id":"W4213223977","doi":"10.1182/bloodadvances.2021006018","title":"A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Morgan Adams Foundation; University of California, San Francisco; Leukemia and Lymphoma Society","keywords":"Medicine; Lymphoma; Primary central nervous system lymphoma; Rituximab; Young adult; Cohort; Pediatrics; Biopsy; Oncology; Diffuse large B-cell lymphoma; Internal medicine","score_opus":0.021012057160672268,"score_gpt":0.28700058047651567,"score_spread":0.2659885233158434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213223977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880671,0.00789742,0.000013423818,0.00021505359,0.00013547202,0.00042593366,0.0002799276,0.00005897108,0.0029067362],"genre_scores_gemma":[0.9965947,0.0007303942,0.00076280744,0.00062038156,0.0001021246,0.00010426311,0.00011132099,0.00003715003,0.0009368369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978813,0.00010981009,0.0006284091,0.00043123172,0.00057804794,0.00037121525],"domain_scores_gemma":[0.99862045,0.0003885937,0.00035507558,0.00036012701,0.00010554281,0.00017019057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003540226,0.00021477698,0.0007104207,0.00008523177,0.00016357139,0.000010240309,0.00014515141,0.000058046953,0.0002985854],"category_scores_gemma":[0.00013382688,0.00016434952,0.00021591425,0.00043118032,0.000067846166,0.000054650223,0.00014798387,0.00011901473,0.000015416015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002683461,0.01557164,0.9787544,0.00009785862,0.00019766985,0.00028442676,0.0000527219,0.000004383229,0.000021940388,0.000036763147,0.00040005162,0.004309775],"study_design_scores_gemma":[0.018069543,0.002974793,0.9669513,0.00002320524,0.0014054022,0.000048074544,0.00007407086,0.000020317582,0.00045035765,0.000039198654,0.009736563,0.00020718733],"about_ca_topic_score_codex":0.000023920771,"about_ca_topic_score_gemma":0.00002812774,"teacher_disagreement_score":0.017801197,"about_ca_system_score_codex":0.00012148731,"about_ca_system_score_gemma":0.00037053833,"threshold_uncertainty_score":0.67019784},"labels":[],"label_agreement":null},{"id":"W4213452461","doi":"10.1182/bloodadvances.2021006482","title":"American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in surgical and medical patients and long-distance travelers in Latin America","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Hematology; Internal medicine; Medicine; Political science","score_opus":0.021935451964083516,"score_gpt":0.3331365418248726,"score_spread":0.3112010898607891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213452461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766178,0.019015003,0.0005653482,0.002329189,0.00007115579,0.0012121365,0.00009823245,0.00003359358,0.000057555375],"genre_scores_gemma":[0.9755114,0.015287002,0.007818416,0.0007731277,0.00004197483,0.0004137709,0.00007375689,0.000048132864,0.00003247502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644625,0.00027170475,0.0011767776,0.00075006834,0.0006191957,0.00073599635],"domain_scores_gemma":[0.99811864,0.00054726447,0.00069258735,0.00026348105,0.0001407711,0.00023725617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010141247,0.00038505817,0.0020439632,0.00020351856,0.00021836984,0.000014591157,0.00023292455,0.00018202403,0.000045434277],"category_scores_gemma":[0.000346283,0.00037784158,0.00024311876,0.0005291874,0.001157843,0.00014319432,0.00030112878,0.00046803584,1.5567487e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004709949,0.008171076,0.8577958,0.0044768844,0.00092650973,0.0001743685,0.010295578,0.00017871028,0.00061703206,0.004291697,0.0028191097,0.109782234],"study_design_scores_gemma":[0.023161784,0.0053040953,0.90701234,0.0014507483,0.0013952729,0.0007086806,0.03843508,0.0048067113,0.0019880335,0.007885556,0.006424621,0.0014270981],"about_ca_topic_score_codex":0.0006418897,"about_ca_topic_score_gemma":0.0007284686,"teacher_disagreement_score":0.10835514,"about_ca_system_score_codex":0.00012367335,"about_ca_system_score_gemma":0.00025514982,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W4213458684","doi":"10.1182/bloodadvances.2021005431","title":"Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University; Impact","funders":"International Society on Thrombosis and Haemostasis; American Society of Hematology; National Hemophilia Foundation","keywords":"Desmopressin; Von Willebrand disease; Medicine; Von Willebrand factor; Meta-analysis; Platelet; Internal medicine; Gastroenterology","score_opus":0.2150800736513667,"score_gpt":0.4152025366015238,"score_spread":0.2001224629501571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213458684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008388352,0.99553853,8.8052883e-7,0.000031380154,0.0000060852435,0.002845278,0.00071545853,0.0000028163993,0.000020727919],"genre_scores_gemma":[0.0013370442,0.9972559,0.00012800428,0.000039348688,0.0000021451624,0.0011803663,0.00003294734,0.0000123097925,0.000011918451],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953918,0.0024891458,0.0014091681,0.00027302717,0.00033508544,0.000101775324],"domain_scores_gemma":[0.99200684,0.0050409166,0.002386931,0.00047882623,0.00005357215,0.000032886433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025190923,0.00027865928,0.014097437,0.00024931057,0.000024224037,0.000007658598,0.00011661409,0.0000738353,0.000060911647],"category_scores_gemma":[0.002445107,0.00013714905,0.0012039787,0.0009373514,0.00008767394,0.00011761437,0.000050476614,0.00014249257,9.120709e-8],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009221754,0.0006799033,0.00027646378,0.88955456,0.104746215,0.000045571313,0.00004199289,2.6924835e-7,4.8717095e-7,0.000016279377,0.000008536698,0.0046204845],"study_design_scores_gemma":[0.0003865039,0.00013048833,0.000032066848,0.026876802,0.96186537,0.000017501416,0.000027831367,1.7675325e-7,0.000016552196,0.000010854468,0.01054005,0.00009581957],"about_ca_topic_score_codex":0.00007257501,"about_ca_topic_score_gemma":0.00007083915,"teacher_disagreement_score":0.86267775,"about_ca_system_score_codex":0.000008414034,"about_ca_system_score_gemma":0.00009955341,"threshold_uncertainty_score":0.96367264},"labels":[],"label_agreement":null},{"id":"W4214479233","doi":"10.1182/bloodadvances.2021006862","title":"Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Population and Public Health; University of British Columbia; Government of British Columbia; BC Centre for Disease Control; Ministry of Health; St. Paul's Hospital","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Vaccination; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; 2019-20 coronavirus outbreak; Coronavirus Infections; Medicine; Pneumonia; Virology; Intensive care medicine; Immunology; Internal medicine; Disease; Outbreak","score_opus":0.038032016259102866,"score_gpt":0.35373139017961547,"score_spread":0.3156993739205126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214479233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952321,0.0015871089,0.00007030676,0.00023472006,0.00030813264,0.0019752642,0.00010335795,0.000028182558,0.00046080424],"genre_scores_gemma":[0.9981626,0.000050550323,0.0005072744,0.00014720387,0.00011325801,0.00078699476,0.00017317945,0.000021977066,0.00003696275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983506,0.00017983303,0.0003537056,0.00028668917,0.0006618268,0.00016730565],"domain_scores_gemma":[0.9984988,0.00025691598,0.00021360711,0.00031143334,0.000660169,0.000059072387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006281545,0.00012426499,0.00031188305,0.0000615967,0.00019360974,0.00000810744,0.00011513133,0.000040156436,0.0003097576],"category_scores_gemma":[0.00027617294,0.00008115982,0.000103459664,0.0002415924,0.00003473628,0.00012246327,0.000059448117,0.00015649239,0.0000018975289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012703225,0.0011468347,0.9023027,0.00016427647,0.00031070464,0.0000022869413,0.0013044432,0.00011045682,0.0003637763,0.00019142606,0.00004457255,0.0927882],"study_design_scores_gemma":[0.008429433,0.0018787351,0.9776996,0.000029392848,0.0009917202,0.0000021566254,0.0010874969,0.00013963363,0.002413175,0.0001824979,0.007020315,0.00012583952],"about_ca_topic_score_codex":0.000013421833,"about_ca_topic_score_gemma":0.00009585181,"teacher_disagreement_score":0.09266236,"about_ca_system_score_codex":0.00008561734,"about_ca_system_score_gemma":0.0002460545,"threshold_uncertainty_score":0.33916286},"labels":[],"label_agreement":null},{"id":"W4220682921","doi":"10.1182/bloodadvances.2021006402","title":"Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood transfusion and management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"King Saud University; Amsterdam University Medical Centers","keywords":"Critically ill; Medicine; Intensive care medicine; Critical illness","score_opus":0.006919767440685692,"score_gpt":0.24080662695247268,"score_spread":0.23388685951178698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220682921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98508364,0.0003356292,0.000027288086,0.0058998275,0.00024935583,0.0010172883,0.00006472449,0.00012421298,0.007198029],"genre_scores_gemma":[0.98571545,0.00024213188,0.0002985039,0.01016822,0.000009211936,0.00019139225,0.000082093604,0.00003356956,0.003259455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980303,0.00008533556,0.00040723314,0.00042360436,0.00068555865,0.00036798892],"domain_scores_gemma":[0.9992636,0.00008744995,0.000063277075,0.00023387828,0.00021736464,0.00013445769],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019154913,0.00021357006,0.00044384872,0.00019089889,0.00018058397,0.000012228712,0.00013403922,0.00004787366,0.0011501918],"category_scores_gemma":[0.00012272871,0.00016876831,0.00010424213,0.00048929185,0.00006104921,0.00011036432,0.00005925487,0.0003386986,0.000009319145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033332055,0.009046659,0.96963835,0.00007384559,0.0004982916,0.00028724864,0.0021316654,0.00010672103,0.00021029792,0.00036462248,0.0004463691,0.016862584],"study_design_scores_gemma":[0.036833253,0.004085148,0.8852012,0.00025796902,0.0009674679,0.000025424328,0.0029622018,0.00011001836,0.0011978953,0.00040817662,0.06722558,0.0007256322],"about_ca_topic_score_codex":0.0000626146,"about_ca_topic_score_gemma":0.00019790174,"teacher_disagreement_score":0.08443715,"about_ca_system_score_codex":0.00006742442,"about_ca_system_score_gemma":0.000045551955,"threshold_uncertainty_score":0.9997629},"labels":[],"label_agreement":null},{"id":"W4220812106","doi":"10.1182/bloodadvances.2020003635","title":"The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Asymptomatic; Hematology; Medical history; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.3663979568180349,"score_gpt":0.537259105832895,"score_spread":0.17086114901486016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220812106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656378,0.0142646935,0.000039012808,0.015787667,0.00096490304,0.001491877,0.000037986334,0.00019473433,0.001581335],"genre_scores_gemma":[0.9892103,0.0013529907,0.0015357217,0.0052880454,0.00017888969,0.0011463165,0.000012799818,0.000029694549,0.0012452392],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952845,0.0027960667,0.00051916315,0.00041771654,0.00039612805,0.00058644655],"domain_scores_gemma":[0.9960899,0.0028093765,0.00039308667,0.00036431098,0.00011847807,0.00022487062],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0020984388,0.00018387972,0.00026847507,0.00006636048,0.0041714516,0.000030537874,0.00023560159,0.00006835455,0.00007954893],"category_scores_gemma":[0.0018065793,0.00013267572,0.000031636435,0.00033162523,0.00007004887,0.0003665334,0.00029160656,0.0006208928,0.00007739893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031451025,0.0005615658,0.9043769,0.0005305785,0.00011186447,0.0000776745,0.008709232,0.000047905258,0.001015796,0.010550055,0.0015004721,0.07220343],"study_design_scores_gemma":[0.0022329302,0.0013127353,0.2522028,0.00041304977,0.0001937033,0.000110914814,0.028110133,0.000028953576,0.00041286057,0.012124605,0.7022631,0.0005941729],"about_ca_topic_score_codex":0.00047346132,"about_ca_topic_score_gemma":0.00090216525,"teacher_disagreement_score":0.7007626,"about_ca_system_score_codex":0.00019093574,"about_ca_system_score_gemma":0.00027642187,"threshold_uncertainty_score":0.99712497},"labels":[],"label_agreement":null},{"id":"W4220837067","doi":"10.1182/bloodadvances.2022007023","title":"1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Essential thrombocythemia; Platelet; Limit (mathematics); Relevance (law); Medicine; Internal medicine; Mathematics; Political science","score_opus":0.01017278419129375,"score_gpt":0.2616825523304963,"score_spread":0.25150976813920256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220837067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98201734,0.014690863,0.00005268974,0.0015347134,0.00030574828,0.00092594046,0.0001071724,0.000059349517,0.00030618845],"genre_scores_gemma":[0.98618466,0.0094063515,0.0013209621,0.0006954171,0.0001369627,0.0016063649,0.00011467815,0.000031716045,0.0005028962],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984248,0.00006093767,0.0002671205,0.0004858177,0.0004876383,0.00027365622],"domain_scores_gemma":[0.9991129,0.00027176682,0.000100588135,0.00026783094,0.00006475609,0.00018215957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115556,0.00021721181,0.00036561748,0.000087353445,0.00053450855,0.000014441802,0.00007633983,0.000040278224,0.000448717],"category_scores_gemma":[0.00012347518,0.00019173422,0.000092974515,0.00023522908,0.000040142862,0.00012435167,0.00017026278,0.00016248484,0.000047987643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046462563,0.0027466556,0.97081953,0.00016616166,0.0008571299,0.00032064645,0.0014857915,0.003008326,0.0020386232,0.0009796781,0.0047761486,0.0123367],"study_design_scores_gemma":[0.008736616,0.0028116202,0.25176215,0.00037883112,0.0011032256,0.00040877357,0.0004914599,0.0001975158,0.049825273,0.00058929285,0.68302387,0.0006713508],"about_ca_topic_score_codex":0.000019102032,"about_ca_topic_score_gemma":0.00006874502,"teacher_disagreement_score":0.7190574,"about_ca_system_score_codex":0.00014880652,"about_ca_system_score_gemma":0.000049541668,"threshold_uncertainty_score":0.7818694},"labels":[],"label_agreement":null},{"id":"W4220949248","doi":"10.1182/bloodadvances.2021006201","title":"Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Confidence interval; Internal medicine; Family history; Population; Monoclonal gammopathy of undetermined significance; Poisson regression; Demography; Gastroenterology; Monoclonal; Immunology; Antibody; Monoclonal antibody","score_opus":0.026839556569976844,"score_gpt":0.30851307704213116,"score_spread":0.2816735204721543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220949248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93286544,0.059304163,0.0069530876,0.00006572113,0.00007018421,0.0004062491,0.00022101245,0.000034184774,0.00007995138],"genre_scores_gemma":[0.93619573,0.0016592895,0.06163094,0.00006241465,0.00003996973,0.000035502995,0.000015957627,0.00001959275,0.0003405799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981757,0.00050699065,0.00020068295,0.00036797224,0.00046862746,0.00028005012],"domain_scores_gemma":[0.9990592,0.00038189552,0.00013422656,0.00022490269,0.000051745865,0.00014805223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070647564,0.00014784816,0.00035065267,0.000099383215,0.00019475266,0.000004402914,0.000059078473,0.000027107479,0.00004472423],"category_scores_gemma":[0.0002253254,0.00013709442,0.000058858626,0.00012815557,0.000115413306,0.00014236741,0.00014255813,0.00024782654,4.9370385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025432054,0.0016628789,0.50280845,0.0012054312,0.0006592208,0.0006997054,0.0010465623,0.000682232,0.32305735,0.000096039905,0.00033840755,0.1652005],"study_design_scores_gemma":[0.028280186,0.006057213,0.7722418,0.0007423335,0.0024057773,0.0011498987,0.002623405,0.040981274,0.12536046,0.0003391362,0.018661465,0.0011570957],"about_ca_topic_score_codex":0.001140039,"about_ca_topic_score_gemma":0.000014120447,"teacher_disagreement_score":0.26943332,"about_ca_system_score_codex":0.0001156628,"about_ca_system_score_gemma":0.00007763027,"threshold_uncertainty_score":0.55905485},"labels":[],"label_agreement":null},{"id":"W4221135558","doi":"10.1182/bloodadvances.2021006835","title":"CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Haematopoiesis; Umbilical cord; Stem cell; Cell sorting; Ex vivo; Biology; Stem cell marker; Cell biology; Hematopoietic stem cell; Cord blood; Immunology; Cancer research; Andrology; In vivo; Flow cytometry; Medicine; Genetics","score_opus":0.022557912237476135,"score_gpt":0.2732047210494349,"score_spread":0.2506468088119588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221135558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98921657,0.004259719,0.0011375495,0.00009197166,0.00035062013,0.00068654504,0.00009657927,0.0000856159,0.004074858],"genre_scores_gemma":[0.9928661,0.0003117792,0.0047373124,0.00015168182,0.000038533057,0.0000390283,0.000031133342,0.000029896522,0.0017945586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980812,0.0000620616,0.00058515737,0.00040905972,0.00054286135,0.00031965075],"domain_scores_gemma":[0.99901676,0.00014005393,0.00029595633,0.0003469139,0.00008346427,0.00011687249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027618613,0.00022671428,0.0005364435,0.000080893646,0.00017208868,0.000014012966,0.00017092617,0.000057407047,0.0006088796],"category_scores_gemma":[0.0000073926462,0.00021120487,0.00014094972,0.0003370853,0.00009880267,0.00014266315,0.000054392225,0.00023385265,0.000016862059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043111018,0.0016650326,0.38825825,0.005319908,0.00039150915,0.00017998811,0.01054294,0.00074996706,0.5900674,0.00035670484,0.0002749993,0.0017622026],"study_design_scores_gemma":[0.005653832,0.00045895475,0.007264958,0.00094642345,0.00073273707,0.0011654866,0.0032264104,0.00017230287,0.9783306,0.000046067114,0.0015640309,0.00043816314],"about_ca_topic_score_codex":0.000012486952,"about_ca_topic_score_gemma":0.0000050102644,"teacher_disagreement_score":0.38826323,"about_ca_system_score_codex":0.000039598508,"about_ca_system_score_gemma":0.00011979944,"threshold_uncertainty_score":0.86126846},"labels":[],"label_agreement":null},{"id":"W4223619433","doi":"10.1182/bloodadvances.2022006968","title":"Cell origin–dependent cooperativity of mutant <i>Dnmt3a</i> and <i>Npm1</i> in clonal hematopoiesis and myeloid malignancy","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute on Aging","keywords":"Biology; Haematopoiesis; RUNX1; Stem cell; Cancer research; Myeloid leukemia; Myeloid; Progenitor cell; Somatic cell; Cell biology; Genetics; Gene","score_opus":0.010065092892087187,"score_gpt":0.2614607939845005,"score_spread":0.2513957010924133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223619433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786146,0.0180943,0.000017167094,0.000742054,0.000058900452,0.000498739,0.00010435823,0.000025093084,0.0018447359],"genre_scores_gemma":[0.99465823,0.0029460578,0.0012298606,0.00035467095,0.000045643814,0.00010617212,0.000014335691,0.000024424258,0.0006206127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982035,0.00012536366,0.00035658563,0.00043472057,0.0005361261,0.00034369918],"domain_scores_gemma":[0.9992549,0.00018954936,0.000108153195,0.00024106709,0.00006361015,0.00014272887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044778798,0.00019055502,0.000492152,0.00015287913,0.00014066442,0.000015090262,0.00012665406,0.0000450852,0.00014027278],"category_scores_gemma":[0.0000611059,0.00016985009,0.000039519895,0.00036649953,0.00018729137,0.00017369549,0.00032561546,0.00040284198,0.0000021001301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013982813,0.0023837667,0.3362486,0.0022194376,0.00016371386,0.0019805848,0.0020228685,0.00016003815,0.64266175,0.0019365816,0.0009857594,0.00783863],"study_design_scores_gemma":[0.020727709,0.0028673825,0.024693368,0.0003597951,0.00031687686,0.0026474132,0.0040661027,0.0004415928,0.87955683,0.00096378423,0.062448017,0.0009111026],"about_ca_topic_score_codex":0.0001324248,"about_ca_topic_score_gemma":0.000061465966,"teacher_disagreement_score":0.31155524,"about_ca_system_score_codex":0.00007620016,"about_ca_system_score_gemma":0.00025334238,"threshold_uncertainty_score":0.69262856},"labels":[],"label_agreement":null},{"id":"W4224054536","doi":"10.1182/bloodadvances.2022007336","title":"Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Antibody; Immunology; Medicine","score_opus":0.008662390606955948,"score_gpt":0.24656578119779393,"score_spread":0.23790339059083798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224054536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764836,0.0001901531,0.000002227211,0.00009720436,0.00012963681,0.00034586265,0.00004885511,0.000032901866,0.0015047869],"genre_scores_gemma":[0.99910897,0.00016483673,0.00037555196,0.00009294644,0.000026241984,0.000034325134,0.00007480363,0.000022592176,0.000099712655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885136,0.000051871044,0.00032160943,0.0002472332,0.00029366792,0.00023426402],"domain_scores_gemma":[0.99940217,0.000036918325,0.00017238269,0.00023222747,0.000092531904,0.00006379818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010257383,0.00014826485,0.00051782734,0.00014730105,0.00008550219,0.00000564098,0.00011404571,0.000029485464,0.00017788695],"category_scores_gemma":[0.000054700573,0.00012300475,0.000041803112,0.00037752884,0.000041137788,0.00013262806,0.00009684624,0.00020560522,0.0000046300775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031102172,0.0011963916,0.9895063,0.00012699616,0.00008057969,0.000034300032,0.0002897862,0.0000048767065,0.0046997885,0.000093407514,0.000010754386,0.0036457758],"study_design_scores_gemma":[0.0034971242,0.0015019815,0.97671366,0.00009625537,0.00013406361,0.000011113544,0.00017318489,0.0000060817215,0.015302433,0.000038885544,0.002377507,0.00014772169],"about_ca_topic_score_codex":0.00004213614,"about_ca_topic_score_gemma":0.000017170938,"teacher_disagreement_score":0.012792673,"about_ca_system_score_codex":0.000035774778,"about_ca_system_score_gemma":0.00007500786,"threshold_uncertainty_score":0.5015988},"labels":[],"label_agreement":null},{"id":"W4224138250","doi":"10.1182/bloodadvances.2021006434","title":"Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia ","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Internal medicine; Hazard ratio; Adverse effect; Oncology; Confidence interval; Leukemia; Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.017817559125266835,"score_gpt":0.2833469322780211,"score_spread":0.26552937315275427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224138250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908908,0.0037150267,0.00012146136,0.00024169967,0.0006442418,0.0030892245,0.00067695294,0.00016647737,0.00045414342],"genre_scores_gemma":[0.98695207,0.00038185492,0.0018326889,0.0002875007,0.0004930144,0.001934256,0.00077047653,0.00012056036,0.0072275805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966828,0.00005865959,0.00044635974,0.0009150153,0.0010297964,0.0008673247],"domain_scores_gemma":[0.99797857,0.00048115608,0.00014744829,0.00080699835,0.00018511422,0.00040070858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015566716,0.0004076912,0.00065155985,0.00018359133,0.00047448854,0.000037945832,0.0003522563,0.00007427937,0.0005815467],"category_scores_gemma":[0.00019436855,0.00031913084,0.00019365591,0.0005071328,0.00009692275,0.00015105409,0.00024313253,0.0001661387,0.00008124535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.21897557,0.0076460065,0.13985278,0.004088153,0.01120686,0.002501465,0.0177683,0.09098915,0.0024048064,0.0016590919,0.032398947,0.47050887],"study_design_scores_gemma":[0.28546593,0.02341206,0.0016872716,0.0003358521,0.00086839683,0.000055003296,0.0005060699,0.0053829337,0.007415304,0.00025178373,0.6738424,0.00077701366],"about_ca_topic_score_codex":0.0015694108,"about_ca_topic_score_gemma":0.001075776,"teacher_disagreement_score":0.64144343,"about_ca_system_score_codex":0.071104184,"about_ca_system_score_gemma":0.01558298,"threshold_uncertainty_score":0.9999261},"labels":[],"label_agreement":null},{"id":"W4224240501","doi":"10.1182/bloodadvances.2022007444","title":"Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; University of Ottawa; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; National Heart, Lung, and Blood Institute; Fonds de Recherche du Québec - Santé; Public Health Agency; Public Health Agency of Canada","keywords":"Platelet; Tissue factor; Platelet activation; Thrombin; Biology; Coagulation; Coronavirus; Degranulation; Protease; Chemistry; Immunology; Cell biology; Molecular biology; Receptor; Coronavirus disease 2019 (COVID-19); Enzyme; Medicine; Biochemistry; Pathology","score_opus":0.027197595878100417,"score_gpt":0.38810937058761197,"score_spread":0.3609117747095115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224240501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992619,0.0010331838,0.00010402388,0.004452945,0.000056925914,0.00083128095,0.0005965943,0.00006207184,0.00024398742],"genre_scores_gemma":[0.9975044,0.00092766783,0.000050940682,0.000933014,0.00004581958,0.00018084685,0.00007159584,0.000018910732,0.00026676184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845845,0.00013108416,0.0003016349,0.0003155335,0.00052305846,0.0002702519],"domain_scores_gemma":[0.9956311,0.0036802664,0.00021390787,0.0003044632,0.000111536814,0.00005872038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015727279,0.00015056352,0.0003361934,0.00005278707,0.00021860746,0.000008614302,0.00020489946,0.00003799149,0.000118260636],"category_scores_gemma":[0.0029058736,0.00010344255,0.0000735878,0.0003503081,0.00019019666,0.00013281422,0.00023462177,0.0004109473,0.000008367303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034687293,0.0005471507,0.0009580518,0.000106988104,0.00014825843,0.000004133748,0.00020524759,0.000013284944,0.9519248,0.000009058695,0.0068965172,0.038839605],"study_design_scores_gemma":[0.0009899078,0.00067246804,0.0013934427,0.000015948908,0.00003718772,6.643733e-7,0.00012552235,0.0000128566935,0.7350574,0.00012803888,0.26148865,0.000077895085],"about_ca_topic_score_codex":0.0002156692,"about_ca_topic_score_gemma":0.0000061832197,"teacher_disagreement_score":0.25459215,"about_ca_system_score_codex":0.000069211696,"about_ca_system_score_gemma":0.00010567585,"threshold_uncertainty_score":0.42182648},"labels":[],"label_agreement":null},{"id":"W4224247201","doi":"10.1182/bloodadvances.2022007371","title":"Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Rituximab; Mantle cell lymphoma; Internal medicine; Bendamustine; Autologous stem-cell transplantation; Hazard ratio; DHAP; International Prognostic Index; Population; Vincristine; Cytarabine; Oncology; CHOP; Gastroenterology; Transplantation; Surgery; Confidence interval; Chemotherapy; Cyclophosphamide; Lymphoma","score_opus":0.010377656319082246,"score_gpt":0.23452596157555222,"score_spread":0.22414830525646998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224247201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940029,0.002893226,0.000019922505,0.00096946314,0.000164118,0.0005632897,0.00010407557,0.00008445475,0.0011986003],"genre_scores_gemma":[0.9960821,0.00043605827,0.0020206112,0.00031783138,0.00008190224,0.00045325872,0.00020127681,0.000025191133,0.0003817503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986029,0.00004725958,0.00025599767,0.0004068443,0.00037501287,0.00031194446],"domain_scores_gemma":[0.9994607,0.000071782975,0.00009606775,0.00024247532,0.000030135436,0.0000988209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087207074,0.00022310724,0.0003779426,0.00018866769,0.0001554303,0.000013981394,0.000090281326,0.00003743286,0.00029000052],"category_scores_gemma":[0.0000059369017,0.00015592322,0.000057079284,0.0004505371,0.00003673771,0.00013023753,0.000015668626,0.00009367334,0.0000136995295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031654835,0.13245806,0.632269,0.001898331,0.00062832993,0.020358758,0.0016179052,0.010130759,0.013593759,0.00088550703,0.0011125157,0.15339221],"study_design_scores_gemma":[0.2784897,0.013603435,0.3349757,0.0006462417,0.0016167919,0.001770117,0.001352977,0.00045325301,0.29500124,0.00012731714,0.07083556,0.0011276525],"about_ca_topic_score_codex":0.00043918766,"about_ca_topic_score_gemma":0.00030787507,"teacher_disagreement_score":0.29729334,"about_ca_system_score_codex":0.00012188241,"about_ca_system_score_gemma":0.00026199588,"threshold_uncertainty_score":0.6358364},"labels":[],"label_agreement":null},{"id":"W4224261285","doi":"10.1182/bloodadvances.2021005910","title":"ATG4A regulates human erythroid maturation and mitochondrial clearance","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; University of Toronto; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; University of Washington; Fred Hutchinson Cancer Research Center","keywords":"Autophagy; Erythropoiesis; Cell biology; Haematopoiesis; Biology; Mitochondrion; Progenitor cell; Stem cell; Myeloid; Immunology; Apoptosis; Biochemistry; Internal medicine; Anemia; Medicine","score_opus":0.009884979490989645,"score_gpt":0.2566982550904163,"score_spread":0.24681327559942667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224261285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299085,0.0037015006,0.000019291625,0.00082643953,0.00072297594,0.0002266972,0.000008930564,0.000091841015,0.0014114901],"genre_scores_gemma":[0.99464446,0.0003349341,0.0011384051,0.0009045289,0.0006674667,0.000052111278,0.00006800625,0.000016074973,0.0021740284],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992931,0.00004957255,0.00014615351,0.00023939011,0.00013988181,0.0001318923],"domain_scores_gemma":[0.9996809,0.000027743608,0.0000703892,0.0001442598,0.000027096474,0.000049649814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004176813,0.00009191236,0.00017591279,0.000048633854,0.0003257989,0.0000091625425,0.000038208727,0.00003062053,0.00033230727],"category_scores_gemma":[0.00001996101,0.00008441664,0.00003963442,0.00010743189,0.00007571867,0.00010611342,0.000045559675,0.00016225164,0.000009836372],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010538171,0.00025530552,0.0022881455,0.00010712107,0.00005077439,0.000042597574,0.00035339213,0.000112590096,0.9861804,0.0022826223,0.0019728055,0.0053003835],"study_design_scores_gemma":[0.0087218005,0.0045281556,0.14044532,0.00008092825,0.00026219973,0.0011862463,0.0012983745,0.00015490616,0.04113319,0.005124377,0.79654455,0.00051991374],"about_ca_topic_score_codex":0.0000063971634,"about_ca_topic_score_gemma":0.0000065839718,"teacher_disagreement_score":0.94504726,"about_ca_system_score_codex":0.000016340824,"about_ca_system_score_gemma":0.000017283066,"threshold_uncertainty_score":0.36385316},"labels":[],"label_agreement":null},{"id":"W4224279372","doi":"10.1182/bloodadvances.2021006728","title":"Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Neurovascular bundle; Platelet; Thrombosis; Antibody; Medicine; Platelet activation; Immunology; Pathology; Internal medicine","score_opus":0.011606395875992541,"score_gpt":0.27085505747684796,"score_spread":0.2592486616008554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224279372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440914,0.003809542,0.0000038766607,0.00042670174,0.00018539702,0.0003816749,0.000033850738,0.000093842784,0.00065596995],"genre_scores_gemma":[0.9971885,0.002086294,0.00032549037,0.00017764329,0.00007535077,0.000034839377,0.000040540664,0.0000432596,0.000028060293],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983105,0.00009221515,0.00037680383,0.0004732307,0.00037625304,0.0003710181],"domain_scores_gemma":[0.99914664,0.00009911605,0.0001736408,0.00035853096,0.000065200205,0.00015687548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015296579,0.000230192,0.0006542775,0.0001810525,0.00029809415,0.000016983324,0.00015069237,0.000034292458,0.00022768063],"category_scores_gemma":[0.0000777127,0.00022344082,0.00013736208,0.00036172537,0.00013997112,0.00025861475,0.00027694143,0.00031952542,0.00000886322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006521516,0.0004023828,0.3235552,0.00027224296,0.0002545989,0.00022512127,0.0005286703,0.000039073646,0.6738597,0.00008919116,0.0000067202336,0.0007018565],"study_design_scores_gemma":[0.004050781,0.00048675045,0.9005312,0.00012513678,0.0005902592,0.00060770265,0.0008789103,0.00008303475,0.09024411,0.00013172242,0.0019203691,0.00035003468],"about_ca_topic_score_codex":0.00008387776,"about_ca_topic_score_gemma":0.0000041310254,"teacher_disagreement_score":0.5836156,"about_ca_system_score_codex":0.000027570544,"about_ca_system_score_gemma":0.000062106694,"threshold_uncertainty_score":0.9111652},"labels":[],"label_agreement":null},{"id":"W4224293251","doi":"10.1182/bloodadvances.2022007397","title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Università degli Studi dell'Insubria; Bayer","keywords":"Medicine; Rivaroxaban; Thrombosis; Surgery; Internal medicine; Cohort; Gastrointestinal bleeding; Prospective cohort study; Warfarin; Atrial fibrillation","score_opus":0.023230894928816467,"score_gpt":0.3271675023617696,"score_spread":0.30393660743295314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224293251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008185,0.0033050715,0.00010391501,0.0002271427,0.00037079092,0.005305071,0.00006993957,0.00004317091,0.0004930634],"genre_scores_gemma":[0.9942425,0.00039562708,0.00030198036,0.00007113267,0.00015344979,0.0045091566,0.000047933907,0.000020504778,0.0002577081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987954,0.000057594018,0.00028582144,0.0003291154,0.00034466598,0.00018742165],"domain_scores_gemma":[0.9992542,0.00010260221,0.00015416941,0.0003591414,0.000083982995,0.00004587885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024541427,0.00014870435,0.00044368082,0.00006421979,0.0002748281,0.000011674095,0.00015245097,0.000012472312,0.0002655201],"category_scores_gemma":[0.000018923653,0.00010055831,0.00018097517,0.00014548001,0.00005587707,0.0000861929,0.000051117262,0.000056871115,0.0000020520426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025720373,0.07380491,0.91139007,0.00013349528,0.0030575194,0.0000168177,0.0032388044,0.00050102174,0.00020848961,0.0023545562,0.0003208428,0.0047162655],"study_design_scores_gemma":[0.0039230357,0.029723981,0.94937897,0.000027949596,0.0023236906,0.0000085556085,0.005201639,0.000080300786,0.00062088505,0.00051968434,0.008070464,0.00012081923],"about_ca_topic_score_codex":0.00009733289,"about_ca_topic_score_gemma":0.00016710415,"teacher_disagreement_score":0.044080924,"about_ca_system_score_codex":0.00010679572,"about_ca_system_score_gemma":0.000041987096,"threshold_uncertainty_score":0.41006488},"labels":[],"label_agreement":null},{"id":"W4224300340","doi":"10.1182/bloodadvances.2022007296","title":"Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Risk stratification; Internal medicine; Medicine; Risk assessment; Stratification (seeds); Gastroenterology; Biology","score_opus":0.0102024391419124,"score_gpt":0.28541389034961395,"score_spread":0.2752114512077016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224300340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98117006,0.002758307,0.0141538195,0.00006567679,0.00022632635,0.00078048505,0.00013162798,0.000042136886,0.0006715876],"genre_scores_gemma":[0.99056786,0.00022711905,0.008879475,0.00000851076,0.000038285336,0.00007964376,0.000057768055,0.0000088573615,0.00013247602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931437,0.000058445115,0.00017732817,0.00017155072,0.00019264857,0.00008568383],"domain_scores_gemma":[0.9995372,0.00007070371,0.00013416688,0.00015635902,0.0000551342,0.00004640396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002848116,0.0000706216,0.00018380418,0.000065048225,0.00011590482,0.0000061505125,0.000032229334,0.000010087816,0.00006276872],"category_scores_gemma":[0.00005692033,0.00006073437,0.00007805103,0.000098091434,0.000040127663,0.000046056033,0.000018491548,0.000076538454,2.604639e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014156944,0.00028312244,0.8757058,0.0005681161,0.0003685647,0.000015025516,0.000110588706,0.00055360736,0.078446396,0.00053566555,0.00013995921,0.043131612],"study_design_scores_gemma":[0.0034678539,0.0017000325,0.9721705,0.00009794776,0.0009320484,0.0009929009,0.004453454,0.00067758316,0.0066355653,0.0000788097,0.008641375,0.00015193044],"about_ca_topic_score_codex":0.000021222255,"about_ca_topic_score_gemma":0.0000036965625,"teacher_disagreement_score":0.09646473,"about_ca_system_score_codex":0.000023252851,"about_ca_system_score_gemma":0.000059472255,"threshold_uncertainty_score":0.24766758},"labels":[],"label_agreement":null},{"id":"W4225293015","doi":"10.1182/bloodadvances.2021005884","title":"Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lymphatic system; Biology; Cell; Pathology; Medicine; Immunology; Genetics","score_opus":0.00688538274554182,"score_gpt":0.2418810157163055,"score_spread":0.23499563297076367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225293015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768919,0.016045615,0.0000032434884,0.0017379798,0.00035576778,0.0006790823,0.00007185183,0.00002792238,0.004186634],"genre_scores_gemma":[0.99660444,0.0004133943,0.0003101271,0.0010675624,0.0000798225,0.00032643168,0.000031557218,0.000023172259,0.0011434614],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869984,0.00007109821,0.0002851514,0.00031602202,0.00035220312,0.00027568405],"domain_scores_gemma":[0.99925387,0.000118377946,0.00012544425,0.0003808479,0.000032200627,0.00008926246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013532309,0.00018457437,0.00031550284,0.00009900174,0.00009458888,0.000009994567,0.00020880323,0.000036018322,0.00021854068],"category_scores_gemma":[0.00001165182,0.00012464085,0.000106472915,0.00032661977,0.00003342058,0.000056166897,0.00012529978,0.00008887392,0.000034238863],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064871926,0.005429417,0.9591378,0.00033241746,0.000099468045,0.00033261525,0.0022589527,0.00081553357,0.0042457916,0.00014588512,0.0040001892,0.022553219],"study_design_scores_gemma":[0.014735438,0.0024352681,0.1507036,0.00015175133,0.00042541974,0.0001502683,0.0021601452,0.00003710021,0.228071,0.00024410711,0.6004324,0.0004535029],"about_ca_topic_score_codex":0.00030712475,"about_ca_topic_score_gemma":0.0000812302,"teacher_disagreement_score":0.8084342,"about_ca_system_score_codex":0.00014875439,"about_ca_system_score_gemma":0.00014974736,"threshold_uncertainty_score":0.5082707},"labels":[],"label_agreement":null},{"id":"W4225308126","doi":"10.1182/bloodadvances.2022007561","title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; University of Ottawa; McGill University; Impact; McMaster University; University of Toronto; Cochrane; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Guideline; Intensive care medicine; Grading (engineering); MEDLINE; Randomized controlled trial; Low molecular weight heparin; Internal medicine; Thrombosis; Pathology","score_opus":0.14710906076741934,"score_gpt":0.4016650422326228,"score_spread":0.2545559814652034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225308126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906623,0.00006599646,0.00035594465,0.006977243,0.000046750112,0.0017358788,0.00014505885,0.000009770315,0.0000010694321],"genre_scores_gemma":[0.9913421,0.00030309058,0.0013498479,0.006846228,0.000011313014,0.000085347856,0.000038387825,0.00001665014,0.0000069983666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754107,0.000318726,0.00077799696,0.0003448174,0.0007711534,0.00024622257],"domain_scores_gemma":[0.9879842,0.009890058,0.00070912065,0.0004382818,0.000931656,0.000046678717],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006972099,0.00017558206,0.00067493564,0.00014260264,0.00014791914,0.0000064505184,0.00017273519,0.000034322886,0.000014963481],"category_scores_gemma":[0.018723184,0.00009981824,0.00014150709,0.0006861659,0.0005160765,0.0001505836,0.00020048364,0.00025121492,1.8393463e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022464888,0.0018570455,0.9800439,0.00024827046,0.0001946084,8.770398e-7,0.00061797776,0.0095962165,0.00029689385,0.00021823564,0.0002668097,0.0044126785],"study_design_scores_gemma":[0.0021462645,0.004151671,0.9843056,0.00022397452,0.0000890798,1.713641e-7,0.00048672076,0.0057251924,0.0008755771,0.00022057012,0.001658844,0.00011631734],"about_ca_topic_score_codex":0.0004264304,"about_ca_topic_score_gemma":0.0000917014,"teacher_disagreement_score":0.018025974,"about_ca_system_score_codex":0.000087574845,"about_ca_system_score_gemma":0.00014704767,"threshold_uncertainty_score":0.98954254},"labels":[],"label_agreement":null},{"id":"W4225443029","doi":"10.1182/bloodadvances.2021006701","title":"Longitudinal study of 2 patients with cyclic thrombocytopenia, <i>STAT3</i> and <i>MPL</i> mutations","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Thrombopoietin; Thrombopoiesis; Platelet; Biology; Blood Platelet Disorders; Pathophysiology; Immunology; Mean platelet volume; Haematopoiesis; Internal medicine; Endocrinology; Megakaryocyte; Genetics; Medicine; Stem cell","score_opus":0.011422922533824681,"score_gpt":0.26282424753496925,"score_spread":0.25140132500114454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225443029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760216,0.0009939255,0.0000036674455,0.000039321734,0.00003071614,0.00060458196,0.00007058324,0.000018345936,0.0006366705],"genre_scores_gemma":[0.9993447,0.000042886004,0.0003102029,0.00005363274,0.0000058149335,0.00008672404,0.0000717593,0.00001205385,0.00007223496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992127,0.000023029583,0.00014985519,0.00021229826,0.0002753691,0.00012678381],"domain_scores_gemma":[0.99964684,0.000034793444,0.000092733855,0.00013369796,0.0000418018,0.00005015595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002810046,0.00010463422,0.0002819195,0.000050065777,0.00018299227,0.000006012783,0.00004453455,0.0000083260575,0.00005246774],"category_scores_gemma":[0.000006889519,0.000079668,0.00001921778,0.00017922658,0.000049571583,0.00011562011,0.000050540515,0.00007533195,0.0000010377568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021815336,0.005029145,0.9923271,0.000024091554,0.00020469366,0.00013797477,0.000530616,0.000036863494,0.000031182833,0.000015542046,0.000013351955,0.0014313202],"study_design_scores_gemma":[0.012381329,0.0055166613,0.97767764,0.000013644216,0.0005516057,0.00005052991,0.0023193825,0.0000021121868,0.00019611898,0.000118212025,0.0010610555,0.00011171718],"about_ca_topic_score_codex":0.000056511042,"about_ca_topic_score_gemma":0.00014025978,"teacher_disagreement_score":0.014649433,"about_ca_system_score_codex":0.000007662446,"about_ca_system_score_gemma":0.000023718414,"threshold_uncertainty_score":0.32487667},"labels":[],"label_agreement":null},{"id":"W4225695252","doi":"10.1182/bloodadvances.2021006429","title":"Shared and distinct genetic features in human and canine B-cell lymphomas","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Biology; Computational biology; Genetics; Evolutionary biology","score_opus":0.015109929321180398,"score_gpt":0.3131975071501615,"score_spread":0.2980875778289811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225695252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774422,0.019190362,5.7424796e-7,0.00039258608,0.00003057513,0.00024386216,0.000018475084,0.000020157742,0.002661186],"genre_scores_gemma":[0.9968785,0.00019265505,0.00092477485,0.00009994814,0.00004612198,0.00008494324,0.000018388557,0.000013046822,0.0017415985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992125,0.000064988766,0.00011492407,0.00025847534,0.00015721226,0.0001919254],"domain_scores_gemma":[0.99969554,0.000053611744,0.000030416066,0.00012321468,0.00001311543,0.00008411404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010201673,0.00009036375,0.00019291275,0.0000958795,0.00015741312,0.000010236728,0.00006704417,0.00002437974,0.00016775688],"category_scores_gemma":[0.000029431076,0.000083392566,0.000013397618,0.00012457946,0.000112158705,0.000045717257,0.000207248,0.00016749954,7.006482e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023493648,0.0005569686,0.9276394,0.00021959898,0.0000229577,0.0020540978,0.00037404886,0.000011133577,0.063487895,0.000031081014,0.00024920524,0.005118659],"study_design_scores_gemma":[0.004645321,0.002628778,0.98048013,0.000022204154,0.00004068231,0.0032221694,0.00032882675,0.000025444466,0.00056425226,0.00018068579,0.0077471216,0.000114360795],"about_ca_topic_score_codex":0.00009159642,"about_ca_topic_score_gemma":0.00021744458,"teacher_disagreement_score":0.06292364,"about_ca_system_score_codex":0.000032195097,"about_ca_system_score_gemma":0.000047408328,"threshold_uncertainty_score":0.340065},"labels":[],"label_agreement":null},{"id":"W4226210798","doi":"10.1182/bloodadvances.2022007082","title":"Outcomes after biochemical or clinical progression in patients with multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Multiple myeloma; Medicine; Internal medicine; MEDLINE; Oncology; Biology; Biochemistry","score_opus":0.019565612470503726,"score_gpt":0.35470788578300794,"score_spread":0.33514227331250424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226210798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980305,0.0006267793,0.0000019224585,0.00020640275,0.000074027914,0.0008678463,0.00004682937,0.000041856998,0.00010384242],"genre_scores_gemma":[0.9952812,0.00003192462,0.0035323799,0.00015877592,0.000037829872,0.0005198323,0.00009931247,0.000021735848,0.00031699898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982554,0.00009458898,0.00031031825,0.00037965033,0.0006135126,0.00034656114],"domain_scores_gemma":[0.99924433,0.00018945534,0.00007178722,0.00025501568,0.00004851289,0.00019091519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013405156,0.00015815151,0.00034149078,0.0000987797,0.00008125588,0.000008987783,0.00010095081,0.00003885745,0.0003042665],"category_scores_gemma":[0.00027172684,0.00008963742,0.000071528426,0.00023137403,0.00009416359,0.00010217432,0.0001532467,0.00028707538,0.00001392896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009537991,0.0039380337,0.9549847,0.000038597937,0.00008513916,0.00044325064,0.000032842374,0.0000010794367,0.000014558927,8.7409705e-7,0.0000440543,0.030878868],"study_design_scores_gemma":[0.019005798,0.0022772632,0.975018,0.00006600631,0.000042467633,0.000009516044,0.000051012925,0.000019708732,0.0003567507,0.0000058731835,0.0030304957,0.000117062555],"about_ca_topic_score_codex":0.000007988019,"about_ca_topic_score_gemma":0.00003254399,"teacher_disagreement_score":0.030761806,"about_ca_system_score_codex":0.000044846394,"about_ca_system_score_gemma":0.000087727654,"threshold_uncertainty_score":0.3655308},"labels":[],"label_agreement":null},{"id":"W4229024752","doi":"10.1182/bloodadvances.2022007218","title":"Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Multiple myeloma; POEMS syndrome; Hematopoietic cell; Hematopoietic stem cell transplantation; Transplantation; Medicine; Haematopoiesis; Oncology; Immunology; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.007848516013601887,"score_gpt":0.23987432446976406,"score_spread":0.23202580845616216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229024752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950106,0.0040691076,0.000027564827,0.0002676451,0.000061032253,0.00024462753,0.000014378086,0.00004097145,0.00026403097],"genre_scores_gemma":[0.9986561,0.00016636889,0.00056430954,0.00033666426,0.000003835521,0.000101179496,0.000011930588,0.00001347601,0.0001461269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992758,0.000034430333,0.00016043722,0.00020555548,0.00016205182,0.00016172028],"domain_scores_gemma":[0.99975884,0.0000481823,0.00004536423,0.000092180075,0.0000075928974,0.000047864552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036986818,0.00011284353,0.00026082335,0.000060043727,0.00006755802,0.000007247426,0.00003833764,0.000017400103,0.000050775634],"category_scores_gemma":[0.0000053489175,0.000088291104,0.000024812398,0.000118254204,0.000048005375,0.00008064841,0.000017147695,0.00013487441,0.0000012510739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047017107,0.00033875668,0.9955275,0.000222504,0.00000919309,0.0010551887,0.0009554317,0.00029448525,0.00037445422,0.0000054493967,0.0000069975094,0.0007398395],"study_design_scores_gemma":[0.0041748583,0.0008662366,0.99057674,0.000036695474,0.00007185606,0.00081431237,0.0017468934,0.00015023815,0.0003563931,0.000033935332,0.0010250675,0.00014677248],"about_ca_topic_score_codex":0.00003961733,"about_ca_topic_score_gemma":0.00036565517,"teacher_disagreement_score":0.0049507874,"about_ca_system_score_codex":0.000008295745,"about_ca_system_score_gemma":0.000014727834,"threshold_uncertainty_score":0.3600407},"labels":[],"label_agreement":null},{"id":"W4229054255","doi":"10.1182/bloodadvances.2022007340","title":"Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Science Foundation Ireland; Health Research Board; Health Service Executive; Wellcome Trust; Canadian Institute for Theoretical Astrophysics","keywords":"Desmopressin; Von Willebrand factor; Von Willebrand disease; Pathogenesis; Internal medicine; Medicine; Endocrinology; Gastroenterology; Platelet","score_opus":0.028089683008118593,"score_gpt":0.2949380253344919,"score_spread":0.26684834232637333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229054255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186975,0.0049604503,0.00005105415,0.0006520164,0.00019456596,0.00053472957,0.0000416044,0.000024051827,0.0016717665],"genre_scores_gemma":[0.9958296,0.0030640853,0.0004172951,0.00034819238,0.00003099707,0.00013658837,0.000010662397,0.000013697104,0.00014889221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988035,0.000117371455,0.00038331884,0.00029158997,0.00022783615,0.00017637774],"domain_scores_gemma":[0.9992466,0.00024975167,0.00017286546,0.0002397219,0.00004023798,0.000050827322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001580046,0.000113745125,0.00033073526,0.000042641714,0.00017831898,0.000006623344,0.000111886424,0.000034445027,0.00001317282],"category_scores_gemma":[0.00019108427,0.00009120387,0.00008678259,0.00030459734,0.00014848058,0.00009616222,0.00005780021,0.00017138373,0.0000026021069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038261674,0.01791173,0.62453705,0.00077266345,0.0011266196,0.000768964,0.004161869,0.004911989,0.06213855,0.014129517,0.00025239645,0.26546246],"study_design_scores_gemma":[0.012581182,0.0018906514,0.9484072,0.0003400849,0.0005018132,0.00006219331,0.0029809072,0.0004192766,0.019949932,0.0017629265,0.010676222,0.00042762456],"about_ca_topic_score_codex":0.000017031272,"about_ca_topic_score_gemma":0.0004210906,"teacher_disagreement_score":0.32387012,"about_ca_system_score_codex":0.000011215877,"about_ca_system_score_gemma":0.00017338061,"threshold_uncertainty_score":0.3719186},"labels":[],"label_agreement":null},{"id":"W4229366946","doi":"10.1182/bloodadvances.2022007673","title":"Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute","keywords":"Genome-wide association study; Heparin-induced thrombocytopenia; Platelet factor 4; Heparin; Immunology; Antibody; Medicine; Cohort; Biology; Internal medicine; Genetics; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.030297550667962428,"score_gpt":0.2995359323270499,"score_spread":0.2692383816590875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229366946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374765,0.0004904861,0.0000014401921,0.0002784812,0.00037408396,0.0016135199,0.00005226086,0.00010324419,0.0033388352],"genre_scores_gemma":[0.9986655,0.00024658922,0.00016617849,0.00016139688,0.000083456514,0.00019389797,0.000051169125,0.00005652563,0.0003752688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964677,0.00031382564,0.00095253036,0.0007072508,0.00091843744,0.00064023776],"domain_scores_gemma":[0.99817127,0.00040952483,0.00055151293,0.0005816455,0.00013320036,0.0001528198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054392056,0.00038489036,0.0014506647,0.00040287097,0.00029801298,0.0000330287,0.00038588807,0.00011737374,0.0005111521],"category_scores_gemma":[0.00039045882,0.0003813469,0.00016189476,0.0008628327,0.000039001123,0.00039116535,0.00042510283,0.0006756157,0.000027354568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018309687,0.0036034838,0.9239618,0.00008496446,0.0004611265,0.000115619885,0.0031270594,0.00007720333,0.06748891,0.000033609533,0.000018071552,0.00084501825],"study_design_scores_gemma":[0.006036783,0.0022585061,0.9573092,0.00003913546,0.000242434,0.000015777827,0.003994169,0.000011044494,0.026604744,0.000109785935,0.0029957036,0.00038274846],"about_ca_topic_score_codex":0.0007197781,"about_ca_topic_score_gemma":0.001355843,"teacher_disagreement_score":0.040884167,"about_ca_system_score_codex":0.0004375819,"about_ca_system_score_gemma":0.0002163245,"threshold_uncertainty_score":0.99986386},"labels":[],"label_agreement":null},{"id":"W4234977819","doi":"10.1182/bloodadvances.2018020230","title":"Who should get long-term anticoagulant therapy for venous thromboembolism and with what?","year":2018,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute; Pfizer","keywords":"Venous thromboembolism; Anticoagulant therapy; Term (time); Medicine; Intensive care medicine; Internal medicine; Thrombosis; Physics","score_opus":0.065056864886307,"score_gpt":0.36844163861189533,"score_spread":0.3033847737255883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234977819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001715916,0.9923034,0.00008799176,0.00013686839,0.0005045222,0.0047556423,0.000050438484,0.00011101588,0.00033420388],"genre_scores_gemma":[0.00008007023,0.99584484,0.0009181454,0.0005701235,0.0011882327,0.0007691627,0.00019418138,0.00017424942,0.00026100807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734265,0.000064683554,0.000588087,0.0009625629,0.00039823278,0.0006438116],"domain_scores_gemma":[0.9982762,0.00018760187,0.00045697528,0.0007193496,0.00013950536,0.00022036687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026515813,0.00077388185,0.0041320096,0.00021327143,0.00021802537,0.00023078952,0.00027695458,0.0002717507,0.00003691743],"category_scores_gemma":[0.000025800548,0.00049080735,0.00036926396,0.00020734838,0.00029004592,0.00041033808,0.000101688376,0.0002544507,0.000014415858],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004841014,0.0014888542,0.00020074687,0.028670281,0.0020590806,0.000114508206,0.0001816299,1.6533522e-7,8.25337e-7,0.00029460475,0.0006607985,0.9662801],"study_design_scores_gemma":[0.002081277,0.003627397,0.0016659823,0.03953789,0.006840041,0.0002902119,0.000055679153,7.1773735e-7,0.000023193355,0.000089163295,0.94512963,0.00065881206],"about_ca_topic_score_codex":0.000010016334,"about_ca_topic_score_gemma":0.000032948068,"teacher_disagreement_score":0.9656213,"about_ca_system_score_codex":0.000033048756,"about_ca_system_score_gemma":0.0001891489,"threshold_uncertainty_score":0.99975437},"labels":[],"label_agreement":null},{"id":"W4239535018","doi":"10.1182/bloodadvances.2019001409","title":"Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University of Ottawa; Western University; McMaster University; Ottawa Hospital; University of Calgary; Impact","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Deep vein; Systematic review; MEDLINE; Context (archaeology); Prospective cohort study; Grading (engineering); Diagnostic accuracy; Cohort; Cohort study; Internal medicine; Thrombosis","score_opus":0.06219621080218339,"score_gpt":0.3538253294311579,"score_spread":0.2916291186289745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239535018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010136966,0.99445856,0.0000046745195,0.00047498563,0.000029094479,0.0044696936,0.00030307894,0.000013940255,0.00023582196],"genre_scores_gemma":[0.00045878981,0.9975337,0.000301302,0.00035913326,0.000016523452,0.0012246233,0.000027977683,0.00004081879,0.00003716638],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960316,0.00035607122,0.0022463952,0.00052768574,0.0006262459,0.0002120085],"domain_scores_gemma":[0.992875,0.0024110188,0.0031894157,0.0012137967,0.00021035204,0.00010043147],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005534155,0.0005338162,0.018510792,0.00027162026,0.000042871055,0.000010689767,0.0005174625,0.00011979746,0.00031863883],"category_scores_gemma":[0.003140179,0.00027396352,0.004346973,0.0018937589,0.00018542519,0.000102438564,0.00030679035,0.00019956703,0.000002629531],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.594127e-7,0.00068365614,0.00019537793,0.8102701,0.18059108,0.0000024375383,0.00006974608,5.527e-7,4.053133e-7,0.00008749169,0.000079170466,0.008019536],"study_design_scores_gemma":[0.00011297381,0.0001025587,0.00013011675,0.09844849,0.8574936,0.0000048652587,0.00005011572,0.0000011764357,0.000020214708,0.00001004435,0.043447334,0.00017852518],"about_ca_topic_score_codex":0.000035995905,"about_ca_topic_score_gemma":0.00003308768,"teacher_disagreement_score":0.7118216,"about_ca_system_score_codex":0.00002126273,"about_ca_system_score_gemma":0.00008797414,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W4280489231","doi":"10.1182/bloodadvances.2021006281","title":"Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute","keywords":"Medicine; Confidence interval; Cohort; Retrospective cohort study; Medical costs; Demography; Disease; Disease control; Cohort study; Internal medicine; Health care; Pediatrics; Environmental health","score_opus":0.004667024122873736,"score_gpt":0.23139686554358602,"score_spread":0.22672984142071229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280489231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835706,0.0066285734,0.000071599,0.004276589,0.00021790665,0.0007691972,0.00021129855,0.00012236583,0.0041318773],"genre_scores_gemma":[0.99495023,0.00033196268,0.0003865057,0.0028835132,0.00013075673,0.00018906353,0.00010617209,0.000038791244,0.0009829893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763924,0.00009407812,0.00029844904,0.0004119864,0.0010684577,0.00048778995],"domain_scores_gemma":[0.99861187,0.00009682116,0.00010227574,0.00030879406,0.000065385684,0.0008148272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002620576,0.00022279585,0.00040768512,0.000103175014,0.00041233486,0.00002343237,0.00025362527,0.000070064714,0.00078877195],"category_scores_gemma":[0.00012445096,0.00017805533,0.00007757071,0.00058253505,0.0001511278,0.00015195446,0.00017922212,0.0005230196,0.000051081046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005482578,0.0016512458,0.981986,0.00012461335,0.0000976002,0.0006918549,0.00044068,0.0008261554,0.00007255877,0.000055670753,0.0036139768,0.009891383],"study_design_scores_gemma":[0.014556211,0.0037437542,0.6198626,0.00058762555,0.00062310195,0.00016838491,0.0020913752,0.00012244101,0.0013129062,0.000088799265,0.35586596,0.0009768225],"about_ca_topic_score_codex":0.000093972216,"about_ca_topic_score_gemma":0.00004102122,"teacher_disagreement_score":0.36212337,"about_ca_system_score_codex":0.00004890699,"about_ca_system_score_gemma":0.00033858255,"threshold_uncertainty_score":0.86364996},"labels":[],"label_agreement":null},{"id":"W4280584583","doi":"10.1182/bloodadvances.2022007450","title":"Treatment of an HLH-mimic disease based on <i>HAVCR2</i> variants with absent TIM-3 expression","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Universiteit van Amsterdam; Amsterdam University Medical Centers","keywords":"Expression (computer science); Disease; Biology; Immunology; Computational biology; Medicine; Pathology; Computer science","score_opus":0.012555546055083048,"score_gpt":0.280896710250797,"score_spread":0.26834116419571397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280584583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929871,0.0029796325,0.000046453373,0.00044354075,0.00005344799,0.00067722605,0.00006119976,0.00005520597,0.0026962198],"genre_scores_gemma":[0.99807066,0.00018214979,0.0004701428,0.00016601628,0.000034654942,0.00022486062,0.00010862909,0.00002494171,0.0007179573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986636,0.00008762321,0.00020073331,0.00028288105,0.000550483,0.00021469143],"domain_scores_gemma":[0.9992144,0.000042568954,0.00009835696,0.00045209427,0.000038592534,0.00015400577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006953095,0.00014733325,0.00027045622,0.00010542035,0.0001779807,0.000006795597,0.00010220905,0.000017008795,0.00039580662],"category_scores_gemma":[0.00001537467,0.00010114252,0.00006572483,0.0001564468,0.000068400965,0.00011456412,0.000028236644,0.000093263014,0.0000069185703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05801229,0.07864223,0.29982987,0.0017903239,0.0006751694,0.006614329,0.0025097982,0.053425726,0.23194781,0.00074219325,0.0008638175,0.26494646],"study_design_scores_gemma":[0.07556593,0.083244115,0.30037886,0.0011173554,0.0012507768,0.00015358403,0.0051907883,0.021470457,0.26558366,0.0004586165,0.24396937,0.0016165015],"about_ca_topic_score_codex":0.000013365637,"about_ca_topic_score_gemma":0.0000020716589,"teacher_disagreement_score":0.26332995,"about_ca_system_score_codex":0.000044053853,"about_ca_system_score_gemma":0.0002659437,"threshold_uncertainty_score":0.43338048},"labels":[],"label_agreement":null},{"id":"W4280593474","doi":"10.1182/bloodadvances.2021006069","title":"Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute","keywords":"Drug; Medicine; Cancer research; Internal medicine; Pharmacology","score_opus":0.005154398578097449,"score_gpt":0.2256533564932729,"score_spread":0.22049895791517543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280593474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916405,0.0081205135,0.00009389004,0.00022884649,0.0002101513,0.00034683748,0.00008686376,0.00001845048,0.0017303856],"genre_scores_gemma":[0.99690527,0.00070315966,0.00016177115,0.00012257697,0.000046268717,0.00012787571,0.00033574324,0.000015737836,0.0015816202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991026,0.0001360896,0.00020712965,0.0002158261,0.00016999454,0.00016836112],"domain_scores_gemma":[0.9994544,0.00002163852,0.00017239264,0.00028935185,0.00004272834,0.000019511708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011287501,0.00012712204,0.00012541676,0.00002278263,0.00027601232,0.000014396065,0.00021065513,0.000026522317,0.00004920351],"category_scores_gemma":[0.000019775935,0.00009478921,0.00008558855,0.00012684708,0.000054121505,0.000013228057,0.00013211297,0.000048583253,0.00000190021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014808076,0.0040620356,0.001225852,0.000028137698,0.000116017436,0.000004488794,0.0008860978,0.0002031383,0.99000275,0.0009344631,0.0006752811,0.0017136645],"study_design_scores_gemma":[0.0047458233,0.00039222537,0.00015610729,0.000004560173,0.000031634954,0.000005463824,0.0006788791,0.000029194656,0.8474315,0.00020902911,0.1462052,0.00011037873],"about_ca_topic_score_codex":0.000034198787,"about_ca_topic_score_gemma":0.000013289261,"teacher_disagreement_score":0.14552993,"about_ca_system_score_codex":0.000020569221,"about_ca_system_score_gemma":0.000048291633,"threshold_uncertainty_score":0.3865392},"labels":[],"label_agreement":null},{"id":"W4281487984","doi":"10.1182/bloodadvances.2022007766","title":"The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Public Health Agency; Public Health Agency of Canada","keywords":"Platelet factor 4; Heparin-induced thrombocytopenia; Heparin; Medicine; Adverse effect; Immunoassay; Immunology; Immune system; Antibody; Internal medicine","score_opus":0.031146597650615785,"score_gpt":0.334289724100438,"score_spread":0.3031431264498222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281487984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98377085,0.011523523,0.000001955421,0.0019186529,0.00072170235,0.0007227195,0.00005022585,0.00007487824,0.00121551],"genre_scores_gemma":[0.9921895,0.006535018,0.0004051539,0.00032060235,0.0001616473,0.00023303261,0.000012441002,0.00004817211,0.00009439909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971742,0.00038400613,0.0009768681,0.00053717085,0.000481858,0.00044592062],"domain_scores_gemma":[0.99761134,0.0008718531,0.00037304853,0.00078051444,0.00015886776,0.00020440119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011094379,0.00028683536,0.0010960212,0.00008708093,0.00076593796,0.000035189336,0.00038869109,0.0000934066,0.00025802376],"category_scores_gemma":[0.00042553083,0.00021022957,0.00021177433,0.0005699521,0.000257957,0.0002348653,0.0004901565,0.0006418169,0.000014402109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030566406,0.0015309596,0.9355677,0.00016640266,0.0008882574,0.000072269366,0.000414871,0.000005812993,0.041778855,0.0034482398,0.00038364079,0.01543734],"study_design_scores_gemma":[0.005044885,0.0024321815,0.892672,0.00009928803,0.00092064973,0.00010767606,0.0014686007,0.000014560066,0.05861937,0.0008610224,0.037373934,0.0003858087],"about_ca_topic_score_codex":0.000059086175,"about_ca_topic_score_gemma":0.00006454424,"teacher_disagreement_score":0.042895667,"about_ca_system_score_codex":0.00003428448,"about_ca_system_score_gemma":0.00029565507,"threshold_uncertainty_score":0.8572913},"labels":[],"label_agreement":null},{"id":"W4281556916","doi":"10.1182/bloodadvances.2022007961","title":"Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis","year":2022,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Discontinuation; Hazard ratio; Internal medicine; Thrombosis; Confidence interval; Incidence (geometry); Meta-analysis; Randomized controlled trial; Surgery","score_opus":0.4452476772469727,"score_gpt":0.45685931607050334,"score_spread":0.011611638823530668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281556916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025390056,0.9910908,0.000050441726,0.00008740588,0.00030304695,0.0040841596,0.0040235915,0.000111878195,0.00022333776],"genre_scores_gemma":[0.000046689467,0.97668177,0.0024416335,0.0006012856,0.00028373135,0.0027147979,0.017061261,0.000110322624,0.000058529607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562436,0.00030217317,0.0010956269,0.0015129548,0.0008995976,0.0005652749],"domain_scores_gemma":[0.99577415,0.00035269166,0.000877861,0.0027445473,0.00005423267,0.00019651977],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008450144,0.0007507845,0.0074774777,0.0005583442,0.00026739138,0.000105577135,0.0012875778,0.00015467245,0.0015725963],"category_scores_gemma":[0.00006903534,0.0005054269,0.0026013725,0.0009078283,0.00006594097,0.00033222794,0.000595337,0.00034162984,0.000011155933],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010153916,0.003208313,0.000009946064,0.004776308,0.39454374,0.000031341915,0.00011134463,0.000010978659,1.6628587e-7,0.00016566148,0.0018719961,0.5952601],"study_design_scores_gemma":[0.00030506973,0.00082012016,0.000025192465,0.00012371076,0.4516523,0.0000083546165,0.00006590022,0.000003555438,0.0000012595151,0.00002314226,0.5466737,0.000297689],"about_ca_topic_score_codex":0.00004631046,"about_ca_topic_score_gemma":0.00006389196,"teacher_disagreement_score":0.59496236,"about_ca_system_score_codex":0.000035649926,"about_ca_system_score_gemma":0.00022321304,"threshold_uncertainty_score":0.9997397},"labels":[],"label_agreement":null},{"id":"W4281636766","doi":"10.1182/bloodadvances.2021006193","title":"Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McMaster University","funders":"Kite Pharma; Chugai Pharmaceutical; Genentech; MorphoSys; SymBio Pharmaceuticals Limited; Ono Pharmaceutical; Teijin Pharma; TG Therapeutics; Kiadis Pharma; Japan Science and Technology Agency; Juno Therapeutics; Astellas Pharma; Eisai; Daiichi-Sankyo; Omeros Corporation; Pfizer; Incyte; BeiGene; Loxo Oncology; Astex Pharmaceuticals; Nippon Shinyaku; Regeneron Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Karyopharm Therapeutics; Atara Biotherapeutics; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Sanofi; Celgene; Amgen; Fuji Pharma; Japan Society for the Promotion of Science; GlaxoSmithKline","keywords":"Diffuse large B-cell lymphoma; Refractory (planetary science); Lymphoma; Medicine; Term (time); Oncology; Internal medicine; Cancer research; Biology; Physics","score_opus":0.009813489538978077,"score_gpt":0.2651330121369403,"score_spread":0.2553195225979622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281636766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232215,0.0026311039,0.00006887212,0.00008274814,0.0001769831,0.001669959,0.0003442165,0.00013164125,0.0025722997],"genre_scores_gemma":[0.97603625,0.0004987843,0.00036576786,0.00027013128,0.0001397026,0.00040716556,0.000724074,0.000109991866,0.021448141],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977001,0.00010022922,0.00030570623,0.00053214846,0.00074272306,0.0006191035],"domain_scores_gemma":[0.99873877,0.00020969221,0.00014996581,0.0005306643,0.00015698688,0.00021392631],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020270792,0.0002646341,0.00039998573,0.00015182197,0.0004224969,0.000022825096,0.00023492498,0.00005916246,0.0018037601],"category_scores_gemma":[0.00004240799,0.00021912031,0.00013896242,0.00034861814,0.00007977811,0.00017764544,0.00014131445,0.00022242623,0.000020204556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012861516,0.03652911,0.86428964,0.00043487898,0.000409317,0.000276709,0.00046600713,0.00000842763,0.012331691,0.00003077112,0.000523236,0.07183868],"study_design_scores_gemma":[0.18801767,0.012454894,0.37387186,0.00013074197,0.0005879141,0.000067638655,0.000292015,0.00004124568,0.019599464,0.000042249274,0.4040797,0.0008145993],"about_ca_topic_score_codex":0.00001066341,"about_ca_topic_score_gemma":0.000033186756,"teacher_disagreement_score":0.4904178,"about_ca_system_score_codex":0.00020227913,"about_ca_system_score_gemma":0.00015044425,"threshold_uncertainty_score":0.99910873},"labels":[],"label_agreement":null},{"id":"W4281795671","doi":"10.1182/bloodadvances.2022007027","title":"Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McMaster University; Western University; University of Ottawa; Jewish General Hospital; McGill University; Ottawa Hospital; Dalhousie University","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Confidence interval; Internal medicine; Major bleeding; Venous thromboembolism; Bleed; Prospective cohort study; Framingham Risk Score; Surgery; Thrombosis; Disease","score_opus":0.016795033515255513,"score_gpt":0.28375296532292127,"score_spread":0.26695793180766575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281795671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178594,0.001839951,0.00017257183,0.00066124054,0.00081511773,0.003053099,0.000043946988,0.00037028798,0.0012578422],"genre_scores_gemma":[0.99217236,0.00027538044,0.0039785365,0.00028535599,0.00064494583,0.0013920427,0.00007309875,0.00008558775,0.0010927013],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975928,0.00004979418,0.00052944693,0.00063520926,0.00056285254,0.0006298893],"domain_scores_gemma":[0.99899346,0.000097469776,0.0003073035,0.0003559958,0.00010765791,0.00013810316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003717365,0.00029157882,0.00079216564,0.00022340214,0.0010614562,0.000057187928,0.00020824387,0.000053949363,0.0002421762],"category_scores_gemma":[0.0001682733,0.0002606499,0.00017079816,0.00038418415,0.000056404162,0.00034567772,0.00022436227,0.00023143213,0.0000057433463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008217906,0.039020948,0.0987805,0.01781343,0.007630132,0.0013114891,0.018637205,0.009647516,0.6362987,0.015808277,0.0023015982,0.14453226],"study_design_scores_gemma":[0.029233368,0.012166222,0.7709446,0.0012126367,0.0071708285,0.0007591606,0.014528293,0.00571179,0.1111351,0.003641954,0.041366745,0.0021292889],"about_ca_topic_score_codex":0.00004794014,"about_ca_topic_score_gemma":0.000028200686,"teacher_disagreement_score":0.6721641,"about_ca_system_score_codex":0.00012324986,"about_ca_system_score_gemma":0.00011725944,"threshold_uncertainty_score":0.99998456},"labels":[],"label_agreement":null},{"id":"W4282021509","doi":"10.1182/bloodadvances.2021006654","title":"Genomic characterization of lymphomas in patients with inborn errors of immunity","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Biology; Lymphoma; Germline; Cancer research; Genome; Genetics; Germline mutation; PTEN; Mutation; Gene; Immunology; PI3K/AKT/mTOR pathway","score_opus":0.0030450367586669622,"score_gpt":0.17875982352370556,"score_spread":0.1757147867650386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282021509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933713,0.0059454287,0.000005937328,0.000008446308,0.0001750752,0.0001788323,0.00008225375,0.000010778694,0.00022193031],"genre_scores_gemma":[0.9994482,0.00006373273,0.000011493648,0.00001607293,3.8569246e-7,0.00002140513,0.00034705794,0.000008163015,0.00008353559],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99924946,0.00013863838,0.00029109267,0.00012576641,0.00004239608,0.00015263924],"domain_scores_gemma":[0.9994872,0.000025741487,0.0002677792,0.00018042036,0.000037102967,0.0000017324721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120869845,0.00009241576,0.00022114583,0.00012181591,0.00011662586,0.0000011785173,0.00021259922,0.00003286701,0.00019199745],"category_scores_gemma":[0.000013223878,0.00008468465,0.00003366096,0.0002643497,0.00014665928,0.000109513516,0.000094712945,0.00012343108,0.0000026791802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051775976,0.0014364588,0.41112804,0.00003804069,0.00006468672,4.3858338e-7,0.0013164211,0.00022836064,0.57664007,0.00019247904,3.595384e-7,0.008436861],"study_design_scores_gemma":[0.0030975833,0.0004883913,0.93755335,0.000020615753,0.000023658926,0.0000016433369,0.00075884064,9.959413e-7,0.05524879,0.000033794335,0.0026616484,0.000110708264],"about_ca_topic_score_codex":0.000075366515,"about_ca_topic_score_gemma":0.000003272842,"teacher_disagreement_score":0.5264253,"about_ca_system_score_codex":0.000015034031,"about_ca_system_score_gemma":0.000050874798,"threshold_uncertainty_score":0.345334},"labels":[],"label_agreement":null},{"id":"W4282923240","doi":"10.1182/bloodadvances.2022007493","title":"Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; University of Southern California","keywords":"Immune system; Diffuse large B-cell lymphoma; Tumor microenvironment; Lymphoma; Cancer research; Biology; Immune checkpoint; Cancer; Immunology; Immunotherapy; Genetics","score_opus":0.0053317857860788395,"score_gpt":0.2019639306737186,"score_spread":0.19663214488763975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282923240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912026,0.0065725353,0.000982537,0.000021558553,0.00016018336,0.00013940665,0.00020852587,0.0000115872335,0.00070108543],"genre_scores_gemma":[0.99850994,0.00012830547,0.0005805059,0.0001227157,0.0000632801,0.000028710565,0.00028851905,0.00002486131,0.00025313243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862707,0.000108563436,0.00036148974,0.00039341985,0.00020642669,0.0003030575],"domain_scores_gemma":[0.9993703,0.000023876553,0.00017793091,0.00034582792,0.00003062258,0.000051494528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001401006,0.00018865959,0.0003502821,0.00020038238,0.00009876517,0.000010963813,0.0003170425,0.00005220835,0.000046707657],"category_scores_gemma":[0.000019374853,0.00019086846,0.000252194,0.00048368602,0.00005521628,0.000004490233,0.00014615073,0.00010769908,6.9652464e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032072773,0.008549976,0.02131829,0.000048163463,0.00015476262,0.000021716614,0.00022233812,0.0021756804,0.96467835,0.0000071406366,0.00000714661,0.002495736],"study_design_scores_gemma":[0.009760186,0.0010081349,0.003693069,0.00000771531,0.00045355916,0.000007754012,0.00031279773,0.00033632535,0.9585064,0.000034886572,0.025510967,0.00036818016],"about_ca_topic_score_codex":0.00014511368,"about_ca_topic_score_gemma":0.00083188404,"teacher_disagreement_score":0.02550382,"about_ca_system_score_codex":0.000014579942,"about_ca_system_score_gemma":0.00004980986,"threshold_uncertainty_score":0.77833897},"labels":[],"label_agreement":null},{"id":"W4283388812","doi":"10.1182/bloodadvances.2022007940","title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; University of Ottawa; McGill University; Impact; McMaster University; University of Toronto; Cochrane; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Guideline; Intensive care medicine; Grading (engineering); MEDLINE; Multidisciplinary approach; Coronavirus disease 2019 (COVID-19); Randomized controlled trial; Clinical trial; Internal medicine; Disease; Infectious disease (medical specialty); Pathology","score_opus":0.1351396081128872,"score_gpt":0.4233162027947268,"score_spread":0.28817659468183965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283388812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793099,0.00004505454,0.0028189165,0.014645565,0.000048786125,0.0026916312,0.00042800736,0.000011038801,0.0000010716533],"genre_scores_gemma":[0.9840852,0.00019833916,0.008828423,0.0064691757,0.000020090944,0.00029864124,0.00006472079,0.00002300271,0.000012398877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749964,0.00025081367,0.0008040723,0.00035332787,0.0008103543,0.00028180462],"domain_scores_gemma":[0.9718703,0.025122428,0.0005240255,0.0004098467,0.0020101652,0.00006323152],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0007311542,0.0001632127,0.0005984786,0.000114079456,0.00021672853,0.0000084365465,0.00017805547,0.00003180687,0.000025004874],"category_scores_gemma":[0.08751845,0.0000949194,0.00017117229,0.00049464934,0.0006038349,0.00012702541,0.00018703555,0.00017550183,1.4019723e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028867694,0.0035216021,0.9700712,0.0013954159,0.00028448863,6.780481e-7,0.00047840396,0.009818615,0.00055495056,0.0020626972,0.0010720498,0.007853107],"study_design_scores_gemma":[0.00664442,0.019997519,0.9216721,0.0007316913,0.00033731887,3.79382e-7,0.0010807237,0.026973967,0.0016403141,0.0014155399,0.019164745,0.00034126698],"about_ca_topic_score_codex":0.00014606363,"about_ca_topic_score_gemma":0.00003943962,"teacher_disagreement_score":0.0867873,"about_ca_system_score_codex":0.000068583286,"about_ca_system_score_gemma":0.0001844479,"threshold_uncertainty_score":0.92016774},"labels":[],"label_agreement":null},{"id":"W4283835454","doi":"10.1182/bloodadvances.2022007250","title":"In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"CRISPR; In vivo; Biology; Myeloid leukemia; Leukemia; Genome editing; Genome; Myeloid; Computational biology; Gene; Cancer research; Genetics","score_opus":0.003674562314736957,"score_gpt":0.23993785539738527,"score_spread":0.23626329308264832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283835454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914736,0.0067970688,0.0010879008,0.000051514533,0.000117740616,0.00014317934,0.000050244304,0.0000084542025,0.00027028754],"genre_scores_gemma":[0.99572915,0.0014096798,0.0018921162,0.00024782104,0.000068530906,0.000059369875,0.000046747722,0.000022614006,0.00052395614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898446,0.000029558565,0.00019985286,0.00034264778,0.0001457158,0.00029777733],"domain_scores_gemma":[0.9997126,0.000011987694,0.000042817108,0.00018387202,0.0000042328347,0.000044507728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010656278,0.0001549908,0.00014195307,0.00008240376,0.00007180316,0.000010175735,0.00020604314,0.00003814061,0.00010506765],"category_scores_gemma":[0.000013385315,0.00018012882,0.000054429176,0.00011975568,0.000033841632,0.000011186637,0.00028051602,0.00014977914,0.0000016676779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067021516,0.00006192544,0.08527095,0.0000147012315,0.00003920701,0.000096556585,0.0001232525,0.07095738,0.8428845,0.000003480006,0.00010216144,0.0003788981],"study_design_scores_gemma":[0.001520799,0.00022970341,0.023976415,0.000008534782,0.000024380293,0.00007565049,0.0011395718,0.00008316922,0.87588125,0.000024500936,0.09669898,0.00033705484],"about_ca_topic_score_codex":0.00006176769,"about_ca_topic_score_gemma":0.00027593022,"teacher_disagreement_score":0.096596815,"about_ca_system_score_codex":0.000048589896,"about_ca_system_score_gemma":0.000030735133,"threshold_uncertainty_score":0.734544},"labels":[],"label_agreement":null},{"id":"W4284665405","doi":"10.1182/bloodadvances.2021005828","title":"HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canada First Research Excellence Fund; Government of Canada; Institut de Valorisation des Données; Compute Canada; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"Vulnerability (computing); HMGA2; Biology; Signature (topology); Computational biology; Cell biology; Cancer research; Molecular biology; Genetics; microRNA; Gene; Computer security; Computer science; Mathematics","score_opus":0.012121265216236311,"score_gpt":0.2841051392563005,"score_spread":0.2719838740400642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284665405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436253,0.003041614,0.000087858,0.0013927168,0.000031024625,0.00056871946,0.00017305225,0.000053208678,0.00028925168],"genre_scores_gemma":[0.99626184,0.000048397604,0.0027528245,0.00027915463,0.000085969354,0.00016017928,0.0001844829,0.000019125035,0.00020805681],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985597,0.000101312464,0.0002054187,0.00035577687,0.0005698133,0.00020795432],"domain_scores_gemma":[0.99940544,0.00006374652,0.00006911482,0.00021384415,0.0001226622,0.00012518752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023989216,0.00014633618,0.00027617515,0.0001327391,0.0002413499,0.0000096579815,0.00007973442,0.00005913602,0.00016293302],"category_scores_gemma":[0.000049299782,0.00010926462,0.00004561979,0.00033432205,0.00012000155,0.00015689468,0.00007390833,0.0004985863,7.4243155e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001854919,0.00037892335,0.012224168,0.00028479582,0.00003302806,0.000053410815,0.0007139893,0.000099457735,0.9821791,0.00035595772,0.00089142093,0.0009307946],"study_design_scores_gemma":[0.01049805,0.005587041,0.1567652,0.00054517284,0.00023389538,0.00053913175,0.002640988,0.000038532806,0.8032252,0.0015739588,0.017849175,0.0005036315],"about_ca_topic_score_codex":0.000018986459,"about_ca_topic_score_gemma":0.000035732974,"teacher_disagreement_score":0.1789539,"about_ca_system_score_codex":0.000056022825,"about_ca_system_score_gemma":0.00009688924,"threshold_uncertainty_score":0.44556817},"labels":[],"label_agreement":null},{"id":"W4285077583","doi":"10.1182/bloodadvances.2022008355","title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Blood Cancer UK; National Cancer Institute; Cancer Research UK; Genentech; Celgene; KWF Kankerbestrijding; Teva Pharmaceutical Industries; GlaxoSmithKline; Barts Charity; Pfizer","keywords":"Biology; Stage (stratigraphy); Follicular lymphoma; Molecular biology; Chromosomal translocation; Genetics; Cancer research; Lymphoma; Gene; Immunology","score_opus":0.006569340776565185,"score_gpt":0.2154114171436622,"score_spread":0.208842076367097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285077583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817772,0.016823798,0.0000038922194,0.000072695075,0.000029626959,0.000377669,0.00019197335,0.000019444422,0.0007037318],"genre_scores_gemma":[0.99733,0.0007023554,0.00082757015,0.00011659248,0.000019859011,0.00009547335,0.000087086446,0.000017572182,0.0008034838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991229,0.000025725738,0.00017803199,0.00026583116,0.00023222536,0.00017527722],"domain_scores_gemma":[0.99955183,0.00003104397,0.00011979476,0.00020471856,0.000007650231,0.000084956046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004938238,0.00014912726,0.0003256438,0.000051171,0.00012487844,0.000008039166,0.000060622267,0.000014215536,0.00027351806],"category_scores_gemma":[0.0000015548916,0.00011358546,0.00005225084,0.00007318936,0.00008121725,0.000056298057,0.00009119327,0.000032604563,0.0000029906312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005358742,0.0018247322,0.98064107,0.0000901245,0.00037084296,0.00039362206,0.00035819886,0.00024125948,0.013079223,0.0000752528,0.000067394925,0.0023223998],"study_design_scores_gemma":[0.026392726,0.001989978,0.85726756,0.000047201123,0.00055070966,0.00028557578,0.0035878115,0.000079157166,0.03208336,0.000008235846,0.07745557,0.0002521181],"about_ca_topic_score_codex":0.0000792827,"about_ca_topic_score_gemma":0.000021753944,"teacher_disagreement_score":0.123373516,"about_ca_system_score_codex":0.000062208856,"about_ca_system_score_gemma":0.000042541913,"threshold_uncertainty_score":0.46318808},"labels":[],"label_agreement":null},{"id":"W4285727921","doi":"10.1182/bloodadvances.2022007300","title":"Unified gene expression signature of novel <i>NPM1</i> exon 5 mutations in acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"NPM1; Exon; Myeloid leukemia; Gene; Biology; Mutation; Myeloid; Leukemia; Gene expression; Cancer research; Genetics; Signature (topology); Karyotype; Chromosome","score_opus":0.01616325110435443,"score_gpt":0.2900097324574762,"score_spread":0.27384648135312173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285727921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912688,0.004074201,0.00047353862,0.0006049764,0.00016446567,0.0007336522,0.00020127771,0.00007464571,0.0024044313],"genre_scores_gemma":[0.9767169,0.00059314154,0.019999849,0.00034941448,0.00010621627,0.00022436265,0.00028161687,0.000045120745,0.0016834026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997962,0.00009034611,0.000422582,0.00042461333,0.00071248325,0.0003879622],"domain_scores_gemma":[0.99898314,0.00017961542,0.000175613,0.00042107093,0.000113254784,0.00012728704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029387348,0.00019547464,0.00040959913,0.00034278762,0.00016451173,0.0000087933895,0.0003103297,0.000094159404,0.00019173304],"category_scores_gemma":[0.00011737377,0.00017874205,0.00009758115,0.0009247394,0.00011732931,0.00021683403,0.0002708982,0.00080515683,0.000004409924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000477918,0.00051579264,0.0024984686,0.000095293755,0.00007151886,0.00023139027,0.0006078642,0.0035202764,0.9892358,0.00014840075,0.00052562315,0.0020716232],"study_design_scores_gemma":[0.010746806,0.00076160365,0.004939147,0.00015223768,0.00019840937,0.00030786084,0.0019985263,0.0007446321,0.9612342,0.0002269264,0.018365819,0.0003237935],"about_ca_topic_score_codex":0.000057375448,"about_ca_topic_score_gemma":0.000016240785,"teacher_disagreement_score":0.028001592,"about_ca_system_score_codex":0.00033829937,"about_ca_system_score_gemma":0.00064975396,"threshold_uncertainty_score":0.7288889},"labels":[],"label_agreement":null},{"id":"W4289278153","doi":"10.1182/bloodadvances.2022007714","title":"Disruption of stem cell niche–confined R-spondin 3 expression leads to impaired hematopoiesis","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Wnt signaling pathway; Haematopoiesis; Stem cell; Progenitor cell; Cell biology; Biology; Niche; Cell fate determination; Hematopoietic stem cell; LGR5; Homeostasis; Signal transduction; Immunology; Genetics; Transcription factor; Gene","score_opus":0.007957642144366797,"score_gpt":0.23880294400927746,"score_spread":0.23084530186491065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289278153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950246,0.0036136743,0.00032420686,0.00006557376,0.00020634725,0.0001700389,0.000030698156,0.000017964176,0.000546851],"genre_scores_gemma":[0.99494535,0.00011503254,0.0011868775,0.00009247135,0.00007427147,0.000141996,0.00006725316,0.000018521276,0.0033582158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990166,0.000056954872,0.0002302624,0.00030147392,0.00020816519,0.00018655317],"domain_scores_gemma":[0.9995382,0.000012659235,0.00012950103,0.00022016518,0.00004401404,0.000055505974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015461759,0.0001313017,0.00015865118,0.000052800537,0.00012655124,0.000008481408,0.00023555369,0.000043501415,0.00015116649],"category_scores_gemma":[0.000006027344,0.00012619392,0.00007423925,0.00015090266,0.000028314382,0.0000063792613,0.00020301237,0.000055676966,0.0000040716936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016227488,0.00010485834,0.006255402,0.000045396468,0.000014898473,0.0000021585279,0.00018257016,0.00048438853,0.9902726,0.000011844807,0.0012418821,0.001221727],"study_design_scores_gemma":[0.0005002084,0.00030448422,0.00076552544,0.000017559436,0.000019262989,0.000004939107,0.00048296622,0.000002729382,0.96320987,0.000023194674,0.034495585,0.00017370716],"about_ca_topic_score_codex":0.0000026335997,"about_ca_topic_score_gemma":0.000003431502,"teacher_disagreement_score":0.033253703,"about_ca_system_score_codex":0.000011751637,"about_ca_system_score_gemma":0.00005791115,"threshold_uncertainty_score":0.51460385},"labels":[],"label_agreement":null},{"id":"W4291173185","doi":"10.1182/bloodadvances.2022007536","title":"Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Blood Cancer UK; Academy of Medical Sciences; Cancer Research UK; Barts Charity; European Hematology Association","keywords":"Diffuse large B-cell lymphoma; Oncology; Lymphoma; Internal medicine; Population; Medicine; Ibrutinib; Clinical trial; Germinal center; Gene signature; Biology; Immunology; B cell; Gene; Chronic lymphocytic leukemia; Leukemia; Gene expression; Genetics","score_opus":0.007225127182962229,"score_gpt":0.23365595563583555,"score_spread":0.22643082845287332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291173185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939885,0.004646611,0.0000068271615,0.000020647629,0.00017596918,0.000507817,0.00038699544,0.00004161684,0.00022501808],"genre_scores_gemma":[0.9980094,0.00033968058,0.0009458372,0.000036192585,0.000037033507,0.00013837586,0.00028298065,0.000023496992,0.00018702792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855095,0.00005953574,0.0002598957,0.00034416525,0.0005267252,0.0002587428],"domain_scores_gemma":[0.99916995,0.000073314455,0.00027623176,0.00027664797,0.000116750176,0.00008712286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009301021,0.00018297398,0.00032207125,0.00008671754,0.00026832902,0.000013366392,0.00010060605,0.000025914524,0.00010419416],"category_scores_gemma":[0.000037081285,0.00012749498,0.00008039916,0.00022777602,0.000046546727,0.00015457321,0.00009541617,0.000063448264,0.0000072583184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008805278,0.018250786,0.9781665,0.00013440484,0.000109329834,0.00007980759,0.00020296613,0.00001331051,0.0011601052,0.000017976334,0.00013308991,0.00085120276],"study_design_scores_gemma":[0.03421092,0.0019562782,0.75901973,0.00012500472,0.0005765208,0.000012862488,0.00051924447,0.00001182555,0.2006727,0.00003984263,0.0026649986,0.00019006598],"about_ca_topic_score_codex":0.000029783734,"about_ca_topic_score_gemma":0.000013189524,"teacher_disagreement_score":0.21914676,"about_ca_system_score_codex":0.000054531487,"about_ca_system_score_gemma":0.00007251874,"threshold_uncertainty_score":0.5199094},"labels":[],"label_agreement":null},{"id":"W4292018553","doi":"10.1182/bloodadvances.2022008150","title":"Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Refractory (planetary science); Confidence interval; Odds ratio; Oncology","score_opus":0.0166545374254523,"score_gpt":0.31204105543230126,"score_spread":0.29538651800684895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292018553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939026,0.0041816356,0.0000025073734,0.0000344694,0.00008760141,0.0007815302,0.000030401265,0.00003353142,0.0009457002],"genre_scores_gemma":[0.9982802,0.0000686547,0.00039458697,0.00005668359,0.00003845442,0.000075605545,0.00010915814,0.000039966337,0.0009366525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979812,0.00014059065,0.0003397089,0.00033325507,0.0009028272,0.00030240064],"domain_scores_gemma":[0.9991185,0.00014255676,0.00014606364,0.0003827336,0.00011293146,0.00009721287],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012808731,0.00016118003,0.00048108958,0.00018473674,0.00010048113,0.0000070091037,0.00018476596,0.00004338697,0.0009433937],"category_scores_gemma":[0.000069641326,0.00012541607,0.00007066386,0.0005343588,0.00008893285,0.00009010511,0.000102514125,0.00023787166,0.0000041061344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023043672,0.005441908,0.83839506,0.00024965726,0.00017872015,0.00014947451,0.0033758718,0.00035716634,0.0048344536,0.000008926876,0.000108899956,0.12385622],"study_design_scores_gemma":[0.0628276,0.022680722,0.7575998,0.00023659771,0.00020861963,0.000017315484,0.005046056,0.000052191197,0.025841005,0.000007015986,0.12507537,0.00040773186],"about_ca_topic_score_codex":0.000049353464,"about_ca_topic_score_gemma":0.00009615009,"teacher_disagreement_score":0.124966465,"about_ca_system_score_codex":0.00016525885,"about_ca_system_score_gemma":0.0002214718,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W4293103533","doi":"10.1182/bloodadvances.2022008160","title":"Anticoagulation in pediatric cancer–associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Bayer","keywords":"Venous thromboembolism; Subgroup analysis; Medicine; Cancer; Internal medicine; Oncology; Gastroenterology; Thrombosis; Meta-analysis","score_opus":0.013750241520241574,"score_gpt":0.28406187763460816,"score_spread":0.2703116361143666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293103533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883136,0.009128819,0.000013332724,0.00021764897,0.00023608835,0.0004998231,0.000054359476,0.000052664935,0.0014836498],"genre_scores_gemma":[0.99445343,0.0047499486,0.00010641669,0.0002134351,0.00008073703,0.00017546852,0.00011942797,0.00002192863,0.00007922431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815583,0.00009866733,0.00050436816,0.0003628914,0.00055109314,0.00032711832],"domain_scores_gemma":[0.99915916,0.0000765535,0.0003466557,0.00027829938,0.00007347085,0.000065870634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000328076,0.00016869446,0.0010886313,0.00086361554,0.00013362602,0.000009938308,0.00015288377,0.000042438576,0.00032804895],"category_scores_gemma":[0.000060288054,0.00017239766,0.00020642075,0.0030699547,0.00003535315,0.00013040457,0.0001177072,0.00016998152,0.0000020169189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006166414,0.0072047743,0.9520694,0.00026993148,0.0021517365,0.000061223254,0.0014886842,0.030129153,0.0010160563,0.0008026379,0.00020993466,0.004534775],"study_design_scores_gemma":[0.0015685038,0.0005526181,0.9868454,0.000031689124,0.007917657,0.0000015501137,0.00045963805,0.0010404414,0.00035395852,0.00012896843,0.0009189036,0.00018068476],"about_ca_topic_score_codex":0.0009505577,"about_ca_topic_score_gemma":0.0010639061,"teacher_disagreement_score":0.034775957,"about_ca_system_score_codex":0.00012622903,"about_ca_system_score_gemma":0.00009390704,"threshold_uncertainty_score":0.7030173},"labels":[],"label_agreement":null},{"id":"W4293116610","doi":"10.1182/bloodadvances.2021006778","title":"Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deferiprone; Medicine; Internal medicine; Deferoxamine; Clinical endpoint; Adverse effect; Gastroenterology; Anemia; Neutropenia; Deferasirox; Thalassemia; Sickle cell anemia; Randomized controlled trial; Pediatrics; Surgery; Disease; Chemotherapy","score_opus":0.017349887221563786,"score_gpt":0.29136336600479285,"score_spread":0.27401347878322907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293116610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931961,0.0044468753,0.000005676488,0.00018096631,0.000081764876,0.0016630123,0.00008552335,0.000009535525,0.00033053308],"genre_scores_gemma":[0.99818236,0.00015143644,0.00032592475,0.00037527655,0.000014213702,0.00023884422,0.000007994036,0.000017300204,0.0006866776],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992461,0.000027984092,0.00017746634,0.00023320098,0.00017052927,0.00014468102],"domain_scores_gemma":[0.9996929,0.000032704284,0.000037349255,0.000121733174,0.000013306804,0.000101974496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001082204,0.000085909654,0.0002016437,0.00006275592,0.00006400914,0.0000059197923,0.00009416998,0.000019057718,0.00008166043],"category_scores_gemma":[0.000016084965,0.00007724048,0.000018286604,0.00017520635,0.000023595414,0.000052402855,0.00007942658,0.00009255347,8.6959943e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043550543,0.11824877,0.51278144,0.0035106083,0.00051204814,0.0006885177,0.08025544,0.0072396044,0.09887309,0.00086053595,0.0031262862,0.13035312],"study_design_scores_gemma":[0.3382071,0.04639339,0.140079,0.00072381936,0.002342424,0.00006479381,0.18964052,0.0007167935,0.0044273674,0.0015378806,0.27388301,0.0019838854],"about_ca_topic_score_codex":0.00011258283,"about_ca_topic_score_gemma":0.00008995668,"teacher_disagreement_score":0.37270242,"about_ca_system_score_codex":0.000012629968,"about_ca_system_score_gemma":0.00005372731,"threshold_uncertainty_score":0.31497753},"labels":[],"label_agreement":null},{"id":"W4293786422","doi":"10.1182/bloodadvances.2022007779","title":"Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Novartis Pharmaceuticals Corporation","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Immunotherapy","score_opus":0.014657238399119334,"score_gpt":0.31693442509164627,"score_spread":0.30227718669252696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293786422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955843,0.00097514596,0.000002513281,0.00007062562,0.00004659235,0.0015027879,0.00009250258,0.000025745072,0.0016997484],"genre_scores_gemma":[0.9984875,0.00010194017,0.00009555269,0.000032708518,0.000029263565,0.000045833967,0.00006830039,0.000028130811,0.0011108171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979794,0.00013352634,0.00045272784,0.00040245077,0.0007491394,0.0002827649],"domain_scores_gemma":[0.99913394,0.0001383155,0.00016107678,0.00037570644,0.0000791721,0.00011177014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037069243,0.00015389576,0.0004254365,0.00018678584,0.000100685305,0.000007798048,0.00012999996,0.00002147064,0.00026352503],"category_scores_gemma":[0.00010253554,0.00012763792,0.000035685312,0.00045846342,0.000095808915,0.00009309017,0.00013638842,0.00028269095,0.0000012324131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19245207,0.06042449,0.57244825,0.00019779682,0.00053037715,0.00063478586,0.0070740026,0.00042808274,0.002865063,0.000020101328,0.00007578406,0.1628492],"study_design_scores_gemma":[0.33431295,0.01990524,0.6347353,0.00006559044,0.00017243516,0.00002759882,0.0017105088,0.000054850665,0.0012783664,0.000010069677,0.007498298,0.00022878876],"about_ca_topic_score_codex":0.000083925974,"about_ca_topic_score_gemma":0.00008115916,"teacher_disagreement_score":0.16262041,"about_ca_system_score_codex":0.00007488937,"about_ca_system_score_gemma":0.00013950226,"threshold_uncertainty_score":0.5204923},"labels":[],"label_agreement":null},{"id":"W4294300890","doi":"10.1182/bloodadvances.2022008443","title":"Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. National Library of Medicine; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health","keywords":"Medicine; Observational study; Randomized controlled trial; Exacerbation; Relative risk; Internal medicine; Meta-analysis; Confidence interval; Cochrane Library","score_opus":0.061763289457590874,"score_gpt":0.36093499712230825,"score_spread":0.2991717076647174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294300890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004963549,0.99119854,0.0000029100177,0.00001932279,0.00009409326,0.006020604,0.0024674025,0.000032641576,0.0001595426],"genre_scores_gemma":[0.0004513627,0.9956652,0.00007845507,0.00004784414,0.000004396987,0.003026021,0.0005126097,0.000038101047,0.0001759963],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948327,0.0017942603,0.002019834,0.0007952101,0.00016617333,0.00039179853],"domain_scores_gemma":[0.996734,0.0009049035,0.00126379,0.00097527,0.000079446916,0.00004258335],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006379705,0.00062120275,0.015023054,0.00062441186,0.00013305277,0.000020741585,0.0007299172,0.00012065242,0.0038952087],"category_scores_gemma":[0.0003904098,0.00044265707,0.0020527986,0.0013631961,0.00008202295,0.00011613441,0.00046486655,0.00029564206,0.000033859647],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008839887,0.000053037726,0.000004942687,0.8857529,0.11271307,0.00001196741,0.0001482172,0.000003697712,5.2030464e-7,0.000105010615,0.0000518079,0.0011459944],"study_design_scores_gemma":[0.00022263723,0.0002577424,9.416518e-7,0.042012077,0.7604016,0.000050654395,0.00047640767,8.6117895e-9,0.0000028328827,0.0000053021563,0.19621342,0.00035633787],"about_ca_topic_score_codex":0.00002972294,"about_ca_topic_score_gemma":0.00045735206,"teacher_disagreement_score":0.8437408,"about_ca_system_score_codex":0.00015617392,"about_ca_system_score_gemma":0.00020049694,"threshold_uncertainty_score":0.99980253},"labels":[],"label_agreement":null},{"id":"W4294301027","doi":"10.1182/bloodadvances.2021006797","title":"The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood groups and transfusion","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Canadian Blood Services; University of Toronto","funders":"Health Canada; Government of Canada; Canadian Blood Services; Australian Government","keywords":"CXCL10; Chemokine; Interleukin 8; Autoimmune hemolytic anemia; Immunology; Medicine; Inflammation; Antibody","score_opus":0.00644863271985712,"score_gpt":0.22351082269366096,"score_spread":0.21706218997380383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294301027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97601175,0.019944975,0.000049012902,0.002389546,0.00039504757,0.00040128958,0.000077408346,0.000061360464,0.00066963007],"genre_scores_gemma":[0.99708736,0.0012488,0.00047911817,0.00013253537,0.00010084826,0.000038887505,0.000026638747,0.000026671993,0.00085911225],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998659,0.000027574286,0.00032857826,0.0003075698,0.00040453498,0.00027275394],"domain_scores_gemma":[0.9992761,0.00009084834,0.00017780764,0.0003138803,0.00006476794,0.00007656511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023002326,0.00018500607,0.00033443858,0.0000699079,0.00044278408,0.000017329321,0.00016295418,0.000047429385,0.00012363959],"category_scores_gemma":[0.00004290929,0.00013098744,0.000112756075,0.00028877205,0.00021852444,0.00009336925,0.00012842288,0.00020870884,0.0000014574787],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030124865,0.0032005303,0.02974421,0.0013585007,0.0010885083,0.0003126845,0.0007798888,0.00016963089,0.81434566,0.0007037467,0.0008358649,0.1444483],"study_design_scores_gemma":[0.03611747,0.0040244046,0.39201242,0.0006580076,0.0037936238,0.0032873382,0.008506461,0.0015563742,0.27520803,0.0011635608,0.27228382,0.0013885013],"about_ca_topic_score_codex":0.00004980367,"about_ca_topic_score_gemma":0.000016470021,"teacher_disagreement_score":0.5391376,"about_ca_system_score_codex":0.0000139269,"about_ca_system_score_gemma":0.000053647138,"threshold_uncertainty_score":0.53415126},"labels":[],"label_agreement":null},{"id":"W4294975927","doi":"10.1182/bloodadvances.2022008258","title":"The outcome of older adults with classic Hodgkin lymphoma in British Columbia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Bleomycin; Internal medicine; Hodgkin lymphoma; Population; Lymphoma; Chemotherapy; Pediatrics","score_opus":0.005573712684059084,"score_gpt":0.22951469428269247,"score_spread":0.22394098159863338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294975927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888709,0.009339441,5.0180284e-7,0.00030067106,0.00009351193,0.0004648153,0.000032208598,0.00002073562,0.0008772222],"genre_scores_gemma":[0.99777794,0.00051310903,0.00019431548,0.0001733272,0.000025387308,0.000388812,0.0000129460705,0.000013995676,0.0009001788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989733,0.000042048996,0.00025492185,0.00021651045,0.0003127709,0.00020042667],"domain_scores_gemma":[0.9994663,0.00012557307,0.00011367404,0.00021270275,0.00003342078,0.000048333746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000981737,0.000076429606,0.00025362743,0.000022137838,0.00016988277,0.000032975502,0.00009885885,0.00001719511,0.000107093794],"category_scores_gemma":[0.000024468098,0.00007073898,0.000058150796,0.00022579244,0.00008259465,0.00005717248,0.000054111275,0.000049716244,0.0000018210836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008876634,0.0012949272,0.8913852,0.00004245016,0.00005780929,0.0003396102,0.0001234733,0.0000070251936,0.0000044308113,0.00001855069,0.00027177526,0.10636599],"study_design_scores_gemma":[0.010253108,0.00074759434,0.9728468,0.00017393372,0.000093513416,0.00026720474,0.0012981821,0.000007306527,0.00016288631,0.00003664506,0.01402505,0.00008776116],"about_ca_topic_score_codex":0.005440265,"about_ca_topic_score_gemma":0.060037795,"teacher_disagreement_score":0.10627823,"about_ca_system_score_codex":0.00007503624,"about_ca_system_score_gemma":0.0000743664,"threshold_uncertainty_score":0.95711404},"labels":[],"label_agreement":null},{"id":"W4294975968","doi":"10.1182/bloodadvances.2022007126","title":"Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation","year":2022,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research","keywords":"Acute promyelocytic leukemia; Presentation (obstetrics); Medicine; Leukemia; Leukocytosis; Internal medicine; Oncology; Intensive care medicine; Biology; Genetics; Surgery; Retinoic acid; Cell culture","score_opus":0.006616031283391415,"score_gpt":0.2154154284493869,"score_spread":0.2087993971659955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294975968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948421,0.0030678406,0.000018845438,0.0011759282,0.00009769985,0.0003592237,0.00028415216,0.000010311699,0.00014387151],"genre_scores_gemma":[0.9107375,0.022956645,0.0036569426,0.033919085,0.0013575276,0.00063740305,0.014666556,0.00032201328,0.011746302],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99866384,0.00005307711,0.00027094767,0.00050614716,0.0002906786,0.000215317],"domain_scores_gemma":[0.99920887,0.000034438126,0.00035521714,0.0002711935,0.00009155747,0.000038725386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043642955,0.00029674298,0.00037706475,0.000050116476,0.00011678996,0.000023934654,0.00016565029,0.00022760518,0.000024328758],"category_scores_gemma":[0.000037518515,0.00023825953,0.000040827457,0.00005589984,0.00019624541,0.000012725326,0.00023843697,0.00024895024,3.8421157e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061172404,0.00013202122,0.95735997,0.0023000827,0.0013548334,0.00013574178,0.00017416774,0.0000060144534,0.02047279,0.000005070826,0.012444455,0.0050031017],"study_design_scores_gemma":[0.0041065323,0.0026996913,0.120334424,0.00011911065,0.0018850317,0.00010797834,0.000059993727,0.00000821941,0.08898697,0.00006180854,0.78033805,0.0012921846],"about_ca_topic_score_codex":0.000004733964,"about_ca_topic_score_gemma":0.0000029276414,"teacher_disagreement_score":0.8370256,"about_ca_system_score_codex":0.000034537235,"about_ca_system_score_gemma":0.0001132279,"threshold_uncertainty_score":0.97159415},"labels":[],"label_agreement":null},{"id":"W4295084519","doi":"10.1182/bloodadvances.2022007947","title":"Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Universiteit Leiden; Leids Universitair Medisch Centrum; Histiocytosis Association","keywords":"Langerhans cell histiocytosis; Histiocytosis; Cohort; Medicine; Cohort study; Internal medicine; Disease","score_opus":0.011352292351694214,"score_gpt":0.29516355255463905,"score_spread":0.28381126020294484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295084519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98616785,0.0007159183,0.0000028071684,0.00012204291,0.00030002563,0.0006452844,0.0001328016,0.00004381027,0.011869466],"genre_scores_gemma":[0.9976421,0.00010917267,0.00024039083,0.00016557421,0.000070021386,0.00030689346,0.00030472074,0.000015885624,0.0011452504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989628,0.00006355115,0.0002529108,0.00028299,0.0002936063,0.00014414475],"domain_scores_gemma":[0.9995919,0.00003310298,0.0001044017,0.00018629206,0.00002730993,0.000057033896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001860243,0.000099238794,0.00021403148,0.00011730355,0.00014352598,0.000011663243,0.00012465226,0.000018283057,0.0003387883],"category_scores_gemma":[0.000038084745,0.00010050496,0.000050263534,0.00014677044,0.0000140795355,0.00011681564,0.000047105073,0.00014049806,0.000020026207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002831943,0.010101013,0.98654336,0.0000027177578,0.00013071232,0.00007189246,0.00087336986,0.00012862815,0.000024712483,0.000022552713,0.000039925806,0.0020328222],"study_design_scores_gemma":[0.0051504797,0.0008413932,0.9838642,0.0000051340057,0.00026148173,0.000010142464,0.0019790384,0.000033234362,0.00003142002,0.000078344565,0.007639608,0.00010556533],"about_ca_topic_score_codex":0.00014535051,"about_ca_topic_score_gemma":0.00029609806,"teacher_disagreement_score":0.011474247,"about_ca_system_score_codex":0.00019780238,"about_ca_system_score_gemma":0.00010229117,"threshold_uncertainty_score":0.40984735},"labels":[],"label_agreement":null},{"id":"W4296324905","doi":"10.1182/bloodadvances.2022007884","title":"A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Transcriptome; Basal (medicine); Cell biology; Chemistry; Internal medicine; Andrology; Biology; Molecular biology; Medicine; Gene expression; Biochemistry; Gene","score_opus":0.0058319011350810995,"score_gpt":0.2172807895008173,"score_spread":0.21144888836573622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296324905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957064,0.0017776015,0.000016657692,0.000026328331,0.000059076043,0.00022691465,0.002082541,0.000021032856,0.000083459905],"genre_scores_gemma":[0.99791664,0.00013507628,0.00083917216,0.00011174544,0.000010329477,0.000012556452,0.0009228159,0.000015227893,0.000036461643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911356,0.000035637117,0.00017848129,0.00027534034,0.00026156148,0.00013544389],"domain_scores_gemma":[0.99955344,0.000059468162,0.00009667828,0.00015971728,0.00004904614,0.00008164854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000016696758,0.0001336668,0.00044964088,0.00011730102,0.00007215728,0.0000057353873,0.000052471663,0.00002440647,0.00042609996],"category_scores_gemma":[0.000009454455,0.00010636565,0.00006465483,0.00039151945,0.00004574637,0.000071199895,0.00001982451,0.0000821025,0.0000016447619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005289698,0.0031286774,0.87584764,0.00002156995,0.008129632,0.00038315417,0.0011308263,0.001267034,0.10164642,0.000004505849,0.00001589741,0.0031349463],"study_design_scores_gemma":[0.038682867,0.0040061483,0.87219673,0.00007166366,0.021650158,0.0000025818217,0.00075331394,0.0012496125,0.058292136,0.00026536814,0.0023274105,0.0005020268],"about_ca_topic_score_codex":0.00053844845,"about_ca_topic_score_gemma":0.00013735546,"teacher_disagreement_score":0.043354288,"about_ca_system_score_codex":0.00001039352,"about_ca_system_score_gemma":0.000038621034,"threshold_uncertainty_score":0.46654955},"labels":[],"label_agreement":null},{"id":"W4297037094","doi":"10.1182/bloodadvances.2021005681","title":"Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Children's Hospital of Eastern Ontario; University of Toronto; SickKids Foundation; University of Ottawa; Hospital for Sick Children; Public Health Ontario","funders":"","keywords":"Medicine; Dabigatran; Thrombophilia; Internal medicine; Factor V Leiden; Direct thrombin inhibitor; Population; Antiphospholipid syndrome; Clinical endpoint; Warfarin; Randomized controlled trial; Venous thrombosis; Thrombosis; Atrial fibrillation","score_opus":0.010128421994820544,"score_gpt":0.24381929464608385,"score_spread":0.23369087265126331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297037094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418634,0.0040688775,0.0000015264482,0.00022710334,0.00003445887,0.0008189888,0.000023127708,0.000015182823,0.0006244218],"genre_scores_gemma":[0.9988538,0.00042178124,0.00034518717,0.00017223941,0.000028692699,0.0001275837,0.000021815065,0.000013826435,0.000015063204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990712,0.00009180655,0.00021005174,0.000240698,0.00022272897,0.00016353077],"domain_scores_gemma":[0.9996173,0.0000328796,0.000078203855,0.00022532365,0.000013247538,0.000033044827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015002112,0.00013546317,0.0003855429,0.000113652124,0.00008406126,0.00000679607,0.00009338225,0.000027143073,0.00006890388],"category_scores_gemma":[0.0000044150725,0.000085521075,0.000034837743,0.0003302225,0.0000853244,0.00007849456,0.000023072358,0.00018578347,4.983478e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033032813,0.012916346,0.85540843,0.00018345901,0.00051157095,0.00010512361,0.016886456,0.00025735924,0.022124227,0.005722276,0.00000632087,0.08554811],"study_design_scores_gemma":[0.0053166533,0.008166913,0.97255456,0.00004525689,0.00016643853,0.0003113772,0.0019072298,0.000008360926,0.009214878,0.001750586,0.00041983635,0.00013793373],"about_ca_topic_score_codex":0.00011007485,"about_ca_topic_score_gemma":0.00017976227,"teacher_disagreement_score":0.11714612,"about_ca_system_score_codex":0.000023193326,"about_ca_system_score_gemma":0.00007718114,"threshold_uncertainty_score":0.34874484},"labels":[],"label_agreement":null},{"id":"W4297874867","doi":"10.1182/bloodadvances.2022008376","title":"Patient perspectives on testing for clonal hematopoiesis of indeterminate potential","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Vignette; Medicine; Population; Psychology; Social psychology; Environmental health","score_opus":0.016499166848581062,"score_gpt":0.2945452642462252,"score_spread":0.27804609739764413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297874867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600124,0.0013687655,0.000069748006,0.00036638853,0.000081173224,0.0005450371,0.00008377937,0.000034186825,0.0014496758],"genre_scores_gemma":[0.9905257,0.000019762141,0.00881021,0.000090268266,0.000099728044,0.00019885504,0.000011545661,0.00002043048,0.00022345758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988113,0.00004125417,0.00020732991,0.0002613791,0.00044733257,0.00023142343],"domain_scores_gemma":[0.99922717,0.0002584768,0.00012293599,0.00017076808,0.00016068766,0.00005999481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015702595,0.00010251092,0.00022999229,0.00013300721,0.00018495774,0.0000055623186,0.00010147837,0.000021279198,0.00008980081],"category_scores_gemma":[0.00041880654,0.00009092918,0.00009257898,0.00021589846,0.00008494465,0.000060478862,0.00012050883,0.00019914584,0.0000015509532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011966703,0.010839609,0.054025188,0.0031949328,0.0014344882,0.0015695394,0.02166703,0.00536759,0.49127224,0.008003764,0.0028081012,0.38785082],"study_design_scores_gemma":[0.02981906,0.059166048,0.03293406,0.00077168725,0.0011293861,0.0025174874,0.1315877,0.0068116398,0.69022214,0.0060297237,0.037454,0.0015570609],"about_ca_topic_score_codex":0.000009282244,"about_ca_topic_score_gemma":6.02853e-7,"teacher_disagreement_score":0.38629377,"about_ca_system_score_codex":0.000097855715,"about_ca_system_score_gemma":0.00015657282,"threshold_uncertainty_score":0.3707984},"labels":[],"label_agreement":null},{"id":"W4304205580","doi":"10.1182/bloodadvances.2022007715","title":"A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; University of Calgary; Hospital for Sick Children; University of British Columbia; University of Toronto; Montreal Children's Hospital; University of Manitoba; SickKids Foundation; BC Children's Hospital; CancerCare Manitoba","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Pediatric Blood and Marrow Transplant Consortium","keywords":"Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; CXCL10; Internal medicine; Disease; CXCL9; Oncology; Immunology; Gastroenterology; Chemokine; Inflammation","score_opus":0.020320077062521206,"score_gpt":0.2876957997354383,"score_spread":0.2673757226729171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304205580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98229206,0.010527014,0.00008131099,0.0008226705,0.0011859407,0.003604889,0.0005871932,0.00006464674,0.0008343052],"genre_scores_gemma":[0.99741256,0.0005399396,0.00013844269,0.00004229152,0.00029091063,0.0007741121,0.000053123702,0.000027869912,0.0007207317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982761,0.00011113781,0.00043163044,0.00035440948,0.0005677784,0.00025892933],"domain_scores_gemma":[0.99761873,0.0014902083,0.00027274172,0.000442652,0.00007293949,0.00010274517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029325427,0.00015715856,0.00027431446,0.00008194848,0.00023444834,0.000007867906,0.00021328517,0.000023406314,0.00007592739],"category_scores_gemma":[0.00072147086,0.000117120326,0.00013928323,0.00045464546,0.00005247593,0.00007502276,0.00006202687,0.00015756456,0.00000439679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012576409,0.010242719,0.9529488,0.0063973595,0.0007977065,0.00036165043,0.0047424906,0.0024255107,0.0025460753,0.00091465394,0.003324371,0.0027222687],"study_design_scores_gemma":[0.07553131,0.009417887,0.8539256,0.00040708602,0.009558312,0.000056529723,0.006760712,0.0003390679,0.004590175,0.0003902049,0.038257554,0.00076554617],"about_ca_topic_score_codex":0.000012478983,"about_ca_topic_score_gemma":0.00005133633,"teacher_disagreement_score":0.09902317,"about_ca_system_score_codex":0.00006409856,"about_ca_system_score_gemma":0.00030397414,"threshold_uncertainty_score":0.47760284},"labels":[],"label_agreement":null},{"id":"W4306249959","doi":"10.1182/bloodadvances.2022007360","title":"Transformation of FL into DLBCL with a PMBL gene expression signature","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"BCL6; Biology; Germinal center; Cancer research; Lymphoma; Follicular lymphoma; Diffuse large B-cell lymphoma; Genetics; B cell; Immunology","score_opus":0.005289266285482754,"score_gpt":0.23605219897205865,"score_spread":0.23076293268657588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306249959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98756117,0.009457608,0.00010899575,0.00046670044,0.000054295644,0.00034931532,0.000021795402,0.00003227389,0.0019478541],"genre_scores_gemma":[0.9950224,0.00027742644,0.0042559016,0.00011698657,0.000029691188,0.0001494698,0.00006404805,0.000008084288,0.00007596729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993681,0.000019632342,0.00013036806,0.00012513099,0.00026741644,0.00008935215],"domain_scores_gemma":[0.99971485,0.000022978464,0.000069562004,0.000120575634,0.000030154933,0.000041872947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041365878,0.00008302031,0.00016176468,0.00004684921,0.000092895745,0.0000031509242,0.00004252287,0.000018996121,0.000088202214],"category_scores_gemma":[0.0000042908796,0.00005441807,0.00004300518,0.00012441083,0.00002058991,0.00011170546,0.000014834263,0.000055911536,0.0000014097931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034923465,0.014656836,0.19732212,0.0012148273,0.0007206096,0.0005104282,0.01604118,0.0021948963,0.57801855,0.001727843,0.0008941754,0.18320622],"study_design_scores_gemma":[0.0073639336,0.0018581799,0.01208583,0.00012823973,0.00024048217,0.00009639532,0.00095777854,0.000020733074,0.95467335,0.00015331295,0.022315335,0.000106425134],"about_ca_topic_score_codex":0.000016021928,"about_ca_topic_score_gemma":0.000006513478,"teacher_disagreement_score":0.37665483,"about_ca_system_score_codex":0.000030119467,"about_ca_system_score_gemma":0.00004362735,"threshold_uncertainty_score":0.22191045},"labels":[],"label_agreement":null},{"id":"W4306632241","doi":"10.1182/bloodadvances.2022007824","title":"Novel insights into mouse models of ectopic proplatelet release","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Ectopic expression; Cell biology; Chemistry; Biology; Computer science; Neuroscience; Genetics; Cell culture","score_opus":0.0148525626853178,"score_gpt":0.2382043368978308,"score_spread":0.223351774212513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306632241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839647,0.0047419746,0.00039547443,0.00016104293,0.00011796681,0.00022179699,0.0000079675,0.000061038736,0.0058962908],"genre_scores_gemma":[0.9933554,0.00016111544,0.003393795,0.00041895077,0.00005426722,0.00006480407,0.000021351012,0.000012278166,0.0025180255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992426,0.000019612758,0.00019654549,0.00017628999,0.00024722077,0.000117733995],"domain_scores_gemma":[0.99953854,0.000047513146,0.000083862105,0.00020558291,0.000049344002,0.00007512925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004908373,0.00009062708,0.00023727212,0.00008850119,0.00008832115,0.000003262414,0.00006342168,0.00002044201,0.00017496002],"category_scores_gemma":[0.000067762514,0.00007410691,0.0000542345,0.00018390332,0.000043899458,0.0001186411,0.00004921871,0.00010992123,0.000004666487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007336246,0.003846631,0.010464902,0.00087952893,0.00035525192,0.0000962379,0.002493405,0.010389902,0.94612634,0.011782264,0.0010072733,0.011824642],"study_design_scores_gemma":[0.012514865,0.0027910634,0.0011561869,0.00013363088,0.00050444144,0.00013821972,0.0017412739,0.008987084,0.8281475,0.010250603,0.13312736,0.0005077915],"about_ca_topic_score_codex":0.00003483911,"about_ca_topic_score_gemma":0.000003459621,"teacher_disagreement_score":0.1321201,"about_ca_system_score_codex":0.000018930075,"about_ca_system_score_gemma":0.00007566556,"threshold_uncertainty_score":0.3021992},"labels":[],"label_agreement":null},{"id":"W4306843199","doi":"10.1182/bloodadvances.2022008747","title":"An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; National Institutes of Health; Astellas Pharma; Incyte; Astex Pharmaceuticals; Gilead Sciences; Jazz Pharmaceuticals; Leukemia and Lymphoma Society; Acceleron; Celgene; Bristol-Myers Squibb; AstraZeneca; National Institute of Diabetes and Digestive and Kidney Diseases; Cardinal Health; Amgen; National Heart, Lung, and Blood Institute; Pfizer; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Myelodysplastic syndromes; MEDLINE; Medicine; Computer science; Political science; Internal medicine","score_opus":0.04899527071681768,"score_gpt":0.39027327191269434,"score_spread":0.34127800119587665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306843199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787601,0.0027405948,0.00005847596,0.014995984,0.00036042734,0.0009792891,0.00012195819,0.00004961844,0.0019335077],"genre_scores_gemma":[0.9942143,0.00037739577,0.0017236246,0.0008243024,0.00036019777,0.000610852,0.00009720932,0.000036897418,0.0017552103],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964941,0.00035348054,0.0004114554,0.0007204118,0.0013529344,0.00066760584],"domain_scores_gemma":[0.99717915,0.0017350471,0.00005997419,0.00070037774,0.00014708473,0.00017836745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014688689,0.00019053943,0.00032881807,0.00047695168,0.00030920946,0.00007223542,0.0011020282,0.0000617614,0.0014736408],"category_scores_gemma":[0.0014211216,0.0001577369,0.00005174975,0.0018935374,0.00017407454,0.00035156656,0.00071387325,0.0014857992,0.00006638023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060611614,0.0041399985,0.86090404,0.00022951687,0.00023063895,0.0072942358,0.013061084,0.01014531,0.004842444,0.0008043861,0.01198118,0.08030599],"study_design_scores_gemma":[0.005818732,0.0011826569,0.23108521,0.0005404733,0.000029239389,0.00016845172,0.012775322,0.0022744143,0.0005849439,0.0009223267,0.744192,0.0004262386],"about_ca_topic_score_codex":0.0009020711,"about_ca_topic_score_gemma":0.00463925,"teacher_disagreement_score":0.7322108,"about_ca_system_score_codex":0.0008149455,"about_ca_system_score_gemma":0.00041400525,"threshold_uncertainty_score":0.9994391},"labels":[],"label_agreement":null},{"id":"W4306913672","doi":"10.1182/bloodadvances.2022007698","title":"The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; American Society of Hematology","keywords":"Medicine; Psychological intervention; Newborn screening; Population; Pediatrics; Clinical trial; Cohort; Disease; Malaria; Intervention (counseling); Family medicine; Environmental health; Internal medicine; Immunology","score_opus":0.049347283640816884,"score_gpt":0.31050408353649117,"score_spread":0.2611567998956743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306913672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91924703,0.06357148,0.0013846972,0.008219054,0.0004033038,0.003732086,0.00007521499,0.00006503604,0.0033021246],"genre_scores_gemma":[0.9891732,0.00069979404,0.006082346,0.0004707427,0.00007289405,0.0006634082,0.000022171169,0.00002027237,0.0027951687],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991841,0.00015945146,0.00015518485,0.00019183561,0.00013752891,0.00017193225],"domain_scores_gemma":[0.9989887,0.0007657725,0.00005359178,0.00011477276,0.000020038713,0.00005712975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042525266,0.00007529619,0.00014224662,0.00004434847,0.0003431452,0.000008332364,0.000055200857,0.00001516541,0.000019453064],"category_scores_gemma":[0.00020178303,0.000051697323,0.00003181798,0.00012270708,0.000056927194,0.000029399407,0.00004380702,0.00014558983,6.1308015e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016817972,0.013597675,0.56504697,0.0005632666,0.0007458435,0.000602669,0.016335927,0.024418108,0.0045976783,0.009713546,0.0065566846,0.34100366],"study_design_scores_gemma":[0.010831155,0.0028137325,0.03713661,0.000028444218,0.00032510914,0.000014943192,0.039468877,0.00074401166,0.00033645408,0.002416458,0.90566945,0.00021476002],"about_ca_topic_score_codex":0.000006399432,"about_ca_topic_score_gemma":0.00001824499,"teacher_disagreement_score":0.89911276,"about_ca_system_score_codex":0.0000066211237,"about_ca_system_score_gemma":0.000050546332,"threshold_uncertainty_score":0.26392302},"labels":[],"label_agreement":null},{"id":"W4307038539","doi":"10.1182/bloodadvances.2022008873","title":"Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B–deficient mice","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Etablissement Français du Sang; Medical Research Council; University of Birmingham; York University; British Heart Foundation; Université de Strasbourg; Institut National de la Santé et de la Recherche Médicale","keywords":"GPVI; Syk; Platelet; Platelet membrane glycoprotein; Collagen receptor; Bruton's tyrosine kinase; Thrombopoietin; Endocrinology; Immunology; Internal medicine; Biology; Receptor; Medicine; Tyrosine kinase; Integrin; Cell biology","score_opus":0.013668239263382733,"score_gpt":0.2698766615671077,"score_spread":0.256208422303725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307038539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882422,0.008758049,8.5921505e-7,0.000109988476,0.000041871353,0.0004828493,0.00007438485,0.000013289109,0.002276517],"genre_scores_gemma":[0.99862075,0.0007679473,0.0002646131,0.00002868374,0.000007098615,0.00008874257,0.000037291098,0.000009137118,0.00017576218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992697,0.000038175396,0.00015530757,0.0002230039,0.0001616134,0.00015214912],"domain_scores_gemma":[0.99965936,0.0000680664,0.00007147379,0.00012397343,0.00001647071,0.000060647726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041237625,0.000117338706,0.0003766327,0.000070815266,0.00007334156,0.0000045139504,0.000033051532,0.000018443114,0.000058007856],"category_scores_gemma":[0.000014956543,0.00009730191,0.000043771393,0.00016123093,0.000049547467,0.000064518,0.000030827356,0.00002935062,0.0000015203769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001888671,0.016615942,0.86647505,0.00010512707,0.0005980695,0.0026633053,0.002094927,0.00006556954,0.071245655,0.00021779777,0.00002453781,0.038005322],"study_design_scores_gemma":[0.058784094,0.014810929,0.75435436,0.00007418091,0.0016555503,0.0018640024,0.0061333864,0.00024688107,0.12748414,0.0007450991,0.03316015,0.0006872001],"about_ca_topic_score_codex":0.00034163267,"about_ca_topic_score_gemma":0.00026312174,"teacher_disagreement_score":0.11212069,"about_ca_system_score_codex":0.0000663137,"about_ca_system_score_gemma":0.000070784605,"threshold_uncertainty_score":0.39678568},"labels":[],"label_agreement":null},{"id":"W4307479764","doi":"10.1182/bloodadvances.2022007823","title":"The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of California, San Francisco; California Institute for Regenerative Medicine","keywords":"Medicine; Pediatrics; Gestational age; Hydrops fetalis; In utero; Pregnancy; Obstetrics; Gestation; Fetus","score_opus":0.003650283768503617,"score_gpt":0.24826264589718056,"score_spread":0.24461236212867693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307479764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959978,0.0012579678,5.7595406e-7,0.0010127135,0.00007201656,0.00040995213,0.000040380477,0.000010223361,0.0011983712],"genre_scores_gemma":[0.9993282,0.00032636957,0.0000127675285,0.00006674353,0.00000635856,0.000034203073,0.000008256872,0.000011861826,0.0002052298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990938,0.00006132499,0.00020510185,0.00015339786,0.0002821276,0.00020427455],"domain_scores_gemma":[0.99947023,0.00013177579,0.00007509956,0.00027166473,0.000017519536,0.00003370693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012235389,0.00011890112,0.0002037443,0.000055253524,0.00016673005,0.000006298281,0.00015757701,0.000031141688,0.000049036305],"category_scores_gemma":[0.0000430203,0.000051444636,0.00008708635,0.0002604966,0.00010266968,0.00004918366,0.00003464261,0.00037596328,7.024759e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056570175,0.0007618512,0.99265975,0.000017766622,0.00007374967,0.000048941947,0.0007585683,0.0008025889,0.00004012054,0.000047593952,0.000057664758,0.0041656955],"study_design_scores_gemma":[0.004773667,0.001567338,0.9892971,0.00007772207,0.000035619538,0.000017911532,0.0026110227,0.000022671667,0.00009835619,0.000053259304,0.001361576,0.000083777246],"about_ca_topic_score_codex":0.00025355932,"about_ca_topic_score_gemma":0.00016587436,"teacher_disagreement_score":0.0042079655,"about_ca_system_score_codex":0.000044284974,"about_ca_system_score_gemma":0.0000704498,"threshold_uncertainty_score":0.20978513},"labels":[],"label_agreement":null},{"id":"W4308056077","doi":"10.1182/bloodadvances.2022007611","title":"Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; Pharmacyclics; Genentech; Syndax Pharmaceuticals; National Institutes of Health; Incyte; Therakos; Florida Department of Health; Gilead Sciences; Amgen; National Heart, Lung, and Blood Institute; Pfizer; National Institute of Allergy and Infectious Diseases; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Disease; Medicine; Intensive care medicine; Hematopoietic stem cell transplantation; Consensus conference; Graft-versus-host disease; Perspective (graphical); Stem cell; Immunology; Bioinformatics; Pathology; Biology; Internal medicine; Computer science","score_opus":0.019626650675470113,"score_gpt":0.3082489974875755,"score_spread":0.2886223468121054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308056077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92550284,0.06478775,0.0004655126,0.0006337291,0.00062139274,0.0030530742,0.0003807473,0.00015560904,0.004399367],"genre_scores_gemma":[0.9939491,0.0010360746,0.0026789738,0.00006906767,0.00020562738,0.0005072795,0.00016015198,0.0000362172,0.0013574642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833,0.00013418254,0.00041090598,0.0004371414,0.00027855934,0.0004092395],"domain_scores_gemma":[0.99913955,0.00023406681,0.00016702291,0.0002917334,0.00007147116,0.000096179116],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015498404,0.00023055279,0.00054487714,0.0001689618,0.00016346264,0.0000058686683,0.00010304327,0.000052992593,0.0010305224],"category_scores_gemma":[0.000040876785,0.00019574423,0.00014471902,0.00032191785,0.000109746565,0.000034240715,0.0000290004,0.00009838399,0.0000131322895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013845721,0.0031348676,0.05367655,0.0049956013,0.0015897595,0.000943028,0.015556444,0.00064665475,0.772904,0.0024159213,0.0004802581,0.14227238],"study_design_scores_gemma":[0.06829346,0.07140027,0.015871478,0.0009174507,0.0043839007,0.003405852,0.012317387,0.0018209401,0.4893337,0.0006024185,0.32957405,0.0020791127],"about_ca_topic_score_codex":0.000097823126,"about_ca_topic_score_gemma":0.000040633244,"teacher_disagreement_score":0.32909378,"about_ca_system_score_codex":0.0004774127,"about_ca_system_score_gemma":0.0007031686,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W4308057391","doi":"10.1182/bloodadvances.2022008216","title":"Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Gilead Sciences; Servier; National Cancer Institute; Regeneron Pharmaceuticals; National Institutes of Health; Sunesis; MacroGenics; Astellas Pharma; Juno Therapeutics; Sierra Oncology; Pfizer; Incyte; CTI Biopharma; Agios Pharmaceuticals; Pharmacyclics; Jazz Pharmaceuticals; PTC Therapeutics; Celgene; Alexion Pharmaceuticals; TG Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Dasatinib; Medicine; Blinatumomab; Prednisone; Minimal residual disease; Internal medicine; Maintenance therapy; Oncology; Chemotherapy; Leukemia; Lymphoblastic Leukemia; Imatinib","score_opus":0.010385931912464253,"score_gpt":0.2800741377065346,"score_spread":0.2696882057940704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308057391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900141,0.0029549238,0.00027893594,0.00092577457,0.00067859713,0.0010363929,0.00015991458,0.00023697328,0.003714397],"genre_scores_gemma":[0.9917941,0.0004129152,0.001831602,0.00056071836,0.0002758831,0.00060199684,0.0003020723,0.000101470345,0.004119262],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957386,0.00023211377,0.0007527603,0.0009090898,0.0014497193,0.0009177146],"domain_scores_gemma":[0.9982744,0.00041426776,0.00027247946,0.0006194861,0.00011585598,0.00030353857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005435595,0.00041832693,0.00070890924,0.00049657753,0.00037581375,0.000045449953,0.0004650216,0.00015256491,0.0006197689],"category_scores_gemma":[0.00039644245,0.0004102536,0.00016135475,0.0015521445,0.00021748508,0.00043711977,0.0004140823,0.00084752124,0.00006878102],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010201571,0.0069692135,0.11283299,0.0010327752,0.0019469117,0.0070158113,0.004385664,0.0031429792,0.6993829,0.000998554,0.07356194,0.07852868],"study_design_scores_gemma":[0.21933839,0.020538988,0.05077587,0.0013762835,0.003995632,0.012465505,0.018219301,0.030182162,0.283731,0.00392522,0.3495399,0.0059117093],"about_ca_topic_score_codex":0.00020441467,"about_ca_topic_score_gemma":0.000032189415,"teacher_disagreement_score":0.4156519,"about_ca_system_score_codex":0.0021990333,"about_ca_system_score_gemma":0.001538131,"threshold_uncertainty_score":0.99983495},"labels":[],"label_agreement":null},{"id":"W4308061192","doi":"10.1182/bloodadvances.2022008123","title":"miR-148a-3p and DDX6 functional link promotes survival of myeloid leukemia cells","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"Seoul National University; Croucher Foundation","keywords":"Biology; RNA Helicase A; Myeloid leukemia; Leukemia; microRNA; Carcinogenesis; TXNIP; Cancer research; Gene; RNA; Genetics; Thioredoxin; Helicase","score_opus":0.010097010604472666,"score_gpt":0.24111239712760107,"score_spread":0.23101538652312842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308061192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936246,0.005256389,0.00010401227,0.00012817707,0.00012656835,0.00011285206,0.00004459038,0.000006798567,0.0005959943],"genre_scores_gemma":[0.99555653,0.0005367024,0.00057486707,0.000048606107,0.0001934265,0.00003070631,0.00006677981,0.000012408145,0.0029799982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918306,0.000056529316,0.00013097472,0.0002391173,0.0002066502,0.00018364079],"domain_scores_gemma":[0.9996682,0.000024661134,0.000058214187,0.0001429894,0.00004498577,0.000060958613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017875529,0.00008705328,0.0001126763,0.000030515865,0.00013934137,0.000009951621,0.00011410618,0.00003263657,0.00005618818],"category_scores_gemma":[0.000039550876,0.000081915015,0.000044107022,0.000072556955,0.00007790951,0.0000054889824,0.00018162848,0.00010223833,0.0000012276521],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008568968,0.00004469195,0.0034452446,0.0000350993,0.000037789865,0.000003707897,0.000014288816,0.00019487321,0.99189913,0.00006823486,0.00019161473,0.0039796536],"study_design_scores_gemma":[0.00079100026,0.000689959,0.0031803271,0.000006914579,0.00001557001,0.000019223424,0.0001813841,0.00007227191,0.9277045,0.00015080866,0.067043826,0.00014422364],"about_ca_topic_score_codex":0.000018732026,"about_ca_topic_score_gemma":0.000021045389,"teacher_disagreement_score":0.06685221,"about_ca_system_score_codex":0.0000078681915,"about_ca_system_score_gemma":0.00010036766,"threshold_uncertainty_score":0.33403975},"labels":[],"label_agreement":null},{"id":"W4308684495","doi":"10.1182/bloodadvances.2022008966","title":"Applying CRISPR-Cas9 screens to dissect hematological malignancies","year":2022,"lang":"en","type":"review","venue":"Blood Advances","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"CRISPR; Context (archaeology); Computational biology; Genome editing; Cas9; Biology; Disease; Epigenomics; Precision medicine; Computer science; Genetics; Gene; Medicine; Pathology; DNA methylation","score_opus":0.030561699196151496,"score_gpt":0.3683949792914444,"score_spread":0.3378332800952929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308684495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006413345,0.99560267,0.002518898,0.000008855741,0.00027833486,0.0008753705,0.00008340007,0.00010015416,0.00046816192],"genre_scores_gemma":[0.00012635578,0.9948941,0.0024429432,0.00007542201,0.00033164173,0.0015231014,0.00018770766,0.00011510007,0.0003036136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982054,0.00006505696,0.00040623388,0.0006954832,0.0002014165,0.00042637388],"domain_scores_gemma":[0.9991748,0.000052200623,0.00011638786,0.0004918957,0.000020618387,0.00014411243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013772104,0.00044357244,0.00087289145,0.0000860327,0.00014528338,0.000033461045,0.0004642746,0.00018602215,0.000054288077],"category_scores_gemma":[0.00014684403,0.00037727848,0.00039426153,0.00022534147,0.000035445388,0.000003009297,0.00041260268,0.00021618628,0.000025310048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001088681,0.00011316582,0.000031079162,0.0060709855,0.00023897328,0.00008498233,0.000019576046,0.00017209622,0.00073303754,0.00012474008,0.0010264373,0.991374],"study_design_scores_gemma":[0.00009407597,0.0001883094,0.0000023001537,0.0006165936,0.00026645145,0.0002317506,0.00005712564,5.634905e-7,0.0015053886,0.000009479106,0.99653226,0.0004957135],"about_ca_topic_score_codex":0.0000024973808,"about_ca_topic_score_gemma":0.000010256205,"teacher_disagreement_score":0.9955058,"about_ca_system_score_codex":0.000011470124,"about_ca_system_score_gemma":0.000066077126,"threshold_uncertainty_score":0.9998679},"labels":[],"label_agreement":null},{"id":"W4309098190","doi":"10.1182/bloodadvances.2022008204","title":"CNL and aCML should be considered as a single entity based on molecular profiles and outcomes","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Astellas Pharma; Academy of Medical Sciences; Cancer Research UK; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Wellcome Trust; Celgene; Gilead Sciences; National Institute for Health and Care Research; Jazz Pharmaceuticals; European Hematology Association; Bristol-Myers Squibb","keywords":"Medicine","score_opus":0.041805317909068766,"score_gpt":0.3431559181950238,"score_spread":0.301350600285955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309098190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845986,0.001201529,0.000018823474,0.011000602,0.000047618272,0.0005321272,0.000029639377,0.00016361094,0.0024074968],"genre_scores_gemma":[0.9940061,0.0002842964,0.0020434344,0.0024877854,0.000037582144,0.000056481844,0.000033743207,0.0000304682,0.0010201174],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986928,0.000055696233,0.00016003926,0.00037314874,0.00040670796,0.00031157458],"domain_scores_gemma":[0.9990863,0.00036083517,0.000044686174,0.00027074004,0.000063654916,0.00017378449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019453355,0.00016811615,0.00031433656,0.00017967519,0.00009484646,0.000042213385,0.00006830142,0.00007738958,0.000052977324],"category_scores_gemma":[0.0010014382,0.00013203216,0.000046137597,0.0002508692,0.00021523457,0.00010502226,0.00009330536,0.00020247085,0.000024505483],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008941754,0.0011563954,0.6055536,0.0015764448,0.00056714885,0.004374525,0.0006333775,0.00007544317,0.349221,0.0023604434,0.004558726,0.029028716],"study_design_scores_gemma":[0.020511981,0.003905404,0.18246834,0.00067790336,0.00065062207,0.0002807712,0.0017704318,0.0026171273,0.7299381,0.004407091,0.05177342,0.0009988341],"about_ca_topic_score_codex":0.000036302314,"about_ca_topic_score_gemma":0.00001713039,"teacher_disagreement_score":0.4230853,"about_ca_system_score_codex":0.000027843194,"about_ca_system_score_gemma":0.00012941957,"threshold_uncertainty_score":0.5384115},"labels":[],"label_agreement":null},{"id":"W4310576934","doi":"10.1182/bloodadvances.2021004909","title":"Anti-FVIII antibodies in Black and White hemophilia A subjects: do <i>F8</i> haplotypes play a role?","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"National Heart, Lung, and Blood Institute; Uniformed Services University of the Health Sciences; National Institutes of Health; U.S. Department of Defense","keywords":"Haplotype; Epitope; Antibody; Population; Immunology; Titer; Biology; Molecular biology; Antigen; Genetics; Genotype; Medicine; Gene","score_opus":0.010487752593832075,"score_gpt":0.27496589634244023,"score_spread":0.2644781437486082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310576934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752772,0.0156055745,3.7975047e-7,0.0017707251,0.000074830576,0.0005017224,0.000035200006,0.00006945876,0.006664919],"genre_scores_gemma":[0.9933665,0.004116004,0.00032426798,0.00018615635,0.00010771714,0.00006454942,0.000027922073,0.000029502078,0.001777415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830633,0.00008573825,0.00025498786,0.00045313744,0.0004554156,0.00044440187],"domain_scores_gemma":[0.999416,0.00009760344,0.000058748672,0.00025169362,0.000039790266,0.00013619238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024314976,0.00021291604,0.0004469077,0.00026071485,0.00021660367,0.000034688477,0.00012457289,0.00004726094,0.00017390783],"category_scores_gemma":[0.000065678236,0.00017015249,0.00006837944,0.00045604922,0.0002159514,0.000176209,0.00019190783,0.00032935705,0.000020089374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023738675,0.00064212637,0.9864183,0.00016444927,0.000091095644,0.0006068334,0.0014971482,0.000036982965,0.007022012,0.00009838531,0.00010989455,0.0030753636],"study_design_scores_gemma":[0.014144663,0.0026748567,0.9060556,0.0004601015,0.00034607135,0.00072238833,0.00834354,0.00024063318,0.024937881,0.0030381065,0.03820497,0.000831174],"about_ca_topic_score_codex":0.00003139013,"about_ca_topic_score_gemma":0.000053273197,"teacher_disagreement_score":0.08036271,"about_ca_system_score_codex":0.000035112756,"about_ca_system_score_gemma":0.000088487075,"threshold_uncertainty_score":0.69386166},"labels":[],"label_agreement":null},{"id":"W4311676575","doi":"10.1182/bloodadvances.2022007729","title":"External validation of the PEGeD diagnostic algorithm for suspected pulmonary embolism in an independent cohort","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Research Foundation; University of Ottawa; Heart and Stroke Foundation of Canada","keywords":"Medicine; Algorithm; Pulmonary embolism; Confidence interval; D-dimer; Cohort; Pulmonary angiography; Pre- and post-test probability; Prospective cohort study; Internal medicine; Cohort study; Computed tomography angiography; Radiology; Angiography; Mathematics","score_opus":0.009769988611154055,"score_gpt":0.2669758896128571,"score_spread":0.25720590100170304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311676575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950911,0.001415439,0.00038669875,0.00027611037,0.00042467273,0.0017467956,0.0000454009,0.000028932564,0.0005848763],"genre_scores_gemma":[0.9967223,0.00030305216,0.0016712795,0.00019028073,0.00013681117,0.0008074703,0.000058080823,0.000020356745,0.00009037372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986931,0.000081368606,0.00030563667,0.00027661692,0.00043696558,0.00020628463],"domain_scores_gemma":[0.9992991,0.00015103522,0.00016126194,0.0002807907,0.000059048412,0.00004873388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030585544,0.00011771491,0.00032029874,0.00010460893,0.00014443476,0.000010669742,0.00020127115,0.000024796898,0.00013027554],"category_scores_gemma":[0.00008960632,0.000094791154,0.000078993384,0.00023358638,0.00003825634,0.00011559307,0.00013529259,0.00014185133,8.604766e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017682186,0.0115738055,0.80839974,0.00035218077,0.00028778886,0.0001646183,0.001532038,0.0029212455,0.013836651,0.005043679,0.0001986677,0.15551278],"study_design_scores_gemma":[0.001781089,0.00045374557,0.98096895,0.00007265812,0.0003395836,0.000029714876,0.0007669264,0.00040385858,0.011459045,0.0020532117,0.0015334378,0.00013778174],"about_ca_topic_score_codex":0.00006699623,"about_ca_topic_score_gemma":0.00003903916,"teacher_disagreement_score":0.17256923,"about_ca_system_score_codex":0.00005527376,"about_ca_system_score_gemma":0.000055734334,"threshold_uncertainty_score":0.3865471},"labels":[],"label_agreement":null},{"id":"W4312211759","doi":"10.1182/bloodadvances.2022008122","title":"Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Cumming School of Medicine, University of Calgary; British Heart Foundation; Wellcome Trust","keywords":"Hemostasis; Platelet; Thrombosis; Key (lock); Medicine; Dynamics (music); Internal medicine; Computer science; Psychology; Computer security","score_opus":0.019952446688249796,"score_gpt":0.2796316609723187,"score_spread":0.25967921428406887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312211759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907037,0.0016374621,0.00013074934,0.0022900365,0.00016833021,0.0008480204,0.00010731553,0.00013639235,0.003977982],"genre_scores_gemma":[0.99668187,0.0013001811,0.0008208295,0.0003761644,0.00014809084,0.0002550921,0.00019450288,0.000027696422,0.00019558448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876034,0.00003935589,0.00023886937,0.00036506602,0.00033319858,0.0002631401],"domain_scores_gemma":[0.9994935,0.00005573018,0.00011136463,0.00020651006,0.000027279943,0.00010564314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001757102,0.00016751015,0.0004566722,0.00009194121,0.0003432172,0.000025375555,0.00008656148,0.000027778711,0.00020238262],"category_scores_gemma":[0.000021910626,0.00015159087,0.000059561055,0.00019429368,0.000059144146,0.00012954645,0.0001805972,0.00016664062,0.00000633826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034069255,0.006850324,0.6496693,0.0034588655,0.0031859763,0.00034396624,0.0036960798,0.00043884796,0.0043563284,0.016508715,0.004269036,0.30688187],"study_design_scores_gemma":[0.008662204,0.004063866,0.5832856,0.00030517243,0.0032224837,0.00024032434,0.0065296665,0.00065340055,0.012299472,0.0022195154,0.37738055,0.0011376835],"about_ca_topic_score_codex":0.000081227925,"about_ca_topic_score_gemma":0.000064654785,"teacher_disagreement_score":0.37311152,"about_ca_system_score_codex":0.00006571121,"about_ca_system_score_gemma":0.000025755819,"threshold_uncertainty_score":0.6181696},"labels":[],"label_agreement":null},{"id":"W4317989607","doi":"10.1182/bloodadvances.2022009389","title":"Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"H. Lundbeck A/S; Incyte; Teva Pharmaceutical Industries; Genentech; Celgene; University of Southampton; Karyopharm Therapeutics; Kite Pharma; Gilead Sciences; Bristol-Myers Squibb; TG Therapeutics; Amgen","keywords":"Ibrutinib; Medicine; Oncology; Internal medicine; CHOP; Clinical trial; Bruton's tyrosine kinase; Phases of clinical research; Immunology; Lymphoma; Cancer research; Leukemia; Receptor","score_opus":0.07110328231378076,"score_gpt":0.48499045889072273,"score_spread":0.41388717657694196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317989607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960694,0.00197502,0.0000021131254,0.00017296555,0.00009398707,0.0008641564,0.000021498658,0.000036833637,0.00076404423],"genre_scores_gemma":[0.9981859,0.0012283999,0.000090448266,0.000045423178,0.00026157763,0.00003894972,0.000026149835,0.00001831881,0.000104880215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99784774,0.00027916257,0.00067278766,0.00034197606,0.00042390573,0.00043441352],"domain_scores_gemma":[0.99769694,0.0016520175,0.00013544492,0.00035749347,0.00004535005,0.00011273783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013727068,0.00016116275,0.00057775585,0.00022779011,0.000039638537,0.000023986493,0.00017901129,0.00011247205,0.000037296955],"category_scores_gemma":[0.0012575523,0.00009969972,0.00013067223,0.0008957513,0.00030052473,0.00014159335,0.00008376645,0.00033778077,0.000010005271],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36129317,0.016595392,0.21367924,0.0018284349,0.0011184908,0.010453586,0.018790815,0.0013352309,0.027053606,0.00014771687,0.0042805797,0.34342372],"study_design_scores_gemma":[0.95445085,0.0038152644,0.025962606,0.0007149652,0.00014433524,0.00017768514,0.0011843272,0.009035045,0.0022073863,0.00017105824,0.0019159568,0.00022053067],"about_ca_topic_score_codex":0.000711789,"about_ca_topic_score_gemma":0.000107204665,"teacher_disagreement_score":0.59315765,"about_ca_system_score_codex":0.0006124062,"about_ca_system_score_gemma":0.0026547874,"threshold_uncertainty_score":0.4709479},"labels":[],"label_agreement":null},{"id":"W4318762955","doi":"10.1182/bloodadvances.2022009411","title":"Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory <i>IDH1</i>-mutated AML","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Refractory (planetary science); Medicine; Internal medicine; IDH1; Oncology; Gastroenterology; Cancer research; Mutation; Biology; Genetics; Gene","score_opus":0.025514762728362655,"score_gpt":0.29738237339112256,"score_spread":0.2718676106627599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318762955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951952,0.00043123116,0.000003751919,0.0011515812,0.00010460997,0.0008928885,0.000070542206,0.00032403253,0.0018261654],"genre_scores_gemma":[0.992395,0.00072994834,0.0014109737,0.0003864503,0.00010872971,0.000114244096,0.000368957,0.00008865864,0.004397045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970257,0.00013829466,0.0004994891,0.00062245625,0.000912157,0.0008018548],"domain_scores_gemma":[0.99824566,0.0004441883,0.0001764793,0.0005574718,0.00023908782,0.00033709602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034370576,0.00030762787,0.00057115447,0.0004758352,0.00020381647,0.000035567602,0.00031975363,0.00015175642,0.00019445892],"category_scores_gemma":[0.00081619516,0.00020692474,0.000058757625,0.0020404388,0.0001917868,0.00047044698,0.0001493884,0.0007578497,0.00022297107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014095416,0.003343356,0.8024785,0.0011221329,0.00074398157,0.005076439,0.0022117854,0.00071052974,0.12472897,0.00007953636,0.025661858,0.019747527],"study_design_scores_gemma":[0.037580665,0.00449693,0.8340235,0.002127628,0.00028601597,0.000106055755,0.0017358384,0.00023837303,0.02453924,0.0002923863,0.093527146,0.001046222],"about_ca_topic_score_codex":0.00012716568,"about_ca_topic_score_gemma":0.00014097584,"teacher_disagreement_score":0.10018973,"about_ca_system_score_codex":0.00019870464,"about_ca_system_score_gemma":0.00057023217,"threshold_uncertainty_score":0.8438146},"labels":[],"label_agreement":null},{"id":"W4318911763","doi":"10.1182/bloodadvances.2022008545","title":"Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Bone marrow transplantation; Hematopoietic cell; Hematopoietic stem cell transplantation; Haematopoiesis; Transplantation; Abatacept; Bone marrow; Immunology; Internal medicine; Oncology; Stem cell; Intensive care medicine; Antibody; Biology","score_opus":0.01056074138490088,"score_gpt":0.25575009553960476,"score_spread":0.2451893541547039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318911763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915431,0.002578006,0.0015162688,0.00048784917,0.00027287804,0.0018796086,0.00011201379,0.0003589732,0.0012512741],"genre_scores_gemma":[0.99238855,0.0020774745,0.0038327822,0.000042581796,0.00011838559,0.00025230128,0.00053211965,0.00005929149,0.0006965352],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821115,0.00004557531,0.00052667677,0.0004440135,0.00034522387,0.0004273871],"domain_scores_gemma":[0.9991731,0.00028940378,0.00012643637,0.00021697477,0.00007438195,0.00011970701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026261364,0.00023695454,0.00039707142,0.00042067576,0.00007780428,0.000018981118,0.00009342887,0.00017940771,0.000103331025],"category_scores_gemma":[0.00004229966,0.00022116523,0.00011569351,0.001077434,0.000035708537,0.00021465322,0.0000070794713,0.00019857995,0.00013801124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029964729,0.0037495994,0.6500444,0.09258538,0.00029129616,0.0053169047,0.030194174,0.0028672016,0.18007837,0.0014538803,0.0022064694,0.028215853],"study_design_scores_gemma":[0.061688125,0.0051982906,0.36391076,0.0018998489,0.0042917803,0.0020218617,0.007824984,0.001046142,0.5347236,0.004229048,0.010081708,0.0030838882],"about_ca_topic_score_codex":0.000007717771,"about_ca_topic_score_gemma":0.000036005895,"teacher_disagreement_score":0.35464516,"about_ca_system_score_codex":0.000025764892,"about_ca_system_score_gemma":0.00007703873,"threshold_uncertainty_score":0.9018856},"labels":[],"label_agreement":null},{"id":"W4319069469","doi":"10.1182/bloodadvances.2022009381","title":"Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta; Université de Montréal; University of Toronto; SickKids Foundation; Stollery Children's Hospital; Hospital for Sick Children; CancerCare Manitoba","funders":"","keywords":"Myeloid leukemia; Refractory (planetary science); Medicine; Leukemia; Down syndrome; Overall survival; Oncology; Internal medicine; Biology; Psychiatry","score_opus":0.01727784567882751,"score_gpt":0.2839042528495991,"score_spread":0.2666264071707716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319069469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656904,0.0002997878,0.000010950687,0.0003955008,0.000073887364,0.000720105,0.00009119634,0.00037633505,0.0014632128],"genre_scores_gemma":[0.9882666,0.00049236295,0.00097376213,0.00009980766,0.000057483612,0.00006672702,0.00023964106,0.00009563213,0.0097080255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971351,0.0001164415,0.0004225446,0.0005348616,0.0011257316,0.0006653154],"domain_scores_gemma":[0.9980373,0.00059028924,0.00028751433,0.00060375,0.00024909127,0.00023204678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047993255,0.00034633014,0.00096903305,0.00032888917,0.00012299155,0.000019002846,0.0003086715,0.00015943138,0.00013074612],"category_scores_gemma":[0.00070432096,0.00019968815,0.000096805095,0.0015146964,0.00035146045,0.00030127057,0.00009946274,0.0005543061,0.000065459244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013428356,0.0003331125,0.9912687,0.000120856195,0.0018855243,0.0010786486,0.0001942257,0.00008509882,0.0014907892,0.00003589757,0.00042079194,0.0017435339],"study_design_scores_gemma":[0.00976932,0.0031965387,0.98210293,0.00036604365,0.0004311911,0.0003194673,0.00032968874,0.000019304078,0.002468785,0.000019267369,0.00065929873,0.00031815108],"about_ca_topic_score_codex":0.000118588854,"about_ca_topic_score_gemma":0.0002562811,"teacher_disagreement_score":0.0091657415,"about_ca_system_score_codex":0.0002758895,"about_ca_system_score_gemma":0.0010597316,"threshold_uncertainty_score":0.8143046},"labels":[],"label_agreement":null},{"id":"W4319826074","doi":"10.1182/bloodadvances.2022009599","title":"Unraveling the pathophysiology of lower-limb postthrombotic syndrome in adolescents: a proof-of-concept study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; Public Health Ontario; University of Toronto","funders":"Physicians' Services Incorporated Foundation","keywords":"Medicine; Pathophysiology; Internal medicine; Cardiology; Percentile","score_opus":0.015109909731539129,"score_gpt":0.28353060120390844,"score_spread":0.2684206914723693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319826074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564934,0.0022690916,0.00001114892,0.00029501162,0.000268322,0.0013598868,0.0000056114604,0.000035325986,0.00010625902],"genre_scores_gemma":[0.99932367,0.0002962431,0.00005927973,0.00014073392,0.000041188116,0.0000811603,0.00000488749,0.000019223842,0.000033629676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986413,0.00008374145,0.00045223182,0.00028151253,0.0002614512,0.00027975612],"domain_scores_gemma":[0.9992744,0.00007526413,0.00017774993,0.0003685597,0.00006501576,0.000039028466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026103153,0.00014911889,0.0006374192,0.00016777265,0.000041230833,0.000004176638,0.00019085227,0.0000392991,0.000016252377],"category_scores_gemma":[0.00011281861,0.00010156801,0.000092228634,0.00062462967,0.00012472,0.00006808008,0.00012592973,0.00013162552,0.0000077516115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017608759,0.10116375,0.6054917,0.010996561,0.0032456547,0.0055899187,0.027501907,0.023493052,0.04222843,0.0026262025,0.00056524697,0.17533669],"study_design_scores_gemma":[0.0032880532,0.0089094695,0.9713455,0.0016449173,0.00050376647,0.00001887138,0.0074144714,0.00011836087,0.005336905,0.0010896481,0.00012208933,0.00020793726],"about_ca_topic_score_codex":0.00006798778,"about_ca_topic_score_gemma":0.000058553436,"teacher_disagreement_score":0.3658538,"about_ca_system_score_codex":0.000012236856,"about_ca_system_score_gemma":0.000039427516,"threshold_uncertainty_score":0.41418234},"labels":[],"label_agreement":null},{"id":"W4319826851","doi":"10.1182/bloodadvances.2022008866","title":"Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb; Amgen","keywords":"Daratumumab; Medicine; Carfilzomib; Pomalidomide; Internal medicine; Multiple myeloma; Confidence interval; Dexamethasone; Oncology; Lenalidomide","score_opus":0.02775344379533928,"score_gpt":0.34334252232052176,"score_spread":0.3155890785251825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319826851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621564,0.0021328852,0.000003016712,0.000055065986,0.000015921223,0.0012331734,0.000019622017,0.000054282635,0.00027041766],"genre_scores_gemma":[0.99782765,0.00036022937,0.0012742539,0.000009339629,0.000020975365,0.00013273841,0.000018462008,0.000024563948,0.000331763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985923,0.00008417332,0.00025553445,0.00039503173,0.00033089658,0.0003420431],"domain_scores_gemma":[0.9992011,0.00021840962,0.000084014006,0.0002425263,0.00007087497,0.00018303774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002108506,0.00018526235,0.00048810738,0.0002833979,0.00008008533,0.000015525336,0.000054353866,0.00004180362,0.0000061292985],"category_scores_gemma":[0.0002766274,0.00013115375,0.000019172398,0.00054669037,0.00014920671,0.00013867747,0.00007147765,0.00014343418,0.000002611403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004021394,0.0028351403,0.96983576,0.00017543536,0.00022865107,0.00074596435,0.0011559778,0.000006427289,0.0043371324,0.0000104404,0.00000483722,0.01664282],"study_design_scores_gemma":[0.13812682,0.0103703225,0.8345631,0.00022701395,0.00021159122,0.00012207046,0.0057034274,0.0005660468,0.0097192,0.000033629032,0.00016368469,0.00019309651],"about_ca_topic_score_codex":0.00030048325,"about_ca_topic_score_gemma":0.0009690843,"teacher_disagreement_score":0.13527268,"about_ca_system_score_codex":0.000013261141,"about_ca_system_score_gemma":0.00004413587,"threshold_uncertainty_score":0.53482944},"labels":[],"label_agreement":null},{"id":"W4321764716","doi":"10.1182/bloodadvances.2022009138","title":"Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; U.S. Navy; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; TG Therapeutics; Medac; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; National Center for Advancing Translational Sciences; HistoGenetics; U.S. Department of Defense; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Multiple myeloma; Medicine; Malignancy; Transplantation; Oncology; Bone transplantation; Internal medicine; Surgery","score_opus":0.017427921747345126,"score_gpt":0.32756835125500866,"score_spread":0.3101404295076635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321764716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734795,0.00064815325,0.000015577152,0.000060108807,0.000027890377,0.0003998401,0.0006949395,0.000058845326,0.0007466724],"genre_scores_gemma":[0.9977611,0.00054732984,0.00056758744,0.00002363905,0.0000136786,0.000033769305,0.00062756997,0.000015537078,0.00040979916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862283,0.000053371277,0.0003661319,0.00026899905,0.00039541844,0.00029324397],"domain_scores_gemma":[0.99890864,0.00038016314,0.00016910252,0.00028926987,0.00013392532,0.000118878044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010497697,0.00017678848,0.00067289826,0.00059839664,0.000040106213,0.0000044607473,0.000090813,0.000059790746,0.00015789301],"category_scores_gemma":[0.00013219967,0.00012192122,0.0004443497,0.0008970322,0.000073578136,0.00011391743,0.000015671647,0.00008234362,0.000020034475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000948178,0.0007306786,0.95452857,0.00043062266,0.003415285,0.00027122578,0.00021990272,0.00013589546,0.027755588,0.000009758714,0.000009815645,0.011544471],"study_design_scores_gemma":[0.004416711,0.0014280103,0.9696146,0.0000726921,0.0010216646,0.000011566256,0.00004394111,0.000075193355,0.023189247,0.000028048455,0.000007709424,0.00009056256],"about_ca_topic_score_codex":0.00014247272,"about_ca_topic_score_gemma":0.00022927063,"teacher_disagreement_score":0.015086077,"about_ca_system_score_codex":0.000030301891,"about_ca_system_score_gemma":0.00009796939,"threshold_uncertainty_score":0.49718028},"labels":[],"label_agreement":null},{"id":"W4323532429","doi":"10.1182/bloodadvances.2022008414","title":"Dabrafenib, alone or in combination with trametinib, in <i>BRAF</i> V600–mutated pediatric Langerhans cell histiocytosis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; National Cancer Institute; National Institute for Health and Care Research; National Institutes of Health; Novartis Pharmaceuticals Corporation","keywords":"Trametinib; Dabrafenib; Medicine; Combination therapy; MEK inhibitor; Internal medicine; Adverse effect; Vomiting; Tolerability; Oncology; Langerhans cell histiocytosis; Gastroenterology; Vemurafenib; MAPK/ERK pathway; Cancer; Biology","score_opus":0.011751827672187328,"score_gpt":0.25811501762134853,"score_spread":0.2463631899491612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323532429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368864,0.0013207209,0.000018023575,0.00045901295,0.00007559094,0.00054507464,0.000022997403,0.00013901925,0.0037309357],"genre_scores_gemma":[0.9949257,0.0012677967,0.0008061336,0.00012540561,0.000034267363,0.00012855053,0.00018522942,0.000031770636,0.0024951727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987318,0.000041034993,0.00030425013,0.0003338067,0.0002737058,0.00031543992],"domain_scores_gemma":[0.9994778,0.00013852374,0.00009466148,0.00016752104,0.00003880964,0.00008267349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012543426,0.00018237202,0.0003607639,0.0004007765,0.000043071075,0.000012892621,0.00007137614,0.00006589581,0.000059914408],"category_scores_gemma":[0.0000753317,0.00013528699,0.000035034886,0.0015962388,0.000042041986,0.00014367903,0.000014853999,0.00013202066,0.00008309574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016316313,0.009716426,0.959762,0.00082718965,0.000092209026,0.00394594,0.0021276276,0.00058584183,0.0005906615,0.000062967374,0.0011544724,0.019503044],"study_design_scores_gemma":[0.19533795,0.010130771,0.73085,0.0011147506,0.0020156458,0.00024648992,0.005095002,0.0015538236,0.017740428,0.0011302115,0.032793853,0.0019911104],"about_ca_topic_score_codex":0.00016041307,"about_ca_topic_score_gemma":0.0009986461,"teacher_disagreement_score":0.22891203,"about_ca_system_score_codex":0.00006815134,"about_ca_system_score_gemma":0.00012756554,"threshold_uncertainty_score":0.5516843},"labels":[],"label_agreement":null},{"id":"W4323810083","doi":"10.1182/bloodadvances.2022009323","title":"Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Brentuximab vedotin; Medicine; Oncology; Internal medicine; Autologous stem-cell transplantation; Refractory (planetary science); Antibody-drug conjugate; Transplantation; Lymphoma; Regimen; Hodgkin lymphoma; Immunology; Antibody; Monoclonal antibody","score_opus":0.005045077618291691,"score_gpt":0.22553880673670618,"score_spread":0.22049372911841447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323810083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963746,0.002207844,0.0000029262392,0.00012345576,0.00015886888,0.000419855,0.00003939776,0.00013350797,0.0005395081],"genre_scores_gemma":[0.99637,0.0025803838,0.00030887788,0.000103218634,0.00007979632,0.00023771798,0.00019316484,0.00002491173,0.00010191433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877805,0.00003573394,0.0002447916,0.00034046092,0.00029860102,0.0003023835],"domain_scores_gemma":[0.99950886,0.00010410228,0.00008451776,0.00017315545,0.00004254663,0.00008679665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057094876,0.00018878444,0.0002691382,0.00023826346,0.000040964205,0.000012709047,0.00005263453,0.00006845756,0.000028014183],"category_scores_gemma":[0.000019098232,0.0001376357,0.000054619508,0.00048841216,0.000032006366,0.00019109357,0.000011615647,0.000052453655,0.000109247274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006409096,0.0019327778,0.9647961,0.00015764269,0.000036902366,0.00080536574,0.00028919516,0.000017123672,0.0000059244685,0.000009196219,0.00005028381,0.031258542],"study_design_scores_gemma":[0.01587117,0.00092157716,0.9811509,0.000112912894,0.00032103123,0.000019572024,0.0000329434,0.0000075259404,0.00035833643,0.000029366678,0.0010171598,0.00015747572],"about_ca_topic_score_codex":0.000027275972,"about_ca_topic_score_gemma":0.00010661538,"teacher_disagreement_score":0.031101065,"about_ca_system_score_codex":0.000069107984,"about_ca_system_score_gemma":0.00008360461,"threshold_uncertainty_score":0.5612621},"labels":[],"label_agreement":null},{"id":"W4324311114","doi":"10.1182/bloodadvances.2022008345","title":"The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Jewish General Hospital; University of Ottawa; McGill University","funders":"National Cancer Institute; National Institutes of Health; Emory University; Terry Fox Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; McGill University; Jewish General Hospital; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Carfilzomib; Proteasome; Bortezomib; Multiple myeloma; Pharmacology; Proteasome inhibitor; Cancer research; Biology; Medicine; Cell biology; Immunology","score_opus":0.02877557707826679,"score_gpt":0.30573534269820646,"score_spread":0.2769597656199397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324311114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942981,0.0019118375,0.0000025476675,0.0014142854,0.0002431608,0.0017624479,0.000049760554,0.00006997929,0.00024787092],"genre_scores_gemma":[0.9980066,0.0006376317,0.00028045854,0.000024106816,0.0002572657,0.00025362245,0.000053094114,0.00002371653,0.00046352757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823993,0.00012342088,0.00035906836,0.0002701144,0.0005209874,0.00048645772],"domain_scores_gemma":[0.9984619,0.00081916875,0.000114319446,0.0003996715,0.00009049962,0.00011444208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022721669,0.00017148568,0.0002803381,0.00011585393,0.00028005202,0.000030280651,0.00023051273,0.000048249323,0.000019172267],"category_scores_gemma":[0.0010550108,0.00008641188,0.00013308367,0.00064897735,0.00032517101,0.00010030246,0.00011233633,0.00019874233,0.00003986862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028756566,0.0010548052,0.7115827,0.00025085476,0.00064517296,0.00037320337,0.0011729397,0.00023976772,0.16624697,0.00022732081,0.00092891575,0.11440165],"study_design_scores_gemma":[0.011737444,0.00041635623,0.8959161,0.00019444227,0.00008476351,0.000014472257,0.0007826619,0.0006056386,0.06983122,0.00050237385,0.019758124,0.00015637421],"about_ca_topic_score_codex":0.00016225154,"about_ca_topic_score_gemma":0.00031921366,"teacher_disagreement_score":0.18433338,"about_ca_system_score_codex":0.00002220239,"about_ca_system_score_gemma":0.00008414343,"threshold_uncertainty_score":0.3523774},"labels":[],"label_agreement":null},{"id":"W4327587643","doi":"10.1182/bloodadvances.2022009202","title":"Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Child Health and Human Development; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; University of Washington","keywords":"Medicaid; Life expectancy; Medicine; Demography; Cohort; Gerontology; Population; Retrospective cohort study; Survival analysis; Cohort study; Confidence interval; Disease; Pediatrics; Health care; Internal medicine; Environmental health","score_opus":0.006399206732609147,"score_gpt":0.24914774799901238,"score_spread":0.24274854126640322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327587643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901575,0.007635528,0.0000111733225,0.00054870034,0.000114287905,0.0006315648,0.000017939683,0.00010443689,0.0007788752],"genre_scores_gemma":[0.99603134,0.0034584024,0.00003558165,0.000038022124,0.000050776645,0.00004287436,0.000060119233,0.000020015224,0.0002628859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986286,0.000034442346,0.00024085605,0.00028075668,0.0006122165,0.00020313378],"domain_scores_gemma":[0.9992732,0.0001193138,0.000099429526,0.00020564998,0.000104671686,0.00019777328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017633078,0.00014384794,0.00033352553,0.00010700365,0.00010324566,0.000009428845,0.000073392905,0.000051017825,0.000037544152],"category_scores_gemma":[0.00011940327,0.00009801169,0.000029792136,0.00039385894,0.0001581974,0.00008741507,0.000048755155,0.00012895769,0.000004247211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017658909,0.00065753784,0.9951134,0.00034873883,0.00017711594,0.00024244848,0.0007841975,0.000055628476,0.000044653432,0.000030945157,0.000021581782,0.0023471806],"study_design_scores_gemma":[0.0037351907,0.0009883739,0.98788685,0.00024182037,0.0007713919,0.0000100623665,0.0056372015,0.00003556691,0.00016807865,0.00004096456,0.000345214,0.00013930639],"about_ca_topic_score_codex":0.000036552756,"about_ca_topic_score_gemma":0.00033786686,"teacher_disagreement_score":0.0072265537,"about_ca_system_score_codex":0.000005393672,"about_ca_system_score_gemma":0.000103056744,"threshold_uncertainty_score":0.39968005},"labels":[],"label_agreement":null},{"id":"W4327681330","doi":"10.1182/bloodadvances.2021006534","title":"American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematología, Sociedad Peruana de Hematología, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"McMaster University","keywords":"Guideline; Medicine; Context (archaeology); Latin Americans; Family medicine; Equity (law); MEDLINE; Pathology; Political science; Geography","score_opus":0.09240075622215446,"score_gpt":0.3962641581856121,"score_spread":0.3038634019634576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327681330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98091465,0.007872131,0.0006164261,0.006833266,0.00017758293,0.0029881846,0.00024409426,0.00009143777,0.00026225005],"genre_scores_gemma":[0.88631725,0.035406422,0.07337083,0.0016242445,0.00034290378,0.0025291776,0.0001653415,0.000115395516,0.0001284509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650866,0.000099644865,0.0012711375,0.0007942254,0.00033947223,0.0009868743],"domain_scores_gemma":[0.99787474,0.0007115736,0.0006611132,0.00036515505,0.00020626598,0.0001811828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007836133,0.0004601891,0.0021766757,0.00043362347,0.00021708178,0.000025818901,0.00025738613,0.00020206168,0.000016469872],"category_scores_gemma":[0.0003986103,0.0004558487,0.00036473374,0.0009832015,0.0006161697,0.0001851338,0.00025018633,0.00022635398,0.000001843432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003841515,0.007542873,0.7391572,0.016132392,0.0032034907,0.00014659304,0.015462904,0.0015623453,0.0022196455,0.042041954,0.06887379,0.103272654],"study_design_scores_gemma":[0.01785603,0.0029372324,0.83476776,0.0027240037,0.0037036492,0.00013122623,0.058752537,0.0075199916,0.009887787,0.03765843,0.022056337,0.0020050171],"about_ca_topic_score_codex":0.00046009134,"about_ca_topic_score_gemma":0.0014720062,"teacher_disagreement_score":0.101267636,"about_ca_system_score_codex":0.00011319744,"about_ca_system_score_gemma":0.00012648404,"threshold_uncertainty_score":0.9997893},"labels":[],"label_agreement":null},{"id":"W4327700886","doi":"10.1182/bloodadvances.2022008793","title":"Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Myeloid; Context (archaeology); Immunology; Lymphocyte; Biology; Genome-wide association study; Medicine; Genetics; Genotype; Gene; Single-nucleotide polymorphism","score_opus":0.022208651154618588,"score_gpt":0.3343515052686889,"score_spread":0.31214285411407033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327700886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960197,0.0019156937,0.0000015203598,0.0009793839,0.00011051804,0.00024890568,0.00003568807,0.00005799673,0.0006306019],"genre_scores_gemma":[0.9982578,0.00053694757,0.000049351176,0.00012289255,0.00022555591,0.000021750908,0.000041396655,0.000017953993,0.0007263297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999161,0.000037573223,0.00015458412,0.00018699729,0.00021987612,0.00023998696],"domain_scores_gemma":[0.9994183,0.00030350516,0.000033038323,0.00016762028,0.00002299891,0.000054520202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016224894,0.00010820251,0.00019684403,0.0001318042,0.00004921158,0.00001737327,0.00013196476,0.00005543594,0.000054107586],"category_scores_gemma":[0.00010935618,0.000066372166,0.000027526055,0.00030694742,0.000105057814,0.00012110633,0.00010741061,0.00013485325,0.000053254138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016710253,0.00003283659,0.9750568,0.00008984261,0.00007351885,0.00016504723,0.0007751334,0.0000024445803,0.00053998973,0.000011742982,0.0025361602,0.020699747],"study_design_scores_gemma":[0.0011514832,0.000104994775,0.97173303,0.0001138638,0.000055061424,0.00002975852,0.0005800872,0.000031272095,0.001729022,0.00019695864,0.024168126,0.000106362175],"about_ca_topic_score_codex":0.00001939683,"about_ca_topic_score_gemma":0.000014465894,"teacher_disagreement_score":0.021631967,"about_ca_system_score_codex":0.000020239282,"about_ca_system_score_gemma":0.00004975092,"threshold_uncertainty_score":0.27065784},"labels":[],"label_agreement":null},{"id":"W4327893160","doi":"10.1182/bloodadvances.2023009792","title":"Influence of participant and reviewer characteristics in application scores for a hematology research training program","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Underrepresented Minority; Significant difference; Demography; Scale (ratio); Physical therapy; Internal medicine; Medical education","score_opus":0.1768389836983987,"score_gpt":0.46006303750300587,"score_spread":0.28322405380460713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327893160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698997,0.0014992199,0.000010195187,0.0006185955,0.000033670465,0.000594692,0.0000057956986,0.000029852947,0.00021802208],"genre_scores_gemma":[0.9966767,0.002570912,0.0003873222,0.000032963144,0.000049861763,0.00023941182,0.0000047589883,0.0000022682382,0.000035803696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915224,0.00008350775,0.00015127735,0.00012708658,0.00025546565,0.00023039701],"domain_scores_gemma":[0.9993015,0.00034845193,0.000055698692,0.000062709165,0.00018906889,0.000042561012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021507847,0.00003378605,0.00015961773,0.00007629301,0.00012724778,0.0000118484495,0.00014121161,0.000033011544,0.0000015391192],"category_scores_gemma":[0.0019262759,0.00003113947,0.000011923613,0.00044887126,0.00046122272,0.000105042986,0.000035408404,0.000060487368,0.0000020443804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006623224,0.00024097989,0.31845605,0.001227545,0.000025637019,0.000013531694,0.06356359,0.000033457585,0.0006663556,0.08955989,0.00019637951,0.5259504],"study_design_scores_gemma":[0.0022356228,0.0011802475,0.37840316,0.0022118588,0.00016464638,0.0000037601094,0.15017062,0.0003125207,0.001133039,0.049435064,0.41431728,0.0004321593],"about_ca_topic_score_codex":0.000082967126,"about_ca_topic_score_gemma":0.00042206113,"teacher_disagreement_score":0.5255182,"about_ca_system_score_codex":0.0000045787847,"about_ca_system_score_gemma":0.00005711116,"threshold_uncertainty_score":0.23060714},"labels":[],"label_agreement":null},{"id":"W4360814881","doi":"10.1182/bloodadvances.2022009619","title":"Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; University of Texas MD Anderson Cancer Center; Society of Interventional Radiology Foundation; Medical College of Wisconsin","keywords":"ARDS; Medicine; Coronavirus disease 2019 (COVID-19); Randomized controlled trial; Placebo; Cord blood; Double blinded; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Internal medicine; Virology; Pathology; Lung; Outbreak; Alternative medicine","score_opus":0.032533290440727405,"score_gpt":0.3506749232289281,"score_spread":0.31814163278820073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360814881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668497,0.006034184,0.00029869837,0.0011636445,0.0010486972,0.02382102,0.00011880019,0.00023582391,0.00042943374],"genre_scores_gemma":[0.9865196,0.0026199722,0.00204086,0.00033629918,0.0007988178,0.005340022,0.000109415036,0.0000924472,0.0021425688],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99653196,0.00031049878,0.0012829382,0.00062280556,0.00071615557,0.0005356573],"domain_scores_gemma":[0.99092567,0.006791297,0.0008957894,0.0007535539,0.00020633863,0.00042733597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015903137,0.0004847722,0.0031678933,0.00047591352,0.00010492433,0.000015386648,0.00026074986,0.00021870948,0.00007201307],"category_scores_gemma":[0.0016114151,0.00034833964,0.001287328,0.00037170478,0.0004075429,0.00013316164,0.000049503466,0.000072481766,0.000014976061],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9747062,0.002317133,0.00031941463,0.0014904827,0.002760895,0.00007835935,0.00024160508,0.0007890108,0.01548552,0.00042990025,0.00018550531,0.0011959951],"study_design_scores_gemma":[0.8640305,0.0066234986,0.000014639128,0.00011250126,0.005378654,0.000017547842,0.000069300935,0.000087445675,0.118219584,0.0005997512,0.0045890696,0.0002575418],"about_ca_topic_score_codex":0.00006636777,"about_ca_topic_score_gemma":0.000037925143,"teacher_disagreement_score":0.110675715,"about_ca_system_score_codex":0.000092075534,"about_ca_system_score_gemma":0.0010737794,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W4361279352","doi":"10.1182/bloodadvances.2022009117","title":"Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Leukemia and Lymphoma Society","keywords":"Chimeric antigen receptor; Medicine; Receptor; Antigen; Cell therapy; Immunology; Internal medicine; Cell; Immunotherapy; Biology; Immune system; Genetics","score_opus":0.028434535764571875,"score_gpt":0.31652089862229865,"score_spread":0.28808636285772676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361279352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396795,0.0013754009,0.000001534812,0.00022772816,0.00040351535,0.000876603,0.000008542205,0.00018742049,0.0029513154],"genre_scores_gemma":[0.9905032,0.0048185945,0.0003652364,0.00012063565,0.00009119851,0.00008379593,0.00009296433,0.00006176747,0.003862602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976259,0.00008580311,0.0004929375,0.0005063396,0.0007068029,0.0005822234],"domain_scores_gemma":[0.9989639,0.00015769967,0.00016794259,0.00043369897,0.00012896034,0.00014779279],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025943972,0.00024591596,0.00048765854,0.00038448581,0.00008920313,0.000027115106,0.00015660358,0.00007860247,0.0009169728],"category_scores_gemma":[0.00018272434,0.00019980088,0.0001378995,0.0011564108,0.000076154574,0.00020678196,0.00007136869,0.00027223513,0.00016004007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031801144,0.0008590913,0.87531924,0.0000335036,0.00010395568,0.000055742872,0.0003370312,0.000009103575,0.022001425,7.731724e-7,0.00019645605,0.10076568],"study_design_scores_gemma":[0.0055491696,0.0010115642,0.94647413,0.000077760415,0.000017670818,0.0000040794334,0.00015767949,0.000010393391,0.02805767,0.000026459222,0.01838813,0.00022527894],"about_ca_topic_score_codex":0.000057049656,"about_ca_topic_score_gemma":0.000022653408,"teacher_disagreement_score":0.10054041,"about_ca_system_score_codex":0.000051689156,"about_ca_system_score_gemma":0.0000791451,"threshold_uncertainty_score":0.9999963},"labels":[],"label_agreement":null},{"id":"W4365135689","doi":"10.1182/bloodadvances.2022009236","title":"Histidine-rich glycoprotein attenuates catheter thrombosis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"McMaster University; Canadian Institutes of Health Research; Hamilton Health Sciences; Heart and Stroke Foundation of Canada","keywords":"Thrombosis; Catheter; Gene knockdown; Saline; Thromboplastin; Partial thromboplastin time; Medicine; Heparin; Factor XII; Chemistry; Internal medicine; Anesthesia; Coagulation; Surgery; Biochemistry","score_opus":0.02528873250166766,"score_gpt":0.2958769326512618,"score_spread":0.27058820014959417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365135689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848941,0.008148835,0.000029809862,0.0024628753,0.00038418412,0.00039436188,0.000020412113,0.0005279371,0.003137477],"genre_scores_gemma":[0.9894811,0.0010829396,0.0009512636,0.00038313185,0.000528109,0.00007727998,0.000088295725,0.000044308672,0.007363601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865216,0.000020507316,0.00028376436,0.00036301574,0.00030213266,0.0003784119],"domain_scores_gemma":[0.9992743,0.000109293665,0.00009454773,0.00031221192,0.00008279351,0.00012682915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013343325,0.00020327047,0.00034084104,0.00013680039,0.0001476019,0.00002417315,0.0001119393,0.00007170724,0.0002565356],"category_scores_gemma":[0.00012734854,0.00016776854,0.00013543642,0.0005303707,0.000089432644,0.00019592835,0.00005011396,0.00009606985,0.00048929104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017914569,0.0010826321,0.86996126,0.00066177914,0.0005430886,0.0002086308,0.0021631122,0.00009646834,0.047009274,0.0020934865,0.01399203,0.06200907],"study_design_scores_gemma":[0.005001287,0.0012185173,0.5168959,0.0006373321,0.0008257637,0.00011825816,0.0006893075,0.00044372334,0.20216647,0.004786472,0.26622915,0.0009878516],"about_ca_topic_score_codex":0.000061093924,"about_ca_topic_score_gemma":0.000032134896,"teacher_disagreement_score":0.35306543,"about_ca_system_score_codex":0.000020145291,"about_ca_system_score_gemma":0.00004851979,"threshold_uncertainty_score":0.6841402},"labels":[],"label_agreement":null},{"id":"W4365135776","doi":"10.1182/bloodadvances.2022009478","title":"Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; London Health Sciences Centre; Western University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Alemtuzumab; Medicine; Internal medicine; Melphalan; Gastroenterology; Immunology; Incidence (geometry); Transplantation","score_opus":0.013888131772990264,"score_gpt":0.2898442365043619,"score_spread":0.27595610473137167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365135776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924057,0.004739317,0.000028969807,0.0006168745,0.000072849405,0.00045934052,0.0000391199,0.00013026773,0.0015075774],"genre_scores_gemma":[0.9973876,0.0009771892,0.00020912998,0.00009468977,0.00006506495,0.00007822883,0.000048042763,0.000020476344,0.0011195824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986256,0.00003660899,0.0003464541,0.00027518562,0.00034886829,0.00036729345],"domain_scores_gemma":[0.999258,0.00007318427,0.00009616819,0.00024481592,0.00021740378,0.000110422254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002722167,0.0001496025,0.0003915476,0.00018484324,0.000103967344,0.000015489723,0.00006997557,0.000064197906,0.00014984586],"category_scores_gemma":[0.0002172179,0.00012775412,0.000078442354,0.00029684146,0.00019199919,0.00021264637,0.00010431362,0.00016898579,0.000023350305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005585986,0.002447821,0.58871496,0.007824303,0.0029644659,0.0032418566,0.010701496,0.000117334974,0.22487338,0.0016268885,0.009103572,0.14279796],"study_design_scores_gemma":[0.007641399,0.0018320534,0.82378936,0.00082830386,0.00034879445,0.000143459,0.008047497,0.00037382674,0.135365,0.0020168244,0.019186093,0.00042741085],"about_ca_topic_score_codex":0.000011495522,"about_ca_topic_score_gemma":0.000004956537,"teacher_disagreement_score":0.23507442,"about_ca_system_score_codex":0.000022879649,"about_ca_system_score_gemma":0.00016333995,"threshold_uncertainty_score":0.5209662},"labels":[],"label_agreement":null},{"id":"W4365136161","doi":"10.1182/bloodadvances.2022009311","title":"Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; AOP Orphan; Italfarmaco; Angelini Pharma; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Jazz Pharmaceuticals; Gilead Sciences; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Constellation Pharmaceuticals","keywords":"Ruxolitinib; Discontinuation; Medicine; Anemia; Internal medicine; Randomized controlled trial; Myelofibrosis; Neutropenia; Adverse effect; Gastroenterology; Bone marrow; Chemotherapy","score_opus":0.029112969208309653,"score_gpt":0.359403814225357,"score_spread":0.33029084501704736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365136161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876208,0.0084625585,0.00011619464,0.00047254213,0.00012609492,0.0025604533,0.00016496472,0.00006614363,0.0004102915],"genre_scores_gemma":[0.98043877,0.018006358,0.0002507927,0.00003988844,0.000048289352,0.00053581706,0.00036076334,0.00001689998,0.00030242436],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996275,0.0009844875,0.0017330337,0.0003996829,0.0003461133,0.00026169998],"domain_scores_gemma":[0.9930919,0.0058003273,0.00060404395,0.00021622612,0.00016324995,0.00012430102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036453686,0.00029508237,0.0070193466,0.0008947507,0.000050086815,0.000023169678,0.000060978033,0.000081813916,0.00019844383],"category_scores_gemma":[0.0039289966,0.00017101491,0.0008287543,0.0016289881,0.0001530622,0.00010459459,0.000028533032,0.00010456667,0.0000047075814],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41976205,0.0026349195,0.5288193,0.00020398352,0.026690194,0.00018496944,0.0006382072,0.0002079544,0.0029558863,0.0006630491,0.000011665994,0.017227795],"study_design_scores_gemma":[0.8304512,0.00057550217,0.14026639,0.00036694534,0.01995399,0.0000035829842,0.00025122357,0.0012849056,0.006526733,0.00005725297,0.00007337953,0.00018889585],"about_ca_topic_score_codex":0.000049543876,"about_ca_topic_score_gemma":0.00029490123,"teacher_disagreement_score":0.41068918,"about_ca_system_score_codex":0.000022966438,"about_ca_system_score_gemma":0.00008233074,"threshold_uncertainty_score":0.6973786},"labels":[],"label_agreement":null},{"id":"W4365136264","doi":"10.1182/bloodadvances.2022009423","title":"Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre; University of Toronto; University Health Network; Health Sciences Centre; Canadian Blood Services; St. Michael's Hospital","funders":"Health Canada; University of Toronto; Canadian Blood Services; Australian Government","keywords":"Phagocytosis; Autoantibody; Platelet; Immunology; Antibody; Macrophage; Immune system; Antigen; Immunoglobulin G; Biology; Biochemistry; In vitro","score_opus":0.007307811708205243,"score_gpt":0.23929860686857615,"score_spread":0.2319907951603709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365136264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955286,0.0027062634,0.0000030427761,0.00007112908,0.00008191347,0.0004144521,0.00037079112,0.00005380323,0.0007700207],"genre_scores_gemma":[0.9979905,0.00075368874,0.00066147535,0.000021708189,0.000013325027,0.000016406553,0.00028382006,0.000027449758,0.00023161656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988079,0.000019379799,0.00033637794,0.0002576908,0.00033496864,0.0002436517],"domain_scores_gemma":[0.9992646,0.00007623646,0.00022817479,0.00027294565,0.00008670278,0.000071340415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004358152,0.00018670678,0.00073062035,0.00010846614,0.00004447377,0.000004788883,0.00010647538,0.0000597661,0.00014864064],"category_scores_gemma":[0.000023308781,0.00013284566,0.000095257885,0.00041086774,0.00010121392,0.00016272237,0.00003799741,0.00007738568,0.000029007791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028236872,0.00377425,0.9217154,0.00051054225,0.0026424632,0.0010192135,0.0009403746,0.0000661921,0.020339245,0.000044806467,0.00010383575,0.04602002],"study_design_scores_gemma":[0.016980164,0.0013667536,0.6977652,0.00030747213,0.0006350126,0.0000064159613,0.00025612334,0.000013016464,0.2809695,0.00017241939,0.0013280845,0.00019984946],"about_ca_topic_score_codex":0.00018064925,"about_ca_topic_score_gemma":0.000033413664,"teacher_disagreement_score":0.26063025,"about_ca_system_score_codex":0.0000116409,"about_ca_system_score_gemma":0.00004265504,"threshold_uncertainty_score":0.54172885},"labels":[],"label_agreement":null},{"id":"W4365479293","doi":"10.1182/bloodadvances.2023009781","title":"Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; CTI Biopharma; Incyte; Sierra Oncology; Celgene; MorphoSys; Servier; Astellas Pharma; Syndax Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb; Agios Pharmaceuticals","keywords":"Myelodysplastic syndromes; Anemia; Medicine; Oncology; Internal medicine","score_opus":0.022392367700130547,"score_gpt":0.3198697072487417,"score_spread":0.29747733954861116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365479293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983576,0.0005611954,0.00005546078,0.00018104189,0.000051118786,0.00061453076,0.000055529792,0.000024217437,0.000099313205],"genre_scores_gemma":[0.9963136,0.0026311788,0.0005466607,0.0000025395393,0.00001821438,0.000073811745,0.00002227443,0.000013151479,0.0003786228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925125,0.00003476764,0.00016641848,0.00019446196,0.00016970948,0.00018337095],"domain_scores_gemma":[0.99917513,0.0004633538,0.000104410814,0.00014253394,0.00006459891,0.00004997843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013844881,0.00010246199,0.00035956257,0.00022288875,0.00002572953,0.000003155915,0.000042693384,0.00005348589,0.00000991235],"category_scores_gemma":[0.00020066273,0.00008180792,0.000044609045,0.00030188673,0.00010477649,0.00009868145,0.000023671068,0.000044321332,0.000002368877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028790825,0.0028587098,0.56317955,0.0029977476,0.000306456,0.00017538991,0.0018994192,0.0002630091,0.13823584,0.00020234226,0.00012372939,0.28687873],"study_design_scores_gemma":[0.016030319,0.008525939,0.77546865,0.0003202308,0.00030923466,0.000042334843,0.00044136256,0.0030167548,0.1941721,0.0007276526,0.0007679282,0.00017750583],"about_ca_topic_score_codex":0.00008987415,"about_ca_topic_score_gemma":0.00007165552,"teacher_disagreement_score":0.28670123,"about_ca_system_score_codex":0.00006940058,"about_ca_system_score_gemma":0.00008088706,"threshold_uncertainty_score":0.33360302},"labels":[],"label_agreement":null},{"id":"W4366083620","doi":"10.1182/bloodadvances.2022009260","title":"Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"Loxo Oncology; Pharmacyclics; Kite Pharma; Genentech; MorphoSys; Juno Therapeutics; Adaptive Biotechnologies; Celltrion; Celgene; Alimera Sciences; BeiGene; MEI Pharma; Sunesis; TG Therapeutics; Regeneron Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Pfizer; Incyte; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Yuhan; Atara Biotherapeutics; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Diffuse large B-cell lymphoma; Refractory (planetary science); Lymphoma; Internal medicine; Medicine; Oncology; Cancer research; Gastroenterology; Biology","score_opus":0.008757305009623545,"score_gpt":0.261308908155294,"score_spread":0.2525516031456705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366083620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945325,0.0015023827,0.0000031618065,0.00014958788,0.00005734706,0.0006238326,0.000039184575,0.000088247434,0.0030037377],"genre_scores_gemma":[0.9858951,0.0032846006,0.00016529637,0.00037224614,0.00006186047,0.00007601341,0.000044315646,0.00006287171,0.010037715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839497,0.000048635287,0.0001963099,0.00042904753,0.00044677922,0.00048425575],"domain_scores_gemma":[0.9992574,0.00012324481,0.00007204143,0.00032793105,0.00007813681,0.00014126739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010921431,0.00020445397,0.00034343798,0.00022635327,0.00008296247,0.00002423632,0.000099856305,0.00008557074,0.00029631294],"category_scores_gemma":[0.00002086082,0.0001609794,0.000042619202,0.0005354319,0.00007880504,0.0002763665,0.00004690667,0.0001829703,0.000037534377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009323292,0.01430889,0.7826823,0.000302545,0.00028680832,0.0002369594,0.005222433,0.000010598417,0.011306889,0.000031326927,0.00065631943,0.17563163],"study_design_scores_gemma":[0.15987034,0.004207862,0.63145584,0.00029477547,0.00008677239,0.000009985585,0.0012594233,0.00022579703,0.048154626,0.00023152251,0.15360181,0.00060124346],"about_ca_topic_score_codex":0.000051625713,"about_ca_topic_score_gemma":0.000056396035,"teacher_disagreement_score":0.1750304,"about_ca_system_score_codex":0.000079312915,"about_ca_system_score_gemma":0.000087758,"threshold_uncertainty_score":0.6564549},"labels":[],"label_agreement":null},{"id":"W4367042374","doi":"10.1182/bloodadvances.2023010039","title":"Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Health Science Centre; Canadian Blood Services; McMaster University","funders":"National Heart, Lung, and Blood Institute; Agency for Healthcare Research and Quality","keywords":"Guideline; Clinical Practice; Medicine; Family medicine; Pathology","score_opus":0.4086942509965733,"score_gpt":0.5974869721055978,"score_spread":0.18879272110902445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367042374","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20367706,0.0626252,0.035109967,0.67977434,0.007469971,0.005766195,0.00047113138,0.0015076968,0.00359844],"genre_scores_gemma":[0.10014128,0.061936297,0.7015805,0.09915644,0.029662957,0.0007165556,0.0023184982,0.00033389812,0.0041535296],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99492896,0.0003017066,0.0027197246,0.0008156061,0.0007840097,0.0004499841],"domain_scores_gemma":[0.98008376,0.015595504,0.0009197637,0.0008478792,0.0023636736,0.00018942919],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004493935,0.00029033364,0.0005535593,0.00008900649,0.00035383916,0.000104317995,0.0003626406,0.00014469746,0.00029165606],"category_scores_gemma":[0.11330358,0.00020625758,0.00042239478,0.0005424745,0.00016638843,0.0010850128,0.00021483916,0.00035000345,0.00014417381],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011384131,0.0007162957,0.015236546,0.000040865743,0.00070786965,0.00009515828,0.0014250095,0.000040996663,0.00092538097,0.00044377265,0.8948463,0.08438339],"study_design_scores_gemma":[0.004919832,0.00037688893,0.006093804,0.000113624745,0.0011920378,0.000039989383,0.060375456,0.0006859238,0.00025773025,0.0017341592,0.9239555,0.00025506006],"about_ca_topic_score_codex":0.00023197291,"about_ca_topic_score_gemma":0.00015903777,"teacher_disagreement_score":0.6664706,"about_ca_system_score_codex":0.00005009289,"about_ca_system_score_gemma":0.000263415,"threshold_uncertainty_score":0.89416546},"labels":[],"label_agreement":null},{"id":"W4367856691","doi":"10.1182/bloodadvances.2023009886","title":"A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Cancer Moonshot; Moonshot Research and Development Program; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Legend Biotech; Adaptive Biotechnologies; Health Resources and Services Administration; Kite Pharma; Daiichi Sankyo Europe; Agios Pharmaceuticals; Takeda Oncology; AstraZeneca; Genentech; National Institutes of Health; MorphoSys; Invitae; Vertex Pharmaceuticals; Ono Pharmaceutical; Mazak Foundation; Cardinal Health; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; GlaxoSmithKline; Kiadis Pharma; Pharmacyclics; bluebird bio; Sanofi; TG Therapeutics; Omeros Corporation; Medical College of Wisconsin; StemCyte; HistoGenetics; Atara Biotherapeutics; Actinium Pharmaceuticals; Gilead Sciences; Celgene; CSL Behring; Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; Sierra Oncology; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Medac; Jazz Pharmaceuticals; CTI Biopharma; Be The Match Foundation","keywords":"Transplantation; Medicine; Stem cell; Myelofibrosis; Oncology; Internal medicine; Biology; Bone marrow; Genetics","score_opus":0.008305577184414827,"score_gpt":0.23136967647607926,"score_spread":0.22306409929166443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367856691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974128,0.00071206264,0.00010992919,0.00006058749,0.00003651973,0.0009701999,0.00008204327,0.00015344843,0.00046242698],"genre_scores_gemma":[0.9979679,0.00044976265,0.00055279216,0.000042743526,0.000030937023,0.0004124555,0.000413254,0.000028759241,0.00010142571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828553,0.00007000536,0.00036800458,0.0004908679,0.0004237446,0.00036183014],"domain_scores_gemma":[0.9991021,0.00030693234,0.0001352315,0.00022906737,0.00009706579,0.00012960692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009633355,0.0002553899,0.0005445985,0.00040556016,0.000111526606,0.000032058982,0.0000691716,0.000056705605,0.000019865636],"category_scores_gemma":[0.000009028186,0.00018572659,0.00012009026,0.0017423199,0.000030397821,0.00015005434,0.0000150249925,0.0000802242,0.000036538746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023089253,0.0005683885,0.9937829,0.00082179107,0.00063915085,0.00021067545,0.00040584686,0.0016902064,0.000040343963,0.000051945826,0.000008061962,0.0015497985],"study_design_scores_gemma":[0.0055279317,0.0010707695,0.9854984,0.0004714789,0.0028869025,0.0000065767267,0.0006523745,0.00017861983,0.0033825515,0.00000699192,0.000102495476,0.00021486125],"about_ca_topic_score_codex":0.000023519604,"about_ca_topic_score_gemma":0.0005778505,"teacher_disagreement_score":0.008284451,"about_ca_system_score_codex":0.00007286773,"about_ca_system_score_gemma":0.000083143845,"threshold_uncertainty_score":0.75737107},"labels":[],"label_agreement":null},{"id":"W4368617865","doi":"10.1182/bloodadvances.2023009675","title":"Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Loxo Oncology; Genentech; National Institutes of Health; Astellas Pharma; Daiichi-Sankyo; Foundation Medicine; Sierra Oncology; Galecto; Pfizer; Incyte; Syndax Pharmaceuticals; Cycle for Survival; Constellation Pharmaceuticals; Ipsen; Jazz Pharmaceuticals; National Heart, Lung, and Blood Institute; Edward P. Evans Foundation; Daiichi Sankyo Europe; National Cancer Institute; Foghorn Therapeutics; Servier; Gilead Sciences; Sanofi; Memorial Sloan-Kettering Cancer Center; Alex's Lemonade Stand Foundation for Childhood Cancer; GlaxoSmithKline; MorphoSys; Ipsen Biopharmaceuticals; Celgene; AstraZeneca; Amgen; Damon Runyon Cancer Research Foundation","keywords":"Myeloid leukemia; Ontogeny; Myelodysplastic syndromes; Gene mutation; Internal medicine; Oncology; Leukemia; Biology; Myeloid; Cancer; Gene; Medicine; Mutation; Genetics; Bone marrow","score_opus":0.018958027206244687,"score_gpt":0.31927056758112354,"score_spread":0.30031254037487887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368617865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503547,0.00085071084,0.00003254967,0.0011977643,0.00013132962,0.00048895116,0.00003828385,0.00023098785,0.0019939647],"genre_scores_gemma":[0.99240917,0.002874502,0.0014175038,0.00008394245,0.00016672519,0.00008849676,0.00035909968,0.00004383243,0.0025567033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983015,0.00006716701,0.00041091567,0.0004393233,0.00032451312,0.00045655065],"domain_scores_gemma":[0.9990945,0.00029178595,0.00009410253,0.0002507118,0.00007877617,0.00019014852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028344014,0.00019994042,0.00037313803,0.0005498898,0.00011779001,0.00003187766,0.00012021613,0.00014209711,0.000056117286],"category_scores_gemma":[0.00019835653,0.0001847212,0.000060605515,0.0011429036,0.0001326872,0.00042265098,0.00010688785,0.0005048253,0.0002218633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005057428,0.0002561571,0.5905269,0.00037884677,0.0014532424,0.0025012745,0.0035842126,0.0006895398,0.21578357,0.00035353057,0.0011637902,0.18280323],"study_design_scores_gemma":[0.009391559,0.0007879653,0.8778613,0.00036903287,0.00070696056,0.00070567045,0.0017561043,0.0021052887,0.08842963,0.0017330687,0.015588924,0.00056447886],"about_ca_topic_score_codex":0.000112135756,"about_ca_topic_score_gemma":0.00010825263,"teacher_disagreement_score":0.28733444,"about_ca_system_score_codex":0.00029526497,"about_ca_system_score_gemma":0.00026763152,"threshold_uncertainty_score":0.75327116},"labels":[],"label_agreement":null},{"id":"W4376132330","doi":"10.1182/bloodadvances.2023009748","title":"<i>FLT3-ITD</i> does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years","year":2023,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Genentech; Servier; Astellas Pharma; Sierra Oncology; Incyte; Boston Pharmaceuticals; bluebird bio; Bristol-Myers Squibb; Foghorn Therapeutics; Jazz Pharmaceuticals; Gilead Sciences; Amgen; Pfizer; Agios Pharmaceuticals; GlaxoSmithKline","keywords":"Myeloid leukemia; Medicine; Internal medicine; Leukemia; Oncology; Myeloid","score_opus":0.013620885975553698,"score_gpt":0.27509041266726314,"score_spread":0.2614695266917094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376132330","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8622044,0.0010882221,0.0000043397636,0.124660134,0.0022424594,0.005389147,0.0019601595,0.0010922453,0.0013589158],"genre_scores_gemma":[0.111992754,0.030022636,0.0077756024,0.69226664,0.025857167,0.008921556,0.017478626,0.0028208161,0.102864176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931315,0.00027394693,0.0011778503,0.0015807862,0.0021209589,0.0017149225],"domain_scores_gemma":[0.997318,0.00059035985,0.0004700107,0.0010342909,0.0002789966,0.00030828876],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004730571,0.00093093683,0.0016392203,0.0010594706,0.0001382018,0.00012798274,0.0009461648,0.0013309885,0.00014105595],"category_scores_gemma":[0.0006957585,0.00073656294,0.00041453913,0.0012509609,0.00040594029,0.0004988679,0.00056906976,0.004985511,0.0005009444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062757573,0.0003960099,0.25850192,0.0023062848,0.001328053,0.025421098,0.0005594122,0.000011454599,0.0014310825,0.0000017098636,0.6938188,0.015596608],"study_design_scores_gemma":[0.01059982,0.0013321362,0.26902077,0.00219538,0.0012316518,0.000087981716,0.0000786155,0.000030875533,0.0058528,0.00007983737,0.70817626,0.0013138758],"about_ca_topic_score_codex":0.0002356304,"about_ca_topic_score_gemma":0.00017375604,"teacher_disagreement_score":0.75021166,"about_ca_system_score_codex":0.0010491912,"about_ca_system_score_gemma":0.0013224175,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W4376226544","doi":"10.1182/bloodadvances.2022007059","title":"CD38 as a pan-hematologic target for chimeric antigen receptor T cells","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Incyte; Andrew McDonough B+ Foundation; American Society of Clinical Oncology; American Association for Cancer Research; St. Baldrick's Foundation; Stand Up To Cancer; National Cancer Institute; Entertainment Industry Foundation; Gilead Sciences; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"Chimeric antigen receptor; CD38; Cart; Haematopoiesis; Antigen; Cancer research; Medicine; Immunology; Myeloid leukemia; Immunotherapy; T cell; Myeloid; Leukemia; Stem cell; Biology; CD34; Immune system; Cell biology","score_opus":0.026737103991852498,"score_gpt":0.3417820071623222,"score_spread":0.31504490317046974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376226544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809532,0.006208419,0.00010191528,0.0016224319,0.0005990153,0.0017611689,0.000060526167,0.0004989016,0.008194426],"genre_scores_gemma":[0.6930332,0.03283147,0.051041078,0.0017351401,0.0026321225,0.0017317606,0.0006894169,0.00037830096,0.21592747],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839234,0.00004161825,0.00024514983,0.0004122719,0.0003508039,0.0005578179],"domain_scores_gemma":[0.99906874,0.0002757546,0.000076886485,0.0003351423,0.00009391783,0.00014955184],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028189336,0.000183546,0.00041724142,0.00016724912,0.00011575421,0.000022488786,0.00018339213,0.000084578154,0.0022350366],"category_scores_gemma":[0.00020107723,0.00014781185,0.00017135177,0.00064824347,0.00010274976,0.00010038018,0.00005757973,0.00015399193,0.0010153071],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043456603,0.00032576232,0.005504507,0.00035869275,0.00020153752,0.00008269846,0.00024865416,0.000012052814,0.9530322,0.00016078453,0.0097165685,0.029921954],"study_design_scores_gemma":[0.0016444862,0.00089061115,0.0005928149,0.000055124536,0.000038274564,0.00003611342,0.00025773735,0.000050863702,0.47841468,0.0012048373,0.5166484,0.00016605317],"about_ca_topic_score_codex":0.000012294833,"about_ca_topic_score_gemma":0.0000033389529,"teacher_disagreement_score":0.50693184,"about_ca_system_score_codex":0.00001935264,"about_ca_system_score_gemma":0.00010484463,"threshold_uncertainty_score":0.99976254},"labels":[],"label_agreement":null},{"id":"W4376608692","doi":"10.1182/bloodadvances.2023009825","title":"Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Toronto General Hospital; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Essential thrombocythemia; Confidence interval; Hazard ratio; Myelofibrosis; Internal medicine; Polycythemia vera; Proportional hazards model; Population; Gastroenterology; Bone marrow","score_opus":0.03246975683870799,"score_gpt":0.355246296950634,"score_spread":0.32277654011192597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376608692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974497,0.00047966835,0.0000024081123,0.00055906415,0.000055889454,0.0012984272,0.00004223054,0.000050474995,0.00006212657],"genre_scores_gemma":[0.99837595,0.0003958527,0.00045020494,0.00010052542,0.000031349744,0.0002726927,0.000020618947,0.000013819581,0.0003389687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998359,0.00015576312,0.0004971616,0.00037411932,0.00041936382,0.0001945931],"domain_scores_gemma":[0.99826014,0.0010965058,0.0002641896,0.00014489866,0.00015526658,0.000078993275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041480453,0.0001777856,0.0005610492,0.00014294044,0.00005742772,0.000011419525,0.0000447806,0.00006844265,0.000021768396],"category_scores_gemma":[0.000764453,0.00012142492,0.000053397205,0.0003581855,0.000019517804,0.00014752866,0.000021253718,0.00013958593,0.000007296193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020254243,0.0017338545,0.9963767,0.00015628483,0.00023295959,0.0000399921,0.00039859087,0.00013288295,0.000010993064,0.000069265385,0.000005182059,0.00064075773],"study_design_scores_gemma":[0.0059437887,0.0020640807,0.98998135,0.00019193943,0.00026916922,0.0000015368007,0.00025983748,0.00025217177,0.00086034794,0.000044219534,0.00001703621,0.00011454139],"about_ca_topic_score_codex":0.000036709815,"about_ca_topic_score_gemma":0.0005188832,"teacher_disagreement_score":0.0063953637,"about_ca_system_score_codex":0.000046063346,"about_ca_system_score_gemma":0.00009964211,"threshold_uncertainty_score":0.49515647},"labels":[],"label_agreement":null},{"id":"W4376872039","doi":"10.1182/bloodadvances.2023010177","title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; University of Calgary; Cochrane","funders":"","keywords":"Thrombophilia; Medicine; Guideline; Family history; Intensive care medicine; Venous thromboembolism; Population; Thrombosis; Venous thrombosis; Factor V Leiden; Risk assessment; Internal medicine; Pathology","score_opus":0.0930723388499114,"score_gpt":0.3781031772352406,"score_spread":0.2850308383853292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376872039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769552,0.0074659595,0.0010285216,0.0046677557,0.00065133505,0.0028715553,0.00013955538,0.00039448807,0.0058256816],"genre_scores_gemma":[0.77325386,0.016947784,0.20640147,0.001372586,0.00043194264,0.00055366475,0.000120730685,0.00011916548,0.00079878536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981045,0.00001782851,0.00071536965,0.00039886503,0.00033250495,0.00043091972],"domain_scores_gemma":[0.99839985,0.00020876048,0.00045310252,0.00040795922,0.0004554522,0.00007487087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035084918,0.00022117532,0.0012475243,0.00012042446,0.00009066364,0.0000058462933,0.0002024759,0.000049398423,0.000019608977],"category_scores_gemma":[0.00012433056,0.00019450915,0.00027496822,0.0009216045,0.00027022223,0.00007877769,0.00016029857,0.00006700764,0.000011466058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033285035,0.013073455,0.058927603,0.048135716,0.014396421,0.00021687125,0.0027794188,0.0039281864,0.05314165,0.057514496,0.2346804,0.51287293],"study_design_scores_gemma":[0.014531461,0.012960087,0.64291227,0.007968338,0.010793501,0.0001317468,0.031009493,0.0040916223,0.09110225,0.024820099,0.15760428,0.0020748496],"about_ca_topic_score_codex":0.00007800007,"about_ca_topic_score_gemma":0.000009952054,"teacher_disagreement_score":0.5839847,"about_ca_system_score_codex":0.000014629922,"about_ca_system_score_gemma":0.00004297828,"threshold_uncertainty_score":0.7931853},"labels":[],"label_agreement":null},{"id":"W4376959694","doi":"10.1182/bloodadvances.2023010044","title":"Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hyundai Hope On Wheels; Anschutz Medical Campus, University of Colorado; National Cancer Institute; National Institutes of Health; School of Medicine, New York University; York University; Children’s Oncology Group","keywords":"Lymphoblastic Leukemia; Flow cytometry; Leukemia; Medicine; Childhood leukemia; Immunology; Cancer research; Oncology","score_opus":0.016970780151433915,"score_gpt":0.3207494288736001,"score_spread":0.30377864872216614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376959694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934095,0.0010342688,0.00026939166,0.00014264636,0.0002679402,0.00087544194,0.00013442019,0.00032774353,0.0035386293],"genre_scores_gemma":[0.990822,0.0019065872,0.0048430623,0.00014417524,0.00012084826,0.00014058284,0.00018939277,0.000099117235,0.0017342322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99531823,0.0001440467,0.0011842899,0.0007873527,0.0014398759,0.0011261884],"domain_scores_gemma":[0.9970454,0.0013069169,0.00040051877,0.0006645884,0.00024771676,0.00033485628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000797054,0.00047770495,0.0012383579,0.0019336023,0.000108412816,0.000037259008,0.0005161678,0.00028392815,0.00009334128],"category_scores_gemma":[0.0012602175,0.00041800775,0.00028316124,0.005951697,0.0001936386,0.00033349305,0.00032145865,0.0005486028,0.0001498799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000390492,0.002696144,0.9333316,0.0012257659,0.0013552962,0.0025739854,0.00067118614,0.019502755,0.02372896,0.00012966622,0.0014646233,0.012929537],"study_design_scores_gemma":[0.028767152,0.0014551814,0.8797152,0.00051474303,0.0008021911,0.00012291865,0.00043614962,0.06778646,0.01896894,0.00023220903,0.0005375162,0.0006613617],"about_ca_topic_score_codex":0.00011944298,"about_ca_topic_score_gemma":0.00003262139,"teacher_disagreement_score":0.05361641,"about_ca_system_score_codex":0.003566951,"about_ca_system_score_gemma":0.0030419666,"threshold_uncertainty_score":0.99982715},"labels":[],"label_agreement":null},{"id":"W4378903121","doi":"10.1182/bloodadvances.2023010281","title":"Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of British Columbia; Pediatric Oncology Group","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Cyclophosphamide; Cumulative incidence; Internal medicine; Tacrolimus; Incidence (geometry); Transplantation; Graft-versus-host disease; Myelodysplastic syndromes; Bone marrow; Gastroenterology; Surgery; Chemotherapy","score_opus":0.01346082217133303,"score_gpt":0.282818043183776,"score_spread":0.26935722101244297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378903121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992224,0.00058725465,0.0013282395,0.00017054344,0.00022826764,0.0031817055,0.00028306746,0.00020090288,0.0017960592],"genre_scores_gemma":[0.9883101,0.0027783683,0.0069948197,0.000041771367,0.00033187438,0.00051019597,0.00017227756,0.000058352267,0.0008022319],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983763,0.000026386135,0.0004334521,0.00039893758,0.00042197507,0.00034293372],"domain_scores_gemma":[0.9988206,0.00045068486,0.0002121347,0.00021125346,0.00019792412,0.00010740929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019908318,0.0002306197,0.00053511304,0.00018228339,0.00007927013,0.00000848068,0.00009660002,0.0000904585,0.000014267986],"category_scores_gemma":[0.00005325854,0.0001743792,0.00012317995,0.00066803116,0.000088400324,0.00017044143,0.000008163947,0.00012582276,0.000017321028],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4192631,0.002859455,0.4636869,0.013504744,0.004747343,0.0020559188,0.019280802,0.0008956293,0.0625961,0.0056784344,0.00044678416,0.0049847774],"study_design_scores_gemma":[0.290067,0.015450926,0.114812665,0.0011098355,0.008324772,0.00044486424,0.0013372478,0.00016369403,0.56397736,0.002359487,0.0010069357,0.0009452556],"about_ca_topic_score_codex":0.000011895422,"about_ca_topic_score_gemma":0.000012025283,"teacher_disagreement_score":0.5013812,"about_ca_system_score_codex":0.000033320295,"about_ca_system_score_gemma":0.00024743623,"threshold_uncertainty_score":0.7110977},"labels":[],"label_agreement":null},{"id":"W4379376555","doi":"10.1182/bloodadvances.2023010179","title":"Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Astellas Pharma; Daiichi Sankyo Europe; Agios Pharmaceuticals; Celgene; Gilead Sciences; Astex Pharmaceuticals; Daiichi-Sankyo; Pfizer; Amgen","keywords":"Internal medicine; Neutropenia; Medicine; Hazard ratio; Febrile neutropenia; Gastroenterology; Cytarabine; Population; Confidence interval; Leukemia; Chemotherapy","score_opus":0.02117231845214376,"score_gpt":0.36261403877819054,"score_spread":0.3414417203260468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379376555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881125,0.002807525,0.0000253517,0.0020835763,0.00023863601,0.0048821573,0.00010499424,0.0004016415,0.001343614],"genre_scores_gemma":[0.9873259,0.005428368,0.0008958894,0.000329293,0.0005423772,0.0020925438,0.00019326557,0.00006817265,0.0031242],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961251,0.00038364,0.0008193106,0.0008793265,0.00082170207,0.0009709055],"domain_scores_gemma":[0.9972552,0.0013567846,0.00016929623,0.00071257714,0.00012916571,0.00037694207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083295396,0.00050472375,0.0017153246,0.0003935593,0.00013463112,0.000055921057,0.00033893232,0.00014532033,0.00011899295],"category_scores_gemma":[0.0013519556,0.0003706332,0.00030956304,0.0021800122,0.00022429133,0.00033853468,0.00016915683,0.00036406572,0.00030467322],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36457282,0.02418634,0.31758964,0.0003894169,0.0076174517,0.043653805,0.0050097946,0.0007560547,0.0076600765,0.00025187843,0.004844276,0.22346844],"study_design_scores_gemma":[0.950142,0.0048020175,0.02535638,0.0001389709,0.0014076714,0.00012802155,0.0012848402,0.0009988402,0.001698369,0.00016068254,0.013439846,0.00044231073],"about_ca_topic_score_codex":0.0013137058,"about_ca_topic_score_gemma":0.0013005284,"teacher_disagreement_score":0.5855692,"about_ca_system_score_codex":0.0013262834,"about_ca_system_score_gemma":0.0008184566,"threshold_uncertainty_score":0.99987453},"labels":[],"label_agreement":null},{"id":"W4379470548","doi":"10.1182/bloodadvances.2022009575","title":"Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Servier; Italfarmaco; Celltrion; Incyte; BeiGene; Pharmacyclics; MEI Pharma; Regeneron Pharmaceuticals; FibroGen; Gilead Sciences; Bayer HealthCare; Sanofi; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Cilag; Astellas Pharma; TG Therapeutics; Amgen; Pfizer; GlaxoSmithKline","keywords":"Refractory (planetary science); Medicine; Multicenter study; Open label; Oncology; Internal medicine; Cancer research; Clinical trial; Biology; Randomized controlled trial","score_opus":0.020355212790046588,"score_gpt":0.32105314748437636,"score_spread":0.30069793469432976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379470548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154824,0.0038559437,0.0000015974794,0.0002170138,0.000086010325,0.0013701888,0.000030183552,0.00012918284,0.0027616331],"genre_scores_gemma":[0.9944898,0.001022621,0.0018073578,0.00016475636,0.000070240676,0.00028546902,0.00004901421,0.000038985552,0.0020717373],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99872553,0.00003980777,0.0002197785,0.00047787465,0.00024658695,0.000290406],"domain_scores_gemma":[0.9992154,0.00015958086,0.00011624375,0.0002993304,0.000049348866,0.00016008837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008846931,0.00024849214,0.00038907453,0.00008710528,0.00017045058,0.00008487222,0.00010340935,0.000050698804,0.000032149554],"category_scores_gemma":[0.000031355947,0.0001609215,0.00002431305,0.00025296744,0.00004743371,0.00029932297,0.00010868428,0.000110571695,0.000052367886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038529763,0.060172636,0.7966349,0.00046117217,0.0009907117,0.0062832246,0.005036929,0.000012770766,0.0037449175,0.000039481292,0.0015558132,0.12121443],"study_design_scores_gemma":[0.6178358,0.05334522,0.2316843,0.0020098572,0.004811826,0.00055475696,0.017823787,0.0006028881,0.026083918,0.00006116104,0.043802097,0.0013843612],"about_ca_topic_score_codex":0.0000844552,"about_ca_topic_score_gemma":0.00011260477,"teacher_disagreement_score":0.61398286,"about_ca_system_score_codex":0.000033842178,"about_ca_system_score_gemma":0.000054110285,"threshold_uncertainty_score":0.6562188},"labels":[],"label_agreement":null},{"id":"W4379879292","doi":"10.1182/bloodadvances.2023010722","title":"CNL and aCML are prognostically distinct: a large National Cancer Database analysis","year":2023,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sierra Oncology; MorphoSys; Astellas Pharma; Galecto; Incyte; Bristol-Myers Squibb; Constellation Pharmaceuticals; CTI Biopharma; Gilead Sciences; Karyopharm Therapeutics; Celgene","keywords":"Oncology; Medicine","score_opus":0.021608255773769108,"score_gpt":0.3620123949419686,"score_spread":0.34040413916819945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379879292","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052276994,0.039443873,0.00047759945,0.89852387,0.0009772162,0.00239588,0.046064567,0.0005883239,0.006300949],"genre_scores_gemma":[0.046238065,0.013296643,0.00886632,0.7540694,0.020361442,0.005129538,0.07846024,0.0004519051,0.07312645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819696,0.000026795306,0.00026299123,0.00058644766,0.0005894898,0.00033730365],"domain_scores_gemma":[0.99894744,0.00025547837,0.00019247261,0.00024699027,0.00025532264,0.00010231227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076236494,0.0002757667,0.0005379234,0.00028144434,0.00014719255,0.00004543135,0.0000887339,0.00016749691,0.00022903147],"category_scores_gemma":[0.00027713538,0.00021142953,0.00014738613,0.0005010997,0.00008195918,0.00012751012,0.00007076083,0.0004336253,0.000026535858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048115853,0.00047968776,0.3050797,0.001500871,0.011320091,0.0023362103,0.00016632736,0.000010425456,0.000011826951,0.00012451847,0.676855,0.002067221],"study_design_scores_gemma":[0.0016166805,0.00008405235,0.060772844,0.00047746388,0.017243033,0.000022962884,0.00004680537,0.000059225844,0.0000146166785,0.00019730357,0.919173,0.0002920008],"about_ca_topic_score_codex":0.00008005656,"about_ca_topic_score_gemma":0.0008311166,"teacher_disagreement_score":0.24430685,"about_ca_system_score_codex":0.00007430983,"about_ca_system_score_gemma":0.000292726,"threshold_uncertainty_score":0.86218464},"labels":[],"label_agreement":null},{"id":"W4380357995","doi":"10.1182/bloodadvances.2023009804","title":"Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Ohio State University","keywords":"Mantle cell lymphoma; Oncology; Internal medicine; Cohort; Medicine; Nomogram; Rituximab; Population; Transplantation; Immunology; Lymphoma","score_opus":0.006465866825415123,"score_gpt":0.2592110797599587,"score_spread":0.2527452129345436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380357995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950242,0.003151804,1.1762208e-7,0.0005215854,0.000037785896,0.0004703357,0.00003304341,0.000051578845,0.0007095162],"genre_scores_gemma":[0.99714524,0.00024566328,0.00032153272,0.000109383516,0.000033092085,0.000097643715,0.00002946532,0.000019148609,0.0019988583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991184,0.000017583558,0.00020620847,0.00026252985,0.00020960401,0.00018571063],"domain_scores_gemma":[0.9994368,0.0000907938,0.00007703362,0.00018065862,0.000026536,0.00018819358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006270611,0.00014879362,0.0003015017,0.00015014588,0.000028931008,0.000006416164,0.000038738403,0.000031795433,0.00006306091],"category_scores_gemma":[0.000028795284,0.000094178955,0.000038748618,0.0002535572,0.00005549982,0.00008016744,0.000045413515,0.00002726031,0.00006790468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060177525,0.0027310632,0.96179587,0.00035019006,0.000063948486,0.0005067657,0.00023653361,0.000022737053,0.001663286,0.00000716167,0.00042289597,0.03159776],"study_design_scores_gemma":[0.010628072,0.0017934704,0.9382961,0.0007151044,0.00018468173,0.000007719787,0.00015034343,0.000026071568,0.040228434,0.000030533763,0.0077651767,0.00017429725],"about_ca_topic_score_codex":0.0000072199678,"about_ca_topic_score_gemma":0.000021030612,"teacher_disagreement_score":0.03856515,"about_ca_system_score_codex":0.000027120048,"about_ca_system_score_gemma":0.00006784312,"threshold_uncertainty_score":0.3840506},"labels":[],"label_agreement":null},{"id":"W4380371132","doi":"10.1182/bloodadvances.2022009430","title":"Intravital imaging of three different microvascular beds in SARS-CoV-2–infected mice","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"University of Toronto; Canadian Institutes of Health Research; Sunnybrook Research Institute","keywords":"Microcirculation; Intravital microscopy; Endothelium; Pathology; Platelet; Blood–brain barrier; Respiratory tract; Biology; Epithelium; Pathogenesis; Immunology; Respiratory system; Medicine; Central nervous system; Anatomy; Endocrinology; Internal medicine","score_opus":0.010630488241704313,"score_gpt":0.29045159685349853,"score_spread":0.2798211086117942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380371132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945313,0.0032222576,0.00013205102,0.00087698776,0.00021406784,0.00060519064,0.000009137216,0.00018614982,0.0002228698],"genre_scores_gemma":[0.99863046,0.00021738165,0.00059444027,0.00029987868,0.00011672535,0.000038576647,0.000044311484,0.000037160033,0.000021048676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850327,0.000052693977,0.0003616274,0.00036282273,0.00032809682,0.0003914843],"domain_scores_gemma":[0.99901116,0.00036569725,0.00011447191,0.00037269184,0.00006564463,0.000070356415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019992067,0.00023190705,0.00051986205,0.00034927324,0.00003344992,0.000015509913,0.00017900397,0.00005894472,0.000008930353],"category_scores_gemma":[0.00043880384,0.0001950174,0.00016229172,0.0005774563,0.00012613766,0.00020699232,0.000108384025,0.0002025169,0.000030105937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006658645,0.0002476356,0.39880475,0.00060635776,0.000093601084,0.00026509137,0.0001425701,0.000010325018,0.5950601,0.00006749467,0.000066457775,0.0045690075],"study_design_scores_gemma":[0.003854946,0.00019729829,0.33743122,0.0005846619,0.00021061236,0.000059657603,0.000047394646,0.0001728643,0.6554914,0.0010798888,0.00065304595,0.00021702985],"about_ca_topic_score_codex":0.00011626534,"about_ca_topic_score_gemma":0.00028837417,"teacher_disagreement_score":0.061373528,"about_ca_system_score_codex":0.000041602536,"about_ca_system_score_gemma":0.00006426651,"threshold_uncertainty_score":0.7952579},"labels":[],"label_agreement":null},{"id":"W4380685261","doi":"10.1182/bloodadvances.2023009885","title":"Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Japan Society for the Promotion of Science; National Institutes of Health; National Cancer Institute; José Carreras Leukämie-Stiftung","keywords":"Medicine; Cumulative incidence; Internal medicine; Graft-versus-host disease; Incidence (geometry); Disease; Cyclophosphamide; Biomarker; Hematopoietic stem cell transplantation; Clinical trial; Transplantation; Immunology; Oncology; Chemotherapy","score_opus":0.025746735733503463,"score_gpt":0.3624145960327663,"score_spread":0.3366678602992629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380685261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808455,0.00037039976,0.00013842463,0.0003009541,0.00018145391,0.000339191,0.00003589753,0.00010538235,0.00044375172],"genre_scores_gemma":[0.9906776,0.0064384993,0.0023792842,0.00008721525,0.00003200037,0.000018719835,0.00006793835,0.00001742923,0.00028132467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987397,0.000103228995,0.00042991617,0.00027385997,0.00021410108,0.00023917276],"domain_scores_gemma":[0.9988812,0.0007040983,0.00010548787,0.00015232031,0.000030509873,0.00012636106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004809094,0.00012560995,0.00029742502,0.00015980426,0.000046367815,0.000014181262,0.00006251328,0.00008685349,0.00003088096],"category_scores_gemma":[0.00028128692,0.00010141837,0.00005553086,0.0003827174,0.00008688278,0.00016446087,0.000019716039,0.00014662668,0.000024550876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057311012,0.000068754285,0.99580234,0.00009665743,0.00018355105,0.00022506858,0.00060847873,0.000014276161,0.0003330805,0.000017460388,0.00004052517,0.0025524849],"study_design_scores_gemma":[0.0026305574,0.00009282956,0.9940114,0.00008603039,0.0002791427,0.00003750207,0.00033688184,0.0001288312,0.0015952266,0.0003829793,0.0003137229,0.00010492237],"about_ca_topic_score_codex":0.00008292339,"about_ca_topic_score_gemma":0.00010938739,"teacher_disagreement_score":0.007406956,"about_ca_system_score_codex":0.000013035597,"about_ca_system_score_gemma":0.00006203733,"threshold_uncertainty_score":0.4135721},"labels":[],"label_agreement":null},{"id":"W4380985977","doi":"10.1182/bloodadvances.2022009468","title":"Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Loxo Oncology; York University; Marie-Josée and Henry R. Kravis Center for Molecular Oncology; NYU Langone Medical Center; Chugai Pharmaceutical; Memorial Sloan-Kettering Cancer Center; Cycle for Survival","keywords":"Myeloid leukemia; Immunology; Hematopoietic stem cell transplantation; Medicine; Immune system; CD8; Leukemia; Myeloid; Haematopoiesis; T cell; Transplantation; Tumor necrosis factor alpha; Stem cell; Cancer research; Biology; Internal medicine","score_opus":0.008981657316935949,"score_gpt":0.2537584699366275,"score_spread":0.24477681261969153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380985977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992894,0.003997777,0.00028451098,0.00012195032,0.00022081318,0.00071082043,0.000027537018,0.00022951505,0.0015130625],"genre_scores_gemma":[0.97973436,0.01618378,0.0028737676,0.000071653216,0.00013430418,0.00025096175,0.0002228353,0.00004949058,0.000478838],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981129,0.000052854797,0.000569508,0.0004311381,0.00038157456,0.0004519878],"domain_scores_gemma":[0.9993592,0.00013473858,0.00010637985,0.00024620176,0.000046003217,0.00010749323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025573582,0.00024404569,0.00038695475,0.00038633237,0.00005097552,0.00001753108,0.0001090476,0.00012946661,0.000052430263],"category_scores_gemma":[0.000012173847,0.00022837092,0.000111095585,0.0009148157,0.000035568104,0.00021715483,0.0000127812655,0.00021039927,0.0002559679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077241537,0.00032036088,0.7871961,0.008443626,0.00009170214,0.004105974,0.0038504323,0.00062387175,0.19309364,0.000085366926,0.000015456144,0.0014010783],"study_design_scores_gemma":[0.0056141876,0.00025221988,0.45807207,0.00044196346,0.0012313024,0.00054433057,0.0004757093,0.0001190343,0.5323425,0.00027753614,0.00013789418,0.0004912686],"about_ca_topic_score_codex":0.0000090061985,"about_ca_topic_score_gemma":0.000017912202,"teacher_disagreement_score":0.33924887,"about_ca_system_score_codex":0.00005027061,"about_ca_system_score_gemma":0.00014805111,"threshold_uncertainty_score":0.9312696},"labels":[],"label_agreement":null},{"id":"W4381838960","doi":"10.1182/bloodadvances.2023010254","title":"Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Seagen; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Nivolumab; Neutropenia; Oncology; Adverse effect; Transplantation; Clinical endpoint; Confidence interval; Lymphoma; Surgery; Chemotherapy; CD30; Clinical trial; Immunotherapy; Cancer","score_opus":0.0092442261172573,"score_gpt":0.24120245862217496,"score_spread":0.23195823250491765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381838960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899323,0.002746178,0.00007355433,0.00069642847,0.00043376273,0.0012670052,0.00017216841,0.00036247008,0.004316124],"genre_scores_gemma":[0.99051464,0.0005748619,0.0034096553,0.00037164296,0.00025848288,0.0007025612,0.0005333752,0.00006908751,0.003565677],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981134,0.000024081892,0.0002838629,0.0004938202,0.00042525126,0.00065956346],"domain_scores_gemma":[0.99896073,0.0002462181,0.00013480909,0.0003277892,0.00012627975,0.00020418323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001558014,0.00029278212,0.00053769525,0.00012910274,0.00019403081,0.000029840437,0.00012430786,0.000070684095,0.000035169855],"category_scores_gemma":[0.00006187079,0.00021534834,0.00017895945,0.00039252042,0.00006645191,0.00015212293,0.000068580404,0.000050179027,0.00012997306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022086745,0.0524713,0.75169826,0.00417045,0.002388713,0.0028760643,0.0018817069,0.00002069706,0.0032416843,0.003589029,0.03268051,0.122894816],"study_design_scores_gemma":[0.4840712,0.015842265,0.3254312,0.0009621298,0.0028321506,0.000274413,0.0016161768,0.00019603738,0.03174592,0.0005465681,0.13538718,0.0010947686],"about_ca_topic_score_codex":0.000016195285,"about_ca_topic_score_gemma":0.000060860748,"teacher_disagreement_score":0.46198446,"about_ca_system_score_codex":0.0000920037,"about_ca_system_score_gemma":0.00026397116,"threshold_uncertainty_score":0.87816507},"labels":[],"label_agreement":null},{"id":"W4382653589","doi":"10.1182/bloodadvances.2023010684","title":"Huynh A, Arnold DM, Michael JV, et al. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. <i>Blood Adv.</i> 2023;7(2):246-250.","year":2023,"lang":"en","type":"erratum","venue":"Blood Advances","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada; American Society of Hematology","keywords":"Antibody; Medicine; Internal medicine; Immunology","score_opus":0.012550401436886606,"score_gpt":0.2733805971205031,"score_spread":0.2608301956836165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382653589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96080726,0.0055025187,0.0000042796373,0.001492836,0.010836106,0.0026082888,0.0017772409,0.00044369954,0.01652777],"genre_scores_gemma":[0.8555191,0.066848144,0.0014305412,0.004850153,0.0015380774,0.00033392568,0.013516981,0.0011178204,0.054845218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99432653,0.00021085881,0.0016398183,0.0014906159,0.0011770946,0.0011550616],"domain_scores_gemma":[0.9962039,0.00023399277,0.0013115217,0.0012425656,0.0006590255,0.00034899486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042989646,0.0012274756,0.003365409,0.0008704275,0.00014466942,0.000060653754,0.0006385964,0.0007637066,0.00010924963],"category_scores_gemma":[0.0004931603,0.0010525755,0.00033537255,0.0013617581,0.0002324012,0.00048688985,0.00037544686,0.0021306386,0.00011664184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014745501,0.0089161685,0.77952296,0.007142257,0.0043823435,0.0013055227,0.0010198758,0.000008768044,0.007559721,0.00011623556,0.183616,0.004935602],"study_design_scores_gemma":[0.011957556,0.003566603,0.71472293,0.009415162,0.0029341816,0.00005704066,0.00028968827,0.000012442539,0.0071548168,0.00009029229,0.24803863,0.0017606188],"about_ca_topic_score_codex":0.00038151274,"about_ca_topic_score_gemma":0.0006076116,"teacher_disagreement_score":0.10528812,"about_ca_system_score_codex":0.0000881775,"about_ca_system_score_gemma":0.0007112167,"threshold_uncertainty_score":0.9991925},"labels":[],"label_agreement":null},{"id":"W4383216145","doi":"10.1182/bloodadvances.2023010045","title":"Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in <i>RUNX1</i>, <i>GATA2</i>, and <i>DDX41</i>","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Alberta Children's Hospital","funders":"Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; National Health and Medical Research Council; Cancer Council South Australia; Medical Research Council; National Institutes of Health; Damon Runyon Cancer Research Foundation; Associazione Italiana per la Ricerca sul Cancro; NHLBI Division of Intramural Research; Royal Adelaide Hospital; Bundesministerium für Bildung und Forschung; Government of South Australia; European Commission; Hospital Research Foundation; Edward P. Evans Foundation; European Hematology Association","keywords":"RUNX1; Germline; GATA2; CEBPA; Germline mutation; Cancer research; Biology; Haematopoiesis; Somatic cell; Epigenetics; Genetics; Oncology; Medicine; Mutation; Gene; Stem cell","score_opus":0.010879256937614276,"score_gpt":0.2717886854290961,"score_spread":0.26090942849148185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383216145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882934,0.008814849,0.000024914583,0.0014233635,0.00008911015,0.0004596471,0.00016447385,0.00009999493,0.00063024316],"genre_scores_gemma":[0.9952208,0.0018791207,0.001165282,0.00029283986,0.000121830555,0.0000905671,0.00030190428,0.000043274697,0.0008843848],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980802,0.00006468044,0.0005030442,0.00036990887,0.00054671464,0.00043545204],"domain_scores_gemma":[0.9989344,0.00042697092,0.00012423923,0.00026668725,0.000097003634,0.00015068639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003872629,0.00020647555,0.0005157553,0.0002505782,0.000057566696,0.000015072921,0.00014315215,0.00009147831,0.00006777447],"category_scores_gemma":[0.00027172567,0.00017919923,0.000054054886,0.00082273805,0.00018285622,0.0002575861,0.000104066596,0.00021782007,0.000033034386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077762577,0.0021548134,0.38888583,0.009345648,0.00074692024,0.006461254,0.004314442,0.00039503482,0.53625673,0.0009047377,0.042803697,0.006953251],"study_design_scores_gemma":[0.05017668,0.00273922,0.5193468,0.005225037,0.0010990837,0.0037008887,0.010160764,0.00857232,0.3677955,0.013041288,0.015758554,0.0023839222],"about_ca_topic_score_codex":0.000035874626,"about_ca_topic_score_gemma":0.000033544187,"teacher_disagreement_score":0.16846126,"about_ca_system_score_codex":0.00002519693,"about_ca_system_score_gemma":0.00020459163,"threshold_uncertainty_score":0.73075324},"labels":[],"label_agreement":null},{"id":"W4384664622","doi":"10.1182/bloodadvances.2023010599","title":"Improved outcomes of UM171–expanded cord blood transplantation compared with other graft sources: real-world evidence","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Université Laval; Centre hospitalier universitaire de Québec; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"Sanofi; Stem Cell Network; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Astellas Pharma; bluebird bio","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Cord blood; Graft-versus-host disease; Surgery; Oncology","score_opus":0.034450255736465575,"score_gpt":0.3177718699345521,"score_spread":0.2833216141980865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384664622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581,0.00047265264,0.00087366713,0.00025624144,0.00010198163,0.00082424964,0.000058147107,0.00030066486,0.0013024053],"genre_scores_gemma":[0.9925478,0.0016406683,0.004224466,0.00010026548,0.00004859236,0.00008733695,0.00007793264,0.00004706762,0.0012258617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982104,0.00006221512,0.00053856993,0.0003864732,0.00048183382,0.00032051152],"domain_scores_gemma":[0.99862814,0.000542138,0.00025570046,0.00032995694,0.00012485024,0.00011919526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022752947,0.00025429213,0.0006079913,0.0002508854,0.0000698655,0.000015639755,0.00013922548,0.000061179686,0.000066442844],"category_scores_gemma":[0.000033921264,0.00018860745,0.000102305006,0.00069311284,0.00013452576,0.00023863818,0.0000074875347,0.00012221477,0.000019056186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015913508,0.00038960125,0.8835736,0.0028255072,0.000498013,0.00013087314,0.0027818095,0.00010925999,0.10701212,0.00016431378,0.00001343604,0.0009101197],"study_design_scores_gemma":[0.012236209,0.0016144802,0.532593,0.0036927648,0.003384102,0.00021501882,0.0014954376,0.0002608011,0.4433964,0.00015268926,0.00039950144,0.00055961346],"about_ca_topic_score_codex":0.00030831294,"about_ca_topic_score_gemma":0.0012596743,"teacher_disagreement_score":0.35098058,"about_ca_system_score_codex":0.000011236206,"about_ca_system_score_gemma":0.00008766027,"threshold_uncertainty_score":0.76911885},"labels":[],"label_agreement":null},{"id":"W4385476260","doi":"10.1182/bloodadvances.2023010334","title":"Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Merck Sharp and Dohme; Celgene; MorphoSys; Innovent Biologics; Regeneron Pharmaceuticals; Seagen; Pfizer; Hexal AG; Genentech; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Cohort; Internal medicine; Refractory (planetary science); Brentuximab vedotin; Lymphoma; Confidence interval; Progression-free survival; Gastroenterology; Surgery; Oncology; Overall survival; Hodgkin lymphoma; Immunotherapy; Cancer","score_opus":0.02890083118372735,"score_gpt":0.32613031287046934,"score_spread":0.297229481686742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385476260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926845,0.0025206613,0.000011433483,0.0013008772,0.000779835,0.0013640035,0.00031661932,0.00024534288,0.0007767392],"genre_scores_gemma":[0.9962618,0.000548034,0.00030403197,0.00015600328,0.0008280373,0.00056595105,0.00023109574,0.000050477982,0.0010546152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980653,0.000091210255,0.00035725487,0.00054618553,0.00045942736,0.00048065596],"domain_scores_gemma":[0.998311,0.00080622535,0.00013006618,0.00051595597,0.000076480974,0.00016029573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002801014,0.0002836043,0.00049690047,0.000057362642,0.0002868674,0.000051699142,0.00019245967,0.00008266349,0.000081778606],"category_scores_gemma":[0.00021626211,0.00017928833,0.0002234101,0.00028597802,0.000108829074,0.00016218459,0.00009507031,0.000086035514,0.00017496313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005087939,0.05766614,0.64193106,0.00013710636,0.0034658313,0.001547303,0.0029298186,0.00001732172,0.0027740854,0.0011478725,0.026096722,0.2571988],"study_design_scores_gemma":[0.118729085,0.009027906,0.62200236,0.00017000837,0.0021851698,0.000026721078,0.006707868,0.00017249736,0.005639198,0.00063180295,0.23413897,0.0005684205],"about_ca_topic_score_codex":0.00016255607,"about_ca_topic_score_gemma":0.00019570993,"teacher_disagreement_score":0.2566304,"about_ca_system_score_codex":0.00008665807,"about_ca_system_score_gemma":0.00013260868,"threshold_uncertainty_score":0.7311166},"labels":[],"label_agreement":null},{"id":"W4385477402","doi":"10.1182/bloodadvances.2023010628","title":"Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Celgene; MorphoSys; Astellas Pharma; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Constellation Pharmaceuticals; Astex Pharmaceuticals; Jazz Pharmaceuticals; AOP Orphan; GlaxoSmithKline","keywords":"Ruxolitinib; Myelofibrosis; Matching (statistics); Medicine; Internal medicine; Pathology","score_opus":0.02895329108079735,"score_gpt":0.3213575054599074,"score_spread":0.29240421437911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385477402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946236,0.0015348067,0.000005164787,0.0016345158,0.00015919078,0.000688558,0.000024682888,0.000073966214,0.0012555238],"genre_scores_gemma":[0.99814504,0.0007735212,0.00032820785,0.00015183572,0.00004144734,0.00015000637,0.000040303854,0.000021741867,0.00034787518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865466,0.00010822902,0.0004031934,0.00025779585,0.00034228564,0.00023382845],"domain_scores_gemma":[0.9991458,0.00028166317,0.00020197175,0.00024579052,0.000073279494,0.000051464755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016240941,0.00017392068,0.000495748,0.00017147759,0.000091524336,0.000013800967,0.000111725596,0.000067443005,0.000049417653],"category_scores_gemma":[0.000057801502,0.00011708287,0.00010292608,0.0007179073,0.00006764669,0.00010354896,0.000036070196,0.00014245007,0.00002229271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002333225,0.0012076691,0.9796142,0.00014590885,0.00011959944,0.000008363925,0.002679546,0.0001833981,0.0029037856,0.0016023411,0.00017578035,0.011126083],"study_design_scores_gemma":[0.0040782634,0.0005283123,0.8613773,0.00035698854,0.00009314989,0.000004888989,0.0008123079,0.0001522944,0.12939477,0.0011387053,0.0019482542,0.00011478471],"about_ca_topic_score_codex":0.000113469905,"about_ca_topic_score_gemma":0.0003282086,"teacher_disagreement_score":0.12649098,"about_ca_system_score_codex":0.000039497358,"about_ca_system_score_gemma":0.00005750257,"threshold_uncertainty_score":0.4774501},"labels":[],"label_agreement":null},{"id":"W4385644744","doi":"10.1182/bloodadvances.2023010151","title":"Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Genentech; Italfarmaco; Swedish Orphan Biovitrum; Grifols; Actuate Therapeutics; Galecto; Sierra Oncology; Pfizer; Incyte; CTI Biopharma; Bristol-Myers Squibb; Constellation Pharmaceuticals; Acceleron; Astellas Pharma; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Alexion Pharmaceuticals; Karyopharm Therapeutics; National Cancer Institute; Gilead Sciences; Sanofi; MorphoSys; Celgene; AstraZeneca; Amgen","keywords":"Ruxolitinib; Anemia; Myelofibrosis; IC50; Medicine; Pharmacology; Cmax; Potency; Internal medicine; Chemistry; Pharmacokinetics; Bone marrow; Biochemistry; In vitro","score_opus":0.006939995416863052,"score_gpt":0.2316811282671716,"score_spread":0.22474113285030856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385644744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963855,0.00037486776,0.000002866639,0.0014080366,0.000049178136,0.00096236303,0.00011892403,0.00010660288,0.0005916665],"genre_scores_gemma":[0.9965414,0.00039303856,0.0016097974,0.00048630088,0.00008410983,0.00037950798,0.00014477374,0.00004364477,0.00031747328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981785,0.000020588372,0.0002852324,0.00053766934,0.000535743,0.00044229458],"domain_scores_gemma":[0.9991914,0.00009307701,0.00009967925,0.00027561028,0.00015578445,0.00018447122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006465087,0.00030134013,0.0004517245,0.00017607557,0.00009461165,0.000031165226,0.000067892215,0.000061927836,0.000070785376],"category_scores_gemma":[0.000025490614,0.00018772233,0.000053966538,0.0006321655,0.00007869083,0.00017941256,0.000033684966,0.00013795914,0.000058804515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077691826,0.0012633393,0.9866226,0.00013468489,0.00010588123,0.00020530909,0.00041545168,0.00003712559,0.00021021554,0.00005140471,0.00029276882,0.009884322],"study_design_scores_gemma":[0.009628319,0.00428787,0.9482215,0.00086321466,0.00021058328,0.000009087559,0.0003796231,0.0000081664875,0.033929598,0.000047776175,0.0021163167,0.00029796863],"about_ca_topic_score_codex":0.00003471857,"about_ca_topic_score_gemma":0.00009252498,"teacher_disagreement_score":0.0384011,"about_ca_system_score_codex":0.00005235692,"about_ca_system_score_gemma":0.00007033338,"threshold_uncertainty_score":0.7655094},"labels":[],"label_agreement":null},{"id":"W4385666790","doi":"10.1182/bloodadvances.2023010402","title":"Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Lymphoma; Cohort; Internal medicine; Rituximab; Oncology; Medicine; Cancer research; Biology; B cell; Immunology; Antibody","score_opus":0.012117921329800859,"score_gpt":0.3426426693604537,"score_spread":0.3305247480306528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385666790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978884,0.0013905488,9.250102e-7,0.000057401154,0.000016099779,0.00043252404,0.000054707565,0.000017723793,0.00014165626],"genre_scores_gemma":[0.9990262,0.00074380304,0.000075837015,0.0000053152667,0.000015101118,0.000021869871,0.000072683295,0.000007862253,0.00003133243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991725,0.00005066016,0.00027412784,0.00019991712,0.00017864112,0.00012415265],"domain_scores_gemma":[0.9994456,0.00015155053,0.00011553595,0.00017058649,0.000055451244,0.00006127904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016662266,0.000107232336,0.00040269212,0.000073851144,0.000012688006,0.0000031419472,0.000033888078,0.000035065612,0.0000035066973],"category_scores_gemma":[0.0000613604,0.00006561421,0.00006700762,0.00047136887,0.000075905555,0.00005074416,0.000023023358,0.00006130756,7.7130375e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049076,0.0036738017,0.99156326,0.00005894844,0.00030222503,0.00031358562,0.0002183599,0.000023678069,0.00045444779,0.000022092865,0.00002018623,0.0028586318],"study_design_scores_gemma":[0.0068628364,0.0036095975,0.9863449,0.00017809312,0.00033104807,0.000007680957,0.00044206285,0.000010073163,0.0021123553,0.000025462099,0.000015637863,0.000060267605],"about_ca_topic_score_codex":0.0006849524,"about_ca_topic_score_gemma":0.00066991866,"teacher_disagreement_score":0.0063720765,"about_ca_system_score_codex":0.000023441686,"about_ca_system_score_gemma":0.000059895934,"threshold_uncertainty_score":0.26756698},"labels":[],"label_agreement":null},{"id":"W4385667451","doi":"10.1182/bloodadvances.2023010201","title":"Peripheral megakaryocytes sound the alarm in COVID-19","year":2023,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); ALARM; Peripheral; Sound (geography); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Acoustics; Internal medicine; Virology; Physics; Engineering; Electrical engineering","score_opus":0.0291288142618131,"score_gpt":0.3212929434661883,"score_spread":0.29216412920437523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385667451","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026659355,0.064415485,0.000022793218,0.9011176,0.0009469755,0.0010935932,0.00015434751,0.00030233324,0.0052874926],"genre_scores_gemma":[0.016326886,0.01152169,0.00054580974,0.94919795,0.0039302143,0.0007249082,0.00090799166,0.00010578252,0.016738763],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837244,0.00014829791,0.0002797916,0.0004846968,0.0002796632,0.00043512648],"domain_scores_gemma":[0.99877614,0.00054306455,0.0001193998,0.00045604014,0.000024553237,0.00008077828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016801314,0.0003266594,0.00057722646,0.00013073355,0.00015245021,0.00002561105,0.00018394145,0.0004151086,0.00016275575],"category_scores_gemma":[0.0002719212,0.00020608862,0.00015653388,0.00022248611,0.00028219598,0.000088816974,0.00005296367,0.0010930472,0.00013783427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020894664,0.00041518675,0.28688914,0.0010359423,0.0010787967,0.08051144,0.0013325196,0.00006249041,0.000035306268,0.00019639754,0.62549204,0.002741787],"study_design_scores_gemma":[0.0028095783,0.00031690043,0.010516508,0.00027045826,0.0006354564,0.0011052468,0.00013710445,0.0000026792454,0.00006979162,0.003516229,0.98035777,0.00026227027],"about_ca_topic_score_codex":0.00012507028,"about_ca_topic_score_gemma":0.00045540035,"teacher_disagreement_score":0.35486573,"about_ca_system_score_codex":0.00011910242,"about_ca_system_score_gemma":0.00023861456,"threshold_uncertainty_score":0.840405},"labels":[],"label_agreement":null},{"id":"W4385971683","doi":"10.1182/bloodadvances.2023010673","title":"Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Cilag; Terry Fox Research Institute; Medical Research Council; Blood Cancer UK; Cancer Research UK; Michael Smith Health Research BC","keywords":"Core (optical fiber); Internal medicine; Biology; Group (periodic table); Oncology; Medicine; Cancer research; Computational biology; Computer science; Chemistry; Telecommunications","score_opus":0.035797141671741854,"score_gpt":0.3546549687342862,"score_spread":0.31885782706254434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385971683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927938,0.006300888,8.120629e-7,0.00023803252,0.000020714613,0.0004233218,0.000032491535,0.0000325735,0.00015736687],"genre_scores_gemma":[0.9978519,0.000991679,0.0008762494,0.000044968005,0.000019589732,0.0001390852,0.000046229772,0.000009170723,0.000021100854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930155,0.000017005057,0.00020734199,0.00023129239,0.00008227548,0.00016051544],"domain_scores_gemma":[0.999589,0.00013607391,0.00009226233,0.000091195965,0.00002863885,0.00006282459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006307473,0.000115821575,0.00042645042,0.00009892441,0.000026492198,0.000008101524,0.000027258951,0.000045843353,0.000006662636],"category_scores_gemma":[0.00004663277,0.00007793138,0.000019308342,0.00022431859,0.0001041603,0.000075406715,0.000036864178,0.000038789014,0.0000017188756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001209605,0.00065014564,0.98955196,0.00022096615,0.00007361654,0.000045000514,0.00032670223,7.127845e-7,0.0012768024,0.00025665067,0.000039459916,0.0074370033],"study_design_scores_gemma":[0.004587925,0.0015406115,0.9900482,0.00039030856,0.00014647917,0.000025719151,0.00032469802,0.000025904985,0.002049561,0.00010060594,0.00067871023,0.00008127368],"about_ca_topic_score_codex":0.0000626341,"about_ca_topic_score_gemma":0.00015427977,"teacher_disagreement_score":0.0073557296,"about_ca_system_score_codex":0.000010572267,"about_ca_system_score_gemma":0.000018657305,"threshold_uncertainty_score":0.31779492},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4386208917","doi":"10.1182/bloodadvances.2023010460","title":"GPRC5C drives branched-chain amino acid metabolism in leukemogenesis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"H2020 Marie Skłodowska-Curie Actions; Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; European Commission","keywords":"Myeloid leukemia; Leukemia; Stem cell; Haematopoiesis; Cancer research; Ectopic expression; Biology; Myeloid; Bone marrow; Oxidative phosphorylation; Internal medicine; Immunology; Cell biology; Medicine; Biochemistry; Gene","score_opus":0.01762603045761066,"score_gpt":0.3000790506303253,"score_spread":0.2824530201727147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386208917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98095167,0.01280809,0.00006475519,0.0019850216,0.00022099329,0.0005198463,0.000022288421,0.00031044387,0.0031168696],"genre_scores_gemma":[0.98525465,0.0060564023,0.0024816783,0.00047859823,0.000522087,0.00016663525,0.0000585313,0.0000684706,0.004912947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977135,0.00010146755,0.00037755884,0.00053681777,0.0005496302,0.0007210276],"domain_scores_gemma":[0.99894154,0.00020470511,0.000076029544,0.0004788174,0.000084323714,0.00021458833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045389985,0.00025210314,0.0005459054,0.00057378085,0.000091141694,0.000025383923,0.0002726915,0.00012686482,0.00013699356],"category_scores_gemma":[0.00047206628,0.00021721034,0.00013059542,0.0015451158,0.00016554495,0.00029993648,0.00015842437,0.00035157768,0.0004968187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006193048,0.0006508225,0.14310539,0.00074320054,0.0004222262,0.002888,0.0024284488,0.00032491985,0.5667541,0.0017249633,0.0032378433,0.27710077],"study_design_scores_gemma":[0.00985697,0.0002479473,0.41529915,0.00026178645,0.0002524735,0.00018773318,0.001667757,0.0010443527,0.44022423,0.0014981899,0.12879874,0.00066069304],"about_ca_topic_score_codex":0.00005801732,"about_ca_topic_score_gemma":0.000098812045,"teacher_disagreement_score":0.27644005,"about_ca_system_score_codex":0.0000940124,"about_ca_system_score_gemma":0.00026324653,"threshold_uncertainty_score":0.88575804},"labels":[],"label_agreement":null},{"id":"W4386881796","doi":"10.1182/bloodadvances.2022008899","title":"CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer; McGill University; Centre hospitalier universitaire de Québec; Université Laval; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fonds de Recherche du Québec - Santé; CHU Sainte-Justine Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Leukemia and Lymphoma Society; Child Health Research Foundation; Merck Canada; Cancer Research Society; Fondation Charles-Bruneau","keywords":"Acute megakaryoblastic leukemia; Cancer research; Leukemia; Cytarabine; Haematopoiesis; Biology; Immunology; Myeloid leukemia; Stem cell; Cell biology","score_opus":0.008774708589116527,"score_gpt":0.2881528674700445,"score_spread":0.27937815888092793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386881796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254227,0.0010507244,0.00019834396,0.0031406402,0.00020480444,0.00092887145,0.0003003306,0.00034520208,0.0012888092],"genre_scores_gemma":[0.97818905,0.0071340767,0.00170978,0.0024004267,0.0011811211,0.00018313072,0.00030706008,0.000111025955,0.008784318],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738383,0.000070438386,0.0003602694,0.00075242925,0.0006903024,0.0007427378],"domain_scores_gemma":[0.99848753,0.00035539237,0.00009404896,0.00034568165,0.00021870769,0.0004986619],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027383142,0.00033271697,0.00048742068,0.00044154705,0.00020839136,0.00005798014,0.00011140628,0.00016501876,0.00004928201],"category_scores_gemma":[0.00031633727,0.0002971167,0.00008967759,0.0014957573,0.00012949518,0.00038094362,0.00023618729,0.0004646629,0.0005981458],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021164692,0.0004491208,0.027667677,0.0014980324,0.0010240369,0.005829252,0.0050077485,0.00012381823,0.43876004,0.00025965608,0.48067608,0.03658805],"study_design_scores_gemma":[0.029773453,0.007969683,0.070242815,0.001259819,0.0044928794,0.0027353987,0.005104532,0.0030374783,0.6737798,0.0013979087,0.19661257,0.0035937077],"about_ca_topic_score_codex":0.0000626734,"about_ca_topic_score_gemma":0.000015727846,"teacher_disagreement_score":0.28406352,"about_ca_system_score_codex":0.00031637534,"about_ca_system_score_gemma":0.00035962908,"threshold_uncertainty_score":0.9999481},"labels":[],"label_agreement":null},{"id":"W4386945494","doi":"10.1182/bloodadvances.2023010591","title":"Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"Medac; Children’s Hospital of Wisconsin Research Institute","keywords":"Medicine; Busulfan; Cumulative incidence; Hematopoietic stem cell transplantation; Internal medicine; ThioTEPA; Fludarabine; Transplantation; Confidence interval; Total body irradiation; Gastroenterology; Pediatrics; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.04343310552699539,"score_gpt":0.381430650750109,"score_spread":0.33799754522311365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507385,0.00038684526,0.00051356055,0.0017882143,0.000113280345,0.0017410119,0.00010086634,0.00011647764,0.00016588932],"genre_scores_gemma":[0.9979048,0.00008373043,0.00043190175,0.00093677576,0.000095486095,0.00022142794,0.000103612045,0.000046352015,0.00017593741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822867,0.00010052295,0.0005180651,0.0004301135,0.00032983697,0.00039277537],"domain_scores_gemma":[0.99881893,0.00033848739,0.0002537372,0.00037869473,0.00010513993,0.00010499746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006503666,0.0002197921,0.00061440154,0.00016250099,0.00006288013,0.000015683228,0.00013085484,0.000058803824,0.000031047053],"category_scores_gemma":[0.00009980258,0.00019499779,0.00009917692,0.00049649505,0.000119733224,0.00020871668,0.000032976663,0.00015249732,0.0000070286505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005106771,0.021142447,0.9189507,0.00380731,0.0039668446,0.0002305094,0.020875074,0.0018222923,0.015880484,0.0013335537,0.00063988386,0.0062441393],"study_design_scores_gemma":[0.15782237,0.021994675,0.6212192,0.0031021866,0.002518355,0.000049239163,0.08201487,0.0009138092,0.09597588,0.008431425,0.0043603824,0.0015975569],"about_ca_topic_score_codex":0.00018853573,"about_ca_topic_score_gemma":0.0023777878,"teacher_disagreement_score":0.29773143,"about_ca_system_score_codex":0.000035338067,"about_ca_system_score_gemma":0.00014439564,"threshold_uncertainty_score":0.79517794},"labels":[],"label_agreement":null},{"id":"W4386955006","doi":"10.1182/bloodadvances.2023011481","title":"ASH Clinical Practice Guidelines: strategies to stay up-to-date","year":2023,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Blood Services; Health Sciences Centre; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Clinical Practice; Medicine; Intensive care medicine; Physical therapy","score_opus":0.10304230353168363,"score_gpt":0.4639794535941333,"score_spread":0.36093715006244964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386955006","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010107444,0.002533748,0.0004496932,0.9725526,0.00539207,0.0020680956,0.00010565198,0.0005086179,0.01537876],"genre_scores_gemma":[0.00006449584,0.008938342,0.028543977,0.93016315,0.014858673,0.0003881886,0.0003163183,0.0001830644,0.016543778],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952873,0.00016286591,0.0014595486,0.0011857228,0.0010918659,0.00081270095],"domain_scores_gemma":[0.9964386,0.00076385995,0.00042303264,0.0010887115,0.000968421,0.0003173739],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011399876,0.0005685957,0.0015283597,0.00033249866,0.00012250849,0.00019698696,0.00051582494,0.00046840173,0.00016784444],"category_scores_gemma":[0.004015373,0.00047800326,0.0003197641,0.0005398283,0.00006872976,0.0003646505,0.00038906615,0.0012617935,0.0026642743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005162236,0.0002572899,0.00005441425,0.00049680984,0.00079117826,0.0018134487,0.00022735557,0.00008250395,0.000008344113,0.00014068732,0.9810964,0.014979933],"study_design_scores_gemma":[0.0008272699,0.0012256461,0.00063878734,0.00082266174,0.0017714297,0.00003097484,0.0020288937,0.0000021269486,0.00003659228,0.00021980125,0.9918686,0.0005272253],"about_ca_topic_score_codex":0.00014036002,"about_ca_topic_score_gemma":0.000092692506,"teacher_disagreement_score":0.042389456,"about_ca_system_score_codex":0.000033716013,"about_ca_system_score_gemma":0.00036261597,"threshold_uncertainty_score":0.9997672},"labels":[],"label_agreement":null},{"id":"W4386955013","doi":"10.1182/bloodadvances.2023010670","title":"A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Institute on Minority Health and Health Disparities; National Heart, Lung, and Blood Institute; Australian Government; St. Jude Children's Research Hospital","keywords":"Medicine; Psychological intervention; mHealth; Internal medicine; Randomized controlled trial; Physical therapy; Pediatrics","score_opus":0.014144387651078852,"score_gpt":0.29780199043150163,"score_spread":0.2836576027804228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386955013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944458,0.0026035358,0.000064846485,0.000875542,0.00009744939,0.000698157,0.0000322301,0.00013628155,0.0010461486],"genre_scores_gemma":[0.99650013,0.00064241106,0.0006790764,0.00039083313,0.000033090295,0.000107295185,0.000055631812,0.000022655826,0.0015688571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987679,0.000035242483,0.0002648236,0.00032179063,0.00025812062,0.0003521373],"domain_scores_gemma":[0.99934703,0.000042925807,0.00007661537,0.00019796987,0.0000352223,0.000300258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016287908,0.0001513479,0.00023116652,0.00020940677,0.00005430997,0.000013693854,0.00009034119,0.000053208263,0.00004511069],"category_scores_gemma":[0.000084028914,0.00011410682,0.000055668814,0.00058935245,0.00004099819,0.00013044776,0.000046941546,0.00017235155,0.00017100609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005847853,0.0023000438,0.88713765,0.001627355,0.00007879415,0.00059225725,0.0030523452,0.0018003932,0.00082197064,0.00006951697,0.0013549532,0.100579925],"study_design_scores_gemma":[0.01719786,0.0042565404,0.938038,0.0044766944,0.00038692987,0.000026003492,0.004402337,0.0011804625,0.0034230575,0.0006991231,0.025167644,0.0007453804],"about_ca_topic_score_codex":0.000073744915,"about_ca_topic_score_gemma":0.00012404678,"teacher_disagreement_score":0.09983455,"about_ca_system_score_codex":0.00002202337,"about_ca_system_score_gemma":0.000092971444,"threshold_uncertainty_score":0.46531412},"labels":[],"label_agreement":null},{"id":"W4387168083","doi":"10.1182/bloodadvances.2023010746","title":"Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Legend Biotech; Sangamo Therapeutics; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Atara Biotherapeutics; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Children’s Hospital of Wisconsin Research Institute; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; HistoGenetics; Seattle Children's Research Institute; Cancer Moonshot; Medical College of Wisconsin; StemCyte; CSL Behring; St. Jude Children's Research Hospital; Kiadis Pharma; bluebird bio; Therakos; Bristol-Myers Squibb; St. Baldrick's Foundation; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Gateway for Cancer Research; Amgen; Incyte; Pfizer; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Transcriptome; Proinflammatory cytokine; Medicine; Haematopoiesis; Internal medicine; Oncology; Biology; Stem cell; Gene expression; Genetics; Gene; Inflammation","score_opus":0.00995883086071241,"score_gpt":0.2693516064353932,"score_spread":0.25939277557468077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387168083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909134,0.008899561,0.00004384626,0.00079749257,0.000058782723,0.00030722588,0.000044279033,0.000105816536,0.00065167825],"genre_scores_gemma":[0.98904705,0.0090320995,0.00014047208,0.00008524279,0.000114590504,0.00007456843,0.00011691392,0.000021184958,0.0013678658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878323,0.000060639075,0.00029301445,0.00032120405,0.00023217281,0.0003097563],"domain_scores_gemma":[0.99961275,0.00009818747,0.00006430573,0.00013860979,0.000024278315,0.00006184223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015659309,0.00017414193,0.00048592268,0.00039207196,0.00011379307,0.00002609391,0.00007053935,0.000066656845,0.000064583786],"category_scores_gemma":[0.000008442401,0.00015729963,0.00015157186,0.0011466423,0.00012232643,0.00020065163,0.000007059232,0.00012617289,0.000012452397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00460408,0.001693432,0.8255117,0.009392393,0.0011057721,0.0021703816,0.036689904,0.0003265867,0.09782455,0.00046101923,0.0002857609,0.019934416],"study_design_scores_gemma":[0.0097870035,0.0005501224,0.9078372,0.00038853285,0.004221099,0.00024806033,0.010712519,0.00018594938,0.047611367,0.000291894,0.017413594,0.00075265195],"about_ca_topic_score_codex":0.000044351018,"about_ca_topic_score_gemma":0.00012734708,"teacher_disagreement_score":0.0823255,"about_ca_system_score_codex":0.000015764375,"about_ca_system_score_gemma":0.000059723992,"threshold_uncertainty_score":0.6414492},"labels":[],"label_agreement":null},{"id":"W4387331321","doi":"10.1182/bloodadvances.2023011308","title":"Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Takeda Oncology; Genentech; National Institutes of Health; MorphoSys; Health Resources and Services Administration; Syndax Pharmaceuticals; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Medical College of Wisconsin; StemCyte; National Center for Advancing Translational Sciences; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Servier; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Pharmacyclics; Agios Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Gateway for Cancer Research; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Jazz Pharmaceuticals; Seagen; CTI Biopharma; Be The Match Foundation","keywords":"Medicine; Hazard ratio; Internal medicine; Transplantation; Confidence interval; Total body irradiation; Gastroenterology; Hematopoietic stem cell transplantation; Oncology; Hematopoietic cell; Proportional hazards model; Chemotherapy; Haematopoiesis; Cyclophosphamide; Stem cell","score_opus":0.01463595337785952,"score_gpt":0.30093863723715136,"score_spread":0.28630268385929186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387331321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040276,0.002591926,0.0037698657,0.0002610587,0.00010150653,0.0011334589,0.0001574889,0.00021182351,0.0013700976],"genre_scores_gemma":[0.99191326,0.00227867,0.001482497,0.00011820176,0.00008141108,0.0003608024,0.00056532485,0.000054626737,0.0031451783],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783534,0.00006139199,0.00038892555,0.00057434145,0.000513679,0.000626307],"domain_scores_gemma":[0.9985458,0.0006676137,0.00008916235,0.00029753832,0.00018834542,0.00021153547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017021284,0.00026650407,0.0005409691,0.00063721824,0.00020015477,0.000043331198,0.00016500866,0.00009554023,0.00012562977],"category_scores_gemma":[0.000113043054,0.00024844942,0.0003301172,0.0016262775,0.00010282908,0.00011293096,0.000024198102,0.00013391064,0.00018334284],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031793783,0.0035766044,0.53035414,0.01565713,0.0034210694,0.0034088593,0.0060007055,0.02198902,0.4048972,0.00026572339,0.00094468804,0.0063054874],"study_design_scores_gemma":[0.02160482,0.0030865322,0.034560155,0.0003576677,0.016804077,0.0018418339,0.0040097735,0.015955523,0.8939295,0.0015345005,0.0046626194,0.0016530284],"about_ca_topic_score_codex":0.0000122145975,"about_ca_topic_score_gemma":0.00023460029,"teacher_disagreement_score":0.49579397,"about_ca_system_score_codex":0.00004119334,"about_ca_system_score_gemma":0.00018006719,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W4387567805","doi":"10.1182/bloodadvances.2023010782","title":"Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; BC Children's Hospital","keywords":"Biology; Immune system; Immunology; Receptor; Leukemia; Tumor necrosis factor alpha; Pathogen; Genetics","score_opus":0.028915559419300244,"score_gpt":0.27321818943730886,"score_spread":0.24430263001800862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387567805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943059,0.003666708,0.00000885045,0.0000744522,0.00058564334,0.00022230517,0.000012268956,0.000048225058,0.0010756215],"genre_scores_gemma":[0.99298817,0.0015757631,0.000025802585,0.000077738034,0.000014357166,0.000020066496,0.000036466972,0.000007288436,0.005254323],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993162,0.00010142274,0.00023247057,0.00018348606,0.00003073021,0.0001356597],"domain_scores_gemma":[0.99950904,0.0001762929,0.000121831494,0.0001574311,0.000025655418,0.000009723281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017248461,0.00010396063,0.00013896865,0.00007079993,0.00020364369,0.000012267089,0.00007817377,0.00005940841,0.000031557593],"category_scores_gemma":[0.00006717977,0.000073426396,0.00003091434,0.00010745922,0.00012560133,0.000116800264,0.000055669676,0.000193951,0.00006828803],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011482476,0.00010363611,0.043470405,0.00006199025,0.000046526526,0.000003367913,0.00083208946,0.00015598703,0.94980884,0.00072179013,0.0006556988,0.004024866],"study_design_scores_gemma":[0.0019310651,0.0005405415,0.6296447,0.000088317865,0.00012698528,0.000030486903,0.0013834332,0.000019746281,0.2766546,0.0005085953,0.08883116,0.00024039365],"about_ca_topic_score_codex":0.00002103361,"about_ca_topic_score_gemma":0.00001174754,"teacher_disagreement_score":0.6731542,"about_ca_system_score_codex":0.00001156711,"about_ca_system_score_gemma":0.0000079900465,"threshold_uncertainty_score":0.29942417},"labels":[],"label_agreement":null},{"id":"W4388033885","doi":"10.1182/bloodadvances.2023009680","title":"Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Hamilton Health Sciences Foundation; Children's Hospital of Philadelphia","keywords":"Disease; Medicine; Life expectancy; Context (archaeology); Young adult; Expectancy theory; Intensive care medicine; Internal medicine; Population; Psychology; Environmental health","score_opus":0.05716270081677282,"score_gpt":0.3198331832174611,"score_spread":0.2626704824006883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388033885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705633,0.02789403,0.00007753027,0.00027088306,0.000041034342,0.00080375356,0.0002922199,0.000018502195,0.000038748352],"genre_scores_gemma":[0.9743105,0.023978285,0.0011389987,0.00004019235,0.000099098834,0.00027990463,0.00008952805,0.0000063315642,0.000057153517],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99956083,0.000011489729,0.00009946657,0.00012663889,0.00008042909,0.00012112222],"domain_scores_gemma":[0.999388,0.00041052132,0.00003893702,0.00009433635,0.000024169,0.0000440544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061224426,0.000072186675,0.0001283886,0.000031389485,0.000040488005,0.0000066778207,0.000042595573,0.00001904986,0.00000142748],"category_scores_gemma":[0.000047791378,0.000041205196,0.0000479905,0.0000676792,0.000030054844,0.000032312237,0.0000052327164,0.000014287103,4.068064e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041937646,0.0034725673,0.2695801,0.0005096095,0.00015263178,0.00002729283,0.0018118004,0.0025393793,0.002916619,0.00035852913,0.0002967814,0.71414095],"study_design_scores_gemma":[0.024846885,0.013343852,0.83308876,0.00022848604,0.00064689387,0.000005237931,0.0010133252,0.0017070379,0.10260059,0.0060888096,0.016126316,0.00030382632],"about_ca_topic_score_codex":0.00003564929,"about_ca_topic_score_gemma":0.000019042936,"teacher_disagreement_score":0.7138371,"about_ca_system_score_codex":0.0000024362057,"about_ca_system_score_gemma":0.000019809962,"threshold_uncertainty_score":0.1680299},"labels":[],"label_agreement":null},{"id":"W4388449166","doi":"10.1182/bloodadvances.2023011578","title":"Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Institutes for BioMedical Research; Fondation Leducq; Horizon Therapeutics; Kowa Company; Amarin Corporation; University of Toronto; XBiotech; Emory University; Brigham and Women's Hospital; Novo Nordisk; Massachusetts General Hospital; Esperion Therapeutics; GlaxoSmithKline; Novartis; National Heart, Lung, and Blood Institute; Winship Cancer Institute; Pfizer; AstraZeneca; American Heart Association","keywords":"Canakinumab; Medicine; Context (archaeology); Proinflammatory cytokine; Anemia; Myelodysplastic syndromes; Immunology; Internal medicine; Inflammation; Disease; Biology; Bone marrow; Anakinra","score_opus":0.007056416499294931,"score_gpt":0.2613323759508636,"score_spread":0.25427595945156867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388449166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944387,0.002393657,0.0000015323151,0.0010875075,0.00008522638,0.0010461716,0.000005139131,0.000021999838,0.00092008413],"genre_scores_gemma":[0.99782485,0.0016197001,0.00004477622,0.0001934183,0.00006392298,0.00012868115,0.00001184544,0.0000068119457,0.000106024665],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917454,0.00011498003,0.00022239886,0.00014078146,0.00022523028,0.00012207209],"domain_scores_gemma":[0.9987751,0.0010201676,0.00006993202,0.00009407454,0.000014974363,0.00002572094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042713818,0.000090955065,0.00043444382,0.00008533964,0.000033012508,0.0000070945935,0.00003427768,0.00004035423,0.000007957711],"category_scores_gemma":[0.00041934903,0.000053178406,0.00007191794,0.00022396584,0.00011501395,0.000048081936,0.00001176408,0.00007955881,0.0000031992283],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8794116,0.004730104,0.007449191,0.007895007,0.00049945863,0.0016198121,0.01105377,0.00004131466,0.03244726,0.020735966,0.0028203495,0.031296216],"study_design_scores_gemma":[0.9629851,0.0013140811,0.007523959,0.00071760453,0.00030100887,0.00006391901,0.0008255979,0.000027703802,0.018714221,0.006737938,0.0006397694,0.0001490819],"about_ca_topic_score_codex":0.000026947175,"about_ca_topic_score_gemma":0.000021628886,"teacher_disagreement_score":0.083573565,"about_ca_system_score_codex":0.000003380346,"about_ca_system_score_gemma":0.000023567103,"threshold_uncertainty_score":0.21685526},"labels":[],"label_agreement":null},{"id":"W4388688064","doi":"10.1182/bloodadvances.2023010716","title":"New and emerging therapies for women, girls, and people with the potential to menstruate with VWD","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"CSL Behring","keywords":"Desmopressin; Von Willebrand factor; Medicine; Von Willebrand disease; Menstrual bleeding; Clinical trial; Intensive care medicine; Pediatrics; Gynecology; Immunology; Internal medicine; Platelet","score_opus":0.0050070971109845396,"score_gpt":0.23883791648091787,"score_spread":0.23383081936993333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388688064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201876,0.0024197774,0.00023074802,0.004730365,0.00002126811,0.0004210714,0.000008385436,0.000041352352,0.00010827183],"genre_scores_gemma":[0.9949472,0.00081816706,0.0022080652,0.00020844086,0.000041204494,0.00009794882,0.0000069540624,0.000015884723,0.0016561692],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999478,0.0000047613576,0.00005262838,0.00016984533,0.00009855031,0.00019621254],"domain_scores_gemma":[0.99976677,0.000028642944,0.000025142475,0.000078729296,0.000018827755,0.000081899045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039108945,0.00010113417,0.00016546731,0.000036528116,0.00012554113,0.000023844448,0.000025284759,0.0000121075445,0.00000647518],"category_scores_gemma":[0.000004416658,0.000049863716,0.000010023471,0.00014697861,0.00002816378,0.00007351846,0.000015038383,0.000028434486,0.0000015863599],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060940403,0.0004291443,0.27677545,0.0006689844,0.0034854026,0.0007097275,0.033066526,0.00032882605,0.006982346,0.00064448133,0.0032465241,0.66756856],"study_design_scores_gemma":[0.054653175,0.01617493,0.66129506,0.00058848603,0.0019026854,0.0014668495,0.05654374,0.00039254257,0.0055907127,0.0068359207,0.19326678,0.0012891061],"about_ca_topic_score_codex":0.00002416627,"about_ca_topic_score_gemma":0.00024812014,"teacher_disagreement_score":0.66627944,"about_ca_system_score_codex":0.0000034379007,"about_ca_system_score_gemma":0.000021891232,"threshold_uncertainty_score":0.20333834},"labels":[],"label_agreement":null},{"id":"W4389040648","doi":"10.1182/bloodadvances.2023010882","title":"<i>JAK2</i> <i>V617F</i> mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Office of Naval Research; Health Resources and Services Administration; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Be The Match Foundation","keywords":"Hazard ratio; Medicine; Myelofibrosis; Internal medicine; Genotyping; Transplantation; International Prognostic Scoring System; Oncology; Hematopoietic stem cell transplantation; Confidence interval; Gastroenterology; Bone marrow; Genotype; Genetics; Myelodysplastic syndromes; Biology","score_opus":0.008063648788985196,"score_gpt":0.2547382195823869,"score_spread":0.24667457079340172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389040648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917246,0.00426908,0.0000018623273,0.0024437015,0.000055126977,0.00049042015,0.00013851827,0.00008005128,0.00079665385],"genre_scores_gemma":[0.994064,0.0032661033,0.00074066024,0.0010437358,0.000033852586,0.0001556308,0.00033520247,0.000019350644,0.0003415004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998981,0.00004760436,0.0002543948,0.0003434916,0.0001615401,0.00021194787],"domain_scores_gemma":[0.9993516,0.00031620273,0.00007743094,0.00009319435,0.000056253702,0.00010529847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011520659,0.00018702849,0.00037708564,0.00013982487,0.00014481788,0.000051674946,0.000021250791,0.000065793414,0.000013299506],"category_scores_gemma":[0.00011456969,0.00015213607,0.00003047492,0.00022190758,0.00008457646,0.00031480117,0.00004685,0.00011150071,0.000004618409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000647812,0.00032546607,0.97520113,0.00017650875,0.0001639619,0.00019236482,0.00088059733,0.000004584916,0.004813342,0.00015595146,0.00013260522,0.017888682],"study_design_scores_gemma":[0.003932401,0.00056641176,0.99012226,0.00015358898,0.00015132452,0.0000844646,0.00020063511,0.000058374924,0.0038914722,0.00014795808,0.0005380031,0.000153082],"about_ca_topic_score_codex":0.0000378291,"about_ca_topic_score_gemma":0.0002687268,"teacher_disagreement_score":0.0177356,"about_ca_system_score_codex":0.000027214703,"about_ca_system_score_gemma":0.000059460224,"threshold_uncertainty_score":0.62039286},"labels":[],"label_agreement":null},{"id":"W4389121666","doi":"10.1182/bloodadvances.2023011219","title":"A Markov analysis of azacitidine and venetoclax vs induction chemotherapy for medically fit patients with AML","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Ven; Azacitidine; Adverse effect; Internal medicine; Induction chemotherapy; Venetoclax; Oncology; Population; Regimen; Chemotherapy regimen; Transplantation; Surgery; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.013151635162512939,"score_gpt":0.2977100895233684,"score_spread":0.2845584543608555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389121666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783456,0.0002507435,0.00018869233,0.00096237945,0.000025721989,0.0005309496,0.000057160723,0.000044686072,0.00010509914],"genre_scores_gemma":[0.99263704,0.0010311018,0.0049111084,0.00022047806,0.00011290723,0.00012215496,0.000286793,0.000029314357,0.00064910995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894226,0.000018042929,0.00019698055,0.00025100063,0.00037538746,0.00021635032],"domain_scores_gemma":[0.99931157,0.00012151157,0.00009391288,0.00017854347,0.0001886974,0.00010578966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019271125,0.000106370535,0.0003713307,0.00035325086,0.000045638288,0.0000065972304,0.00006761888,0.000059185713,0.000050917755],"category_scores_gemma":[0.00015713183,0.00007665222,0.00006217136,0.0011834522,0.00013361577,0.000095258954,0.000023646418,0.00009444895,0.0000013633208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005736104,0.0004901334,0.7515914,0.0008564326,0.0057690395,0.000026577085,0.00071573653,0.00019645944,0.00636559,0.00008009785,0.0023053405,0.22586708],"study_design_scores_gemma":[0.013289206,0.0030161066,0.9489519,0.00017513889,0.0022015583,0.0000064073347,0.00023576712,0.0030522125,0.008380972,0.00013319845,0.0203316,0.00022593461],"about_ca_topic_score_codex":0.000018047114,"about_ca_topic_score_gemma":0.000025623589,"teacher_disagreement_score":0.22564115,"about_ca_system_score_codex":0.00004755332,"about_ca_system_score_gemma":0.00012178632,"threshold_uncertainty_score":0.31257868},"labels":[],"label_agreement":null},{"id":"W4389297506","doi":"10.1182/bloodadvances.2023010579","title":"Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Daratumumab; Internal medicine; Medicine; Lenalidomide; Hazard ratio; Oncology; Population; Dexamethasone; Subgroup analysis; Confidence interval","score_opus":0.016520869720489155,"score_gpt":0.2990142377944913,"score_spread":0.28249336807400216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389297506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981756,0.00057175895,0.000013054978,0.00005590514,0.000019967116,0.00076333893,0.0002951118,0.000038260605,0.00006695937],"genre_scores_gemma":[0.9974475,0.00023859889,0.0013313764,0.000027216849,0.000031064646,0.00021075811,0.00016127923,0.000026758615,0.0005254776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988584,0.00002601742,0.0001724842,0.00029686556,0.00034991634,0.0002963432],"domain_scores_gemma":[0.99926513,0.00012749978,0.000087396766,0.00021304117,0.0001597141,0.00014722743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059952472,0.00016664564,0.00040719917,0.00032195006,0.00007595629,0.000017286015,0.000049801092,0.000039721093,0.00004671914],"category_scores_gemma":[0.00004077271,0.000090262605,0.00006415382,0.0008552527,0.00012639714,0.00018105368,0.00002110958,0.00006566496,0.0000031016702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022090558,0.00047191177,0.95317507,0.00009118172,0.0029252388,0.0002407322,0.0004114091,0.0000047395465,0.00010557723,0.0000049335936,0.000007039708,0.020471605],"study_design_scores_gemma":[0.014011189,0.0065166242,0.976761,0.000087761604,0.0010491004,0.0000042477654,0.00007218758,0.00007710017,0.0008344942,0.000007917561,0.00045740083,0.00012098276],"about_ca_topic_score_codex":0.000056864872,"about_ca_topic_score_gemma":0.00044498284,"teacher_disagreement_score":0.023585921,"about_ca_system_score_codex":0.000012410259,"about_ca_system_score_gemma":0.000058672333,"threshold_uncertainty_score":0.36808023},"labels":[],"label_agreement":null},{"id":"W4389329605","doi":"10.1182/bloodadvances.2023011721","title":"Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Ludwig Center at Harvard; Sierra Oncology; Astellas Pharma; U.S. Department of Defense; Gilead Sciences; Genentech; Bristol-Myers Squibb; AstraZeneca; Servier; Pfizer","keywords":"Azacitidine; Medicine; Venetoclax; Internal medicine; Hypomethylating agent; Myeloid leukemia; Adverse effect; Interleukin-3 receptor; Minimal residual disease; Leukemia; Decitabine; Myelodysplastic syndromes; Oncology; Gastroenterology; Immunology; Chronic lymphocytic leukemia; Bone marrow; Biology","score_opus":0.022409650278020325,"score_gpt":0.33712194328773853,"score_spread":0.3147122930097182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389329605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649423,0.00019118663,0.0000698466,0.00036363886,0.000055600805,0.001903911,0.000025697955,0.0000969787,0.00079889665],"genre_scores_gemma":[0.99501175,0.0008545809,0.0022132285,0.00006033625,0.000099984674,0.0003338864,0.00013404,0.00005452256,0.0012377007],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977511,0.000093916824,0.00048337632,0.00045226724,0.00070693676,0.0005123683],"domain_scores_gemma":[0.9989652,0.00020285576,0.00018816096,0.00036702573,0.0001430402,0.00013368699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047602417,0.00025609057,0.00073013414,0.00068265863,0.00004087305,0.00001530707,0.00019353667,0.00010535649,0.000029808398],"category_scores_gemma":[0.0001533842,0.00016843538,0.000043589964,0.0022510292,0.00023404081,0.00033106146,0.00005596319,0.000420936,0.000014169234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7585801,0.008642949,0.10316789,0.0014681468,0.0008634435,0.0070777657,0.0026162977,0.0012443176,0.05133743,0.000674615,0.00051174016,0.063815325],"study_design_scores_gemma":[0.8776702,0.035145238,0.006962709,0.0014033425,0.0003343239,0.0002682973,0.0012673135,0.003941738,0.06864189,0.00022732628,0.0036043196,0.0005332763],"about_ca_topic_score_codex":0.00018695767,"about_ca_topic_score_gemma":0.0010211368,"teacher_disagreement_score":0.11909015,"about_ca_system_score_codex":0.0004579285,"about_ca_system_score_gemma":0.0014951486,"threshold_uncertainty_score":0.6868595},"labels":[],"label_agreement":null},{"id":"W4389943594","doi":"10.1182/bloodadvances.2023011492","title":"Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pharmacyclics; Genentech; Adaptive Biotechnologies; Juno Therapeutics; Incyte; BeiGene; Loxo Oncology; TG Therapeutics; University of Pennsylvania; Seagen; Kite Pharma; Society for Immunotherapy of Cancer; Mallinckrodt Pharmaceuticals; Atara Biotherapeutics; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; GlaxoSmithKline; Regeneron Pharmaceuticals; Leukemia and Lymphoma Society; Legend Biotech; MorphoSys; Celgene; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Bendamustine; Immunology; Lymphoma; Rituximab","score_opus":0.014826103761929521,"score_gpt":0.2868707754483552,"score_spread":0.2720446716864257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389943594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322754,0.001865515,0.000005297359,0.0021307478,0.00007623614,0.0004053641,0.00003663399,0.00023514501,0.0020175395],"genre_scores_gemma":[0.97317755,0.0037437405,0.00094995776,0.00037389464,0.0006174473,0.00010595078,0.00012706457,0.00008509496,0.02081928],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983712,0.000041521092,0.00024046464,0.00040385427,0.00052799494,0.0004149725],"domain_scores_gemma":[0.99918485,0.00010545769,0.000101264755,0.0002806347,0.00015838185,0.00016941153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003007789,0.00020986957,0.0003478128,0.0001992401,0.00014950785,0.000033875822,0.00009381472,0.00009192665,0.00047754514],"category_scores_gemma":[0.00012382893,0.00016162799,0.00006127268,0.0005281441,0.00015321336,0.00017066048,0.00007026947,0.00015594331,0.0000443784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009654122,0.00020518058,0.254979,0.0005747236,0.0004924662,0.0003391813,0.0013859146,0.000026640319,0.6215054,0.000097680444,0.0012664029,0.11816204],"study_design_scores_gemma":[0.011013107,0.0023332401,0.49964276,0.0006586338,0.00046092598,0.00035253196,0.001088235,0.00038417045,0.33319893,0.0008298041,0.14938144,0.0006562213],"about_ca_topic_score_codex":0.000023978018,"about_ca_topic_score_gemma":0.000071623115,"teacher_disagreement_score":0.28830644,"about_ca_system_score_codex":0.00004994732,"about_ca_system_score_gemma":0.000117117685,"threshold_uncertainty_score":0.6590998},"labels":[],"label_agreement":null},{"id":"W4390061307","doi":"10.1182/bloodadvances.2023011583","title":"RNA-seq–based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Princess Takamatsu Cancer Research Fund; Research Manitoba","keywords":"microRNA; Gene expression profiling; Biology; Oncology; Fold change; Gene; Gene expression; Bioinformatics; Computational biology; Internal medicine; Medicine; Cancer research; Genetics","score_opus":0.004303003926900069,"score_gpt":0.23193599048511987,"score_spread":0.2276329865582198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390061307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637866,0.0028394712,0.00006582372,0.000016768445,0.00015176067,0.00023187997,0.00009180863,0.00003399522,0.00018983387],"genre_scores_gemma":[0.99807197,0.0006531996,0.00036127932,0.000042082567,0.00019361617,0.00003333563,0.00041651426,0.00002870994,0.00019928897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877715,0.000063936895,0.00027774306,0.0004020708,0.0002348026,0.0002443213],"domain_scores_gemma":[0.9993077,0.000025026204,0.00016989627,0.0003279086,0.00006593062,0.0001035471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121650024,0.00017096233,0.00016219096,0.00015118012,0.000032513166,0.000011129415,0.00023624665,0.00020212008,0.000017123968],"category_scores_gemma":[0.00007488334,0.00016888736,0.00007794924,0.00035012758,0.00004310648,0.000015888134,0.00006964683,0.000090910806,0.0000142024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023768199,0.0002811724,0.018266615,0.0001840822,0.000037738548,0.00005144411,0.00003617033,0.007520515,0.97272587,0.00001890836,0.0002973914,0.0003424019],"study_design_scores_gemma":[0.0041948278,0.0006352503,0.060635474,0.000046246103,0.00022260088,0.000008408486,0.00004714848,0.0008525412,0.9313384,0.0003446543,0.0013094875,0.00036494472],"about_ca_topic_score_codex":0.000011603963,"about_ca_topic_score_gemma":0.00003733143,"teacher_disagreement_score":0.04236886,"about_ca_system_score_codex":0.000030345922,"about_ca_system_score_gemma":0.00031715186,"threshold_uncertainty_score":0.68870264},"labels":[],"label_agreement":null},{"id":"W4390061629","doi":"10.1182/bloodadvances.2023011814","title":"Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Gateway for Cancer Research; CSL Behring; Bristol-Myers Squibb; Amgen; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Medicine; Hematopoietic cell; Internal medicine; Cyclophosphamide; Transplantation; Haematopoiesis; Stem cell; Chemotherapy","score_opus":0.02645697796824841,"score_gpt":0.306195066447848,"score_spread":0.2797380884795996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390061629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928906,0.00074870785,0.0017522322,0.001757373,0.0005938042,0.00099092,0.00010058134,0.00056900963,0.0005967853],"genre_scores_gemma":[0.9918076,0.0016621745,0.0039266297,0.0002653677,0.00017244439,0.00023999333,0.00020955844,0.00006413405,0.0016521238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975582,0.00007507072,0.00063110644,0.0006013076,0.0005594258,0.0005749293],"domain_scores_gemma":[0.99871755,0.00031207662,0.00012439015,0.00034600185,0.000112088695,0.00038787635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032394487,0.00029897154,0.0005567001,0.00039131087,0.00017187456,0.000055406097,0.00016870299,0.00016281108,0.00010530006],"category_scores_gemma":[0.00012635578,0.0002679079,0.00015260563,0.00074538204,0.00006302068,0.0002616891,0.000025279644,0.00023320403,0.0007780059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022379886,0.0017395077,0.74246603,0.0024303338,0.0011061381,0.0036838464,0.014539649,0.00096485927,0.22397529,0.0009597612,0.0009609717,0.0049356166],"study_design_scores_gemma":[0.020472156,0.0017271976,0.57057685,0.014198559,0.0035042858,0.0013866797,0.00815597,0.000900868,0.36660647,0.0014490352,0.008956413,0.0020655177],"about_ca_topic_score_codex":0.000028464732,"about_ca_topic_score_gemma":0.00006551645,"teacher_disagreement_score":0.17188919,"about_ca_system_score_codex":0.000056691293,"about_ca_system_score_gemma":0.000055485234,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W4390062087","doi":"10.1182/bloodadvances.2023011002","title":"Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital","funders":"Cancer Moonshot; Moonshot Research and Development Program; National Institute of Allergy and Infectious Diseases; Gilead Sciences; National Cancer Institute; National Institutes of Health; Astellas Pharma; Adaptive Biotechnologies; Incyte; bluebird bio; National Heart, Lung, and Blood Institute; Actinium Pharmaceuticals; CareDx; Atara Biotherapeutics; Bristol-Myers Squibb; AstraZeneca; CSL Behring; BeiGene; HistoGenetics; GlaxoSmithKline; Health Resources and Services Administration; Astellas Pharma US; Amgen; Office of Naval Research; Jazz Pharmaceuticals; Be The Match Foundation","keywords":"Medicine; Intensive care unit; Dialysis; Intensive care medicine; Transplantation; Intensive care; Pediatrics; Internal medicine","score_opus":0.01603877741609896,"score_gpt":0.2803425716782115,"score_spread":0.2643037942621126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390062087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192655,0.0066341707,0.00005281681,0.00010861091,0.00025612698,0.00057201955,0.00006242805,0.00012089657,0.0002663498],"genre_scores_gemma":[0.98016316,0.019086605,0.00021613055,0.00009815781,0.000053185802,0.000056660545,0.00010741584,0.000033263448,0.00018541147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844825,0.00005833279,0.0003989772,0.00043179106,0.00030020124,0.00036245116],"domain_scores_gemma":[0.999166,0.0002392058,0.00010629577,0.00022280012,0.00012258237,0.00014309672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012470827,0.00023451674,0.00045902922,0.0003154785,0.000062155625,0.000013829424,0.000089561916,0.00010305184,0.000018468556],"category_scores_gemma":[0.00005689176,0.00019660954,0.00008331905,0.00043032604,0.00005108005,0.00010385367,0.000019428035,0.00019408154,0.000069253925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060060167,0.00007649257,0.99023443,0.0013111052,0.000025346615,0.00061512983,0.006300308,0.000015072154,0.000544116,0.0000039581446,0.0000054556654,0.00080850744],"study_design_scores_gemma":[0.003253281,0.0001856521,0.9860539,0.00029072602,0.0005539857,0.00013313124,0.0017366946,0.000004879509,0.0075151795,0.00004004819,0.000018067172,0.00021447592],"about_ca_topic_score_codex":0.000012918139,"about_ca_topic_score_gemma":0.00011186858,"teacher_disagreement_score":0.012452435,"about_ca_system_score_codex":0.000020231786,"about_ca_system_score_gemma":0.00004248448,"threshold_uncertainty_score":0.8017504},"labels":[],"label_agreement":null},{"id":"W4390322679","doi":"10.1182/bloodadvances.2023011964","title":"Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTs","year":2023,"lang":"en","type":"review","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; McGill University","funders":"Janssen Pharmaceuticals; Canadian Institutes of Health Research; Gilead Sciences; Sanofi; Pfizer; Amgen","keywords":"Venetoclax; Meta-analysis; Medicine; Adverse effect; Oncology; Hematologic Neoplasms; MEDLINE; Internal medicine; Intensive care medicine; Leukemia; Cancer; Biology; Chronic lymphocytic leukemia","score_opus":0.09874279848536982,"score_gpt":0.40978968672075566,"score_spread":0.31104688823538584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390322679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016960637,0.99149156,0.000021129572,0.0000044239914,0.000022475238,0.0077265035,0.0005195524,0.000023317689,0.000021446953],"genre_scores_gemma":[0.00020863774,0.9972612,0.00029030253,0.000018264944,0.000009512111,0.0018127988,0.000066102206,0.00004784502,0.0002853215],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959864,0.00048606415,0.0021619524,0.00048043122,0.00060043874,0.00028470423],"domain_scores_gemma":[0.99315095,0.0023598147,0.0030533324,0.00093540933,0.00040994634,0.00009055741],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001566998,0.00043800476,0.014725043,0.0005755378,0.000029178726,0.0000017777745,0.00028736907,0.00018944993,0.000038617578],"category_scores_gemma":[0.0022851229,0.00024958147,0.0035990833,0.0017938993,0.00016407267,0.000054975917,0.00009034311,0.00014695624,0.0000031431512],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012201956,0.00009479882,0.000008084517,0.80021244,0.1992343,0.000008339175,0.000030992105,0.0000103127195,5.927249e-7,0.000032523796,0.000006057847,0.00034934375],"study_design_scores_gemma":[0.0019798458,0.0004151908,0.0000012680321,0.11480598,0.8804249,0.000078845354,0.000029384231,0.000022556156,0.000031175066,0.00007136266,0.0019739915,0.00016549941],"about_ca_topic_score_codex":0.000113385744,"about_ca_topic_score_gemma":0.00003278187,"teacher_disagreement_score":0.68540645,"about_ca_system_score_codex":0.0005794708,"about_ca_system_score_gemma":0.0025387462,"threshold_uncertainty_score":0.99999565},"labels":[],"label_agreement":null},{"id":"W4390572101","doi":"10.1182/bloodadvances.2023011735","title":"Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Astellas Pharma; Leukemia and Lymphoma Society of Canada; Celgene; Sierra Oncology; Leukemia and Lymphoma Society; Princess Margaret Cancer Foundation; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Cytarabine; Internal medicine; Daunorubicin; Gastroenterology; Myeloid leukemia; Confidence interval; Retrospective cohort study; Odds ratio; Myeloid; Hypomethylating agent; Oncology; Leukemia; Biology","score_opus":0.02021642297003689,"score_gpt":0.3423091176300899,"score_spread":0.322092694660053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390572101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98513216,0.012414473,0.000018575634,0.0013990914,0.00017039444,0.00040505303,0.000029894682,0.000037542683,0.0003927955],"genre_scores_gemma":[0.9955124,0.0035104179,0.0005458463,0.00014451853,0.000049339433,0.000055725835,0.00001848557,0.00001461488,0.00014861659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999098,0.000024982117,0.00026799535,0.00032685482,0.00012416167,0.000158019],"domain_scores_gemma":[0.99928653,0.00012935276,0.000058129295,0.00009160789,0.00036107228,0.000073289564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005294466,0.00018932935,0.00044024794,0.000177226,0.00003221203,0.000047158857,0.000021721498,0.00005186626,0.000028511224],"category_scores_gemma":[0.00014024002,0.0001330772,0.00003958623,0.0001857255,0.00017263865,0.00031010856,0.000027326336,0.00012766979,0.0000030790866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023302096,0.004375698,0.7127512,0.0030179126,0.004033099,0.002963474,0.01915892,0.0001898559,0.102294594,0.018338041,0.0010007533,0.12954621],"study_design_scores_gemma":[0.021952547,0.008697722,0.4984402,0.003433398,0.0017428718,0.0017569255,0.06392435,0.0014105592,0.39050806,0.0032486792,0.004051049,0.0008336547],"about_ca_topic_score_codex":0.000051214392,"about_ca_topic_score_gemma":0.00009695332,"teacher_disagreement_score":0.28821346,"about_ca_system_score_codex":0.000016631206,"about_ca_system_score_gemma":0.00007966381,"threshold_uncertainty_score":0.54267305},"labels":[],"label_agreement":null},{"id":"W4390605783","doi":"10.1182/bloodadvances.2023011636","title":"Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Thalassemia; Gestational diabetes; Ferritin; Gestational age; Caesarean section; Beta thalassemia; Birth weight; Gestation; Pediatrics; Internal medicine","score_opus":0.0256430651651141,"score_gpt":0.34187208500089483,"score_spread":0.3162290198357807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390605783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023400187,0.99630487,0.0000010091916,0.00023911629,0.000046099412,0.0031090814,0.00008646824,0.00003739453,0.00015255026],"genre_scores_gemma":[0.000053687414,0.997803,0.00013154875,0.00012978047,0.0000065215095,0.00043381716,0.000046106456,0.000044579585,0.0013509861],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99735916,0.00020517912,0.0011792157,0.0006961078,0.00022822483,0.00033210797],"domain_scores_gemma":[0.9987215,0.00025881332,0.0003939915,0.00039664458,0.000029812769,0.0001992364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029083842,0.0006097605,0.009060761,0.0004530773,0.000035620666,0.000053456668,0.00008359284,0.00024853725,0.0000288843],"category_scores_gemma":[0.00029340424,0.00031255872,0.0008768808,0.00071244605,0.00012919882,0.00011190896,0.00012998215,0.0005038637,0.000007051269],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.2751874e-7,0.000049391474,0.00016278555,0.93579924,0.05434205,0.00017212568,0.00008459012,2.03143e-8,1.7488933e-8,0.000019261655,0.000012078434,0.009357692],"study_design_scores_gemma":[0.0002593738,0.0000649368,0.00001358206,0.22689782,0.761937,0.00014874175,0.00008970293,8.5265015e-7,3.5146833e-8,0.00002121445,0.010334135,0.00023257165],"about_ca_topic_score_codex":0.000016781314,"about_ca_topic_score_gemma":0.00007235583,"teacher_disagreement_score":0.7089014,"about_ca_system_score_codex":0.000026163409,"about_ca_system_score_gemma":0.00007449778,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W4390605838","doi":"10.1182/bloodadvances.2023012380","title":"Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"LEO Pharma; University of Ottawa; Sanofi; CytoSorbents Europe; GlaxoSmithKline; AstraZeneca; Servier; Pfizer","keywords":"Apixaban; Perioperative; Medicine; Intensive care medicine; Internal medicine; Anesthesia","score_opus":0.013397992720097363,"score_gpt":0.2800686746807587,"score_spread":0.26667068196066135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390605838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918736,0.0025001352,0.0000489795,0.00041859687,0.000108479406,0.0010576342,0.000006093614,0.00006912307,0.006603569],"genre_scores_gemma":[0.9949934,0.00045443964,0.0028083532,0.00004747917,0.000055414697,0.000015178986,0.00003804028,0.000019033687,0.0015686611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907583,0.0000144382175,0.0002358571,0.00026693553,0.0002484429,0.00015847497],"domain_scores_gemma":[0.9996643,0.00007345831,0.00006292651,0.00011503673,0.00004656632,0.00003768631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005002999,0.00014501651,0.00025695507,0.00015454556,0.0000324675,0.000019175151,0.000050759274,0.000026173406,0.000036908772],"category_scores_gemma":[0.00002798939,0.000103503524,0.000047766807,0.00038228827,0.00003787801,0.00030539106,0.000035705838,0.00006838426,0.000007339395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017285106,0.00009814638,0.9730728,0.0037833175,0.00053527905,0.00012047972,0.0013921374,0.000833089,0.00015936476,0.0049509373,0.000021171918,0.013304736],"study_design_scores_gemma":[0.015171127,0.0038557057,0.95343024,0.0070379004,0.0006603871,0.0000051955517,0.0065088626,0.00009794419,0.0044018473,0.00032542084,0.008020118,0.00048526307],"about_ca_topic_score_codex":0.0000012867762,"about_ca_topic_score_gemma":0.00005109966,"teacher_disagreement_score":0.019642603,"about_ca_system_score_codex":0.000028141287,"about_ca_system_score_gemma":0.000052563577,"threshold_uncertainty_score":0.42207512},"labels":[],"label_agreement":null},{"id":"W4390794854","doi":"10.1182/bloodadvances.2023011442","title":"Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors &amp;gt;5 BU","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novo Nordisk; Sanofi; Swedish Orphan Biovitrum; CSL Behring; Bayer; Pfizer","keywords":"Medicine; Titer; Hazard ratio; Internal medicine; Prothrombin complex concentrate; Regimen; Gastroenterology; Prospective cohort study; Immune tolerance; Confidence interval; Immunology; Immune system; Antibody; Warfarin","score_opus":0.009651476060200632,"score_gpt":0.28059605348270833,"score_spread":0.2709445774225077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390794854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974097,0.025039332,3.2721243e-7,0.00022715254,0.000049358336,0.00029403163,0.0000068709014,0.000030138737,0.00025575058],"genre_scores_gemma":[0.99662566,0.0018279272,0.00055302226,0.0000052804603,0.00009256137,0.000021173657,0.0000030092322,0.00001960605,0.0008517586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901265,0.000012423386,0.00022313451,0.00029138674,0.00021220873,0.00024822186],"domain_scores_gemma":[0.9996877,0.000043908352,0.000035005964,0.000119809214,0.000028703873,0.000084911975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010610651,0.0001497236,0.00032559058,0.0001645026,0.000057483947,0.000022314436,0.00003880489,0.000053149863,0.000009915187],"category_scores_gemma":[0.00002559261,0.0001001407,0.000028180028,0.00026019439,0.00013866837,0.00023072812,0.000051454677,0.00015367466,0.0000014874906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002376161,0.000118382384,0.94518644,0.0023969419,0.000051844207,0.00054430304,0.0011597689,0.0000064606743,0.026031688,0.000013545569,0.0000019037573,0.02425113],"study_design_scores_gemma":[0.007815926,0.0014005841,0.80491585,0.01314528,0.00026733108,0.0022547783,0.0008597219,0.00044307153,0.16701712,0.0003313247,0.001109336,0.00043970207],"about_ca_topic_score_codex":0.000022927734,"about_ca_topic_score_gemma":0.00015424621,"teacher_disagreement_score":0.14098543,"about_ca_system_score_codex":0.000017193957,"about_ca_system_score_gemma":0.00004199687,"threshold_uncertainty_score":0.40836194},"labels":[],"label_agreement":null},{"id":"W4390942391","doi":"10.1182/bloodadvances.2023012062","title":"Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech; Servier; Astellas Pharma; Chugai Pharmaceutical; Agios Pharmaceuticals; Astex Pharmaceuticals; Gilead Sciences; National Comprehensive Cancer Network; Eisai; Syndax Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Celgene; Universität Ulm; AstraZeneca; Pfizer; Amgen","keywords":"Refractory (planetary science); Chemotherapy; Medicine; Oncology; Internal medicine; Biology","score_opus":0.013772402750220554,"score_gpt":0.3323051704801433,"score_spread":0.31853276772992273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390942391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96241874,0.026853321,0.00013958002,0.0056190137,0.00073181605,0.0026209156,0.00003239042,0.00019408992,0.001390135],"genre_scores_gemma":[0.98598796,0.0038022716,0.0017356756,0.0017051495,0.0013027168,0.0007896798,0.000045793404,0.00009503031,0.004535742],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973878,0.00021337385,0.0006823912,0.0006295542,0.00052600267,0.000560876],"domain_scores_gemma":[0.99823385,0.0008703722,0.000085468026,0.00040243973,0.00020137425,0.00020648692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008564253,0.00033361898,0.0011317662,0.0004662696,0.000033491087,0.000062012965,0.0001750253,0.0001734326,0.0008563363],"category_scores_gemma":[0.0014608672,0.00024172441,0.00035367397,0.00059343636,0.00034492754,0.00030272978,0.000059826,0.0008808251,0.0001537267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9555052,0.0008796985,0.000100106154,0.00027594954,0.0004351006,0.0023661456,0.001141853,0.0000025867303,0.0062855706,0.00008155187,0.0019499385,0.030976316],"study_design_scores_gemma":[0.9212355,0.0019378302,0.000077628974,0.0006789097,0.00028927124,0.0001328125,0.0003660597,0.0004245006,0.0060517294,0.0005119919,0.06801438,0.00027939247],"about_ca_topic_score_codex":0.00003281114,"about_ca_topic_score_gemma":0.000022164915,"teacher_disagreement_score":0.06606444,"about_ca_system_score_codex":0.00018973048,"about_ca_system_score_gemma":0.0004498176,"threshold_uncertainty_score":0.9857235},"labels":[],"label_agreement":null},{"id":"W4391163375","doi":"10.1182/bloodadvances.2023011233","title":"Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Incidence (geometry); Transplantation; Stem cell; Medicine; Pediatrics; Internal medicine; Biology; Genetics","score_opus":0.005493602977349979,"score_gpt":0.23461453445482208,"score_spread":0.2291209314774721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391163375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261403,0.006123294,0.00031471596,0.000024934068,0.00013315599,0.0004617406,0.00013842699,0.000045347242,0.00014438106],"genre_scores_gemma":[0.9946929,0.004721209,0.0003316609,0.00001726124,0.000023743463,0.000045098666,0.000028503771,0.000022449043,0.000117125564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988276,0.000057519446,0.0003492763,0.0003189575,0.00026893214,0.00017771391],"domain_scores_gemma":[0.9994477,0.00025270032,0.000062693245,0.00012876958,0.00003391514,0.000074201525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011072052,0.0001704606,0.0002772491,0.0001612655,0.000018233459,0.000017624256,0.00004481448,0.00008557773,0.00003627226],"category_scores_gemma":[0.0000053493477,0.00013481264,0.000051747986,0.00018890164,0.000059678296,0.00032657504,0.000005366837,0.00016358067,0.000009039979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060662045,0.00012851447,0.9777877,0.003919489,0.00003690147,0.00024161382,0.013356129,0.000004191244,0.0017115105,0.000008549466,0.000001808823,0.0021970037],"study_design_scores_gemma":[0.0014479223,0.00024408782,0.92722666,0.0026008815,0.00036867516,0.00006527309,0.00055380986,0.0000532126,0.06725045,0.000030855863,0.000019699295,0.00013848009],"about_ca_topic_score_codex":0.0001276351,"about_ca_topic_score_gemma":0.00012257007,"teacher_disagreement_score":0.065538935,"about_ca_system_score_codex":0.000012918933,"about_ca_system_score_gemma":0.00003404431,"threshold_uncertainty_score":0.54975},"labels":[],"label_agreement":null},{"id":"W4391163407","doi":"10.1182/bloodadvances.2023011475","title":"A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Swedish Orphan Biovitrum; Sanofi","keywords":"Post-hoc analysis; Post hoc; Medicine; Internal medicine; Pharmacology","score_opus":0.012184867369270857,"score_gpt":0.2888203220005948,"score_spread":0.27663545463132394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391163407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930356,0.004127531,0.0000010885128,0.00064520794,0.000055272052,0.0013471757,0.000040165956,0.00003629827,0.0007116569],"genre_scores_gemma":[0.9981794,0.0004296217,0.00013037038,0.000047930873,0.00007893789,0.00008195244,0.00018305208,0.000018030241,0.00085070654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983053,0.00010662527,0.00035378715,0.00033923108,0.0005987588,0.00029626495],"domain_scores_gemma":[0.9992131,0.00021893707,0.00006420548,0.00026324164,0.00016333548,0.0000771919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002574734,0.00019043066,0.00049903186,0.0005074314,0.00005476608,0.000037736303,0.00013104365,0.00006869072,0.000053408152],"category_scores_gemma":[0.00011098946,0.00009415366,0.0001505234,0.0025738876,0.00009846391,0.00017125768,0.0000306435,0.0001855624,0.000007132026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022532001,0.0021170538,0.92289275,0.00056417775,0.004009663,0.00069691445,0.0037694317,0.000037310292,0.00009669327,0.000047214926,0.00008765111,0.043149125],"study_design_scores_gemma":[0.14651231,0.018527798,0.8032001,0.0036672815,0.015625894,0.00007014248,0.0018197987,0.00027948507,0.0043744156,0.00010809434,0.0049142977,0.0009003236],"about_ca_topic_score_codex":0.000059672537,"about_ca_topic_score_gemma":0.0005472664,"teacher_disagreement_score":0.12398031,"about_ca_system_score_codex":0.000043277116,"about_ca_system_score_gemma":0.00023236232,"threshold_uncertainty_score":0.38394746},"labels":[],"label_agreement":null},{"id":"W4391329405","doi":"10.1182/bloodadvances.2023011869","title":"A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"MEDLINE; Medicine; Internal medicine; Biology","score_opus":0.04385610189046887,"score_gpt":0.43534037409903725,"score_spread":0.3914842722085684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391329405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931206,0.003593138,0.000017242039,0.0010111713,0.00006280415,0.00035232265,0.00004667419,0.000045357672,0.0017506646],"genre_scores_gemma":[0.9949974,0.002138648,0.0016604473,0.00004001144,0.00003714991,0.00002638427,0.000035095745,0.00002401363,0.0010408554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785817,0.00013406224,0.0008808523,0.00043949415,0.00041806512,0.00026933162],"domain_scores_gemma":[0.9984014,0.000828779,0.00019714105,0.0003326073,0.000109179695,0.00013086738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061126804,0.0001895559,0.0016373661,0.0010888894,0.000020322957,0.000015403306,0.00012643154,0.000100784295,0.0000976797],"category_scores_gemma":[0.00022871295,0.00012924359,0.00014914466,0.0023522119,0.00035778352,0.00012330491,0.0000784305,0.00040217844,0.000002191352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004752765,0.00039758673,0.983911,0.0005985031,0.0028711427,0.00015961782,0.0013059938,0.000028981081,0.0008794179,0.00023779474,0.000084027284,0.009050657],"study_design_scores_gemma":[0.003393716,0.0014146263,0.97672236,0.0009997508,0.0037918445,0.0000144834985,0.0010742379,0.007699185,0.0027018036,0.00006365023,0.0019303564,0.00019397208],"about_ca_topic_score_codex":0.00048964977,"about_ca_topic_score_gemma":0.0059817894,"teacher_disagreement_score":0.008856685,"about_ca_system_score_codex":0.000035616533,"about_ca_system_score_gemma":0.00017975907,"threshold_uncertainty_score":0.52704006},"labels":[],"label_agreement":null},{"id":"W4391337917","doi":"10.1182/bloodadvances.2023011620","title":"Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Genentech; Swedish Orphan Biovitrum; Sierra Oncology; Pfizer; Incyte; CTI Biopharma; Syndax Pharmaceuticals; Bristol-Myers Squibb; Constellation Pharmaceuticals; Agios Pharmaceuticals; Cancer Center, University of Kansas; Astex Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Servier; Memorial Sloan-Kettering Cancer Center; Jazz Pharmaceuticals; Kite Pharma; Shionogi; Amgen; Ohio State University; Karyopharm Therapeutics; MorphoSys; Celgene; AstraZeneca; Astellas Pharma; TG Therapeutics","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Bone marrow","score_opus":0.022074267639499635,"score_gpt":0.33314619034157544,"score_spread":0.3110719227020758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391337917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600613,0.00062128605,0.00001131479,0.00046298857,0.00006765675,0.0020017822,0.00064260024,0.000040753213,0.00014546036],"genre_scores_gemma":[0.99614275,0.000048972433,0.0028982544,0.00008843945,0.00006661088,0.00046437368,0.000058015004,0.000024860034,0.00020773524],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9986502,0.00005399524,0.00031445676,0.00047559635,0.00029121432,0.00021454597],"domain_scores_gemma":[0.99868464,0.00074970536,0.00006787222,0.00020449984,0.00014319435,0.00015009742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017386729,0.00020395967,0.0003636633,0.00014319441,0.0000737939,0.000028758472,0.0000420002,0.000031322055,0.000011286695],"category_scores_gemma":[0.00025183617,0.0001330755,0.000045505596,0.0001868332,0.000040366445,0.000102728416,0.000021232996,0.00006428321,0.0000040949753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4259331,0.07191643,0.3312037,0.0010322559,0.001807226,0.0004110011,0.009823308,0.00011891502,0.001390842,0.00058149814,0.002063987,0.15371773],"study_design_scores_gemma":[0.118738204,0.35419822,0.45235717,0.0022765412,0.0016057725,0.000020909403,0.0014689617,0.000070013615,0.03362882,0.0000613741,0.035036385,0.0005376356],"about_ca_topic_score_codex":0.000007119462,"about_ca_topic_score_gemma":0.000018468032,"teacher_disagreement_score":0.3071949,"about_ca_system_score_codex":0.000019347128,"about_ca_system_score_gemma":0.000056205954,"threshold_uncertainty_score":0.54266614},"labels":[],"label_agreement":null},{"id":"W4391338127","doi":"10.1182/bloodadvances.2023012109","title":"Large B-cell lymphoma-<i>IRF4</i>+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent; Japan Agency for Medical Research and Development; Cancer Research Institute","keywords":"IRF4; Neoplasm; Lymphoma; Chemotherapy; B cell; Malignant lymphoma; Cancer research; Medicine; Oncology; Internal medicine; Immunology; Biology; Pathology; Transcription factor; Antibody; Genetics; Gene","score_opus":0.002666590924800702,"score_gpt":0.22399379010229203,"score_spread":0.22132719917749133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391338127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95415515,0.03934572,0.0000013526118,0.0011945616,0.0001028003,0.0007834402,0.000089047084,0.000082150575,0.004245764],"genre_scores_gemma":[0.9915959,0.003738592,0.0006797167,0.0005388489,0.000119783945,0.00015099099,0.00007580748,0.00004927809,0.0030510877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841356,0.000033414104,0.00028774823,0.00060416147,0.00022352693,0.00043757557],"domain_scores_gemma":[0.99945945,0.00006205843,0.000041888292,0.0002531984,0.000019092053,0.00016433065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012931877,0.0002896294,0.00043103742,0.00022123802,0.00003646875,0.00006821569,0.00009473568,0.00011497418,0.00013743287],"category_scores_gemma":[0.000013137624,0.00023123855,0.0000765995,0.00054064195,0.000021501286,0.00017028561,0.000054990167,0.00009602868,0.00015745345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006311095,0.013552875,0.9077228,0.00091783295,0.00026506235,0.00205966,0.006729542,0.000015897243,0.013544176,0.00014113718,0.0070151915,0.047404718],"study_design_scores_gemma":[0.030188201,0.00063829793,0.8642256,0.0014394296,0.00022750116,0.0011328112,0.00034780108,0.000095607065,0.07708725,0.00007392618,0.02396058,0.00058294577],"about_ca_topic_score_codex":0.000112985705,"about_ca_topic_score_gemma":0.00018874624,"teacher_disagreement_score":0.06354308,"about_ca_system_score_codex":0.000091719354,"about_ca_system_score_gemma":0.00011900937,"threshold_uncertainty_score":0.9429634},"labels":[],"label_agreement":null},{"id":"W4391466207","doi":"10.1182/bloodadvances.2023010805","title":"Structural variants involving <i>MLLT10</i> fusion are associated with adverse outcomes in pediatric acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Hope Foundation","keywords":"Myeloid leukemia; Medicine; Myeloid; Leukemia; Adverse effect; MEDLINE; Internal medicine; Oncology; Bioinformatics; Cancer research; Biology; Biochemistry","score_opus":0.012444261593703682,"score_gpt":0.2770061316516866,"score_spread":0.26456187005798293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391466207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899478,0.00742284,0.000008192442,0.00058724784,0.00035687984,0.0006083452,0.00006369479,0.00032020785,0.00068482454],"genre_scores_gemma":[0.99379385,0.002873307,0.00073524826,0.00030961452,0.00031229027,0.000054253873,0.00007715261,0.00007960844,0.0017646617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719775,0.00009989595,0.00045697272,0.0007043499,0.00080176396,0.0007392753],"domain_scores_gemma":[0.9987776,0.0003273173,0.00014848425,0.00037015177,0.00014408422,0.00023235659],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033394503,0.0003883703,0.0006579092,0.00051912334,0.0001357061,0.00006917498,0.00026332427,0.00019479597,0.000081694474],"category_scores_gemma":[0.00046184412,0.00027382796,0.00012593745,0.0014266071,0.000103128456,0.00076299,0.00016718668,0.0008971422,0.00005202589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030924586,0.00012670892,0.9829556,0.00051992154,0.00048611054,0.005275676,0.00060513197,0.00018821043,0.007211991,0.00007814435,0.0004294904,0.0018137655],"study_design_scores_gemma":[0.0066935276,0.00048282367,0.9838732,0.0011520362,0.00095437525,0.00026806406,0.0006847083,0.002608422,0.0019621865,0.00018182481,0.0005377767,0.0006010652],"about_ca_topic_score_codex":0.00008630649,"about_ca_topic_score_gemma":0.00048789146,"teacher_disagreement_score":0.0063842814,"about_ca_system_score_codex":0.0007338563,"about_ca_system_score_gemma":0.0008321696,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W4391593572","doi":"10.1182/bloodadvances.2023012091","title":"Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Japan Society for the Promotion of Science; National Cancer Institute; National Institutes of Health; Amgen; Servier; José Carreras Leukämie-Stiftung","keywords":"Graft-versus-host disease; Medicine; Host (biology); Mount; Disease; Immunology; Intensive care medicine; Internal medicine; Biology; Ecology","score_opus":0.010768063154609465,"score_gpt":0.30991055720828403,"score_spread":0.29914249405367455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391593572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685411,0.012635192,0.0063104676,0.0028233624,0.0018589238,0.00058094156,0.00133414,0.0002975467,0.005618353],"genre_scores_gemma":[0.9943313,0.0024036218,0.0018336001,0.0000642334,0.00011489504,0.000035323617,0.00039453368,0.000020258292,0.0008022171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985685,0.000027136548,0.00037508082,0.00035061772,0.00049555494,0.00018315142],"domain_scores_gemma":[0.99924624,0.00016567811,0.000085097214,0.00023966514,0.000120239536,0.00014310195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009858253,0.00016849636,0.0003519507,0.00032462194,0.000036375768,0.000035673595,0.00013267524,0.00004761406,0.00054385816],"category_scores_gemma":[0.000030405778,0.00014048218,0.00027018235,0.0005979256,0.00011539375,0.00023338552,0.000022967144,0.00010364215,0.000035112756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010818088,0.0034376215,0.47232676,0.008581793,0.19307856,0.016183129,0.0063350764,0.0007764052,0.22854859,0.040640365,0.0013717489,0.017901868],"study_design_scores_gemma":[0.014149816,0.0013039213,0.48085633,0.0019901178,0.1972675,0.00040298695,0.0014213858,0.00654203,0.23600201,0.0010521876,0.057517324,0.0014944008],"about_ca_topic_score_codex":0.000014758975,"about_ca_topic_score_gemma":0.000015594283,"teacher_disagreement_score":0.056145575,"about_ca_system_score_codex":0.000044084623,"about_ca_system_score_gemma":0.00010808974,"threshold_uncertainty_score":0.5954866},"labels":[],"label_agreement":null},{"id":"W4391658112","doi":"10.1182/bloodadvances.2023012155","title":"Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Neurotrauma Foundation; Canadian Blood Services; University of Toronto; FPInnovations; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Humanized mouse; Blockade; Receptor; Pharmacology; Platelet; Immunology; Medicine; Cancer research; Chemistry; Internal medicine; Immune system","score_opus":0.027674693429361134,"score_gpt":0.32855877872175965,"score_spread":0.3008840852923985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391658112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901712,0.0063056587,0.000019413605,0.0005270334,0.00011385405,0.000300396,0.00004505354,0.00007074169,0.0024466617],"genre_scores_gemma":[0.9901407,0.0010817574,0.0026745654,0.000038965598,0.00029870425,0.00003268098,0.000058119334,0.000027769524,0.0056467834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853694,0.000031527932,0.0004086517,0.0003335602,0.00038218,0.00030711092],"domain_scores_gemma":[0.9995601,0.000051908686,0.00005510428,0.00015649998,0.000071734394,0.000104622595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016632942,0.00017480468,0.00036580188,0.00027321445,0.000066291555,0.000017888306,0.00010063734,0.00008077071,0.00025390778],"category_scores_gemma":[0.00003896968,0.00014012922,0.00010296722,0.00033276368,0.00013116021,0.00017413567,0.000069282694,0.0003221112,0.0000372823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085122755,0.00058678066,0.006489668,0.0021491337,0.000184627,0.00020273175,0.0006905628,0.0004993717,0.95745873,0.004291105,0.00043360415,0.026162473],"study_design_scores_gemma":[0.005860045,0.001792936,0.0045525064,0.0025396368,0.0001610712,0.00031845117,0.00023260397,0.00965526,0.9314466,0.0076276613,0.03524324,0.0005699904],"about_ca_topic_score_codex":0.00008738477,"about_ca_topic_score_gemma":0.00014495612,"teacher_disagreement_score":0.034809634,"about_ca_system_score_codex":0.000028537173,"about_ca_system_score_gemma":0.00008413465,"threshold_uncertainty_score":0.5714304},"labels":[],"label_agreement":null},{"id":"W4391658156","doi":"10.1182/bloodadvances.2023011743","title":"Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk; Moderna; Argenx; Incyte; bluebird bio; Celgene; Silence Therapeutics; Sanofi; Alexion Pharmaceuticals; Amgen; Pfizer; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Erythropoiesis; Pyruvate kinase deficiency; Pyruvate kinase; Ineffective erythropoiesis; Internal medicine; Endocrinology; Medicine; Metabolism; Anemia; Glycolysis","score_opus":0.0033288109312628435,"score_gpt":0.22358079894911698,"score_spread":0.22025198801785414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391658156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914174,0.0067137154,0.000020031273,0.00019023867,0.00027788978,0.00036749206,0.000015419797,0.00008499897,0.0009128119],"genre_scores_gemma":[0.99782103,0.0010857292,0.00045956418,0.0002834902,0.000075117205,0.00004236438,0.00002389174,0.000019975841,0.00018880553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990465,0.000032221735,0.00016296114,0.0003940347,0.0001445781,0.00021970346],"domain_scores_gemma":[0.9995687,0.000113195914,0.000038975533,0.00013568331,0.00007235808,0.00007107633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043493397,0.00017518386,0.00024841796,0.00014310666,0.0000522463,0.000017841983,0.00003232351,0.00006202078,0.000024015315],"category_scores_gemma":[0.00008354033,0.000119756216,0.00003466323,0.00030023526,0.00015350866,0.0002419182,0.000028189397,0.00016900757,0.000015686308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002490008,0.001994737,0.74617875,0.0034545623,0.00015175261,0.00038931725,0.002211945,0.000037989405,0.088560164,0.0017070178,0.00029180475,0.15253194],"study_design_scores_gemma":[0.007537104,0.00633936,0.9674317,0.0012067211,0.00029974993,0.00003416039,0.0009082072,0.00014314156,0.010908375,0.0005747773,0.004127162,0.00048948935],"about_ca_topic_score_codex":0.00004587426,"about_ca_topic_score_gemma":0.00008776832,"teacher_disagreement_score":0.221253,"about_ca_system_score_codex":0.00002613385,"about_ca_system_score_gemma":0.000038661787,"threshold_uncertainty_score":0.48835167},"labels":[],"label_agreement":null},{"id":"W4391838668","doi":"10.1182/bloodadvances.2023012463","title":"Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"bluebird bio; Mallinckrodt Pharmaceuticals; Jazz Pharmaceuticals","keywords":"Extracorporeal Photopheresis; Photopheresis; Graft-versus-host disease; Immunology; Medicine; Hematopoietic stem cell transplantation; T cell; Mixed lymphocyte reaction; CD19; Immune system; CD8; Transplantation; Internal medicine; Lymphoma","score_opus":0.040692693254508416,"score_gpt":0.34950940949916676,"score_spread":0.30881671624465834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391838668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8402372,0.15521519,0.00002747761,0.00036125391,0.00023281373,0.0021400615,0.000107768494,0.00006376935,0.0016144788],"genre_scores_gemma":[0.9635819,0.024711484,0.0002645489,0.00003989771,0.0004404261,0.0009230465,0.000021770871,0.000059904472,0.009956994],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986879,0.000038636335,0.00023543653,0.00037556636,0.0003441825,0.00031827248],"domain_scores_gemma":[0.9988004,0.000515348,0.000049175815,0.000386721,0.00008211953,0.00016622974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113909504,0.00022182346,0.0002792015,0.00007250384,0.00007393456,0.000058381476,0.000110644505,0.00004693622,0.0010291899],"category_scores_gemma":[0.000016570353,0.00012830352,0.00030893236,0.00020157712,0.00015208582,0.00011049936,0.000010006883,0.000086013024,0.000009991462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044577625,0.003985932,0.0037810004,0.001205605,0.0017583385,0.00083197514,0.0018501756,0.00006514092,0.4238974,0.00022675435,0.00019692989,0.5176231],"study_design_scores_gemma":[0.019100634,0.013435848,0.0053198333,0.00040219634,0.001511133,0.000030088731,0.0012865213,0.00059458555,0.509402,0.00096549996,0.44748095,0.0004707701],"about_ca_topic_score_codex":0.0001048892,"about_ca_topic_score_gemma":0.000059800645,"teacher_disagreement_score":0.51715237,"about_ca_system_score_codex":0.000059264235,"about_ca_system_score_gemma":0.00030628417,"threshold_uncertainty_score":0.999884},"labels":[],"label_agreement":null},{"id":"W4392501727","doi":"10.1182/bloodadvances.2023012127","title":"Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Occupational Cancer Research Centre; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; Pfizer","keywords":"Myeloid leukemia; Transcription factor; Gene; Myeloid; Cancer research; Transcription (linguistics); Biology; Medicine; Genetics; Internal medicine; Immunology","score_opus":0.015642065460070187,"score_gpt":0.2757519528654116,"score_spread":0.2601098874053414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392501727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96161777,0.036520157,0.00008823634,0.000247893,0.00030175885,0.0005914109,0.00004895332,0.00030685886,0.0002769894],"genre_scores_gemma":[0.99519086,0.0032143127,0.00059080333,0.00003527858,0.00015448825,0.000093595,0.00016771466,0.000051605246,0.00050133216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830407,0.000045981003,0.00041042673,0.0005444743,0.00030496588,0.00039009022],"domain_scores_gemma":[0.9993225,0.00023633985,0.000061242186,0.00020487688,0.000033785607,0.00014126042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010654463,0.0003380369,0.0004536765,0.00031430766,0.000099762205,0.00005919769,0.000078368445,0.00012953515,0.00011169752],"category_scores_gemma":[0.000059634902,0.00026008795,0.00012009167,0.00042950857,0.00011294386,0.00055388,0.000021277652,0.00030084528,0.000014653188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009189038,0.00023255861,0.32565907,0.0012110143,0.0006967313,0.00032200041,0.0020425988,0.0009639169,0.6143311,0.00015334011,0.000018891596,0.054276846],"study_design_scores_gemma":[0.010360276,0.0009998301,0.35905844,0.0021705457,0.0014581445,0.00023720226,0.0015543303,0.0021615485,0.60911196,0.0005871355,0.011510107,0.00079044804],"about_ca_topic_score_codex":0.00017156044,"about_ca_topic_score_gemma":0.00024336546,"teacher_disagreement_score":0.0534864,"about_ca_system_score_codex":0.001041064,"about_ca_system_score_gemma":0.0006440051,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W4392767130","doi":"10.1182/bloodadvances.2023012019","title":"EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Japan Society for the Promotion of Science; Daiko Foundation","keywords":"Biology; Epstein–Barr virus; Lymphoma; Genome; T-cell lymphoma; Virus; Cancer research; Virology; Gene; Genetics; Immunology","score_opus":0.004401979613176985,"score_gpt":0.22222258701245293,"score_spread":0.21782060739927595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392767130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98303807,0.0127674565,0.000029405648,0.00063188287,0.00015634278,0.0002120854,0.000111362315,0.00006194295,0.0029914593],"genre_scores_gemma":[0.99855995,0.00019430088,0.00024251622,0.0001649898,0.000061635714,0.000012952579,0.000024316892,0.000019570496,0.00071975304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990954,0.000028711376,0.00019009555,0.00021275441,0.00027439708,0.0001986388],"domain_scores_gemma":[0.99958074,0.00007186725,0.00010222048,0.00012986221,0.000059736896,0.000055567474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000707804,0.00014085688,0.00023995466,0.000048886912,0.00012620937,0.000030462039,0.000076725,0.00006541785,0.000045939592],"category_scores_gemma":[0.000048149468,0.000086442175,0.00008186697,0.0002920847,0.00013664803,0.00014663725,0.000032282074,0.00009279122,0.0000015728504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002222216,0.0040411525,0.70600915,0.0057947217,0.010099114,0.00050581736,0.0193271,0.0016636135,0.16185804,0.05289252,0.002368798,0.033217765],"study_design_scores_gemma":[0.027717456,0.0023128523,0.90643233,0.0015741453,0.004670551,0.00026691874,0.0032718678,0.0027118516,0.023916466,0.015908407,0.00997359,0.0012435936],"about_ca_topic_score_codex":0.00004984934,"about_ca_topic_score_gemma":0.00009505087,"teacher_disagreement_score":0.20042317,"about_ca_system_score_codex":0.000051264862,"about_ca_system_score_gemma":0.00018811374,"threshold_uncertainty_score":0.35250095},"labels":[],"label_agreement":null},{"id":"W4392978281","doi":"10.1182/bloodadvances.2023011445","title":"Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute for Occupational Safety and Health; National Cancer Institute; Ludwig Center at Harvard; National Institutes of Health; Edward P. Evans Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Gilead Sciences; Fondation pour la Recherche Médicale; Leukemia and Lymphoma Society; Glenn Foundation for Medical Research","keywords":"Biology; CD14; Haematopoiesis; Inflammation; Proinflammatory cytokine; Immunology; T cell; Myeloid; Cancer research; Genetics; Immune system; Stem cell","score_opus":0.01712623689656025,"score_gpt":0.29077161099723603,"score_spread":0.2736453741006758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392978281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825519,0.015646318,0.00010956531,0.00013125104,0.00006269147,0.0005308788,0.0000150360065,0.00008492408,0.00086746895],"genre_scores_gemma":[0.9929482,0.0009187972,0.0051416648,0.000024128307,0.0002235517,0.000053944557,0.000036604208,0.000032277167,0.00062085764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988434,0.000038432427,0.00031354983,0.00030669646,0.00029226372,0.00020570784],"domain_scores_gemma":[0.99938697,0.00016014474,0.000076518554,0.00019720334,0.0000982161,0.00008093795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026070233,0.00013505829,0.00025345123,0.00019590376,0.000080089754,0.00002453205,0.000074213094,0.00007948276,0.000046916142],"category_scores_gemma":[0.000049704406,0.000114256705,0.000053423904,0.00021042781,0.00012215371,0.00023734622,0.000055057088,0.00023164591,0.000014017544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006668366,0.00006416896,0.0060273465,0.0016400202,0.000052382846,0.00004756805,0.00037725375,0.000004238801,0.9864077,0.0015558801,0.00018963694,0.003567146],"study_design_scores_gemma":[0.0009360109,0.00017433496,0.006337645,0.00044955424,0.000043999305,0.000036466878,0.0003324761,0.000088856475,0.98651916,0.000546127,0.0044080447,0.00012732417],"about_ca_topic_score_codex":0.0000065804134,"about_ca_topic_score_gemma":0.000001464204,"teacher_disagreement_score":0.014727522,"about_ca_system_score_codex":0.000066104265,"about_ca_system_score_gemma":0.0001437918,"threshold_uncertainty_score":0.46592534},"labels":[],"label_agreement":null},{"id":"W4393127041","doi":"10.1182/bloodadvances.2023012367","title":"SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Megakaryocyte; Transcriptome; Bone marrow; Biology; Platelet; Inflammation; Immunology; Thrombopoiesis; Haematopoiesis; Cell biology; Gene expression; Gene; Stem cell","score_opus":0.01871985539094396,"score_gpt":0.2869132420566706,"score_spread":0.2681933866657267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393127041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96617913,0.027188536,0.000007641469,0.003477183,0.00021005496,0.0003457794,0.000007601112,0.000026852542,0.0025572395],"genre_scores_gemma":[0.9975494,0.0018341967,0.000021562455,0.00033101896,0.00004000171,0.000048135906,0.0000036008894,0.000008625489,0.00016342099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999351,0.00004952821,0.00015511843,0.00012795448,0.00019015641,0.00012624574],"domain_scores_gemma":[0.9996518,0.00010129622,0.00003083749,0.00019410581,0.000014719499,0.0000072738567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013473793,0.00010125116,0.00016170723,0.000044774544,0.000069365065,0.000020882931,0.00009033215,0.00003144173,0.0000066938874],"category_scores_gemma":[0.000025619585,0.000039569568,0.00010672351,0.0003226105,0.00010706352,0.00012533096,0.000010518134,0.0001428356,0.0000064606265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007142707,0.00456778,0.20651983,0.002460112,0.0019217615,0.0013181785,0.024837932,0.0002788172,0.5949681,0.014238124,0.0035324038,0.14464273],"study_design_scores_gemma":[0.0061965445,0.0010440231,0.20284592,0.0015471708,0.0018643338,0.0013049144,0.0023981358,0.0006855513,0.59935343,0.02620891,0.15611,0.00044107187],"about_ca_topic_score_codex":0.00020471163,"about_ca_topic_score_gemma":0.0004501816,"teacher_disagreement_score":0.1525776,"about_ca_system_score_codex":0.000008732768,"about_ca_system_score_gemma":0.000027581564,"threshold_uncertainty_score":0.16136001},"labels":[],"label_agreement":null},{"id":"W4393184830","doi":"10.1182/bloodadvances.2023011030","title":"Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Jewish General Hospital","funders":"National Cancer Institute; Incyte; BeiGene; Genentech; AstraZeneca; Celgene; Seagen; Gilead Sciences; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Brentuximab vedotin; Nivolumab; Lymphoma; Medicine; Oncology; Internal medicine; Refractory (planetary science); CD30; Immunotherapy; Biology; Cancer","score_opus":0.011272349752706407,"score_gpt":0.2798334425537646,"score_spread":0.26856109280105817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393184830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86897016,0.116343126,0.00039777072,0.00057149335,0.00061509846,0.0017022068,0.0001472449,0.00039217106,0.010860741],"genre_scores_gemma":[0.96806616,0.00499023,0.0022143414,0.00030223216,0.00047526896,0.00025469446,0.000103576946,0.000172985,0.023420507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967878,0.000083074876,0.0005123494,0.0010736805,0.00065557647,0.000887503],"domain_scores_gemma":[0.9983578,0.00047026406,0.0000983888,0.00047548357,0.00022534309,0.0003727607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017988976,0.00051728607,0.0006988233,0.00026783647,0.00030696535,0.00022295665,0.00024121857,0.0002186463,0.00016480434],"category_scores_gemma":[0.00016975166,0.00046953143,0.00026734002,0.0003640454,0.0003431567,0.00032193967,0.00012437343,0.00018476631,0.00008257829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0103650745,0.013123322,0.010242085,0.013637558,0.0010641649,0.010712214,0.0067083547,0.00013763952,0.14328864,0.00076526037,0.010785321,0.77917033],"study_design_scores_gemma":[0.0747307,0.010900891,0.00049495365,0.001182117,0.0012392325,0.023251615,0.0042015626,0.021144232,0.06984528,0.001683342,0.78915405,0.00217201],"about_ca_topic_score_codex":0.000072925446,"about_ca_topic_score_gemma":0.00009553915,"teacher_disagreement_score":0.7783687,"about_ca_system_score_codex":0.00040378948,"about_ca_system_score_gemma":0.0010139893,"threshold_uncertainty_score":0.99977565},"labels":[],"label_agreement":null},{"id":"W4393252371","doi":"10.1182/bloodadvances.2024012862","title":"Race and ethnicity reporting and representation in hemophilia clinical trials","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ethnic group; Census; Representativeness heuristic; Medicine; Clinical trial; Demography; Population; Race (biology); Gerontology; Family medicine; Internal medicine; Psychology; Environmental health; Political science; Gender studies","score_opus":0.22719154842318562,"score_gpt":0.537361420925668,"score_spread":0.31016987250248235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393252371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96345806,0.03133184,0.000010644799,0.0035660677,0.00013325315,0.00038978466,0.0000018817266,0.000044933084,0.0010635473],"genre_scores_gemma":[0.9835505,0.013285707,0.0010103943,0.00004697101,0.00029409557,0.000019243087,0.0000073528563,0.00000968846,0.0017760806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811924,0.0002471998,0.0009605878,0.00035365197,0.00017397819,0.00014534421],"domain_scores_gemma":[0.99833524,0.0012443118,0.00016766656,0.00012260239,0.000027969403,0.00010220418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041866186,0.00008282006,0.00047860204,0.00009410608,0.00003610842,0.000033770833,0.000019544572,0.00007391931,0.00002040445],"category_scores_gemma":[0.007404268,0.00005535693,0.00006526966,0.00019272542,0.00010504291,0.00015386476,0.000036352227,0.00023053934,0.000005042034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015708218,0.00014077772,0.72145945,0.00030763843,0.00008372939,0.0010031214,0.00025852406,8.7678194e-7,0.003582884,0.00011490198,0.00012927824,0.2727617],"study_design_scores_gemma":[0.008893929,0.0010054585,0.9280203,0.0019193345,0.00072615733,0.000981457,0.0010786374,0.0019052776,0.029687006,0.0070208027,0.018376144,0.00038549077],"about_ca_topic_score_codex":0.00002240179,"about_ca_topic_score_gemma":0.00002122673,"teacher_disagreement_score":0.2723762,"about_ca_system_score_codex":0.000008857909,"about_ca_system_score_gemma":0.000056559536,"threshold_uncertainty_score":0.8864135},"labels":[],"label_agreement":null},{"id":"W4393280322","doi":"10.1182/bloodadvances.2023011739","title":"Double-negative T cells utilize a TNFα–JAK1–ICAM-1 cytotoxic axis against acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; Toronto General Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Myeloid leukemia; Cytotoxic T cell; Cytotoxicity; Cancer research; Leukemia; Flow cytometry; Tumor necrosis factor alpha; Immunology; Medicine; Chemistry; In vitro; Biochemistry","score_opus":0.022102472702105164,"score_gpt":0.32007254931942475,"score_spread":0.29797007661731956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393280322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8886784,0.01926328,0.000120587836,0.0011948306,0.0009918972,0.0019407639,0.00013903408,0.0007380728,0.086933136],"genre_scores_gemma":[0.87352085,0.017452467,0.0028705483,0.0007074749,0.0013012701,0.000364737,0.00008071489,0.00019615931,0.10350576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969078,0.000082148756,0.00046068456,0.0008862813,0.00085894746,0.00080414966],"domain_scores_gemma":[0.99833065,0.00038810182,0.000077240984,0.000666114,0.00015903944,0.00037882125],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003503094,0.00042670086,0.0006249837,0.00032077738,0.00015204177,0.00014767528,0.00033740242,0.00017998945,0.0024570615],"category_scores_gemma":[0.000054095926,0.00034804066,0.0003258011,0.0009851924,0.00034488944,0.00041838878,0.00014881765,0.0007805146,0.0007005728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012287872,0.00023086279,0.00018615393,0.00051362126,0.00097414444,0.001497166,0.0011530893,0.000035171834,0.9144755,0.00027571435,0.0019865695,0.07744322],"study_design_scores_gemma":[0.0041863793,0.00063212827,0.00016197756,0.00045357374,0.00029910207,0.00014618678,0.00042601995,0.00035046702,0.726286,0.0004601389,0.26623276,0.00036526335],"about_ca_topic_score_codex":0.000053961325,"about_ca_topic_score_gemma":0.00005028595,"teacher_disagreement_score":0.2642462,"about_ca_system_score_codex":0.00031586082,"about_ca_system_score_gemma":0.00063844555,"threshold_uncertainty_score":0.9998972},"labels":[],"label_agreement":null},{"id":"W4394594448","doi":"10.1182/bloodadvances.2023011102","title":"Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; University of Toronto; Health Sciences Centre; Canadian Blood Services; McMaster University","funders":"","keywords":"Advice (programming); Terminology; Concordance; Transparency (behavior); Clinical Practice; Medicine; Variety (cybernetics); Underpinning; Medical education; Family medicine; Political science; Internal medicine; Computer science; Engineering; Law","score_opus":0.28734616877055114,"score_gpt":0.5959706096954132,"score_spread":0.308624440924862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394594448","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73715734,0.06852547,0.015914965,0.10908944,0.015322527,0.002881869,0.00072038046,0.0018101117,0.048577882],"genre_scores_gemma":[0.297764,0.009866048,0.64746594,0.02944438,0.012903514,0.000059906044,0.00037505114,0.0002165268,0.0019046261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924655,0.0003580277,0.0051256865,0.00086693536,0.0008245178,0.00035934153],"domain_scores_gemma":[0.9774842,0.018775431,0.0012342434,0.0007209503,0.0014970723,0.00028806776],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0065931496,0.0002945852,0.00088804413,0.00008770275,0.000074335985,0.00008854885,0.0002764686,0.00025073966,0.0004276218],"category_scores_gemma":[0.14534774,0.00022879883,0.00048362723,0.0003864122,0.00021614866,0.0012567055,0.0001884266,0.0008782471,0.00017597483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014055935,0.0023125545,0.17566696,0.00054371386,0.0016074422,0.00037765005,0.0002507706,0.00003429278,0.00058963697,0.0018277919,0.042311132,0.7730725],"study_design_scores_gemma":[0.0033437703,0.0010142014,0.0094976025,0.0011087379,0.0025502176,0.00008346064,0.0014612649,0.0013531337,0.00041802996,0.0047531165,0.9740938,0.00032269754],"about_ca_topic_score_codex":0.00032974058,"about_ca_topic_score_gemma":0.0002240024,"teacher_disagreement_score":0.93178266,"about_ca_system_score_codex":0.000025411975,"about_ca_system_score_gemma":0.00043982986,"threshold_uncertainty_score":0.9330146},"labels":[],"label_agreement":null},{"id":"W4394596323","doi":"10.1182/bloodadvances.2023011000","title":"Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"NIH Clinical Center; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Immune system; Placebo; CD8; Internal medicine; Immune dysregulation; Clinical trial; Immunology; Lymphocyte; Pediatrics; Alternative medicine","score_opus":0.008652111482124279,"score_gpt":0.2821339996319304,"score_spread":0.2734818881498061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394596323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877713,0.008829497,0.000021773527,0.00019695831,0.0000820687,0.0012782444,0.000018746076,0.0002194962,0.0015819316],"genre_scores_gemma":[0.9964626,0.0011791557,0.00049684703,0.000032434586,0.0001776372,0.00031933482,0.000051122777,0.000078008416,0.0012028831],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769056,0.000055127322,0.0002698635,0.0007694467,0.00057858264,0.000636447],"domain_scores_gemma":[0.9990411,0.00020865045,0.00005556222,0.0003691539,0.000109491775,0.00021606882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000915828,0.00037239582,0.00053170265,0.00031683032,0.00007395303,0.000057262765,0.00011665148,0.00010446572,0.00006197785],"category_scores_gemma":[0.000029080831,0.00022400457,0.00006542194,0.0010402477,0.00019072036,0.0004235656,0.00003872016,0.00031418516,0.0000526135],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064382866,0.014951205,0.39308226,0.017438952,0.00991711,0.23282732,0.021948436,0.00065308134,0.03651534,0.0006509148,0.00038594415,0.20724657],"study_design_scores_gemma":[0.23497294,0.07017721,0.105849266,0.04209434,0.0018457415,0.04152841,0.0020921677,0.0014748959,0.49324107,0.00019683232,0.0039795474,0.0025475684],"about_ca_topic_score_codex":0.0004070197,"about_ca_topic_score_gemma":0.0012165282,"teacher_disagreement_score":0.45672575,"about_ca_system_score_codex":0.005395509,"about_ca_system_score_gemma":0.0043250807,"threshold_uncertainty_score":0.9984226},"labels":[],"label_agreement":null},{"id":"W4394770437","doi":"10.1182/bloodadvances.2023012541","title":"The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia","year":2024,"lang":"en","type":"review","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Swedish Orphan Biovitrum; Daiichi Sankyo Europe; Agios Pharmaceuticals; Public Health Agency of Canada; Public Health Agency; Sanofi; Argenx; Chugai Pharmaceutical; Amgen","keywords":"Immune thrombocytopenia; Guideline; Medicine; MEDLINE; Clinical trial; Population; Family medicine; Relevance (law); Intensive care medicine; Internal medicine; Environmental health; Pathology; Political science","score_opus":0.043776891053396216,"score_gpt":0.4023210212437499,"score_spread":0.3585441301903537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394770437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001817932,0.99576527,3.8722388e-7,0.0019595127,0.00028685364,0.001139496,0.00013148399,0.0000144121,0.00068442785],"genre_scores_gemma":[0.000002500571,0.99749184,0.00023411556,0.00045050727,0.00005066492,0.000083272374,0.00006135323,0.000034969915,0.0015907513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980739,0.0000975136,0.0010104704,0.00030014213,0.0003155126,0.000202498],"domain_scores_gemma":[0.9979418,0.0002244589,0.00094461103,0.00073423696,0.00012536514,0.000029535384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026074052,0.00033871978,0.003040959,0.00002571851,0.00007597519,0.0000050454414,0.00037375363,0.000074535266,0.000025166994],"category_scores_gemma":[0.00013896576,0.00013241988,0.0012950235,0.0004990711,0.00035128486,0.000023408249,0.00013817847,0.00029540743,0.000026334385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000074235213,0.0001925841,0.000007241794,0.10264509,0.0016585066,0.000018307766,0.000010087228,6.0035546e-8,0.0000028530544,0.0003363769,0.028895244,0.8662262],"study_design_scores_gemma":[0.00020080234,0.00018841517,0.000003847545,0.1329345,0.0048350645,0.00015361179,0.00002238831,2.2772302e-7,0.000042009753,0.00008011946,0.8614455,0.000093523035],"about_ca_topic_score_codex":0.00003131852,"about_ca_topic_score_gemma":0.000008319778,"teacher_disagreement_score":0.8661327,"about_ca_system_score_codex":0.000019849396,"about_ca_system_score_gemma":0.00027994352,"threshold_uncertainty_score":0.5399926},"labels":[],"label_agreement":null},{"id":"W4394770687","doi":"10.1182/bloodadvances.2023011510","title":"Clonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepository","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Biorepository; Medicine; Malignancy; Internal medicine; Prospective cohort study; Disease; Hematologic malignancy; Cohort; Oncology; Bioinformatics; Biobank; Biology","score_opus":0.005859118181534548,"score_gpt":0.25333109554222416,"score_spread":0.2474719773606896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394770687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96044415,0.03550765,0.000022080438,0.001687118,0.000099507546,0.0008744086,0.000019411389,0.000054753353,0.0012909444],"genre_scores_gemma":[0.9958714,0.0022252467,0.0010468272,0.00008368321,0.0002473171,0.000415669,0.000022917015,0.000016830036,0.000070074864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986227,0.000058210975,0.00027791137,0.00047642886,0.0003591025,0.00020564275],"domain_scores_gemma":[0.99936694,0.00028396677,0.000054220614,0.0001668347,0.000052626332,0.00007539389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002158335,0.00023756284,0.00035483658,0.00012946152,0.00015426177,0.00013033865,0.000050616654,0.000072487695,0.00002225668],"category_scores_gemma":[0.000055367407,0.00014619378,0.0000800511,0.00024837963,0.00017424938,0.00029535565,0.000039303286,0.00020277713,0.000003838751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084661275,0.00024342317,0.98361444,0.0004901169,0.00041432658,0.00039544274,0.0009344122,0.0000027103238,0.0006199551,0.011412571,0.00010002103,0.0016878961],"study_design_scores_gemma":[0.0011921042,0.0002551576,0.9810833,0.00048257632,0.00049432804,0.00124622,0.00021583351,0.000075904405,0.010874349,0.0017504294,0.0021597554,0.00017003961],"about_ca_topic_score_codex":0.000021265214,"about_ca_topic_score_gemma":0.000100025325,"teacher_disagreement_score":0.03542731,"about_ca_system_score_codex":0.00003322356,"about_ca_system_score_gemma":0.000060216455,"threshold_uncertainty_score":0.59616095},"labels":[],"label_agreement":null},{"id":"W4394822828","doi":"10.1182/bloodadvances.2023011771","title":"Optimized cytogenetic risk-group stratification of <i>KMT2A</i>-rearranged pediatric acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Daiichi Sankyo Europe; National Institutes of Health; Chugai Pharmaceutical; Sumitomo Dainippon Pharma Oncology; National Cancer Institute; Medac; Gilead Sciences; Children's Cancer and Leukaemia Group; Barncancerfonden; Swedish Orphan Biovitrum; Moderna; Syndax Pharmaceuticals; bluebird bio; St. Jude Children's Research Hospital; Jazz Pharmaceuticals; Pfizer; Amgen","keywords":"Myeloid leukemia; Risk stratification; Leukemia; Oncology; Myeloid; Cytogenetics; Medicine; Internal medicine; Biology; Cancer research; Genetics; Gene","score_opus":0.01280825383467573,"score_gpt":0.29172583952535364,"score_spread":0.2789175856906779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394822828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93293744,0.05518416,0.0035107518,0.00047486837,0.00042368882,0.00129407,0.00017806281,0.00039411316,0.005602868],"genre_scores_gemma":[0.9313866,0.034880612,0.031097675,0.00005948743,0.00076877704,0.0001477025,0.00015547409,0.0000834513,0.0014202545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752873,0.00013246779,0.00059271697,0.0006235992,0.00066584884,0.0004566331],"domain_scores_gemma":[0.9985221,0.00032034577,0.0001838079,0.0005856517,0.0001715303,0.0002165705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004908056,0.00028660503,0.0005253298,0.0003716364,0.00010380286,0.00005751535,0.000272644,0.00016125607,0.00017738213],"category_scores_gemma":[0.00017891321,0.00023755185,0.00021687827,0.0010065795,0.00016106122,0.00029613715,0.00006845288,0.0005423099,0.000111379675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027623952,0.001148521,0.042488407,0.005227858,0.0029220744,0.001142657,0.0017978572,0.0020735718,0.7591614,0.0019230298,0.0063052867,0.1730469],"study_design_scores_gemma":[0.036599968,0.0073693404,0.0805276,0.001534329,0.020685317,0.0016231546,0.0019345668,0.019644,0.7468145,0.00449819,0.07563035,0.003138657],"about_ca_topic_score_codex":0.00006097408,"about_ca_topic_score_gemma":0.0000110362125,"teacher_disagreement_score":0.16990826,"about_ca_system_score_codex":0.00018226412,"about_ca_system_score_gemma":0.0006871008,"threshold_uncertainty_score":0.96870834},"labels":[],"label_agreement":null},{"id":"W4394841497","doi":"10.1182/bloodadvances.2024012931","title":"Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Agency for Healthcare Research and Quality","keywords":"Foundation (evidence); Thrombophilia; Extension (predicate logic); Medicine; Intensive care medicine; Internal medicine; Computer science; Political science; Thrombosis; Law","score_opus":0.3370342596802451,"score_gpt":0.6174828715691121,"score_spread":0.280448611888867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394841497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85107654,0.014533441,0.034393705,0.08601263,0.007447756,0.002110224,0.00012831426,0.00026496287,0.004032451],"genre_scores_gemma":[0.6822423,0.00394222,0.30817544,0.004107651,0.0013389918,0.000015121649,0.000049089118,0.000044576416,0.000084662715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99335724,0.00036059273,0.004437466,0.0005811249,0.001054402,0.0002092012],"domain_scores_gemma":[0.98507446,0.008385111,0.0008728828,0.0010342526,0.004482117,0.00015120266],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00578347,0.0002101161,0.0006324466,0.00010085301,0.00009329026,0.000034121753,0.00029791525,0.00015779598,0.00032750113],"category_scores_gemma":[0.16515453,0.00012817908,0.00038047737,0.0006005401,0.0005719705,0.0009538698,0.00018633295,0.0004068231,0.00002475647],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012008605,0.0022284356,0.008917157,0.00037411143,0.00043855183,0.000046838293,0.00019906912,0.00037095958,0.009911331,0.063783966,0.014047534,0.8984812],"study_design_scores_gemma":[0.0073729507,0.004571055,0.04623409,0.0049697626,0.007864021,0.0009071331,0.005667758,0.025348188,0.00782456,0.12805735,0.76044554,0.0007375943],"about_ca_topic_score_codex":0.000048249545,"about_ca_topic_score_gemma":0.000048635426,"teacher_disagreement_score":0.8977436,"about_ca_system_score_codex":0.000016069433,"about_ca_system_score_gemma":0.00063884945,"threshold_uncertainty_score":0.8418777},"labels":[],"label_agreement":null},{"id":"W4394981536","doi":"10.1182/bloodadvances.2023011049","title":"Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; José Carreras Leukämie-Stiftung; University of Minnesota","keywords":"Amphiregulin; Biomarker; Internal medicine; Medicine; Oncology; Disease; Immunology; Biology; Cancer; Epidermal growth factor receptor; Genetics","score_opus":0.007853760023854274,"score_gpt":0.26796460608818784,"score_spread":0.26011084606433355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394981536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943552,0.0037966354,0.000095820076,0.000026420754,0.00031906288,0.0004608285,0.000102559294,0.00006053462,0.00078294345],"genre_scores_gemma":[0.99728775,0.0007671812,0.0013677048,0.000052056428,0.00005934248,0.000028178047,0.00005028835,0.000028007282,0.00035948295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870193,0.000034092544,0.00031655713,0.0003741034,0.00036278335,0.00021055067],"domain_scores_gemma":[0.99940073,0.000038683356,0.000104016726,0.00024685092,0.00007024982,0.00013948369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019694038,0.00018287174,0.00033722783,0.00014855812,0.000029528332,0.0000150463275,0.00006119501,0.000081708204,0.000067091976],"category_scores_gemma":[0.00003881211,0.00012592856,0.000052312298,0.00029092253,0.00012457572,0.00026395058,0.00003438356,0.00014544839,0.000004872546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026742855,0.0003223096,0.966029,0.00018064267,0.0005343268,0.0002683952,0.00021149364,0.0000011206424,0.000338242,0.00005920454,0.00005303456,0.03173479],"study_design_scores_gemma":[0.0035842785,0.0018058978,0.97624993,0.00029670662,0.0010460945,0.000020212652,0.00014622063,0.00004846001,0.007483204,0.00037194224,0.008747892,0.00019917186],"about_ca_topic_score_codex":0.00004046759,"about_ca_topic_score_gemma":0.00003588793,"teacher_disagreement_score":0.031535618,"about_ca_system_score_codex":0.000012984858,"about_ca_system_score_gemma":0.000104065366,"threshold_uncertainty_score":0.5135218},"labels":[],"label_agreement":null},{"id":"W4395465396","doi":"10.1182/bloodadvances.2023012469","title":"Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Pharmacyclics; Takeda Oncology; Genentech; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Legend Biotech; Sangamo Therapeutics; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Atara Biotherapeutics; Novavax; Jazz Pharmaceuticals; StemCyte; aTyr; CSL Behring; St. Jude Children's Research Hospital; HistoGenetics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer","keywords":"Ethnic group; Hematopoietic cell; Haematopoiesis; Transplantation; Hematopoietic stem cell transplantation; Medicine; Demography; Immunology; Internal medicine; Biology; Stem cell; Political science; Genetics; Sociology; Law","score_opus":0.012558571118926198,"score_gpt":0.2818086667874888,"score_spread":0.26925009566856256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395465396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479296,0.047776155,0.000115845454,0.0002033227,0.00024326709,0.00018460795,0.000022345504,0.000066638095,0.0034581702],"genre_scores_gemma":[0.9927043,0.005513029,0.0005532638,0.000034519762,0.00006918357,0.00007562889,0.00004124805,0.000023091165,0.0009857538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988198,0.00005423987,0.00034532664,0.00032694958,0.00021594943,0.00023767771],"domain_scores_gemma":[0.9996359,0.00016391887,0.000023633831,0.00010120254,0.00001382202,0.00006156412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001809418,0.00016789287,0.00029775265,0.00044120415,0.000015211798,0.000026928195,0.000037804206,0.00008703005,0.00011079456],"category_scores_gemma":[0.0000056049857,0.00015644157,0.000051413368,0.00045830678,0.00006575176,0.00025743293,0.000004939537,0.0001639771,0.000013065502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094643113,0.0007216459,0.8091973,0.021089276,0.000078508936,0.006041579,0.051183235,0.000044688542,0.013215947,0.0008614716,0.000019772813,0.09660012],"study_design_scores_gemma":[0.006088796,0.00037995746,0.9476472,0.0041012843,0.0005895992,0.00066226086,0.0034859516,0.0003141984,0.03342446,0.001076009,0.0015876754,0.00064260775],"about_ca_topic_score_codex":0.000045034343,"about_ca_topic_score_gemma":0.0012149842,"teacher_disagreement_score":0.13844988,"about_ca_system_score_codex":0.000020127653,"about_ca_system_score_gemma":0.000034306362,"threshold_uncertainty_score":0.6379502},"labels":[],"label_agreement":null},{"id":"W4396515165","doi":"10.1182/bloodadvances.2024012646","title":"Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Jazz Pharmaceuticals; StemCyte; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; CSL Behring; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; Gateway for Cancer Research; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen","keywords":"Filgrastim; Term (time); Peripheral blood; Stem cell; Peripheral Blood Stem Cells; Medicine; Immunology; Internal medicine; Granulocyte colony-stimulating factor; Hematopoietic stem cell transplantation; Biology; Transplantation; Genetics","score_opus":0.012057720232768054,"score_gpt":0.2696585224523246,"score_spread":0.2576008022195565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396515165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753,0.008335115,0.0006719636,0.00008949977,0.0002095865,0.0005728811,0.00003224483,0.00021066809,0.0023480214],"genre_scores_gemma":[0.9945187,0.0007671311,0.0021335203,0.000032498436,0.00003796536,0.000046568784,0.000046390833,0.000048038288,0.0023691726],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985341,0.000038533206,0.00042636547,0.00037775605,0.0003616709,0.00026156765],"domain_scores_gemma":[0.99924344,0.00020789272,0.00009268754,0.00026546282,0.00007174469,0.0001187764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100828285,0.00025222334,0.00051409716,0.00012252167,0.00003752614,0.000023821198,0.00009650896,0.0000940188,0.00022787797],"category_scores_gemma":[0.0000054739407,0.00017316257,0.00012479977,0.0003196956,0.00010943452,0.00016770307,0.000011295012,0.00018142023,0.000021109612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039408237,0.00090735167,0.9520642,0.005959123,0.000973178,0.0011432306,0.0019465109,0.00016041767,0.033304494,0.00015974019,0.000012290019,0.0029753696],"study_design_scores_gemma":[0.019266808,0.0033413148,0.32095355,0.005392004,0.0077020014,0.0014825938,0.0011057716,0.00032463187,0.63890296,0.00008394045,0.00048952247,0.00095491053],"about_ca_topic_score_codex":0.000012454719,"about_ca_topic_score_gemma":0.000027273194,"teacher_disagreement_score":0.63111067,"about_ca_system_score_codex":0.000015073197,"about_ca_system_score_gemma":0.000107966494,"threshold_uncertainty_score":0.70613647},"labels":[],"label_agreement":null},{"id":"W4396578041","doi":"10.1182/bloodadvances.2024013293","title":"ASH Guideline Oversight Subcommittee Response to Jacobs et al regarding Industry Payments to ASH Guideline Panelists","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; Health Sciences Centre; Canadian Blood Services; McMaster University; University of Toronto; Hamilton Health Sciences","funders":"National Heart, Lung, and Blood Institute","keywords":"Guideline; Payment; Accounting; Business; Actuarial science; Medicine; Family medicine; Environmental health; Political science; Finance; Law","score_opus":0.19100000434507863,"score_gpt":0.4586273748694029,"score_spread":0.2676273705243243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396578041","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.396128,0.011926943,0.005779406,0.5730008,0.0038279467,0.0014929537,0.0016234982,0.0003818303,0.0058386563],"genre_scores_gemma":[0.3998265,0.00078291196,0.07609156,0.5026043,0.002337961,0.00048800625,0.00034707587,0.000274918,0.017246766],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99228585,0.0004951814,0.0049407915,0.0012526938,0.0002744206,0.0007510818],"domain_scores_gemma":[0.9963006,0.001301791,0.0008094082,0.00086068833,0.00016510407,0.0005624236],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019600898,0.0004043309,0.001051248,0.0007572877,0.0002329432,0.0003129989,0.0005936808,0.00025982482,0.00079174986],"category_scores_gemma":[0.007597601,0.00048428925,0.00019595564,0.0007044281,0.000041137628,0.0010413929,0.00027369516,0.00052870123,0.0037807967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015583442,0.00012215805,0.009728444,0.00013904946,0.00015547927,0.000032448577,0.0011805375,0.002444148,0.0003016423,0.005942086,0.9787649,0.0010333002],"study_design_scores_gemma":[0.0008014061,0.0002023286,0.0029426382,0.00031304127,0.000019285908,0.000018099181,0.00068236276,0.0006132069,0.0001808132,0.0017483202,0.9919137,0.0005648097],"about_ca_topic_score_codex":0.00034549684,"about_ca_topic_score_gemma":0.00020821711,"teacher_disagreement_score":0.07039646,"about_ca_system_score_codex":0.0004913765,"about_ca_system_score_gemma":0.00029873682,"threshold_uncertainty_score":0.99976087},"labels":[],"label_agreement":null},{"id":"W4396872898","doi":"10.1182/bloodadvances.2024012880","title":"Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; Servier; Astellas Pharma; Galecto; CTI Biopharma; Taiho Pharmaceutical; Incyte; Astex Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Medicine; Internal medicine; Oncology; Venetoclax; Myeloid; Myeloid leukemia; Chemotherapy; Leukemia","score_opus":0.021811294847639103,"score_gpt":0.3361240990998265,"score_spread":0.3143128042521874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396872898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916405,0.008365962,0.000063804415,0.0005036301,0.00004786021,0.0010998236,0.00006494943,0.000027680346,0.0006622518],"genre_scores_gemma":[0.99727005,0.0013751674,0.0008703001,0.00004450828,0.000044955,0.00016997968,0.00008180763,0.000017961711,0.00012527102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880445,0.0000672934,0.00022882738,0.0003131018,0.00035541953,0.00023090417],"domain_scores_gemma":[0.9994249,0.00019346333,0.000043467815,0.00019221727,0.00007825675,0.00006772432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000976047,0.00019521071,0.0003540558,0.00014491809,0.000045966066,0.000040350347,0.00008871658,0.000030302357,0.000009395043],"category_scores_gemma":[0.000039572322,0.000090048336,0.000038830633,0.00037809397,0.00013983985,0.00019189801,0.000028698154,0.00028907153,0.0000030863703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013517026,0.004613197,0.6239804,0.0005919429,0.0005494459,0.00013821915,0.0059918864,0.000048486036,0.00007880128,0.0008347559,0.00007668892,0.36174446],"study_design_scores_gemma":[0.0529642,0.015332005,0.87796724,0.0007112449,0.0011184912,0.00013338104,0.0027982427,0.0048626475,0.006724502,0.00032488373,0.036315657,0.00074752304],"about_ca_topic_score_codex":0.000015565947,"about_ca_topic_score_gemma":0.000020154414,"teacher_disagreement_score":0.36099696,"about_ca_system_score_codex":0.00006857128,"about_ca_system_score_gemma":0.00024413814,"threshold_uncertainty_score":0.36720645},"labels":[],"label_agreement":null},{"id":"W4398133344","doi":"10.1182/bloodadvances.2023011875","title":"A novel transmembrane <i>CXCR4</i> variant that expands the WHIM genotype-phenotype paradigm","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Horizon 2020 Framework Programme; EUSA Pharma; Deutsche Forschungsgemeinschaft","keywords":"CXCR4; Phenotype; Biology; Chemotaxis; Chemokine; Immunology; Receptor; Genetics; Gene","score_opus":0.018055961495497794,"score_gpt":0.26314484852381315,"score_spread":0.24508888702831536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398133344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48734996,0.39393792,0.043537933,0.027212532,0.004753986,0.002143359,0.00014936001,0.0013522108,0.039562747],"genre_scores_gemma":[0.99288183,0.002437532,0.001517875,0.0007055062,0.0009839127,0.000037481273,0.000024685361,0.000049358525,0.0013618062],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986983,0.000017726847,0.0002336461,0.00037694525,0.00034435757,0.0003290372],"domain_scores_gemma":[0.9993439,0.00017957612,0.00003903395,0.00029354653,0.000027744778,0.00011624597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022528677,0.00022095958,0.000310259,0.000060177746,0.00013073714,0.000085944914,0.0001544957,0.00007716093,0.00034059156],"category_scores_gemma":[0.000022554772,0.00012962731,0.00017605239,0.00033364698,0.00008705565,0.00017788705,0.00002232646,0.0002867346,0.00004246379],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008507154,0.0017477188,0.0035349543,0.003188074,0.0018740507,0.0010765207,0.008755399,0.0004984172,0.73920625,0.030614488,0.0030727251,0.20558071],"study_design_scores_gemma":[0.0031743452,0.00044082187,0.0008310095,0.00093217543,0.0012929172,0.0012510434,0.00047337133,0.0010875111,0.16548814,0.0021637667,0.82228845,0.0005764395],"about_ca_topic_score_codex":0.000026408392,"about_ca_topic_score_gemma":0.00002174819,"teacher_disagreement_score":0.8192157,"about_ca_system_score_codex":0.000018389535,"about_ca_system_score_gemma":0.00011618069,"threshold_uncertainty_score":0.5286048},"labels":[],"label_agreement":null},{"id":"W4398199821","doi":"10.1182/bloodadvances.2024013074","title":"Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; Moonshot Research and Development Program; National Institute of Environmental Health Sciences; St. Jude Children's Research Hospital; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Alexion Pharmaceuticals; bluebird bio; Pharmacyclics; Takeda Oncology; AstraZeneca; Genentech; National Institutes of Health; MorphoSys; Seagen; Adaptive Biotechnologies; Health Resources and Services Administration; Syndax Pharmaceuticals; Legend Biotech; Sangamo Therapeutics; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; GlaxoSmithKline; Kiadis Pharma; MEI Pharma; Jazz Pharmaceuticals; CSL Behring; HistoGenetics; Atara Biotherapeutics; Actinium Pharmaceuticals; National Cancer Institute; Incyte; Servier; Gilead Sciences; Sanofi; Gateway for Cancer Research; Celgene; Bristol-Myers Squibb; Cidara Therapeutics; Omeros Corporation; Vertex Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Medicine; Internal medicine; Quartile; Transplantation; Socioeconomic status; Ethnic group; Disease; Hematopoietic stem cell transplantation; Graft-versus-host disease; Confidence interval; Population","score_opus":0.012307676599334351,"score_gpt":0.29066434364659677,"score_spread":0.2783566670472624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398199821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913842,0.007784989,0.00005604756,0.00027434077,0.00005163248,0.00022088486,0.00012395908,0.00003370624,0.00007020415],"genre_scores_gemma":[0.99825096,0.0012059916,0.00024293602,0.000048081365,0.00002579427,0.0000070821575,0.000028752227,0.0000112472635,0.00017916072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906075,0.000022799686,0.00014721681,0.00032432238,0.00026596585,0.00017897085],"domain_scores_gemma":[0.9992351,0.00029819383,0.000050944313,0.0001660626,0.00006203848,0.00018767256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008552461,0.00013281254,0.00036875127,0.00019139204,0.00013471868,0.00001609486,0.000067100766,0.000038443068,0.00005651047],"category_scores_gemma":[0.000069492904,0.00009409956,0.000078240766,0.00023736147,0.00029749735,0.00022271034,0.00028594147,0.000096349555,0.0000037839447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000696064,0.00010944507,0.99373776,0.0002639791,0.0019594936,0.000036266418,0.000508825,0.0000038240883,0.000010633248,0.00006237579,0.000021295948,0.002590064],"study_design_scores_gemma":[0.0039341208,0.00029484706,0.9913604,0.000042071777,0.0036095157,6.9159404e-7,0.00013128319,0.00018102971,0.000033567514,0.00003820284,0.00026799884,0.00010623766],"about_ca_topic_score_codex":0.00003995307,"about_ca_topic_score_gemma":0.00009224356,"teacher_disagreement_score":0.0068667186,"about_ca_system_score_codex":0.00006472821,"about_ca_system_score_gemma":0.000111743815,"threshold_uncertainty_score":0.38372687},"labels":[],"label_agreement":null},{"id":"W4399203533","doi":"10.1182/bloodadvances.2024012939","title":"Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AOP Orphan; Agence Nationale de la Recherche; Relay Therapeutics; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Astex Pharmaceuticals; MEI Pharma; Jazz Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Myelofibrosis; Anemia; Medicine; Internal medicine; Gastroenterology; Bone marrow","score_opus":0.008121336556417046,"score_gpt":0.2615354574995308,"score_spread":0.2534141209431137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399203533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888312,0.00966134,0.000028156894,0.00023042473,0.000038230948,0.0010182493,0.00008071349,0.000009048459,0.00010262432],"genre_scores_gemma":[0.99454033,0.004172734,0.00103587,0.000012429185,0.000023614246,0.000107005064,0.000026594895,0.000010700879,0.000070709204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994154,0.000011080176,0.00019106826,0.00017423532,0.00010865992,0.000099571604],"domain_scores_gemma":[0.9993842,0.0003830183,0.000045569956,0.00011539384,0.000042215986,0.000029567937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031366275,0.00011363784,0.00027401967,0.00004681747,0.000025873207,0.0000055674714,0.000021845468,0.000022307619,0.000016122332],"category_scores_gemma":[0.000011972971,0.00005344145,0.00004638789,0.00010162591,0.00006856344,0.000044457705,0.000005625839,0.000020254867,4.537367e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016426721,0.0019033459,0.81624556,0.00032020325,0.00026740503,0.0000045434153,0.0011982954,0.000036284997,0.00011597487,0.00021186723,0.000008156708,0.17804568],"study_design_scores_gemma":[0.009329599,0.0073497845,0.9554879,0.00048311186,0.0005363018,0.0000020219718,0.00009316677,0.00003452738,0.021373177,0.000020764683,0.0052214325,0.00006819351],"about_ca_topic_score_codex":0.000020419362,"about_ca_topic_score_gemma":0.000044481207,"teacher_disagreement_score":0.17797749,"about_ca_system_score_codex":0.000022530543,"about_ca_system_score_gemma":0.000026227952,"threshold_uncertainty_score":0.21792792},"labels":[],"label_agreement":null},{"id":"W4399566448","doi":"10.1182/bloodadvances.2024012693","title":"Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Center for Chronic Disease Prevention and Health Promotion; National Heart, Lung, and Blood Institute; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; Seagen; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; National Center for Advancing Translational Sciences; HistoGenetics; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; University of Southern California; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Astellas Pharma; Adaptive Biotechnologies; MorphoSys; California Department of Public Health; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Centers for Disease Control and Prevention; Gateway for Cancer Research; Amgen; Incyte; Pfizer","keywords":"Cumulative incidence; Population; Medicine; Incidence (geometry); Cohort; Cancer registry; Transplantation; Hematopoietic cell; Oncology; Demography; Internal medicine; Environmental health; Biology; Mathematics; Haematopoiesis","score_opus":0.015718975780833862,"score_gpt":0.35668703570638705,"score_spread":0.3409680599255532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399566448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93041086,0.06325912,0.0009602904,0.0035495604,0.000118739255,0.0009289631,0.00019161453,0.000066932735,0.00051390217],"genre_scores_gemma":[0.99530506,0.00089576875,0.0021743302,0.0005105891,0.00020396331,0.0006071151,0.000010603542,0.000022775932,0.00026981725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998856,0.000024815432,0.00020710345,0.0003256511,0.00028192395,0.00030449088],"domain_scores_gemma":[0.9988444,0.00080783525,0.000036069254,0.00018336267,0.000057133715,0.0000712072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025397865,0.00014552435,0.00022276162,0.00007942758,0.00005527912,0.000057595906,0.00011895339,0.000050356586,0.00002631684],"category_scores_gemma":[0.00046280492,0.00008698102,0.000041957104,0.00022640429,0.00021048746,0.00017142388,0.00005285501,0.00019229914,0.000009776417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004521738,0.0009174648,0.81421447,0.015631877,0.0011340561,0.008876919,0.019541655,0.0013573876,0.016810402,0.002558088,0.010209441,0.10422652],"study_design_scores_gemma":[0.01942614,0.003449351,0.38346085,0.025287297,0.0024680258,0.0046463315,0.0077914395,0.22199483,0.051069535,0.03570198,0.24232353,0.002380692],"about_ca_topic_score_codex":0.00011152526,"about_ca_topic_score_gemma":0.00020096773,"teacher_disagreement_score":0.4307536,"about_ca_system_score_codex":0.00010841889,"about_ca_system_score_gemma":0.00037652816,"threshold_uncertainty_score":0.3546983},"labels":[],"label_agreement":null},{"id":"W4400018844","doi":"10.1182/bloodadvances.2024013451","title":"Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Cancer Moonshot; National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Myelofibrosis; Transplantation; Gastroenterology; Surgery; Hematopoietic cell; Bone marrow; Haematopoiesis; Stem cell","score_opus":0.010134579352549945,"score_gpt":0.29850450830052117,"score_spread":0.2883699289479712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400018844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986221,0.012383169,0.0000069744897,0.00035593644,0.000060746177,0.00044210427,0.000017593404,0.000025347805,0.0004871353],"genre_scores_gemma":[0.9964357,0.0027595896,0.0005319134,0.00003298125,0.000019708228,0.00010395868,0.0000069918656,0.00000798023,0.0001011805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941015,0.000021023026,0.00018236453,0.0001892228,0.0001133738,0.000083888866],"domain_scores_gemma":[0.99973345,0.00012586336,0.000022128397,0.00006905369,0.000017879196,0.000031604268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006450436,0.00009646691,0.0002517618,0.000100005935,0.00001597946,0.000012027405,0.000018308401,0.0000205992,0.000021196198],"category_scores_gemma":[0.000014692754,0.000064476706,0.000030375983,0.0001248065,0.000023895125,0.00010215679,0.0000056207728,0.000045871424,0.0000035847956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007561978,0.00075762294,0.984474,0.00033274584,0.00019028089,0.00012019497,0.0018620875,0.0000050543936,0.0004252887,0.00035075142,0.0000042212187,0.011402149],"study_design_scores_gemma":[0.0020490256,0.0009731693,0.9866241,0.00031632054,0.00040886074,0.00002118707,0.0005727,0.000017489067,0.008436049,0.00014719031,0.00036453578,0.00006933845],"about_ca_topic_score_codex":0.000041236337,"about_ca_topic_score_gemma":0.0003077383,"teacher_disagreement_score":0.01133281,"about_ca_system_score_codex":0.000007554885,"about_ca_system_score_gemma":0.000023858265,"threshold_uncertainty_score":0.26292837},"labels":[],"label_agreement":null},{"id":"W4400060772","doi":"10.1182/bloodadvances.2023011833","title":"Chronic TNF in the aging microenvironment exacerbates <i>Tet2</i> loss-of-function myeloid expansion","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Ontario Institute for Cancer Research; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research","keywords":"Myeloid; Haematopoiesis; Tumor necrosis factor alpha; Biology; Immunology; Progenitor cell; Cancer research; Mutant; Bone marrow; Stem cell; Cell biology; Genetics; Gene","score_opus":0.011443218854192026,"score_gpt":0.27801585258156086,"score_spread":0.26657263372736884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400060772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8588548,0.13521634,0.00030503116,0.0034505033,0.00025063945,0.0005857628,0.000007640755,0.00007120086,0.0012581204],"genre_scores_gemma":[0.98767364,0.010335178,0.00045120055,0.00022827304,0.00046031122,0.000071691706,0.000031568412,0.000023829296,0.0007242993],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985078,0.00007823213,0.00028929004,0.00035661022,0.00043156036,0.00033651394],"domain_scores_gemma":[0.9993033,0.00022097785,0.000045885095,0.00035932145,0.000018736122,0.000051823332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041137976,0.00016569051,0.00022837844,0.00016115133,0.00006021928,0.000030907675,0.00018013887,0.00005923061,0.000107177395],"category_scores_gemma":[0.000040995532,0.000107906715,0.00008604879,0.0004061987,0.00016317361,0.00023465762,0.00007194849,0.00039638247,0.000051158633],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002599975,0.0004665144,0.028085094,0.0025033352,0.00021754006,0.00090394483,0.0023294783,0.00061639614,0.6889651,0.00060191087,0.0015285691,0.2735221],"study_design_scores_gemma":[0.004290423,0.0019899607,0.038300723,0.0027276801,0.00048913277,0.000629973,0.0026112264,0.0010437319,0.39073855,0.001276202,0.55542314,0.0004792809],"about_ca_topic_score_codex":0.00003516621,"about_ca_topic_score_gemma":0.00002457005,"teacher_disagreement_score":0.5538946,"about_ca_system_score_codex":0.00020842261,"about_ca_system_score_gemma":0.0001721034,"threshold_uncertainty_score":0.4400308},"labels":[],"label_agreement":null},{"id":"W4400226763","doi":"10.1182/bloodadvances.2023011747","title":"Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Institut National Du Cancer; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Stem cell; Gene; Biology; Gene expression; Leukemia; Precursor cell; Cell; Cell biology; Cancer research; Genetics","score_opus":0.010980017199927299,"score_gpt":0.28488868979626547,"score_spread":0.27390867259633817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400226763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96071726,0.036862046,0.00008226731,0.00006886605,0.00014409606,0.0012793286,0.0000129530345,0.00013472534,0.00069844845],"genre_scores_gemma":[0.9810415,0.0073843715,0.010253909,0.000027861459,0.00014297823,0.00027295187,0.000020613912,0.00005692875,0.0007988675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760395,0.00012972312,0.0006456094,0.00060265436,0.0004933582,0.0005247278],"domain_scores_gemma":[0.9991278,0.00017521241,0.00010102387,0.00040277076,0.00006863959,0.00012452996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029311923,0.00024789647,0.00045329132,0.00054288586,0.000025358646,0.000026833275,0.00023369864,0.00018044838,0.000033109096],"category_scores_gemma":[0.000026349066,0.00021073427,0.00009593255,0.00083977496,0.0001204106,0.00022870013,0.00011158338,0.00054729177,0.000035667705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023758176,0.00044182336,0.016910244,0.001721354,0.000018562077,0.0004726787,0.0005087682,0.00081072544,0.9024038,0.000008087806,0.00023132401,0.07623507],"study_design_scores_gemma":[0.0027338597,0.0007317826,0.011052039,0.0017218136,0.00005961566,0.00006114022,0.00030383543,0.0036028754,0.97537977,0.00011344749,0.00401201,0.00022780722],"about_ca_topic_score_codex":0.00012532141,"about_ca_topic_score_gemma":0.000052829,"teacher_disagreement_score":0.07600726,"about_ca_system_score_codex":0.0004328481,"about_ca_system_score_gemma":0.00055794837,"threshold_uncertainty_score":0.8593494},"labels":[],"label_agreement":null},{"id":"W4400493461","doi":"10.1182/bloodadvances.2024012968","title":"A phase 2 study of a longitudinal multidimensional rehabilitation program for allogeneic blood and marrow transplantation patients","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cancer survivorship and care","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Rehabilitation; Bone marrow transplantation; Transplantation; Bone transplantation; Longitudinal study; Oncology; Physical therapy; Internal medicine; Surgery; Pathology","score_opus":0.01196663879287463,"score_gpt":0.32625069373961374,"score_spread":0.3142840549467391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400493461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938906,0.0038934513,0.00007076251,0.000074041105,0.00019537944,0.0016974278,0.00010095441,0.000057787092,0.00001963801],"genre_scores_gemma":[0.9963818,0.00012651966,0.0028302146,0.00001051513,0.000055436536,0.00044835775,0.000111685265,0.0000137845755,0.000021690183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916726,0.00002535687,0.00021723725,0.00027581185,0.00020449328,0.00010984418],"domain_scores_gemma":[0.999523,0.00016993022,0.000042530868,0.000083023995,0.00013041055,0.000051127594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000995174,0.000104001694,0.00018205625,0.00008496335,0.00003839278,0.000009782577,0.00002121979,0.000030631778,0.000007623888],"category_scores_gemma":[0.000037462705,0.00008584283,0.000058142185,0.00013831076,0.000041347717,0.0001214232,0.0000058711453,0.000048424343,3.0142664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034281663,0.027104884,0.60870266,0.006316248,0.0006715502,0.00006404329,0.013321222,0.000015425168,0.010140307,0.00018495962,0.00003847818,0.33001208],"study_design_scores_gemma":[0.1420743,0.22045143,0.5633166,0.003420598,0.01363741,0.00019674432,0.012368765,0.001066506,0.030952705,0.0007774751,0.010553801,0.0011836886],"about_ca_topic_score_codex":0.000032209875,"about_ca_topic_score_gemma":0.00036012236,"teacher_disagreement_score":0.3288284,"about_ca_system_score_codex":0.000007175741,"about_ca_system_score_gemma":0.000032632466,"threshold_uncertainty_score":0.3500569},"labels":[],"label_agreement":null},{"id":"W4400766504","doi":"10.1182/bloodadvances.2024013158","title":"Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Frailty in Older Adults","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"Cancer Care Ontario; Conquer Cancer Foundation","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Health care; Medicine; Gerontology; Internal medicine; Political science","score_opus":0.008944399572207903,"score_gpt":0.2761649665246753,"score_spread":0.26722056695246743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400766504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9133342,0.077899955,0.0015367267,0.002619894,0.00051471713,0.0021318845,0.00067350524,0.0003252399,0.0009638715],"genre_scores_gemma":[0.9928168,0.0012223682,0.0032137993,0.0009100221,0.00014162039,0.00009812177,0.00053442625,0.000057012057,0.0010058121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987902,0.000020691954,0.00021215624,0.00039789412,0.00025760537,0.00032144558],"domain_scores_gemma":[0.99932253,0.000101309684,0.0000659795,0.00019841545,0.00014939332,0.00016235253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000582232,0.00018753232,0.00028422233,0.00008513955,0.00011636381,0.0000431236,0.000055994897,0.00005755716,0.000008644238],"category_scores_gemma":[0.00005630002,0.00014362442,0.000038965572,0.00017455616,0.000042424635,0.00025203245,0.000026791544,0.00006458301,0.000007705326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010584183,0.0058468175,0.22423567,0.009512601,0.000208535,0.000051596464,0.0071764584,0.0000026185544,0.000052602456,0.0004840543,0.008831565,0.74253905],"study_design_scores_gemma":[0.06829772,0.0059838225,0.08497052,0.0030736988,0.00042039005,0.000038698887,0.0016598522,0.00042698428,0.0024776587,0.000069251946,0.83196974,0.0006116425],"about_ca_topic_score_codex":0.00002163914,"about_ca_topic_score_gemma":0.00028388295,"teacher_disagreement_score":0.8231382,"about_ca_system_score_codex":0.000101987025,"about_ca_system_score_gemma":0.00015802892,"threshold_uncertainty_score":0.5856834},"labels":[],"label_agreement":null},{"id":"W4400903739","doi":"10.1182/bloodadvances.2023012462","title":"Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Providence Health Care","funders":"Swedish Orphan Biovitrum; Sanofi","keywords":"Term (time); Medicine; Pediatrics; Psychology; Family medicine","score_opus":0.035030314578107354,"score_gpt":0.37679764887178496,"score_spread":0.3417673342936776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400903739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967259,0.0016012503,0.0000044804847,0.0003141647,0.0000824694,0.00093897886,0.00001933079,0.000087121814,0.00022628462],"genre_scores_gemma":[0.9919337,0.00083810475,0.0026164134,0.0000449464,0.0001397679,0.000074562384,0.000024823301,0.00004444253,0.004283216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805015,0.000084467596,0.0004393608,0.0005366809,0.0005289014,0.00036041127],"domain_scores_gemma":[0.9989579,0.00029406694,0.000066521796,0.0003968813,0.00007287212,0.00021180771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000268935,0.00023241207,0.00062939135,0.00022287546,0.00003241476,0.000026480608,0.00015218687,0.000109640096,0.00015734872],"category_scores_gemma":[0.00012534276,0.00010591109,0.00008714944,0.0006010974,0.0003199012,0.0002578627,0.00003753646,0.0003725378,0.000016756023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009530341,0.0015797416,0.94167596,0.0009991076,0.00031690113,0.006224417,0.00042213133,0.0000015928086,0.00007099198,0.000012745474,0.00000962509,0.03915645],"study_design_scores_gemma":[0.007785584,0.017782526,0.97028446,0.0021306372,0.00018470499,0.0001859965,0.00022950995,0.000011785781,0.0008871195,0.000017748109,0.00029905586,0.00020084422],"about_ca_topic_score_codex":0.00003804714,"about_ca_topic_score_gemma":0.0019010076,"teacher_disagreement_score":0.038955607,"about_ca_system_score_codex":0.000025720985,"about_ca_system_score_gemma":0.00042305398,"threshold_uncertainty_score":0.43189287},"labels":[],"label_agreement":null},{"id":"W4401012430","doi":"10.1182/bloodadvances.2024012707","title":"What is in a name: defining pediatric refractory ITP","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; SickKids Foundation; Hospital for Sick Children; St. Michael's Hospital; Children's Hospital of Eastern Ontario","funders":"National Institutes of Health; Swedish Orphan Biovitrum; Horizon Therapeutics; Argenx; bluebird bio; Agios Pharmaceuticals; Foundation for Women and Girls with Blood Disorders; Sanofi; Pfizer","keywords":"Medicine; Immune thrombocytopenia; Refractory (planetary science); Disease; Intensive care medicine; Pediatrics; Terminology; Clinical trial; Internal medicine; Platelet","score_opus":0.009392199360348425,"score_gpt":0.28664951153914286,"score_spread":0.27725731217879446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401012430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6811652,0.31577063,0.0000017758472,0.00049104536,0.00032640557,0.000094278905,0.0000052814994,0.000058998536,0.0020863793],"genre_scores_gemma":[0.93153965,0.06640663,0.00041256126,0.00035113914,0.000095556024,0.000024216488,0.00001678783,0.00001846815,0.0011350159],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992591,0.000009272832,0.0001472433,0.00024917602,0.00014273384,0.00019245864],"domain_scores_gemma":[0.9997272,0.00007004064,0.000022921848,0.000112809794,0.000012057102,0.000055008524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050473172,0.00011240122,0.00019713506,0.00013638267,0.000025344707,0.000049217226,0.00003731146,0.000048191378,0.00010762383],"category_scores_gemma":[0.000020758276,0.0000890362,0.00005388771,0.00026107763,0.000015296391,0.0004995872,0.000015796659,0.00013715788,0.00019905162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001699824,0.0019146936,0.4328613,0.0014403198,0.00034938147,0.015464722,0.0036837973,0.000012345175,0.00030183524,0.00066068035,0.0021653867,0.5409756],"study_design_scores_gemma":[0.01487951,0.0025654703,0.083027706,0.004055316,0.002211725,0.0015188198,0.004862947,0.00042670433,0.0036000896,0.010494979,0.8709816,0.0013751637],"about_ca_topic_score_codex":0.00001251755,"about_ca_topic_score_gemma":0.00001881003,"teacher_disagreement_score":0.8688162,"about_ca_system_score_codex":0.000020328831,"about_ca_system_score_gemma":0.00006276698,"threshold_uncertainty_score":0.3630791},"labels":[],"label_agreement":null},{"id":"W4401013822","doi":"10.1182/bloodadvances.2023012346","title":"Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Deutsche Krebshilfe","keywords":"Cog; Lymphoma; Hodgkin lymphoma; Medicine; Internal medicine; Computer science","score_opus":0.018507492515148757,"score_gpt":0.2820127166110735,"score_spread":0.26350522409592475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401013822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7904219,0.20461482,0.00001296477,0.0030794728,0.00035504054,0.00047012576,0.00007800294,0.000117497526,0.00085014483],"genre_scores_gemma":[0.9847728,0.012299149,0.0006567938,0.00084802037,0.0007946429,0.00011328657,0.00008057489,0.000048026846,0.00038668758],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99828035,0.000096714895,0.00035660164,0.000648044,0.00031243177,0.00030587503],"domain_scores_gemma":[0.9985018,0.0006566369,0.000103812454,0.0005367247,0.000044627435,0.00015639685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024540184,0.0002990396,0.00037075934,0.000045338806,0.00029773754,0.00023941828,0.0001306272,0.000074328076,0.00006125942],"category_scores_gemma":[0.00014030866,0.00015964572,0.00008710316,0.00017639286,0.00027358416,0.0003063982,0.000105821186,0.00011627737,0.000011453234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023191235,0.0014016817,0.25516748,0.00021577888,0.0014969159,0.0059368494,0.0047295103,0.0000063287707,0.004320925,0.0015774766,0.0035542184,0.7213609],"study_design_scores_gemma":[0.004550938,0.0007886107,0.6988567,0.0006179493,0.0034575958,0.0035115923,0.0022790814,0.00030329518,0.0062527945,0.0026105714,0.27628428,0.00048656648],"about_ca_topic_score_codex":0.00062420045,"about_ca_topic_score_gemma":0.0006855842,"teacher_disagreement_score":0.72087437,"about_ca_system_score_codex":0.000037480757,"about_ca_system_score_gemma":0.000119831144,"threshold_uncertainty_score":0.6510163},"labels":[],"label_agreement":null},{"id":"W4401158031","doi":"10.1182/bloodadvances.2024013275","title":"Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Busulfan; Medicine; Immunity; Association (psychology); Internal medicine; Pediatrics; Immunology; Immune system; Psychology; Cyclophosphamide; Chemotherapy","score_opus":0.0038126317043853312,"score_gpt":0.22746361948698698,"score_spread":0.22365098778260165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401158031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95807666,0.041151546,0.000032188742,0.000044350694,0.00023553053,0.00021841109,0.00015700224,0.000024181714,0.000060148934],"genre_scores_gemma":[0.99920756,0.000120997676,0.00012544103,0.000015564192,0.0000012892987,0.000034502824,0.0001009272,0.000009828016,0.00038387137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993727,0.00006234081,0.00022814247,0.00014748106,0.00003679416,0.00015249316],"domain_scores_gemma":[0.9994705,0.00016486873,0.00012895609,0.0001364253,0.00009614967,0.00000314731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015523912,0.00010996926,0.00023727487,0.000063339976,0.00006595279,0.0000072403636,0.000089623034,0.000089751346,0.000026440133],"category_scores_gemma":[0.000069979964,0.000079718986,0.000051837054,0.00009330587,0.00010906028,0.00024624215,0.000023339306,0.00009438873,0.0000015812524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074977777,0.0011227868,0.9249027,0.00045497503,0.0007319175,4.500242e-7,0.0028341708,0.000008898221,0.022202643,0.00034541675,0.000009930469,0.046636354],"study_design_scores_gemma":[0.0026572656,0.001482976,0.9706731,0.00014618512,0.0002669176,0.0000010051345,0.0009621533,0.000002329296,0.013436572,0.00035311893,0.009825148,0.00019322155],"about_ca_topic_score_codex":0.00002279902,"about_ca_topic_score_gemma":0.00001768934,"teacher_disagreement_score":0.046443135,"about_ca_system_score_codex":0.000006039698,"about_ca_system_score_gemma":0.00002432723,"threshold_uncertainty_score":0.3250846},"labels":[],"label_agreement":null},{"id":"W4401209106","doi":"10.1182/bloodadvances.2024013095","title":"Prevalence and characterization of anti-VWF antibodies in a population of patients with type 3 VWD","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"College of Medicine, Drexel University; University of North Carolina at Chapel Hill; School of Medicine, Emory University; Weill Cornell Medical College; National Institutes of Health; Queen's University; Washington University in St. Louis; University of Texas Health Science Center at Houston; National Heart, Lung, and Blood Institute; Loma Linda University; Vanderbilt University; Drexel University; University of Texas Southwestern Medical Center; College of Engineering, Michigan State University; Johns Hopkins University; Cincinnati Children's Hospital Medical Center; Tulane University; University of Pittsburgh; Nationwide Children's Hospital; Rush University; Johns Hopkins Children's Center; Wayne State University; Yale University; Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Royal College of Surgeons in Ireland; Emory University; Michigan State University; University of Pennsylvania","keywords":"Von Willebrand factor; Antibody; Von Willebrand disease; Immunology; Medicine; Platelet; Population; Thromboelastometry","score_opus":0.005606070538864402,"score_gpt":0.24703118583302353,"score_spread":0.2414251152941591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401209106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976068,0.002104024,0.0000022516303,0.000011838717,0.000026501884,0.00015533774,0.000023701938,0.000007812531,0.000061717656],"genre_scores_gemma":[0.99832386,0.0014416598,0.000115865805,0.0000038564176,0.00000391576,0.0000018368512,0.000080464044,0.0000043402665,0.000024229425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996864,0.0000051828333,0.00010051219,0.00008893696,0.000074594296,0.00004435335],"domain_scores_gemma":[0.99986905,0.0000089261575,0.000040473995,0.000040829225,0.000030791867,0.000009929506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014929379,0.00004522623,0.00012909387,0.000059059243,0.00000650054,0.0000025982372,0.000009921996,0.000014622126,0.000004126595],"category_scores_gemma":[0.000008588418,0.000032078904,0.0000070928654,0.000116442614,0.00002096174,0.00014034589,0.0000050607937,0.000018071607,3.0304255e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006317565,0.00017946085,0.9926653,0.0006977497,0.000026699738,0.000009019206,0.000089714355,8.0866744e-7,0.0034854233,0.000043573295,1.2803811e-7,0.0027389454],"study_design_scores_gemma":[0.0006503499,0.00027282996,0.99583596,0.00054932776,0.00006938323,0.0000022265858,0.0000051919037,0.000020351668,0.0024930062,0.00004160283,0.000030231538,0.000029531704],"about_ca_topic_score_codex":0.00001050828,"about_ca_topic_score_gemma":0.000008056041,"teacher_disagreement_score":0.003170665,"about_ca_system_score_codex":0.0000021755034,"about_ca_system_score_gemma":0.000010217913,"threshold_uncertainty_score":0.13081397},"labels":[],"label_agreement":null},{"id":"W4401246395","doi":"10.1182/bloodadvances.2023011540","title":"The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Jewish General Hospital; McGill University Health Centre; McGill University; TD Bank","keywords":"Myeloid leukemia; Cytarabine; Cancer research; Ubiquitin ligase; Nucleoside analogue; Deoxycytidine kinase; Azacitidine; Leukemia; Gene knockdown; Biology; Nucleoside; Medicine; Deoxycytidine; Ubiquitin; Cell culture; Cancer; Immunology; Internal medicine; Gemcitabine; DNA methylation; Biochemistry; Gene expression; Genetics; Gene","score_opus":0.011273368243301564,"score_gpt":0.30827612789128384,"score_spread":0.2970027596479823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401246395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429476,0.016721537,0.000028118935,0.03747939,0.00022975552,0.00087499566,0.00002999259,0.00018955064,0.0014990292],"genre_scores_gemma":[0.9840433,0.004181417,0.00082903035,0.001983601,0.00040114525,0.00023225594,0.000010039686,0.00007737604,0.008241829],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726045,0.00032037534,0.00045383486,0.000582731,0.00060114526,0.0007814491],"domain_scores_gemma":[0.99684364,0.0019697263,0.000048097103,0.00078974594,0.00010169411,0.00024709126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018020603,0.0002894796,0.000348375,0.00026045355,0.0003088822,0.00021411698,0.00058891665,0.00011076787,0.000050708473],"category_scores_gemma":[0.001008008,0.00015640445,0.00014766774,0.0012672435,0.00028586035,0.000258253,0.0002712538,0.0008444717,0.0003415496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014088563,0.00032800782,0.006008299,0.0005131362,0.0013774644,0.01040627,0.007587036,0.0014467353,0.6024067,0.003967236,0.030481149,0.32138944],"study_design_scores_gemma":[0.003485701,0.0015055417,0.04675678,0.0012588615,0.00045493897,0.0010273844,0.0033448408,0.0042008054,0.18983133,0.0033105682,0.74414176,0.00068148324],"about_ca_topic_score_codex":0.00016045994,"about_ca_topic_score_gemma":0.00037493202,"teacher_disagreement_score":0.7136606,"about_ca_system_score_codex":0.00047723684,"about_ca_system_score_gemma":0.0008156326,"threshold_uncertainty_score":0.63779885},"labels":[],"label_agreement":null},{"id":"W4401596439","doi":"10.1182/bloodadvances.2024013197","title":"Iron deficiency resolution and time to resolution in an American health system","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Research Resources; National Institutes of Health; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Interquartile range; Medicine; Confidence interval; Ferritin; Hazard ratio; Anemia; Medical record; Retrospective cohort study; Internal medicine; Pediatrics","score_opus":0.007992402654467047,"score_gpt":0.2866155594611463,"score_spread":0.27862315680667926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92934746,0.06366297,0.00045187335,0.0021531878,0.00014378433,0.00047527484,0.000014479055,0.00020183407,0.0035491379],"genre_scores_gemma":[0.99585867,0.0006275537,0.00275403,0.00030434696,0.000103794744,0.000021513162,0.00001721994,0.000014490622,0.0002983626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905175,0.00006446051,0.00018869936,0.00029778268,0.00015677827,0.00024052853],"domain_scores_gemma":[0.99965703,0.0000196079,0.00003333745,0.00013934405,0.000014995316,0.00013568024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024748888,0.00009321963,0.00020202514,0.00018448672,0.00005877108,0.000021690159,0.000037253907,0.000021442856,0.000007827173],"category_scores_gemma":[0.00002973598,0.00008017491,0.000017568675,0.0004045236,0.00005785707,0.00018100638,0.000016617358,0.00007868655,0.000058384165],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096113764,0.0012031434,0.03431444,0.008924157,0.000013056775,0.0001853115,0.006750509,0.0016981403,0.015654828,0.024431318,0.0026377742,0.9032262],"study_design_scores_gemma":[0.008169312,0.013840548,0.6707456,0.005392056,0.00056596036,0.00058900437,0.023125382,0.01787353,0.0009581518,0.0006424383,0.25625274,0.00184525],"about_ca_topic_score_codex":0.00021425363,"about_ca_topic_score_gemma":0.0001426197,"teacher_disagreement_score":0.90138096,"about_ca_system_score_codex":0.000046167115,"about_ca_system_score_gemma":0.00007424034,"threshold_uncertainty_score":0.32694378},"labels":[],"label_agreement":null},{"id":"W4402471159","doi":"10.1182/bloodadvances.2024012982","title":"Point-of-care CAR T manufacturing solutions: can 1 model fit all?","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Point (geometry); Computer science; Mathematics","score_opus":0.045130513431129046,"score_gpt":0.33922728022692095,"score_spread":0.2940967667957919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402471159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82929313,0.14322034,0.00055867055,0.0031330653,0.00048560978,0.0010165893,0.000156894,0.00039718376,0.021738542],"genre_scores_gemma":[0.98441076,0.0033974098,0.0023121668,0.00014912337,0.00024245809,0.000051644063,0.00003096436,0.000043876018,0.009361596],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880534,0.000019404895,0.00019896773,0.00028910858,0.00035076297,0.00033641263],"domain_scores_gemma":[0.9994181,0.0000805144,0.00002528074,0.00029827195,0.000064344465,0.00011351309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011021377,0.00013901951,0.00024204083,0.0001480543,0.000054116947,0.000024179055,0.00011652679,0.000057098245,0.0004435884],"category_scores_gemma":[0.00002985213,0.00011099278,0.00014016239,0.00012001541,0.0000809088,0.00013453742,0.00006356501,0.00023656298,0.000020431315],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063517835,0.00059260783,0.0016608419,0.008620049,0.001699252,0.00091521366,0.010774638,0.014356721,0.45340356,0.0036866975,0.0024503919,0.50120485],"study_design_scores_gemma":[0.0021532853,0.00079978723,0.0003463697,0.0013128642,0.000557914,0.0002144372,0.0026260905,0.011279971,0.757784,0.0035057422,0.21894975,0.0004697598],"about_ca_topic_score_codex":0.000054572873,"about_ca_topic_score_gemma":0.00010598772,"teacher_disagreement_score":0.50073504,"about_ca_system_score_codex":0.000067264446,"about_ca_system_score_gemma":0.00015774934,"threshold_uncertainty_score":0.48569816},"labels":[],"label_agreement":null},{"id":"W4402590252","doi":"10.1182/bloodadvances.2024013777","title":"Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; MorphoSys; Swedish Orphan Biovitrum; Sierra Oncology; Incyte; bluebird bio; Sarepta Therapeutics; Jazz Pharmaceuticals; Vertex Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; Massachusetts General Hospital; Servier; Pfizer; Amgen","keywords":"Medicine; Thrombocytosis; Bleed; Internal medicine; Essential thrombocythemia; Incidence (geometry); Cumulative incidence; Gastroenterology; Thrombosis; Platelet; Von Willebrand factor; Surgery; Cohort","score_opus":0.007852097513491925,"score_gpt":0.24457378985571063,"score_spread":0.2367216923422187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402590252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924449,0.0061733606,0.00002097865,0.000086970394,0.00006789007,0.00032964468,0.000030208756,0.00002966823,0.0008163929],"genre_scores_gemma":[0.99596685,0.0022229757,0.0016519382,0.00001552497,0.000050585317,0.000035019657,0.000013363194,0.000016857119,0.000026856786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912316,0.000018894476,0.00019818757,0.00028723845,0.00021724346,0.00015528359],"domain_scores_gemma":[0.9996113,0.00011466244,0.00005996666,0.00010847956,0.00004898446,0.000056595043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006490915,0.00014916298,0.0003391207,0.00010037804,0.000036026773,0.000018765968,0.000028450846,0.00003721267,0.000054830623],"category_scores_gemma":[0.000026843887,0.00009599983,0.00003784478,0.00019080838,0.00008129415,0.0001755131,0.000022947777,0.00010493638,0.0000028692875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011760415,0.0005136376,0.9917242,0.00022714506,0.00029680337,0.000024982233,0.0003693554,0.000007229047,0.00050243904,0.00035355994,0.00001499209,0.0058480725],"study_design_scores_gemma":[0.0037194535,0.0010831198,0.95220697,0.0010333457,0.00066892756,0.0000083809955,0.0001253403,0.000051194074,0.04040342,0.0002291024,0.00033680993,0.00013396658],"about_ca_topic_score_codex":0.000030387682,"about_ca_topic_score_gemma":0.00005768853,"teacher_disagreement_score":0.039900977,"about_ca_system_score_codex":0.000020812153,"about_ca_system_score_gemma":0.00003714668,"threshold_uncertainty_score":0.39147595},"labels":[],"label_agreement":null},{"id":"W4402590543","doi":"10.1182/bloodadvances.2024013932","title":"UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Heart, Lung, and Blood Institute; Bill and Melinda Gates Foundation","keywords":"Haematopoiesis; Stem cell; Disease; Gene; Hematopoietic stem cell transplantation; Genetic enhancement; Immunology; Biology; Medicine; Genetics; Internal medicine","score_opus":0.004234848629827645,"score_gpt":0.21014873962876685,"score_spread":0.2059138909989392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402590543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94276917,0.055872355,0.00011459742,0.000095041694,0.00018340343,0.00039858717,0.00010087507,0.00005686496,0.00040908006],"genre_scores_gemma":[0.9967838,0.0022324028,0.0004439464,0.00004752036,0.00003656442,0.000025743167,0.00003508647,0.000023571416,0.00037137224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989372,0.000020992087,0.00023345649,0.00034205755,0.00027462168,0.00019166265],"domain_scores_gemma":[0.99944264,0.00007125142,0.00006792438,0.00019361675,0.000048488277,0.00017605696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003507579,0.00018308501,0.00028883084,0.00005432536,0.00004941457,0.000021558162,0.000059966922,0.000051895084,0.00002892102],"category_scores_gemma":[0.0000031608804,0.00011981662,0.00005678499,0.00014013618,0.00012024318,0.000113876595,0.000024015873,0.000103913175,0.000008843002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007750208,0.023755912,0.22311212,0.041606534,0.0048524803,0.0028054763,0.029909583,0.0035530962,0.43412215,0.0018731523,0.0013889167,0.22527038],"study_design_scores_gemma":[0.006775217,0.0012021491,0.008593605,0.0021915764,0.0018138057,0.0000051142106,0.0020155525,0.00037626666,0.9703414,0.0005065601,0.005619492,0.00055926404],"about_ca_topic_score_codex":0.000018057523,"about_ca_topic_score_gemma":0.0000042336633,"teacher_disagreement_score":0.53621924,"about_ca_system_score_codex":0.000009653223,"about_ca_system_score_gemma":0.000067093315,"threshold_uncertainty_score":0.488598},"labels":[],"label_agreement":null},{"id":"W4402756059","doi":"10.1182/bloodadvances.2024013478","title":"Thrombophilia testing: does practice follow guidelines?","year":2024,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Thrombophilia; Medicine; MEDLINE; Intensive care medicine; Internal medicine; Biology; Thrombosis","score_opus":0.05259393840902899,"score_gpt":0.34638507206227537,"score_spread":0.2937911336532464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402756059","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022592158,0.03472219,0.000019362282,0.8979166,0.0037995619,0.0011531329,0.000065860266,0.00056977704,0.061527595],"genre_scores_gemma":[0.00023161364,0.007935202,0.024591671,0.9276355,0.018570764,0.00028218547,0.00026452157,0.00022341087,0.020265142],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964093,0.00006662944,0.0008066356,0.0010831354,0.00096203963,0.0006722491],"domain_scores_gemma":[0.9974083,0.0005668872,0.00040007473,0.0008960437,0.0006100777,0.000118619624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003740412,0.00064811605,0.0012630011,0.00025184476,0.00013034939,0.0001652063,0.00034192536,0.0004902532,0.00023882485],"category_scores_gemma":[0.002330175,0.00042885292,0.00033706115,0.0004481269,0.000111764864,0.00034126986,0.00023625245,0.0015411344,0.00060485216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000102870235,0.00032982265,0.00013234462,0.0023015214,0.0010688562,0.005074259,0.000054877637,0.0000050258723,0.00007985332,0.00014650117,0.9841276,0.006669044],"study_design_scores_gemma":[0.00063496723,0.00047234615,0.00014533244,0.0021462115,0.0062266923,0.00025607183,0.00009488684,0.000010548372,0.00021070335,0.0019379377,0.9873331,0.0005311952],"about_ca_topic_score_codex":0.00012893922,"about_ca_topic_score_gemma":0.000017344446,"teacher_disagreement_score":0.04126245,"about_ca_system_score_codex":0.000064716274,"about_ca_system_score_gemma":0.00021958922,"threshold_uncertainty_score":0.9998163},"labels":[],"label_agreement":null},{"id":"W4402824677","doi":"10.1182/bloodadvances.2024013414","title":"Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Chronic lymphocytic leukemia; Haematopoiesis; Myeloid leukemia; Immunology; Indeterminate; Myeloid; Medicine; Leukemia; Cancer research; Biology; Stem cell; Genetics","score_opus":0.004372831565118015,"score_gpt":0.2465154665939159,"score_spread":0.2421426350287979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402824677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929097,0.005644242,0.00004628684,0.00006428206,0.00011967842,0.00044097123,0.000023297744,0.0000721338,0.0006793879],"genre_scores_gemma":[0.99799377,0.00033453,0.0008762908,0.00003799075,0.00013595213,0.000041048883,0.000031881198,0.00004239171,0.0005061762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816954,0.00003593798,0.0003572833,0.00040076533,0.000618668,0.00041782195],"domain_scores_gemma":[0.99934816,0.00008362277,0.00006844319,0.00028071765,0.00010602179,0.000113006674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014208713,0.00020683251,0.0004100065,0.0003390648,0.000034300054,0.000023236467,0.00016805984,0.00009507751,0.00011169631],"category_scores_gemma":[0.000043136897,0.00015399905,0.00008245507,0.00056947034,0.00020885219,0.00029545114,0.00008767392,0.00028940986,0.00003466199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008599711,0.001339144,0.69011444,0.022027051,0.0022038368,0.008074813,0.0019136851,0.005639052,0.028416561,0.0014728213,0.001059365,0.22913952],"study_design_scores_gemma":[0.045454957,0.007583995,0.76994693,0.007910668,0.0011154651,0.0006473311,0.00033785193,0.014047513,0.14122958,0.0008818361,0.009465494,0.0013783727],"about_ca_topic_score_codex":0.00010352611,"about_ca_topic_score_gemma":0.000050184302,"teacher_disagreement_score":0.22776115,"about_ca_system_score_codex":0.0022039576,"about_ca_system_score_gemma":0.0030586608,"threshold_uncertainty_score":0.6279899},"labels":[],"label_agreement":null},{"id":"W4402829158","doi":"10.1182/bloodadvances.2024014415","title":"Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Johns Hopkins University","keywords":"Medicine; Antiphospholipid syndrome; Incidence (geometry); Titer; Internal medicine; Thrombosis; Thrombophilia; Pediatrics; Venous thromboembolism; Lupus anticoagulant; Venous thrombosis; Prospective cohort study; Antibody; Immunology","score_opus":0.012854728900983145,"score_gpt":0.2823732752547701,"score_spread":0.2695185463537869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402829158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573107,0.009570376,0.0000074233485,0.0022492227,0.00030671016,0.0015749385,0.00004301089,0.00011078129,0.00040645423],"genre_scores_gemma":[0.9912951,0.0071004466,0.000467207,0.0006067811,0.00024860876,0.00012145663,0.000030466425,0.000034741726,0.00009517797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866223,0.000029710895,0.00026256428,0.00046179487,0.00028123808,0.00030246435],"domain_scores_gemma":[0.99941456,0.0001748598,0.000048536145,0.00027889345,0.000018647886,0.000064473774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017185992,0.00023472345,0.0006076558,0.00008308058,0.000114250775,0.000113933005,0.00013405069,0.000052399297,0.00004278451],"category_scores_gemma":[0.000050406154,0.0001306381,0.00007511063,0.00023510621,0.000148178,0.00021425029,0.000077566816,0.00019720844,0.000014581429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004671675,0.0013188714,0.98870325,0.00010607153,0.001098963,0.000034364202,0.001628768,0.0000045756215,0.00018463703,0.00056532625,0.0006898503,0.0051981807],"study_design_scores_gemma":[0.013185805,0.0011873898,0.9767673,0.0005095141,0.0008164508,0.000011424493,0.00041688388,0.000008829949,0.0007871761,0.00023253854,0.005861885,0.00021481045],"about_ca_topic_score_codex":0.000561598,"about_ca_topic_score_gemma":0.00021509374,"teacher_disagreement_score":0.0127186375,"about_ca_system_score_codex":0.00002027431,"about_ca_system_score_gemma":0.000055850207,"threshold_uncertainty_score":0.53272676},"labels":[],"label_agreement":null},{"id":"W4402975451","doi":"10.1182/bloodadvances.2024014139","title":"Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; Impact; McMaster University","funders":"","keywords":"Meta-analysis; Multiple myeloma; Medicine; Oncology; MEDLINE; Internal medicine; Biology","score_opus":0.057377145620243784,"score_gpt":0.36597223175094773,"score_spread":0.30859508613070397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402975451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027959104,0.98251164,0.00003014928,0.00010237999,0.000024747666,0.015483518,0.0017193884,0.00008084182,0.000044513155],"genre_scores_gemma":[0.000024652394,0.98251647,0.0030308454,0.00011791758,0.000037606384,0.010546381,0.0016449217,0.000107826585,0.0019733792],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964083,0.00025708816,0.0011098481,0.0010297231,0.00066586625,0.00052921474],"domain_scores_gemma":[0.9965346,0.0012356729,0.0006450319,0.000938198,0.0002757698,0.00037074115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003500285,0.0008652921,0.01094601,0.00046120584,0.00011333166,0.00007867415,0.00021208602,0.00014575373,0.00005604946],"category_scores_gemma":[0.00094609475,0.00041391057,0.0026719724,0.0010636507,0.000089288296,0.00014080864,0.00008465229,0.00027388605,0.00004793104],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023306524,0.00033854568,0.00004873515,0.72070545,0.2746194,0.00011249847,0.0000110181945,8.7894975e-8,2.9090879e-9,0.000008078495,0.00013729859,0.003995579],"study_design_scores_gemma":[0.0016545809,0.0004985481,0.000006019707,0.07264208,0.82727104,0.00002997735,0.000007826005,0.0000034859152,1.5886219e-7,0.0000047845597,0.09756,0.0003214993],"about_ca_topic_score_codex":0.000022735623,"about_ca_topic_score_gemma":0.00010110165,"teacher_disagreement_score":0.64806336,"about_ca_system_score_codex":0.00006472776,"about_ca_system_score_gemma":0.00017582333,"threshold_uncertainty_score":0.99983126},"labels":[],"label_agreement":null},{"id":"W4403152806","doi":"10.1182/bloodadvances.2024013756","title":"Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Selection (genetic algorithm); Transplantation; Computer science; Computational biology; Machine learning; Artificial intelligence; Medicine; Biology; Internal medicine","score_opus":0.009809484060171627,"score_gpt":0.2815315142204878,"score_spread":0.27172203016031615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403152806","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08384412,0.0043807025,0.89724,0.005990597,0.00046667233,0.0020138903,0.00011399033,0.0036266223,0.0023234112],"genre_scores_gemma":[0.81612223,0.005733236,0.17252253,0.0006644826,0.00012227971,0.00021506572,0.00017663295,0.00009325615,0.004350273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887687,0.000031046922,0.00030915992,0.00034799636,0.00021307313,0.00022185588],"domain_scores_gemma":[0.99958646,0.00011281075,0.00004448384,0.00010277942,0.000058119414,0.00009533029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018136932,0.00022126069,0.00029156625,0.0002913955,0.00009565,0.000054915854,0.00006696736,0.00014034598,0.00018351854],"category_scores_gemma":[0.000029644449,0.00017356708,0.00011972765,0.00044933354,0.000026819069,0.0002625919,0.0000069371636,0.00039769933,0.000035263758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011226326,0.0007263077,0.29040113,0.0051780245,0.0009463207,0.00041442175,0.0045648753,0.0033170918,0.6671844,0.0033917415,0.00014863718,0.022604393],"study_design_scores_gemma":[0.0035168002,0.0014667973,0.05038833,0.001507889,0.0019217427,0.0016606107,0.00026483389,0.0014314963,0.8949268,0.0004562805,0.041535318,0.0009231276],"about_ca_topic_score_codex":0.000066814115,"about_ca_topic_score_gemma":0.000052284755,"teacher_disagreement_score":0.7322781,"about_ca_system_score_codex":0.000031418127,"about_ca_system_score_gemma":0.00004289934,"threshold_uncertainty_score":0.70778596},"labels":[],"label_agreement":null},{"id":"W4403176170","doi":"10.1182/bloodadvances.2024013861","title":"Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; Hospital for Sick Children; University of Toronto","funders":"H2020 European Research Council; National Institute of Nursing Research; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Physical therapy; Randomized controlled trial; Anxiety; Psychological intervention; Chronic pain; Cognitive behavioral therapy; Intervention (counseling); Depression (economics); Quality of life (healthcare); Internal medicine; Psychiatry","score_opus":0.006130559620388445,"score_gpt":0.2696759449674177,"score_spread":0.26354538534702926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403176170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96022654,0.035867445,0.00013467966,0.00053088495,0.00013418411,0.00094522705,0.00006876029,0.00007109903,0.0020211597],"genre_scores_gemma":[0.9968622,0.0012586736,0.00017534864,0.00020398745,0.00008422131,0.00020143048,0.0002008603,0.000023247872,0.0009900285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938786,0.000011722399,0.0001154295,0.00022531269,0.00010077763,0.00015890067],"domain_scores_gemma":[0.9996943,0.00006597002,0.000022388522,0.000067287656,0.000050808914,0.00009925808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005190414,0.00011202154,0.000119691154,0.00006796827,0.00003055057,0.00003405776,0.000028289503,0.000036761525,0.000015625525],"category_scores_gemma":[0.000026074651,0.00007674419,0.000050195824,0.00016135487,0.000050302915,0.00021456864,0.000004726215,0.000092893184,0.000006960544],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029503251,0.003758592,0.04744131,0.00080254785,0.000037687907,0.00010073624,0.0011998262,0.000008797805,0.00007260128,0.00006849874,0.00026151442,0.94329756],"study_design_scores_gemma":[0.09118965,0.058532786,0.07665899,0.046468105,0.0030236281,0.00017481593,0.09727257,0.0031679654,0.014920712,0.0058278264,0.5986129,0.004150082],"about_ca_topic_score_codex":0.000008960939,"about_ca_topic_score_gemma":0.000011665126,"teacher_disagreement_score":0.9391475,"about_ca_system_score_codex":0.000012311154,"about_ca_system_score_gemma":0.0002435958,"threshold_uncertainty_score":0.3129537},"labels":[],"label_agreement":null},{"id":"W4403219926","doi":"10.1182/bloodadvances.2024013845","title":"Adeno-associated virus and hepatocytes: frenemies?","year":2024,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Virology; Virus; Adeno-associated virus; Medicine; Biology; Genetics; Gene; Recombinant DNA","score_opus":0.013196268649566923,"score_gpt":0.2827732101815407,"score_spread":0.2695769415319738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403219926","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36368373,0.516036,0.000014435183,0.113450766,0.001114603,0.0010692617,0.0015119116,0.00021734217,0.0029019746],"genre_scores_gemma":[0.046751343,0.13052244,0.0005901443,0.7328139,0.020058006,0.00083167217,0.007666581,0.00091790373,0.059847992],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780583,0.00013866565,0.00027008043,0.0008543241,0.00036685972,0.0005642558],"domain_scores_gemma":[0.99914974,0.00004592644,0.00011731281,0.00051351904,0.00009038752,0.00008312554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017791854,0.0004264839,0.0003670935,0.000109225366,0.00010507931,0.0001086829,0.00040221104,0.0008140863,0.000081758124],"category_scores_gemma":[0.000098711906,0.0003931001,0.00015356114,0.00013650591,0.00020159484,0.000006164663,0.00024076315,0.0008949476,0.00007723333],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024570656,0.000087810346,0.00036824614,0.00039764217,0.00092210417,0.00043162753,0.000045780278,0.0000058024816,0.13830951,0.0000024528285,0.8546413,0.004541993],"study_design_scores_gemma":[0.00044928645,0.001417869,0.000014035794,0.00010722447,0.00011777107,0.000025142894,0.000010085087,0.0000041853127,0.1640044,0.0002485362,0.8331735,0.00042795602],"about_ca_topic_score_codex":0.000028776034,"about_ca_topic_score_gemma":0.0003380468,"teacher_disagreement_score":0.6193631,"about_ca_system_score_codex":0.00002139246,"about_ca_system_score_gemma":0.00016069223,"threshold_uncertainty_score":0.99985206},"labels":[],"label_agreement":null},{"id":"W4403624984","doi":"10.1182/bloodadvances.2024014219","title":"American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Queen's University; McMaster University; Ottawa Hospital; McMaster University Medical Centre; University Health Network; University of Toronto; Canadian Agency for Drugs and Technologies in Health; St. Michael's Hospital; St. Joseph’s Healthcare Hamilton; Toronto Western Hospital; Public Health Agency of Canada; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Intensive care medicine; Guideline; Executive summary; Grading (engineering); MEDLINE; Multidisciplinary approach; Pathology","score_opus":0.09298871257045513,"score_gpt":0.45175736224500923,"score_spread":0.35876864967455413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403624984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90500844,0.0037959504,0.073391326,0.010749517,0.00027389848,0.0055664256,0.0009958097,0.00018030587,0.000038325084],"genre_scores_gemma":[0.9451546,0.0014185761,0.051564958,0.0012987461,0.000099923505,0.00018453895,0.000048397058,0.000031971507,0.00019826645],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856895,0.000029847222,0.0004793231,0.0003630985,0.0003349521,0.00022384048],"domain_scores_gemma":[0.98451936,0.0142586185,0.00021248215,0.00019736102,0.0007126064,0.00009957971],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0002738022,0.00014467447,0.00060469395,0.000088417015,0.0000689423,0.0000077438945,0.000069879294,0.000041285264,0.0000033938763],"category_scores_gemma":[0.02640363,0.00009776023,0.00020821442,0.00029491266,0.0004844627,0.000132127,0.000057869605,0.000079685786,2.3916746e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004762138,0.0034949745,0.86586446,0.03398958,0.0028272516,0.000008499226,0.0017691568,0.0016558194,0.0033497326,0.0032137253,0.012480082,0.06658457],"study_design_scores_gemma":[0.020831157,0.09856714,0.32251996,0.018001085,0.0036892241,0.0000050969447,0.0034506014,0.029803673,0.02952232,0.008429935,0.46343142,0.0017483769],"about_ca_topic_score_codex":0.000071210015,"about_ca_topic_score_gemma":0.00001825185,"teacher_disagreement_score":0.5433445,"about_ca_system_score_codex":0.000042482683,"about_ca_system_score_gemma":0.00030536906,"threshold_uncertainty_score":0.9817974},"labels":[],"label_agreement":null},{"id":"W4403859777","doi":"10.1182/bloodadvances.2024013890","title":"The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculté de Médecine, Université de Genève; Fondation Medic; Ligue Genevoise Contre le Cancer; Université de Genève; Institute of Genetics; Institute of Genetics and Genomics of Geneva; Hôpitaux Universitaires de Genève","keywords":"Ubiquitin ligase; Myeloid leukemia; Ubiquitin; Cancer research; DNA ligase; mitochondrial fusion; Leukemia; Biology; Cell cycle; Cell biology; Apoptosis; Mitochondrial DNA; Immunology; Genetics; Gene","score_opus":0.007813432256689935,"score_gpt":0.2980657208130744,"score_spread":0.29025228855638446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403859777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95683473,0.035343654,0.000020063562,0.0038848,0.00035192468,0.0013450523,0.000017857898,0.00017376059,0.002028171],"genre_scores_gemma":[0.9657119,0.021234287,0.0060649207,0.00017433346,0.0011907866,0.0004237286,0.00005284338,0.00010189195,0.0050453367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774367,0.00011617346,0.00037151942,0.0005963473,0.00056113966,0.00061112683],"domain_scores_gemma":[0.99885976,0.00044054782,0.000061481995,0.00035925407,0.000065380525,0.00021358836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004157618,0.00025698871,0.00030657265,0.00018964356,0.00025369113,0.00017296057,0.00022175982,0.00013889988,0.000032561995],"category_scores_gemma":[0.00019627131,0.00015757562,0.00007975118,0.00049259263,0.0002890769,0.00032098702,0.00028794023,0.0007110923,0.00004450404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013935354,0.00026074614,0.002585725,0.0010698013,0.00012350397,0.0023319507,0.0011045091,0.0000070015235,0.557079,0.0003048114,0.0021555123,0.43158388],"study_design_scores_gemma":[0.008439392,0.0022890873,0.00574167,0.0031679396,0.00041042813,0.0009129641,0.00097419036,0.0052657574,0.821991,0.00297389,0.14715995,0.0006736894],"about_ca_topic_score_codex":0.000037054226,"about_ca_topic_score_gemma":0.0000677643,"teacher_disagreement_score":0.4309102,"about_ca_system_score_codex":0.00019397691,"about_ca_system_score_gemma":0.00055318524,"threshold_uncertainty_score":0.6425747},"labels":[],"label_agreement":null},{"id":"W4403859802","doi":"10.1182/bloodadvances.2024014555","title":"Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Janssen Biotech; Genentech; National Institutes of Health; Swedish Orphan Biovitrum; Omeros Corporation; Incyte; BeiGene; Angiocrine Bioscience; Parker Institute for Cancer Immunotherapy; Servier; Memorial Sloan-Kettering Cancer Center; National Cancer Institute; Medpace; Celgene; Gilead Sciences; Sanofi; Pfizer; Seres Therapeutics; Amgen","keywords":"Medicine; Weight loss; Cachexia; Internal medicine; Cancer; Lymphoma; Oncology; Obesity","score_opus":0.015093004599438645,"score_gpt":0.30787951075646797,"score_spread":0.29278650615702934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403859802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94818836,0.047663767,0.00001410952,0.0019342075,0.00022154392,0.0010172116,0.0001910392,0.00014713517,0.0006226431],"genre_scores_gemma":[0.9715767,0.0045483527,0.0001586721,0.00043660193,0.0002751831,0.00033830223,0.000047407506,0.00009286165,0.022525942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831086,0.00003572378,0.0002091774,0.0004946584,0.0004955708,0.00045403442],"domain_scores_gemma":[0.9991699,0.0002060956,0.00007883934,0.00021843181,0.00015933765,0.00016740792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019239422,0.00027573004,0.00047527137,0.00013535975,0.000110411434,0.000073445386,0.00012527281,0.00012557868,0.00025780103],"category_scores_gemma":[0.00003772872,0.00017880189,0.0001207274,0.00027758005,0.00014271183,0.00018531337,0.000030267764,0.00017259258,0.0000041353974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009615923,0.0006055286,0.8781882,0.00052946515,0.0015675101,0.0004202147,0.0009172582,0.0000066746943,0.010557531,0.00007141828,0.00042449546,0.10575013],"study_design_scores_gemma":[0.042437945,0.0045867967,0.5293767,0.0017783284,0.0012132019,0.00023601073,0.001319638,0.0004205951,0.12111948,0.0011774987,0.2951421,0.0011917186],"about_ca_topic_score_codex":0.000108516506,"about_ca_topic_score_gemma":0.0009002002,"teacher_disagreement_score":0.3488115,"about_ca_system_score_codex":0.00011909783,"about_ca_system_score_gemma":0.00025606406,"threshold_uncertainty_score":0.72913295},"labels":[],"label_agreement":null},{"id":"W4404091391","doi":"10.1182/bloodadvances.2024014475","title":"Donor age contributes more to the rheological properties of stored red blood cells than donor sex and biological age distribution","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood transfusion and management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"Health Canada; Canadian Blood Services; Australian Government","keywords":"Red blood cell; Tonicity; Erythrocyte deformability; Biology; Isotonic; Andrology; Physiology; Immunology; Internal medicine; Endocrinology; Medicine","score_opus":0.020416513621930463,"score_gpt":0.25140712554120026,"score_spread":0.23099061191926978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404091391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97138196,0.017827785,0.0004909244,0.008268657,0.00023833168,0.0012268524,0.00010103036,0.00016327175,0.00030121033],"genre_scores_gemma":[0.9949296,0.0029295955,0.00036764794,0.00049240375,0.00010730185,0.00012201722,0.00006410188,0.000011252989,0.00097607175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872994,0.00007849852,0.00031569455,0.00040982908,0.00019301538,0.00027302236],"domain_scores_gemma":[0.9994753,0.00008851211,0.000042941178,0.00023670199,0.000046884707,0.0001096629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002800521,0.00020367118,0.00041079745,0.000056971563,0.00010432891,0.00004834167,0.00014258278,0.00009801004,0.000025476838],"category_scores_gemma":[0.000097919496,0.00010272851,0.00010683411,0.00024784688,0.00032043166,0.00006713072,0.0001136903,0.00017993491,0.0000056280187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001992335,0.003483781,0.023644725,0.00245808,0.0022492225,0.0018448627,0.0028990055,0.000057007386,0.89746076,0.018249957,0.005198445,0.040461794],"study_design_scores_gemma":[0.0061344244,0.0032051124,0.07661049,0.001326432,0.0022654494,0.00011770361,0.0026610114,0.00012396785,0.5220606,0.00083737104,0.3840587,0.0005987514],"about_ca_topic_score_codex":0.00003006456,"about_ca_topic_score_gemma":0.00004854858,"teacher_disagreement_score":0.37886027,"about_ca_system_score_codex":0.000010496127,"about_ca_system_score_gemma":0.00002158834,"threshold_uncertainty_score":0.4189147},"labels":[],"label_agreement":null},{"id":"W4404516283","doi":"10.1182/bloodadvances.2024014430","title":"CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease","year":2024,"lang":"en","type":"review","venue":"Blood Advances","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Medicine; Disease; Internal medicine; Oncology; Germline mutation; Population; Bioinformatics; Immunology; Genetics; Mutation; Biology","score_opus":0.022989865467583526,"score_gpt":0.31874167792929115,"score_spread":0.2957518124617076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404516283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090527144,0.9934078,0.0000012292986,0.001303485,0.00044963477,0.001010802,0.000088463836,0.00011147166,0.0027218831],"genre_scores_gemma":[0.000195564,0.994421,0.000034781122,0.00013412346,0.0006707978,0.0002591794,0.00023017495,0.000064433385,0.003989927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981726,0.00008442892,0.0005557089,0.0005498259,0.0003637305,0.00027373628],"domain_scores_gemma":[0.998878,0.00018736957,0.00020998986,0.00046939502,0.000050306815,0.00020492198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018758659,0.00046783584,0.0013456544,0.00012203935,0.00026287598,0.00008310746,0.00014819324,0.00013682726,0.00029660718],"category_scores_gemma":[0.000115830044,0.00025835226,0.00038411756,0.00031001677,0.00027953208,0.00012638526,0.00014676317,0.00031867845,0.00016549256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048024056,0.00034321152,0.0006197814,0.16330059,0.0022825203,0.0004351083,0.00033892045,0.0000010479501,0.0000042539327,0.01647807,0.011490749,0.80465776],"study_design_scores_gemma":[0.0003262541,0.00006926404,0.0002750065,0.009409067,0.0051343483,0.0007784078,0.000048440852,0.0000012512454,0.000003078526,0.0017889468,0.9818803,0.00028560404],"about_ca_topic_score_codex":0.000004796255,"about_ca_topic_score_gemma":0.000032360673,"teacher_disagreement_score":0.9703896,"about_ca_system_score_codex":0.00003480287,"about_ca_system_score_gemma":0.00025200748,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W4404561564","doi":"10.1182/bloodadvances.2024014781","title":"PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Graft-versus-host disease; Hematopoietic stem cell transplantation; Internal medicine; Cyclophosphamide; Gastroenterology; Transplantation; Immunology; Chemotherapy","score_opus":0.01823377067336204,"score_gpt":0.285367548404076,"score_spread":0.267133777730714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404561564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90578383,0.018866627,0.06714796,0.0013260761,0.0013864409,0.0032995904,0.00041764422,0.00075487694,0.0010169453],"genre_scores_gemma":[0.9835872,0.0009617264,0.013728941,0.00014585626,0.00023407929,0.0004730378,0.0004553349,0.00008682847,0.00032700293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980418,0.000042827032,0.00047430993,0.00061750127,0.0004119441,0.00041162106],"domain_scores_gemma":[0.99871826,0.0005276583,0.000079321304,0.00029187487,0.00010218948,0.0002806689],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020819072,0.00031928805,0.00037567,0.0002607221,0.00011874445,0.000078326186,0.0001214419,0.000110579276,0.0000835251],"category_scores_gemma":[0.0000383658,0.00027896976,0.00025624063,0.00042851377,0.00007528389,0.00024204316,0.0000055009777,0.00015457433,0.00006551889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020086583,0.0036275885,0.041742835,0.21716462,0.0010989752,0.0037942117,0.0066616093,0.0032985355,0.6853288,0.0037963588,0.0002884767,0.0131114],"study_design_scores_gemma":[0.021024853,0.0025997448,0.0061914865,0.0049678157,0.006376754,0.00016809662,0.0009074625,0.003139435,0.94312674,0.0012482993,0.008828952,0.0014203885],"about_ca_topic_score_codex":0.00000593415,"about_ca_topic_score_gemma":0.000015521682,"teacher_disagreement_score":0.25779793,"about_ca_system_score_codex":0.000039951396,"about_ca_system_score_gemma":0.00029787252,"threshold_uncertainty_score":0.99996626},"labels":[],"label_agreement":null},{"id":"W4404754793","doi":"10.1182/bloodadvances.2024014929","title":"Generalized additive logit models for clinical prediction","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of Canada; Statistics Canada","funders":"","keywords":"Logit; Logistic regression; Generalized additive model; Econometrics; Mixed logit; Statistics; Mathematics; Computer science","score_opus":0.06752517926557867,"score_gpt":0.39676536492230835,"score_spread":0.3292401856567297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404754793","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038879171,0.015069099,0.97277445,0.0023788398,0.0028482575,0.00047343186,0.00011082115,0.0009769569,0.0014802183],"genre_scores_gemma":[0.4267167,0.005158473,0.56136113,0.0012896556,0.0028312367,0.00056645164,0.00008970031,0.000051044153,0.0019356043],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99857944,0.00012315292,0.0003301935,0.00054467464,0.00018442942,0.0002380817],"domain_scores_gemma":[0.99886286,0.00060789095,0.00006245703,0.00029223744,0.00008883061,0.00008570743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004426315,0.00011506204,0.00017126238,0.00006448365,0.000109833134,0.00012461083,0.00040182177,0.000074862866,0.000010308855],"category_scores_gemma":[0.00016953658,0.000097359116,0.00011625107,0.00019911237,0.000039519527,0.00083271007,0.00009191511,0.00021202481,0.000018279903],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026335063,0.000116819974,0.0025385797,0.00026662616,0.000088445195,0.00003046401,0.0004762097,0.01146101,0.000020342342,0.39487585,0.006377558,0.58372176],"study_design_scores_gemma":[0.00036555214,0.00033623833,0.00044432073,0.000083166706,0.000020691366,0.000014545048,0.000009558145,0.7410269,0.000113857044,0.061266407,0.19619098,0.00012779924],"about_ca_topic_score_codex":0.000009686375,"about_ca_topic_score_gemma":0.000007756468,"teacher_disagreement_score":0.72956586,"about_ca_system_score_codex":0.000014895371,"about_ca_system_score_gemma":0.00009783919,"threshold_uncertainty_score":0.39701894},"labels":[],"label_agreement":null},{"id":"W4404945099","doi":"10.1182/bloodadvances.2024013267","title":"Congenital T-cell activation impairs transitional-to-follicular B-cell maturation in humans","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Pfizer; Broad Institute; AstraZeneca; National Institutes of Health; Bristol-Myers Squibb","keywords":"Immunoglobulin D; B cell; Cell biology; CD40; Biology; T cell; mTORC1; Cell; Immunology; Immune system; Signal transduction; Cytotoxic T cell; In vitro; Antibody; PI3K/AKT/mTOR pathway; Biochemistry","score_opus":0.00660035695546517,"score_gpt":0.22236552477201374,"score_spread":0.21576516781654856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404945099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97443247,0.019562392,0.0005425071,0.0005076772,0.000921494,0.00038151734,0.000043967928,0.00017964464,0.0034283204],"genre_scores_gemma":[0.9947478,0.00032774196,0.00021697064,0.00015885217,0.000070679416,0.00007581703,0.00030531842,0.000025163812,0.0040716254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986903,0.0001190129,0.00032889267,0.00044698428,0.00005070649,0.00036407544],"domain_scores_gemma":[0.9995773,0.00012556434,0.000051059407,0.00018107358,0.000042251962,0.000022761422],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013140717,0.0002268681,0.00023800733,0.00026147658,0.00013343754,0.000038901966,0.00016825258,0.00023056238,0.0004099667],"category_scores_gemma":[0.000011544667,0.00020624539,0.0001074937,0.00031634897,0.00009808902,0.00038112182,0.000029835204,0.00033595672,0.0009860875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015439748,0.00039116247,0.00017718392,0.000070650836,0.00006180764,0.000026963358,0.00082390156,0.00008986071,0.99598765,0.0005196163,0.00044419587,0.0012526043],"study_design_scores_gemma":[0.0015363389,0.00026191722,0.00065903954,0.00006645844,0.00006741555,0.00003252313,0.00048664454,0.000008995238,0.9192021,0.00063852046,0.076748975,0.0002910715],"about_ca_topic_score_codex":0.000046704186,"about_ca_topic_score_gemma":0.00007608815,"teacher_disagreement_score":0.07678556,"about_ca_system_score_codex":0.000036497957,"about_ca_system_score_gemma":0.00006184613,"threshold_uncertainty_score":0.99979174},"labels":[],"label_agreement":null},{"id":"W4405184163","doi":"10.1182/bloodadvances.2024013945","title":"The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Canada","funders":"Canadian Institutes of Health Research; Bristol-Myers Squibb; Samsung; Genentech; Janssen Research and Development; National Institutes of Health; National Health Laboratory Service; University College London; Revance; Boston Scientific Corporation; CSL Behring; GlaxoSmithKline; Washington University in St. Louis; Novo Nordisk; Teva Pharmaceutical Industries; Sanofi; Gilead Sciences; BioClinica; Pfizer; Heart and Stroke Foundation of Canada; Esperion Therapeutics; MicroPort; Duke Clinical Research Institute; Brown University","keywords":"Clinical trial; Inclusion (mineral); Harmonization; Equity (law); Diversity (politics); Medicine; Terminology; Clinical study design; Timeline; Family medicine; Internal medicine; Political science; Psychology; Geography","score_opus":0.6032530859383062,"score_gpt":0.6612064472372111,"score_spread":0.05795336129890494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405184163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88577044,0.01943688,0.0010415954,0.08850617,0.0006184926,0.001193042,0.000036281006,0.00009467589,0.0033024305],"genre_scores_gemma":[0.9791448,0.015401433,0.0029826332,0.00224217,0.00012011426,0.000020126112,0.0000039452375,0.000012951975,0.00007182046],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99569184,0.0016111966,0.0010995386,0.0005186202,0.00074775313,0.00033108212],"domain_scores_gemma":[0.94778454,0.05117623,0.0002190451,0.00033358313,0.00025119903,0.00023542158],"candidate_categories":["metaresearch","open_science"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.029406609,0.00013766905,0.0009901505,0.00010040274,0.00037740325,0.00002871394,0.0005226722,0.00022992521,0.000012801674],"category_scores_gemma":[0.02968089,0.00008429071,0.00019239073,0.0004989745,0.0017069646,0.0001254306,0.0274205,0.0014794448,0.0000053090193],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017598995,0.001220172,0.16847773,0.0012084438,0.0005102731,0.00026678672,0.010549365,0.0000036152685,0.0006960421,0.13026747,0.000766496,0.6842737],"study_design_scores_gemma":[0.003253151,0.006264639,0.0093572745,0.0017556056,0.00027870582,0.00011648439,0.01078284,0.0008780066,0.0049395403,0.95436645,0.007718113,0.0002891839],"about_ca_topic_score_codex":0.0001399705,"about_ca_topic_score_gemma":0.0025463335,"teacher_disagreement_score":0.824099,"about_ca_system_score_codex":0.000030213438,"about_ca_system_score_gemma":0.0003677509,"threshold_uncertainty_score":0.9994301},"labels":[],"label_agreement":null},{"id":"W4405273291","doi":"10.1182/bloodadvances.2024014903","title":"Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"Cilag; Berlin Institute of Health; Swedish Orphan Biovitrum; Incyte; BeiGene; Agios Pharmaceuticals; Regeneron Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Gilead Sciences; Sanofi; Pfizer; Les Laboratories Pierre Fabre; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Bendamustine; Refractory (planetary science); Cytokine release syndrome; Rituximab; Oncology; Salvage therapy; Gastroenterology; Lymphoma; Surgery; Chemotherapy; Immunotherapy; Cancer; Chimeric antigen receptor; Biology","score_opus":0.016827185534477724,"score_gpt":0.3415337235392444,"score_spread":0.3247065380047667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405273291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844513,0.008391415,0.000037459893,0.00019504021,0.00012417293,0.0014329172,0.00006871472,0.00005072142,0.0052482774],"genre_scores_gemma":[0.9889493,0.001203775,0.00078844494,0.000025869142,0.00012974441,0.00007451411,0.000029296218,0.00003124943,0.008767808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986608,0.000058124828,0.00034269708,0.00034885976,0.0003408326,0.00024870635],"domain_scores_gemma":[0.99869,0.00090751797,0.000051113333,0.0001916919,0.00008540745,0.000074251424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055310386,0.00013179953,0.0003139801,0.00029490876,0.000043217082,0.00001544859,0.000079275276,0.00004214005,0.00014287364],"category_scores_gemma":[0.0001477269,0.00011262638,0.000073057876,0.00039273387,0.00006088756,0.00013086322,0.000050160146,0.000120363475,0.000004170131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014357091,0.043698173,0.30907306,0.0036572518,0.0007724647,0.00055560947,0.007568967,0.000036401598,0.07643929,0.0037799869,0.00037041755,0.53969127],"study_design_scores_gemma":[0.11408772,0.0048665847,0.5501772,0.00077299145,0.00035006867,0.000033951976,0.0022677497,0.0015859505,0.015757173,0.000400977,0.30925268,0.00044692957],"about_ca_topic_score_codex":0.000055244847,"about_ca_topic_score_gemma":0.00043353974,"teacher_disagreement_score":0.53924435,"about_ca_system_score_codex":0.000072189934,"about_ca_system_score_gemma":0.00015151946,"threshold_uncertainty_score":0.45927703},"labels":[],"label_agreement":null},{"id":"W4405837485","doi":"10.1182/bloodadvances.2024014625","title":"Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Pharma; Incyte; CSL Behring; Gilead Sciences; Division of Materials Research; Celgene; BeiGene; Daiichi Sankyo Europe; Sanofi; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Transplantation; Observational study; Internal medicine; Retrospective cohort study; Pediatrics; Intensive care unit; Bone marrow","score_opus":0.028132859133466397,"score_gpt":0.3150878821616425,"score_spread":0.2869550230281761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405837485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883457,0.004123951,0.0000068264185,0.0022555154,0.000080292026,0.003116616,0.001897637,0.00007396135,0.00009951385],"genre_scores_gemma":[0.9949436,0.001296617,0.0014207575,0.0003493835,0.00017690053,0.00081834,0.00066045934,0.000037657584,0.00029627501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985523,0.00007364822,0.00029579864,0.0005899192,0.00024626055,0.00024207408],"domain_scores_gemma":[0.99868363,0.0006928345,0.00008674192,0.00034227545,0.00007135584,0.00012317867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007549976,0.00026619068,0.00038470156,0.000056377045,0.0002042855,0.000113547474,0.00004756366,0.000022616412,0.0000056316576],"category_scores_gemma":[0.000022842389,0.00012732847,0.00006643483,0.000119231205,0.000034358294,0.00013734003,0.000025450425,0.00006588989,0.0000020775012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087960385,0.0012618682,0.946579,0.00007341528,0.00071331573,0.00002682851,0.008160647,0.0000029371288,0.0000010156631,0.0000268546,0.0004123773,0.04186213],"study_design_scores_gemma":[0.009216625,0.010236249,0.9327945,0.00066667795,0.00085833744,0.0000015167684,0.0024810373,0.0000054518305,0.00036869018,0.000008357026,0.04321699,0.00014554091],"about_ca_topic_score_codex":0.0023633419,"about_ca_topic_score_gemma":0.013021837,"teacher_disagreement_score":0.04280461,"about_ca_system_score_codex":0.00011408538,"about_ca_system_score_gemma":0.00007314953,"threshold_uncertainty_score":0.72664905},"labels":[],"label_agreement":null},{"id":"W4405906667","doi":"10.1182/bloodadvances.2024014865","title":"Advancing drug development in myelodysplastic syndromes","year":2024,"lang":"en","type":"review","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"Genentech; U.S. Food and Drug Administration; National Institutes of Health; Paracelsus Medizinische Privatuniversität; Cincinnati Children's Hospital Medical Center; Università degli Studi di Firenze; National Heart, Lung, and Blood Institute; Acceleron; Eli Lilly and Company; Universidad de Salamanca; Memorial Sloan-Kettering Cancer Center; University of Washington; Bristol-Myers Squibb; Cleveland Clinic; University of Miami; Pfizer; Northwestern University; Incyte; National Cancer Institute; Servier; Ohio State University; University of Pennsylvania; Alexion Pharmaceuticals; Massachusetts General Hospital; Sanofi; AstraZeneca; Celgene","keywords":"Myelodysplastic syndromes; Medicine; Decitabine; Drug development; Clinical trial; Oncology; Stem cell; Transplantation; Intensive care medicine; Hematopoietic stem cell transplantation; Food and drug administration; Drug; Internal medicine; Pharmacology; Bone marrow","score_opus":0.02886272746914764,"score_gpt":0.3608832563954044,"score_spread":0.3320205289262568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405906667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119562756,0.99578196,0.000011286756,0.00008112209,0.00047062678,0.0013708341,0.000017745864,0.00018164421,0.0019652257],"genre_scores_gemma":[0.0000197363,0.98574114,0.0053780354,0.000037817703,0.00030162613,0.0005274999,0.00012968003,0.00016551427,0.0076989383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626344,0.00011469485,0.0010890004,0.00096612854,0.00066815485,0.0008985549],"domain_scores_gemma":[0.99848825,0.00048019877,0.00019016718,0.0004900199,0.00006580501,0.00028558943],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054281316,0.0007187886,0.0025804562,0.0010625056,0.00007116474,0.000054568663,0.00039257895,0.00024376376,0.000105748375],"category_scores_gemma":[0.00040627588,0.00051344204,0.0003377421,0.0012610484,0.000100027035,0.0001913682,0.00032461653,0.0014932737,0.0012227527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010425522,0.00012361504,0.00003952159,0.095605485,0.00037096415,0.0030717244,0.00012941327,0.0000014864407,0.0000010725167,0.00005427188,0.00079727103,0.89979476],"study_design_scores_gemma":[0.0005168822,0.000060758037,0.00000842704,0.077971265,0.0015151127,0.0012548935,0.000066218825,0.0000040824307,0.000012663698,0.000037217273,0.9181062,0.0004462808],"about_ca_topic_score_codex":0.000009032591,"about_ca_topic_score_gemma":0.00006836773,"teacher_disagreement_score":0.9173089,"about_ca_system_score_codex":0.00085881376,"about_ca_system_score_gemma":0.0032083949,"threshold_uncertainty_score":0.9997317},"labels":[],"label_agreement":null},{"id":"W4406158641","doi":"10.1182/bloodadvances.2024014689","title":"The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Identification (biology); Stage (stratigraphy); Hodgkin lymphoma; Lymphoma; Computer science; Risk model; Oncology; Internal medicine; Computational biology; Medicine; Risk analysis (engineering); Biology","score_opus":0.008848177751884546,"score_gpt":0.2788198384813748,"score_spread":0.26997166072949025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406158641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928517,0.005799231,0.00044151273,0.000100079196,0.00006373779,0.00038498922,0.00018929211,0.000018026194,0.00015148244],"genre_scores_gemma":[0.99040794,0.007768635,0.0015028542,0.00001364401,0.00001838409,0.000066667424,0.000091597365,0.0000059748363,0.00012429834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99906194,0.000042858606,0.0004365765,0.0002082724,0.00015370782,0.00009666941],"domain_scores_gemma":[0.99926144,0.00013639733,0.00024191957,0.00024975155,0.00008679996,0.000023714556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019804928,0.00009635687,0.00020542488,0.0000985167,0.00006567361,0.0000093675535,0.000052701165,0.000043465083,8.490843e-7],"category_scores_gemma":[0.00016363242,0.00006823761,0.00003689701,0.00019907198,0.00007270678,0.00024187531,0.000019111798,0.00003084514,1.6807428e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051089743,0.0028010905,0.44404286,0.00019560158,0.000098150434,0.000003230229,0.00039122652,0.004990216,0.0071341223,0.0039199064,0.0000052215837,0.5359075],"study_design_scores_gemma":[0.004859275,0.00025633452,0.92175424,0.00018740195,0.0002644819,0.000002695579,0.00071206276,0.026312366,0.043105334,0.0023138751,0.00017543533,0.000056493005],"about_ca_topic_score_codex":0.00007589696,"about_ca_topic_score_gemma":0.00029615298,"teacher_disagreement_score":0.535851,"about_ca_system_score_codex":0.00004498637,"about_ca_system_score_gemma":0.00006286514,"threshold_uncertainty_score":0.2782649},"labels":[],"label_agreement":null},{"id":"W4406203366","doi":"10.1182/bloodadvances.2024015219","title":"Working toward international consensus defining pediatric “refractory ITP”","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Refractory (planetary science); Medicine; MEDLINE; Intensive care medicine; Political science; Metallurgy; Materials science; Law","score_opus":0.21147329102038803,"score_gpt":0.41521951463725687,"score_spread":0.20374622361686884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406203366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45011768,0.16902038,0.006169194,0.075815864,0.018992335,0.0011379865,0.00034889238,0.0004922815,0.2779054],"genre_scores_gemma":[0.9750375,0.0022969397,0.011837826,0.0073318407,0.00089107215,0.000088229426,0.000034008997,0.00002787139,0.002454706],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965352,0.000112993555,0.0023690378,0.00054060173,0.00009153615,0.00035063454],"domain_scores_gemma":[0.9969469,0.0012970967,0.0013040723,0.000300961,0.000059498667,0.00009149859],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037697533,0.0001806789,0.00059406005,0.00048823343,0.0001803562,0.000098448036,0.000365563,0.00011052924,0.0002669106],"category_scores_gemma":[0.0031506394,0.00023791906,0.00011248842,0.00028593233,0.000055087963,0.00030215233,0.00008479763,0.00020297027,0.0008656842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018218938,0.00016810127,0.7482823,0.00023956531,0.00014225046,0.0000044717,0.00064200116,0.00033794862,0.0000028092736,0.23361708,0.014414557,0.002130674],"study_design_scores_gemma":[0.0017018752,0.00005245374,0.0412775,0.00016053926,0.00003872331,0.0000074930413,0.0012392154,0.00076901034,0.000021179267,0.041807156,0.9124109,0.00051392335],"about_ca_topic_score_codex":0.000076908305,"about_ca_topic_score_gemma":0.00004914416,"teacher_disagreement_score":0.89799637,"about_ca_system_score_codex":0.00018536451,"about_ca_system_score_gemma":0.00016358763,"threshold_uncertainty_score":0.99991226},"labels":[],"label_agreement":null},{"id":"W4406352467","doi":"10.1182/bloodadvances.2024014948","title":"Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Italfarmaco; EUSA Pharma; MorphoSys; Cancer Research UK; Incyte; BeiGene; Gilead Sciences; Fondazione CRT; Associazione Italiana per la Ricerca sul Cancro; AstraZeneca; Eli Lilly and Company","keywords":"Mantle cell lymphoma; Chemoimmunotherapy; Internal medicine; Lenalidomide; Medicine; Oncology; Hematopoietic stem cell transplantation; Lymphoma; Clinical trial; Transplantation; Cohort; Autologous stem-cell transplantation; Multiple myeloma; Rituximab","score_opus":0.04235724640786973,"score_gpt":0.39158264064620313,"score_spread":0.3492253942383334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406352467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98600453,0.004513071,0.000037357342,0.0028870595,0.0005578895,0.0009090631,0.00033983696,0.000040891562,0.0047103246],"genre_scores_gemma":[0.9943156,0.000894611,0.0013720882,0.000583514,0.00047747808,0.000056183344,0.00008768843,0.000019832923,0.002193004],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970269,0.00039409962,0.0011692577,0.0005008758,0.0004856663,0.00042317223],"domain_scores_gemma":[0.9944377,0.004470164,0.00023528087,0.00067525223,0.00009119466,0.00009041723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018022946,0.00020741769,0.00080674526,0.00012427788,0.00008344008,0.000016061655,0.00041513707,0.00018610278,0.000064365464],"category_scores_gemma":[0.0027898168,0.00013393656,0.00028313976,0.0004953471,0.00022918261,0.00010324624,0.00024250419,0.00036972275,0.00003721412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15817623,0.011559211,0.7818273,0.0008665575,0.00077767845,0.0007371516,0.0010920148,0.000015068832,0.002178429,0.0017167358,0.026869666,0.01418401],"study_design_scores_gemma":[0.5264092,0.0016015976,0.33757788,0.00070673664,0.0006517763,0.00001829554,0.002048441,0.0002151374,0.03252208,0.0014935542,0.0963156,0.00043968542],"about_ca_topic_score_codex":0.00024413437,"about_ca_topic_score_gemma":0.0002737309,"teacher_disagreement_score":0.44424936,"about_ca_system_score_codex":0.00006973815,"about_ca_system_score_gemma":0.00043743738,"threshold_uncertainty_score":0.5461774},"labels":[],"label_agreement":null},{"id":"W4406798656","doi":"10.1182/bloodadvances.2022009461","title":"Audit of B-cell cancer genes","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Gene; Exome; Biology; Computational biology; Candidate gene; Exome sequencing; Genetics; Bioinformatics; Mutation","score_opus":0.010070982775733267,"score_gpt":0.30955480964488197,"score_spread":0.2994838268691487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406798656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005957181,0.9974031,0.000060273294,0.00000768662,0.0005541255,0.00038185882,0.00018507855,0.0000109971725,0.0013373333],"genre_scores_gemma":[0.000017973649,0.9930793,0.00039209527,0.0000098890105,0.00052031875,0.00014896269,0.00030036425,0.00003105829,0.005500037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878496,0.00005630074,0.00041104652,0.00044265005,0.00012224812,0.00018277194],"domain_scores_gemma":[0.9990177,0.000024064295,0.00042739714,0.00041024562,0.00008330983,0.000037275895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000057089714,0.00028794602,0.0007196441,0.00008824661,0.000035147877,0.000007193628,0.0002621639,0.00033181874,0.000029509718],"category_scores_gemma":[0.000023270823,0.0002565119,0.0003524516,0.00021924193,0.0000615717,0.0000031258346,0.00010660123,0.00009341424,0.0000039437396],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059849317,0.000056700028,0.000009097336,0.015002696,0.00020831508,6.616147e-7,0.0000020841376,0.00009296101,0.002204789,0.00000867128,0.0006369504,0.9817711],"study_design_scores_gemma":[0.000209147,0.00006140183,0.000001373875,0.0038270473,0.0009130607,0.000004097589,0.0000022482288,4.949864e-7,0.023832869,0.000010403793,0.97090006,0.00023781117],"about_ca_topic_score_codex":0.000012847068,"about_ca_topic_score_gemma":0.000067726316,"teacher_disagreement_score":0.9815333,"about_ca_system_score_codex":0.00001752077,"about_ca_system_score_gemma":0.0005910677,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W4407007830","doi":"10.1182/bloodadvances.2024013656","title":"Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Seagen; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Hazard ratio; Odds ratio; Internal medicine; Refractory (planetary science); Leukapheresis; Surgery; Gastroenterology; Confidence interval","score_opus":0.015372867371088561,"score_gpt":0.3482179956828738,"score_spread":0.33284512831178525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407007830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027271464,0.96430796,0.000002806168,0.000010966312,0.00002137678,0.0031852515,0.00023343606,0.000050361952,0.004916349],"genre_scores_gemma":[0.00050854945,0.982369,0.000389452,0.000017750026,0.00007237105,0.00019823015,0.00044779218,0.000107636064,0.015889207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973091,0.0001571729,0.00061527744,0.00066140364,0.00071638596,0.0005406514],"domain_scores_gemma":[0.9982088,0.0002279533,0.00028623448,0.00078263436,0.00025262806,0.00024175462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018055011,0.0005943749,0.0026818237,0.00079746224,0.00003107122,0.000018187135,0.00031625965,0.00018871269,0.000793188],"category_scores_gemma":[0.000092658076,0.00034476252,0.00033634933,0.0018326482,0.00011622748,0.00009516531,0.00007890152,0.00045305633,0.000044317392],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016244173,0.0019112296,0.024091424,0.012220926,0.0013910229,0.00011922174,0.000041305193,0.00001293332,0.00005131699,0.0000012036342,0.00010198228,0.95843303],"study_design_scores_gemma":[0.020575501,0.027727375,0.025332525,0.12986079,0.0047774524,0.000059564045,0.000018132283,0.0000031772975,0.00043909124,0.0000062367735,0.7896399,0.0015602376],"about_ca_topic_score_codex":0.00009095041,"about_ca_topic_score_gemma":0.000034091958,"teacher_disagreement_score":0.95687276,"about_ca_system_score_codex":0.00022172242,"about_ca_system_score_gemma":0.0010041173,"threshold_uncertainty_score":0.99990046},"labels":[],"label_agreement":null},{"id":"W4407200103","doi":"10.1182/bloodadvances.2024015514","title":"Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Haemonetics Corporation; National Institute of Academic Anaesthesia","keywords":"Plasmin; Fibrinogen; Fibrin; Western blot; Coagulopathy; Antithrombin; Thrombin; Von Willebrand factor; Internal medicine; Medicine; Chemistry; Endocrinology; Andrology; Immunology; Platelet; Biochemistry; Enzyme; Heparin","score_opus":0.013866028034546906,"score_gpt":0.27644123747276317,"score_spread":0.2625752094382163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407200103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184835,0.0072655114,0.000035992332,0.00020641829,0.000034677476,0.00031117542,0.000075075244,0.000016076854,0.00020673331],"genre_scores_gemma":[0.99724746,0.00091589324,0.00039303734,0.00010948694,0.000021418506,0.000017831422,0.000015312758,0.000005114597,0.0012744331],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994388,0.000017136133,0.00015267407,0.00016560756,0.00012678724,0.000098966346],"domain_scores_gemma":[0.99966544,0.000038185102,0.00008930212,0.00007303348,0.00008250452,0.000051564468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028516039,0.00008793457,0.00024312452,0.000082432285,0.00004649926,0.000009541679,0.000024282062,0.00004346859,0.000008960213],"category_scores_gemma":[0.0000330658,0.000060905568,0.000016032154,0.00020727087,0.00004377404,0.00008897047,0.000019928082,0.000051092084,2.8259169e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003078293,0.00016879395,0.8902293,0.0014654931,0.00046096285,0.000061136125,0.00070011494,0.0000016390533,0.059189804,0.00006785042,0.000020163683,0.047326915],"study_design_scores_gemma":[0.0034443832,0.0010780838,0.4146565,0.0007824611,0.00057906256,0.00005035005,0.00018615612,0.00030410208,0.57798666,0.00011002536,0.0006437097,0.00017854296],"about_ca_topic_score_codex":0.000029679482,"about_ca_topic_score_gemma":0.000043627544,"teacher_disagreement_score":0.51879686,"about_ca_system_score_codex":0.000008427808,"about_ca_system_score_gemma":0.0000336075,"threshold_uncertainty_score":0.24836569},"labels":[],"label_agreement":null},{"id":"W4407200272","doi":"10.1182/bloodadvances.2024015410","title":"Diagnosis, management, and outcomes of drug-induced erythrocytosis: a systematic review","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Erythropoietin; Systematic review; Epoetin alfa; Internal medicine; Regimen; Intensive care medicine; MEDLINE","score_opus":0.010682137919126212,"score_gpt":0.3067421758669891,"score_spread":0.2960600379478629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407200272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019879393,0.9968325,0.0000019534496,0.000014871798,0.000083558196,0.002327755,0.00007973969,0.0000109893435,0.0006287593],"genre_scores_gemma":[0.00004318945,0.99673754,0.00019675045,0.00012044006,0.000014728689,0.0019160644,0.00013425284,0.000025600033,0.00081145094],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983692,0.00013093324,0.000675082,0.00049820554,0.00013419207,0.00019239417],"domain_scores_gemma":[0.9987656,0.000063993306,0.0005135699,0.0005715304,0.000036316884,0.000049010625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000109084016,0.000429842,0.0022756543,0.00008233401,0.000048278085,0.000013901876,0.00027484688,0.00012384536,0.000003001213],"category_scores_gemma":[0.000089108755,0.00030077275,0.00043191932,0.00017321826,0.000037994305,0.0000053494555,0.00020429865,0.00006411251,0.0000031415154],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.262663e-7,0.00020667646,0.00016411926,0.9017222,0.0019193812,0.000005407541,0.0000019584795,9.3200265e-9,1.7293713e-7,0.000037590416,0.00019675179,0.0957449],"study_design_scores_gemma":[0.00058567344,0.00008603554,0.00000883137,0.73221284,0.023244308,0.000014067812,0.00002433006,7.926182e-9,0.00010115363,0.000037389796,0.2432938,0.0003915612],"about_ca_topic_score_codex":0.000004383394,"about_ca_topic_score_gemma":0.000016049804,"teacher_disagreement_score":0.24309705,"about_ca_system_score_codex":0.0000046191585,"about_ca_system_score_gemma":0.000047850135,"threshold_uncertainty_score":0.99994445},"labels":[],"label_agreement":null},{"id":"W4407306965","doi":"10.1182/bloodadvances.2024015176","title":"Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Nivolumab; Medicine; Clinical endpoint; Internal medicine; Adverse effect; Randomized controlled trial; Phases of clinical research; Progressive disease; Oncology; Surgery; Chemotherapy; Gastroenterology; Cancer; Immunotherapy","score_opus":0.012071033307761802,"score_gpt":0.33146551756274606,"score_spread":0.31939448425498423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407306965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993932,0.0020127085,0.0007617082,0.00025615178,0.00009829592,0.0015337422,0.000014945614,0.000009573511,0.0013808582],"genre_scores_gemma":[0.9974734,0.000109157365,0.0007889342,0.00012430397,0.000060719998,0.00021470884,0.00001560124,0.000015145556,0.0011980238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982023,0.00041157223,0.00040780392,0.00042240007,0.0002671419,0.00028874184],"domain_scores_gemma":[0.9991318,0.0000995077,0.000077382356,0.00048070835,0.000113750124,0.00009688217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008885944,0.00016527389,0.0003757373,0.00015010707,0.00008448054,0.00002303928,0.0003982493,0.00006146319,0.000009137403],"category_scores_gemma":[0.00066099304,0.00012253504,0.00010081682,0.00041349433,0.0000809605,0.000006433396,0.00028888468,0.00012684253,0.0000051197744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016254162,0.0009822994,0.00037229902,0.000015273039,0.00011581419,0.000014038302,0.0003170927,0.00030695923,0.97124285,0.00004553408,0.0002256532,0.010108029],"study_design_scores_gemma":[0.046170436,0.00068725116,0.00005242051,0.00006889076,0.000057735688,0.0000027225778,0.0014024281,0.0000319756,0.93052864,0.00009293754,0.020771414,0.00013315633],"about_ca_topic_score_codex":0.00008033072,"about_ca_topic_score_gemma":0.00024153189,"teacher_disagreement_score":0.040714215,"about_ca_system_score_codex":0.00008039646,"about_ca_system_score_gemma":0.0002043568,"threshold_uncertainty_score":0.49968338},"labels":[],"label_agreement":null},{"id":"W4407511924","doi":"10.1182/bloodadvances.2024015257","title":"How donor age affects RBC deformability in storage","year":2025,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Blood preservation; Chemistry; Medicine; Andrology","score_opus":0.006653103978082862,"score_gpt":0.2345876695874288,"score_spread":0.22793456560934594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407511924","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04694273,0.039239496,0.0000482096,0.88751173,0.0018624102,0.0021037322,0.00009505272,0.00028069728,0.021915946],"genre_scores_gemma":[0.06682862,0.013001328,0.0016460973,0.84209913,0.0038621374,0.00039469084,0.0015643411,0.00017893342,0.07042474],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980742,0.00009883471,0.00028781395,0.000600861,0.00035156775,0.000586745],"domain_scores_gemma":[0.99895597,0.00020188566,0.00014620049,0.00056992983,0.000045788383,0.000080241036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000158881,0.00042511494,0.00083806185,0.00028149865,0.00006957082,0.000052804447,0.00020775873,0.00097234565,0.00003367897],"category_scores_gemma":[0.00032379996,0.0003252122,0.00024708288,0.0004113217,0.00016368419,0.00018523041,0.00007940532,0.0022936324,0.000011476328],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021141444,0.0008788454,0.012869674,0.012058498,0.00051772065,0.017725173,0.00045490699,0.00005335585,0.00021985194,0.000050301187,0.91010934,0.04485089],"study_design_scores_gemma":[0.0022292866,0.00023065157,0.00089203747,0.0014281693,0.00031941332,0.000057613463,0.00015192859,0.000008723002,0.000259777,0.00023490473,0.9938309,0.0003565707],"about_ca_topic_score_codex":0.000046838857,"about_ca_topic_score_gemma":0.00010890487,"teacher_disagreement_score":0.083721556,"about_ca_system_score_codex":0.000102226826,"about_ca_system_score_gemma":0.00021008067,"threshold_uncertainty_score":0.99992},"labels":[],"label_agreement":null},{"id":"W4407744248","doi":"10.1182/bloodadvances.2024014407","title":"ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Primary (astronomy); MAPK/ERK pathway; Cancer research; Leukemia; Chemistry; Medicine; Internal medicine; Signal transduction; Biochemistry","score_opus":0.005626262265479921,"score_gpt":0.2563103083110505,"score_spread":0.2506840460455706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407744248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865691,0.0067206337,0.0003584277,0.00014910377,0.00005360653,0.00068380916,0.00000721944,0.000083156745,0.0053749518],"genre_scores_gemma":[0.9952255,0.0018540852,0.0008655866,0.00057458226,0.000108738845,0.000099082215,0.000046746427,0.000026370737,0.0011992945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826336,0.00005202902,0.0003337898,0.00052504044,0.00040033,0.00042547993],"domain_scores_gemma":[0.9989542,0.00038560198,0.00009919562,0.00033981496,0.000090387475,0.00013083174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016400262,0.00023842326,0.0003981191,0.000277385,0.00009479947,0.000039966228,0.00008031297,0.00011389497,0.000046450623],"category_scores_gemma":[0.00014704993,0.00019637789,0.00004129737,0.00065724214,0.00025441963,0.00030455564,0.0000826707,0.00018819948,0.000012907211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01421606,0.0019022502,0.032367386,0.030619243,0.001563238,0.0036583133,0.0020372998,0.010671569,0.71902615,0.004700986,0.004991938,0.17424558],"study_design_scores_gemma":[0.06278472,0.0010908784,0.011283947,0.0062752296,0.00043268088,0.00026454328,0.00026909605,0.008935038,0.9011051,0.0007841552,0.006231263,0.0005433548],"about_ca_topic_score_codex":0.0006449982,"about_ca_topic_score_gemma":0.00014044711,"teacher_disagreement_score":0.18207896,"about_ca_system_score_codex":0.027790848,"about_ca_system_score_gemma":0.021201413,"threshold_uncertainty_score":0.98434746},"labels":[],"label_agreement":null},{"id":"W4407744262","doi":"10.1182/bloodadvances.2024015712","title":"Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Intensive care medicine","score_opus":0.024151143343204076,"score_gpt":0.33969388413691126,"score_spread":0.3155427407937072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407744262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963763,0.001197913,0.00016298713,0.0003669773,0.00005344721,0.0010749265,0.000043534295,0.00007349422,0.0006504328],"genre_scores_gemma":[0.99699485,0.0002546704,0.0013100901,0.0008838795,0.000029007118,0.0002494714,0.00017354082,0.000031331387,0.00007318085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847,0.00010976,0.00030380566,0.000521718,0.00026385486,0.00033086736],"domain_scores_gemma":[0.9986245,0.00018125081,0.00018036424,0.00027858187,0.0006353598,0.00009993342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006673937,0.0003687874,0.0005969723,0.00022465018,0.00014701382,0.00010776118,0.00007090633,0.000067587025,0.00006400208],"category_scores_gemma":[0.00007341208,0.00021368507,0.000051582316,0.00055618584,0.00011087007,0.0003539394,0.000012640923,0.0001945105,0.0000030539463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00311492,0.003846395,0.9645855,0.000048224647,0.00031465763,0.00012894369,0.000101769496,0.000090860805,0.00019346444,0.00001488053,0.000045527,0.027514854],"study_design_scores_gemma":[0.049133968,0.004732439,0.87604886,0.0011713459,0.0003750775,0.0000027968465,0.0004357775,0.00014296662,0.06702173,0.000018822171,0.00064132735,0.00027490288],"about_ca_topic_score_codex":0.00008626409,"about_ca_topic_score_gemma":0.00019710159,"teacher_disagreement_score":0.08853666,"about_ca_system_score_codex":0.0000714263,"about_ca_system_score_gemma":0.00020630879,"threshold_uncertainty_score":0.8713824},"labels":[],"label_agreement":null},{"id":"W4407829487","doi":"10.1182/bloodadvances.2024015292","title":"BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Rituximab; Medicine; Lymphoma; CHOP; Internal medicine; Oncology; Cancer research","score_opus":0.004071240537659484,"score_gpt":0.21840127292166742,"score_spread":0.21433003238400794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407829487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914145,0.0018014541,0.000039003575,0.0002960023,0.0000816568,0.000626583,0.00003665117,0.00006049582,0.0056436867],"genre_scores_gemma":[0.995376,0.0013478602,0.0011732125,0.00022775623,0.00002563269,0.00014667501,0.00006351442,0.00001895677,0.0016204295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988326,0.000019050347,0.00021982801,0.00039626786,0.00021643967,0.0003158018],"domain_scores_gemma":[0.9994899,0.00004674536,0.000076695156,0.0002304072,0.00008362751,0.00007264139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033094973,0.00023631817,0.0003694331,0.00016198777,0.00006729285,0.00002006285,0.000068055015,0.0000620341,0.000026917318],"category_scores_gemma":[0.0000070655597,0.0001316964,0.000034679146,0.00049026654,0.0000625518,0.00019920908,0.000010540032,0.000056488007,0.000016686581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034706704,0.007038248,0.96909183,0.00023757461,0.00013335834,0.0004186471,0.00012616103,0.000030307023,0.000057358775,0.00008563635,0.00014135322,0.019168854],"study_design_scores_gemma":[0.09480845,0.0019739533,0.8645209,0.002075627,0.000650989,0.000095698684,0.000268841,0.000016104996,0.023464998,0.000065726235,0.0117303245,0.00032840413],"about_ca_topic_score_codex":0.00026732098,"about_ca_topic_score_gemma":0.0007025422,"teacher_disagreement_score":0.10457095,"about_ca_system_score_codex":0.000111809866,"about_ca_system_score_gemma":0.00016635914,"threshold_uncertainty_score":0.5370423},"labels":[],"label_agreement":null},{"id":"W4407988405","doi":"10.1182/bloodadvances.2024013800","title":"Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Clinical significance; Myeloid; Multiplex; Breakpoint; Fusion gene; Chromosome; Computational biology; Genetics; Gene; Pathology; Cancer research; Medicine","score_opus":0.015782602461741135,"score_gpt":0.3396708981396799,"score_spread":0.32388829567793875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407988405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8958699,0.10087827,0.000081295955,0.0016841595,0.000053112457,0.0004173229,0.000004521121,0.00008651695,0.0009248767],"genre_scores_gemma":[0.98552126,0.008120303,0.0050332197,0.00063182705,0.000018845258,0.0001104587,0.0000030099227,0.000019811223,0.0005412954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879515,0.00007909216,0.00026086345,0.00037649373,0.00016875446,0.00031966018],"domain_scores_gemma":[0.9993478,0.00021427547,0.00004482099,0.0002068501,0.00012769815,0.000058559144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013649522,0.00019973058,0.0005024383,0.00022926748,0.000058726062,0.000014219075,0.0001127721,0.00007327711,0.000004534994],"category_scores_gemma":[0.00054704427,0.00014339376,0.000048133075,0.00047295858,0.00038861998,0.000088766035,0.00016107557,0.00023099848,0.0000074695517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058735226,0.0007554949,0.3730962,0.0027440502,0.0012345418,0.0047548874,0.003496217,0.00004906925,0.5845006,0.016864572,0.0010588245,0.010858183],"study_design_scores_gemma":[0.0052842856,0.0007292369,0.01836852,0.0020140419,0.00029981532,0.00039203285,0.011169052,0.00008244886,0.9468303,0.0097523825,0.004714906,0.000363028],"about_ca_topic_score_codex":0.00001348438,"about_ca_topic_score_gemma":0.00006723537,"teacher_disagreement_score":0.36232963,"about_ca_system_score_codex":0.0000899838,"about_ca_system_score_gemma":0.00017695164,"threshold_uncertainty_score":0.5847428},"labels":[],"label_agreement":null},{"id":"W4408099258","doi":"10.1182/bloodadvances.2024015086","title":"Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Nivolumab; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.007325588110520284,"score_gpt":0.2586844360969415,"score_spread":0.25135884798642116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408099258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788196,0.013340343,0.00017129075,0.000719821,0.00028688647,0.0024913398,0.000037619702,0.00011332924,0.0040197885],"genre_scores_gemma":[0.980077,0.00051128725,0.006641813,0.00035974476,0.000035860765,0.00045210193,0.000057442667,0.00003505915,0.0118296435],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987154,0.000033809913,0.0003356632,0.0003721816,0.00021824197,0.00032470957],"domain_scores_gemma":[0.99923646,0.00018845766,0.000147383,0.0002758643,0.00011004219,0.000041785155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000124783,0.00020460463,0.00038529615,0.00016703129,0.00010850235,0.000020728468,0.00010667452,0.00009883993,0.000028625042],"category_scores_gemma":[0.00009854103,0.00014065491,0.000085306754,0.0005500953,0.00013012522,0.00022791288,0.000023909768,0.00015788886,0.0000021675207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11683046,0.007118469,0.79118806,0.002888304,0.0007085412,0.00012766046,0.0017212917,0.00004458536,0.004114202,0.00057418173,0.0020948106,0.07258943],"study_design_scores_gemma":[0.25918475,0.017275112,0.28168786,0.0063153803,0.0011483519,0.000025169671,0.0019214675,0.00018247537,0.029679975,0.0009136504,0.40033364,0.0013321681],"about_ca_topic_score_codex":0.00002147378,"about_ca_topic_score_gemma":0.00017109982,"teacher_disagreement_score":0.5095002,"about_ca_system_score_codex":0.00011266348,"about_ca_system_score_gemma":0.0003173559,"threshold_uncertainty_score":0.57357407},"labels":[],"label_agreement":null},{"id":"W4408246537","doi":"10.1182/bloodadvances.2024014858","title":"Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; Janssen Research and Development; MorphoSys; Seagen; Swedish Orphan Biovitrum; Vertex Pharmaceuticals; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen","keywords":"Medicine; Internal medicine; Hazard ratio; Calcineurin; Graft-versus-host disease; Cyclophosphamide; Gastroenterology; Transplantation; Proportional hazards model; Immunology; Confidence interval; Chemotherapy","score_opus":0.01693444424196785,"score_gpt":0.30497528916896033,"score_spread":0.2880408449269925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408246537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93367,0.0008198764,0.06284451,0.00020491071,0.00014005555,0.00052768114,0.000036965295,0.00010946719,0.0016465526],"genre_scores_gemma":[0.9832941,0.00038410898,0.01568662,0.00017460545,0.00003783698,0.000036767615,0.00008267695,0.000022572201,0.00028071195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982606,0.00005895655,0.00048998283,0.00047376537,0.0003805368,0.00033613108],"domain_scores_gemma":[0.9990875,0.00020731882,0.0001656203,0.00030680557,0.00012444262,0.00010830461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015585311,0.00029361874,0.0008354505,0.0006134505,0.00013256152,0.000045359888,0.00013593584,0.00006844552,0.000057667414],"category_scores_gemma":[0.0000127464955,0.0002198264,0.0001970953,0.0013131996,0.000095797135,0.00022282879,0.000010514733,0.00016161402,0.0000041373087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026508712,0.00025110555,0.9836206,0.0005290841,0.003403962,0.00015789148,0.0026426155,0.0039910176,0.0048430366,0.00012518828,0.0000013200821,0.00016911911],"study_design_scores_gemma":[0.017984342,0.0002685236,0.7783395,0.0041136723,0.03593162,0.00029460064,0.006186467,0.011148943,0.14431193,0.00026580543,0.00010152076,0.0010530639],"about_ca_topic_score_codex":0.00040083058,"about_ca_topic_score_gemma":0.00081303366,"teacher_disagreement_score":0.20528106,"about_ca_system_score_codex":0.000048097692,"about_ca_system_score_gemma":0.00009807242,"threshold_uncertainty_score":0.896426},"labels":[],"label_agreement":null},{"id":"W4408474555","doi":"10.1182/bloodadvances.2024014695","title":"Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Centre hospitalier universitaire de Québec","funders":"National Cancer Institute","keywords":"Medicine; Peripheral neuropathy; Peripheral; Internal medicine; MEDLINE; Physical medicine and rehabilitation; Endocrinology; Biology","score_opus":0.018764890440464043,"score_gpt":0.3296748747763478,"score_spread":0.3109099843358838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408474555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630064,0.0025589142,0.000011977878,0.0002407751,0.00010849812,0.0003471438,0.000003973133,0.000012984591,0.00041511192],"genre_scores_gemma":[0.9982649,0.00012991071,0.00011068376,0.0014415081,0.00000647052,0.000007285227,0.000001784263,0.000005710753,0.000031754305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988771,0.00012683778,0.0004354517,0.00023723446,0.00018559663,0.00013779852],"domain_scores_gemma":[0.99942476,0.00010392465,0.00013684531,0.00026483013,0.000044459488,0.000025182713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001434052,0.00011890673,0.00044485877,0.00020957031,0.000059754086,0.000014525909,0.000074412135,0.00002450981,0.000007838252],"category_scores_gemma":[0.0002092787,0.00007607937,0.000111419155,0.0009892028,0.000072853065,0.000081730745,0.00004083375,0.00011938033,5.1393926e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009544267,0.0008994796,0.9916236,0.000020349167,0.00033756916,0.00009282104,0.0011584321,0.00014735427,0.00040190737,0.0000115974935,0.0000028332183,0.0052086497],"study_design_scores_gemma":[0.0016222404,0.00047500592,0.9862515,0.000020998195,0.0018500969,0.000004572241,0.0087188305,0.00051622593,0.000026705298,0.000025418269,0.00042047005,0.000067941095],"about_ca_topic_score_codex":0.0002859035,"about_ca_topic_score_gemma":0.0007547962,"teacher_disagreement_score":0.0075603984,"about_ca_system_score_codex":0.000005165412,"about_ca_system_score_gemma":0.000032055937,"threshold_uncertainty_score":0.31024268},"labels":[],"label_agreement":null},{"id":"W4408475496","doi":"10.1182/bloodadvances.2024014707","title":"Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Prednisone; Internal medicine; Rituximab; Vincristine; Hazard ratio; CHOP; Gastroenterology; Cyclophosphamide; Diffuse large B-cell lymphoma; Neutropenia; Lymphoma; Febrile neutropenia; Adverse effect; Confidence interval; Subgroup analysis; Surgery; Chemotherapy","score_opus":0.004697327659869831,"score_gpt":0.2778089905230055,"score_spread":0.27311166286313565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408475496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967454,0.00178223,0.0000068043523,0.000055022727,0.000030713534,0.0006659356,0.000047097736,0.00001181842,0.0006549544],"genre_scores_gemma":[0.99933004,0.00010293872,0.000076618024,0.00022767895,0.000008810475,0.00009003066,0.000054823013,0.0000069653534,0.00010208589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989632,0.00006380501,0.0002457975,0.0002492688,0.000293048,0.0001849062],"domain_scores_gemma":[0.9993479,0.000109595276,0.000097573204,0.00035704058,0.000051828236,0.000036016914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110599496,0.00013606918,0.00039421118,0.00027192247,0.000040307805,0.000013794015,0.00011264138,0.000027737531,0.000014211586],"category_scores_gemma":[0.000018732142,0.00007808318,0.00009961723,0.0011184884,0.00003239941,0.0000747115,0.00002846726,0.000034749788,0.0000020605487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017248538,0.112227395,0.8802234,0.000027371441,0.0009598482,0.00016828006,0.0013484763,0.0000026690243,0.000013083358,0.000037458853,0.00002097924,0.0047985357],"study_design_scores_gemma":[0.06350763,0.0011203727,0.9283563,0.000052257015,0.0041245604,6.1856844e-7,0.0015531856,0.000016163764,0.0004624587,0.000005459197,0.0007305885,0.00007043451],"about_ca_topic_score_codex":0.00021577325,"about_ca_topic_score_gemma":0.00063164975,"teacher_disagreement_score":0.11110702,"about_ca_system_score_codex":0.000033846198,"about_ca_system_score_gemma":0.000045207005,"threshold_uncertainty_score":0.31841397},"labels":[],"label_agreement":null},{"id":"W4408780651","doi":"10.1182/bloodadvances.2024015212","title":"Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"ADAMTS13; Chemistry; Von Willebrand factor; Proteases; Protease; ADAMTS; Thrombin; Proteolysis; Elastase; Cleavage (geology); Neutrophil elastase; Molecular biology; Biochemistry; Metalloproteinase; Platelet; Immunology; Enzyme; Thrombospondin; Medicine; Biology","score_opus":0.014279970191410862,"score_gpt":0.2645942265060851,"score_spread":0.25031425631467424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408780651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925472,0.0028878015,0.00078862545,0.00010470803,0.0002734649,0.0024004227,0.000083860825,0.00006852051,0.0008453795],"genre_scores_gemma":[0.9934914,0.000004839131,0.0050027496,0.000047495156,0.0000074708246,0.0008318429,0.00005356223,0.0000068705262,0.00055376947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987087,0.000104791754,0.00054153946,0.00034335238,0.000058930716,0.00024263833],"domain_scores_gemma":[0.99925697,0.00007891519,0.00016873013,0.00033397475,0.00013756758,0.000023837352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024141875,0.00015450576,0.0002639878,0.000107556196,0.00014150633,0.000009328616,0.00022334847,0.00004899019,0.00009737976],"category_scores_gemma":[0.0002691169,0.00013533622,0.00005425827,0.00021527913,0.00006649867,0.000099761,0.00012325356,0.00006575515,0.000032631255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027425284,0.0004614862,0.0072007887,0.0005171451,0.000154707,7.6141276e-7,0.0002509871,0.000004523179,0.9646254,0.0004581542,0.00009567059,0.025956083],"study_design_scores_gemma":[0.0010500866,0.00011268305,0.013497416,0.00029672947,0.00005498927,4.3092433e-7,0.0006325218,0.0000012109215,0.9492838,0.0001422497,0.034770038,0.00015785877],"about_ca_topic_score_codex":0.000016308168,"about_ca_topic_score_gemma":0.00016123005,"teacher_disagreement_score":0.03467437,"about_ca_system_score_codex":0.000057739526,"about_ca_system_score_gemma":0.0003101085,"threshold_uncertainty_score":0.55188507},"labels":[],"label_agreement":null},{"id":"W4409199387","doi":"10.1182/bloodadvances.2024014965","title":"Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Associazione Italiana per la Ricerca sul Cancro; National Cancer Institute; National Institutes of Health; Cancer Research UK; Edward P. Evans Foundation; Università degli Studi di Pavia; Leukemia and Lymphoma Society; University of Washington; Damon Runyon Cancer Research Foundation","keywords":"Myelodysplastic syndromes; RUNX1; Progenitor cell; Biology; Mutant; Haematopoiesis; Mutation; Cancer research; Myeloid; Stem cell; Genetics; Gene; Immunology; Bone marrow","score_opus":0.011488204010377595,"score_gpt":0.32914452504345054,"score_spread":0.31765632103307295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409199387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734814,0.006700287,0.00012267346,0.00081157853,0.00013021317,0.0004820462,0.000018024739,0.000050501185,0.004336555],"genre_scores_gemma":[0.9959869,0.00039394887,0.002597848,0.00004511341,0.000050107217,0.000059016693,0.000020361405,0.000013844876,0.0008329035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985325,0.000053237254,0.00038755932,0.00031235677,0.00038091387,0.00033344072],"domain_scores_gemma":[0.99911517,0.00036693117,0.000090893176,0.0002476717,0.000098044446,0.00008126635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021803839,0.0001593045,0.000426619,0.00029319339,0.000045176024,0.000010386592,0.000171944,0.00007677936,0.00005902947],"category_scores_gemma":[0.0006433017,0.00011853004,0.00006689436,0.00064616546,0.00020170797,0.00012861678,0.00012128071,0.0002737275,0.000010892485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009974753,0.0011774055,0.8802783,0.0018438054,0.00019767748,0.0007603265,0.0001729963,0.0000294554,0.04412451,0.0024734417,0.00022198338,0.06772265],"study_design_scores_gemma":[0.009854187,0.0013848888,0.8254644,0.005620478,0.00034082873,0.00030929674,0.00048024382,0.001080137,0.13973513,0.0025839268,0.012750402,0.00039606006],"about_ca_topic_score_codex":0.00002062685,"about_ca_topic_score_gemma":0.000038365164,"teacher_disagreement_score":0.09561062,"about_ca_system_score_codex":0.000084248044,"about_ca_system_score_gemma":0.00038658042,"threshold_uncertainty_score":0.48335147},"labels":[],"label_agreement":null},{"id":"W4409257500","doi":"10.1182/bloodadvances.2024014100","title":"Red blood cells with reduced deformability are selectively cleared from circulation in a mouse model","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Vancouver General Hospital; British Columbia Institute of Technology; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Health Canada; Canadian Blood Services; Australian Government","keywords":"Clearance; Endogeny; Spleen; Red blood cell; Chemistry; Erythrocyte deformability; Immunology; Biology; Biochemistry; Medicine","score_opus":0.011509883656677338,"score_gpt":0.2482711314674434,"score_spread":0.23676124781076605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409257500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970753,0.00032140978,0.00062846794,0.00026236058,0.00008059326,0.00041259322,0.000027270487,0.00010046387,0.0010915496],"genre_scores_gemma":[0.9941829,0.0000938431,0.0045821127,0.00039046636,0.00004684745,0.000047448382,0.000041122195,0.000013266692,0.0006020173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894845,0.000063008796,0.0002542327,0.00040310758,0.00012930472,0.00020187855],"domain_scores_gemma":[0.9993854,0.000058349062,0.00011107961,0.00026328478,0.00012394799,0.000057946003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007232699,0.00015501108,0.00034287898,0.00012192972,0.000063393374,0.000008129248,0.000058417332,0.0001074456,0.000021170454],"category_scores_gemma":[0.00007023671,0.00012705875,0.000052545995,0.00034956814,0.000060836945,0.00016568034,0.000019883473,0.00021448075,0.0000047399603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021325029,0.0010608591,0.09530601,0.00015859965,0.00014994919,0.00001684173,0.00040207477,0.023064887,0.8766346,0.00005060901,0.0000394937,0.0009835801],"study_design_scores_gemma":[0.0139098205,0.000769736,0.32604778,0.00043791186,0.0005084981,0.000015216703,0.00079864287,0.021877501,0.63170797,0.0032482198,0.00024641393,0.00043231354],"about_ca_topic_score_codex":0.000062234016,"about_ca_topic_score_gemma":0.0002463525,"teacher_disagreement_score":0.24492665,"about_ca_system_score_codex":0.000047055455,"about_ca_system_score_gemma":0.00015169279,"threshold_uncertainty_score":0.51813054},"labels":[],"label_agreement":null},{"id":"W4409263096","doi":"10.1182/bloodadvances.2024015371","title":"Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre; University of Toronto; University Health Network; Impact; McMaster University","funders":"","keywords":"Medicine; Antithrombotic; Pulmonary embolism; Relative risk; Randomized controlled trial; Confidence interval; Internal medicine; Deep vein; Number needed to harm; Meta-analysis; Thrombosis; Surgery; Number needed to treat","score_opus":0.0450294606748574,"score_gpt":0.35303418448132823,"score_spread":0.3080047238064708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409263096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000016184431,0.98549926,0.000020804775,0.00026418778,0.00008158602,0.012597256,0.0002899873,0.00004068531,0.0012046027],"genre_scores_gemma":[0.0000050999593,0.9922641,0.0007469725,0.0005720283,0.000034265417,0.0049049538,0.00033717594,0.000035114066,0.0011003066],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960352,0.00036420356,0.0020387461,0.00081916805,0.00043692827,0.00030576534],"domain_scores_gemma":[0.9970952,0.00027102843,0.0012533952,0.0010497075,0.00014876272,0.00018188458],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00049463037,0.00073465816,0.020731108,0.0006047706,0.000077520024,0.000029790574,0.00022415971,0.00012624885,0.00017226457],"category_scores_gemma":[0.00015624624,0.00045202256,0.0029165144,0.0011162445,0.000043778524,0.000099779965,0.0001474411,0.0001506153,0.00001365804],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018926727,0.0018612867,1.3025829e-7,0.75575787,0.19954163,0.000011899679,0.000062548854,8.259102e-7,9.238273e-8,0.00011284637,0.00015349417,0.042495478],"study_design_scores_gemma":[0.00014648719,0.00076801033,0.0000069895304,0.10337189,0.7755509,0.000016689217,0.000012479512,8.20326e-8,0.0000036578886,0.0000150170035,0.119856946,0.00025087452],"about_ca_topic_score_codex":0.000025793099,"about_ca_topic_score_gemma":0.00005091537,"teacher_disagreement_score":0.652386,"about_ca_system_score_codex":0.00017589242,"about_ca_system_score_gemma":0.00037724458,"threshold_uncertainty_score":0.9997932},"labels":[],"label_agreement":null},{"id":"W4409264039","doi":"10.1182/bloodadvances.2025015862","title":"Agents of shield: glycans mask antibody epitopes on ADAMTS13","year":2025,"lang":"en","type":"letter","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Epitope; Glycan; Antibody; Molecular biology; Chemistry; Computational biology; Virology; Biology; Immunology; Glycoprotein","score_opus":0.015577588265546968,"score_gpt":0.2984281988180642,"score_spread":0.28285061055251726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409264039","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.116494,0.2210523,0.00020724356,0.5017732,0.035337035,0.0071362546,0.018468581,0.0011722123,0.09835915],"genre_scores_gemma":[0.29688582,0.004792172,0.00037750156,0.5384169,0.003829388,0.0005574022,0.016524974,0.0002257088,0.13839011],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790114,0.00028777108,0.0006105332,0.00060516555,0.00011542304,0.00047996684],"domain_scores_gemma":[0.99824655,0.0005062279,0.000443333,0.000724239,0.000064950065,0.000014724403],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000088909714,0.00042864558,0.0007920228,0.00028577674,0.00011619714,0.000014173999,0.00074960553,0.0005203211,0.0016850574],"category_scores_gemma":[0.00010163737,0.0003799698,0.0002729408,0.00016005289,0.00019019167,0.00007880172,0.00017405658,0.0006956831,0.00023098923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007940283,0.0002775848,0.0040367325,0.0010740517,0.00094696635,0.00010853582,0.000070116024,0.0000070574215,0.0034764162,0.0001927416,0.9874556,0.002274771],"study_design_scores_gemma":[0.0009789828,0.0002614658,0.00085017097,0.0011120648,0.000395954,0.0000141181845,0.00007855366,1.0950628e-7,0.01149144,0.00020430077,0.98427796,0.00033486725],"about_ca_topic_score_codex":0.000075677715,"about_ca_topic_score_gemma":0.00002330493,"teacher_disagreement_score":0.21626014,"about_ca_system_score_codex":0.000021739443,"about_ca_system_score_gemma":0.00011163245,"threshold_uncertainty_score":0.99986523},"labels":[],"label_agreement":null},{"id":"W4409285352","doi":"10.1182/bloodadvances.2025016180","title":"The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Institut de Recerca contra la Leucèmia Josep Carreras; Instituto de Salud Carlos III","keywords":"Survivin; Cancer research; Cell cycle; microRNA; Carcinogenesis; Downregulation and upregulation; Biology; BCL6; Gene knockdown; Cell cycle checkpoint; Lymphoma; Transcriptome; Apoptosis; Cancer; Immunology; Germinal center; Gene; Gene expression; B cell; Genetics","score_opus":0.00464690909312963,"score_gpt":0.23581188364141026,"score_spread":0.23116497454828064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409285352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8968091,0.10084647,0.000011542849,0.0004883919,0.000091356174,0.00025601144,0.000019281051,0.000008982475,0.0014688512],"genre_scores_gemma":[0.9940087,0.005656052,0.000017293698,0.00014949139,0.000017018,0.000029332517,0.0000025804236,0.000007565262,0.00011196872],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990934,0.000091904505,0.00025780287,0.00016002408,0.00021172724,0.00018511288],"domain_scores_gemma":[0.999377,0.00024618555,0.00012474922,0.00016792222,0.00006293128,0.000021221575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022433672,0.000112094545,0.0002486427,0.00006263578,0.000087856846,0.000009936243,0.00013974016,0.000055000037,0.0000066915954],"category_scores_gemma":[0.00010415769,0.00006514869,0.00006885692,0.0003306774,0.000107035106,0.000052352916,0.000027786893,0.000056226134,6.769293e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002277815,0.0016606824,0.21765465,0.00070582755,0.0010629335,0.000026188214,0.0032291862,0.0004631511,0.20160224,0.0070076925,0.000096013326,0.56421363],"study_design_scores_gemma":[0.017321168,0.001542814,0.8177931,0.0007948221,0.0017969549,0.00003220661,0.024804516,0.002276919,0.09705919,0.01573183,0.020388091,0.00045841193],"about_ca_topic_score_codex":0.00008014107,"about_ca_topic_score_gemma":0.00040253598,"teacher_disagreement_score":0.6001384,"about_ca_system_score_codex":0.000012656465,"about_ca_system_score_gemma":0.000104215804,"threshold_uncertainty_score":0.26566866},"labels":[],"label_agreement":null},{"id":"W4409285391","doi":"10.1182/bloodadvances.2024014523","title":"Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Air Liquide (Canada)","funders":"Cilag; Grifols; BeiGene; MEI Pharma; TG Therapeutics; Gilead Sciences; AstraZeneca; Eli Lilly and Company","keywords":"Ibrutinib; Hazard ratio; Internal medicine; Medicine; Oncology; Chronic lymphocytic leukemia; Bendamustine; Idelalisib; Confidence interval; Leukemia","score_opus":0.036254512643150244,"score_gpt":0.3441972454570205,"score_spread":0.3079427328138703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409285391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9040935,0.09238893,0.00016508838,0.00027275813,0.00016423436,0.0007950864,0.000033904646,0.000058133504,0.0020283442],"genre_scores_gemma":[0.99535346,0.0012900379,0.0017232074,0.0001091445,0.00012801471,0.00007261567,0.000047693327,0.000017365626,0.001258467],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99720305,0.00031683675,0.0008345501,0.0005796701,0.00058672606,0.000479183],"domain_scores_gemma":[0.99731046,0.0012927956,0.00034540708,0.00072133937,0.00019686746,0.00013310421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006634392,0.00029052162,0.0020644916,0.00058665464,0.00007662665,0.000015494867,0.0002295127,0.00013364025,0.00015972796],"category_scores_gemma":[0.00043560588,0.00022168591,0.00072485884,0.0032374978,0.00029319496,0.00016322201,0.00013495133,0.0004433019,0.000013893462],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010789887,0.015469636,0.2140963,0.0023332357,0.5050173,0.0013998238,0.0037619655,0.2100043,0.00609636,0.007318145,0.008188807,0.015524295],"study_design_scores_gemma":[0.123498514,0.0027897255,0.12320528,0.00074313476,0.58313173,0.00002890114,0.00097383396,0.008170745,0.11970835,0.0024455718,0.033982884,0.0013213238],"about_ca_topic_score_codex":0.0017588867,"about_ca_topic_score_gemma":0.0012800695,"teacher_disagreement_score":0.20183355,"about_ca_system_score_codex":0.0011157363,"about_ca_system_score_gemma":0.0017156998,"threshold_uncertainty_score":0.9040089},"labels":[],"label_agreement":null},{"id":"W4409309664","doi":"10.1182/bloodadvances.2024015494","title":"Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Western University; St. Joseph’s Healthcare Hamilton; Stollery Children's Hospital; Hospital for Sick Children; St Joseph's Health Care; University of Toronto; London Health Sciences Centre; McMaster University; Impact","funders":"Canadian Institutes of Health Research; Health Canada; Einstein Stiftung Berlin; Swedish Orphan Biovitrum; Canadian Blood Services; Agios Pharmaceuticals; Australian Government; Sanofi; Pfizer","keywords":"Medicine; Bleed; Tranexamic acid; Pediatrics; Cohort; Immune thrombocytopenia; Platelet transfusion; Young adult; Retrospective cohort study; Thrombopoietin; Internal medicine; Platelet; Surgery","score_opus":0.0042997228792724836,"score_gpt":0.27933820419077865,"score_spread":0.27503848131150616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409309664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232286,0.0047546746,0.0000053830922,0.00022902031,0.000034611614,0.0009776955,0.0000037007287,0.000024752107,0.0016472802],"genre_scores_gemma":[0.99890417,0.00037075698,0.0004895595,0.0000775864,0.000010849235,0.000068654546,0.0000075205144,0.000008029699,0.00006286328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924886,0.000015367354,0.00015905392,0.0002797914,0.00011506188,0.00018188395],"domain_scores_gemma":[0.99973553,0.00004834685,0.000020532569,0.00012072203,0.00003281072,0.00004205332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057813002,0.00012566138,0.0003812385,0.00007637768,0.000056327277,0.00001801878,0.000039455,0.000027726164,0.000010741229],"category_scores_gemma":[0.000050256967,0.00008793074,0.000017863013,0.00014347422,0.000065493055,0.00015793118,0.000036536152,0.00010458692,0.000002209921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034710148,0.001882361,0.99495685,0.00004570006,0.00028177895,0.00024794563,0.00019478035,7.0045576e-7,0.00004636773,0.000039754763,0.0000018450947,0.0019548056],"study_design_scores_gemma":[0.011396674,0.0006109769,0.98597896,0.0004715073,0.00038388942,0.00005201909,0.00060156384,0.000016693173,0.0003380472,0.00005031401,0.000017472714,0.0000818722],"about_ca_topic_score_codex":0.00014530266,"about_ca_topic_score_gemma":0.00030312515,"teacher_disagreement_score":0.011049573,"about_ca_system_score_codex":0.000012075307,"about_ca_system_score_gemma":0.000019997913,"threshold_uncertainty_score":0.35857117},"labels":[],"label_agreement":null},{"id":"W4409493832","doi":"10.1182/bloodadvances.2024015719","title":"Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"MorphoSys; Swedish Orphan Biovitrum; Incyte; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Bispecific antibody; Refractory (planetary science); Lymphoma; Antibody therapy; Medicine; Antibody; CAR T-cell therapy; Cancer research; Oncology; Internal medicine; Immunology; T cell; Chimeric antigen receptor; Biology; Monoclonal antibody; Immune system","score_opus":0.009952427921185381,"score_gpt":0.3055829094655686,"score_spread":0.2956304815443832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409493832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95298827,0.03310324,0.000016081556,0.00038693624,0.00022375904,0.00065557583,0.00003302784,0.000051383027,0.012541759],"genre_scores_gemma":[0.9711694,0.0069771796,0.00040440733,0.0003421725,0.00007195838,0.00006595413,0.000023574947,0.000042807715,0.02090251],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979242,0.00011269785,0.0004908565,0.00047842518,0.00047711487,0.00051671424],"domain_scores_gemma":[0.9987452,0.00023726828,0.00011665383,0.00067253434,0.00012788024,0.0001004642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031418825,0.00028436983,0.0006804487,0.0004833478,0.000045469445,0.000018100383,0.00025437324,0.00016731389,0.0008631068],"category_scores_gemma":[0.000040253162,0.0002272057,0.00022184482,0.00067552144,0.00013457694,0.00013551874,0.00007463719,0.0002787767,0.000031052772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010495157,0.00502466,0.65719354,0.0003301066,0.000115867864,0.0001711887,0.0004043721,0.000002391574,0.32457748,0.000059561444,0.0002198497,0.010851451],"study_design_scores_gemma":[0.03514592,0.00075069966,0.25944728,0.00026466884,0.00007835125,0.0000079190195,0.0010400073,0.000010758953,0.27324408,0.00016856089,0.4294986,0.00034313384],"about_ca_topic_score_codex":0.00004480345,"about_ca_topic_score_gemma":0.00013821399,"teacher_disagreement_score":0.42927876,"about_ca_system_score_codex":0.000067941815,"about_ca_system_score_gemma":0.00021996463,"threshold_uncertainty_score":0.9450414},"labels":[],"label_agreement":null},{"id":"W4409575037","doi":"10.1182/bloodadvances.2024015288","title":"Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Calcineurin; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Cyclophosphamide; Anti-thymocyte globulin; Hematopoietic cell; Cumulative incidence; Immunology; T cell; Gastroenterology; Young adult; Haematopoiesis; Immune system; Oncology; Stem cell; Chemotherapy; Biology","score_opus":0.005061069500360093,"score_gpt":0.22822727640300258,"score_spread":0.2231662069026425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409575037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98249614,0.0016776798,0.0014311012,0.00017067479,0.00014519418,0.0007374771,0.00008626003,0.000090222224,0.013165233],"genre_scores_gemma":[0.9954083,0.0013620679,0.0012518179,0.00052816345,0.000021333051,0.00011891632,0.00022393583,0.000033281223,0.001052208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981669,0.000101501406,0.0004954495,0.0004755156,0.0003928755,0.00036776712],"domain_scores_gemma":[0.99906063,0.0003415512,0.00013463995,0.00024560187,0.00010567042,0.00011189129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019082257,0.00028417265,0.00047667633,0.00022694818,0.000045411096,0.000022579648,0.00009199347,0.0001583113,0.00011556483],"category_scores_gemma":[0.000024905026,0.00025069443,0.00009665513,0.00044682922,0.000048712605,0.00022751698,0.000006284309,0.00020510616,0.000022372844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033484302,0.006706835,0.9154246,0.013378884,0.0005934711,0.0036675618,0.0070084957,0.0004032339,0.016988596,0.00014079569,0.00016276453,0.0020404612],"study_design_scores_gemma":[0.06257156,0.0022633397,0.48721448,0.013960323,0.0027296615,0.0001822118,0.0011323366,0.0002653693,0.4269666,0.0010108617,0.0004107773,0.0012924875],"about_ca_topic_score_codex":0.00008544506,"about_ca_topic_score_gemma":0.00059632567,"teacher_disagreement_score":0.42821014,"about_ca_system_score_codex":0.000062921936,"about_ca_system_score_gemma":0.00019077469,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W4409758277","doi":"10.1182/bloodadvances.2025016512","title":"2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Genentech; Sanofi Genzyme; Sanofi","keywords":"Guideline; Medicine; Von Willebrand disease; MEDLINE; Disease management; Intensive care medicine; Disease; Family medicine; Pediatrics; Von Willebrand factor; Internal medicine; Pathology","score_opus":0.11024726285572382,"score_gpt":0.4438823129412912,"score_spread":0.3336350500855674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409758277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001957333,0.9910173,0.000001169219,0.0018256017,0.0005044605,0.0017272608,0.00006499415,0.0000142246,0.00288768],"genre_scores_gemma":[0.00014500754,0.9952881,0.00015653839,0.00017283688,0.00027009522,0.0005877796,0.00005556343,0.000022020124,0.0033020987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776715,0.00013128165,0.00096125744,0.0005558022,0.00038438282,0.00020014595],"domain_scores_gemma":[0.9973898,0.0011905188,0.00048122468,0.0007589606,0.00007935472,0.00010017723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000479868,0.00038030875,0.0013203203,0.00007219448,0.00013739793,0.000025316052,0.000190982,0.00009422828,0.000038254573],"category_scores_gemma":[0.0006508133,0.00017421841,0.0004499543,0.00023164567,0.000108290944,0.000036565383,0.00011767324,0.00024901764,0.0000095989435],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006726875,0.00071047334,0.010840679,0.00884849,0.0015659744,0.001887459,0.0000039180363,0.0000011063826,7.897479e-9,0.00026491962,0.0029014857,0.9729082],"study_design_scores_gemma":[0.0007599172,0.00018716899,0.0010960704,0.058680344,0.0057378034,0.000019045963,0.0000416484,5.11972e-7,0.0000037454697,0.00018519002,0.93313515,0.00015341361],"about_ca_topic_score_codex":0.000006209788,"about_ca_topic_score_gemma":0.0000022343588,"teacher_disagreement_score":0.9727548,"about_ca_system_score_codex":0.000016999833,"about_ca_system_score_gemma":0.00010581506,"threshold_uncertainty_score":0.71044207},"labels":[],"label_agreement":null},{"id":"W4409758329","doi":"10.1182/bloodadvances.2024015490","title":"Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Janssen Pharmaceuticals; Chugai Pharmaceutical; Samsung; Grifols; Swedish Orphan Biovitrum; BioCryst; Apellis Pharmaceuticals; Argenx; Incyte; Novo Nordisk; Sanofi; Celgene; AstraZeneca; Alexion Pharmaceuticals; Pfizer; Amgen","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Anemia; Population; Hemolysis; Internal medicine; Hemoglobinuria; Gastroenterology; Hemolytic anemia; Immunology; Complement system; Antibody","score_opus":0.01191389438309478,"score_gpt":0.2782307819318245,"score_spread":0.26631688754872973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409758329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110997,0.005051209,0.000056658046,0.00032166924,0.00031893,0.0009811517,0.00007196627,0.00011434854,0.001974107],"genre_scores_gemma":[0.997067,0.00082871655,0.00020517092,0.00019292746,0.000028212633,0.00034177623,0.00012313065,0.000017483022,0.0011956005],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979796,0.0002514709,0.00062889373,0.00065295957,0.00006837468,0.00041871794],"domain_scores_gemma":[0.9988014,0.00039019668,0.00019782576,0.00053241197,0.0000466738,0.000031491527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013935508,0.00031640218,0.0005860081,0.0001971509,0.00013585451,0.000022363949,0.00027478416,0.00010224319,0.0003869422],"category_scores_gemma":[0.00009359155,0.00020893458,0.00014509258,0.00028659456,0.00012452589,0.00010811467,0.000050024068,0.00013142683,0.000103015824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056851007,0.018777397,0.3963154,0.0014851459,0.0068377815,0.0016315832,0.0031244627,0.00032349382,0.113620736,0.003091481,0.00047198826,0.39746952],"study_design_scores_gemma":[0.1026277,0.02087841,0.29441774,0.010948212,0.0024191102,0.00015954569,0.008388878,0.000030375586,0.32111764,0.00044471858,0.23580746,0.0027602029],"about_ca_topic_score_codex":0.0000847726,"about_ca_topic_score_gemma":0.0002447576,"teacher_disagreement_score":0.39470932,"about_ca_system_score_codex":0.0000870703,"about_ca_system_score_gemma":0.00017012484,"threshold_uncertainty_score":0.8520105},"labels":[],"label_agreement":null},{"id":"W4410029978","doi":"10.1182/bloodadvances.2025016114","title":"Finding the right fit: assessment of fitness in AML","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of British Columbia","funders":"","keywords":"Medicine; Biology","score_opus":0.018913909890270638,"score_gpt":0.3748222995840976,"score_spread":0.35590838969382693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410029978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93797344,0.0035561752,0.0003160861,0.0051090373,0.00017304198,0.0005758021,0.000009582684,0.000027678732,0.052259166],"genre_scores_gemma":[0.9942417,0.00045641276,0.0017594228,0.00022418574,0.000049369148,0.00004970671,0.0000048793936,0.000006934274,0.0032073455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990654,0.000056979134,0.00023443131,0.00017770007,0.00024953473,0.00021593369],"domain_scores_gemma":[0.9992227,0.00034292025,0.00005711729,0.00028686674,0.000059780657,0.000030641448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034194213,0.00008788997,0.00024025465,0.00015515367,0.000056640696,0.000009010626,0.0001982306,0.000043351323,0.00010467137],"category_scores_gemma":[0.00016035028,0.0000537082,0.000048537357,0.00053531,0.000118462536,0.000084519306,0.000089235684,0.0002743227,0.0000033172391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020195302,0.0010816357,0.8910046,0.0012997466,0.00034444613,0.00030258487,0.0005437912,0.00055407925,0.02029297,0.030548451,0.002656263,0.051169455],"study_design_scores_gemma":[0.007569427,0.0003454105,0.79228836,0.0013854486,0.00022726966,0.000037805286,0.0011202717,0.0021897827,0.09182395,0.003409578,0.09936409,0.00023863874],"about_ca_topic_score_codex":0.000034615496,"about_ca_topic_score_gemma":0.00007231796,"teacher_disagreement_score":0.09871629,"about_ca_system_score_codex":0.000084655105,"about_ca_system_score_gemma":0.00031660197,"threshold_uncertainty_score":0.21901569},"labels":[],"label_agreement":null},{"id":"W4410140459","doi":"10.1182/bloodadvances.2025016229","title":"Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Genentech; Swedish Orphan Biovitrum; Servier; Astellas Pharma; Incyte; bluebird bio; Agios Pharmaceuticals; Astex Pharmaceuticals; Celgene; Gilead Sciences; Syndax Pharmaceuticals; BeiGene; Daiichi Sankyo Europe; Sanofi; Pfizer; Amgen","keywords":"Azacitidine; Placebo; Medicine; Internal medicine; Oncology; Clinical endpoint; Gastroenterology; Randomized controlled trial; Biology; Pathology","score_opus":0.01056674117436585,"score_gpt":0.3171685288221179,"score_spread":0.30660178764775203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410140459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935336,0.0020178368,0.000047398273,0.0003500119,0.000060599432,0.0013795728,0.000092346585,0.000045337183,0.0024732677],"genre_scores_gemma":[0.9962615,0.00066105503,0.0014499697,0.000046047422,0.00007440606,0.00010699852,0.000031698153,0.000025464251,0.0013428712],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760395,0.00017581136,0.00072582165,0.0004996983,0.0005921891,0.00040252478],"domain_scores_gemma":[0.998213,0.000524895,0.00028311717,0.00055459514,0.000312018,0.00011238517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044580616,0.00024753565,0.00078538875,0.00046229915,0.00005044571,0.000008028952,0.0002487806,0.000086231375,0.000024669365],"category_scores_gemma":[0.000593377,0.0001875575,0.00006136217,0.0016099724,0.0001972298,0.00016959534,0.00009367938,0.00045041478,0.0000022756021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041252024,0.04042283,0.71149445,0.0015792112,0.0019859395,0.0024122146,0.003952515,0.0013721664,0.110582046,0.0002220216,0.00167726,0.08304731],"study_design_scores_gemma":[0.2892015,0.035857517,0.31031322,0.0017988615,0.001188935,0.00004008802,0.0049286196,0.00033668254,0.35001004,0.00020554817,0.0055231694,0.0005957938],"about_ca_topic_score_codex":0.0013033323,"about_ca_topic_score_gemma":0.00091246224,"teacher_disagreement_score":0.40118122,"about_ca_system_score_codex":0.00008656262,"about_ca_system_score_gemma":0.0004387225,"threshold_uncertainty_score":0.76483727},"labels":[],"label_agreement":null},{"id":"W4410140470","doi":"10.1182/bloodadvances.2025016042","title":"Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharma; Astellas Pharma; National Institute for Health and Care Research; National Cancer Institute; Incyte; Sanofi; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Bosutinib; Tolerability; Discontinuation; Medicine; Adverse effect; Internal medicine; Oncology; Myeloid leukemia; Imatinib; Dasatinib","score_opus":0.009538012546709346,"score_gpt":0.28064886711593745,"score_spread":0.2711108545692281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410140470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913312,0.005415776,0.000004290674,0.00048760898,0.00029172556,0.0006019541,0.000021821623,0.00004166082,0.0018039283],"genre_scores_gemma":[0.9930934,0.00057283114,0.0016272294,0.00027880876,0.000057644786,0.00010592898,0.000026743717,0.00002643374,0.004211008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982035,0.000060959897,0.00060816045,0.0004428238,0.00027980778,0.00040474368],"domain_scores_gemma":[0.999148,0.00016899972,0.000095282034,0.00045410352,0.00005301309,0.000080567785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002311413,0.0002239775,0.0006659657,0.00034403978,0.000017914304,0.000011393996,0.0001463188,0.00013640127,0.00014669125],"category_scores_gemma":[0.00033164222,0.00021431284,0.00012410415,0.00070258166,0.000104107035,0.00017649005,0.00007958733,0.00024445608,0.000025105035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00508619,0.001707172,0.93553185,0.0008116534,0.00031798042,0.0014062616,0.0022696494,0.00014771527,0.01142352,0.00016482545,0.00014564054,0.04098751],"study_design_scores_gemma":[0.042703643,0.0011106797,0.90922207,0.002393382,0.00033912485,0.000022333019,0.00035412319,0.00016866809,0.027245522,0.0005170871,0.0155397635,0.00038362172],"about_ca_topic_score_codex":0.000288923,"about_ca_topic_score_gemma":0.0016250007,"teacher_disagreement_score":0.040603887,"about_ca_system_score_codex":0.00022876283,"about_ca_system_score_gemma":0.00045726084,"threshold_uncertainty_score":0.8739424},"labels":[],"label_agreement":null},{"id":"W4410151754","doi":"10.1182/bloodadvances.2025015860","title":"ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; Servier; Blood Cancer UK; AOP Orphan; Swedish Orphan Biovitrum; Galecto; Novartis Pharma; Astellas Pharma; Incyte; Celgene; AstraZeneca; Pfizer","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Anemia; Neutropenia; Adverse effect; International Prognostic Scoring System; Phases of clinical research; Clinical trial; Gastroenterology; Surgery; Toxicity; Bone marrow; Myelodysplastic syndromes","score_opus":0.01639570833985633,"score_gpt":0.29476738531813995,"score_spread":0.27837167697828363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410151754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963479,0.00016936412,0.000009751251,0.00010762627,0.000016812039,0.0020740358,0.000016212007,0.0000107123,0.0012475777],"genre_scores_gemma":[0.9977754,0.000021831644,0.0016122614,0.000116336334,0.000005084961,0.0003662897,0.000026181027,0.000013876675,0.00006276126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990748,0.000026201138,0.0002567541,0.0002754499,0.00021989312,0.00014687648],"domain_scores_gemma":[0.99948305,0.00006537705,0.000110777306,0.00020222375,0.000105820334,0.00003277082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008980823,0.00015732636,0.00038469327,0.0001682077,0.000035968016,0.000022021844,0.000108393215,0.000029808663,0.000017994636],"category_scores_gemma":[0.000013109388,0.00009695435,0.000010588617,0.00036600928,0.000042327963,0.00036380618,0.000033679327,0.00007175789,4.4968505e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016331873,0.020884775,0.967976,0.00004761856,0.0001389757,0.0000038062624,0.001963254,0.000026357826,0.000039562212,0.0012287323,0.0000012335524,0.006056525],"study_design_scores_gemma":[0.03218023,0.0097152805,0.9526167,0.0005592392,0.000080645994,5.232431e-7,0.002396339,0.0000060905268,0.0020795877,0.000119566306,0.00014495793,0.00010082207],"about_ca_topic_score_codex":0.00040458565,"about_ca_topic_score_gemma":0.004235385,"teacher_disagreement_score":0.030547043,"about_ca_system_score_codex":0.000035329624,"about_ca_system_score_gemma":0.00006115684,"threshold_uncertainty_score":0.39536834},"labels":[],"label_agreement":null},{"id":"W4410286880","doi":"10.1182/bloodadvances.2024015515","title":"The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute; Ottawa Hospital; University of Ottawa; Population Health Research Institute; McMaster University","funders":"Instituto de Salud Carlos III; National Health and Medical Research Council; Medical Research Council; Australian and New Zealand College of Anaesthetists; Ministério da Saúde; American Heart Association; Inyuvesi Yakwazulu-Natali; Canada Research Chairs; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Suomen Kulttuurirahasto; Chinese University of Hong Kong; National Institute for Health and Care Research; Academic Medical Organization of Southwestern Ontario; Government of Canada; McMaster University; Department of Surgery, University of Manitoba; Canadian Institutes of Health Research; Jane ja Aatos Erkon Säätiö; Stryker; Universidad Industrial de Santander; Universiti Malaya; Manitoba Medical Service Foundation; Heart and Stroke Foundation of Canada; Manitoba Health Research Council; Hamilton Health Sciences; American Society of Nephrology; Suomen Lääketieteen Säätiö","keywords":"Medicine; Poisson regression; Relative risk; Risk assessment; Risk factor; Confidence interval; Venous thromboembolism; Surgery; Abdominal surgery; Internal medicine; Thrombosis; Population","score_opus":0.008752206680076837,"score_gpt":0.25412427478194666,"score_spread":0.24537206810186982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410286880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99155325,0.005761465,0.000241329,0.00071228505,0.00049493357,0.0009384126,0.0001067001,0.000021740987,0.00016988121],"genre_scores_gemma":[0.98341477,0.01562871,0.00060799235,0.000108184366,0.000044150514,0.00012910811,0.000021095078,0.000010165327,0.000035840552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998849,0.00007852465,0.0004243903,0.0002321164,0.00020536417,0.00021060038],"domain_scores_gemma":[0.99833333,0.00093431113,0.0003564667,0.0002251916,0.00009510443,0.000055597113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034443985,0.00014298447,0.00043596007,0.000105781306,0.00024907372,0.000025543332,0.00005453181,0.000033796565,0.000008568061],"category_scores_gemma":[0.00026895848,0.00009683639,0.00013735089,0.000114140115,0.000085061176,0.000080000624,0.000059847895,0.00007737441,0.000001021864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004951564,0.0012229334,0.29561907,0.0006150458,0.0008156698,0.0000036900024,0.00044743737,0.00007938275,0.00071739015,0.0012209486,0.0014011267,0.6973621],"study_design_scores_gemma":[0.002385497,0.0007528325,0.82626164,0.0006193972,0.0016494619,0.0000046209666,0.0012882022,0.00018621275,0.076444246,0.0020743464,0.08807208,0.00026147263],"about_ca_topic_score_codex":0.00010405512,"about_ca_topic_score_gemma":0.00003158519,"teacher_disagreement_score":0.6971007,"about_ca_system_score_codex":0.000025149031,"about_ca_system_score_gemma":0.000052222716,"threshold_uncertainty_score":0.39488736},"labels":[],"label_agreement":null},{"id":"W4410301560","doi":"10.1182/bloodadvances.2025016681","title":"A global survey on practice changes and barriers to the use of direct oral anticoagulants in children","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Centre for Global Health Research; SickKids Foundation; University of Toronto; Public Health Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Family medicine; Cross-sectional study; Environmental health","score_opus":0.06102033356356575,"score_gpt":0.36887285732407704,"score_spread":0.3078525237605113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410301560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919226,0.0009671804,0.000013904013,0.005818308,0.00010039632,0.00048741317,0.00004005796,0.000014798786,0.00063534325],"genre_scores_gemma":[0.9973214,0.0005175674,0.0004679513,0.0012668524,0.000047932663,0.0000016842353,0.000009535697,0.0000029594785,0.00036410577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944556,0.00009830146,0.00011074016,0.00013353745,0.00011786413,0.00009402594],"domain_scores_gemma":[0.9994238,0.00033278306,0.000049594,0.000120772,0.000032137523,0.000040908842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025940378,0.000068850306,0.00020523234,0.0000659901,0.00003349248,0.000015497591,0.000040690862,0.000019212026,0.0000045270053],"category_scores_gemma":[0.0024067503,0.000044609227,0.000017712799,0.00037324702,0.000026713555,0.00009360378,0.000040918494,0.000027803895,0.0000010635744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032726186,0.0000100983425,0.98798484,0.000011580896,0.00008975618,0.000001692517,0.00003728767,0.000108907654,0.000008932346,0.0001651021,0.000335193,0.010919363],"study_design_scores_gemma":[0.000753044,0.00011631189,0.9693202,0.0000617174,0.00011236437,0.0000013021759,0.000054722394,0.000014484312,0.00013563148,0.000011317729,0.029376967,0.000041950778],"about_ca_topic_score_codex":0.00048136103,"about_ca_topic_score_gemma":0.0016880608,"teacher_disagreement_score":0.029041773,"about_ca_system_score_codex":0.000007589153,"about_ca_system_score_gemma":0.000021699936,"threshold_uncertainty_score":0.28812787},"labels":[],"label_agreement":null},{"id":"W4410425696","doi":"10.1182/bloodadvances.2024015634","title":"Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"National Cancer Institute; Centers for Disease Control and Prevention; University of California, San Francisco; University of Southern California; California Department of Public Health","keywords":"Medicine; Logistic regression; Psychological intervention; Socioeconomic status; Internal medicine; CAR T-cell therapy; Disadvantaged; Oncology; Population; Cancer; Environmental health; Nursing","score_opus":0.043124636876642905,"score_gpt":0.36626355476231093,"score_spread":0.323138917885668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410425696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98454195,0.010302749,0.00033012062,0.00037752665,0.00013201815,0.0013675324,0.0003834168,0.000062450155,0.0025022055],"genre_scores_gemma":[0.98770195,0.0030508342,0.0009188739,0.000728022,0.00012831736,0.00026073266,0.001520136,0.00004426238,0.0056468616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779505,0.000109547684,0.0004009075,0.00066150597,0.00060409406,0.00042891927],"domain_scores_gemma":[0.99784654,0.00047683698,0.00012952188,0.0011622616,0.0002667843,0.000118064505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004261207,0.00023851218,0.0006300994,0.00061572465,0.00008211565,0.000057386183,0.00069303904,0.00010320916,0.00025162732],"category_scores_gemma":[0.00019122657,0.00017626102,0.00010957632,0.001418231,0.00014000612,0.00046395257,0.00018015743,0.00029006155,0.0000017441284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018882366,0.0015925323,0.96362853,0.00037078577,0.0011178836,0.000019219182,0.00040422037,0.000044516124,0.0006129694,0.00001963157,0.00041247578,0.029889017],"study_design_scores_gemma":[0.057919066,0.0027317726,0.49420834,0.0006539398,0.002234108,0.0000020062014,0.0023135806,0.0005239315,0.009759965,0.00033292966,0.4285036,0.000816761],"about_ca_topic_score_codex":0.00029442765,"about_ca_topic_score_gemma":0.00090467755,"teacher_disagreement_score":0.4694202,"about_ca_system_score_codex":0.00006750785,"about_ca_system_score_gemma":0.00032823504,"threshold_uncertainty_score":0.7187716},"labels":[],"label_agreement":null},{"id":"W4410773604","doi":"10.1182/bloodadvances.2024015328","title":"American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; McMaster University; McMaster Children's Hospital; Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"International Society on Thrombosis and Haemostasis","keywords":"Medicine; Guideline; Intensive care medicine; Multidisciplinary approach; Interim; MEDLINE; Thrombosis; Venous thromboembolism; Clinical trial; Venous thrombosis; Family medicine; Surgery; Internal medicine; Pathology","score_opus":0.05349728080506826,"score_gpt":0.3716966001374169,"score_spread":0.31819931933234863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410773604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451554,0.0013148909,0.0002060342,0.00253996,0.0002868484,0.00066505495,0.00012154573,0.000024103652,0.00032605158],"genre_scores_gemma":[0.96766764,0.007547273,0.023564637,0.0008179873,0.000068732406,0.00007307709,0.00012069085,0.000015377624,0.00012461204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890846,0.000014817642,0.000470704,0.0002770889,0.0001779367,0.00015101189],"domain_scores_gemma":[0.99912846,0.000096611504,0.0002505892,0.00015382553,0.00033405595,0.00003646234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007353588,0.00016095256,0.0006702214,0.00010126098,0.000040506173,0.000004736547,0.000067779394,0.000067969384,0.000012337204],"category_scores_gemma":[0.00003838921,0.00013264375,0.00020250016,0.00033010548,0.000102173326,0.000058593738,0.000026255917,0.000035780136,4.2597765e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005652616,0.016756313,0.85412234,0.0012728899,0.003230046,0.0000012584944,0.002044728,0.00011576329,0.0047754087,0.0062740673,0.015187585,0.09565433],"study_design_scores_gemma":[0.03426555,0.007454619,0.78291833,0.00061673246,0.0033554346,0.0000038626545,0.003111932,0.0020028707,0.14677997,0.004341047,0.014564248,0.0005853987],"about_ca_topic_score_codex":0.00003700165,"about_ca_topic_score_gemma":0.000014679477,"teacher_disagreement_score":0.14200455,"about_ca_system_score_codex":0.000034293702,"about_ca_system_score_gemma":0.000078597186,"threshold_uncertainty_score":0.54090554},"labels":[],"label_agreement":null},{"id":"W4410801539","doi":"10.1182/bloodadvances.2025016141","title":"Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Alexion Pharmaceuticals; bluebird bio; Pharmacyclics; Adaptive Biotechnologies; Health Resources and Services Administration; Kite Pharma; Daiichi Sankyo Europe; Takeda Oncology; AstraZeneca; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genentech; MorphoSys; U.S. Navy; Legend Biotech; Sangamo Therapeutics; Seagen; CTI Biopharma; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; U.S. Department of Health and Human Services; GlaxoSmithKline; Kiadis Pharma; Medac; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; HistoGenetics; Children's Hospital of Philadelphia; Gateway for Cancer Research; Celgene; Omeros Corporation; Vertex Pharmaceuticals; U.S. Department of Defense; Sanofi; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Bristol-Myers Squibb; Cidara Therapeutics; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Amgen; Atara Biotherapeutics; Actinium Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Cytokine release syndrome; Chimeric antigen receptor; Lymphoma; Internal medicine; Cumulative incidence; Incidence (geometry); CD19; Immunology; Gastroenterology; Transplantation; Antigen; Immunotherapy; Cancer","score_opus":0.010808022390614186,"score_gpt":0.3128229019549339,"score_spread":0.3020148795643197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410801539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699175,0.014040556,0.0010943162,0.00029736297,0.00039298087,0.0011685647,0.00014559164,0.00014729208,0.012795855],"genre_scores_gemma":[0.9167016,0.029757185,0.002904473,0.000722723,0.0005513085,0.0005070483,0.0004050252,0.00006294363,0.048387658],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979596,0.000104603714,0.0003956756,0.0006619279,0.00035566848,0.00052253896],"domain_scores_gemma":[0.99866384,0.00027313572,0.0001373371,0.00061447313,0.00017656987,0.00013463573],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029984736,0.00029056845,0.00064738846,0.00070581265,0.0001539932,0.000054016826,0.00015954496,0.0001142786,0.002247146],"category_scores_gemma":[0.000030868883,0.0002505533,0.0004885145,0.0020841984,0.00005890038,0.00017557669,0.000052301162,0.00014688411,0.000048210248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036040973,0.005467801,0.7031714,0.00022296929,0.0026498288,0.000017676668,0.00032961761,0.000014053714,0.21591465,0.0000418075,0.0017013693,0.06686478],"study_design_scores_gemma":[0.015413116,0.00047492236,0.1463173,0.00006483026,0.0010512987,6.176398e-7,0.00007931275,0.00016945443,0.2803166,0.00020188231,0.5555901,0.00032056574],"about_ca_topic_score_codex":0.0008264435,"about_ca_topic_score_gemma":0.0011324768,"teacher_disagreement_score":0.55685407,"about_ca_system_score_codex":0.00009497486,"about_ca_system_score_gemma":0.00016539924,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W4411230511","doi":"10.1182/bloodadvances.2025016160","title":"Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Seagen; Jazz Pharmaceuticals; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Lymphoblastic Leukemia; Thrombosis; Apixaban; Internal medicine; Oncology; Intensive care medicine; Leukemia; Pediatrics; Warfarin","score_opus":0.006935031750963809,"score_gpt":0.2738855370249652,"score_spread":0.2669505052740014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411230511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961585,0.0027320953,0.00013405648,0.00012342863,0.00006277589,0.00046120872,0.000015249915,0.000023752804,0.00028894405],"genre_scores_gemma":[0.9968523,0.00205598,0.00087373494,0.00008587321,0.000035820074,0.0000072242988,0.000016416257,0.000009029768,0.00006362068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989406,0.00005642139,0.00033884766,0.00029615348,0.00021753651,0.00015047907],"domain_scores_gemma":[0.9993585,0.00020517282,0.00014901845,0.00016720338,0.000056846304,0.0000632761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015081228,0.00014073796,0.00040545288,0.00014276203,0.00004698309,0.000007795706,0.00005159707,0.000051547282,0.000004740265],"category_scores_gemma":[0.00011874193,0.00011852312,0.000030361856,0.0003399018,0.00009081758,0.00015911573,0.00005501029,0.00008935958,4.3925223e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044662564,0.0005110066,0.9945063,0.00060877134,0.0001073704,0.0000015496246,0.00036180805,0.00000977192,0.000024889696,0.000071947296,0.000008379456,0.0033415726],"study_design_scores_gemma":[0.009308381,0.0005221004,0.988295,0.0005047702,0.00063099083,0.0000016047727,0.00007441451,0.000008541522,0.00031915153,0.00015193883,0.00007597508,0.000107099935],"about_ca_topic_score_codex":0.00006024394,"about_ca_topic_score_gemma":0.0002536149,"teacher_disagreement_score":0.008861755,"about_ca_system_score_codex":0.000050073628,"about_ca_system_score_gemma":0.00015698299,"threshold_uncertainty_score":0.48332325},"labels":[],"label_agreement":null},{"id":"W4411603000","doi":"10.1182/bloodadvances.2025015881","title":"Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Takeda Oncology; National Institutes of Health; MorphoSys; Health Resources and Services Administration; Syndax Pharmaceuticals; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Jazz Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; StemCyte; Actinium Pharmaceuticals; CareDx; University of Pittsburgh; HistoGenetics; U.S. Department of Defense; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Navy; Gateway for Cancer Research; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Amgen; Atara Biotherapeutics; National Cancer Institute; Servier; Gilead Sciences","keywords":"Medicine; Refractory (planetary science); Internal medicine; Gastroenterology; Pediatrics; Biology","score_opus":0.07493340698245726,"score_gpt":0.4053863752245954,"score_spread":0.33045296824213816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411603000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98695415,0.0028767549,0.00022659304,0.0016236791,0.00012116841,0.0013313834,0.00050081813,0.00005758193,0.006307846],"genre_scores_gemma":[0.9747265,0.0015282469,0.0055472273,0.0011092605,0.00031777285,0.00015981996,0.0020753455,0.000056199875,0.01447964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984941,0.0000641727,0.00025584016,0.0005099648,0.0003632596,0.0003126453],"domain_scores_gemma":[0.997701,0.0006213185,0.000096433614,0.0014261532,0.00009349778,0.00006160878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002551334,0.00015890709,0.00034008466,0.00012154056,0.00007456541,0.00004041975,0.00056917424,0.000034832326,0.00012140154],"category_scores_gemma":[0.0001998633,0.00009885885,0.00004857946,0.0006472186,0.00016189928,0.00017230415,0.00016077158,0.00021261559,0.000003471337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022231261,0.0005951548,0.95234704,0.000091246715,0.0005119216,0.000018285773,0.000078425845,0.000010932293,0.004077081,0.000119040946,0.004032359,0.035895366],"study_design_scores_gemma":[0.008577385,0.00043586481,0.8109422,0.000375952,0.00049565424,7.175803e-7,0.000250885,0.000115887146,0.0070020277,0.0006619373,0.17093429,0.00020720257],"about_ca_topic_score_codex":0.0015677714,"about_ca_topic_score_gemma":0.012229716,"teacher_disagreement_score":0.16690193,"about_ca_system_score_codex":0.00004366028,"about_ca_system_score_gemma":0.00013460603,"threshold_uncertainty_score":0.6824469},"labels":[],"label_agreement":null},{"id":"W4411636348","doi":"10.1182/bloodadvances.2025017058","title":"Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Centre hospitalier universitaire de Québec; McMaster Children's Hospital; Hospital for Sick Children","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; International Society on Thrombosis and Haemostasis","keywords":"Medicine; Thrombolysis; Pulmonary embolism; Thrombosis; Randomized controlled trial; Thrombus; Population; Relative risk; Venous thrombosis; Internal medicine; Meta-analysis; Deep vein; Confidence interval; Intensive care medicine; Cardiology; Surgery; Myocardial infarction","score_opus":0.03949002822481621,"score_gpt":0.3556122944810178,"score_spread":0.31612226625620155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411636348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022238762,0.98732865,0.000091988164,0.00013682703,0.00004934107,0.011674291,0.0003885068,0.000047547856,0.00028064693],"genre_scores_gemma":[0.000015229399,0.99563575,0.0011224299,0.0003276159,0.00006346274,0.0022710627,0.00015994455,0.0000516662,0.00035285612],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960323,0.00025880142,0.0020053396,0.0009302908,0.00038920614,0.00038407868],"domain_scores_gemma":[0.995769,0.0014026738,0.0014787806,0.0009893226,0.00019923346,0.00016095929],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00085264875,0.0007720009,0.026218856,0.0007321081,0.00014003894,0.00003474884,0.00027709597,0.00020536211,0.000067471585],"category_scores_gemma":[0.00060582405,0.00049912266,0.0031104833,0.0016202042,0.00010459689,0.000106611194,0.00020258478,0.00019773403,0.0000025272],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036906442,0.0005955693,0.0000013672632,0.7752293,0.21965714,0.000004452272,0.000029519306,6.100887e-7,1.8892509e-8,0.0003440041,0.00009963484,0.004034722],"study_design_scores_gemma":[0.00051587215,0.00028138276,0.00002218295,0.052719392,0.9156378,0.000016794198,0.000017805316,3.9554246e-7,3.6856187e-7,0.000042534073,0.030398251,0.00034721],"about_ca_topic_score_codex":0.000012508883,"about_ca_topic_score_gemma":0.000010261933,"teacher_disagreement_score":0.72250986,"about_ca_system_score_codex":0.000026643036,"about_ca_system_score_gemma":0.00017128125,"threshold_uncertainty_score":0.999746},"labels":[],"label_agreement":null},{"id":"W4411874249","doi":"10.1182/bloodadvances.2025016725","title":"Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Novo Nordisk; ZonMw; National Institutes of Health; Science Foundation Ireland; Amgen; Pfizer; Swedish Orphan Biovitrum; CSL Behring","keywords":"Medicine; Young adult; Internal medicine","score_opus":0.005018554475386242,"score_gpt":0.30471972554532917,"score_spread":0.29970117106994293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411874249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987688,0.0071436767,2.5386558e-7,0.0003555526,0.000032565,0.0006772884,0.000004305791,0.000014808825,0.004083555],"genre_scores_gemma":[0.99785954,0.0015699838,0.000046717014,0.00019286622,0.000009099779,0.0002407138,0.000010693321,0.0000041642247,0.00006621424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951696,0.00004216779,0.00010130158,0.00013429328,0.00009414732,0.000111106194],"domain_scores_gemma":[0.99956703,0.00025702504,0.000030148189,0.00012162304,0.0000067492774,0.000017398086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000787078,0.000092069895,0.00022717442,0.000059785172,0.000030310131,0.000008670084,0.000048999013,0.000025707306,0.000003012866],"category_scores_gemma":[0.00005455583,0.000051217772,0.000036185822,0.00014956942,0.00007070965,0.000035312187,0.000011819991,0.00006258258,0.0000015930451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002744436,0.0017246432,0.61138886,0.0005889809,0.00011051485,0.0005673346,0.00015980296,0.0000025439542,0.00014675758,0.0003282685,0.00013465986,0.3845732],"study_design_scores_gemma":[0.01962065,0.013913119,0.82715684,0.0033195785,0.0010034491,0.000053817934,0.00024307692,0.000028546872,0.11340342,0.0014075274,0.019564703,0.00028526565],"about_ca_topic_score_codex":0.000033164546,"about_ca_topic_score_gemma":0.00010897638,"teacher_disagreement_score":0.38428792,"about_ca_system_score_codex":0.0000037768198,"about_ca_system_score_gemma":0.00001007784,"threshold_uncertainty_score":0.20886001},"labels":[],"label_agreement":null},{"id":"W4411874273","doi":"10.1182/bloodadvances.2025016497","title":"Therapeutic innovations in hemophilia: the essential role of a positive reinvestment cycle","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"Genentech; CSL Behring; Sanofi; Novo Nordisk; Regeneron Pharmaceuticals; Pfizer","keywords":"Haemophilia; Medicine; Intensive care medicine; Pediatrics","score_opus":0.008366004249388572,"score_gpt":0.3094606534265609,"score_spread":0.3010946491771724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411874273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96214736,0.010276761,0.000015155261,0.0077281073,0.00005166428,0.000589446,0.0000067899114,0.000016352067,0.019168373],"genre_scores_gemma":[0.99767613,0.00044487274,0.00018940368,0.0003004011,0.000036141737,0.000057764086,0.000011155443,0.0000051241814,0.001279011],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930435,0.00003916149,0.00019053665,0.00014083264,0.0001716025,0.00015349456],"domain_scores_gemma":[0.99956983,0.0001056958,0.00003704225,0.0001835057,0.00008227025,0.000021677251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011031715,0.000079099766,0.00016339812,0.00014233115,0.00006423292,0.000006487665,0.00008188135,0.00003488519,0.000024999641],"category_scores_gemma":[0.000038427705,0.00004730013,0.000045224606,0.00065619254,0.00013980747,0.000058067628,0.000034694887,0.00012072479,0.0000057418247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008198265,0.005636917,0.3631941,0.00043163702,0.001340192,0.00012654779,0.0025781186,0.00014586617,0.3061131,0.2021868,0.0001435929,0.117283314],"study_design_scores_gemma":[0.005476324,0.00048035072,0.24599187,0.0005974489,0.00036701516,0.000020900095,0.0019121679,0.0003216732,0.6787316,0.060623094,0.0053118807,0.0001656717],"about_ca_topic_score_codex":0.000034755514,"about_ca_topic_score_gemma":0.000031155578,"teacher_disagreement_score":0.37261853,"about_ca_system_score_codex":0.000023255052,"about_ca_system_score_gemma":0.00013041725,"threshold_uncertainty_score":0.19288433},"labels":[],"label_agreement":null},{"id":"W4412488898","doi":"10.1182/bloodadvances.2024014654","title":"Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti–PD-1–refractory Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Refractory (planetary science); Internal medicine; Clinical trial; Lesion; Oncology; Gastroenterology; Surgery; Cancer; Immunotherapy","score_opus":0.010172272588648537,"score_gpt":0.3021202913284249,"score_spread":0.2919480187397763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412488898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777762,0.0073689716,0.00023580596,0.00051450735,0.00030560888,0.0009264036,0.000023983157,0.00008430117,0.012764177],"genre_scores_gemma":[0.98960173,0.00028042728,0.00917139,0.00028040164,0.00008115914,0.00013805061,0.000023975328,0.000028240598,0.00039464573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978252,0.000078666475,0.0006863309,0.00058830454,0.00036965415,0.0004518501],"domain_scores_gemma":[0.99847037,0.0005408164,0.00022232719,0.00048444135,0.00013081322,0.00015121706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012254663,0.0003441402,0.0008789354,0.00045481688,0.00009337469,0.000021227032,0.00018131269,0.00012233469,0.000034154236],"category_scores_gemma":[0.0005556681,0.00029280782,0.00018328229,0.00076516747,0.00010191632,0.0002650011,0.000121377394,0.000115402436,0.000032813685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060521215,0.0153621575,0.47867104,0.0017027715,0.0015315493,0.0013575844,0.004666514,0.0063887653,0.006627612,0.008970662,0.0005642811,0.46810493],"study_design_scores_gemma":[0.04431865,0.0012448098,0.92256737,0.002468609,0.00057563226,0.00007543817,0.0003057833,0.0007694991,0.022599906,0.0005304389,0.004167174,0.00037670415],"about_ca_topic_score_codex":0.00021303752,"about_ca_topic_score_gemma":0.000052976702,"teacher_disagreement_score":0.46772823,"about_ca_system_score_codex":0.00039100499,"about_ca_system_score_gemma":0.0004901673,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W4412492231","doi":"10.1182/bloodadvances.2024015519","title":"In vivo CRISPR screening reveals cooperation of <i>KMT2D</i> and <i>TP53</i> deficiencies in B-cell lymphomagenesis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"","keywords":"Biology; Cancer research; CRISPR; YAP1; Diffuse large B-cell lymphoma; Transplantation; Lymphoma; Genetics; Gene; Immunology; Transcription factor; Medicine","score_opus":0.013408603913164462,"score_gpt":0.30233026421181747,"score_spread":0.288921660298653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412492231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675561,0.020928344,0.0002396537,0.0004054736,0.000047946505,0.00041610308,0.0000060194325,0.000016110947,0.010384214],"genre_scores_gemma":[0.9879123,0.0035425893,0.0022147214,0.0004395772,0.00002566561,0.000035519308,0.000002390122,0.000011719471,0.0058155134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885416,0.000073050294,0.00034423883,0.00027032502,0.00022004779,0.00023817361],"domain_scores_gemma":[0.9994278,0.00019475233,0.000055229324,0.00019138466,0.00008740046,0.000043462955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042761877,0.000118146476,0.0003334671,0.00031724744,0.000039694114,0.000016373591,0.00008745677,0.000058533333,0.00009650581],"category_scores_gemma":[0.00013742605,0.00010894823,0.000034960318,0.00077367394,0.000112080066,0.0001974764,0.000055580967,0.00009785407,9.987303e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021232948,0.00030586027,0.127594,0.0002981495,0.000010588562,0.000028822607,0.00026921622,0.000107913744,0.8620596,0.00017425479,0.00012950234,0.008809805],"study_design_scores_gemma":[0.0043861875,0.00022608903,0.012960217,0.0003914243,0.00004023228,0.000014380299,0.0006427856,0.00018813492,0.97161096,0.00013846146,0.009278505,0.00012259462],"about_ca_topic_score_codex":0.0001940899,"about_ca_topic_score_gemma":0.00033443182,"teacher_disagreement_score":0.114633776,"about_ca_system_score_codex":0.000030087678,"about_ca_system_score_gemma":0.000106281375,"threshold_uncertainty_score":0.444278},"labels":[],"label_agreement":null},{"id":"W4412493495","doi":"10.1182/bloodadvances.2025016651","title":"High-grade B-cell lymphoma, not otherwise specified: an LLMPP study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; University of Toronto; University Health Network; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome British Columbia; National Cancer Institute; Genome Canada","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Not Otherwise Specified; Cell of origin; Biology; Germinal center; Population; Cancer research; Oncology; Pathology; Medicine; B cell; Internal medicine; Cancer; Immunology; Antibody","score_opus":0.01410312446159241,"score_gpt":0.28861591362199057,"score_spread":0.2745127891603982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412493495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292166,0.0054277163,0.000008680364,0.00061982335,0.00040126502,0.00082101446,0.000018623257,0.00014058009,0.009640635],"genre_scores_gemma":[0.9930157,0.0006106018,0.0014822553,0.0008533538,0.00022463541,0.00016335705,0.000018890643,0.000023699513,0.0036075064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855584,0.00005408333,0.0002998509,0.0005064096,0.00028761846,0.00029618465],"domain_scores_gemma":[0.9990423,0.00009710329,0.000082604165,0.00057834014,0.000052019095,0.00014768809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000936763,0.00025701168,0.0004405919,0.00012681728,0.00012404,0.00004114639,0.00015216807,0.000057933237,0.00010081861],"category_scores_gemma":[0.000020027905,0.0001938007,0.00010200346,0.0002816988,0.000054310694,0.00016837152,0.000046860747,0.000048418133,0.00008518625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009062964,0.10307568,0.7328844,0.00023949145,0.0009431432,0.0014178567,0.001081233,0.000034405944,0.0032372177,0.004154979,0.0017083368,0.15031692],"study_design_scores_gemma":[0.04146462,0.0029685595,0.7219707,0.00013887286,0.0013624014,0.00002789392,0.0023088946,0.000010358714,0.1535996,0.00045907023,0.07529644,0.0003925903],"about_ca_topic_score_codex":0.00025821084,"about_ca_topic_score_gemma":0.00024247388,"teacher_disagreement_score":0.15036239,"about_ca_system_score_codex":0.00008387579,"about_ca_system_score_gemma":0.0001108594,"threshold_uncertainty_score":0.7902963},"labels":[],"label_agreement":null},{"id":"W4412620438","doi":"10.1182/bloodadvances.2024015014","title":"Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; Legend Biotech; Pharmacyclics; Eurostars; Genentech; Health Resources and Services Administration; Aptitude Health; Seagen; Incyte; Juno Therapeutics; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Actinium Pharmaceuticals; CareDx; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Gateway for Cancer Research; Celgene; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Alexion Pharmaceuticals; Spectrum Pharmaceuticals; Mallinckrodt Pharmaceuticals; Kite Pharma; Society for Immunotherapy of Cancer; Astellas Pharma US; Amgen","keywords":"Medicine; Hazard ratio; Internal medicine; Bendamustine; Mantle cell lymphoma; Cumulative incidence; Oncology; Confidence interval; Salvage therapy; Odds ratio; Melphalan; Gastroenterology; Lymphoma; Surgery; Transplantation; Chemotherapy; Rituximab","score_opus":0.02176219910519934,"score_gpt":0.3536270628012587,"score_spread":0.3318648636960594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412620438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9294157,0.0062037413,0.0006131905,0.0008560135,0.00038973204,0.0016546652,0.00016565189,0.00019112424,0.060510173],"genre_scores_gemma":[0.61905813,0.002536795,0.0067363135,0.00028120002,0.00010569273,0.00018290292,0.000096731,0.00004888052,0.37095338],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806744,0.00006430601,0.00055838743,0.00048176287,0.00041990125,0.00040818303],"domain_scores_gemma":[0.99804133,0.0006861803,0.00020537579,0.0007396956,0.00020485176,0.00012255725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035191607,0.00023646788,0.0009528131,0.00083631446,0.000090591035,0.000017169428,0.00025032004,0.00009613335,0.00081185903],"category_scores_gemma":[0.0001732828,0.00017738283,0.00042830638,0.0018695785,0.0001260198,0.00011220471,0.000073309246,0.00011568226,0.0000066493712],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074413763,0.0070218565,0.45128974,0.0031322755,0.009529235,0.00017671246,0.00046860514,0.00010392432,0.37761146,0.00080823514,0.0029834465,0.13943312],"study_design_scores_gemma":[0.025752038,0.0015426169,0.30243748,0.0002602939,0.007935948,0.000006718378,0.00053474447,0.00045090422,0.40280434,0.00042438274,0.25730103,0.0005494983],"about_ca_topic_score_codex":0.00026548374,"about_ca_topic_score_gemma":0.0010504911,"teacher_disagreement_score":0.3104432,"about_ca_system_score_codex":0.00010100378,"about_ca_system_score_gemma":0.0003858145,"threshold_uncertainty_score":0.8889287},"labels":[],"label_agreement":null},{"id":"W4412621220","doi":"10.1182/bloodadvances.2025016399","title":"Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed <i>IDH1</i> -mutated AML","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer; Servier; Jazz Pharmaceuticals; Astellas Pharma; Aptitude Health; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Azacitidine; Placebo; IDH1; Hazard ratio; Oncology; Isocitrate dehydrogenase; Myeloid leukemia; Gastroenterology; Confidence interval; Mutation; Pathology; Biology","score_opus":0.016162170831825116,"score_gpt":0.3119642186254878,"score_spread":0.29580204779366265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412621220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003756,0.0032894958,0.000026128115,0.0021539915,0.00017643652,0.0023118672,0.00015018717,0.00008195747,0.0017723577],"genre_scores_gemma":[0.99659973,0.00094628736,0.00024267216,0.00051304704,0.00015756195,0.0001886995,0.00014776885,0.000030745945,0.001173475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971645,0.0002870651,0.000805608,0.00063274754,0.000609048,0.0005010284],"domain_scores_gemma":[0.9961923,0.0024247083,0.00021328579,0.0008641296,0.0001899239,0.00011566048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055119407,0.00028539405,0.0007088134,0.00022671958,0.00010745841,0.00003472175,0.00053715025,0.000108144966,0.000048173082],"category_scores_gemma":[0.0015275228,0.00020054234,0.000088937464,0.0010718656,0.00017669471,0.0002031143,0.00025696022,0.0005877403,0.000020632731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026645944,0.005430897,0.8947009,0.00038788197,0.0011987104,0.0041429214,0.009294663,0.0012143113,0.029627038,0.00006684185,0.008152174,0.019137729],"study_design_scores_gemma":[0.1363536,0.0023591677,0.7718292,0.0017259372,0.0007430679,0.0000300248,0.007915751,0.00040516496,0.07524372,0.0002743748,0.0026366883,0.000483337],"about_ca_topic_score_codex":0.0024072148,"about_ca_topic_score_gemma":0.005870012,"teacher_disagreement_score":0.12287171,"about_ca_system_score_codex":0.0001748511,"about_ca_system_score_gemma":0.0004894747,"threshold_uncertainty_score":0.81778795},"labels":[],"label_agreement":null},{"id":"W4412743418","doi":"10.1182/bloodadvances.2025016989","title":"ASH sickle cell disease CPKD guidelines report","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Disease; Medicine; Cell; Sickle cell anemia; Internal medicine; Immunology; Biology; Biochemistry","score_opus":0.009365221344161867,"score_gpt":0.3010980391598232,"score_spread":0.29173281781566135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412743418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43534377,0.14433503,0.0007660406,0.027567226,0.001962907,0.0010252225,0.000024564679,0.00052184565,0.38845336],"genre_scores_gemma":[0.7109256,0.013875479,0.0073689646,0.0075009903,0.0005239233,0.00007977636,0.00013503099,0.000052409145,0.25953782],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892354,0.000013246797,0.00036228137,0.00030611712,0.00017965282,0.0002151418],"domain_scores_gemma":[0.99920547,0.000030791296,0.00007930241,0.0003734747,0.0001579106,0.00015306336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011871436,0.00013591914,0.00022104451,0.000073484494,0.0000912586,0.000013214954,0.000079748716,0.00006297967,0.00014203227],"category_scores_gemma":[0.0003843082,0.00010358327,0.00011137198,0.0002515103,0.00006634069,0.00008012669,0.000043897147,0.00012608217,0.000075402626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011537537,0.006721426,0.4296638,0.0044455156,0.0008498243,0.015002706,0.00038616752,0.0014877473,0.015797118,0.003854504,0.35412335,0.16651407],"study_design_scores_gemma":[0.0019222016,0.00005856392,0.0049571395,0.00034681888,0.0005415344,0.000066606866,0.0003226978,0.00008427029,0.004851095,0.0013666197,0.9853046,0.0001778854],"about_ca_topic_score_codex":0.000015499223,"about_ca_topic_score_gemma":0.0000047712992,"teacher_disagreement_score":0.6311812,"about_ca_system_score_codex":0.00001022855,"about_ca_system_score_gemma":0.00021518086,"threshold_uncertainty_score":0.42240033},"labels":[],"label_agreement":null},{"id":"W4412984585","doi":"10.1182/bloodadvances.2025016949","title":"Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); Princess Margaret Cancer Centre","funders":"Genentech; Servier; Regeneron Pharmaceuticals; Cilag; Astellas Pharma; Alexion Pharmaceuticals; Seagen; Gilead Sciences; BeiGene; Sanofi; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Tolerability; Adverse effect; Dosing; Photophobia; Refractory (planetary science); Internal medicine; Surgery","score_opus":0.0425052666653595,"score_gpt":0.3572799157750413,"score_spread":0.31477464910968184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412984585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923121,0.0025172126,0.0007118863,0.0027564971,0.00006724188,0.00081811164,0.0000069786706,0.000020113275,0.00078987406],"genre_scores_gemma":[0.9969635,0.0003064406,0.002182124,0.0004332258,0.000030713578,0.000031364023,0.0000060698635,0.0000047107023,0.000041824384],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886614,0.00017761589,0.00043811536,0.00025215695,0.00014677418,0.00011920142],"domain_scores_gemma":[0.9990501,0.0005069717,0.00011882423,0.00023650481,0.00004606128,0.000041535288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010719699,0.000104180646,0.0004572024,0.00010039477,0.000055802288,0.000019683173,0.00006975589,0.000049133672,0.0000068024256],"category_scores_gemma":[0.0005581666,0.0000724464,0.0000308522,0.00029329918,0.0000568178,0.000075454926,0.000028754244,0.000085441476,6.918088e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014176526,0.0027917817,0.30335692,0.0011697336,0.00024386609,0.000008623398,0.0049846675,0.0001272559,0.34236163,0.057293452,0.00009962037,0.2861448],"study_design_scores_gemma":[0.0068636043,0.00038875217,0.87320125,0.00064655306,0.00036558762,0.000017317583,0.0009086426,0.00026484678,0.11030155,0.005428468,0.0014544394,0.0001589781],"about_ca_topic_score_codex":0.000029117457,"about_ca_topic_score_gemma":0.000026545044,"teacher_disagreement_score":0.56984437,"about_ca_system_score_codex":0.000007937318,"about_ca_system_score_gemma":0.000029292036,"threshold_uncertainty_score":0.29542783},"labels":[],"label_agreement":null},{"id":"W4413114116","doi":"10.1182/bloodadvances.2025017004","title":"Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Atypical hemolytic uremic syndrome; Eculizumab; Discontinuation; Odds ratio; Meta-analysis; Internal medicine; Cohort; Subgroup analysis; Cohort study; Hazard ratio; Confidence interval; Immunology; Intensive care medicine; Pediatrics; Complement system; Antibody","score_opus":0.03573699454088747,"score_gpt":0.34614895355600694,"score_spread":0.3104119590151195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022451732,0.9949846,0.000012459359,0.000026769349,0.000052987984,0.004497419,0.00033765586,0.000025662184,0.000039973023],"genre_scores_gemma":[0.0015231431,0.9960828,0.000030543648,0.0000262966,0.0000024706083,0.0011291243,0.00053626526,0.000014392668,0.00065499893],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957894,0.0013172083,0.0019743112,0.00058865035,0.00008127455,0.00024913467],"domain_scores_gemma":[0.99658877,0.0014055908,0.0012088316,0.0007196098,0.00005539406,0.00002179864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049197616,0.00047361729,0.010087734,0.00052340364,0.000043768865,0.0000124161215,0.00042885044,0.00018196044,0.00027148728],"category_scores_gemma":[0.0007757166,0.00031446453,0.0019163446,0.0010309067,0.000107734915,0.000084991865,0.00015387106,0.00020682476,0.000025592062],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005925913,0.00023208288,0.000009773715,0.895443,0.10315901,0.000009320217,0.000009735054,6.8333776e-7,4.5715234e-7,0.00009653286,0.000028367385,0.0010050785],"study_design_scores_gemma":[0.00037713867,0.00004434729,0.000013838223,0.13861011,0.85551256,0.0000882051,0.000010987241,8.1846416e-8,0.0000021452524,0.000014501871,0.005089734,0.00023635782],"about_ca_topic_score_codex":0.000010546523,"about_ca_topic_score_gemma":0.000040883213,"teacher_disagreement_score":0.7568329,"about_ca_system_score_codex":0.000035584755,"about_ca_system_score_gemma":0.00012270616,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W4413139122","doi":"10.1182/bloodadvances.2024015599","title":"New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Legend Biotech; Pharmacyclics; Eurostars; Genentech; National Institutes of Health; Juno Therapeutics; Astellas Pharma; Swedish Orphan Biovitrum; Omeros Corporation; BeiGene; Pfizer; Incyte; bluebird bio; Jazz Pharmaceuticals; National Cancer Institute; Servier; Gilead Sciences; Moffitt Cancer Center; Society for Immunotherapy of Cancer; Cidara Therapeutics; Celgene; Fred Hutchinson Cancer Research Center; Karyopharm Therapeutics; Memorial Sloan-Kettering Cancer Center; Massachusetts General Hospital; Amgen; Bristol-Myers Squibb","keywords":"Medicine; Comorbidity; Internal medicine; Hazard ratio; Lymphoma; Diabetes mellitus; Gastroenterology; Confidence interval","score_opus":0.01401590502790424,"score_gpt":0.2952427108687055,"score_spread":0.2812268058408013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413139122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973092,0.01315073,0.0014079666,0.00046886518,0.0004231048,0.0016381199,0.00009827484,0.00015077404,0.009570167],"genre_scores_gemma":[0.9316506,0.0047819745,0.0015941453,0.00067220157,0.00033627747,0.00019824614,0.00014039189,0.00007917768,0.060546983],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979939,0.000109652836,0.00027862843,0.0005030301,0.00048130917,0.00063352135],"domain_scores_gemma":[0.99875677,0.00030233635,0.00012335599,0.0004267159,0.00020123454,0.00018961105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037372924,0.00029606387,0.0005480803,0.00015901266,0.00013623075,0.00004609204,0.00022537891,0.00013978544,0.0011087407],"category_scores_gemma":[0.00006395172,0.00023103759,0.00017059837,0.000650824,0.000069174566,0.00014058096,0.000051431787,0.00018302453,0.000020548077],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013637892,0.009900228,0.73351663,0.00036271662,0.0012494336,0.00007145196,0.0005205183,0.000005765432,0.124691665,0.00006350302,0.006232975,0.10974721],"study_design_scores_gemma":[0.05803588,0.0020124048,0.12753688,0.00023980044,0.0001682274,0.0000044192993,0.00025240902,0.000054100758,0.20951216,0.00016703538,0.6015111,0.000505576],"about_ca_topic_score_codex":0.00007815458,"about_ca_topic_score_gemma":0.0001754661,"teacher_disagreement_score":0.60597974,"about_ca_system_score_codex":0.000079960235,"about_ca_system_score_gemma":0.00053746754,"threshold_uncertainty_score":0.9998044},"labels":[],"label_agreement":null},{"id":"W4413141479","doi":"10.1182/bloodadvances.2024015600","title":"Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; Ottawa Hospital; University of Ottawa; Health Canada","funders":"Pharmacyclics; Genentech; Astellas Pharma; EUSA Pharma; Seagen; Regeneron Pharmaceuticals; Incyte; F. Hoffmann-La Roche; Kite Pharma; Gilead Sciences; Ipsen; BeiGene; Daiichi Sankyo Europe; University College London Hospitals NHS Foundation Trust; Sanofi; Swedish Orphan Biovitrum; Omeros Corporation; Spectrum Pharmaceuticals; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Refractory (planetary science); Clinical endpoint; Adverse effect; Lymphoma; Surgery; Gastroenterology; Oncology; Clinical trial; Hodgkin lymphoma","score_opus":0.021684557376753625,"score_gpt":0.35288138836029603,"score_spread":0.3311968309835424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413141479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98413724,0.00847925,0.00008027724,0.0007662387,0.00040998746,0.002430623,0.00004993616,0.00016992226,0.0034765017],"genre_scores_gemma":[0.9887374,0.0004808193,0.0017480744,0.00048013811,0.00016496766,0.0011575987,0.00004305114,0.000027105363,0.0071608624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984999,0.000042246407,0.00039496087,0.00050919474,0.00022350911,0.0003301925],"domain_scores_gemma":[0.99876803,0.00040757316,0.00012705367,0.00046420688,0.000115691146,0.00011745022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013234362,0.0002697705,0.00054882176,0.00016104586,0.00016570545,0.000028799195,0.00011643509,0.00006982349,0.000052795192],"category_scores_gemma":[0.00028040132,0.00018227099,0.0001471506,0.0003335342,0.00006200251,0.00014489838,0.000044974968,0.00005107248,0.000015678183],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007848652,0.090766065,0.1774907,0.00061351474,0.0020897172,0.001227331,0.0005203647,0.0000039428546,0.0016587911,0.00084957725,0.006833083,0.71009827],"study_design_scores_gemma":[0.2681644,0.027750595,0.1423629,0.0007691424,0.004790532,0.00011207375,0.0024560879,0.00012245942,0.02590116,0.00052053964,0.52639997,0.00065013836],"about_ca_topic_score_codex":0.000037567457,"about_ca_topic_score_gemma":0.00010266894,"teacher_disagreement_score":0.70944816,"about_ca_system_score_codex":0.00016907956,"about_ca_system_score_gemma":0.00036438456,"threshold_uncertainty_score":0.7432795},"labels":[],"label_agreement":null},{"id":"W4413257665","doi":"10.1182/bloodadvances.2025016778","title":"Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Omeros Corporation; Angiocrine Bioscience; Gilead Sciences; Sanofi; Bristol-Myers Squibb; National Cancer Institute; Incyte; Royal College of Physicians and Surgeons of Canada; Amgen","keywords":"CD19; Lymphoma; B cell; Cell; Cancer research; Medicine; Biology; Immunology; Antibody; Genetics","score_opus":0.020859460373952095,"score_gpt":0.3463436107200448,"score_spread":0.32548415034609274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413257665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8826783,0.009559349,0.000007353844,0.0002787138,0.0001300541,0.00063480274,0.00003024559,0.00009654752,0.106584646],"genre_scores_gemma":[0.93993074,0.0022718247,0.00075436325,0.00017438407,0.000035056903,0.000059851292,0.0000214789,0.000020814603,0.056731492],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982537,0.00014928693,0.00044960534,0.00035961563,0.00037044927,0.00041733115],"domain_scores_gemma":[0.9988324,0.00037500096,0.00012548784,0.00042616515,0.00016367694,0.0000772855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026576206,0.00023635224,0.00086620584,0.00048241008,0.000055954886,0.000013460794,0.00020946455,0.00006945393,0.00037091455],"category_scores_gemma":[0.00003581298,0.00019127665,0.0001478909,0.0010024436,0.00014890764,0.00010923364,0.0000709204,0.00017674995,0.00001363188],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007491549,0.004817383,0.7908512,0.0004386912,0.00032732254,0.000059682683,0.0022413058,0.000010431314,0.19498992,0.0005141642,0.0004249892,0.004575768],"study_design_scores_gemma":[0.020921735,0.00036778793,0.39261222,0.00024574687,0.00014511695,0.00000246636,0.0023398332,0.00009239961,0.52514774,0.00039980432,0.05745122,0.0002739249],"about_ca_topic_score_codex":0.00040176304,"about_ca_topic_score_gemma":0.0025353234,"teacher_disagreement_score":0.39823896,"about_ca_system_score_codex":0.000075878444,"about_ca_system_score_gemma":0.00021551909,"threshold_uncertainty_score":0.7800035},"labels":[],"label_agreement":null},{"id":"W4413258081","doi":"10.1182/bloodadvances.2025016670","title":"Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; University of Toronto; Hospital for Sick Children","funders":"National Institutes of Health; York University; National Cancer Institute; Children's Cancer Research Fund","keywords":"Medicine; Ethnic group; Hazard ratio; Socioeconomic status; Confidence interval; Quartile; Internal medicine; Demography; Gerontology; Population; Environmental health","score_opus":0.004700426683825824,"score_gpt":0.2766454076069605,"score_spread":0.2719449809231347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413258081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917631,0.0034730833,0.00007986302,0.0002813501,0.000056353296,0.00087802083,0.000011510776,0.000048459675,0.0034082339],"genre_scores_gemma":[0.9965327,0.001019298,0.0018905806,0.000068712405,0.000055810615,0.00006321232,0.000055478984,0.00002185874,0.00029234975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802685,0.00012176539,0.000497653,0.00055148307,0.00041582301,0.0003864017],"domain_scores_gemma":[0.998847,0.00029292481,0.0002253626,0.0003880886,0.000119227145,0.00012740462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004867559,0.00020799293,0.0006545582,0.00022888447,0.000046516598,0.000008492612,0.00015357553,0.00016785518,0.000010831538],"category_scores_gemma":[0.0004984067,0.00016207864,0.000049515416,0.0004691741,0.00040179284,0.00017456253,0.0001425849,0.0004174038,0.0000010068942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016478976,0.0006650934,0.9896005,0.00010262287,0.00027289972,0.00034576192,0.00042758803,0.000015467083,0.001640316,0.00014890812,0.000033142067,0.005099815],"study_design_scores_gemma":[0.011779309,0.0009528785,0.98153144,0.0005188898,0.00020191056,0.00086315797,0.00039118892,0.00012637906,0.0031961494,0.000101203375,0.0001896545,0.00014784651],"about_ca_topic_score_codex":0.0020828887,"about_ca_topic_score_gemma":0.004927612,"teacher_disagreement_score":0.010131412,"about_ca_system_score_codex":0.00017142537,"about_ca_system_score_gemma":0.0004506838,"threshold_uncertainty_score":0.6609375},"labels":[],"label_agreement":null},{"id":"W4413258423","doi":"10.1182/bloodadvances.2025017116","title":"The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; José Carreras Leukämie-Stiftung; Medpace; National Cancer Institute; National Institutes of Health; Alexion Pharmaceuticals; Japan Society for the Promotion of Science; AstraZeneca","keywords":"Medicine; Internal medicine; Biomarker; Clinical endpoint; Cohort; Gastroenterology; Severity of illness; Oncology; Clinical trial","score_opus":0.07282915183811059,"score_gpt":0.42716469436268084,"score_spread":0.3543355425245702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413258423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97530144,0.010007332,0.00070244615,0.012157101,0.00032586217,0.00057777745,0.000030701834,0.00003251567,0.0008648184],"genre_scores_gemma":[0.96610975,0.0016477929,0.029694324,0.0018655086,0.000032062548,0.00017149476,0.000012324177,0.000012343981,0.0004543984],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99915403,0.000053950236,0.00029149937,0.0002450469,0.0000894376,0.00016600794],"domain_scores_gemma":[0.9967247,0.0029019155,0.00007587293,0.00019142793,0.00004721242,0.00005884939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004641173,0.000115275325,0.00023010105,0.000042263546,0.00015343894,0.000046157562,0.000059874823,0.000042850912,0.0000064900196],"category_scores_gemma":[0.0004845111,0.00006710224,0.00012153129,0.000098344135,0.00018500857,0.000050565137,0.000037918355,0.00008024992,0.0000016449865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00731589,0.001806527,0.37422737,0.00010550995,0.0038113159,0.000072148454,0.0002090239,0.000001945239,0.0075323307,0.0052176546,0.0022503063,0.59744996],"study_design_scores_gemma":[0.014799225,0.0021105192,0.8709601,0.00053282926,0.0031556145,0.00011153436,0.0010081406,0.00055902224,0.02669813,0.0021797002,0.07761806,0.00026708623],"about_ca_topic_score_codex":0.0000075866387,"about_ca_topic_score_gemma":0.00001781803,"teacher_disagreement_score":0.59718287,"about_ca_system_score_codex":0.000010708547,"about_ca_system_score_gemma":0.000046776902,"threshold_uncertainty_score":0.273635},"labels":[],"label_agreement":null},{"id":"W4413316408","doi":"10.1182/bloodadvances.2025017214","title":"Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Ontario Institute for Cancer Research","funders":"Astellas Pharma; International Myeloma Society; Celgene; BeiGene; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Multiple myeloma; Medicine; Internal medicine; Odds ratio; Confidence interval; Population; Disease; Stage (stratigraphy); Bone marrow; Biology; Environmental health","score_opus":0.03007711981643215,"score_gpt":0.38988789659169804,"score_spread":0.3598107767752659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413316408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907638,0.0060952483,0.000020475045,0.00016011714,0.000033514956,0.001958857,0.00003852324,0.000018831093,0.0009106284],"genre_scores_gemma":[0.9982887,0.00065891654,0.00027282172,0.000013141367,0.000018464098,0.00038867295,0.000033781154,0.0000052031182,0.00032031376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983903,0.00024772406,0.00030859772,0.00042946805,0.0004172774,0.00020661556],"domain_scores_gemma":[0.9989076,0.00028560657,0.00009383669,0.00029071435,0.00027232696,0.0001498896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059870526,0.00013349057,0.00041979618,0.0006401236,0.000052942272,0.0000057719303,0.00007446724,0.00002680685,0.000040800904],"category_scores_gemma":[0.0015991847,0.00010116484,0.000057948724,0.0012197868,0.00015740306,0.00009890332,0.000059816437,0.00008473375,9.2917355e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048330083,0.0017316935,0.98683584,0.00018775855,0.0006878037,0.000026509713,0.00020918183,0.00003285833,0.00015254383,0.00011029541,0.0000027647393,0.0095394375],"study_design_scores_gemma":[0.008648551,0.00032798637,0.9842708,0.00012620431,0.003245625,2.962872e-7,0.0002569235,0.0016930011,0.0004865881,0.0008595809,0.000017860933,0.00006657708],"about_ca_topic_score_codex":0.00056781573,"about_ca_topic_score_gemma":0.008478567,"teacher_disagreement_score":0.00947286,"about_ca_system_score_codex":0.00007294746,"about_ca_system_score_gemma":0.00023309776,"threshold_uncertainty_score":0.4731239},"labels":[],"label_agreement":null},{"id":"W4413316564","doi":"10.1182/bloodadvances.2024015282","title":"Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Takeda Oncology; Genentech; National Institutes of Health; Kyowa Hakko Kirin; Memorial Sloan-Kettering Cancer Center; Chugai Pharmaceutical; Celltrion; Seagen; Kite Pharma; Gilead Sciences; Eisai; BeiGene; Daiichi Sankyo Europe; Sanofi; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"CHOP; Medicine; Prednisone; Internal medicine; Vincristine; Anaplastic large-cell lymphoma; Cyclophosphamide; Lymphoma; Oncology; Peripheral T-cell lymphoma; Chemotherapy; Gastroenterology; Immunology; T cell; Immune system","score_opus":0.011150924414558954,"score_gpt":0.3162519335843498,"score_spread":0.3051010091697908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413316564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928603,0.00082615396,0.00000392441,0.0022281355,0.00008220494,0.00082257384,0.0000069291777,0.000010372821,0.0031594085],"genre_scores_gemma":[0.99021626,0.0003027412,0.00024924806,0.00015999669,0.000039433973,0.00007051973,0.000003363359,0.000011283116,0.008947178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981914,0.00042806534,0.0004054427,0.00019839528,0.0005439734,0.0002327302],"domain_scores_gemma":[0.9982365,0.0011681808,0.00017423746,0.00029464375,0.000101497084,0.000024975001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015947819,0.00012463967,0.000477765,0.00024429942,0.000022736109,0.000009788639,0.00018412663,0.00008284899,0.00009317133],"category_scores_gemma":[0.00067879685,0.000080747435,0.00008973454,0.00066091225,0.00006261886,0.000088613444,0.000027392703,0.0001645931,0.0000010378643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18379147,0.002180246,0.75769,0.00018336937,0.00014419471,0.000039387116,0.0018885649,0.000029952367,0.047465947,0.000035527864,0.00006906072,0.006482257],"study_design_scores_gemma":[0.14599614,0.002384686,0.78620076,0.00022750287,0.000116706666,0.000004576729,0.0018799468,0.000028113513,0.054546166,0.0001262934,0.008356874,0.00013223293],"about_ca_topic_score_codex":0.00013694825,"about_ca_topic_score_gemma":0.00066225184,"teacher_disagreement_score":0.037795343,"about_ca_system_score_codex":0.00015097513,"about_ca_system_score_gemma":0.00034368155,"threshold_uncertainty_score":0.3292785},"labels":[],"label_agreement":null},{"id":"W4413420129","doi":"10.1182/bloodadvances.2024015611","title":"Reflecting on 30 years of miRNA biology in malignant hematology: current challenges and future directions","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"microRNA; Biology; Computational biology; Context (archaeology); Haematopoiesis; Microvesicles; Systems biology; Hematology; Translation (biology); Myeloid leukemia; Bioinformatics; Stem cell; Cancer research; Messenger RNA; Immunology; Genetics; Gene","score_opus":0.018619598931487652,"score_gpt":0.3317485239265706,"score_spread":0.31312892499508294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413420129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7514014,0.24769482,0.00000907051,0.00015403578,0.00017575623,0.0000789863,0.000004671544,0.0000056378876,0.0004755657],"genre_scores_gemma":[0.9494032,0.0501996,0.00024445623,0.00001803235,0.00008857253,0.000018089302,0.000012819542,0.000004938459,0.000010283237],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948084,0.00004600315,0.00013195988,0.00021780693,0.00002458442,0.00009881025],"domain_scores_gemma":[0.99975795,0.000018455108,0.00006116267,0.00012450297,0.000021595975,0.000016355561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006035978,0.000069299844,0.0001151055,0.00007274355,0.000020953226,0.0000019687552,0.000051155228,0.00007078901,0.000002175413],"category_scores_gemma":[0.000040220337,0.00006786208,0.00002550214,0.00006332529,0.000049291633,0.0000024214858,0.000036562764,0.00004658394,4.4178668e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067132954,0.00030820214,0.010134711,0.00022060802,0.00007506896,0.0000026433725,0.00014131959,0.000013263572,0.4803901,0.009567129,0.00003133478,0.4990485],"study_design_scores_gemma":[0.0013431463,0.00031251097,0.12570918,0.00035097264,0.000060151095,0.000015676344,0.00036418976,0.000008176305,0.47631943,0.0037239094,0.39153022,0.0002624226],"about_ca_topic_score_codex":0.0000018549114,"about_ca_topic_score_gemma":0.000043498265,"teacher_disagreement_score":0.49878606,"about_ca_system_score_codex":0.0000041976414,"about_ca_system_score_gemma":0.000022049913,"threshold_uncertainty_score":0.27673352},"labels":[],"label_agreement":null},{"id":"W4413420152","doi":"10.1182/bloodadvances.2025016485","title":"Diagnosis of von Willebrand disease","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Pfizer","keywords":"Von Willebrand disease; Medicine; Von Willebrand factor; Intensive care medicine; Disease; Pediatrics; Immunology; Pathology","score_opus":0.005399719638762212,"score_gpt":0.26827675073004686,"score_spread":0.26287703109128463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413420152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610397,0.03195882,0.000009088149,0.0007030252,0.00006935538,0.00016476322,0.000019292096,0.000020157055,0.0060157655],"genre_scores_gemma":[0.9944254,0.004100784,0.00023137694,0.00018851882,0.000011810026,0.000039376337,0.0000140185975,0.000003957429,0.0009847477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996173,0.0000058542146,0.00010048883,0.000113769165,0.000076428725,0.000086179425],"domain_scores_gemma":[0.999736,0.000042233456,0.00002872356,0.000117530995,0.000022669334,0.000052851512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014813744,0.00006507407,0.00017885845,0.000048958784,0.000025216645,0.0000026734544,0.000030021376,0.000015754587,0.000044062763],"category_scores_gemma":[0.00005262821,0.000049054288,0.000053915144,0.000117528594,0.000035912104,0.000056308112,0.000011822859,0.000025384012,0.0000044382623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015462594,0.00084595586,0.9596435,0.00021924448,0.00015633153,0.00015048271,0.000018875717,0.0000041374124,0.00009150063,0.00035181618,0.00037450067,0.03798903],"study_design_scores_gemma":[0.011295663,0.0003726206,0.8137339,0.0011413081,0.001842011,0.0000111124045,0.00011868552,0.000020586036,0.039180174,0.008583068,0.12348898,0.00021193853],"about_ca_topic_score_codex":0.00000671353,"about_ca_topic_score_gemma":0.000006609012,"teacher_disagreement_score":0.14590964,"about_ca_system_score_codex":0.0000038433072,"about_ca_system_score_gemma":0.000033335615,"threshold_uncertainty_score":0.20003758},"labels":[],"label_agreement":null},{"id":"W4413425365","doi":"10.1182/bloodadvances.2025017219","title":"<i>USP7</i> alterations are associated with a poor survival in pediatric T-cell acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa; Instituto de Salud Carlos III; Eusko Jaurlaritza; Fundación Mutua Madrileña; Euskal Herriko Unibertsitatea; St. Jude Children's Research Hospital","keywords":"Lymphoblastic Leukemia; Medicine; Leukemia; Overall survival; Oncology; Internal medicine; Cancer research","score_opus":0.007774489894771825,"score_gpt":0.2614250162620494,"score_spread":0.2536505263672776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413425365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802527,0.0022690492,0.0011729785,0.00088824733,0.00028943917,0.0008393224,0.000078696234,0.00018757807,0.014022023],"genre_scores_gemma":[0.9917199,0.00087172136,0.00085079117,0.0006142282,0.0001883727,0.00014671685,0.00008278827,0.000042918582,0.00548257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755806,0.00011543794,0.00046344532,0.0005733615,0.0006258566,0.00066386507],"domain_scores_gemma":[0.99824226,0.00077381765,0.00017971847,0.00036183503,0.00025670513,0.00018564411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025084856,0.00031476392,0.0005885706,0.00047076077,0.00014702196,0.000056175228,0.00024812834,0.00015351098,0.000033725806],"category_scores_gemma":[0.00056449074,0.00025340673,0.00008677173,0.0018334106,0.00012506016,0.00025783616,0.00010345004,0.00035652777,0.00003825448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017560796,0.0029218558,0.9749439,0.0009860548,0.0008942289,0.0031168007,0.00035148126,0.002353352,0.004668479,0.00056654174,0.0057212464,0.0017199857],"study_design_scores_gemma":[0.13845998,0.0040971222,0.7817361,0.003811182,0.008175283,0.00041444533,0.0017151762,0.016143642,0.0325706,0.0011798565,0.00906657,0.002630047],"about_ca_topic_score_codex":0.000052850133,"about_ca_topic_score_gemma":0.0005757749,"teacher_disagreement_score":0.1932078,"about_ca_system_score_codex":0.000975519,"about_ca_system_score_gemma":0.0025307157,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W4413680874","doi":"10.1182/bloodadvances.2025016701","title":"Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Hospital for Sick Children","funders":"Medac; Swedish Orphan Biovitrum; Incyte; bluebird bio; Jazz Pharmaceuticals; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Gilead Sciences; Sanofi; Amgen; Pfizer; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Disease; Medicine; Quality of life (healthcare); Cell; Intensive care medicine; Internal medicine; Pediatrics; Biology; Genetics","score_opus":0.0047812848538065795,"score_gpt":0.2410163927468761,"score_spread":0.23623510789306953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413680874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853148,0.012275103,0.0000058200017,0.00048583804,0.00008981766,0.0007670165,0.00003509154,0.00002272112,0.0010038093],"genre_scores_gemma":[0.99819654,0.00034965802,0.00018734473,0.0006124138,0.000004551495,0.00003981891,0.000038068538,0.000012467449,0.00055913994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983346,0.00008757599,0.00075544824,0.0002992964,0.00023235976,0.00029074214],"domain_scores_gemma":[0.99929017,0.000035393994,0.00021215728,0.00024547827,0.00005738183,0.00015944825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019099191,0.0001613016,0.0004666465,0.0001600276,0.000025212868,0.0000038834332,0.00007030151,0.000078843776,0.000041278487],"category_scores_gemma":[0.00008111458,0.0001236644,0.00005139892,0.00048116525,0.00006681267,0.00009668863,0.00003941592,0.00019239567,0.0000031670775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017475992,0.0022826442,0.990282,0.0013179168,0.000044685552,0.000012264856,0.00017880303,0.00024712711,0.00004839575,0.000020295858,0.000018866802,0.0037994196],"study_design_scores_gemma":[0.013443264,0.00034983232,0.98444664,0.0007470821,0.000040922485,1.2053327e-7,0.00022714213,0.000025994703,0.00012445424,0.00014398656,0.00031428234,0.00013625073],"about_ca_topic_score_codex":0.0004619262,"about_ca_topic_score_gemma":0.00018771939,"teacher_disagreement_score":0.012881753,"about_ca_system_score_codex":0.00005297734,"about_ca_system_score_gemma":0.0003662344,"threshold_uncertainty_score":0.5042888},"labels":[],"label_agreement":null},{"id":"W4413745962","doi":"10.1182/bloodadvances.2025016702","title":"Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcel","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; BC Children's Hospital; Hospital for Sick Children","funders":"National Institutes of Health; Swedish Orphan Biovitrum; bluebird bio; Jazz Pharmaceuticals; Alexion Pharmaceuticals; Vertex Pharmaceuticals; Chiesi USA; Silence Therapeutics; Sanofi; Amgen; Pfizer; National Center for Advancing Translational Sciences; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Thalassemia; Medicine; Quality of life (healthcare); Blood transfusion; Beta thalassemia; Intensive care medicine; Pediatrics; Internal medicine; Nursing","score_opus":0.0054438541655944485,"score_gpt":0.2535369022453521,"score_spread":0.24809304807975763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413745962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950917,0.008007785,0.00002043581,0.00055582466,0.00013468739,0.00091662334,0.000017994844,0.00002445019,0.0008130157],"genre_scores_gemma":[0.99808544,0.0009975254,0.00020930408,0.0003654244,0.000004413904,0.000051402443,0.000021483967,0.000013238065,0.00025179138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979305,0.00010437292,0.0010038412,0.00033630943,0.00031243358,0.0003125378],"domain_scores_gemma":[0.99935365,0.000045212688,0.00020003294,0.00023304559,0.000065266955,0.00010280403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033565078,0.00017700734,0.00058693293,0.00023145166,0.000028254568,0.0000040996592,0.00007932144,0.00013686775,0.000047683134],"category_scores_gemma":[0.000077910576,0.00013382934,0.00005686826,0.00054567825,0.00006460639,0.000095190146,0.000026945654,0.0002719458,0.0000019705765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013252756,0.0019100894,0.9852708,0.0007353894,0.00008580371,0.000011122465,0.00033109088,0.00011968881,0.00040629535,0.000030673764,0.0000053937733,0.009768393],"study_design_scores_gemma":[0.0154538965,0.000574653,0.98154753,0.0010096843,0.000035678648,4.9793414e-7,0.0003724793,0.00001569377,0.0006187678,0.00010728473,0.00013158406,0.00013222154],"about_ca_topic_score_codex":0.0011323433,"about_ca_topic_score_gemma":0.0009861329,"teacher_disagreement_score":0.014128621,"about_ca_system_score_codex":0.00007384688,"about_ca_system_score_gemma":0.0002978493,"threshold_uncertainty_score":0.5457402},"labels":[],"label_agreement":null},{"id":"W4413965630","doi":"10.1182/bloodadvances.2025016915","title":"Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"NIH Clinical Center; National Cancer Institute; Medac; Swedish Orphan Biovitrum; bluebird bio; Atara Biotherapeutics; Memorial Sloan-Kettering Cancer Center; Les Laboratories Pierre Fabre; Celgene; Sanofi; Bristol-Myers Squibb; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Immune system; Transplantation; Flow cytometry; Medicine; Hematopoietic cell; CD8; Immunology; Limiting; Oncology; Intensive care medicine; Haematopoiesis; Internal medicine; Stem cell; Biology","score_opus":0.019579479921312582,"score_gpt":0.31210634472210913,"score_spread":0.29252686480079654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413965630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378681,0.054142002,0.0024770165,0.0040331963,0.0005879084,0.00039502778,0.000009340606,0.000054772714,0.0004326268],"genre_scores_gemma":[0.9816052,0.0058467444,0.011651793,0.00026630895,0.00019100282,0.000094532115,0.000006142016,0.000012436636,0.00032586444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989243,0.000079787875,0.00032385575,0.00030007545,0.00019528354,0.00017666542],"domain_scores_gemma":[0.9984524,0.0011123095,0.00008090698,0.0002603768,0.000044298835,0.00004969409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024272953,0.0001463486,0.00025271217,0.000032980948,0.00007030085,0.000056170386,0.00007616355,0.000057091154,0.00003712628],"category_scores_gemma":[0.0003471948,0.000103543374,0.000061116094,0.00012235933,0.0000927745,0.00047709767,0.000049645045,0.00019593087,0.000013709412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019687056,0.00025740787,0.84347796,0.00046210116,0.00022322287,0.0002789773,0.0009239785,8.208311e-7,0.13792811,0.00013067498,0.000062167564,0.01428587],"study_design_scores_gemma":[0.0029309096,0.00019772966,0.866708,0.008299126,0.0007965688,0.0002086611,0.00093758054,0.00002898358,0.11382852,0.0005409143,0.0053029233,0.00022007471],"about_ca_topic_score_codex":0.00007271302,"about_ca_topic_score_gemma":0.000020259715,"teacher_disagreement_score":0.048295256,"about_ca_system_score_codex":0.000020518883,"about_ca_system_score_gemma":0.00003898281,"threshold_uncertainty_score":0.4222376},"labels":[],"label_agreement":null},{"id":"W4414051486","doi":"10.1182/bloodadvances.2024015427","title":"The lncRNA <i>ELDR</i> suppresses tumorigenicity of AML by interfering with DNA replication and chromatin accessibility","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut de Readaptation Gingras Lindsay de Montreal; Institute for Research in Immunology and Cancer; McGill University; Université de Montréal; Hôpital Maisonneuve-Rosemont; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Chromatin; DNA replication; Myeloid leukemia; Demethylase; Chromatin immunoprecipitation; Replication factor C; Proliferating cell nuclear antigen; Small interfering RNA; Transcription factor","score_opus":0.006719221263422101,"score_gpt":0.2986539211420436,"score_spread":0.2919346998786215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414051486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894536,0.006513913,0.00033881326,0.0012099445,0.000029811386,0.00044412288,0.000014213976,0.000041688254,0.0024621102],"genre_scores_gemma":[0.9971241,0.001225845,0.0008117676,0.000091421294,0.00002780949,0.000059763555,0.000009470299,0.000009010042,0.00064084935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989348,0.000052362517,0.00026898418,0.0003493376,0.00020361727,0.00019088043],"domain_scores_gemma":[0.99871796,0.00032747563,0.000118760145,0.00064847484,0.00013364639,0.00005370451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035084912,0.00011321396,0.00023332727,0.000038513273,0.00013505854,0.000032218948,0.00021405827,0.000034696146,0.0000086154905],"category_scores_gemma":[0.00043543754,0.00006676848,0.000026153397,0.00025712597,0.00030552805,0.0001905252,0.00013192499,0.00017339233,6.8220453e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011740342,0.0003459682,0.23765764,0.0013286048,0.0002875827,0.000009498311,0.0002878616,0.0000042403703,0.6951289,0.00042766056,0.0022846207,0.06106339],"study_design_scores_gemma":[0.0012437351,0.00026017832,0.053462643,0.00026083415,0.00009052836,0.000019783167,0.00028253897,0.0000911931,0.9352606,0.0003291702,0.00861996,0.00007882542],"about_ca_topic_score_codex":0.00006450622,"about_ca_topic_score_gemma":0.0000651937,"teacher_disagreement_score":0.2401317,"about_ca_system_score_codex":0.000040520797,"about_ca_system_score_gemma":0.00013973289,"threshold_uncertainty_score":0.27227396},"labels":[],"label_agreement":null},{"id":"W4414083768","doi":"10.1182/bloodadvances.2025017107","title":"Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Spinal Cord Injury BC","funders":"Terry Fox Research Institute; Eisai; Provincial Health Services Authority; Genome British Columbia; Veracyte; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Genome Canada; Uehara Memorial Foundation; Genentech; AstraZeneca","keywords":"Tumor microenvironment; Lymphoma; Immune system; B cell; Population; Antibody; Diffuse large B-cell lymphoma; Flow cytometry","score_opus":0.004965431327938098,"score_gpt":0.2131167080039927,"score_spread":0.20815127667605463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414083768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9018543,0.09596767,0.00006726653,0.0006133954,0.00046715603,0.00024874444,0.00010327831,0.00005509034,0.0006231241],"genre_scores_gemma":[0.98995066,0.0052410676,0.00010803085,0.00042666338,0.000040629453,0.00009262869,0.000070856775,0.000011632072,0.004057809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985271,0.00018986085,0.00032364996,0.00051471876,0.000030838866,0.0004138171],"domain_scores_gemma":[0.99895924,0.000615695,0.00014725245,0.0002297985,0.000015824622,0.000032174226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011103392,0.00025140494,0.00045038748,0.00007886078,0.0002531923,0.000019232699,0.00023577258,0.00016529976,0.000105253224],"category_scores_gemma":[0.00013068477,0.00020646017,0.000060226525,0.0001293928,0.00047881296,0.00007447884,0.00012203943,0.00016393619,0.000046665053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008213448,0.00024840463,0.79354393,0.00006785766,0.00033605946,0.000009217126,0.00007017535,3.1044112e-7,0.12353535,0.00026508622,0.0047578854,0.07708356],"study_design_scores_gemma":[0.0034920403,0.00048497698,0.747471,0.00014763667,0.00027117095,0.000036056266,0.00017444823,2.097254e-7,0.070320785,0.001119444,0.17615905,0.0003231949],"about_ca_topic_score_codex":0.000056284214,"about_ca_topic_score_gemma":0.00005132185,"teacher_disagreement_score":0.17140117,"about_ca_system_score_codex":0.000030892745,"about_ca_system_score_gemma":0.000045197736,"threshold_uncertainty_score":0.84192014},"labels":[],"label_agreement":null},{"id":"W4414161409","doi":"10.1182/bloodadvances.2025017674","title":"Developing an artificial intelligence–generated peptide targeting platelet-type von Willebrand disease","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Lawrence College; Queen's University; Carleton University; University of Ottawa","funders":"","keywords":"In silico; Peptide; Von Willebrand factor; Platelet; In vivo; Ex vivo; Glycoprotein; Von Willebrand disease","score_opus":0.022556189673556267,"score_gpt":0.30877310556409626,"score_spread":0.28621691589054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414161409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941857,0.0073991558,0.0010070362,0.00047502838,0.00034572947,0.0003202373,0.000009508353,0.00013962714,0.0008850986],"genre_scores_gemma":[0.9919016,0.0012071572,0.00560552,0.0004419418,0.0001162461,0.000020813273,0.00022568324,0.000019278463,0.0004617633],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987988,0.00003163112,0.0003156103,0.0003792717,0.00016289277,0.00031179798],"domain_scores_gemma":[0.9994503,0.000042926917,0.00006694926,0.00017562005,0.00011022082,0.00015395739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008969486,0.0002053829,0.00031327514,0.00012333512,0.00021117493,0.000038673028,0.0000880609,0.0000569105,0.0000547795],"category_scores_gemma":[0.0001561016,0.00017198376,0.000055414523,0.0004383225,0.000057623594,0.0002405492,0.000030291627,0.000115411734,0.000028419536],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045559388,0.0038387696,0.29288074,0.0009587053,0.0015367143,0.005284422,0.00096113223,0.0022832598,0.031344067,0.016596675,0.0005294911,0.6392301],"study_design_scores_gemma":[0.00879678,0.0023879204,0.03931375,0.0031633785,0.002692834,0.0002213537,0.0046447036,0.007954021,0.670195,0.11419031,0.14323401,0.0032059473],"about_ca_topic_score_codex":0.000016292985,"about_ca_topic_score_gemma":0.000053234366,"teacher_disagreement_score":0.6388509,"about_ca_system_score_codex":0.000033923832,"about_ca_system_score_gemma":0.00023486557,"threshold_uncertainty_score":0.7013294},"labels":[],"label_agreement":null},{"id":"W4414161693","doi":"10.1182/bloodadvances.2025016439","title":"mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrow","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hypoxia (environmental); Bone marrow; PI3K/AKT/mTOR pathway; Mechanistic target of rapamycin; Multiple myeloma; Glycolysis; Glutamine; Reprogramming","score_opus":0.010824140415334233,"score_gpt":0.2575288928604443,"score_spread":0.24670475244511006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414161693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97289985,0.02564805,0.00013458704,0.0007895738,0.00008731319,0.00028437347,0.0000065761496,0.000028968947,0.00012070387],"genre_scores_gemma":[0.9955857,0.00079666247,0.0030153838,0.000135711,0.00006762545,0.000013787372,0.0000012168574,0.000011067424,0.0003728506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991969,0.00003113041,0.0002071966,0.0002700271,0.00014138926,0.00015338016],"domain_scores_gemma":[0.9993704,0.00018127529,0.0001271712,0.00021546235,0.00004572986,0.000059948165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023374172,0.00013745982,0.00036221475,0.00005462815,0.00009645663,0.000020286316,0.00004598932,0.00005325812,0.000011000078],"category_scores_gemma":[0.00007650705,0.000090261616,0.00006252901,0.00018390724,0.0001489434,0.00009543683,0.00006108054,0.00012486691,3.0637938e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017378666,0.00017461933,0.033841923,0.00025775484,0.00019656829,0.0000049746,0.0005564978,0.0000058444825,0.88917524,0.00015555856,0.000045252324,0.075411975],"study_design_scores_gemma":[0.0016943131,0.00008641959,0.02339114,0.00015662577,0.00034250898,0.00002170215,0.0006659623,0.00028683845,0.9691584,0.00046691785,0.0036242644,0.00010489267],"about_ca_topic_score_codex":0.000089518755,"about_ca_topic_score_gemma":0.000052844727,"teacher_disagreement_score":0.079983175,"about_ca_system_score_codex":0.0000057154043,"about_ca_system_score_gemma":0.000041425905,"threshold_uncertainty_score":0.36807618},"labels":[],"label_agreement":null},{"id":"W4414161973","doi":"10.1182/bloodadvances.2025017937","title":"Overall survival, conditioning, and MRD in MORPHO","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institutes of Health; Astellas Pharma","keywords":"","score_opus":0.01096864869183514,"score_gpt":0.3267125645469144,"score_spread":0.31574391585507927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414161973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9318642,0.0054776696,0.0033508854,0.019160226,0.000099328514,0.00050304044,0.000011047955,0.00021999558,0.03931362],"genre_scores_gemma":[0.97916,0.0016270537,0.0151305385,0.0016343204,0.000040836625,0.0000810785,0.000019741281,0.0000055337637,0.002300867],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958557,0.000008456972,0.00011351353,0.00013490941,0.00006719689,0.000090336354],"domain_scores_gemma":[0.9997563,0.000050667786,0.000021049087,0.00011179261,0.000018299505,0.00004190399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071054266,0.000052044295,0.00012287282,0.00005377045,0.00003040951,0.000008585258,0.000035402125,0.000025302379,0.000053273212],"category_scores_gemma":[0.00006957584,0.00004470992,0.0000144412925,0.000109125824,0.00007321873,0.000048830916,0.000023144017,0.000093585746,0.0000024309431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006634468,0.0011968733,0.64211446,0.0006613048,0.000094817784,0.000112990674,0.00014577917,0.0000056967747,0.0398288,0.23545997,0.046574604,0.03373834],"study_design_scores_gemma":[0.0036885398,0.0001376433,0.14125574,0.0009196179,0.00014420762,0.00003934431,0.000117259835,0.00044102466,0.023966126,0.044373684,0.78469497,0.00022185345],"about_ca_topic_score_codex":0.000033167384,"about_ca_topic_score_gemma":0.000009473244,"teacher_disagreement_score":0.7381204,"about_ca_system_score_codex":0.0000063442453,"about_ca_system_score_gemma":0.000025182577,"threshold_uncertainty_score":0.18232176},"labels":[],"label_agreement":null},{"id":"W4414320836","doi":"10.1182/bloodadvances.2025017611","title":"Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Sierra Oncology; Syndax Pharmaceuticals; Deutsche Krebshilfe; Pfizer; Edward P. Evans Foundation; Celgene; AstraZeneca; Swedish Orphan Biovitrum; Astex Pharmaceuticals","keywords":"Anemia; Adverse effect; Diarrhea; Myelodysplastic syndromes; Peripheral edema; Confidence interval","score_opus":0.01488714063017105,"score_gpt":0.29024025427029143,"score_spread":0.2753531136401204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414320836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000040930295,0.989845,0.000148209,0.00005190222,0.000077907025,0.009058988,0.00061541377,0.0000634719,0.00013502727],"genre_scores_gemma":[0.000009847615,0.9938197,0.0006856444,0.00017186378,0.000010840163,0.002178374,0.00038772606,0.000058622,0.0026773675],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99691033,0.00024299278,0.0011967045,0.00084595603,0.00039524393,0.00040877188],"domain_scores_gemma":[0.996969,0.0007493647,0.001103504,0.0007438055,0.00024113206,0.00019320828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003130644,0.000827521,0.012135942,0.00044921273,0.00015013175,0.000040073766,0.00021001505,0.0002880005,0.00010279476],"category_scores_gemma":[0.0007045959,0.0004181732,0.002489893,0.0012873397,0.00009935952,0.00010337698,0.00006608739,0.0003661029,0.000015081489],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010694801,0.00020429013,0.000019137342,0.81047237,0.18616816,0.000016437058,0.000009331034,0.0000016578512,3.773818e-10,0.0000047261424,0.000050907493,0.0030422648],"study_design_scores_gemma":[0.0006291166,0.000498649,0.0000012250575,0.1701857,0.77915347,0.00004240828,0.000012343514,0.0000019053783,1.1532385e-8,0.00000487429,0.049123365,0.00034695896],"about_ca_topic_score_codex":0.0000051228167,"about_ca_topic_score_gemma":0.00001529676,"teacher_disagreement_score":0.6402867,"about_ca_system_score_codex":0.00003467144,"about_ca_system_score_gemma":0.00020448638,"threshold_uncertainty_score":0.999827},"labels":[],"label_agreement":null},{"id":"W4414320880","doi":"10.1182/bloodadvances.2025016827","title":"Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Hope Foundation","keywords":"Follicular lymphoma; Logistic regression; Gene expression profiling; Cohort; Clinical trial; Lymphoma; Gene expression; Retrospective cohort study; Confidence interval","score_opus":0.004189811290160337,"score_gpt":0.2238877554359425,"score_spread":0.21969794414578217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414320880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980374,0.0011365387,0.000046082394,0.000042523836,0.0000304087,0.0005669359,0.0000056411595,0.000009832854,0.00012465504],"genre_scores_gemma":[0.9883952,0.000029747232,0.011326147,0.00005521379,0.0000064216906,0.00010014909,0.000031528416,0.0000051567376,0.000050429582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993053,0.000014226056,0.00017124874,0.00019959366,0.00020542297,0.00010422974],"domain_scores_gemma":[0.99970984,0.000019687603,0.000053894226,0.000109594715,0.000055195993,0.000051781593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003915755,0.00010172152,0.00018641235,0.00010556583,0.000027143244,0.0000034293669,0.0000323085,0.000038750033,0.0000022627703],"category_scores_gemma":[0.000018609628,0.000068779766,0.00001579315,0.00017482013,0.000009428779,0.00008151334,0.000023770703,0.000016923275,8.048979e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029153517,0.0011004036,0.98134595,0.00006808879,0.0000688173,0.0000073034043,0.0002807613,0.000015527477,0.0012498264,0.000010387764,0.000006888825,0.015554503],"study_design_scores_gemma":[0.0054665306,0.00026010058,0.7019389,0.00061118184,0.00005458201,4.992901e-7,0.000019087372,5.020111e-7,0.29111484,0.000010552253,0.00047752034,0.000045689394],"about_ca_topic_score_codex":0.000011650147,"about_ca_topic_score_gemma":0.0000067050123,"teacher_disagreement_score":0.28986502,"about_ca_system_score_codex":0.000044071105,"about_ca_system_score_gemma":0.000063758496,"threshold_uncertainty_score":0.28047577},"labels":[],"label_agreement":null},{"id":"W4414490680","doi":"10.1182/bloodadvances.2025017081","title":"Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Bundesamt für Gesundheit; European Commission; European Federation of Pharmaceutical Industries and Associations; Ministerie van Volksgezondheid, Welzijn en Sport; AstraZeneca; Celgene; Gilead Sciences; National Institute for Health and Care Excellence; Eli Lilly and Company; Pulmonary Fibrosis Foundation","keywords":"Quality of life (healthcare); Cohort; Anxiety; Disease; Cohort study; MEDLINE; Depression (economics)","score_opus":0.011472708846043041,"score_gpt":0.2682026959169495,"score_spread":0.25672998707090644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923828,0.0015236174,0.0000024179812,0.00014050459,0.000029721694,0.0012325083,0.000005287958,0.00006424537,0.0046188524],"genre_scores_gemma":[0.99602556,0.0004308196,0.0002742593,0.00023599056,0.0000049117407,0.0001121261,0.00002767592,0.000029273333,0.0028593978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829423,0.000089426176,0.0003824173,0.00042822037,0.00040560044,0.00040009047],"domain_scores_gemma":[0.9990724,0.00010187628,0.00012140538,0.00038857205,0.00025091588,0.000064828855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096025295,0.0002571247,0.0005764455,0.00034793303,0.000037699792,0.000018461284,0.00010913899,0.000060653798,0.00009035292],"category_scores_gemma":[0.00006405202,0.0001524198,0.000036552043,0.0013167291,0.00012378191,0.0001287075,0.000030746232,0.00021787932,0.00000390402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020823656,0.0018341762,0.9863088,0.00007311999,0.00011050599,0.00039331682,0.00019410129,0.0000262532,0.00413622,0.000013118594,0.000010188045,0.0048178],"study_design_scores_gemma":[0.0182368,0.0029997653,0.92925364,0.00033517813,0.00004635599,0.000010623099,0.0002470386,0.0000036578158,0.046269175,0.000019346264,0.002358229,0.00022018842],"about_ca_topic_score_codex":0.00012693969,"about_ca_topic_score_gemma":0.00020982996,"teacher_disagreement_score":0.05705519,"about_ca_system_score_codex":0.000048420792,"about_ca_system_score_gemma":0.00014965858,"threshold_uncertainty_score":0.6215499},"labels":[],"label_agreement":null},{"id":"W4414642437","doi":"10.1182/bloodadvances.2025017244","title":"Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in <i>FLT3</i> -mutated AML","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"RCPA Foundation; Blood Cancer UK; Astellas Pharma; National Cancer Research Institute; Servier; Amgen; Pfizer; Cancer Research UK; Royal College of Pathologists of Australasia","keywords":"Gemtuzumab ozogamicin; Midostaurin; Cytarabine; Myeloid leukemia; Cumulative incidence; Chemotherapy; Induction chemotherapy; Fms-Like Tyrosine Kinase 3; Concomitant","score_opus":0.007209435744216486,"score_gpt":0.28147252130163924,"score_spread":0.27426308555742274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414642437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339455,0.0035020555,0.000076621116,0.0012685892,0.000024709836,0.00046710842,0.0000040162126,0.00003066936,0.0012316824],"genre_scores_gemma":[0.99496996,0.0028483304,0.0015704242,0.0001640205,0.00001905368,0.000008590994,0.0000119047345,0.000015301966,0.0003924123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990679,0.00004305184,0.0002485678,0.00027950632,0.00015788854,0.00020305418],"domain_scores_gemma":[0.999508,0.00013695653,0.00007456566,0.00016224069,0.00006259208,0.000055598204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018003512,0.00013359933,0.00035465564,0.00022323536,0.000045414687,0.000009760848,0.000054164164,0.00006387933,0.000007444564],"category_scores_gemma":[0.00007339572,0.00010603078,0.000015478345,0.0004904528,0.00022323987,0.00013037778,0.000040384333,0.00024805748,4.1185953e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01785803,0.0014077403,0.47786844,0.0015899205,0.0007255858,0.00019113428,0.0031162528,0.00019994917,0.16828996,0.0013348332,0.00013607217,0.3272821],"study_design_scores_gemma":[0.07084681,0.0022511247,0.6716025,0.002014011,0.0002772385,0.00023036648,0.0022479082,0.00049275305,0.24130307,0.00038772763,0.007964001,0.00038251912],"about_ca_topic_score_codex":0.00009916416,"about_ca_topic_score_gemma":0.000057916797,"teacher_disagreement_score":0.3268996,"about_ca_system_score_codex":0.000058644455,"about_ca_system_score_gemma":0.00014860663,"threshold_uncertainty_score":0.43238097},"labels":[],"label_agreement":null},{"id":"W4414735770","doi":"10.1182/bloodadvances.2024015610","title":"Applying principles of vaccine development to oncomicrobial vaccines","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC","funders":"Canadian Glycomics Network; Canadian Institutes of Health Research; Cancer Research UK","keywords":"Vaccination; Cervical cancer; Hepatitis B virus; Human papillomavirus; Cancer; Hepatitis B; Global health; Virus","score_opus":0.010105470172990214,"score_gpt":0.24875367188255915,"score_spread":0.23864820170956894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414735770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630065,0.003771728,0.0039377594,0.000113363756,0.00020344325,0.00049390964,0.0000074774025,0.000014192268,0.0051574577],"genre_scores_gemma":[0.9428224,0.0003138692,0.054285448,0.0003181703,0.00009549835,0.00018117743,0.000070840964,0.0000149636035,0.0018976509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924153,0.000009027672,0.0003542581,0.00017267274,0.000058591322,0.0001639173],"domain_scores_gemma":[0.9995646,0.00000674714,0.00009565465,0.0002316378,0.0000696674,0.000031709576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010653088,0.00013070788,0.0001785855,0.000068421636,0.00006876412,0.000013933715,0.0002245883,0.000050130213,0.000005572161],"category_scores_gemma":[0.00005191466,0.00011252589,0.000047173533,0.0001351579,0.0000062067766,0.0000069328644,0.00021511185,0.00003620816,0.000004245601],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022286193,0.00027571255,0.025203591,0.00039378298,0.00022431959,7.2518196e-7,0.00018617963,0.0011591254,0.8975463,0.0011789652,0.00088810275,0.07272035],"study_design_scores_gemma":[0.00058151333,0.000074138705,0.0041269204,0.000053245625,0.000019261059,0.0000036247288,0.00011387373,0.000011470739,0.62761366,0.000018715027,0.36726922,0.00011433159],"about_ca_topic_score_codex":0.0000030499764,"about_ca_topic_score_gemma":0.000031952553,"teacher_disagreement_score":0.36638114,"about_ca_system_score_codex":0.0000053651515,"about_ca_system_score_gemma":0.00008080263,"threshold_uncertainty_score":0.45886728},"labels":[],"label_agreement":null},{"id":"W4414869610","doi":"10.1182/bloodadvances.2025017194","title":"Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; U.S. Navy; Legend Biotech; Alexion Pharmaceuticals; bluebird bio; Pharmacyclics; Daiichi Sankyo Europe; Takeda Oncology; Astellas Pharma US; University of Texas MD Anderson Cancer Center; AstraZeneca; Genentech; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; Janssen Research and Development; MorphoSys; Seagen; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; Kiadis Pharma; Medac; Jazz Pharmaceuticals; Omeros Corporation; Karyopharm Therapeutics; HistoGenetics; Eli Lilly and Company; U.S. Department of Defense; Moonshot Research and Development Program; Sanofi; CSL Behring; Bristol-Myers Squibb; Vertex Pharmaceuticals; Mallinckrodt Pharmaceuticals; Gateway for Cancer Research; Actinium Pharmaceuticals; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Amgen; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Cyclophosphamide; Proportional hazards model; Confidence interval; Transplantation; Hematopoietic cell; Acute leukemia; Hematopoietic stem cell transplantation; Graft-versus-host disease","score_opus":0.01068376123034541,"score_gpt":0.27362294630439077,"score_spread":0.26293918507404535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414869610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642705,0.0035771618,0.024784701,0.00047298163,0.00043358406,0.0008756348,0.00006183465,0.00027093463,0.0052526905],"genre_scores_gemma":[0.9855929,0.0027232962,0.010271141,0.00040433437,0.000050633265,0.00003693602,0.00020188373,0.000046091278,0.0006727817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774194,0.00007474703,0.0007403966,0.000535837,0.00042875184,0.00047835472],"domain_scores_gemma":[0.99899554,0.0002479738,0.00012744243,0.0003304178,0.00011846386,0.0001801571],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002022746,0.00034759004,0.000597126,0.00024797526,0.00016160373,0.00004410827,0.00015221152,0.0002183179,0.000113909075],"category_scores_gemma":[0.000021529982,0.0003258885,0.0001780591,0.0005606926,0.00011946597,0.00026134,0.000010622481,0.00029067497,0.000052150877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036885238,0.002170454,0.212509,0.019373367,0.0007012053,0.002830137,0.00367494,0.0010425206,0.74857336,0.00424326,0.00007677571,0.0011164541],"study_design_scores_gemma":[0.009236496,0.00028077868,0.037658196,0.0034242957,0.0041143466,0.001527396,0.00052936096,0.00060041423,0.9399793,0.0013134565,0.00073243154,0.0006034889],"about_ca_topic_score_codex":0.000080632766,"about_ca_topic_score_gemma":0.000021207437,"teacher_disagreement_score":0.191406,"about_ca_system_score_codex":0.000054692904,"about_ca_system_score_gemma":0.00018608368,"threshold_uncertainty_score":0.9999193},"labels":[],"label_agreement":null},{"id":"W4415053014","doi":"10.1182/bloodadvances.2025017282","title":"Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with <i>MYC</i> / <i>BCL2</i> rearrangements, DLBCL morphology","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Hôpital du Sacré-Cœur de Montréal; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Chemoimmunotherapy; Follicular lymphoma; Lymphoma; Rituximab; Cohort; Guideline; Retrospective cohort study; Diffuse large B-cell lymphoma","score_opus":0.006088559667140422,"score_gpt":0.23686720687315738,"score_spread":0.23077864720601696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415053014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915744,0.005703454,0.000024961251,0.0027354748,0.00028971076,0.000600341,0.000016998909,0.000056135686,0.0014155122],"genre_scores_gemma":[0.9943884,0.0011450303,0.0027783923,0.000533041,0.00012392305,0.00013053903,0.00021616556,0.000019231142,0.00066527695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984963,0.00006207447,0.00045952568,0.00046041547,0.0002441118,0.00027757214],"domain_scores_gemma":[0.9991415,0.000107695036,0.00020249505,0.00039984452,0.000085282954,0.00006314585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010498845,0.00022650987,0.0005380702,0.00025455694,0.00004697105,0.0000098919645,0.00008917288,0.00009058112,0.000031212654],"category_scores_gemma":[0.000054641063,0.00017592989,0.00006867363,0.00060095754,0.00008480514,0.00016204316,0.00003385679,0.00006356332,0.000008316226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057678664,0.00624869,0.9771239,0.00028210183,0.00021053526,0.0001341936,0.00007752294,0.0001348184,0.0035345613,0.0012814928,0.0015659994,0.008829387],"study_design_scores_gemma":[0.03063903,0.00074376527,0.87105674,0.0002669994,0.00065138005,0.00006399781,0.00018146333,0.000008728832,0.07934517,0.00048829877,0.016353734,0.00020067811],"about_ca_topic_score_codex":0.0010108242,"about_ca_topic_score_gemma":0.00036879373,"teacher_disagreement_score":0.10606715,"about_ca_system_score_codex":0.00011995749,"about_ca_system_score_gemma":0.00008525064,"threshold_uncertainty_score":0.7174213},"labels":[],"label_agreement":null},{"id":"W4415237830","doi":"10.1182/bloodadvances.2025017536","title":"Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: a propensity score–matched study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Assistance publique-Hôpitaux de Paris; GlaxoSmithKline; Amgen","keywords":"Azathioprine; Mycophenolate; Hazard ratio; Cytopenia; Mycophenolic acid; Confidence interval; Proportional hazards model","score_opus":0.02018530179874954,"score_gpt":0.26602026824424957,"score_spread":0.2458349664455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415237830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91493744,0.07955821,0.00042178182,0.00017485004,0.0014264366,0.0022007965,0.000026475149,0.00024777904,0.0010062398],"genre_scores_gemma":[0.9838855,0.0007266424,0.00012576776,0.0001538347,0.000011288004,0.0004015534,0.000048642993,0.000027289636,0.014619479],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780416,0.00016579447,0.00067093456,0.0006474435,0.00006307829,0.00064855523],"domain_scores_gemma":[0.9987278,0.00023890297,0.0002397386,0.0006110192,0.00017396185,0.000008576479],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049665285,0.00038151076,0.0007461323,0.00021461958,0.00075998984,0.00004836242,0.0006689096,0.00015854981,0.00017676895],"category_scores_gemma":[0.00029457713,0.0002904761,0.00016615538,0.00066348544,0.000164895,0.00029647903,0.00028206658,0.00035457488,0.00013004162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017131722,0.03133223,0.28580338,0.0023821422,0.0043909317,0.00017815904,0.009807028,0.000507829,0.44461715,0.007052526,0.0010171698,0.19577973],"study_design_scores_gemma":[0.06672957,0.0063882438,0.5477602,0.00043502866,0.0038609782,0.00015988326,0.010026118,0.00004030013,0.09182007,0.003919585,0.265853,0.003007068],"about_ca_topic_score_codex":0.00007635855,"about_ca_topic_score_gemma":0.000032951728,"teacher_disagreement_score":0.3527971,"about_ca_system_score_codex":0.000022817741,"about_ca_system_score_gemma":0.0002571757,"threshold_uncertainty_score":0.99995476},"labels":[],"label_agreement":null},{"id":"W4415352822","doi":"10.1182/bloodadvances.2025017860","title":"Danazol treatment for telomere biology disorders: long-term results of a phase 1/2 study","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Danazol; Telomere; Telomerase; Phase (matter)","score_opus":0.024865114000741415,"score_gpt":0.3804650734883973,"score_spread":0.3555999594876559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415352822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98702747,0.008683417,0.00030698284,0.0004629771,0.0002557275,0.0019982725,0.00020209789,0.00007294045,0.0009900948],"genre_scores_gemma":[0.9960469,0.0015757409,0.000750727,0.00007187902,0.000092911054,0.00022932794,0.000100347825,0.000014919367,0.0011172307],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99856055,0.00004428695,0.0004991987,0.00048048765,0.00011055109,0.00030495474],"domain_scores_gemma":[0.9989403,0.00026513913,0.00016187713,0.00045490728,0.00009476653,0.0000830319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110310524,0.00023443258,0.00059277524,0.00020566018,0.00009209734,0.0000080065465,0.00013948031,0.0000666393,0.000013237239],"category_scores_gemma":[0.00019940453,0.00017379317,0.00013945386,0.00032348392,0.00013446037,0.00008414293,0.00003063254,0.0000636026,0.0000024316355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043543978,0.01748171,0.42965046,0.00043940818,0.0008367178,0.000038312315,0.0011015539,0.0000029655841,0.010559118,0.00036701432,0.00009905008,0.5350693],"study_design_scores_gemma":[0.2816798,0.071921974,0.3307848,0.0014731422,0.0054563438,0.000048059603,0.008571626,0.00008968245,0.21314363,0.0023123482,0.083090566,0.0014280439],"about_ca_topic_score_codex":0.000080114456,"about_ca_topic_score_gemma":0.00054535206,"teacher_disagreement_score":0.5336413,"about_ca_system_score_codex":0.000030216856,"about_ca_system_score_gemma":0.00013132821,"threshold_uncertainty_score":0.708708},"labels":[],"label_agreement":null},{"id":"W4415404479","doi":"10.1182/bloodadvances.2025016821","title":"Utility of placental growth factor for preeclampsia prediction in pregnancies complicated by sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster University Medical Centre; The Scarborough Hospital; Hamilton Health Sciences; Toronto General Hospital; University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Placental growth factor; Preeclampsia; Context (archaeology); Disease; Pregnancy; Gestational age; Gestation","score_opus":0.006286961887272759,"score_gpt":0.24254089083407046,"score_spread":0.2362539289467977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415404479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97425187,0.018765768,0.0004218501,0.00037112142,0.00013740001,0.0013042137,0.00076898054,0.00007510176,0.0039037073],"genre_scores_gemma":[0.9980954,0.000585449,0.00019716982,0.00005735201,0.00000947654,0.000059616512,0.0001272894,0.00000854858,0.00085972535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916506,0.000020070105,0.00027497168,0.00023954065,0.000114073664,0.0001863103],"domain_scores_gemma":[0.9995635,0.00006388886,0.00007425234,0.00015098011,0.00006960906,0.000077751276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039942897,0.000120222,0.00023636957,0.00006340967,0.000045582918,0.0000045214397,0.00006847826,0.00007196014,0.00002723533],"category_scores_gemma":[0.000085011474,0.00010008955,0.00007654863,0.0002069586,0.00010888034,0.0000948184,0.00002288636,0.00009860166,0.0000010727425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001322781,0.0028325196,0.9654525,0.0030099521,0.00008350803,0.000003929085,0.00028770455,0.000026506206,0.02083322,0.00018479917,0.0022608552,0.0037017216],"study_design_scores_gemma":[0.014796112,0.00068181765,0.7661572,0.0015903002,0.0005111606,0.000002638357,0.0011290859,0.0028238888,0.19222938,0.0014744912,0.018291045,0.0003128772],"about_ca_topic_score_codex":0.00002060458,"about_ca_topic_score_gemma":0.000009945906,"teacher_disagreement_score":0.1992953,"about_ca_system_score_codex":0.000013361803,"about_ca_system_score_gemma":0.000089980414,"threshold_uncertainty_score":0.40815336},"labels":[],"label_agreement":null},{"id":"W4415442914","doi":"10.1182/bloodadvances.2025017731","title":"Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; University of Toronto","funders":"Janssen Pharmaceuticals; Samsung; Novo Nordisk; Agios Pharmaceuticals; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; Omeros Corporation; BioCryst; Regeneron Pharmaceuticals; BeiGene; Sanofi; Celgene; AstraZeneca; Alexion Pharmaceuticals; Pfizer; Amgen","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Adverse effect; Clinical endpoint; Hemoglobinuria; Clinical trial; Anemia; Hemolysis","score_opus":0.002885365793110706,"score_gpt":0.23132779925954047,"score_spread":0.22844243346642976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415442914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881885,0.010465729,0.0000115622815,0.00004687662,0.0001414703,0.00038330237,0.00003144486,0.000017347636,0.00071377796],"genre_scores_gemma":[0.99950147,0.000109453926,0.0000867857,0.000054458687,0.000005786427,0.000016013031,0.00002637732,0.0000054416655,0.0001942214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927086,0.00007996297,0.00025932933,0.00019617689,0.00003107717,0.00016261474],"domain_scores_gemma":[0.99957573,0.00011779025,0.00010837315,0.00015224505,0.0000342475,0.000011613488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059305374,0.000116917676,0.00023981136,0.00008097355,0.00005164019,0.000004976887,0.00011871529,0.000043712276,0.0001207151],"category_scores_gemma":[0.000027362921,0.000091224734,0.00002173278,0.000120302124,0.00011752816,0.000074732074,0.00003614214,0.000071758834,0.00000558565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028506592,0.0005104693,0.98483217,0.00007284562,0.00016721923,0.0000012728972,0.000114927425,0.000020306517,0.003054107,0.00049810356,0.00006590913,0.0078119845],"study_design_scores_gemma":[0.016152684,0.00044733737,0.95829403,0.00028881582,0.00005505512,0.000002403136,0.00009594575,2.4924822e-7,0.013193327,0.00024160223,0.011103855,0.0001247156],"about_ca_topic_score_codex":0.000029877725,"about_ca_topic_score_gemma":0.000037730904,"teacher_disagreement_score":0.026538186,"about_ca_system_score_codex":0.00001160076,"about_ca_system_score_gemma":0.00004299254,"threshold_uncertainty_score":0.37200367},"labels":[],"label_agreement":null},{"id":"W4415442974","doi":"10.1182/bloodadvances.2025017837","title":"Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children; Agricultural Research Institute of Ontario; Children's Hospital of Eastern Ontario","funders":"National Institutes of Health","keywords":"Myeloid leukemia; Minimal residual disease; Down syndrome; Chemotherapy; Disease; Leukemia; Myeloid; Induction chemotherapy","score_opus":0.0054398641858060415,"score_gpt":0.2533660069236029,"score_spread":0.24792614273779684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415442974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696199,0.022854954,0.00007841227,0.0003618655,0.00008152728,0.00073513703,0.00022129524,0.00004177499,0.006005105],"genre_scores_gemma":[0.9882176,0.007180811,0.0034453766,0.00007489032,0.000019485524,0.000068039626,0.000041236883,0.00003548412,0.00091711094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970383,0.00034486983,0.000783535,0.00055209163,0.0007698863,0.0005113302],"domain_scores_gemma":[0.9978374,0.00047007692,0.00035548306,0.00084012083,0.00025152412,0.00024538452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010495423,0.00028444364,0.00079336896,0.0006044017,0.00007196055,0.000009585971,0.00034374866,0.0001385912,0.00006546312],"category_scores_gemma":[0.0028757346,0.0002527783,0.00019224122,0.0012369911,0.00038163492,0.00020515353,0.00017513259,0.00068303,0.0000097337115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005866925,0.00090389693,0.9445602,0.0023820205,0.0011148961,0.0018021595,0.00016910033,0.004019215,0.02587419,0.0010976105,0.0011796334,0.0110301515],"study_design_scores_gemma":[0.018457625,0.0012060836,0.84694004,0.0023313889,0.002494565,0.000094370174,0.0006626692,0.0006317881,0.11505559,0.008688745,0.0028369962,0.0006001272],"about_ca_topic_score_codex":0.00079053565,"about_ca_topic_score_gemma":0.00012501498,"teacher_disagreement_score":0.09762015,"about_ca_system_score_codex":0.0002929603,"about_ca_system_score_gemma":0.0013896365,"threshold_uncertainty_score":0.99999243},"labels":[],"label_agreement":null},{"id":"W4415734847","doi":"10.1182/bloodadvances.2025017620","title":"Retreatment with R-CHOP–like therapy in patients with late relapse of diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Hôpital du Sacré-Cœur de Montréal; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Incyte; BeiGene; Seagen; Gilead Sciences; Veracyte; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company","keywords":"International Prognostic Index; Regimen; Lymphoma; Stage (stratigraphy); Overall survival; Performance status; Chemotherapy; Confidence interval","score_opus":0.0031681085524921113,"score_gpt":0.21466799324006597,"score_spread":0.21149988468757386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415734847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910962,0.005395144,0.0000027832868,0.00012223389,0.00005238145,0.0007383507,0.00002718677,0.00003067818,0.0025350228],"genre_scores_gemma":[0.99600965,0.0019165414,0.00075610855,0.0002591793,0.000008750339,0.000119692326,0.00003695459,0.000018402547,0.000874711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889714,0.000027004773,0.00024026523,0.00032339175,0.00025838372,0.00025383773],"domain_scores_gemma":[0.99931234,0.00006125294,0.00012270082,0.0003545331,0.00008254754,0.00006663288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004257113,0.00022395268,0.00040851397,0.00012691657,0.000043697015,0.000008556067,0.000064941334,0.000049934573,0.000012623812],"category_scores_gemma":[0.000006533853,0.00012725098,0.000054303546,0.00032787857,0.00005381818,0.00010645589,0.000021118722,0.00003801409,0.000004139697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018879882,0.033520553,0.9517625,0.00007174438,0.0002756534,0.00009715957,0.00017263071,0.000004418749,0.000032301414,0.00008200883,0.000035052686,0.012057973],"study_design_scores_gemma":[0.118614,0.0034862007,0.8636528,0.0004680674,0.00022966474,0.0000020036084,0.000066150395,0.0000026258163,0.008737655,0.000027777389,0.0045860526,0.0001269465],"about_ca_topic_score_codex":0.00006414956,"about_ca_topic_score_gemma":0.00010570944,"teacher_disagreement_score":0.11672602,"about_ca_system_score_codex":0.00009032002,"about_ca_system_score_gemma":0.00010726377,"threshold_uncertainty_score":0.51891446},"labels":[],"label_agreement":null},{"id":"W4415734869","doi":"10.1182/bloodadvances.2025017745","title":"Decitabine-cedazuridine in patients with MDS and <i>TP53</i> mutations","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Takeda Oncology; University of Texas MD Anderson Cancer Center; Genentech; Sierra Oncology; Daiichi Sankyo Europe; Gilead Sciences; Servier; Celldex Therapeutics; Daiichi-Sankyo; Pfizer; Incyte; CTI Biopharma; Agios Pharmaceuticals; Alexion Pharmaceuticals; Apellis Pharmaceuticals; Celgene; BioCryst; Syndax Pharmaceuticals; Acceleron; Astex Pharmaceuticals; Ipsen; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; Karyopharm Therapeutics; Ipsen Biopharmaceuticals; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma; Amgen","keywords":"Propensity score matching; Parenteral nutrition; Hypomethylating agent; Myelodysplastic syndromes; Cohort; Overall survival; Retrospective cohort study","score_opus":0.0039205917959274925,"score_gpt":0.262517802524773,"score_spread":0.2585972107288455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415734869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059904,0.0016419032,0.000082101324,0.0010593153,0.000032964832,0.00041406832,0.000010318539,0.00003333475,0.006126958],"genre_scores_gemma":[0.9953645,0.00020617511,0.003066232,0.00036173288,0.000024713643,0.000047057903,0.000035836103,0.000011542004,0.00088224583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918485,0.000020082916,0.000156421,0.00023148452,0.0001942794,0.00021289622],"domain_scores_gemma":[0.9995111,0.00011249572,0.000028687626,0.0001685816,0.00010735237,0.00007176262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000778544,0.00010532255,0.00019680183,0.00020174238,0.000052200703,0.000012069797,0.0000618436,0.000036039437,0.000015980566],"category_scores_gemma":[0.00015339661,0.00007863783,0.000015509797,0.00051061466,0.00010459352,0.00016306514,0.00004487798,0.00016481763,0.000004983838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030293365,0.00033337952,0.9863967,0.00011006869,0.000049627364,0.000030543753,0.000080040925,0.000021501755,0.0002957631,0.00046550142,0.00019621829,0.011717729],"study_design_scores_gemma":[0.014332954,0.0005975661,0.96448064,0.00033963393,0.00013475637,0.000009951262,0.00018806562,0.000067005654,0.004052226,0.00053771306,0.0150989,0.0001605901],"about_ca_topic_score_codex":0.00002011855,"about_ca_topic_score_gemma":0.000060441504,"teacher_disagreement_score":0.021916054,"about_ca_system_score_codex":0.000045218603,"about_ca_system_score_gemma":0.00015678644,"threshold_uncertainty_score":0.32067576},"labels":[],"label_agreement":null},{"id":"W4415735130","doi":"10.1182/bloodadvances.2025017862","title":"Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Daiichi Sankyo Europe; Gilead Sciences; Servier; LEO Pharma; National Cancer Institute; Regeneron Pharmaceuticals; National Institutes of Health; Novo Nordisk; Swedish Orphan Biovitrum; Astellas Pharma; Seagen; Pfizer; Incyte; MorphoSys; Celgene; Alexion Pharmaceuticals; Jazz Pharmaceuticals; Teva Pharmaceutical Industries; Syndax Pharmaceuticals; BeiGene; Sanofi; Amgen; National Heart, Lung, and Blood Institute; Eli Lilly and Company","keywords":"Derivation; Confidence interval; Venous thromboembolism; Proportional hazards model; Cohort; Retrospective cohort study; Cohort study; Risk assessment; Pulmonary embolism","score_opus":0.011053453498573762,"score_gpt":0.2943692381374073,"score_spread":0.2833157846388335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415735130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987529,0.0014998234,0.009754251,0.00010583731,0.00003512783,0.0003347765,0.000021444665,0.000032584903,0.0006871904],"genre_scores_gemma":[0.9949298,0.0013506709,0.003467524,0.000044325156,0.000028750295,0.000032519045,0.000030447298,0.000008297055,0.00010765026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991359,0.000041271844,0.00025229534,0.00020785941,0.00021287204,0.00014979838],"domain_scores_gemma":[0.9995466,0.00008454257,0.000093488095,0.00014069962,0.000094374576,0.000040312334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001555971,0.000092216054,0.00023831837,0.00020622861,0.000031039577,0.00000905652,0.00004881674,0.00006645958,0.0000046350087],"category_scores_gemma":[0.00018078258,0.00008263071,0.000021209582,0.00024389998,0.00006901654,0.00019526976,0.00003150252,0.00011773232,0.0000011644615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013362917,0.0021223,0.70287794,0.0010498067,0.0004138494,0.000072702016,0.0017073452,0.027037645,0.20441276,0.0013506121,0.00016018152,0.0574586],"study_design_scores_gemma":[0.011121241,0.0006878226,0.45391417,0.0009346055,0.0006134649,0.00005552706,0.00015607385,0.23754391,0.28454453,0.010101531,0.00016463787,0.00016246554],"about_ca_topic_score_codex":0.00015321303,"about_ca_topic_score_gemma":0.000014689183,"teacher_disagreement_score":0.24896374,"about_ca_system_score_codex":0.00009525858,"about_ca_system_score_gemma":0.00015869872,"threshold_uncertainty_score":0.33695823},"labels":[],"label_agreement":null},{"id":"W4416086893","doi":"10.1182/bloodadvances.2025016845","title":"A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Ipsen; Mallinckrodt Pharmaceuticals; Seagen; National Institutes of Health; Incyte; BeiGene; Genentech; AstraZeneca","keywords":"Lenalidomide; Blinatumomab; Concomitant; Adverse effect; Phases of clinical research; Toxicity; Lymphoma; Neurotoxicity","score_opus":0.01619469634600543,"score_gpt":0.3483985157154631,"score_spread":0.33220381936945764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416086893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848545,0.008581989,0.00003266428,0.00007155662,0.00006207179,0.00093560404,0.000010327207,0.000028377877,0.0054228706],"genre_scores_gemma":[0.9946317,0.0005951137,0.0001393998,0.0000529449,0.000026062164,0.00004390438,0.000008650034,0.00001512194,0.004487085],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981231,0.00020525554,0.0005076387,0.00047284312,0.00041305646,0.000278105],"domain_scores_gemma":[0.99848497,0.00070568797,0.00015830333,0.00041110505,0.00013538827,0.00010454794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004456186,0.00020355059,0.00078660925,0.0010149619,0.0000574774,0.000014906185,0.00014963647,0.00008543303,0.00015979503],"category_scores_gemma":[0.00023995413,0.00017743859,0.00011822519,0.0021414626,0.00016610521,0.00010065198,0.00011997289,0.0002499533,0.0000031146942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015573525,0.16148128,0.52501845,0.00066694344,0.0048757927,0.0008793194,0.0066714403,0.00040331553,0.17715356,0.000115508345,0.00012239853,0.107038446],"study_design_scores_gemma":[0.48310062,0.025235202,0.26385763,0.00074331055,0.009366643,0.000035898876,0.015344477,0.002056342,0.1930216,0.0005222859,0.0058426373,0.0008733431],"about_ca_topic_score_codex":0.00015756904,"about_ca_topic_score_gemma":0.00038622358,"teacher_disagreement_score":0.4675271,"about_ca_system_score_codex":0.00007061047,"about_ca_system_score_gemma":0.00014965127,"threshold_uncertainty_score":0.72357357},"labels":[],"label_agreement":null},{"id":"W4416355981","doi":"10.1182/bloodadvances.2025017953","title":"Deferral of immunosuppression in acquired hemophilia","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; St. Michael's Hospital","funders":"","keywords":"Immunosuppression; Deferral; MEDLINE; Haematopoiesis","score_opus":0.01581906173102047,"score_gpt":0.33552026809086793,"score_spread":0.31970120635984745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416355981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717884,0.01085956,0.0000042891393,0.0010189478,0.00009463672,0.00025860645,0.0000028692607,0.000020329735,0.015952336],"genre_scores_gemma":[0.99349284,0.0008808503,0.0005902382,0.000041787287,0.0000249201,0.00001856776,0.000010699919,0.000005332129,0.0049347393],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992693,0.000026054555,0.00020528119,0.00015692682,0.00016333569,0.00017910122],"domain_scores_gemma":[0.99963874,0.000056041332,0.00002912601,0.0001971971,0.00004278929,0.00003609376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008472835,0.00008334258,0.00023969321,0.00017756564,0.000027387627,0.0000035970868,0.00007900516,0.000055120312,0.00006831314],"category_scores_gemma":[0.00008118581,0.000058885656,0.00006022015,0.0003180361,0.000104456216,0.000080503974,0.000046634803,0.00006645233,0.0000066907064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068481336,0.001293043,0.7530584,0.0005490733,0.000109257555,0.00011665001,0.00019216703,0.0000092672135,0.20532724,0.00092774286,0.00021797311,0.03751437],"study_design_scores_gemma":[0.0069739097,0.00044934408,0.30289608,0.0012113344,0.000112883616,0.000014497247,0.00027362735,0.000050504015,0.67606944,0.0027037,0.009121917,0.00012276438],"about_ca_topic_score_codex":0.000014731014,"about_ca_topic_score_gemma":0.000008762458,"teacher_disagreement_score":0.4707422,"about_ca_system_score_codex":0.00001659337,"about_ca_system_score_gemma":0.00008130824,"threshold_uncertainty_score":0.24012874},"labels":[],"label_agreement":null},{"id":"W4416378440","doi":"10.1182/bloodadvances.2025016958","title":"Comprehensive analysis of complement activation in a hydroxyurea-treated patient cohort with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Academy of Finland; Pfizer","keywords":"Complement system; Heme; Complement (music); Hemoglobin; Disease; Hemoglobinopathy; Cell; Sickle cell anemia","score_opus":0.004514657431966917,"score_gpt":0.24152237360724185,"score_spread":0.23700771617527494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416378440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413633,0.0018665134,0.000111625144,0.00023588659,0.000016007358,0.0005553886,0.000017816701,0.000021825337,0.0030386082],"genre_scores_gemma":[0.99892265,0.0003540105,0.00021793363,0.00019704938,0.0000028708198,0.000034658653,0.00016919784,0.0000058781407,0.00009575343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991566,0.000029946663,0.0002666684,0.00021596559,0.0001873985,0.00014340482],"domain_scores_gemma":[0.9994839,0.000048937705,0.00010905884,0.00018677095,0.000106905834,0.000064429674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025239595,0.00011908043,0.0003658053,0.00033013304,0.000033900054,0.0000039020115,0.000037647016,0.000030822055,0.000033245924],"category_scores_gemma":[0.000011118887,0.000086184635,0.00007389344,0.0012093529,0.00006105888,0.000052008196,0.000019213006,0.0000808401,8.024383e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056268356,0.0013260981,0.9828366,0.00024185295,0.0011613852,0.000025682308,0.00020559138,0.00820291,0.0030272475,0.00007445599,0.000035282952,0.0023001856],"study_design_scores_gemma":[0.0046910006,0.0005502442,0.9558599,0.00051244686,0.0055653607,4.6146047e-7,0.0016806594,0.0020506734,0.02404825,0.00006573693,0.0047829323,0.00019235679],"about_ca_topic_score_codex":0.00018959228,"about_ca_topic_score_gemma":0.000064952066,"teacher_disagreement_score":0.026976746,"about_ca_system_score_codex":0.000029171477,"about_ca_system_score_gemma":0.00006359008,"threshold_uncertainty_score":0.35145074},"labels":[],"label_agreement":null},{"id":"W4416507969","doi":"10.1182/bloodadvances.2025017083","title":"Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"Genentech; Servier; Astellas Pharma; Nippon Shinyaku; Incyte; BeiGene; Astex Pharmaceuticals; Celgene; Amgen; Ariad Pharmaceuticals; Ascentage Pharma; Jazz Pharmaceuticals; Teva Pharmaceutical Industries; Karyopharm Therapeutics; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; Pfizer; Bristol-Myers Squibb","keywords":"Venetoclax; Cytarabine; Myeloid leukemia; Azacitidine; NPM1; Population; Chemotherapy; Chemotherapy regimen","score_opus":0.005691558317478645,"score_gpt":0.2824183766750267,"score_spread":0.2767268183575481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416507969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705976,0.0009468655,0.0003354903,0.00033888908,0.000020428351,0.0010788359,0.000025690537,0.000011810507,0.0001822155],"genre_scores_gemma":[0.99499035,0.0007267018,0.0037723905,0.00017614115,0.000019025576,0.00008231794,0.000048532085,0.000011275758,0.00017326875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929726,0.000017868204,0.00020168867,0.00021185081,0.00012660722,0.00014471314],"domain_scores_gemma":[0.9991898,0.00010593204,0.00009555815,0.00017596189,0.00039701955,0.000035742516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010291836,0.0000949568,0.00023928942,0.00014955568,0.000025678653,0.0000061117175,0.00005766737,0.000042208845,0.0000039789347],"category_scores_gemma":[0.00021642754,0.00007130392,0.000019565858,0.00027998112,0.00009845495,0.000095249474,0.00001483656,0.000110703375,4.57007e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045694932,0.00036759712,0.94046897,0.00065332174,0.00015775941,0.0000024453673,0.0003603695,0.00011987898,0.006957528,0.00028489766,0.0002179026,0.04583986],"study_design_scores_gemma":[0.022992918,0.0016259112,0.88641745,0.000569294,0.00010949747,0.0000013549555,0.0004443989,0.0006714777,0.08443622,0.0012083404,0.0013824082,0.00014072971],"about_ca_topic_score_codex":0.00004506016,"about_ca_topic_score_gemma":0.00004307936,"teacher_disagreement_score":0.07747869,"about_ca_system_score_codex":0.00006469551,"about_ca_system_score_gemma":0.00020556204,"threshold_uncertainty_score":0.29076895},"labels":[],"label_agreement":null},{"id":"W4416664626","doi":"10.1182/bloodadvances.2025016812","title":"Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"NHLBI Division of Intramural Research; Children's Hospital of Pittsburgh; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Institutes of Health; Feinberg School of Medicine; Rare Diseases Clinical Research Network; Atara Biotherapeutics; Children's Healthcare of Atlanta; Saint Louis University; Children’s Hospital of Wisconsin Research Institute; National Center for Advancing Translational Sciences; Les Laboratories Pierre Fabre; Seattle Children's Research Institute; California Institute of Regenerative Medicine; University of Cincinnati; Children's National Hospital; Johns Hopkins University; Memorial Sloan-Kettering Cancer Center; University of Washington; Pfizer; Northwestern University; Health Resources and Services Administration; Texas Children's Hospital; University of Minnesota; Children's Hospital of Philadelphia; Children's Hospital Colorado; Amgen; Emory University; U.S. Department of Health and Human Services; Aflac; bluebird bio; Cincinnati Children's Hospital Medical Center","keywords":"Sibling; Transplantation; Severe combined immunodeficiency; Cohort; Conditioning regimen; Retrospective cohort study; Hematopoietic stem cell transplantation; Hematopoietic cell","score_opus":0.00712664970114236,"score_gpt":0.25752650434851865,"score_spread":0.2503998546473763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416664626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8917147,0.097309,0.004443948,0.001214005,0.0025157018,0.00073849945,0.000090956346,0.0001691705,0.0018040013],"genre_scores_gemma":[0.99567133,0.0003742534,0.000267028,0.0004762696,0.000003542148,0.00016390585,0.00049427355,0.00001590699,0.0025334805],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984843,0.00009516424,0.00055757596,0.00040603607,0.000048916623,0.00040799315],"domain_scores_gemma":[0.9984169,0.00088563206,0.00020338308,0.00043323328,0.00005710681,0.0000037577709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038906746,0.00024885143,0.0004128918,0.00008298796,0.00081261876,0.000048414244,0.00046294977,0.0001492781,0.000037796563],"category_scores_gemma":[0.00020699951,0.0001768561,0.00032188572,0.00029557364,0.0001322773,0.00025963786,0.000043250464,0.00021388574,0.000021301388],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018472339,0.0021563468,0.2622327,0.00039235924,0.004432106,0.0000730747,0.010637175,0.0010675794,0.61994654,0.009372937,0.00050789677,0.08733404],"study_design_scores_gemma":[0.037317667,0.0005432856,0.5019812,0.0011715952,0.00408719,0.00015223645,0.02179343,0.000077009936,0.17715526,0.031548362,0.2218699,0.0023028613],"about_ca_topic_score_codex":0.00024182205,"about_ca_topic_score_gemma":0.000028259497,"teacher_disagreement_score":0.4427913,"about_ca_system_score_codex":0.000014187766,"about_ca_system_score_gemma":0.0001025615,"threshold_uncertainty_score":0.7211983},"labels":[],"label_agreement":null},{"id":"W4416848478","doi":"10.1182/bloodadvances.2025017934","title":"American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University Hospital Foundation","funders":"","keywords":"Hematology; Myeloid leukemia; Guideline; Transplantation; Population; Hematopoietic stem cell transplantation; Venetoclax; Induction chemotherapy; Gemtuzumab ozogamicin; Azacitidine","score_opus":0.020689133210197535,"score_gpt":0.36216380644320423,"score_spread":0.3414746732330067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416848478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98060524,0.0076877754,0.0021607492,0.006680521,0.00011749312,0.0015531448,0.000055639142,0.00008694041,0.0010524691],"genre_scores_gemma":[0.691099,0.014245045,0.27979195,0.0061258813,0.00045744705,0.0012299531,0.00019321343,0.00009763964,0.006759896],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979472,0.00004717353,0.0007433456,0.00050436787,0.00024179886,0.00051611156],"domain_scores_gemma":[0.99795026,0.0008091033,0.00023993799,0.00037288436,0.00053677894,0.00009101409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027657696,0.0002457012,0.00086586433,0.0002144696,0.0000717351,0.000009376418,0.00023895029,0.000116665644,0.000018646817],"category_scores_gemma":[0.00092296215,0.00020714545,0.00024570661,0.00087561016,0.0002896875,0.00013014123,0.000108009735,0.0002529348,0.0000028438442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032511773,0.0009831793,0.2828034,0.004694799,0.0017620352,0.00020920542,0.0023260447,0.0003987676,0.03006245,0.0011835573,0.078737184,0.5935882],"study_design_scores_gemma":[0.13323247,0.004365058,0.144797,0.012887608,0.0025852735,0.00026682406,0.032425568,0.036028404,0.5270676,0.0018913143,0.10245946,0.0019934415],"about_ca_topic_score_codex":0.00062809483,"about_ca_topic_score_gemma":0.00027956365,"teacher_disagreement_score":0.59159476,"about_ca_system_score_codex":0.00026557772,"about_ca_system_score_gemma":0.0009850786,"threshold_uncertainty_score":0.84471464},"labels":[],"label_agreement":null},{"id":"W4416968887","doi":"10.1182/bloodadvances.2025018079","title":"Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pharmacyclics; Genentech; National Institutes of Health; Incyte; Gilead Sciences; Regeneron Pharmaceuticals; Leukemia and Lymphoma Society; Ipsen; BeiGene; Daiichi Sankyo Europe; Sanofi; Pfizer; National Institute of Allergy and Infectious Diseases; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Follicular lymphoma; Lymphoma; Context (archaeology); Clinical trial; Disease; Chemotherapy; Follicular phase","score_opus":0.01563828593378401,"score_gpt":0.3053785913689192,"score_spread":0.2897403054351352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416968887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8306094,0.030811854,0.00008439617,0.10374064,0.006030916,0.00060418446,0.000221475,0.000101749494,0.02779543],"genre_scores_gemma":[0.9781297,0.00094193075,0.0027627153,0.0017848866,0.00023692499,0.00013523758,0.00026824552,0.000008715646,0.015731633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991912,0.000027482052,0.00018704406,0.00028203253,0.00017926388,0.0001329384],"domain_scores_gemma":[0.99906373,0.00044189047,0.000054271906,0.0003059267,0.000089881985,0.00004427987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091095084,0.000105354186,0.00013730272,0.00006050916,0.00023967243,0.00010933382,0.0001363647,0.000029148867,0.00028428048],"category_scores_gemma":[0.00016290483,0.000066568755,0.000095810916,0.00026794322,0.00012140475,0.000055085515,0.000060813225,0.000038334718,0.000064146276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108129854,0.0021080521,0.2618988,0.00002062309,0.0015169916,0.00013413957,0.00028341232,0.000018645085,0.0004949369,0.006251741,0.1696183,0.55754626],"study_design_scores_gemma":[0.002947068,0.000023002282,0.086144015,0.00029840172,0.00040526045,0.000015727728,0.00045089037,0.00006586391,0.0044037416,0.0018761074,0.9032895,0.00008043285],"about_ca_topic_score_codex":0.000050107457,"about_ca_topic_score_gemma":0.00014304896,"teacher_disagreement_score":0.7336712,"about_ca_system_score_codex":0.000060470586,"about_ca_system_score_gemma":0.00013520097,"threshold_uncertainty_score":0.31126717},"labels":[],"label_agreement":null},{"id":"W4416969158","doi":"10.1182/bloodadvances.2024015408","title":"Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Children's Health Foundation; Science Foundation Ireland","keywords":"PRC2; Wnt signaling pathway; Myeloid leukemia; Leukemia; Asparaginase; Epigenetics; Asparagine; Signal transduction; Function (biology)","score_opus":0.016026371726327447,"score_gpt":0.3097219673547701,"score_spread":0.29369559562844266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416969158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813316,0.008625961,0.00069779553,0.0014738792,0.0001987155,0.00050757825,0.0000138996975,0.000117105286,0.007033487],"genre_scores_gemma":[0.9931916,0.0005800026,0.001326515,0.00037239617,0.00007822882,0.00009514626,0.000020357564,0.000022741491,0.0043130037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982993,0.00011278688,0.0002571568,0.00049562746,0.00038863719,0.00044647648],"domain_scores_gemma":[0.99899995,0.00032822724,0.00008816368,0.00034342232,0.00010179835,0.00013843896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026090615,0.00020132365,0.00034512414,0.00019974164,0.00008472719,0.000032049764,0.00012492892,0.0001055032,0.000021562952],"category_scores_gemma":[0.00069954887,0.00018007554,0.000054484655,0.00058419176,0.000118108044,0.000309465,0.00006352556,0.0002942329,0.000012231671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006981471,0.002337479,0.027091002,0.0010842199,0.00038269028,0.0007314595,0.00033757888,0.000029377466,0.9219741,0.0020256522,0.0057585444,0.031266388],"study_design_scores_gemma":[0.011375734,0.0004734745,0.06309529,0.0016698539,0.0002514455,0.000049389113,0.00026281303,0.00017430552,0.7865159,0.0028990319,0.13275756,0.00047523985],"about_ca_topic_score_codex":0.00014401488,"about_ca_topic_score_gemma":0.0005626098,"teacher_disagreement_score":0.13545828,"about_ca_system_score_codex":0.00036985512,"about_ca_system_score_gemma":0.0007441137,"threshold_uncertainty_score":0.7343267},"labels":[],"label_agreement":null},{"id":"W4417028294","doi":"10.1182/bloodadvances.2025017662","title":"Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Manitoba; CancerCare Manitoba; BC Children's Hospital","funders":"National Cancer Institute; Daiichi Sankyo Europe; Grifols; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Les Laboratories Pierre Fabre; National Center for Advancing Translational Sciences; Health Resources and Services Administration; Medac; Pfizer; Incyte; bluebird bio; Eli Lilly and Company; CSL Behring; Atara Biotherapeutics; Horizon Therapeutics; Memorial Sloan-Kettering Cancer Center; NHLBI Division of Intramural Research; Swedish Orphan Biovitrum; Children's Hospital of Philadelphia; National Heart, Lung, and Blood Institute; Amgen; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Hematopoietic cell; Hematopoietic stem cell transplantation; Transplantation; Hematology; Haematopoiesis; Myeloid; Clinical trial","score_opus":0.0042228811458124415,"score_gpt":0.2545017142277527,"score_spread":0.25027883308194027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417028294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8256401,0.009625401,0.1508971,0.00040553478,0.0011315052,0.0007210768,0.00007115632,0.000042878473,0.0114652775],"genre_scores_gemma":[0.98862517,0.0010273212,0.0026664892,0.0001442724,0.00005819576,0.00012111783,0.0002958102,0.000013248911,0.007048394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992994,0.000011856643,0.00020065659,0.00028313597,0.000059673817,0.0001452505],"domain_scores_gemma":[0.9995955,0.000016439135,0.00007559925,0.00021575895,0.00006655655,0.000030138122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080451435,0.00010384855,0.000109934364,0.000041374566,0.000092043956,0.000018897696,0.00009605761,0.00006732354,0.000013341949],"category_scores_gemma":[0.000029537809,0.000102607475,0.00009796791,0.00008373988,0.000015088625,0.0000070628603,0.000016918788,0.00004406837,0.0000031311197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007262345,0.00034560345,0.00055135804,0.00035219494,0.000091568305,0.00006771629,0.000033733555,0.00006493042,0.9940748,0.0016511732,0.0012326943,0.0014616036],"study_design_scores_gemma":[0.0006150981,0.00020712143,0.00020517626,0.000040160732,0.00012526206,0.00038956106,0.00007237769,0.000031849137,0.7934059,0.0010858283,0.2036744,0.00014726544],"about_ca_topic_score_codex":0.000003819151,"about_ca_topic_score_gemma":0.000019762541,"teacher_disagreement_score":0.20244172,"about_ca_system_score_codex":0.0000042500224,"about_ca_system_score_gemma":0.000047650345,"threshold_uncertainty_score":0.41842112},"labels":[],"label_agreement":null},{"id":"W4417201075","doi":"10.1182/bloodadvances.2025016338","title":"Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"AstraZeneca; Genentech; National Cancer Institute; National Institutes of Health; Swedish Orphan Biovitrum; Children's Discovery Institute","keywords":"Pure red cell aplasia; Cytopenia; Bone marrow failure; Myeloid; Disease; Hematopoietic stem cell transplantation; Bone marrow; Transplantation; Immune system; Aplastic anemia","score_opus":0.003467437545169783,"score_gpt":0.23431203331671244,"score_spread":0.23084459577154265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417201075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506384,0.001973447,0.0014507775,0.000005542045,0.00006128097,0.00015552684,0.00003248853,0.0000028955365,0.0012541758],"genre_scores_gemma":[0.99637556,0.0023445599,0.0009385284,0.000028474758,0.0000075624107,0.000007663917,0.00014347391,0.0000045467004,0.000149644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953413,0.000016878004,0.00017805169,0.00015778009,0.000050798564,0.0000623844],"domain_scores_gemma":[0.99973357,0.000008527901,0.00010180377,0.00010122777,0.000039119783,0.000015751122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030336892,0.00007116288,0.00011886739,0.000023562992,0.000020791786,0.0000029000198,0.000036862486,0.00003772843,0.0000019275706],"category_scores_gemma":[0.0000031593233,0.000057810234,0.000026893991,0.000042755364,0.000056434215,0.000004353761,0.000013689799,0.000019220375,2.4175188e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033088928,0.00069448823,0.98256606,0.0004163606,0.00016050607,9.877043e-7,0.0000120116565,0.0000020692414,0.0004758934,0.00014732344,0.000016155083,0.015177272],"study_design_scores_gemma":[0.004780511,0.0009346481,0.94683295,0.00009381206,0.00061990006,4.730257e-7,0.000062136525,0.0000013033352,0.044445336,0.00031812748,0.001797221,0.00011355117],"about_ca_topic_score_codex":0.0000016557024,"about_ca_topic_score_gemma":0.0000045623856,"teacher_disagreement_score":0.04396944,"about_ca_system_score_codex":5.63127e-7,"about_ca_system_score_gemma":0.000007908999,"threshold_uncertainty_score":0.23574328},"labels":[],"label_agreement":null},{"id":"W4417253881","doi":"10.1182/bloodadvances.2025017243","title":"Systematic functional validation of IKAROS variants from patients and laboratory-generated mutations","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; Children's Hospital of Western Ontario; London Health Sciences Centre; University of Manitoba; Western University","funders":"Instituto de Salud Carlos III; Agencia Estatal de Investigación; NIH Clinical Center; U.S. Department of Health and Human Services; National Institutes of Health; Ministerio de Ciencia e Innovación","keywords":"Germline; Mutagenesis; Transcription factor; Mutation; Immune system; Function (biology); Innate immune system","score_opus":0.008081627727240664,"score_gpt":0.26213753530310147,"score_spread":0.25405590757586083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417253881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960267,0.0011551676,0.0014802185,0.00011519147,0.00016566309,0.00050203485,0.00014801015,0.000027474409,0.00037954957],"genre_scores_gemma":[0.9977399,0.000053376403,0.0015050772,0.000083775725,0.000036416688,0.000057265846,0.00023402029,0.000007655161,0.00028252407],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999058,0.000070809205,0.00030350417,0.00018215693,0.00028224709,0.00010327271],"domain_scores_gemma":[0.9989729,0.0003044436,0.00010781698,0.00013868429,0.0004244153,0.000051725005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097679265,0.00008639438,0.00024879567,0.000120585726,0.00006153147,0.000014813355,0.000042593452,0.00004988997,0.000039365645],"category_scores_gemma":[0.0006943919,0.0000701748,0.000021073423,0.00037534788,0.000065156506,0.00014540472,0.000027063466,0.000057898807,0.000008040956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012216433,0.004053066,0.54038346,0.040224303,0.0041898456,0.000068368485,0.0014614094,0.0008975152,0.3986826,0.0037814616,0.003167802,0.0018685261],"study_design_scores_gemma":[0.024624208,0.00056695275,0.31926805,0.009429749,0.0027669254,0.000009377937,0.0007354927,0.0042821583,0.63509005,0.0025285252,0.0002848674,0.0004136385],"about_ca_topic_score_codex":0.000018963576,"about_ca_topic_score_gemma":0.0000030851204,"teacher_disagreement_score":0.23640747,"about_ca_system_score_codex":0.000054920463,"about_ca_system_score_gemma":0.0003007527,"threshold_uncertainty_score":0.28616452},"labels":[],"label_agreement":null},{"id":"W4417256274","doi":"10.1182/bloodadvances.2025018527","title":"Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"Pharmacyclics; Genentech; Incyte; Ipsen; BeiGene; Regeneron Pharmaceuticals; Seagen; Gilead Sciences; Loxo Oncology; TG Therapeutics; Pfizer; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Rituximab; Mantle cell lymphoma; Retrospective cohort study; Lymphoma; Maintenance therapy; Clinical trial; Overall survival","score_opus":0.0024159603800341634,"score_gpt":0.2047243923878011,"score_spread":0.20230843200776694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417256274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894468,0.0059323134,0.000022202146,0.00037470597,0.000100798585,0.0005487345,0.00008788818,0.000028725479,0.0034577881],"genre_scores_gemma":[0.99573445,0.00057644997,0.0024234368,0.00026174771,0.000026095806,0.00015954675,0.000044219676,0.000018594981,0.00075543625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864876,0.000010110316,0.00037719018,0.00038607803,0.00025627523,0.00032160585],"domain_scores_gemma":[0.99923867,0.00007195742,0.00012712863,0.00034630802,0.00014525506,0.00007068551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045837816,0.00024173585,0.0005412969,0.00016126543,0.000040016363,0.000010003243,0.0000994965,0.00006313594,0.0000530573],"category_scores_gemma":[0.000024716157,0.00017120858,0.00008347295,0.0003419929,0.00008238197,0.00013401946,0.000056501707,0.000050167455,0.000016184615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012327688,0.018265758,0.9621172,0.00042369362,0.00007670835,0.000116180665,0.000058847112,0.000022738754,0.000005485266,0.00019460743,0.00006924057,0.017416758],"study_design_scores_gemma":[0.068560116,0.00089152186,0.91612285,0.0011459138,0.0003004931,0.0000047298613,0.000042450636,0.000018522624,0.006277842,0.00021184002,0.0062478962,0.00017579908],"about_ca_topic_score_codex":0.00009077272,"about_ca_topic_score_gemma":0.00042688695,"teacher_disagreement_score":0.06732735,"about_ca_system_score_codex":0.00008766668,"about_ca_system_score_gemma":0.00007647561,"threshold_uncertainty_score":0.69816834},"labels":[],"label_agreement":null},{"id":"W4417280346","doi":"10.1182/bloodadvances.2025017393","title":"Impact of age on graft-versus-host disease and overall survival in pediatric hematopoietic cell transplant recipients","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; National Institutes of Health; MorphoSys; Seagen; Health Resources and Services Administration; Syndax Pharmaceuticals; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; U.S. Department of Health and Human Services; Astellas Pharma US; Gateway for Cancer Research; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Incidence (geometry); Disease; Hematopoietic stem cell transplantation; Transplantation; Overall survival; Young adult; Hematopoietic cell; Graft-versus-host disease","score_opus":0.012839291770696896,"score_gpt":0.2893509076232866,"score_spread":0.2765116158525897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417280346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932324,0.0023102106,0.000046006895,0.00006193025,0.00023777713,0.000432793,0.00006574013,0.000027430226,0.0035856883],"genre_scores_gemma":[0.99553514,0.0040012007,0.00015342285,0.000023419856,0.000036063313,0.000019330197,0.000040662973,0.000015138445,0.00017560735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987279,0.00005608735,0.00036899486,0.0003216292,0.00027942812,0.0002459159],"domain_scores_gemma":[0.9991987,0.00031302441,0.000082978564,0.00021936775,0.0000304019,0.00015552639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012652446,0.0002004826,0.00039533703,0.00026096616,0.000028524613,0.000009104606,0.000077179844,0.000061229875,0.000024921093],"category_scores_gemma":[0.000034701046,0.00016634406,0.000114028786,0.0003004214,0.00005099208,0.00009105856,0.00000992056,0.0001350178,0.000004533054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026831634,0.00098424,0.9907397,0.0018288163,0.000064155625,0.00031456235,0.00054549845,0.000059673057,0.0023100437,0.0003020813,0.000013247389,0.00015479562],"study_design_scores_gemma":[0.008926544,0.0005436355,0.9855046,0.0006792353,0.0006053278,0.000005567736,0.00004437079,0.000016852198,0.00330483,0.00019056864,0.000020353573,0.00015807533],"about_ca_topic_score_codex":0.000033723372,"about_ca_topic_score_gemma":0.000031073905,"teacher_disagreement_score":0.0062433807,"about_ca_system_score_codex":0.00003159328,"about_ca_system_score_gemma":0.0000985415,"threshold_uncertainty_score":0.67833143},"labels":[],"label_agreement":null},{"id":"W4417474681","doi":"10.1182/bloodadvances.2025018655","title":"Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McMaster University","funders":"","keywords":"Multiple myeloma; Overall survival; MEDLINE; Survival analysis; Retrospective cohort study; Immunopathology","score_opus":0.01934420190524761,"score_gpt":0.3338939976282746,"score_spread":0.314549795723027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417474681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412537,0.0014839807,0.000006613101,0.0003176353,0.000033059627,0.0014099756,0.000030320445,0.000032742653,0.0025602982],"genre_scores_gemma":[0.993708,0.00028066384,0.005174676,0.000037051996,0.00002057432,0.00013919704,0.000052442912,0.00001604763,0.0005713026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986137,0.00006880135,0.00028643582,0.00031979688,0.00041326508,0.00029797442],"domain_scores_gemma":[0.9988856,0.00040757156,0.0000841517,0.00033736124,0.00012307768,0.00016224073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009657022,0.0001787031,0.00048077424,0.00026166358,0.000057248435,0.000018665432,0.0001330647,0.000037434926,0.000042825526],"category_scores_gemma":[0.00025513227,0.000119774806,0.000031831147,0.0005123204,0.00009094091,0.00014086734,0.000084167186,0.00011020856,0.000007981294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027116567,0.0017243882,0.8115157,0.000072762894,0.0001000221,0.00002531167,0.00012288906,0.0000083570885,0.0004941266,0.000017942504,0.00009401324,0.18311282],"study_design_scores_gemma":[0.02116198,0.0016819686,0.9671761,0.0005488285,0.000030222398,3.073822e-7,0.00009458334,0.00013206895,0.0072702244,0.000035783614,0.0017604902,0.000107436244],"about_ca_topic_score_codex":0.00028385207,"about_ca_topic_score_gemma":0.0014091852,"teacher_disagreement_score":0.18300538,"about_ca_system_score_codex":0.000027595377,"about_ca_system_score_gemma":0.00008203167,"threshold_uncertainty_score":0.4884275},"labels":[],"label_agreement":null},{"id":"W7117161304","doi":"10.1182/bloodadvances.2025018775","title":"Rapid detection of fibrinolytic activation in postpartum hemorrhage and acute obstetric coagulopathy using a novel assay","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Scotland; Friends of ANCHOR; British Heart Foundation; National Institute of Academic Anaesthesia","keywords":"Fibrinolysis; Coagulopathy; Placental abruption; Amniotic fluid embolism; Plasmin; Hemostasis; Coagulation; Pregnancy","score_opus":0.018000468489888153,"score_gpt":0.2827128416910155,"score_spread":0.26471237320112734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117161304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873636,0.003696907,0.007397123,0.00014931787,0.00024335278,0.0005417078,0.000010671919,0.00005098872,0.0005463291],"genre_scores_gemma":[0.9933303,0.00030991752,0.006145094,0.00007561639,0.00003604707,0.000018213475,0.0000117214795,0.000016318207,0.000056774777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987538,0.00004859247,0.00040414,0.00033604656,0.00023666015,0.00022080264],"domain_scores_gemma":[0.9991323,0.00027735307,0.0001981209,0.00020742699,0.00013266958,0.000052137704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020420582,0.00017143512,0.00035276441,0.00060527766,0.00006193533,0.000017728133,0.000056023586,0.000094333096,0.0000033954916],"category_scores_gemma":[0.00053383975,0.00017139225,0.000051508392,0.0011058858,0.00006934473,0.00038491076,0.000038104838,0.00016243714,8.137187e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003280727,0.0003464932,0.017556071,0.0006363738,0.000061140265,0.000017697388,0.00021520401,0.00005382883,0.84000874,0.000056148427,6.2693954e-7,0.14071964],"study_design_scores_gemma":[0.0050378246,0.00035815782,0.19906487,0.0006724189,0.00036671007,0.00008707987,0.00056671025,0.0035171746,0.7898433,0.00016638152,0.00012685727,0.00019247513],"about_ca_topic_score_codex":0.00003770324,"about_ca_topic_score_gemma":0.000026622572,"teacher_disagreement_score":0.18150881,"about_ca_system_score_codex":0.00009941355,"about_ca_system_score_gemma":0.00010871693,"threshold_uncertainty_score":0.6989173},"labels":[],"label_agreement":null},{"id":"W7160232576","doi":"10.1182/bloodadvances.2025018362","title":"Dual action of pimozide through lysosome disruption and inhibition of STATs induces apoptosis in chronic lymphocytic leukemia (CLL)","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Venetoclax; Pimozide; Chronic lymphocytic leukemia; Apoptosis; Lysosome; Downregulation and upregulation; PI3K/AKT/mTOR pathway; Protein kinase B","score_opus":0.02625815589277021,"score_gpt":0.34421720785582954,"score_spread":0.31795905196305935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7160232576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914997,0.006715819,0.00011060123,0.000072380426,0.00010578083,0.00048830936,0.000014528823,0.000032748565,0.00096011406],"genre_scores_gemma":[0.9928954,0.0062572258,0.0004694001,0.00003509791,0.00007665505,0.000049388433,0.000030548297,0.000015716174,0.0001705329],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982707,0.00007226931,0.00057275116,0.00036457714,0.00041306007,0.00030664884],"domain_scores_gemma":[0.99911577,0.00022662427,0.00021084902,0.00027013553,0.0001206217,0.00005597997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023421198,0.00018017764,0.00048866577,0.0003255586,0.00004548176,0.000011028941,0.00006360913,0.00013954414,0.000020962663],"category_scores_gemma":[0.00020178931,0.00016424607,0.00006689913,0.00071676733,0.00030030892,0.0005073959,0.000089284884,0.00016850496,0.0000023986665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010392079,0.0002631633,0.003101348,0.0060436204,0.00023138695,0.000038467824,0.00107806,0.0018627355,0.9514333,0.0019064412,0.00005344882,0.032948792],"study_design_scores_gemma":[0.019583149,0.0005960919,0.0054721064,0.0018731857,0.00020025743,0.000042202148,0.000948303,0.001881695,0.9670588,0.0018825387,0.00030405677,0.00015764115],"about_ca_topic_score_codex":0.0016712652,"about_ca_topic_score_gemma":0.00035772705,"teacher_disagreement_score":0.032791153,"about_ca_system_score_codex":0.015958406,"about_ca_system_score_gemma":0.008982531,"threshold_uncertainty_score":0.9966356},"labels":[],"label_agreement":null}]}